data_2m4l_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m4l _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 105.205 -2.146 . . . . 42.01 105.205 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -93.27 160.43 14.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.598 1.159 . . . . 75.22 109.838 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.8 p -91.17 167.7 12.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.559 0.618 . . . . 73.42 110.276 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.79 116.87 4.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.884 0.849 . . . . 63.4 109.663 160.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.1 tp -54.18 125.63 19.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.651 -1.24 . . . . 74.14 107.651 157.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -145.42 172.52 13.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.169 0.985 . . . . 74.53 110.07 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -1.06 0.69 Allowed 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 126.954 2.102 . . . . 64.42 115.331 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -122.95 -36.99 2.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 120.17 1.35 . . . . 71.52 112.66 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -73.94 -30.71 62.7 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.358 0.981 . . . . 60.33 112.884 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.0 tp -66.58 -22.9 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.62 1.1 . . . . 73.13 112.903 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.37 126.23 24.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.134 1.374 . . . . 72.32 110.905 -164.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 131.28 -172.74 20.65 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.783 2.135 . . . . 74.4 110.59 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -91.09 162.85 14.51 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.435 1.094 . . . . 75.41 111.567 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -148.84 122.44 9.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.506 0.722 . . . . 71.53 111.045 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 t -127.35 160.73 30.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.954 1.301 . . . . 75.3 112.474 -174.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.58 -66.17 0.94 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.566 1.946 . . . . 75.24 107.1 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.12 -179.44 48.0 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 129.37 3.366 . . . . 71.11 106.578 -170.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.1 pt -111.61 16.26 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 113.746 1.017 . . . . 74.51 113.746 -158.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -115.79 -178.82 3.48 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.682 1.193 . . . . 71.44 113.098 -166.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.33 -93.5 0.01 OUTLIER Glycine 0 C--N 1.34 0.79 0 C-N-CA 127.547 2.499 . . . . 73.23 114.976 157.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.3 m -140.76 92.86 2.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.865 -1.902 . . . . 72.41 105.865 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -100.17 168.44 9.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.214 1.007 . . . . 64.31 110.473 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -134.95 145.29 48.03 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.192 1.797 . . . . 62.12 106.817 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.57 146.07 50.66 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.869 0.868 . . . . 73.44 108.852 -177.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.0 mt -134.71 158.77 43.26 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 125.041 1.336 . . . . 72.44 109.87 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t -144.12 155.53 43.98 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.843 2.057 . . . . 63.11 108.552 164.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -144.69 126.89 15.69 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 127.161 2.185 . . . . 64.12 107.611 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -101.59 159.45 15.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.959 1.704 . . . . 74.54 108.491 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.01 -38.02 28.2 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.823 -0.171 . . . . 74.52 110.634 -175.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -129.15 21.86 5.71 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.503 0.668 . . . . 71.11 110.815 -170.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.68 -112.85 1.6 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.745 1.64 . . . . 44.42 109.413 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 p -141.39 175.85 9.34 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.157 1.783 . . . . 73.2 109.555 -164.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -98.75 170.02 23.73 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.611 -0.995 . . . . 54.14 110.611 161.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.7 m -144.84 144.13 30.97 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.78 -0.835 . . . . 74.12 109.18 167.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -130.9 126.13 35.32 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.09 1.356 . . . . 73.31 107.69 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.69 159.07 17.36 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.047 0.832 . . . . 72.23 111.315 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 mt -136.99 136.01 47.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.347 -2.094 . . . . 75.33 105.347 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.42 167.24 14.1 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.015 1.326 . . . . 72.55 108.988 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.32 127.57 33.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.12 -1.437 . . . . 75.35 107.12 160.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 44.95 -73.07 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 131.446 3.898 . . . . 74.53 113.923 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.16 43.71 1.43 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.292 1.437 . . . . 54.11 112.55 175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.7 m -144.51 135.61 12.47 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.809 1.243 . . . . 74.11 109.579 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.51 129.3 12.66 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.291 3.327 . . . . 75.25 111.17 168.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.3 mm -122.31 -22.48 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.903 0.881 . . . . 74.45 112.093 -173.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 t -130.54 170.2 14.56 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 120.545 -1.347 . . . . 74.25 109.048 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -159.6 144.33 15.23 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 127.765 2.426 . . . . 62.22 105.31 165.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -152.08 162.55 40.93 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.731 1.612 . . . . 72.31 106.707 162.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.9 mtm -130.0 162.84 27.78 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.84 -1.17 . . . . 73.13 107.84 167.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -157.15 145.79 19.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 123.877 0.736 . . . . 72.44 109.276 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.64 159.65 31.65 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.168 -1.419 . . . . 75.21 107.168 161.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -148.73 166.87 27.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 121.645 -0.659 . . . . 75.43 110.239 166.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -134.46 167.1 21.39 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.507 1.123 . . . . 74.34 108.571 167.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.8 mm -121.92 86.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.373 -1.714 . . . . 75.44 106.373 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.7 23.49 8.75 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.364 0.666 . . . . 71.13 110.105 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.73 14.04 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 114.68 1.363 . . . . 63.5 114.68 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.39 27.58 65.89 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 120.889 -1.132 . . . . 75.14 111.31 -168.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -139.39 161.31 37.77 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 127.209 2.204 . . . . 75.2 105.935 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mt -71.05 133.27 32.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 105.761 -1.94 . . . . 75.51 105.761 164.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -101.58 120.3 40.11 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.432 -1.692 . . . . 73.3 106.432 163.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.4 mm -105.31 137.49 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.308 -1.738 . . . . 75.2 106.308 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -160.6 1.31 0.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.424 0.898 . . . . 75.12 113.424 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -148.36 117.62 6.88 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 104.937 -2.246 . . . . 72.31 104.937 171.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.0 t -128.54 155.49 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 105.816 -1.92 . . . . 74.43 105.816 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.64 162.29 39.6 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.574 -0.898 . . . . 74.53 108.574 174.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.74 -21.75 15.37 Favored 'Cis proline' 0 CA--C 1.535 0.567 0 N-CA-C 113.872 0.681 . . . . 71.14 113.872 -8.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 93.57 6.96 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 104.942 -2.244 . . . . 64.22 104.942 174.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.16 140.76 58.91 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.091 0.956 . . . . 53.1 109.589 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -127.44 168.05 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.833 1.253 . . . . 75.14 110.094 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 t -55.64 148.04 37.45 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 123.844 0.715 . . . . 75.41 109.938 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.29 139.81 42.83 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.175 1.916 . . . . 75.53 111.261 169.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -152.36 174.11 14.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.919 1.287 . . . . 71.1 109.874 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -112.74 158.98 19.41 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.546 0.738 . . . . 75.33 109.439 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.8 mt -130.32 112.24 13.12 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.165 1.386 . . . . 75.53 109.679 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -62.55 122.06 14.86 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.876 1.27 . . . . 72.1 108.06 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.3 p -154.72 163.67 39.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.599 0.36 . . . . 71.32 110.738 174.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -126.74 158.42 36.54 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.055 0.942 . . . . 75.51 109.298 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.1 tt -151.54 154.15 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.144 -1.058 . . . . 72.51 108.144 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -141.44 -9.35 0.96 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.84 1.793 . . . . 75.23 115.84 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.82 -73.53 0.21 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.378 -1.889 . . . . 75.31 108.378 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 p -117.52 1.64 12.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.851 1.056 . . . . 72.34 113.851 -169.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.6 m -119.74 106.79 12.47 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.846 2.058 . . . . 54.3 110.469 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -75.07 128.32 35.27 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.639 -1.288 . . . . 75.12 108.333 164.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -117.25 95.09 4.82 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 119.039 -0.505 . . . . 74.52 110.681 164.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.1 t -86.11 132.5 31.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.038 0.835 . . . . 72.34 109.407 169.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -91.41 -31.71 15.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.923 0.889 . . . . 73.32 112.212 -176.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 t -139.67 163.74 31.78 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.71 1.604 . . . . 71.42 110.556 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.58 -179.86 30.62 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 122.628 1.127 . . . . 73.2 112.662 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.1 m -58.08 -31.05 66.72 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.687 1.595 . . . . 54.23 112.52 173.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -103.69 11.99 35.3 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.169 0.588 . . . . 71.33 109.887 -167.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.01 117.14 5.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.4 2.28 . . . . 71.43 110.591 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.12 -123.39 1.1 Allowed Glycine 0 C--O 1.237 0.324 0 C-N-CA 124.381 0.991 . . . . 74.43 111.6 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.4 t -145.0 142.41 29.77 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.152 1.781 . . . . 75.5 107.747 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -142.91 152.18 41.79 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.164 0.438 . . . . 75.43 111.762 167.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -91.4 147.89 22.71 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.476 -0.565 . . . . 72.33 109.476 167.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -58.55 147.53 31.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.995 0.918 . . . . 75.54 108.653 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 . . . . . 0 N--CA 1.467 0.383 0 C-N-CA 125.776 1.63 . . . . 72.33 109.0 179.591 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 105.64 -1.985 . . . . 65.0 105.64 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -101.14 163.25 12.37 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 124.604 1.162 . . . . 65.31 111.02 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.3 p -101.06 162.13 13.11 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.595 -0.521 . . . . 65.23 109.595 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.1 117.51 4.44 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.035 1.334 . . . . 74.13 110.551 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.0 tp -66.4 105.64 1.51 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.629 -1.249 . . . . 73.21 107.629 165.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -126.56 172.8 9.94 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.951 -1.022 . . . . 70.31 111.123 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.89 -5.68 22.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.901 2.48 . . . . 73.31 112.764 -169.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -109.81 -28.64 8.68 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.223 0.92 . . . . 73.0 110.352 171.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -66.43 -35.41 80.23 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.887 0.875 . . . . 74.04 112.71 -169.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.77 -15.24 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 113.133 0.79 . . . . 72.43 113.133 -173.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.8 mm -68.79 122.19 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.121 0.968 . . . . 74.04 111.218 -161.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.78 -168.91 24.35 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.624 1.583 . . . . 64.32 111.319 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -88.66 159.95 17.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.463 1.105 . . . . 74.44 110.284 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -142.36 125.94 16.84 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.435 1.494 . . . . 74.43 109.756 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.7 t -123.58 164.02 19.84 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.191 0.997 . . . . 74.1 112.394 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.418 ' HB ' ' CE2' ' A' ' 95' ' ' TYR . 3.2 t -129.43 -5.96 4.76 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.856 1.663 . . . . 63.1 112.967 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.23 176.01 14.7 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 108.099 -2.0 . . . . 73.42 108.099 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 pt -135.65 7.44 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.46 0.911 . . . . 71.13 113.46 -160.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.26 165.04 15.37 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.877 1.671 . . . . 74.13 110.109 -174.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.81 -84.47 0.02 OUTLIER Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.063 1.316 . . . . 74.25 113.167 169.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -148.25 95.42 2.46 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.212 1.405 . . . . 74.53 108.081 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -114.34 177.52 4.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.152 -0.967 . . . . 72.41 110.109 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -132.66 172.63 12.29 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.251 1.421 . . . . 73.54 107.369 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.04 136.3 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.802 -1.555 . . . . 74.23 106.802 173.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.1 mt -115.85 152.74 32.78 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.327 -0.99 . . . . 73.32 108.327 165.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 p -144.62 143.41 30.76 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.633 1.173 . . . . 61.2 108.554 173.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -138.89 124.66 19.71 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.012 0.925 . . . . 74.4 108.759 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.32 156.71 20.79 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.164 -1.421 . . . . 71.23 107.164 164.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -72.19 -47.83 47.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.868 0.842 . . . . 72.23 109.197 165.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.88 -1.45 24.17 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.87 2.068 . . . . 72.23 111.439 -161.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.78 -122.35 3.62 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.297 -1.921 . . . . 70.11 108.297 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 p -133.0 -175.45 3.79 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.503 2.321 . . . . 74.14 107.741 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -107.12 164.27 13.17 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.123 -1.191 . . . . 70.04 110.123 164.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.97 147.59 35.43 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.659 1.184 . . . . 72.04 108.73 -175.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -134.88 140.64 45.95 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.373 -1.343 . . . . 65.51 107.373 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.15 160.42 25.83 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 111.264 -0.734 . . . . 74.2 111.264 164.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 52.0 mt -122.79 145.4 29.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 105.3 -2.111 . . . . 71.43 105.3 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -133.89 166.34 22.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.992 1.317 . . . . 71.31 109.014 -173.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.99 139.42 39.67 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.304 -0.998 . . . . 74.41 108.304 157.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 44.48 -75.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 130.358 3.463 . . . . 73.54 115.975 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.31 47.77 1.29 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.6 0.636 . . . . 72.42 112.069 167.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 m -144.06 132.67 11.11 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.459 1.504 . . . . 74.35 109.324 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.31 132.24 16.15 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.604 2.869 . . . . 74.32 110.333 165.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.48 -23.58 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.774 0.829 . . . . 65.32 111.835 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.4 t -141.44 162.76 34.69 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.065 -1.647 . . . . 72.25 109.864 169.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -160.74 137.56 8.88 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.348 2.259 . . . . 71.43 107.428 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -161.28 165.49 29.1 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.537 1.535 . . . . 73.14 107.661 168.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.3 mtm -134.31 163.33 29.87 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.897 -1.149 . . . . 73.3 107.897 170.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -163.09 146.88 10.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.8 0.84 . . . . 71.42 110.231 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.31 161.01 31.44 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.205 -1.035 . . . . 73.11 108.205 162.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -144.02 171.38 14.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.784 -0.573 . . . . 72.4 109.594 165.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -137.01 161.8 35.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.863 0.865 . . . . 74.34 109.718 167.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.0 mm -105.18 103.68 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.922 -1.51 . . . . 73.43 106.922 165.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -134.67 24.48 3.69 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.329 -0.857 . . . . 73.31 113.193 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -163.72 14.1 0.06 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.604 1.962 . . . . 74.4 116.053 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.33 18.21 57.79 Favored Glycine 0 CA--C 1.539 1.558 0 O-C-N 120.119 -1.613 . . . . 72.31 113.069 -168.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -134.12 -171.48 2.76 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.4 3.08 . . . . 70.0 107.208 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.17 113.49 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 121.242 1.837 . . . . 74.04 107.515 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -82.74 102.55 11.62 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.766 -1.198 . . . . 73.43 107.766 171.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 mm -81.32 137.57 21.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 105.898 -1.89 . . . . 74.44 105.898 168.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -151.15 -8.94 0.23 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.03 1.493 . . . . 71.3 115.03 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -144.77 112.71 6.36 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.361 -1.348 . . . . 73.33 107.361 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.2 t -122.47 154.28 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.776 1.63 . . . . 71.02 107.749 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.49 162.21 52.66 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.44 1.096 . . . . 73.42 108.393 172.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -83.75 -14.17 35.86 Favored 'Cis proline' 0 CA--C 1.536 0.624 0 N-CA-C 113.78 0.646 . . . . 70.23 113.78 -9.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.76 115.89 31.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 103.72 -2.696 . . . . 74.22 103.72 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -93.5 143.82 25.93 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.0 0.812 . . . . 70.42 109.571 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -132.81 172.4 12.62 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.276 1.43 . . . . 73.11 109.878 -171.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 t -54.41 146.36 33.3 Favored Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 123.61 0.569 . . . . 62.1 109.564 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.97 144.7 77.38 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.937 1.758 . . . . 53.2 109.799 165.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -154.92 164.44 38.87 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.998 0.919 . . . . 73.04 110.501 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.3 127.54 49.24 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.707 0.803 . . . . 74.34 109.333 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.28 112.68 24.34 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.452 1.501 . . . . 74.33 108.77 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.29 123.25 17.72 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.778 -1.193 . . . . 70.41 107.778 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.13 156.84 33.4 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.225 0.61 . . . . 74.02 110.458 175.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -129.57 156.25 44.5 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.802 1.241 . . . . 74.43 111.056 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.3 tt -151.25 146.54 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 122.491 0.316 . . . . 74.43 110.844 -171.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -149.31 43.51 0.94 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.303 1.841 . . . . 73.23 111.435 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.63 -89.74 1.63 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 110.385 -1.086 . . . . 72.01 110.385 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -20.26 24.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.099 -1.429 . . . . 72.21 114.823 -171.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -102.74 108.14 19.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 122.017 2.19 . . . . 71.43 111.278 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.0 tp -87.6 123.81 32.86 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.335 -1.478 . . . . 65.3 108.53 168.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -118.67 91.04 3.46 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.02 0.928 . . . . 74.22 109.931 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.2 t -86.1 130.94 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.934 -1.136 . . . . 73.0 107.934 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -85.39 -32.65 22.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.957 -0.544 . . . . 74.02 111.946 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.5 t -143.32 167.89 21.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.68 1.192 . . . . 74.32 110.774 -169.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.71 178.86 43.62 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-O 122.432 1.018 . . . . 65.22 112.624 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 m -51.87 -27.93 14.34 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.719 1.608 . . . . 74.44 112.65 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -101.16 10.89 40.37 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.209 0.818 . . . . 72.02 113.209 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.02 105.21 0.3 Allowed 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.375 -0.828 . . . . 74.14 110.084 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.84 -136.71 2.48 Favored Glycine 0 CA--C 1.519 0.302 0 O-C-N 121.169 -0.957 . . . . 70.23 112.57 -172.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.2 t -153.29 116.77 4.67 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.33 1.052 . . . . 73.22 109.367 -171.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.418 ' CE2' ' HB ' ' A' ' 18' ' ' THR . 88.4 m-85 -139.78 152.44 46.59 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 121.466 -0.771 . . . . 71.32 110.561 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -116.74 146.28 42.91 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 118.647 -0.692 . . . . 74.44 110.393 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -54.7 148.15 13.28 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.932 -1.136 . . . . 72.32 107.932 173.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 106.407 -1.701 . . . . 72.22 106.407 166.573 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 . . . . . 0 CA--C 1.517 -0.31 0 N-CA-C 108.25 -1.019 . . . . 72.54 108.25 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -118.03 147.84 42.83 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.462 0.305 . . . . 74.23 111.775 -170.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.8 p -83.39 171.05 13.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.465 0.706 . . . . 71.34 110.3 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -56.88 123.38 14.86 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.303 -0.862 . . . . 73.13 109.768 155.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.24 134.01 53.93 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 124.879 1.272 . . . . 72.34 110.524 157.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -140.48 174.74 10.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.468 -0.938 . . . . 71.55 108.468 163.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -69.31 40.99 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.8 1.64 . . . . 74.34 110.289 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -134.26 -59.61 0.82 Allowed 'General case' 0 N--CA 1.466 0.374 0 O-C-N 118.269 -2.77 . . . . 64.32 108.212 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -73.2 -26.27 61.09 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.572 0.749 . . . . 63.54 111.47 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.04 -20.02 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 119.459 1.027 . . . . 71.44 112.506 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.2 mm -68.66 144.41 14.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 121.23 -0.918 . . . . 73.51 109.521 -169.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.23 -153.82 17.36 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 124.944 1.259 . . . . 64.15 110.296 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -120.79 154.16 36.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.279 1.431 . . . . 73.55 109.494 -168.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -152.13 117.1 5.17 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.006 0.922 . . . . 74.45 109.593 -161.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.2 t -122.81 166.76 14.46 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.21 1.368 . . . . 73.43 112.024 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -125.19 2.75 7.88 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.661 1.584 . . . . 72.55 111.829 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.08 -177.37 36.57 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 120.503 1.501 . . . . 65.15 111.667 176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.6 pt -128.78 5.31 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.391 1.476 . . . . 75.13 111.387 -175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -147.15 -173.23 4.19 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.52 1.528 . . . . 71.11 110.237 -164.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 48.48 -104.19 0.08 OUTLIER Glycine 0 C--N 1.339 0.734 0 C-N-CA 126.25 1.881 . . . . 43.34 111.763 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -138.39 97.66 3.42 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.593 -1.632 . . . . 74.34 106.593 172.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -111.78 177.76 4.54 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.77 0.828 . . . . 72.51 110.712 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -154.57 155.76 35.35 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.005 0.922 . . . . 74.41 108.934 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.01 131.0 36.58 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.846 1.659 . . . . 63.24 108.298 -168.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mt -115.38 153.68 30.59 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.769 1.628 . . . . 73.13 108.895 170.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 p -147.19 153.39 39.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.31 -0.996 . . . . 74.42 108.31 167.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -144.63 141.97 29.77 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.948 1.299 . . . . 73.33 108.85 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -110.69 158.93 18.07 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.272 1.429 . . . . 71.34 108.147 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.84 -29.42 40.14 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.909 -0.316 . . . . 71.43 111.683 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.36 10.59 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.108 1.363 . . . . 74.42 110.139 -164.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.33 -124.02 2.82 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 125.017 1.294 . . . . 73.43 110.127 -169.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -140.31 167.14 22.85 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.822 -1.177 . . . . 73.31 107.822 168.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -93.36 176.25 36.83 Favored Glycine 0 CA--C 1.523 0.551 0 O-C-N 121.53 -0.732 . . . . 73.23 112.057 170.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.85 161.65 33.62 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.108 0.963 . . . . 63.24 109.828 171.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -141.99 151.06 42.15 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.274 -1.01 . . . . 70.42 108.274 168.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.77 161.76 32.53 Favored Glycine 0 CA--C 1.525 0.662 0 O-C-N 121.524 -0.735 . . . . 64.12 111.621 163.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.5 mt -124.83 149.58 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 127.047 2.139 . . . . 73.51 105.356 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -134.0 164.78 26.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.271 1.428 . . . . 74.21 110.149 -170.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.2 m -133.9 120.42 20.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.977 2.111 . . . . 70.34 106.006 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.254 0.9 OUTLIER 45.02 -81.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 130.016 3.326 . . . . 74.33 114.582 -173.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.67 43.54 1.73 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.786 1.635 . . . . 74.43 109.335 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.3 m -137.4 129.22 16.55 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.059 1.744 . . . . 64.4 107.635 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.37 136.92 32.52 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.747 2.298 . . . . 73.21 109.435 168.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.6 mm -120.56 -22.23 3.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 118.658 -0.687 . . . . 70.13 111.279 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.3 p -139.02 169.81 17.11 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.884 1.22 . . . . 72.33 110.782 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -159.15 153.27 23.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.827 -1.079 . . . . 74.21 108.307 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -166.61 161.49 15.93 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 105.649 -1.982 . . . . 74.43 105.649 165.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.8 mtm -122.57 159.01 28.68 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.389 -1.708 . . . . 74.24 106.389 160.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.18 141.01 17.13 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 123.991 0.807 . . . . 72.53 109.503 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -78.7 156.48 28.92 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 123.079 1.419 . . . . 73.33 108.391 166.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -151.84 169.05 23.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.171 -1.377 . . . . 72.41 110.021 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -141.44 163.17 33.65 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.113 0.965 . . . . 65.13 109.475 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.6 mm -120.05 89.33 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.791 -1.559 . . . . 65.55 106.791 170.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -123.42 25.81 8.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.598 1.159 . . . . 72.31 110.529 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -164.41 14.35 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.785 1.234 . . . . 74.22 112.604 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 26.69 69.86 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 120.451 -0.88 . . . . 72.31 111.219 -172.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -151.22 164.47 36.5 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.466 3.106 . . . . 65.34 106.817 -168.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.9 mt -100.27 109.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.404 -1.702 . . . . 74.11 106.404 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -80.9 106.17 12.7 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.065 -1.457 . . . . 70.51 107.065 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.1 mm -85.54 140.21 16.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.968 -1.493 . . . . 74.4 106.968 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -156.52 -2.69 0.12 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 115.868 1.803 . . . . 72.14 115.868 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -148.03 120.99 8.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 103.618 -2.734 . . . . 71.32 103.618 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.8 t -133.47 154.09 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 125.314 1.446 . . . . 62.53 107.436 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.94 163.54 37.48 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.651 1.181 . . . . 74.23 109.055 172.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.24 -21.39 13.66 Favored 'Cis proline' 0 C--N 1.345 0.374 0 N-CA-C 113.968 0.719 . . . . 62.24 113.968 -7.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -100.78 101.05 11.81 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.329 -2.1 . . . . 71.44 105.329 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -61.64 139.08 58.33 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.775 1.23 . . . . 74.44 110.417 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -114.56 158.42 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.072 1.749 . . . . 72.21 109.095 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -65.04 148.87 97.52 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.657 -0.868 . . . . 74.33 108.657 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.63 145.58 52.52 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.567 2.178 . . . . 74.23 112.478 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -156.15 167.88 29.05 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.887 1.275 . . . . 74.34 110.307 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -106.51 130.55 54.27 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.917 -1.142 . . . . 74.11 107.917 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.0 mt -106.39 132.64 52.18 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 125.956 1.702 . . . . 70.52 109.103 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.65 128.12 34.79 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.672 1.189 . . . . 72.53 110.694 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 p -150.29 164.98 34.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.499 1.519 . . . . 71.14 109.47 169.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -127.8 164.1 22.92 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.906 2.082 . . . . 62.51 112.239 159.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.8 tt -155.3 160.24 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.556 -1.275 . . . . 73.35 107.556 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.6 m -128.38 -66.1 0.86 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.493 2.317 . . . . 74.53 109.914 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.68 -83.76 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 106.998 -2.441 . . . . 73.33 106.998 170.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 p -95.08 -8.5 36.4 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.082 1.882 . . . . 72.55 116.082 -167.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.2 m -101.63 98.86 9.1 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 121.342 1.883 . . . . 73.51 109.34 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.03 119.11 19.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.005 -1.85 . . . . 73.55 106.005 165.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -108.05 88.88 2.83 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.618 -0.882 . . . . 71.31 108.618 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 t -80.23 128.32 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.858 -1.164 . . . . 74.21 107.858 169.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.65 -46.58 16.92 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.4 -0.81 . . . . 73.32 112.078 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 t -126.12 -172.85 2.71 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.575 1.08 . . . . 74.54 111.584 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.8 177.98 51.91 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.99 -1.244 . . . . 73.34 109.99 -171.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.5 m -60.49 -19.22 56.13 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.659 -0.906 . . . . 65.33 111.803 164.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -89.78 0.63 56.89 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.299 0.64 . . . . 65.55 112.371 -170.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.96 108.45 0.4 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.083 2.153 . . . . 74.44 110.261 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.79 -150.12 6.52 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 121.833 0.685 . . . . 72.53 112.583 -167.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 t -144.86 125.76 14.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.852 -1.907 . . . . 74.24 105.852 165.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -122.9 124.65 43.7 Favored 'General case' 0 C--O 1.226 -0.168 0 O-C-N 121.641 -0.662 . . . . 74.45 110.606 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -88.09 18.17 4.48 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.335 1.606 . . . . 75.25 115.335 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 26.3 tttt 62.43 156.03 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 127.172 2.189 . . . . 72.41 110.677 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 127.059 2.144 . . . . 71.45 106.8 -175.409 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 . . . . . 0 C--O 1.237 0.403 0 N-CA-C 107.494 -1.298 . . . . 72.15 107.494 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -108.29 161.26 15.17 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.906 2.082 . . . . 74.34 109.989 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.4 p -90.4 167.65 12.46 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.569 0.622 . . . . 74.34 109.896 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -51.63 125.18 14.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.132 0.968 . . . . 73.23 108.77 159.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.4 tp -67.66 118.99 11.67 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.29 -1.374 . . . . 73.31 107.29 161.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.442 HD21 ' ND2' ' A' ' 11' ' ' ASN . 21.2 m-80 -119.45 162.78 18.27 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 105.273 -2.121 . . . . 71.04 105.273 168.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -61.12 -44.91 96.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.16 -1.052 . . . . 62.25 108.16 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -53.83 -21.81 8.34 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.781 1.632 . . . . 75.54 113.918 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.442 ' ND2' HD21 ' A' ' 8' ' ' ASN . 93.0 m-20 -90.27 -29.78 17.94 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.283 0.947 . . . . 73.24 113.085 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.2 tp -87.66 -10.92 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.24 1.016 . . . . 73.23 111.923 -168.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mm -60.31 135.56 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.303 1.041 . . . . 71.23 111.523 -175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.1 175.59 14.14 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.31 1.91 . . . . 61.13 110.847 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -78.17 159.09 28.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.972 -0.751 . . . . 74.3 108.972 164.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -149.59 146.15 27.17 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.588 1.155 . . . . 74.32 109.261 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.8 p -134.96 175.4 9.61 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.247 1.385 . . . . 73.23 112.851 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.2 t -133.8 12.94 4.03 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.451 1.1 . . . . 73.42 113.217 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.03 176.97 14.86 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.839 -1.704 . . . . 52.1 108.839 -175.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.0 pt -130.88 15.24 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.857 0.863 . . . . 74.41 112.612 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -108.91 165.1 11.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.118 1.367 . . . . 73.33 111.456 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.0 -101.35 0.72 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.561 -1.016 . . . . 73.1 110.561 162.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.3 m -141.7 117.3 10.31 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.455 -2.054 . . . . 73.22 105.455 162.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -114.99 179.23 4.01 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.689 1.595 . . . . 74.23 109.295 -176.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -142.81 139.85 31.1 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.165 1.386 . . . . 74.44 108.918 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.0 144.6 48.44 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.82 1.648 . . . . 73.5 108.306 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mt -124.76 155.62 39.03 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.358 1.863 . . . . 74.51 109.261 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.7 t -143.78 152.23 40.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.31 1.444 . . . . 75.13 107.735 163.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -149.13 127.68 12.34 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 127.128 2.171 . . . . 74.12 107.002 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.54 163.32 12.55 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.576 0.75 . . . . 71.11 111.386 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.37 -30.19 37.88 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.982 0.734 . . . . 60.55 112.982 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.75 2.26 3.14 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.271 0.357 . . . . 72.21 110.975 -172.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.11 -129.41 5.68 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.678 1.609 . . . . 71.34 109.827 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.8 p -138.71 -175.42 4.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.328 2.251 . . . . 74.5 106.175 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.67 -177.81 22.4 Favored Glycine 0 C--O 1.238 0.385 0 N-CA-C 109.862 -1.295 . . . . 72.14 109.862 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.7 p -159.77 152.16 21.03 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.797 1.036 . . . . 72.1 113.797 -163.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -129.55 112.82 14.11 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.364 1.866 . . . . 73.34 107.299 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.17 109.21 0.95 Allowed Glycine 0 C--N 1.341 0.857 0 C-N-CA 124.376 0.988 . . . . 54.52 112.053 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.6 mt -76.61 143.06 13.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.463 1.105 . . . . 74.43 108.239 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -131.73 125.12 31.21 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.031 1.333 . . . . 71.22 109.301 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -88.31 112.69 23.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.597 -1.261 . . . . 74.31 107.597 166.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 53.06 -78.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.995 2.518 . . . . 72.13 112.342 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.94 21.09 2.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.423 1.889 . . . . 74.22 112.492 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 m -116.76 118.02 37.08 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.393 1.477 . . . . 53.13 107.675 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.61 125.69 14.81 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.576 2.184 . . . . 73.11 108.702 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.4 mm -117.24 -3.9 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.672 0.789 . . . . 74.13 110.907 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.4 t -152.17 163.7 38.84 Favored 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 120.169 -1.582 . . . . 62.34 108.998 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -157.7 144.92 18.3 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.022 1.729 . . . . 75.5 106.939 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -167.77 153.59 7.39 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 105.629 -1.989 . . . . 71.21 105.629 165.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 mtm -132.32 153.9 50.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.564 1.146 . . . . 74.43 108.83 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -163.2 154.37 16.97 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.747 0.819 . . . . 74.2 109.527 -174.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.92 169.09 16.42 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.143 2.177 . . . . 75.12 109.601 172.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.68 162.02 36.55 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.258 1.023 . . . . 72.01 110.261 171.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -134.11 131.31 38.58 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.49 -1.3 . . . . 74.12 107.49 160.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.48 107.66 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 105.597 -2.001 . . . . 75.05 105.597 163.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -152.66 45.9 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.463 0.705 . . . . 61.43 109.137 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.95 14.49 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.811 2.444 . . . . 73.14 111.966 162.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.94 25.24 71.93 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.393 -1.442 . . . . 71.32 110.822 -160.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.416 ' HE ' ' CG ' ' A' ' 76' ' ' ASP . 76.4 mtt85 -140.05 158.75 43.57 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 126.724 2.009 . . . . 72.44 106.512 176.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.08 138.77 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.168 -1.79 . . . . 73.25 106.168 172.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -117.49 115.96 26.19 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.81 2.044 . . . . 72.11 107.111 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.4 mm -97.71 143.05 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.979 -1.489 . . . . 74.23 106.979 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -159.36 -2.62 0.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.067 1.506 . . . . 73.14 115.067 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -148.42 125.19 11.18 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.084 -2.562 . . . . 73.42 104.084 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.2 t -132.14 152.33 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 125.212 1.405 . . . . 71.23 107.787 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.4 151.94 48.7 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 125.833 1.653 . . . . 75.1 106.678 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.52 -6.74 50.3 Favored 'Cis proline' 0 CA--C 1.534 0.513 0 CA-C-N 119.378 0.814 . . . . 61.01 113.983 4.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.28 108.61 18.77 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.791 -1.929 . . . . 73.21 105.791 172.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.63 127.97 34.28 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.097 1.359 . . . . 74.32 108.142 169.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -125.16 160.38 29.27 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.635 0.774 . . . . 71.11 110.078 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -56.89 147.05 55.89 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.051 0.941 . . . . 70.02 109.437 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.93 147.19 89.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.979 1.786 . . . . 70.31 111.07 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -157.56 151.41 24.24 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.269 1.828 . . . . 54.23 108.17 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -81.22 160.23 24.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.637 -1.165 . . . . 72.25 107.931 165.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.83 127.28 38.3 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.467 1.107 . . . . 74.13 108.711 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.416 ' CG ' ' HE ' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -81.22 115.2 20.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.621 -1.622 . . . . 74.33 106.621 175.035 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -146.1 151.7 38.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.717 1.207 . . . . 65.21 107.773 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -117.8 157.99 25.58 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.253 1.021 . . . . 73.32 109.373 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 tt -151.65 151.78 11.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 118.689 -0.672 . . . . 71.15 109.537 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.4 m -141.68 -6.98 0.99 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.339 1.607 . . . . 73.12 115.339 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.23 -82.35 0.17 Allowed Glycine 0 N--CA 1.461 0.308 0 O-C-N 120.363 -1.46 . . . . 63.31 109.552 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.5 p -104.32 -13.54 16.1 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.534 -0.746 . . . . 73.22 112.057 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 m -90.01 101.63 14.34 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.45 1.477 . . . . 74.0 109.784 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 tp -81.58 138.94 35.32 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.419 -1.326 . . . . 72.43 107.419 159.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -127.66 144.43 51.08 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.617 -0.883 . . . . 74.13 108.617 163.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 t -127.99 127.21 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.793 -1.558 . . . . 74.4 106.793 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -96.45 -20.84 18.12 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.436 0.902 . . . . 70.02 113.436 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -155.48 172.89 17.49 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.62 1.568 . . . . 70.24 108.655 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.92 177.93 49.11 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-O 122.285 0.936 . . . . 73.34 111.383 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 t -60.84 -26.99 67.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.24 -0.565 . . . . 74.22 111.724 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.81 6.26 49.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.397 -0.811 . . . . 70.2 113.042 -172.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -46.4 101.61 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.926 1.691 . . . . 74.22 110.651 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.95 -174.14 39.88 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.067 0.841 . . . . 70.03 112.382 -158.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.7 p -140.43 100.75 3.95 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.551 1.541 . . . . 71.33 107.716 -169.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -115.78 150.94 36.1 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.721 0.408 . . . . 73.42 110.629 -169.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -120.59 16.87 12.05 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.331 1.234 . . . . 73.31 114.331 -167.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.5 tttt 68.16 142.42 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 129.891 3.277 . . . . 71.24 111.629 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 . . . . . 0 C--O 1.235 0.321 0 C-N-CA 127.708 2.403 . . . . 72.43 107.581 -179.958 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 105.683 -1.969 . . . . 72.24 105.683 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -135.5 156.5 48.8 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 128.34 2.656 . . . . 75.15 108.077 -171.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -76.81 168.5 19.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.132 0.492 . . . . 71.43 111.304 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -55.45 143.95 27.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.993 1.317 . . . . 74.52 109.055 164.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.3 tp -83.73 121.96 27.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.244 -1.391 . . . . 73.53 107.244 164.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -131.17 172.7 11.82 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.363 1.065 . . . . 75.11 109.762 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -10.36 23.05 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.92 -1.038 . . . . 74.42 113.103 173.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -107.42 -31.61 8.09 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 121.094 1.77 . . . . 75.12 113.073 -168.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -86.18 -27.76 24.34 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.008 -0.996 . . . . 52.32 112.452 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 tp -65.76 -27.7 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.791 1.632 . . . . 75.11 111.534 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 mm -54.09 121.79 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 C-N-CA 125.854 1.661 . . . . 75.13 110.744 -169.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.95 176.31 14.42 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 123.964 0.792 . . . . 72.44 111.255 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.45 157.94 24.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.706 0.803 . . . . 75.21 109.433 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -147.02 143.68 28.57 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.87 0.868 . . . . 73.22 109.346 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.8 t -140.01 166.0 25.82 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.53 0.732 . . . . 72.34 110.82 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.466 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 14.2 t -119.34 -6.51 10.32 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.952 2.101 . . . . 73.55 111.393 176.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.66 175.8 43.37 Favored Glycine 0 C--N 1.337 0.593 0 O-C-N 120.503 -1.373 . . . . 60.44 110.978 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.7 pt -133.47 15.02 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.169 1.387 . . . . 74.13 110.046 -173.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -148.94 -175.8 5.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.145 1.778 . . . . 73.41 109.703 -165.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.69 -99.9 0.04 OUTLIER Glycine 0 C--N 1.337 0.592 0 C-N-CA 126.789 2.138 . . . . 71.34 112.823 165.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.9 m -148.14 129.24 14.55 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 104.364 -2.458 . . . . 74.22 104.364 167.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -143.47 -174.78 4.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.373 1.069 . . . . 75.55 109.342 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -136.39 164.67 27.58 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.284 1.434 . . . . 75.11 109.549 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.33 133.06 23.83 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.243 1.417 . . . . 75.45 108.63 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 mt -121.07 160.41 23.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.953 0.901 . . . . 74.34 109.86 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 t -137.12 154.12 50.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.041 1.736 . . . . 62.45 106.631 159.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -145.03 130.26 18.58 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.566 1.546 . . . . 74.01 108.24 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.87 152.18 23.59 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.507 1.123 . . . . 64.35 109.822 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.82 -37.46 73.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.91 1.284 . . . . 73.25 110.516 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.67 21.26 4.65 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.31 1.044 . . . . 64.05 110.753 -171.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -130.36 -129.08 3.06 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.482 1.039 . . . . 75.42 110.599 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 p -124.19 -175.05 3.14 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.421 1.888 . . . . 74.24 108.442 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.79 167.13 13.04 Favored Glycine 0 C--O 1.237 0.322 0 N-CA-C 109.252 -1.539 . . . . 73.32 109.252 162.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.04 153.24 49.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.701 0.801 . . . . 74.01 108.859 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -137.73 121.54 17.58 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.127 1.371 . . . . 72.41 107.761 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.61 162.53 19.83 Favored Glycine 0 C--N 1.331 0.297 0 N-CA-C 110.293 -1.123 . . . . 75.32 110.293 174.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.0 mt -127.15 143.36 40.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.962 -1.866 . . . . 73.31 105.962 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -136.01 124.65 23.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.417 1.087 . . . . 75.43 108.687 -166.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.2 m -84.69 124.27 31.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.837 -1.542 . . . . 72.43 106.837 166.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 44.64 -78.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 129.059 2.943 . . . . 74.44 115.127 176.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.2 68.03 1.09 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.64 1.576 . . . . 62.01 107.612 165.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.7 m -152.97 130.96 6.2 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 126.591 1.957 . . . . 75.3 107.089 170.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.01 135.85 26.12 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.563 2.842 . . . . 75.12 110.509 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.7 mm -130.89 -21.25 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.007 0.923 . . . . 75.42 111.729 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.1 m -142.01 155.58 45.43 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 120.551 -1.343 . . . . 71.33 109.105 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -155.98 143.27 19.22 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.751 1.22 . . . . 72.34 109.629 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -159.75 159.59 32.97 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.1 1.76 . . . . 71.32 106.94 166.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.9 mtm -133.5 148.46 51.69 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.564 -1.643 . . . . 73.3 106.564 172.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -158.5 142.52 15.56 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.474 -0.565 . . . . 73.12 109.474 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.47 157.16 30.61 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.591 -1.263 . . . . 73.31 107.591 170.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -151.08 164.53 36.26 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.629 -0.67 . . . . 74.31 109.953 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -132.1 158.3 41.96 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.614 1.166 . . . . 73.35 108.235 164.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.9 mm -113.63 87.11 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.552 -2.018 . . . . 73.23 105.552 166.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -126.25 23.04 7.08 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 122.424 1.107 . . . . 74.23 110.759 -170.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.76 14.28 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.317 1.847 . . . . 74.14 113.606 -170.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.61 15.55 61.99 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 121.368 -0.833 . . . . 54.13 111.338 -172.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -145.43 162.05 38.24 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 128.847 2.859 . . . . 74.42 105.893 -170.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 mt -91.27 109.46 21.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.612 -1.625 . . . . 74.21 106.612 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -78.86 104.78 9.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.77 -1.567 . . . . 75.54 106.77 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.0 mm -88.89 131.39 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.152 -2.166 . . . . 73.35 105.152 170.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -154.74 -1.14 0.17 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 115.93 1.826 . . . . 75.42 115.93 -175.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -148.86 123.5 9.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.761 -1.94 . . . . 72.22 105.761 162.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.5 t -129.14 141.45 46.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 125.823 1.649 . . . . 71.14 107.827 -174.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.41 164.06 46.68 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.327 1.051 . . . . 75.12 108.246 173.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.23 -19.76 15.33 Favored 'Cis proline' 0 N--CA 1.454 -0.84 0 CA-C-N 119.285 0.78 . . . . 74.11 111.98 -14.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -98.27 102.21 13.89 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.912 -1.514 . . . . 64.54 106.912 -176.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -88.41 131.8 34.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.022 -0.99 . . . . 71.53 110.493 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -127.39 174.7 8.78 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.676 1.19 . . . . 74.43 110.382 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 t -61.02 154.89 58.05 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.152 1.381 . . . . 71.43 111.625 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.51 147.3 57.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.359 2.706 . . . . 71.13 112.593 171.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -161.01 164.59 30.85 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.648 1.179 . . . . 74.52 110.441 171.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -91.68 148.54 22.18 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.956 -0.757 . . . . 74.14 108.956 169.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -124.39 137.43 54.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.178 1.791 . . . . 74.43 108.474 175.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -98.71 133.22 43.34 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.766 -0.827 . . . . 61.24 108.766 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 2.1 p -151.68 165.64 33.73 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.091 1.356 . . . . 71.52 109.433 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.44 161.18 19.48 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.404 -0.591 . . . . 72.42 109.404 160.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.4 tt -137.47 146.94 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.462 -1.31 . . . . 75.22 107.462 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.3 p -111.7 -10.74 14.05 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.579 0.751 . . . . 64.52 112.037 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.69 -63.09 0.59 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 107.452 -2.259 . . . . 72.12 107.452 -169.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 p -112.55 -15.57 13.02 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.575 -1.202 . . . . 73.31 114.155 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.1 m -104.45 137.0 42.96 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.599 1.545 . . . . 75.54 107.878 168.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.76 143.4 29.14 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.898 -1.519 . . . . 74.51 106.898 161.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -133.07 85.65 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.154 -1.054 . . . . 74.24 108.154 170.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.41 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 44.4 t -75.65 124.75 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.3 -0.63 . . . . 73.34 109.3 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -92.94 -24.95 18.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.147 0.979 . . . . 65.23 112.547 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.0 t -152.52 160.86 43.2 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.013 0.824 . . . . 70.33 110.285 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.26 176.17 19.39 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.956 1.741 . . . . 65.24 111.134 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.1 m -55.62 -26.98 47.07 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.619 0.768 . . . . 53.35 111.548 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -101.89 11.79 38.02 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.022 0.929 . . . . 73.13 113.046 -174.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.6 108.73 0.37 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.207 1.403 . . . . 64.52 110.929 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.59 -169.8 41.51 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 122.113 0.841 . . . . 70.21 113.03 -169.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -118.65 126.29 51.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.929 2.092 . . . . 65.45 107.473 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.466 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 23.9 m-85 -140.07 159.33 42.42 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.789 0.328 . . . . 73.45 110.499 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -120.57 149.55 42.27 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.487 1.115 . . . . 74.45 109.154 170.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -61.17 143.19 55.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.99 -1.115 . . . . 71.01 107.99 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 105.685 -1.969 . . . . 74.12 105.685 175.128 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 CA--C 1.512 -0.51 0 N-CA-C 107.36 -1.348 . . . . 75.13 107.36 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -87.57 147.79 25.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.187 -1.824 . . . . 75.04 109.936 -174.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.22 167.59 17.58 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.884 0.874 . . . . 71.31 110.528 168.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -55.58 136.26 50.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.882 1.325 . . . . 73.24 109.65 157.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.7 tp -66.96 139.24 57.69 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.363 -1.347 . . . . 74.44 107.363 154.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -140.11 170.42 15.88 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.713 -1.588 . . . . 75.41 106.713 163.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 p -44.25 -60.62 1.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.248 2.619 . . . . 74.05 109.809 171.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -71.69 -17.24 62.24 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.259 -1.337 . . . . 73.43 110.245 -170.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -82.64 -37.16 25.3 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 117.763 -1.113 . . . . 73.12 110.596 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 tp -74.98 -15.87 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 121.381 1.901 . . . . 73.21 113.363 -170.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mm -56.35 136.32 19.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.448 1.099 . . . . 64.52 110.762 -173.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 131.45 -175.08 19.79 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.777 1.18 . . . . 74.22 112.727 170.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.54 146.08 25.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.093 1.757 . . . . 73.21 108.612 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -140.3 111.61 7.19 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.789 0.836 . . . . 75.1 110.221 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -118.18 143.59 46.39 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.257 1.023 . . . . 73.0 108.971 -175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 t -82.35 -43.99 16.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.251 0.621 . . . . 73.03 109.419 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.5 172.8 44.7 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.74 1.638 . . . . 64.33 110.335 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.9 pt -115.94 45.37 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 122.924 1.345 . . . . 72.22 109.854 -164.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -131.06 178.81 6.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.251 1.42 . . . . 53.4 111.619 -156.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.79 -24.34 18.63 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 127.228 2.347 . . . . 75.34 115.597 -163.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.2 m -150.2 119.94 7.05 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.596 -1.631 . . . . 71.14 106.596 170.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -146.41 -178.95 6.43 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.043 0.838 . . . . 73.1 110.918 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -143.26 146.08 33.31 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.289 1.436 . . . . 74.0 108.39 -171.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.31 135.02 45.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.698 -1.223 . . . . 74.3 107.698 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 mt -123.13 155.75 36.38 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.201 1.401 . . . . 75.41 108.275 172.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.9 p -146.85 152.42 38.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.695 0.798 . . . . 55.12 109.567 167.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.62 119.84 12.19 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.602 -1.629 . . . . 75.04 106.602 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -84.94 169.51 13.98 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.694 -0.854 . . . . 64.15 108.694 169.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -93.58 -25.61 17.47 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.599 1.16 . . . . 62.54 112.92 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.09 32.09 1.24 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.416 1.086 . . . . 75.51 108.714 -174.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.19 -112.57 1.1 Allowed Glycine 0 C--N 1.339 0.698 0 N-CA-C 109.02 -1.632 . . . . 71.31 109.02 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.4 p -139.92 -165.66 1.93 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.735 1.214 . . . . 75.15 109.346 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.09 171.18 14.77 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.423 1.011 . . . . 55.25 110.852 166.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.53 148.94 35.08 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.907 -0.775 . . . . 62.45 108.907 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -138.83 124.25 19.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.472 1.109 . . . . 73.45 108.572 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.62 165.49 21.46 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.808 -0.917 . . . . 71.2 110.808 175.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -124.49 148.49 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 104.862 -2.273 . . . . 75.4 104.862 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -141.84 165.1 28.41 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.449 1.1 . . . . 75.22 108.716 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.3 m -136.24 112.69 9.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.91 2.084 . . . . 75.44 107.866 171.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 54.13 -78.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 127.51 2.324 . . . . 71.43 114.374 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.21 47.97 1.49 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.202 1.801 . . . . 75.33 110.457 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.2 m -154.83 137.66 10.3 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.024 1.73 . . . . 73.23 108.669 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.68 142.21 22.72 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 124.057 3.172 . . . . 71.41 110.593 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.6 mm -130.69 -7.48 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 126.028 1.731 . . . . 63.3 110.843 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.9 t -153.7 164.76 37.76 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 119.721 -1.862 . . . . 72.41 109.117 163.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -157.31 123.07 4.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.71 2.404 . . . . 73.22 106.837 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -139.0 164.22 30.33 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.381 1.472 . . . . 64.13 107.152 164.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mtm -135.87 156.28 49.02 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.967 1.307 . . . . 74.05 107.673 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -159.39 151.94 21.44 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.575 0.75 . . . . 75.03 110.27 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -82.4 166.85 19.05 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.349 -0.612 . . . . 75.25 109.349 166.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -148.23 160.9 42.48 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.238 0.615 . . . . 74.44 111.787 172.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -131.39 154.99 48.06 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.215 -1.402 . . . . 73.42 107.215 164.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.3 mm -104.16 107.72 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 106.018 -1.845 . . . . 74.33 106.018 164.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.75 24.62 2.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.946 1.461 . . . . 73.35 114.946 171.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.88 14.66 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.631 1.573 . . . . 73.05 114.835 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.43 11.84 84.02 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 120.114 -1.616 . . . . 74.05 115.12 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -121.37 -165.73 1.27 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.292 1.837 . . . . 74.45 107.765 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.6 mt -114.84 110.18 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.753 1.615 . . . . 55.15 107.179 172.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -76.88 103.17 6.67 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 107.363 -1.347 . . . . 75.25 107.363 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.5 mm -90.49 140.12 16.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 105.697 -1.964 . . . . 74.01 105.697 170.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -158.31 -5.01 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 115.131 1.53 . . . . 75.23 115.131 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -144.87 112.75 6.34 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.224 -2.88 . . . . 73.14 103.224 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.1 t -132.29 152.69 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.949 -1.501 . . . . 71.11 106.949 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.83 162.11 34.73 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.482 1.513 . . . . 75.44 107.18 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.84 -26.47 9.61 Favored 'Cis proline' 0 N--CA 1.459 -0.536 0 CA-C-N 119.833 0.976 . . . . 65.32 112.396 -9.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -87.16 107.7 18.58 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 104.789 -2.3 . . . . 74.24 104.789 167.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -70.74 159.66 34.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.954 0.407 . . . . 74.35 110.479 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.93 153.7 48.26 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.828 1.251 . . . . 73.14 108.778 171.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.4 t -50.89 151.13 4.64 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.559 1.944 . . . . 71.12 111.643 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.03 154.05 67.08 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.521 2.147 . . . . 74.13 113.335 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -168.45 166.04 12.38 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.142 1.377 . . . . 74.23 109.847 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -103.08 111.33 23.64 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.492 -1.299 . . . . 70.12 107.492 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.1 mt -77.61 113.99 16.0 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.956 0.903 . . . . 70.41 108.866 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.44 116.29 4.96 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.119 1.768 . . . . 70.23 108.697 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 9.5 p -151.13 158.77 44.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.658 -0.651 . . . . 74.44 112.637 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 163.0 16.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.316 -0.856 . . . . 75.41 110.972 174.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 tt -141.31 149.98 20.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.518 1.127 . . . . 72.33 108.425 170.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.6 p -129.02 -6.67 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.354 1.242 . . . . 75.04 114.354 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.6 -71.51 0.37 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.304 -1.519 . . . . 73.04 109.304 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.1 p -121.4 4.12 10.23 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.537 -0.745 . . . . 73.44 112.987 175.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.9 m -107.6 133.31 52.23 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.282 -1.377 . . . . 62.41 107.282 170.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.1 tp -108.6 130.57 55.31 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.258 2.223 . . . . 75.03 107.299 166.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -125.69 99.71 6.11 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.009 1.324 . . . . 75.1 110.009 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.8 t -93.61 131.81 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.854 -0.795 . . . . 75.32 108.854 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -87.56 -23.42 24.35 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.844 1.258 . . . . 75.42 113.329 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -153.12 166.39 32.63 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.129 -0.982 . . . . 65.11 109.849 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.67 175.44 36.92 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.709 -0.956 . . . . 54.42 110.709 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.1 m -60.05 -21.61 61.63 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.253 1.021 . . . . 75.22 112.016 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -101.85 6.34 41.45 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.914 1.686 . . . . 64.44 112.776 -172.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.65 110.66 0.83 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.509 1.924 . . . . 73.2 109.337 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.52 -136.31 2.64 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 123.451 0.548 . . . . 73.01 112.527 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.5 t -154.92 113.45 3.54 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.289 -1.745 . . . . 74.0 106.289 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -133.07 152.76 51.93 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.165 -0.959 . . . . 74.42 109.446 -168.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -118.98 141.42 48.68 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.282 1.033 . . . . 75.13 108.331 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -58.37 134.74 56.88 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.263 -1.384 . . . . 74.34 107.263 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 . . . . . 0 C--N 1.326 -0.439 0 N-CA-C 107.741 -1.207 . . . . 73.3 107.741 175.651 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 . . . . . 0 N--CA 1.441 -0.88 0 N-CA-C 105.198 -2.149 . . . . 72.52 105.198 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -111.15 166.49 11.03 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.263 -1.79 . . . . 74.52 110.625 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -84.65 163.93 18.95 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.055 -0.72 . . . . 62.14 109.055 168.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -51.71 124.33 12.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.109 0.957 . . . . 74.44 109.283 153.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.17 134.3 55.76 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.529 0.681 . . . . 64.3 109.538 157.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -139.02 169.14 18.34 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.624 -1.621 . . . . 71.32 106.624 163.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -49.85 -57.19 7.9 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.944 0.498 . . . . 74.43 109.687 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -64.34 -17.33 63.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.843 0.683 . . . . 74.14 112.843 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -78.87 -44.39 22.94 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.854 0.861 . . . . 74.34 110.496 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.9 tp -74.96 -24.56 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 O-C-N 120.329 -1.482 . . . . 70.42 112.225 -170.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 mm -47.88 125.46 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.573 1.949 . . . . 73.53 112.53 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.17 -178.57 18.87 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.11 0.862 . . . . 70.43 112.828 168.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -72.78 147.89 45.1 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 125.675 1.59 . . . . 73.55 110.534 171.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.48 ' CH2' ' HE3' ' A' ' 97' ' ' LYS . 93.7 m95 -137.76 117.84 13.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.257 1.423 . . . . 74.31 108.669 176.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t -116.61 174.2 6.21 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.785 1.234 . . . . 71.31 110.038 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -142.98 1.31 1.26 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.315 1.446 . . . . 72.51 111.363 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.49 176.91 14.6 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 126.477 1.989 . . . . 74.24 108.465 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.75 11.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 113.123 0.786 . . . . 65.34 113.123 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -113.06 -171.35 1.85 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 125.426 1.49 . . . . 73.44 110.184 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 48.43 -90.42 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 126.495 1.998 . . . . 70.23 114.51 153.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.8 m -144.93 100.48 3.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.734 -1.95 . . . . 72.35 105.734 169.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -115.44 171.68 7.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.15 -0.685 . . . . 73.11 109.15 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -146.46 151.84 38.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.145 -1.798 . . . . 73.53 106.145 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.67 146.83 50.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.815 -1.921 . . . . 70.44 105.815 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.03 159.97 35.98 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.479 -0.934 . . . . 70.44 108.479 161.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.2 p -133.36 154.55 50.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.498 0.719 . . . . 65.55 109.772 164.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -139.69 125.09 19.07 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.428 -2.064 . . . . 64.41 105.428 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -109.99 161.4 15.55 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.138 -1.43 . . . . 64.42 107.138 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -97.13 -21.04 17.56 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.586 -0.696 . . . . 72.13 112.518 -168.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -124.41 -5.78 7.67 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 122.853 0.461 . . . . 74.5 111.835 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.96 -120.38 4.36 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.01 1.767 . . . . 61.31 109.819 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.3 p -148.27 175.37 11.13 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 128.481 2.712 . . . . 73.43 106.535 -172.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.86 -166.87 23.33 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 119.392 0.996 . . . . 72.23 112.32 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 m -148.8 164.9 33.07 Favored 'General case' 0 CA--C 1.521 -0.144 0 O-C-N 121.214 -1.168 . . . . 71.51 109.674 168.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -143.15 125.33 15.44 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.488 -1.301 . . . . 73.12 107.488 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.14 159.04 20.49 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.064 -0.815 . . . . 72.53 111.064 170.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.6 mt -133.31 140.61 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 105.843 -1.91 . . . . 73.53 105.843 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -132.02 157.11 44.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.161 0.985 . . . . 74.51 110.022 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -125.86 116.88 22.24 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.19 2.196 . . . . 63.15 106.172 167.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 48.75 -76.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 129.182 2.993 . . . . 71.42 114.169 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.21 29.61 2.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.775 1.63 . . . . 72.13 112.969 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.0 m -137.22 130.46 17.28 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 124.911 1.284 . . . . 72.11 109.541 -174.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.38 133.63 21.22 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.997 3.132 . . . . 70.41 110.857 170.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.4 mm -128.44 -3.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 125.899 1.68 . . . . 71.31 111.275 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 t -145.63 171.28 14.94 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 119.277 -2.139 . . . . 70.52 107.837 165.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -166.37 140.89 4.32 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.729 1.612 . . . . 73.41 107.54 168.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -157.82 162.29 38.41 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.668 1.587 . . . . 73.44 107.074 169.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.6 mtm -130.44 155.42 46.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.237 -1.394 . . . . 74.33 107.237 166.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -163.35 156.22 18.67 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.206 1.002 . . . . 74.11 109.486 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -91.89 167.66 11.97 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.599 0.76 . . . . 72.22 109.385 170.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -135.97 164.71 27.36 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.642 1.177 . . . . 73.44 110.185 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -130.1 126.38 37.44 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.649 -1.611 . . . . 74.5 106.649 160.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mm -92.88 94.58 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 104.643 -2.354 . . . . 73.41 104.643 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -135.54 22.99 3.41 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.78 0.8 . . . . 72.32 112.237 -168.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -170.43 13.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.696 1.199 . . . . 50.23 112.696 171.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.17 13.4 82.94 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 121.6 -0.688 . . . . 72.23 112.33 -169.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -130.87 166.5 20.76 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.33 2.252 . . . . 74.54 106.828 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.6 mt -105.32 104.38 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.694 -1.595 . . . . 74.52 106.694 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -84.44 123.1 29.86 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.079 1.352 . . . . 74.42 107.865 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.6 mm -99.64 150.95 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.873 1.669 . . . . 74.43 107.82 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -160.97 -17.51 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 116.36 1.985 . . . . 73.53 116.36 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -135.66 109.4 8.07 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 105.318 -2.104 . . . . 71.14 105.318 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.74 149.99 25.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.975 1.71 . . . . 70.43 107.54 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.4 160.8 65.42 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.357 1.063 . . . . 72.24 108.203 173.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.46 -11.02 42.51 Favored 'Cis proline' 0 C--N 1.345 0.362 0 N-CA-C 114.222 0.816 . . . . 71.12 114.222 -2.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -108.14 109.39 20.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.053 -2.203 . . . . 74.25 105.053 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.38 145.61 55.5 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.387 0.429 . . . . 73.52 110.106 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -129.66 164.34 24.13 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.675 1.19 . . . . 74.35 110.554 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -62.25 149.76 86.34 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.713 0.805 . . . . 74.5 109.944 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.99 147.37 49.05 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.188 2.592 . . . . 62.11 111.618 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -162.06 157.03 22.87 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.277 2.231 . . . . 72.41 110.2 174.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -94.74 119.5 33.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.001 0.921 . . . . 74.12 109.085 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -91.12 138.75 31.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.573 1.149 . . . . 72.42 109.815 171.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -81.88 123.2 28.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.694 -1.225 . . . . 74.42 107.694 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.6 p -148.49 168.54 22.43 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.41 0.684 . . . . 63.42 109.515 165.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.69 163.7 25.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.825 1.65 . . . . 73.51 112.604 159.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 tt -145.66 160.14 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.477 1.511 . . . . 64.11 107.058 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.2 t -126.71 -35.57 2.31 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.32 3.048 . . . . 73.34 109.413 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.79 -52.72 0.09 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 127.31 2.386 . . . . 72.33 110.177 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.7 p -138.73 7.75 2.54 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.565 1.32 . . . . 70.23 114.565 -158.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.1 m -131.25 105.41 7.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 129.26 3.024 . . . . 65.22 107.712 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.48 121.41 23.81 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.701 -1.963 . . . . 71.23 105.701 173.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 ttmm -101.87 86.62 2.94 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.87 -1.159 . . . . 65.13 107.87 165.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.9 t -79.17 129.95 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.307 -1.368 . . . . 73.1 107.307 167.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -96.77 -30.57 13.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.956 0.902 . . . . 55.24 112.053 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -150.99 173.43 14.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.297 1.039 . . . . 71.11 110.291 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.48 -178.69 25.36 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 109.849 -1.3 . . . . 72.34 109.849 -172.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 t -64.23 -25.12 67.92 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 122.119 -0.636 . . . . 71.53 110.718 172.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -101.44 10.26 40.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.241 1.417 . . . . 63.22 112.22 -168.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.45 0.28 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 127.001 2.121 . . . . 74.14 112.122 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 -162.94 31.1 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 121.616 -0.677 . . . . 74.12 112.578 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.4 p -119.23 106.25 12.16 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.582 1.553 . . . . 72.34 107.978 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -120.81 130.8 54.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.849 0.75 . . . . 65.12 111.44 -168.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -81.39 127.96 33.33 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.971 0.908 . . . . 74.52 108.91 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HE3' ' CH2' ' A' ' 16' ' ' TRP . 31.2 ttmt -60.94 135.29 57.74 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.917 -1.142 . . . . 73.52 107.917 165.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 122.283 1.04 . . . . 74.11 109.117 177.533 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 . . . . . 0 CA--C 1.515 -0.391 0 CA-C-O 121.923 0.868 . . . . 72.0 109.194 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -85.1 157.76 20.6 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.832 1.653 . . . . 73.4 111.045 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.14 176.29 8.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.705 0.802 . . . . 64.02 111.574 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -56.73 134.14 54.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.947 0.899 . . . . 74.11 109.772 156.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 tp -74.45 138.21 43.12 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.331 -1.359 . . . . 74.3 107.331 159.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -143.45 163.67 32.45 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.352 -1.721 . . . . 73.4 106.352 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.12 -51.33 54.58 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.746 0.654 . . . . 73.43 109.502 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -71.34 -16.22 62.43 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 117.933 -1.032 . . . . 73.22 113.36 -170.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -80.14 -41.87 24.57 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.456 1.025 . . . . 75.43 109.678 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.45 41.58 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.77 0.828 . . . . 75.22 110.568 -176.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.3 mm -112.21 125.5 69.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 O-C-N 119.939 -1.726 . . . . 74.4 108.48 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.46 179.69 16.47 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.651 1.119 . . . . 75.4 111.883 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -79.95 164.82 23.2 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.912 1.285 . . . . 72.22 109.474 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -142.35 145.65 34.14 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.176 0.99 . . . . 63.42 110.462 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.6 t -134.09 165.27 25.44 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.448 -1.407 . . . . 64.21 110.237 164.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.406 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 12.0 t -112.68 -12.21 13.43 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.587 1.555 . . . . 64.13 111.556 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.27 178.05 23.09 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 107.931 -2.068 . . . . 75.31 107.931 -166.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.3 pt -134.43 22.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.526 1.13 . . . . 64.4 110.827 -167.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 154.72 49.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.398 1.479 . . . . 72.01 107.238 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.49 -160.04 10.89 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.12 -0.491 . . . . 75.24 112.561 -172.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.8 m -79.95 88.59 5.32 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.678 1.191 . . . . 71.24 108.906 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -96.34 172.05 8.2 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 122.367 1.079 . . . . 72.44 110.843 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -141.15 118.26 11.27 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.184 -1.413 . . . . 74.32 107.184 -151.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.94 106.62 14.93 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.777 2.031 . . . . 64.51 109.226 -173.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 mt -90.81 158.26 16.92 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.509 1.124 . . . . 74.01 108.751 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.1 t -143.2 163.18 33.64 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.822 -0.807 . . . . 61.31 108.822 155.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -149.01 128.51 13.09 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.126 1.77 . . . . 75.23 109.34 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -104.38 144.77 31.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.084 1.354 . . . . 54.14 109.626 171.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.71 -27.41 63.96 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.37 1.068 . . . . 73.4 112.014 -174.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -128.15 0.7 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 129.248 3.019 . . . . 54.32 110.93 -164.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.94 -116.61 2.17 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 125.229 1.395 . . . . 72.44 110.047 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.3 p -140.23 177.75 7.77 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.352 2.261 . . . . 73.44 107.188 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -103.96 176.72 23.95 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 124.07 0.843 . . . . 73.53 111.183 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -140.86 158.67 43.62 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.448 1.499 . . . . 74.2 108.813 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -141.56 120.08 12.43 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.195 1.398 . . . . 75.22 107.267 164.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.83 114.48 1.42 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.891 1.71 . . . . 75.31 110.103 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.0 mt -78.27 140.59 16.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.46 -1.311 . . . . 74.01 107.46 171.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -124.96 154.51 41.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.943 -1.503 . . . . 62.42 106.943 170.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.63 118.11 24.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.286 -1.375 . . . . 75.11 107.286 174.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m120 68.63 -64.68 0.3 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 126.421 1.888 . . . . 71.43 113.675 162.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -158.06 49.75 0.4 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.048 1.295 . . . . 43.32 110.937 158.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 m -150.85 134.69 9.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.149 1.38 . . . . 71.42 109.109 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.19 131.19 21.49 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.12 2.547 . . . . 73.4 110.541 168.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.7 mm -126.85 4.7 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.024 0.93 . . . . 74.42 110.816 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.9 t -152.48 172.84 15.92 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 119.883 -1.761 . . . . 75.41 109.922 166.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -174.74 118.15 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.665 1.986 . . . . 75.02 108.113 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -142.48 158.04 44.11 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.281 1.432 . . . . 71.12 107.694 165.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.8 mtm -134.03 150.19 51.21 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.138 -1.43 . . . . 74.42 107.138 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.5 151.38 20.55 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 122.892 0.477 . . . . 75.32 110.985 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.76 167.21 22.22 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.838 -0.801 . . . . 74.33 108.838 166.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -146.79 166.86 25.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.677 0.791 . . . . 75.1 109.878 167.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -133.54 155.77 49.0 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.442 -1.688 . . . . 75.22 106.442 161.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.0 mm -114.02 98.56 7.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.844 -1.91 . . . . 74.32 105.844 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -130.03 23.13 5.29 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.029 0.752 . . . . 72.33 113.029 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -170.01 14.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.09 1.356 . . . . 71.34 114.07 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.43 18.61 75.47 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.272 -0.892 . . . . 75.31 112.461 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -140.36 173.29 11.65 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 128.586 2.754 . . . . 75.34 105.963 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.0 mt -102.72 117.81 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.866 -1.161 . . . . 75.01 107.866 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -84.51 122.17 28.63 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.686 1.194 . . . . 73.43 108.154 170.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mm -109.95 132.88 57.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.92 1.688 . . . . 74.44 106.626 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -160.87 6.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.777 1.399 . . . . 75.43 114.777 -169.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -148.68 123.15 9.71 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.024 -2.584 . . . . 75.41 104.024 163.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.8 t -136.27 148.85 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.467 -1.308 . . . . 74.15 107.467 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.68 163.31 32.12 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 107.364 -1.347 . . . . 75.35 107.364 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.63 -11.21 31.97 Favored 'Cis proline' 0 CA--C 1.534 0.487 0 CA-C-N 118.713 0.576 . . . . 74.33 113.378 -2.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.38 132.58 36.1 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.296 -1.742 . . . . 52.24 106.296 167.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.41 135.75 38.85 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 118.755 0.707 . . . . 73.32 109.335 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -124.14 168.4 12.95 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 124.169 0.987 . . . . 75.34 110.744 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 t -47.84 143.42 6.22 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.83 2.052 . . . . 75.35 110.675 166.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 159.0 53.78 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.253 1.969 . . . . 74.44 110.963 172.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -168.13 177.15 5.66 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.5 1.52 . . . . 74.3 108.349 172.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -106.99 155.94 19.27 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.708 -0.849 . . . . 75.02 108.708 171.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.8 mt -123.56 129.54 51.34 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.161 1.784 . . . . 73.32 109.298 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.09 123.25 29.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.177 1.391 . . . . 73.21 109.522 174.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 p -148.84 168.38 23.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.582 1.953 . . . . 75.34 108.033 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.08 154.88 50.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.887 1.275 . . . . 74.43 108.482 169.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 tt -136.95 156.54 34.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.362 -1.347 . . . . 75.34 107.362 173.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.45 26.06 0.68 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.692 0.997 . . . . 74.42 113.692 166.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.47 -94.28 0.18 Allowed Glycine 0 C--O 1.228 -0.229 0 N-CA-C 107.849 -2.1 . . . . 74.11 107.849 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.273 36.1 p -105.88 1.27 26.63 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.397 -0.811 . . . . 71.31 112.539 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.6 m -98.13 135.71 39.4 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.926 1.239 . . . . 75.02 109.207 168.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.43 137.0 45.2 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.824 -1.547 . . . . 75.43 106.824 162.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -121.37 85.05 2.34 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.356 1.062 . . . . 73.1 108.688 169.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.8 t -76.77 125.88 36.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.132 -1.062 . . . . 75.22 108.132 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -80.49 -53.27 6.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.148 0.579 . . . . 73.1 110.977 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.4 t -128.85 176.35 7.92 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.391 0.996 . . . . 60.01 112.251 -168.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.18 -175.81 44.89 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 125.622 1.582 . . . . 72.44 110.819 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.59 -27.9 65.07 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.083 -0.657 . . . . 74.12 111.583 176.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -101.17 14.26 32.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.983 -0.532 . . . . 72.44 112.128 -170.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.47 111.09 0.58 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.756 1.222 . . . . 72.02 110.385 172.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.49 -169.35 42.31 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.545 0.593 . . . . 73.2 113.885 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.9 p -113.8 118.15 33.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.479 1.911 . . . . 74.22 108.179 -174.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.406 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 47.2 m-85 -127.77 167.45 16.49 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.79 0.723 . . . . 75.24 112.879 -171.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -125.75 128.94 48.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 129.809 3.244 . . . . 74.0 106.932 -175.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -61.78 152.0 32.56 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.889 -0.782 . . . . 75.44 108.889 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.566 0 C-N-CA 128.598 2.759 . . . . 73.2 109.621 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 . . . . . 0 C--O 1.236 0.377 0 CA-C-O 122.789 1.281 . . . . 72.52 109.145 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -76.11 152.34 36.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.082 -1.417 . . . . 73.54 110.925 -170.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 p -73.32 173.09 10.03 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.716 0.77 . . . . 70.24 110.635 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -49.6 133.63 20.67 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.238 -1.346 . . . . 72.05 109.676 160.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.9 tp -74.92 127.87 34.23 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.054 -1.461 . . . . 73.45 107.054 156.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -137.24 162.14 34.31 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.165 -1.42 . . . . 72.35 107.165 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -53.68 -48.46 69.47 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.775 1.23 . . . . 54.44 109.689 -176.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -26.36 61.88 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.748 1.619 . . . . 72.14 111.133 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -68.09 -37.36 81.13 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.949 0.795 . . . . 73.32 111.002 -174.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.26 -9.72 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.842 0.682 . . . . 74.52 112.842 -171.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.2 mm -61.65 124.76 16.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.788 1.235 . . . . 72.31 110.488 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.63 -177.24 27.0 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.58 1.086 . . . . 73.54 110.556 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -92.89 156.21 17.1 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.432 -0.951 . . . . 74.14 108.432 163.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -126.6 178.49 5.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.913 2.485 . . . . 64.5 108.473 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 t -167.72 169.41 11.77 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.012 1.725 . . . . 72.53 108.601 160.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.531 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 10.0 t -132.36 -1.26 3.57 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.089 1.756 . . . . 74.42 112.463 172.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.77 -178.17 30.86 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 120.922 -1.111 . . . . 73.23 110.556 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.8 pt -140.26 13.78 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.44 1.496 . . . . 70.43 111.146 -166.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -126.75 179.26 5.45 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.01 1.324 . . . . 64.3 111.518 -168.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 44.79 -93.81 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.693 1.616 . . . . 63.32 114.881 153.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 93.6 m -134.68 127.39 30.99 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.245 -1.391 . . . . 63.23 107.245 157.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -136.66 -179.77 5.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.21 1.804 . . . . 71.42 108.813 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -154.0 153.71 32.45 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.132 1.373 . . . . 74.1 109.008 -171.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.05 124.46 23.4 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.191 1.797 . . . . 73.42 108.66 -171.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.425 ' CD1' ' HD1' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -114.52 137.94 51.23 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.511 1.524 . . . . 72.11 109.336 176.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -139.66 134.63 32.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.215 -1.031 . . . . 53.33 108.215 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -133.12 106.75 7.79 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.919 1.688 . . . . 70.34 107.352 -170.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -77.03 152.54 35.09 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.231 -1.025 . . . . 71.44 108.231 169.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.35 -27.67 56.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.471 0.915 . . . . 71.31 113.471 -174.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -135.2 13.65 3.55 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 122.817 0.447 . . . . 75.3 111.16 -166.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.36 -112.2 1.57 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.246 1.403 . . . . 52.34 111.21 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.5 p -139.31 -173.96 3.74 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.555 1.542 . . . . 74.3 108.006 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.57 176.3 20.45 Favored Glycine 0 C--O 1.239 0.446 0 O-C-N 120.817 -1.177 . . . . 72.12 111.437 167.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.2 p -136.69 159.06 42.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.088 -0.654 . . . . 73.31 111.616 -166.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.425 ' HD1' ' CD1' ' A' ' 27' ' ' LEU . 29.1 t80 -134.8 113.14 11.31 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.768 1.227 . . . . 71.44 108.841 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -124.71 112.6 1.79 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 109.64 -1.384 . . . . 72.4 109.64 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.3 mt -86.47 144.54 9.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 105.36 -2.089 . . . . 70.42 105.36 170.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -131.56 158.5 40.8 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.585 1.554 . . . . 73.5 108.022 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.45 126.77 50.09 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.361 1.464 . . . . 72.14 107.595 167.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 53.36 -78.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.024 2.529 . . . . 73.44 113.026 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.35 34.8 0.97 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.723 1.609 . . . . 64.23 111.871 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.8 m -141.7 131.67 12.73 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 127.345 2.258 . . . . 71.32 109.301 -170.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.24 132.99 10.59 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.997 3.132 . . . . 72.41 111.436 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.4 mm -124.48 -21.35 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 112.809 0.67 . . . . 72.42 112.809 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -150.13 154.24 37.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 120.92 1.691 . . . . 61.13 108.308 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -160.69 128.88 4.54 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.715 1.206 . . . . 74.41 108.028 -169.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -162.23 160.02 26.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.179 -1.415 . . . . 74.3 107.179 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.2 mtm -134.13 154.02 51.46 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.939 0.896 . . . . 71.42 108.622 173.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -163.56 153.79 15.54 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.757 0.823 . . . . 71.1 111.117 -176.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -84.6 169.51 14.31 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.951 0.881 . . . . 73.21 109.868 171.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -137.37 160.5 38.89 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.371 1.468 . . . . 72.44 110.53 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -132.96 153.84 51.05 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.751 -1.574 . . . . 73.04 106.751 154.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.1 mm -108.87 100.06 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 105.739 -1.948 . . . . 74.31 105.739 170.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.42 23.65 4.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.257 0.551 . . . . 64.13 112.045 -171.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.27 14.93 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.206 1.802 . . . . 74.01 113.351 -170.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.4 17.98 71.07 Favored Glycine 0 CA--C 1.535 1.296 0 O-C-N 120.465 -1.397 . . . . 65.05 110.901 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -144.09 164.42 30.72 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 129.359 3.064 . . . . 72.41 106.474 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.6 mt -95.48 121.26 45.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.963 -1.495 . . . . 74.34 106.963 -176.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -87.1 111.56 21.04 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.923 1.289 . . . . 72.54 107.606 167.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mm -86.14 140.7 15.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.013 -1.847 . . . . 74.52 106.013 167.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -156.51 -5.24 0.11 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 115.794 1.776 . . . . 75.53 115.794 -176.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -151.55 103.25 2.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.931 -1.137 . . . . 73.42 107.931 -171.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 t -129.11 141.9 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.019 0.928 . . . . 73.44 109.692 -167.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.08 163.87 48.0 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 126.126 1.77 . . . . 75.34 107.271 175.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.37 -17.79 20.14 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 119.096 0.713 . . . . 73.32 113.479 -4.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -102.2 130.55 48.88 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.137 -1.431 . . . . 72.42 107.137 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -72.8 145.15 47.21 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 123.601 0.563 . . . . 74.14 110.41 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -137.54 144.51 42.15 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.708 1.203 . . . . 73.51 108.734 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.0 t -52.14 148.33 11.52 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 118.202 -0.904 . . . . 72.32 110.167 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.57 153.78 75.5 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.148 2.565 . . . . 71.44 111.476 172.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -160.18 164.61 32.73 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.947 1.299 . . . . 71.24 109.39 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -97.43 158.14 15.63 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.084 -0.71 . . . . 70.11 109.084 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 mt -134.17 116.9 15.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.849 2.059 . . . . 73.22 108.516 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -73.51 117.63 15.5 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.761 1.624 . . . . 61.22 107.577 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.8 161.95 39.61 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.232 -0.918 . . . . 71.31 109.566 168.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.458 ' HZ1' ' CD ' ' A' ' 87' ' ' GLU . 5.6 mptt -115.62 161.48 18.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.817 -1.083 . . . . 74.34 110.08 161.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 tt -147.8 151.83 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.0 -1.111 . . . . 73.23 108.0 170.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.9 m -128.14 -1.96 5.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.471 1.108 . . . . 73.24 112.427 171.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.68 -74.68 0.43 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 108.316 -1.914 . . . . 71.41 108.316 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.0 p -93.7 -1.55 55.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.661 0.986 . . . . 70.33 113.661 -174.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -125.42 134.61 52.05 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.895 1.278 . . . . 73.35 108.423 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.54 131.67 49.12 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.152 -1.795 . . . . 74.31 106.152 166.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -120.39 84.38 2.21 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.313 -0.995 . . . . 74.54 108.313 171.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.3 t -77.4 128.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.362 -0.977 . . . . 70.3 108.362 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.458 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 17.6 mt-10 -96.23 -22.41 17.27 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.227 1.195 . . . . 73.34 114.227 -174.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.8 t -150.21 179.0 8.46 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.311 1.444 . . . . 73.33 109.651 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.52 -177.96 52.3 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 122.706 1.17 . . . . 71.31 110.567 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.4 m -63.74 -11.83 29.7 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.155 1.782 . . . . 71.53 114.085 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -107.97 9.17 28.65 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.528 1.131 . . . . 71.5 113.18 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.22 105.84 0.23 Allowed 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.126 -1.609 . . . . 74.31 110.633 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 173.32 -159.29 29.31 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.81 0.719 . . . . 50.42 113.042 -163.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -133.18 128.91 37.02 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 125.33 1.452 . . . . 72.41 109.003 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.531 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 16.6 m-85 -134.88 149.38 50.3 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 123.871 0.868 . . . . 71.4 108.996 -173.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -118.57 151.05 38.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.099 -1.074 . . . . 73.35 108.099 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -68.62 151.65 46.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.091 -1.077 . . . . 74.54 108.091 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 123.434 1.588 . . . . 73.51 106.944 176.68 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 108.786 -0.82 . . . . 64.04 108.786 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.506 ' CD1' ' HE3' ' A' ' 78' ' ' LYS . 98.1 m95 -126.78 157.16 39.92 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.925 1.69 . . . . 70.4 110.647 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -82.73 175.24 10.28 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.037 0.835 . . . . 74.03 110.853 168.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -53.48 156.72 2.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.179 1.392 . . . . 75.11 110.345 163.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.0 tp -103.58 132.66 49.65 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.738 -1.574 . . . . 75.44 107.23 162.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -143.61 -175.3 4.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 127.323 2.249 . . . . 75.44 108.577 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 p -78.65 9.29 4.22 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.431 1.092 . . . . 74.4 113.673 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -130.38 -40.28 1.28 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.56 1.527 . . . . 54.21 112.184 -162.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -72.3 -31.65 65.9 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.948 1.299 . . . . 75.11 110.272 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.9 tp -75.76 -24.83 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.836 1.198 . . . . 73.2 111.864 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.6 mm -55.74 97.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 127.835 2.454 . . . . 74.24 111.974 -174.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.65 179.91 44.62 Favored Glycine 0 N--CA 1.445 -0.731 0 O-C-N 122.27 -0.269 . . . . 73.5 113.085 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -100.0 148.68 24.26 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.53 1.932 . . . . 75.14 108.531 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -146.55 135.34 22.29 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.753 0.821 . . . . 73.2 110.036 -171.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -140.44 170.9 14.93 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.941 -1.099 . . . . 74.54 108.841 166.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 t -118.8 -18.04 9.01 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.469 1.108 . . . . 74.12 111.559 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.84 -168.15 38.14 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 107.501 -2.24 . . . . 63.33 107.501 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.5 pt -139.98 -5.52 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.018 0.927 . . . . 72.13 112.742 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -93.21 173.59 7.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 120.077 1.308 . . . . 74.21 110.746 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.33 -94.56 0.01 OUTLIER Glycine 0 C--N 1.338 0.676 0 C-N-CA 126.528 2.014 . . . . 51.12 113.268 155.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.67 133.2 39.79 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.925 -1.139 . . . . 71.34 107.925 164.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -143.42 179.76 6.91 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.99 1.716 . . . . 75.44 107.67 174.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -143.28 133.5 24.49 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.962 -1.125 . . . . 74.44 107.962 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.8 155.17 18.98 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.996 1.718 . . . . 75.53 107.923 171.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 mt -145.9 141.81 28.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.552 -2.018 . . . . 75.34 105.552 164.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.0 m -138.24 147.83 44.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.156 -1.053 . . . . 74.44 108.156 173.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -141.85 121.31 13.23 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.087 1.755 . . . . 74.53 107.84 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -96.88 157.98 15.64 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.833 0.853 . . . . 74.41 109.579 167.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -78.87 -33.05 46.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.729 -0.669 . . . . 75.51 111.723 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -119.61 5.18 11.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.788 0.435 . . . . 71.32 111.4 -163.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.08 -111.09 0.95 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 125.448 1.499 . . . . 40.13 110.544 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.0 p -137.25 178.64 6.93 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.477 1.911 . . . . 72.31 108.797 -163.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -133.97 -174.78 13.63 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.493 -1.043 . . . . 73.31 110.493 164.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 t -148.28 160.02 43.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.609 -0.886 . . . . 62.3 108.609 -168.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -140.7 137.71 33.7 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.252 2.221 . . . . 72.32 105.695 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.53 147.35 16.66 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.402 -1.079 . . . . 43.31 110.402 166.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.1 mt -97.45 140.33 17.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 105.783 -1.932 . . . . 73.34 105.783 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -133.92 133.34 41.32 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.577 0.703 . . . . 75.51 109.867 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.2 t -79.75 -172.58 3.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.108 2.163 . . . . 64.53 108.439 169.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -44.68 -42.47 7.59 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 126.689 1.996 . . . . 60.31 113.422 -172.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -159.74 49.32 0.3 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.097 -0.705 . . . . 75.13 109.097 162.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.7 m -146.92 136.07 11.44 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.517 -0.754 . . . . 75.52 109.268 -173.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.56 142.27 18.23 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 124.295 3.33 . . . . 72.34 113.147 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.3 -8.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 114.137 1.162 . . . . 62.33 114.137 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.04 145.53 15.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.021 -1.675 . . . . 72.44 107.751 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -159.2 129.28 5.7 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.022 -1.473 . . . . 75.41 107.022 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -153.77 167.69 28.8 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.129 1.372 . . . . 74.31 108.436 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.9 mtm -135.13 158.34 44.6 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 123.479 0.712 . . . . 75.14 109.93 165.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -155.1 160.05 40.69 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.235 -0.893 . . . . 73.52 108.909 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.14 164.05 15.18 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.304 -1.369 . . . . 74.42 107.304 168.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -136.27 165.66 25.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.962 -0.563 . . . . 74.01 109.758 170.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -131.37 159.2 38.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.024 -0.732 . . . . 73.21 109.024 158.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.3 mm -118.38 89.55 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 104.522 -2.399 . . . . 73.24 104.522 171.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -118.95 23.48 11.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.907 1.283 . . . . 62.02 111.474 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.33 21.59 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.339 1.456 . . . . 75.01 113.317 -173.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.95 22.65 70.58 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 120.554 -1.341 . . . . 63.32 112.082 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -148.44 163.0 38.45 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 127.374 2.269 . . . . 74.4 107.02 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.0 mt -87.92 130.33 37.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.924 -1.51 . . . . 61.41 106.924 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -108.56 107.54 18.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.198 1.399 . . . . 75.43 108.829 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 mm -78.67 138.9 19.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.655 -1.609 . . . . 75.32 106.655 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -158.25 -5.43 0.08 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 116.375 1.991 . . . . 75.02 116.375 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -150.78 110.06 3.96 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 103.959 -2.608 . . . . 73.02 103.959 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.4 t -128.74 141.9 45.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.137 -1.06 . . . . 75.21 108.137 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.41 164.29 45.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.172 1.389 . . . . 73.13 107.806 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -75.62 -7.87 25.45 Favored 'Cis proline' 0 CA--C 1.538 0.697 0 CA-C-N 119.259 0.771 . . . . 73.11 112.325 -11.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.1 109.63 20.23 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.183 0.993 . . . . 74.52 110.548 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.55 128.63 36.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 122.488 1.137 . . . . 64.05 110.365 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -107.92 177.79 4.71 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.684 1.594 . . . . 74.31 109.509 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -76.66 149.14 80.59 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.842 -0.799 . . . . 72.44 108.842 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.75 149.53 83.58 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.347 2.031 . . . . 54.22 111.037 171.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -168.39 167.35 11.96 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.072 0.949 . . . . 75.04 110.248 172.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -98.29 156.94 16.47 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.134 0.574 . . . . 74.15 109.849 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.69 128.9 35.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.7 2.0 . . . . 75.3 107.824 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.521 ' H ' ' CG2' ' A' ' 88' ' ' THR . 5.1 m-20 -84.68 129.63 34.81 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.037 -1.838 . . . . 74.02 106.037 174.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.42 150.47 23.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.371 1.868 . . . . 73.14 107.558 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HE3' ' CD1' ' A' ' 4' ' ' TRP . 23.6 mtmt -128.55 145.46 51.12 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.069 -1.456 . . . . 75.22 107.069 -171.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.3 tt -143.93 152.4 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.02 -1.474 . . . . 74.1 107.02 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.9 t -128.64 -61.92 1.04 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.54 -1.282 . . . . 75.23 107.54 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.7 -102.0 0.27 Allowed Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 106.384 -2.686 . . . . 60.11 106.384 166.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.3 p -79.4 10.92 3.3 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.431 1.271 . . . . 75.34 114.431 -173.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.8 m -118.76 127.62 53.72 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 121.084 1.765 . . . . 73.04 109.7 171.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.15 125.64 41.79 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.085 1.354 . . . . 75.32 107.383 165.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.5 tttm -111.88 87.94 2.68 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.082 0.953 . . . . 74.44 109.065 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.9 t -72.03 134.5 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.777 -1.194 . . . . 64.31 107.777 174.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -97.11 -37.94 9.93 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.577 0.751 . . . . 63.23 110.292 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.521 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.0 t -137.7 161.41 36.59 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.054 1.741 . . . . 74.41 110.004 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.38 179.08 19.37 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.284 1.421 . . . . 72.43 112.639 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.8 m -57.24 -24.02 51.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.36 0.664 . . . . 74.42 111.444 166.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -100.83 5.04 43.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.399 1.88 . . . . 72.02 111.545 -169.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.1 103.53 0.15 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.438 1.495 . . . . 75.2 111.235 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.25 -164.74 33.1 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 123.793 0.711 . . . . 60.32 112.64 -169.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 54.3 p -130.08 120.61 24.93 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.512 1.125 . . . . 74.21 109.589 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -127.74 152.09 48.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.715 0.806 . . . . 60.23 109.226 -170.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -111.37 140.86 45.59 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.3 1.04 . . . . 75.2 108.458 175.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -66.59 125.87 27.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.772 -1.196 . . . . 75.51 107.772 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--N 1.325 -0.474 0 C-N-CA 124.833 1.253 . . . . 72.21 107.827 179.819 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 CA--C 1.512 -0.498 0 N-CA-C 105.645 -1.983 . . . . 74.13 105.645 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -125.61 150.33 47.63 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.798 1.639 . . . . 64.55 109.733 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -72.07 171.86 11.15 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.469 0.652 . . . . 75.24 110.219 170.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -51.79 130.97 30.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.244 -0.889 . . . . 75.45 108.75 158.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.14 124.56 21.98 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.898 -1.149 . . . . 72.23 107.898 151.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -137.65 171.08 14.98 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 118.772 -1.171 . . . . 74.12 111.358 160.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p -69.08 36.02 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.142 2.577 . . . . 74.24 112.387 172.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -137.78 -58.18 0.67 Allowed 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 125.051 1.34 . . . . 63.15 109.006 -170.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -77.03 -21.53 54.4 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 118.563 -0.732 . . . . 74.44 112.107 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.7 -19.02 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.43 1.092 . . . . 75.44 113.57 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.3 mm -65.67 118.85 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.449 -0.945 . . . . 73.51 108.449 -171.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.75 173.69 23.88 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.336 0.97 . . . . 74.14 111.544 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -80.46 156.39 26.61 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.803 -1.184 . . . . 71.11 107.803 162.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -141.67 135.12 29.59 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.737 -0.602 . . . . 75.51 109.689 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -137.76 150.66 47.44 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.956 1.703 . . . . 74.13 109.627 -167.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.0 p -89.84 -77.16 0.4 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.933 -1.506 . . . . 75.31 106.933 161.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.87 -168.48 14.23 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 126.682 2.087 . . . . 75.44 109.879 -177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.0 pt -118.21 20.37 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.397 1.479 . . . . 73.42 110.792 -171.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -137.15 157.34 46.9 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.376 1.87 . . . . 63.13 108.478 -168.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.31 -172.09 7.69 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 121.633 0.574 . . . . 64.23 113.586 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.3 m -79.76 90.2 5.23 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.458 -1.312 . . . . 73.0 107.458 175.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.1 p-80 -110.54 -179.48 3.77 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.498 1.519 . . . . 75.05 110.371 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -140.89 157.6 45.14 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.073 1.349 . . . . 73.35 110.271 -169.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.95 140.94 32.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.702 1.601 . . . . 74.24 107.993 -173.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -123.87 169.48 11.54 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.981 0.913 . . . . 73.42 109.689 168.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.0 t -140.29 160.48 39.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.806 -1.553 . . . . 64.55 106.806 158.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -147.81 121.63 9.31 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.682 1.993 . . . . 63.33 106.271 168.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -95.33 156.23 16.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.829 0.851 . . . . 73.11 109.048 172.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.48 -23.96 37.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 61.11 111.957 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -133.16 10.68 4.18 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.046 0.758 . . . . 73.34 113.046 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.44 -119.98 3.92 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.588 -1.405 . . . . 34.23 109.588 173.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 p -141.33 -169.9 2.96 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.831 2.452 . . . . 74.13 106.505 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.6 179.05 19.21 Favored Glycine 0 CA--C 1.522 0.49 0 O-C-N 120.936 -1.102 . . . . 73.42 110.905 167.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -136.47 165.32 26.1 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.57 1.548 . . . . 73.11 109.284 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -152.44 109.62 3.54 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.551 1.541 . . . . 74.25 109.813 171.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.99 147.48 16.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.232 -1.147 . . . . 74.35 110.232 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.6 mt -119.87 139.85 45.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 105.828 -1.916 . . . . 74.24 105.828 169.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -122.41 165.82 15.71 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.942 1.297 . . . . 75.42 109.449 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 m -131.22 112.98 13.29 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.482 1.913 . . . . 73.2 106.869 160.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 m120 55.24 -73.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 130.161 3.384 . . . . 73.01 113.892 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.24 44.24 1.54 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.95 1.3 . . . . 73.12 109.649 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.5 m -150.17 123.01 4.27 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 107.758 -1.201 . . . . 75.03 107.758 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.6 137.73 36.65 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.342 2.028 . . . . 60.4 108.967 167.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.3 mm -126.35 -25.42 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.442 1.097 . . . . 74.33 110.791 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.5 t -141.12 157.85 44.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 120.63 -1.294 . . . . 73.5 109.194 169.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -151.0 135.84 17.32 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 129.166 2.987 . . . . 74.32 105.139 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.58 163.19 40.09 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.454 -2.054 . . . . 70.44 105.454 165.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.9 mtm -130.28 167.98 17.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.431 -0.952 . . . . 74.52 108.431 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -160.6 148.85 16.35 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.585 0.754 . . . . 63.54 109.132 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.67 163.9 20.45 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.953 -1.129 . . . . 74.34 107.953 163.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -150.88 161.84 41.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.889 -0.507 . . . . 74.51 109.935 172.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -129.32 159.48 36.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.072 -1.084 . . . . 74.14 108.072 156.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.3 mm -105.02 102.43 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 103.638 -2.727 . . . . 73.45 103.638 162.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.94 27.22 2.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.093 0.949 . . . . 73.13 109.655 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.52 15.1 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 114.206 1.187 . . . . 74.23 114.206 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.93 23.72 66.01 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.564 -1.415 . . . . 73.51 109.564 -168.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -149.56 163.06 38.89 Favored 'General case' 0 N--CA 1.445 -0.712 1 C-N-CA 132.143 4.177 . . . . 73.53 103.843 -171.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.23 155.23 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.635 -1.617 . . . . 73.35 106.635 172.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -124.12 124.36 42.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.649 2.379 . . . . 74.45 106.911 164.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 mm -114.04 137.17 48.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.541 1.936 . . . . 74.44 106.458 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -160.08 6.96 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.281 1.215 . . . . 72.23 114.281 -172.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -151.96 123.81 8.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.17 -2.53 . . . . 71.11 104.17 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.3 t -132.57 144.81 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.943 -1.503 . . . . 74.11 106.943 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.21 159.95 68.9 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 108.165 -1.05 . . . . 73.51 108.165 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.58 -7.5 47.5 Favored 'Cis proline' 0 CA--C 1.534 0.485 0 N-CA-C 113.815 0.66 . . . . 74.33 113.815 -3.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -116.71 120.66 39.28 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.318 -1.734 . . . . 52.23 106.318 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -76.57 124.47 27.66 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.633 1.173 . . . . 72.5 108.686 -174.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 mttm -97.5 166.04 11.71 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.581 -0.896 . . . . 72.24 108.581 169.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.82 149.88 15.67 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.577 1.151 . . . . 64.11 109.315 171.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -68.9 142.84 53.01 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.217 1.944 . . . . 73.52 110.499 169.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -150.79 165.39 33.68 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 120.898 -1.126 . . . . 73.13 109.864 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -99.61 159.06 15.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.668 -0.864 . . . . 74.43 108.668 167.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.1 mt -131.54 118.9 20.76 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.373 1.069 . . . . 72.52 109.272 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -59.67 112.35 1.78 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.109 -1.441 . . . . 64.52 107.109 167.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.2 168.63 19.29 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 107.042 -1.466 . . . . 75.31 107.042 166.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.38 170.54 15.58 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.838 1.255 . . . . 73.11 111.49 163.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 tt -154.4 147.98 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 123.478 0.711 . . . . 75.41 109.303 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 m -151.39 48.81 0.82 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 129.473 3.109 . . . . 73.25 110.412 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.68 -66.9 3.32 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 126.207 1.86 . . . . 61.51 112.19 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -124.7 2.57 8.21 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.82 1.415 . . . . 75.34 114.82 -168.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 m -118.9 100.88 7.65 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.698 1.599 . . . . 72.55 107.806 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.3 tp -77.52 125.15 28.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.933 -1.506 . . . . 75.52 106.933 166.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -119.06 92.64 3.85 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 123.988 0.915 . . . . 72.43 108.973 177.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.78 137.35 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.669 -1.234 . . . . 75.35 107.669 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -100.58 -14.68 18.09 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.209 1.188 . . . . 75.32 114.209 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.1 t -151.6 163.87 38.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.429 1.013 . . . . 70.55 112.525 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.79 -175.79 53.28 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-O 122.832 1.24 . . . . 72.25 110.314 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.3 m -49.22 -27.62 3.85 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.802 1.641 . . . . 71.23 113.362 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -95.83 2.06 53.52 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.191 1.182 . . . . 62.55 114.191 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.68 105.17 0.14 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.347 1.059 . . . . 65.51 111.211 -173.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 173.47 -138.54 4.65 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.91 0.767 . . . . 72.35 112.62 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.8 t -150.5 132.14 14.89 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.416 1.486 . . . . 75.34 107.934 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -134.36 134.22 41.51 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 123.721 0.808 . . . . 73.54 109.323 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -75.98 153.93 36.19 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.428 -0.953 . . . . 72.11 108.428 167.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -69.84 154.97 41.25 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.555 -0.905 . . . . 75.15 108.555 168.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 . . . . . 0 C--N 1.327 -0.386 0 C-N-CA 126.224 1.81 . . . . 74.51 107.461 163.819 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 105.546 -2.02 . . . . 75.13 105.546 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -114.55 155.17 26.96 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 126.447 1.899 . . . . 75.1 110.778 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 p -72.27 175.64 5.93 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.35 -0.611 . . . . 64.42 109.35 164.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -56.92 150.23 17.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.337 1.065 . . . . 73.44 110.114 155.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.1 tp -84.76 129.23 34.85 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 125.722 1.609 . . . . 75.43 107.159 155.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -135.44 166.23 23.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.363 -1.347 . . . . 74.32 107.363 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 t -67.29 -2.61 6.24 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.574 1.15 . . . . 75.24 112.788 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -108.01 -36.8 6.24 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.131 -0.981 . . . . 73.33 109.436 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.82 -23.92 66.54 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.39 1.076 . . . . 74.21 112.895 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.3 tp -90.12 -16.1 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.0 1.32 . . . . 75.44 113.101 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.3 mm -69.75 130.5 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.952 1.301 . . . . 62.13 110.983 -163.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.34 -175.24 20.82 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.783 1.658 . . . . 63.51 110.324 175.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -82.17 169.97 16.0 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.403 -0.962 . . . . 73.33 108.403 167.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -132.58 -175.86 3.9 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.556 -1.276 . . . . 74.2 107.556 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 t -169.05 167.04 10.81 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.722 1.601 . . . . 75.21 109.745 162.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.513 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 2.3 t -136.98 -19.43 1.3 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.506 1.122 . . . . 62.22 112.799 -177.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.78 171.27 38.77 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.666 -1.774 . . . . 63.01 108.666 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.81 19.11 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.972 1.309 . . . . 75.01 110.578 -169.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.76 -179.65 6.59 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 127.195 2.198 . . . . 64.31 108.33 -174.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.02 -117.58 6.94 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.108 0.861 . . . . 74.02 111.964 170.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.2 m -132.13 98.95 4.56 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.664 -1.235 . . . . 71.3 107.664 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -114.56 171.11 7.83 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.471 1.108 . . . . 73.14 110.21 -175.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -138.92 136.05 35.07 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.854 -1.165 . . . . 74.44 107.854 -165.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.51 96.17 4.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.028 1.331 . . . . 75.25 109.392 -171.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.0 mt -77.89 153.24 32.8 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.633 1.573 . . . . 72.44 110.811 164.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.0 p -141.16 158.77 43.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.871 1.268 . . . . 75.55 109.267 162.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -141.12 124.65 16.75 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.015 1.326 . . . . 75.45 108.415 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.5 159.91 16.26 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.206 1.402 . . . . 61.51 107.746 170.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -83.96 -32.95 24.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.802 0.841 . . . . 73.33 112.239 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -138.87 30.32 2.27 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.641 1.176 . . . . 63.32 109.836 -172.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -127.86 -110.92 1.61 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.448 -1.461 . . . . 71.55 109.448 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.2 p -146.01 -170.66 3.53 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.049 2.14 . . . . 73.45 107.361 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.0 167.92 12.93 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.846 -1.302 . . . . 51.32 109.846 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -144.29 155.86 44.01 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.826 -0.808 . . . . 63.44 110.199 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -139.93 120.48 14.17 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.164 1.385 . . . . 63.32 107.764 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.85 157.18 15.13 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.752 -1.339 . . . . 72.33 109.752 168.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.3 mt -122.28 146.59 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 105.835 -1.913 . . . . 60.25 105.835 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -134.82 144.68 47.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.227 1.411 . . . . 72.31 108.449 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.9 125.87 48.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.192 -2.151 . . . . 71.34 105.192 158.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.2 m120 62.86 -83.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.582 1.553 . . . . 75.32 112.977 160.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.4 59.98 0.96 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.642 1.177 . . . . 74.5 108.651 163.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.0 m -144.89 130.19 9.36 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 127.137 2.175 . . . . 75.13 106.316 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.94 141.48 48.76 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.452 2.101 . . . . 74.03 109.651 167.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.3 mm -131.73 -22.26 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.763 1.225 . . . . 75.14 110.998 -174.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.9 t -143.47 167.66 21.67 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.576 -1.328 . . . . 75.01 110.251 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -160.09 146.88 16.03 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.551 1.94 . . . . 75.34 108.726 -175.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -159.05 164.05 35.78 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.386 1.874 . . . . 74.32 107.573 163.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.5 mtm -121.18 156.84 31.52 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.744 1.618 . . . . 73.33 107.149 162.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -161.3 138.01 8.53 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.141 0.976 . . . . 63.11 109.711 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -75.11 163.24 27.77 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.705 0.764 . . . . 74.24 109.262 166.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -153.08 158.15 41.49 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.799 0.84 . . . . 75.13 111.064 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -137.06 158.28 44.81 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.562 -0.711 . . . . 73.31 110.485 169.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.5 mm -111.14 90.85 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 106.81 -1.552 . . . . 73.01 106.81 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -121.5 22.86 10.55 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.381 1.252 . . . . 71.25 114.381 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -174.9 14.98 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 116.341 1.978 . . . . 64.05 116.341 -173.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.27 16.23 77.06 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 119.475 -2.016 . . . . 62.25 114.39 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -130.69 -170.7 2.39 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.796 2.038 . . . . 71.04 108.269 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.4 mt -113.2 106.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.802 1.637 . . . . 74.31 107.263 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -72.12 124.13 24.33 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.539 -1.282 . . . . 73.43 107.539 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.8 mm -111.15 139.07 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.406 -2.072 . . . . 74.21 105.406 170.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -157.49 8.57 0.17 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.954 0.902 . . . . 75.34 112.306 -175.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -152.6 118.9 5.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 103.18 -2.896 . . . . 75.44 103.18 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -135.65 152.23 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.223 -2.14 . . . . 75.23 105.223 169.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.05 161.64 54.61 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 125.34 1.456 . . . . 73.15 107.583 173.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -81.86 -6.81 46.39 Favored 'Cis proline' 0 CA--C 1.54 0.789 0 N-CA-C 114.319 0.854 . . . . 71.21 114.319 -6.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.92 104.78 14.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 104.731 -2.322 . . . . 63.42 104.731 168.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -64.01 155.2 31.86 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.814 0.696 . . . . 72.45 110.495 170.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -129.67 162.29 28.67 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.109 1.364 . . . . 73.05 107.854 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 t -54.92 149.26 24.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 109.072 -0.714 . . . . 73.21 109.072 171.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.12 147.19 53.7 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.241 1.961 . . . . 61.34 110.992 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -156.52 174.05 16.01 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.825 1.25 . . . . 71.15 109.755 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -117.05 131.08 57.02 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.811 -1.181 . . . . 74.45 107.811 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.5 mt -101.06 116.4 32.75 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.649 1.179 . . . . 74.22 108.578 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.9 116.28 5.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.844 1.258 . . . . 72.05 108.045 172.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.1 p -139.42 156.77 46.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.757 0.789 . . . . 71.44 110.045 161.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HZ2' ' CD ' ' A' ' 87' ' ' GLU . 25.5 mttt -116.28 159.34 22.01 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.279 -1.328 . . . . 74.04 108.964 168.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 tt -152.89 154.35 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.671 -1.603 . . . . 75.23 106.671 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.8 p -133.37 -11.22 2.83 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.836 1.421 . . . . 62.0 114.836 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.32 -91.17 0.15 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 107.098 -2.401 . . . . 74.43 107.098 -165.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.5 p -106.7 -0.42 23.62 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.454 1.65 . . . . 71.02 115.454 -167.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.6 m -114.16 109.93 19.18 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.568 1.947 . . . . 74.31 109.878 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.89 136.1 40.12 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 119.837 -1.789 . . . . 64.42 107.39 167.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -119.2 88.63 2.97 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.602 -0.518 . . . . 74.3 109.602 162.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.0 t -81.5 133.03 30.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.859 -0.793 . . . . 71.35 108.859 170.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.42 ' CD ' ' HZ2' ' A' ' 78' ' ' LYS . 33.0 mt-10 -106.43 -18.59 13.94 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.708 1.203 . . . . 74.23 112.872 -171.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.4 t -155.75 171.66 19.64 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.244 1.417 . . . . 64.01 109.298 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.81 178.28 40.78 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 122.836 1.242 . . . . 64.23 110.378 -173.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.1 m -59.55 -21.37 60.18 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 113.706 1.002 . . . . 74.43 113.706 174.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -109.96 19.48 18.99 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.342 1.608 . . . . 73.11 115.342 -176.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.14 109.24 0.56 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.171 0.988 . . . . 74.31 111.484 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.83 -156.15 26.7 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.184 1.374 . . . . 54.41 112.912 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -119.81 125.48 48.67 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.979 1.312 . . . . 64.03 110.158 -173.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.513 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 6.1 m-85 -133.3 152.23 51.92 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.003 0.43 . . . . 74.01 110.848 -174.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -103.53 138.3 40.41 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.352 1.461 . . . . 73.24 107.473 172.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -52.78 149.23 6.43 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.295 0.952 . . . . 74.24 109.408 166.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 . . . . . 0 C--O 1.237 0.415 0 C-N-CA 126.52 1.928 . . . . 74.43 108.208 169.612 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 . . . . . 0 CA--C 1.511 -0.549 0 N-CA-C 106.172 -1.788 . . . . 75.23 106.172 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -106.51 -174.09 2.45 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.755 2.022 . . . . 75.53 111.592 -173.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.7 p -110.4 160.67 16.37 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.597 0.759 . . . . 74.53 110.126 168.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.56 127.16 26.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.11 2.164 . . . . 73.43 109.288 173.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 tp -79.7 92.04 5.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.893 -1.151 . . . . 74.11 107.893 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -94.56 164.36 13.01 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 125.33 1.452 . . . . 65.21 107.581 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.45 -45.89 73.19 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.241 1.016 . . . . 74.12 109.873 172.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -76.51 -19.35 58.07 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 119.454 -0.898 . . . . 70.2 112.425 -170.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.2 -40.5 62.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.914 -0.491 . . . . 71.3 111.003 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.1 tp -76.61 -13.32 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 120.91 -1.119 . . . . 74.41 113.695 -170.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 mm -52.28 136.0 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.032 1.333 . . . . 74.44 112.655 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.58 178.85 15.66 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 125.855 1.693 . . . . 72.24 110.739 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -84.87 167.06 16.33 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.405 -0.961 . . . . 73.53 108.405 165.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -147.41 139.86 24.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.417 -1.327 . . . . 74.24 107.417 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 t -141.71 170.09 16.37 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.569 -1.332 . . . . 71.2 110.203 166.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.3 t -132.71 0.43 3.57 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.462 2.305 . . . . 75.33 111.546 -173.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.93 179.28 38.12 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.175 -1.17 . . . . 75.52 110.175 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.2 pt -130.8 22.87 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.711 1.604 . . . . 73.22 109.571 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -142.53 -175.88 4.64 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.328 1.451 . . . . 74.24 109.654 -169.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.84 -119.38 16.08 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.534 -1.026 . . . . 55.34 110.534 156.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -131.79 101.69 5.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.979 -1.86 . . . . 73.34 105.979 161.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -114.34 172.5 6.97 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.641 0.734 . . . . 74.41 109.061 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -143.14 144.58 32.27 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.418 -0.956 . . . . 74.42 108.418 -160.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.84 103.13 5.93 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 122.994 0.518 . . . . 73.23 109.671 -167.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.5 mt -94.64 154.45 17.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.467 1.107 . . . . 71.55 110.068 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 p -146.12 125.16 12.82 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.425 1.09 . . . . 74.35 109.769 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -124.03 114.96 20.43 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 120.166 1.348 . . . . 74.21 109.793 -174.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -92.42 152.76 19.54 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 124.151 0.907 . . . . 73.3 110.033 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -81.26 -20.48 40.85 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 114.268 1.21 . . . . 73.11 114.268 -174.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -133.48 1.11 3.39 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.328 0.513 . . . . 74.22 112.245 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.83 -123.17 5.2 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.435 -1.466 . . . . 43.15 109.435 173.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.3 p -134.74 -171.1 2.7 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.858 1.663 . . . . 72.32 108.542 -164.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.37 165.65 12.15 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.99 -0.844 . . . . 64.13 110.99 165.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -142.56 166.38 24.82 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.846 0.859 . . . . 65.53 110.832 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -146.99 133.0 19.18 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.492 -1.299 . . . . 73.52 107.492 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.45 161.62 24.48 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.184 -1.167 . . . . 62.11 110.184 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.3 mt -131.94 121.51 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.109 -1.811 . . . . 71.24 106.109 -174.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -118.49 132.53 56.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.72 1.208 . . . . 71.11 109.016 -171.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 m -97.68 119.24 35.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.554 -1.276 . . . . 73.13 107.554 166.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 46.77 -85.2 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 127.844 2.457 . . . . 75.22 113.72 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.51 56.68 1.65 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.827 1.251 . . . . 72.04 109.402 170.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 m -143.58 122.57 7.32 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.154 1.782 . . . . 72.44 107.84 171.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.44 137.6 36.77 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.842 2.362 . . . . 73.13 109.847 165.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.0 mm -128.17 -15.27 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.187 0.995 . . . . 71.33 111.164 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.4 t -135.56 167.41 21.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 119.775 -1.828 . . . . 71.24 110.059 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -163.47 147.27 10.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.303 -0.862 . . . . 74.42 108.921 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -167.99 165.96 13.41 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.444 1.498 . . . . 63.15 108.311 166.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.3 mtm -133.48 161.29 34.97 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.089 1.356 . . . . 72.23 108.048 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -162.6 140.11 8.17 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.992 1.317 . . . . 71.32 109.155 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.42 161.81 26.8 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.271 -1.011 . . . . 74.34 108.271 163.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -144.14 164.56 30.33 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.669 -0.644 . . . . 74.53 109.344 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -136.7 156.42 48.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.806 -0.813 . . . . 74.34 108.806 166.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.0 mm -107.04 99.81 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 106.173 -1.788 . . . . 74.22 106.173 168.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.2 28.52 3.75 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.885 0.874 . . . . 72.44 112.353 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -163.14 14.01 0.07 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.003 1.721 . . . . 74.33 115.129 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.49 21.03 47.92 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.254 -1.529 . . . . 74.54 113.111 -168.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -132.69 -168.45 2.07 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.86 2.864 . . . . 74.44 106.875 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.7 mt -118.32 110.89 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.897 -1.52 . . . . 72.32 106.897 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -80.78 120.24 24.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.332 -1.359 . . . . 72.32 107.332 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.0 mm -108.02 135.0 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 105.356 -2.09 . . . . 71.14 105.356 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -154.06 8.29 0.35 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.809 0.843 . . . . 64.22 112.494 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -151.6 121.08 6.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 104.168 -2.53 . . . . 74.41 104.168 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.5 t -136.26 149.91 27.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.051 -1.833 . . . . 74.52 106.051 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.99 160.29 53.32 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.6 1.56 . . . . 72.53 108.04 177.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.78 -13.66 27.89 Favored 'Cis proline' 0 CA--C 1.535 0.555 0 CA-C-N 119.539 0.871 . . . . 74.24 113.802 -10.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.76 103.1 15.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 104.022 -2.584 . . . . 62.24 104.022 171.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -66.82 160.07 26.75 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.307 -0.627 . . . . 73.22 109.307 167.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -137.9 174.7 10.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.118 1.367 . . . . 74.43 108.315 168.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.5 t -51.32 150.76 5.86 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 108.861 -0.792 . . . . 71.35 108.861 168.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -65.2 153.23 79.27 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.077 1.851 . . . . 74.25 109.333 163.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -159.3 172.07 18.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.555 1.542 . . . . 74.43 109.008 175.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -114.15 146.01 40.89 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.846 -1.168 . . . . 71.54 107.846 172.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.3 mt -123.9 115.98 22.16 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.769 1.228 . . . . 74.54 107.94 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.06 127.53 33.46 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.205 1.002 . . . . 73.53 108.353 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.9 m -144.73 160.66 40.86 Favored 'General case' 0 CA--C 1.522 -0.124 0 O-C-N 121.787 -0.57 . . . . 72.41 109.803 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -121.41 155.72 34.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.333 1.453 . . . . 72.53 108.695 173.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 tt -145.75 148.23 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 119.095 0.862 . . . . 70.1 110.532 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.0 p -152.37 77.53 1.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.552 1.141 . . . . 64.33 109.913 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.4 -59.63 0.17 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 127.838 2.637 . . . . 74.23 115.385 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 p -132.6 22.16 4.3 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.479 1.111 . . . . 72.13 112.294 174.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.7 m -127.68 131.89 49.74 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.682 1.193 . . . . 72.24 107.989 167.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.98 131.96 56.44 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.524 1.929 . . . . 75.12 107.885 167.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -120.14 98.57 6.13 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.489 1.516 . . . . 73.23 108.183 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.6 t -75.89 125.59 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.436 -1.69 . . . . 63.32 106.436 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -83.15 -33.86 26.16 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.512 0.596 . . . . 64.2 111.474 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.0 t -146.76 155.77 42.64 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.446 1.498 . . . . 74.2 109.127 -170.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.07 -175.42 15.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 124.978 1.275 . . . . 53.21 111.414 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -24.61 63.29 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.895 -1.05 . . . . 63.43 112.432 169.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.487 ' CD ' ' HH ' ' A' ' 95' ' ' TYR . 11.1 mm-40 -111.68 24.19 13.01 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.406 1.003 . . . . 72.14 112.342 -168.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.39 102.41 0.23 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.341 1.456 . . . . 75.03 112.659 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.74 -124.97 0.92 Allowed Glycine 0 N--CA 1.463 0.498 0 C-N-CA 124.23 0.919 . . . . 75.14 112.557 -173.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -152.2 147.48 26.45 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.691 1.196 . . . . 63.33 111.186 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.487 ' HH ' ' CD ' ' A' ' 91' ' ' GLU . 61.7 m-85 -143.51 146.7 33.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.336 1.454 . . . . 71.24 110.0 176.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -115.19 27.24 9.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.522 1.129 . . . . 73.52 113.69 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttt 61.76 159.28 0.06 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.692 1.997 . . . . 63.24 111.255 -170.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 . . . . . 0 C--N 1.324 -0.522 0 C-N-CA 127.786 2.434 . . . . 73.14 106.083 163.345 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 104.1 -2.556 . . . . 61.04 104.1 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -121.81 -178.63 3.88 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 125.755 1.622 . . . . 71.22 108.624 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.6 p -111.42 170.19 8.29 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.588 0.631 . . . . 73.45 111.072 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.36 119.07 5.42 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.548 1.139 . . . . 70.05 109.669 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.9 tp -70.84 123.24 21.51 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.528 -1.656 . . . . 73.44 106.528 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -136.85 175.2 9.83 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.053 0.941 . . . . 65.33 108.903 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.3 p -58.51 -41.07 84.55 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.56 1.544 . . . . 73.34 111.821 -174.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.89 -30.14 35.53 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.384 0.674 . . . . 61.22 109.857 -174.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.6 -38.51 91.38 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.394 0.543 . . . . 74.22 111.021 -170.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.5 tp -74.43 -24.81 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.616 1.166 . . . . 70.51 112.636 -172.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm -57.02 109.58 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.91 1.684 . . . . 74.14 111.21 -168.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.97 172.89 32.99 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.784 -0.926 . . . . 54.12 110.784 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -86.51 160.02 19.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.42 -0.956 . . . . 72.43 108.42 159.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -146.89 140.86 26.0 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.475 1.51 . . . . 74.11 108.894 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.0 t -138.09 179.42 6.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.238 1.415 . . . . 65.43 107.874 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 t -137.27 -40.03 0.59 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.647 -1.283 . . . . 71.21 112.034 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.86 179.6 30.79 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 106.652 -2.579 . . . . 74.22 106.652 167.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.8 pt -130.41 36.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.304 1.041 . . . . 65.44 109.678 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -139.61 174.39 10.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.947 1.299 . . . . 71.44 109.606 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.68 -95.22 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.991 1.758 . . . . 52.11 114.024 169.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -139.44 141.89 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 105.688 -1.967 . . . . 74.52 105.688 162.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -151.45 -179.47 7.41 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.487 1.115 . . . . 73.23 108.112 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -142.47 140.86 32.04 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.131 0.973 . . . . 72.43 108.767 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.32 154.08 17.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.859 2.064 . . . . 74.33 107.032 170.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 mt -145.02 147.76 32.97 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.39 1.876 . . . . 73.43 105.951 169.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 p -151.02 154.71 37.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.015 0.825 . . . . 73.2 110.516 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -143.56 118.12 9.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.257 1.023 . . . . 71.23 108.782 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.5 158.76 25.76 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.61 -0.885 . . . . 52.04 108.61 164.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -79.6 -39.04 32.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.023 0.529 . . . . 71.31 110.427 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.29 8.79 7.88 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.897 0.879 . . . . 75.02 110.678 -166.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.27 -133.21 5.36 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 126.694 2.092 . . . . 74.54 108.062 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -126.35 -177.89 4.14 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.299 1.44 . . . . 75.14 108.441 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.27 160.1 15.27 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.667 1.603 . . . . 62.22 110.461 171.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 m -133.63 158.2 43.83 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.326 1.051 . . . . 71.54 109.871 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -149.1 129.11 13.49 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.464 1.906 . . . . 72.43 107.082 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.87 119.21 1.11 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.226 -1.15 . . . . 71.53 110.226 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.463 ' H ' ' HB3' ' A' ' 47' ' ' SER . 35.9 mt -75.95 150.63 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.558 -0.905 . . . . 74.22 108.558 174.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -132.09 133.58 44.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.443 1.497 . . . . 73.2 108.222 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 m -83.17 135.34 34.83 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 105.792 -1.929 . . . . 73.23 105.792 159.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 43.42 -80.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.785 2.434 . . . . 72.51 115.825 156.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.07 64.42 1.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.073 0.949 . . . . 73.43 111.597 162.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 m -157.65 135.83 7.48 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 128.469 2.707 . . . . 71.23 108.875 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.25 119.89 5.76 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.312 3.341 . . . . 74.11 111.927 170.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 mm -122.8 17.12 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.611 1.564 . . . . 73.53 111.071 -173.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.463 ' HB3' ' H ' ' A' ' 39' ' ' ILE . 30.4 t -158.03 164.26 36.91 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 119.492 -2.005 . . . . 63.52 108.117 157.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -158.72 127.86 5.53 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.898 2.079 . . . . 73.2 106.122 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -143.4 169.31 17.9 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.145 1.778 . . . . 71.44 107.604 163.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.0 mtm -145.92 160.43 41.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.44 1.096 . . . . 75.32 110.302 170.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -161.89 147.55 13.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.626 1.57 . . . . 73.41 108.23 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.59 176.18 7.87 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.447 1.476 . . . . 73.53 108.614 170.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -157.43 161.96 38.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.266 -0.896 . . . . 65.5 111.139 168.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -131.15 165.0 24.26 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.454 0.702 . . . . 74.04 109.338 163.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.8 mm -123.8 83.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 105.753 -1.943 . . . . 73.4 105.753 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.28 24.14 10.89 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.064 1.346 . . . . 65.44 110.074 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -164.25 13.51 0.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.963 1.305 . . . . 73.04 114.092 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.65 14.6 65.22 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 120.977 -1.077 . . . . 73.34 111.843 -171.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -137.19 170.94 15.25 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.143 2.177 . . . . 73.41 106.625 173.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 mt -75.27 165.61 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.446 -1.316 . . . . 73.44 107.446 176.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -136.52 108.62 7.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.976 2.11 . . . . 71.2 106.179 162.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mm -93.46 145.59 7.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 106.02 -1.845 . . . . 65.54 106.02 168.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -150.25 -1.45 0.41 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.131 1.16 . . . . 75.03 114.131 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.36 115.92 3.84 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.079 -2.563 . . . . 75.44 104.079 -167.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.34 149.43 32.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.295 1.038 . . . . 74.44 108.459 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.64 164.41 32.88 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.998 2.119 . . . . 63.32 106.094 168.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.03 -16.09 19.67 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.412 0.826 . . . . 70.4 113.69 -5.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.09 119.89 34.37 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.683 -1.599 . . . . 72.31 106.683 172.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -79.4 141.66 36.67 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 118.668 0.667 . . . . 73.52 110.281 177.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -136.61 160.16 39.65 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.605 1.162 . . . . 73.3 111.315 -177.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 t -57.69 151.62 40.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.588 1.955 . . . . 65.34 111.464 170.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.88 158.05 38.88 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.665 2.91 . . . . 74.42 112.484 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -171.04 172.4 5.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.664 1.186 . . . . 73.43 111.176 173.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -115.93 96.89 5.8 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.963 1.705 . . . . 71.51 110.052 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.2 mt -75.54 133.13 41.06 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 126.238 1.815 . . . . 64.4 109.258 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.1 130.49 34.48 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.776 1.23 . . . . 73.33 109.303 176.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.3 p -154.64 166.62 32.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.487 1.915 . . . . 72.52 109.306 170.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -131.57 155.33 47.69 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.643 1.577 . . . . 74.51 109.649 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.9 tt -146.89 147.92 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.411 1.084 . . . . 65.54 108.122 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 m -138.74 -5.37 1.53 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.185 1.394 . . . . 74.11 114.626 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.02 -89.89 0.11 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 107.978 -2.049 . . . . 73.1 107.978 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.0 p -119.8 -4.35 10.2 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.676 1.361 . . . . 73.21 114.676 -172.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -99.08 114.14 26.7 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 121.039 1.745 . . . . 73.54 110.582 172.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.5 tp -85.49 116.17 23.64 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 119.441 -2.037 . . . . 63.12 108.297 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.87 105.51 15.73 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.011 0.924 . . . . 63.43 109.792 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.426 ' HB ' ' H ' ' A' ' 93' ' ' GLY . 18.5 t -90.12 127.68 42.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.132 -0.692 . . . . 71.22 109.132 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -85.53 -38.2 18.79 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 118.662 0.664 . . . . 64.14 110.699 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -148.54 173.35 13.23 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.092 0.86 . . . . 74.34 110.962 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.42 177.07 23.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 125.088 1.328 . . . . 64.13 110.361 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.8 m -53.48 -30.94 43.51 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.589 1.155 . . . . 74.22 110.252 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -89.51 0.52 56.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.713 1.005 . . . . 73.5 113.713 -174.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.48 109.87 0.26 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.801 1.64 . . . . 71.41 109.651 -175.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.426 ' H ' ' HB ' ' A' ' 86' ' ' VAL . . . 166.15 -167.97 39.6 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 109.024 -1.63 . . . . 71.44 109.024 -167.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.8 t -135.13 147.98 49.64 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.108 -1.071 . . . . 72.53 108.108 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -146.68 160.53 42.09 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.17 1.388 . . . . 73.43 109.97 -167.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.78 140.25 49.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.441 1.496 . . . . 74.21 109.405 175.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -60.77 144.47 52.35 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.776 1.231 . . . . 74.32 109.952 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 . . . . . 0 CA--C 1.534 0.365 0 C-N-CA 126.861 2.064 . . . . 74.52 109.11 178.235 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 . . . . . 0 C--O 1.236 0.379 0 N-CA-C 105.745 -1.946 . . . . 65.15 105.745 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -117.42 154.01 32.11 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.581 1.153 . . . . 71.53 110.48 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.2 p -75.32 165.85 24.52 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.28 -0.637 . . . . 73.25 109.28 172.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -64.19 130.93 45.86 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.755 1.264 . . . . 75.14 108.873 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.04 133.83 55.16 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 114.597 -1.183 . . . . 75.55 109.184 164.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.31 166.7 23.85 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.157 -1.383 . . . . 71.12 109.428 166.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -44.9 78.09 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 124.328 1.017 . . . . 71.34 108.957 167.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -60.83 -24.82 66.17 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.963 -1.086 . . . . 73.12 112.152 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -85.96 -26.86 25.25 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 118.432 -0.794 . . . . 71.44 112.457 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.0 tp -88.07 -7.52 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.54 1.064 . . . . 75.12 112.168 -171.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.406 ' O ' ' HE3' ' A' ' 97' ' ' LYS . 18.3 mm -62.23 114.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.218 1.407 . . . . 75.51 110.445 -172.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.6 173.92 25.71 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.435 -1.066 . . . . 63.11 110.435 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -85.62 151.55 23.81 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.369 -1.345 . . . . 74.54 107.369 162.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -138.58 123.84 19.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.108 1.363 . . . . 73.44 108.772 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -129.1 170.13 13.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.327 0.651 . . . . 74.15 109.403 173.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.43 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 12.5 t -126.82 -6.07 6.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.77 1.628 . . . . 71.15 111.369 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.07 177.46 19.9 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 108.665 -1.774 . . . . 63.12 108.665 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 pt -131.65 -11.04 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.702 0.801 . . . . 73.53 112.655 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -72.05 153.72 41.56 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 120.104 -1.623 . . . . 73.51 110.409 173.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.18 -111.64 3.31 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.698 -1.057 . . . . 72.52 111.237 165.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.6 m -141.78 107.49 5.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.966 -1.494 . . . . 74.12 106.966 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -103.11 175.43 5.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 122.229 1.014 . . . . 73.42 110.779 -174.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -126.89 140.08 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.461 1.905 . . . . 71.33 106.826 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.45 143.51 51.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.94 1.296 . . . . 75.54 108.428 -176.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.0 mt -132.12 156.75 45.81 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.034 -1.469 . . . . 75.14 107.034 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.0 p -154.92 97.64 1.97 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.689 1.596 . . . . 75.52 112.311 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -91.59 132.42 36.33 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.243 1.417 . . . . 75.53 110.289 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' A' ' 34' ' ' THR . 2.7 p30 -94.11 165.33 12.68 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 127.77 2.428 . . . . 60.35 108.949 159.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -104.26 6.64 35.57 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.059 1.744 . . . . 73.52 110.549 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -149.94 7.3 0.62 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 115.162 1.541 . . . . 75.31 115.162 175.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.06 -110.97 1.51 Allowed Glycine 0 C--N 1.337 0.632 0 CA-C-N 118.498 0.59 . . . . 72.54 112.132 -170.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.425 ' H ' ' CG ' ' A' ' 30' ' ' ASP . 35.4 p -147.16 131.83 17.86 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.418 1.487 . . . . 74.44 107.927 -174.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.95 175.96 34.06 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.137 -0.785 . . . . 71.42 111.137 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m -145.04 164.27 31.69 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.817 -1.402 . . . . 75.41 111.943 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -141.63 120.5 12.73 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.024 -0.732 . . . . 63.41 109.024 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -121.35 161.65 15.35 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.553 1.073 . . . . 64.14 111.097 177.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.4 mt -137.7 133.62 45.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.962 -1.866 . . . . 73.22 105.962 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -125.93 127.03 45.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.593 1.557 . . . . 75.22 108.965 -170.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -86.01 112.83 21.59 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.149 -1.056 . . . . 55.2 108.149 166.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.24 -85.95 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.921 2.089 . . . . 74.3 110.307 -169.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.92 -0.42 3.41 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.155 0.982 . . . . 60.1 112.264 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.5 m -84.11 119.65 73.61 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.267 1.427 . . . . 74.43 108.161 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.36 140.19 57.26 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.862 2.375 . . . . 64.51 109.778 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.8 mm -124.42 -41.61 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 124.213 1.005 . . . . 75.11 109.655 -177.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.2 t -124.63 156.18 37.91 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 121.495 -0.753 . . . . 73.31 109.641 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -154.82 152.99 30.47 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.987 1.715 . . . . 75.41 108.235 172.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -161.48 161.07 29.92 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 127.723 2.409 . . . . 75.4 107.286 168.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.6 mtm -124.3 163.3 21.95 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.199 1.0 . . . . 75.23 110.048 166.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -164.57 141.7 6.38 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.433 1.093 . . . . 71.35 111.035 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.8 158.83 20.83 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.151 0.98 . . . . 72.54 108.961 164.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -151.33 166.73 30.07 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.158 -0.964 . . . . 75.21 110.556 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -138.07 149.3 45.88 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.187 -1.042 . . . . 75.43 108.187 165.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.2 mm -116.61 92.98 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 106.888 -1.523 . . . . 74.33 106.888 172.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -134.31 23.32 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.648 0.779 . . . . 74.51 112.484 -173.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -166.71 14.13 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.805 0.842 . . . . 75.12 111.791 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.77 5.59 57.39 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.342 -0.848 . . . . 72.15 111.947 -171.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.453 ' HB3' ' HA ' ' A' ' 76' ' ' ASP . 0.6 OUTLIER -121.51 145.01 48.39 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 130.458 3.503 . . . . 74.25 109.551 173.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.98 121.04 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.583 -1.636 . . . . 74.33 106.583 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -88.75 112.36 23.08 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.474 -1.676 . . . . 75.55 106.474 169.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 mm -103.92 138.4 28.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 106.304 -1.739 . . . . 74.22 106.304 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -158.62 2.59 0.1 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.767 1.025 . . . . 75.44 113.767 -172.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -153.43 125.15 7.72 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 103.544 -2.762 . . . . 64.53 103.544 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.9 t -135.49 152.23 31.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.973 -1.491 . . . . 73.23 106.973 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.78 160.66 52.59 Favored Pre-proline 0 C--O 1.239 0.549 0 C-N-CA 123.855 0.862 . . . . 74.42 109.046 175.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.78 -8.01 16.91 Favored 'Cis proline' 0 CA--C 1.534 0.523 0 CA-C-N 118.794 0.605 . . . . 62.43 113.45 -8.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -108.09 107.05 17.55 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.643 -1.244 . . . . 71.51 107.643 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -67.35 140.67 57.25 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.966 -0.753 . . . . 75.12 108.966 169.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -130.89 172.8 11.63 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.143 1.377 . . . . 75.32 109.146 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.7 t -49.81 150.53 3.77 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.422 1.489 . . . . 72.44 110.798 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -66.1 154.23 74.89 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.874 1.716 . . . . 63.44 110.009 163.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -160.82 153.02 20.22 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.471 1.908 . . . . 74.31 109.767 170.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -98.11 140.38 32.51 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.185 -1.042 . . . . 74.24 108.185 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.1 mt -119.76 109.22 15.36 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 126.53 1.932 . . . . 74.12 108.683 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.453 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 5.0 m-20 -62.58 131.56 49.48 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.828 -1.175 . . . . 63.21 107.828 174.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.8 p -150.8 173.0 14.72 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.483 1.513 . . . . 73.55 109.831 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -139.23 158.43 44.19 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.227 0.611 . . . . 70.52 110.233 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 tt -151.06 144.02 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 118.227 0.467 . . . . 73.21 110.528 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.0 t -133.23 33.46 3.61 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.662 1.585 . . . . 74.41 108.244 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.4 -56.85 4.22 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 120.912 -1.118 . . . . 74.31 111.962 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.85 -25.25 11.32 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.043 1.127 . . . . 73.11 114.043 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.0 m -102.29 127.76 49.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.827 1.194 . . . . 75.51 108.056 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.8 tp -94.81 137.7 33.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.875 2.07 . . . . 64.22 108.808 159.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -136.15 87.91 2.34 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.6 1.16 . . . . 70.45 110.221 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.64 128.5 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.189 -1.041 . . . . 63.34 108.189 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -86.35 -25.72 25.23 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.607 0.763 . . . . 74.22 111.367 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 t -153.71 158.36 40.89 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.181 1.392 . . . . 72.22 110.579 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.18 177.47 20.93 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 124.664 1.126 . . . . 74.44 111.17 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.3 m -60.69 -16.82 43.4 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.204 1.402 . . . . 62.24 113.694 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -109.32 8.81 25.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.8 1.64 . . . . 64.52 112.844 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.12 116.34 2.73 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.311 1.844 . . . . 74.44 109.5 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.15 -153.26 21.76 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 122.158 0.866 . . . . 74.45 113.204 -172.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.7 t -135.43 123.93 23.5 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 126.191 1.796 . . . . 64.54 106.503 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.43 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 60.9 m-85 -141.01 157.72 44.94 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.556 1.169 . . . . 75.42 109.481 -175.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -127.62 138.06 52.73 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.356 -1.35 . . . . 73.32 107.356 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HE3' ' O ' ' A' ' 13' ' ' ILE . 25.5 tttt -51.39 145.88 7.87 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.641 1.576 . . . . 62.34 109.32 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 CA--C 1.544 0.719 0 C-N-CA 128.469 2.708 . . . . 75.52 109.463 179.258 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 . . . . . 0 N--CA 1.443 -0.783 0 N-CA-C 104.814 -2.291 . . . . 65.11 104.814 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -115.15 157.2 23.95 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 125.056 1.343 . . . . 72.44 110.157 172.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.59 173.08 12.95 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.18 0.514 . . . . 74.03 109.877 169.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -59.21 151.65 22.48 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.948 -1.023 . . . . 74.13 109.754 167.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 tp -90.89 130.0 36.88 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.872 -1.529 . . . . 73.25 106.872 165.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -139.2 168.02 20.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.694 1.198 . . . . 74.45 109.259 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -74.04 33.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.945 0.898 . . . . 72.11 111.482 175.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.76 -32.44 0.44 Allowed 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 119.875 -1.765 . . . . 74.01 113.178 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -82.82 -30.3 28.86 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 116.976 -1.488 . . . . 73.11 111.969 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 tp -70.43 -24.63 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 121.636 2.016 . . . . 73.35 113.136 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.83 104.57 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.778 2.031 . . . . 74.25 111.246 -174.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.99 171.2 32.82 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.089 0.852 . . . . 72.14 111.034 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -76.13 152.28 36.77 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.106 0.962 . . . . 65.21 109.066 163.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -146.41 153.5 40.55 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.601 1.16 . . . . 70.33 109.299 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 t -153.45 165.24 36.45 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.812 -1.18 . . . . 70.14 110.304 166.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 25' ' ' LYS . 4.4 t -115.79 -9.82 11.82 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.69 1.596 . . . . 65.12 111.413 -175.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.04 -172.6 44.85 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.489 -0.757 . . . . 72.23 111.209 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.5 pt -134.77 14.69 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.032 2.133 . . . . 65.44 110.71 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -144.34 179.35 7.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.861 1.664 . . . . 74.34 111.653 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.25 -104.98 0.23 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.038 1.78 . . . . 72.12 111.755 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.6 m -139.74 101.88 4.3 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 106.128 -1.804 . . . . 74.21 106.128 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -117.7 178.73 4.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.827 1.251 . . . . 72.05 109.423 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.403 ' H ' HG23 ' A' ' 18' ' ' THR . 1.5 mptt -144.8 154.38 42.63 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.072 0.949 . . . . 72.05 109.941 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.22 154.5 18.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.382 1.873 . . . . 72.01 107.529 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mt -138.31 144.82 40.6 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.855 -1.535 . . . . 73.12 106.855 160.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.9 p -139.03 155.03 48.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.814 1.188 . . . . 73.14 109.764 166.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.426 ' CD2' ' CE2' ' A' ' 53' ' ' TYR . 22.2 m-85 -143.09 125.19 15.33 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.549 1.94 . . . . 73.14 106.039 -175.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -101.35 154.04 19.13 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.467 -1.679 . . . . 72.12 106.467 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -74.87 -41.38 59.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.841 0.746 . . . . 53.31 111.38 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -108.59 -1.74 19.37 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.113 0.565 . . . . 65.41 111.672 -162.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.81 -112.22 1.54 Allowed Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.26 -0.736 . . . . 31.04 111.26 -169.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 80.3 p -145.3 172.67 12.82 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.022 1.329 . . . . 74.23 107.773 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.03 -166.46 14.64 Favored Glycine 0 CA--C 1.524 0.627 0 O-C-N 120.973 -1.08 . . . . 63.15 111.865 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -155.44 156.94 36.2 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 121.264 -1.139 . . . . 73.43 111.694 -170.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -135.52 145.54 47.17 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.325 1.45 . . . . 65.43 108.104 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.15 154.5 25.54 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 109.93 -1.268 . . . . 63.45 109.93 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.7 mt -113.29 143.77 22.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.034 -1.469 . . . . 73.14 107.034 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -132.22 119.27 20.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.499 1.52 . . . . 74.03 109.211 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -85.86 107.98 17.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.617 -1.994 . . . . 74.44 105.617 166.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.72 -57.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 129.749 3.219 . . . . 74.32 115.721 174.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -154.94 25.3 0.43 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.684 1.594 . . . . 62.41 112.307 167.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.5 m -131.51 125.16 20.51 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.89 1.276 . . . . 73.45 108.282 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.06 124.8 7.53 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.738 2.959 . . . . 74.31 112.159 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.2 mm -114.65 -13.17 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.264 1.426 . . . . 73.21 112.762 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.7 m -151.6 163.73 38.42 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.086 -1.009 . . . . 74.21 109.133 170.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -164.23 127.47 2.51 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.639 1.976 . . . . 74.31 108.057 -173.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.77 166.94 26.94 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.879 1.671 . . . . 73.44 108.354 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.8 mtm -137.93 151.25 47.79 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.545 -0.909 . . . . 72.12 108.545 170.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.74 146.76 18.11 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.327 1.451 . . . . 74.21 110.913 -171.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -81.22 176.24 9.94 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.301 -1.0 . . . . 74.44 108.301 167.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CE2' ' CD2' ' A' ' 29' ' ' PHE . 5.9 m-85 -141.97 159.19 42.73 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.87 -0.604 . . . . 74.13 110.2 171.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -130.78 132.21 45.14 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.296 -1.372 . . . . 71.04 107.296 161.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.42 106.88 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 105.939 -1.875 . . . . 74.33 105.939 164.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -127.94 23.98 6.08 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.401 0.62 . . . . 74.25 111.244 174.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.67 13.73 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.471 0.915 . . . . 72.44 113.471 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.32 13.43 62.59 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 120.892 -1.13 . . . . 71.03 111.286 -163.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.4 mmt85 -136.89 152.82 50.65 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.768 2.027 . . . . 73.12 105.917 -172.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.8 mt -88.06 115.24 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 107.147 -1.427 . . . . 74.04 107.147 -170.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -87.38 111.11 20.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.147 -1.057 . . . . 72.02 108.147 169.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.2 mm -79.51 138.99 18.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.021 -1.844 . . . . 72.23 106.021 163.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -145.79 2.84 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.859 1.429 . . . . 74.11 114.859 175.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.4 100.46 0.34 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.014 -1.476 . . . . 74.03 107.014 -156.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.9 t -130.34 143.27 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.401 1.08 . . . . 61.44 108.34 -176.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.04 158.91 71.32 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.371 1.869 . . . . 74.33 106.597 171.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -84.95 -6.41 53.31 Favored 'Cis proline' 0 CA--C 1.54 0.793 0 CA-C-N 119.533 0.869 . . . . 65.12 113.581 -6.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.09 102.79 10.73 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 105.973 -1.862 . . . . 72.02 105.973 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.43 151.97 43.53 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.234 1.016 . . . . 74.41 112.079 -174.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -128.48 164.66 22.27 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.35 1.86 . . . . 72.21 111.017 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 t -63.01 150.43 88.33 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.796 0.838 . . . . 73.44 109.292 165.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.77 137.66 25.07 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.696 2.264 . . . . 65.34 111.186 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -152.77 164.1 38.44 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.729 0.812 . . . . 74.15 111.451 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -93.39 154.37 17.99 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.244 0.617 . . . . 73.05 110.932 173.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -128.62 126.13 39.57 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.553 1.941 . . . . 74.22 107.728 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -76.77 116.08 17.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.669 -1.975 . . . . 63.21 105.669 172.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -142.46 159.24 42.62 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.157 -0.683 . . . . 63.23 109.157 169.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -132.01 156.97 45.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.444 1.498 . . . . 71.21 110.537 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 tt -146.85 156.81 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.495 -0.557 . . . . 73.33 109.495 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.4 46.5 0.66 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 123.482 1.61 . . . . 73.14 110.898 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.19 -73.13 0.33 Allowed Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 113.583 -1.644 . . . . 65.41 109.262 171.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.4 p -119.91 -2.77 10.26 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 114.152 1.168 . . . . 74.31 114.152 -173.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.3 m -106.62 130.11 54.43 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.264 -1.384 . . . . 73.31 107.264 164.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.91 136.42 38.23 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.177 1.791 . . . . 72.15 107.524 163.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -120.65 88.77 3.0 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.662 1.185 . . . . 71.32 109.329 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.6 t -77.07 118.85 24.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.922 -1.51 . . . . 73.44 106.922 172.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -78.14 -39.97 39.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.465 0.575 . . . . 65.44 111.142 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 t -144.0 174.73 10.6 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.123 0.874 . . . . 74.35 111.258 -166.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.55 -179.17 47.65 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 125.683 1.611 . . . . 42.55 111.272 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.4 m -58.92 -21.87 58.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.356 1.462 . . . . 72.44 113.101 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -106.62 10.28 31.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.938 1.295 . . . . 74.45 112.474 -177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.45 109.57 0.46 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.298 1.439 . . . . 71.42 110.738 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -175.74 -169.89 37.91 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.547 1.07 . . . . 71.31 111.269 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -129.61 121.58 27.37 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.481 -1.674 . . . . 72.31 106.481 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -126.29 145.45 50.41 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.048 0.539 . . . . 73.05 109.842 -165.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -97.38 148.95 22.65 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.448 -0.945 . . . . 70.33 108.448 164.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -59.7 150.13 28.69 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.435 1.494 . . . . 74.32 109.486 166.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 126.251 1.82 . . . . 73.23 113.076 -170.641 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--O 1.236 0.371 0 N-CA-C 107.56 -1.274 . . . . 74.22 107.56 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -88.47 150.86 22.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.134 0.974 . . . . 75.41 110.283 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.64 175.99 7.64 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.619 1.568 . . . . 63.22 109.996 171.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -74.15 123.08 23.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.06 0.944 . . . . 73.43 111.164 172.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.7 tp -60.69 129.29 40.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.239 -0.652 . . . . 74.42 109.239 162.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -146.35 168.27 21.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.653 0.74 . . . . 72.44 109.709 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.07 21.14 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.814 3.245 . . . . 74.43 113.446 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.83 -52.13 0.63 Allowed 'General case' 0 C--O 1.232 0.177 0 O-C-N 119.904 -1.748 . . . . 74.1 110.916 176.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -64.19 -26.38 68.49 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.66 1.118 . . . . 72.1 113.015 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.8 tp -70.52 -25.09 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.417 1.487 . . . . 73.1 113.469 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.77 129.89 34.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 123.443 0.697 . . . . 65.42 110.08 -163.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.36 -172.42 18.72 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.12 1.819 . . . . 65.23 111.397 174.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -82.27 160.7 22.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.361 1.465 . . . . 74.22 111.264 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -141.13 158.28 44.13 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.702 1.601 . . . . 73.54 108.182 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 p -146.78 169.08 19.83 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.8 2.091 . . . . 71.14 112.733 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -132.78 -5.33 3.19 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.608 1.563 . . . . 75.44 112.704 -171.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.8 172.94 14.9 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.251 -1.939 . . . . 75.45 108.251 -171.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.9 pt -138.11 27.42 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.452 1.101 . . . . 74.34 110.79 -168.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -125.89 174.88 8.07 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 124.559 1.144 . . . . 74.15 112.063 -171.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 43.66 -88.47 0.01 OUTLIER Glycine 0 C--N 1.341 0.854 0 C-N-CA 127.505 2.479 . . . . 63.01 114.017 149.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.3 m -130.44 122.23 27.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.485 -1.672 . . . . 63.43 106.485 159.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -131.72 -167.54 1.88 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.822 1.649 . . . . 72.23 107.757 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.43 156.08 18.31 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.241 1.816 . . . . 64.01 107.522 -162.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.95 132.4 20.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.789 2.436 . . . . 72.11 109.812 -177.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.4 mt -116.71 156.75 26.61 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.218 2.207 . . . . 75.34 108.498 175.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 t -137.18 156.31 48.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.025 -1.842 . . . . 65.53 106.025 160.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -143.1 129.78 20.3 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.35 1.46 . . . . 72.22 107.704 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.21 167.04 11.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.569 0.748 . . . . 71.44 110.76 171.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -81.88 -33.41 30.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.237 0.615 . . . . 71.5 110.572 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -138.08 28.82 2.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.867 0.841 . . . . 70.14 110.927 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.31 -116.62 2.54 Favored Glycine 0 C--N 1.33 0.232 0 N-CA-C 108.565 -1.814 . . . . 71.21 108.565 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.2 p -146.11 -175.07 4.61 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.398 1.479 . . . . 65.52 107.173 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.82 170.52 17.09 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.881 -0.888 . . . . 73.55 110.881 162.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.1 p -135.42 166.85 22.2 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.322 1.049 . . . . 74.41 110.89 171.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -149.59 105.96 3.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.044 -1.465 . . . . 75.05 107.044 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.51 104.02 1.02 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.577 -1.009 . . . . 72.14 110.577 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 mt -73.83 134.26 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 106.42 -1.696 . . . . 74.02 106.42 170.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -123.56 135.85 54.22 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.257 1.423 . . . . 72.32 108.238 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.28 136.29 36.96 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 107.622 -1.251 . . . . 62.23 107.622 163.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 45.89 -78.91 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 129.065 2.946 . . . . 74.02 114.655 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.27 65.47 1.02 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.793 1.237 . . . . 75.34 110.335 163.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.0 m -155.32 132.84 6.5 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.562 1.945 . . . . 72.25 108.939 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.15 134.99 26.2 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.433 2.756 . . . . 64.45 110.357 172.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.3 mm -127.48 -20.78 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.146 0.578 . . . . 75.01 111.31 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.7 t -138.76 163.69 31.53 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 120.526 -1.359 . . . . 74.43 108.268 167.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -163.45 132.36 3.93 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 126.891 2.076 . . . . 74.04 106.694 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -148.96 159.22 44.4 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.474 -1.676 . . . . 75.35 106.474 162.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.9 mtm -130.78 145.56 52.0 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.643 -1.614 . . . . 74.15 106.643 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -164.09 140.13 6.35 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.955 -0.387 . . . . 74.51 109.955 -167.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.42 174.16 3.55 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.503 1.121 . . . . 64.14 109.671 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -154.13 172.12 18.06 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.302 -0.873 . . . . 73.43 110.941 162.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -133.31 153.77 51.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.407 -0.961 . . . . 72.3 108.407 158.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.1 mm -102.67 101.12 11.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.356 -1.72 . . . . 65.33 106.356 165.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -136.67 24.52 3.13 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.503 1.521 . . . . 73.11 110.363 -171.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -169.73 14.27 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.641 1.576 . . . . 62.52 114.045 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.47 18.88 68.23 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 120.773 -1.204 . . . . 74.43 112.129 -170.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 -136.48 166.56 23.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 128.704 2.802 . . . . 74.42 105.436 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.58 150.09 4.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.117 -1.438 . . . . 75.44 107.117 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -119.99 125.17 47.73 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.61 1.964 . . . . 75.41 105.757 165.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mm -113.44 132.7 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.479 -2.045 . . . . 72.14 105.479 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -156.41 -2.61 0.12 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.314 0.857 . . . . 71.52 113.314 -170.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -145.52 111.65 5.66 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 105.526 -2.027 . . . . 74.34 105.526 174.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.28 146.84 33.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.067 -1.827 . . . . 72.14 106.067 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.58 160.73 58.01 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 106.72 -1.585 . . . . 74.11 106.72 174.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.47 -10.0 38.23 Favored 'Cis proline' 0 CA--C 1.537 0.645 0 CA-C-N 119.085 0.709 . . . . 72.11 113.532 -7.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.96 97.23 7.12 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 104.563 -2.384 . . . . 71.43 104.563 172.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -65.76 140.53 58.44 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.547 -0.908 . . . . 71.22 108.547 168.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -126.59 171.15 11.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.308 1.043 . . . . 74.15 109.459 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -47.15 141.69 5.94 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.276 1.031 . . . . 72.34 108.719 171.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.45 139.72 42.0 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.518 1.478 . . . . 70.53 109.466 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -144.64 162.33 36.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.629 0.772 . . . . 75.12 110.397 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -99.28 156.61 16.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.467 -0.938 . . . . 72.2 108.467 170.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.4 mt -127.55 110.12 12.4 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.734 -1.21 . . . . 75.1 107.734 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -57.98 129.19 40.8 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.481 -1.303 . . . . 73.12 107.481 170.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.48 165.46 35.59 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.508 0.723 . . . . 75.51 109.359 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -126.86 167.94 15.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.506 1.522 . . . . 72.21 111.143 164.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.0 tt -157.71 154.79 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.796 -0.816 . . . . 75.53 108.796 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.8 m -138.48 -5.27 1.59 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 118.195 2.665 . . . . 72.11 118.195 168.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.2 -52.52 0.51 Allowed Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.956 -1.258 . . . . 75.23 109.956 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -121.22 -20.88 6.58 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 116.757 -1.592 . . . . 73.42 113.82 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.1 m -96.51 116.83 29.72 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 121.141 1.791 . . . . 63.44 110.124 168.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.45 140.13 29.84 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.645 1.178 . . . . 75.51 109.752 159.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -132.1 91.25 2.93 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.131 0.972 . . . . 75.3 110.968 170.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.4 t -80.67 133.24 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.106 -1.072 . . . . 75.11 108.106 173.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -89.84 -30.7 17.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.499 0.72 . . . . 74.21 112.675 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.5 t -143.38 171.59 13.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.571 1.078 . . . . 73.12 110.69 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.25 179.67 49.61 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-O 122.997 1.331 . . . . 73.14 110.787 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.3 m -58.13 -20.07 37.49 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.691 1.197 . . . . 43.52 113.757 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -110.46 16.49 21.54 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.386 0.513 . . . . 75.34 112.386 -174.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.15 105.37 0.58 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.787 0.835 . . . . 73.33 111.69 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.35 -135.18 2.16 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 118.836 0.744 . . . . 61.2 113.074 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.4 t -138.58 119.9 14.77 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.866 1.666 . . . . 74.11 109.12 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.59 152.06 51.1 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.354 -0.841 . . . . 74.2 109.24 -166.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -119.05 129.8 55.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 117.636 -1.173 . . . . 75.44 108.698 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -47.39 140.65 5.47 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.333 1.053 . . . . 74.53 109.297 172.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 . . . . . 0 N--CA 1.473 0.682 0 C-N-CA 126.107 1.763 . . . . 63.33 109.172 178.632 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 122.441 1.115 . . . . 62.12 108.34 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -72.73 152.55 41.59 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.064 1.346 . . . . 75.11 110.385 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -78.63 166.39 22.58 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.027 0.376 . . . . 64.45 110.356 167.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -51.58 132.49 30.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.269 1.033 . . . . 73.33 108.669 163.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.8 tp -72.41 122.97 22.12 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.454 -1.684 . . . . 61.44 106.454 157.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -135.43 165.24 25.94 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.015 -1.476 . . . . 74.53 107.015 174.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -57.91 -43.68 86.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 124.184 0.928 . . . . 73.23 110.732 -165.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -75.75 -24.03 56.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.784 0.834 . . . . 72.05 111.728 -171.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -71.15 -39.55 71.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.517 0.599 . . . . 75.23 111.806 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.7 tp -83.18 -14.72 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.214 1.006 . . . . 74.13 112.307 -167.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 mm -57.97 145.29 9.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.846 1.258 . . . . 74.11 109.755 -176.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.72 -170.09 13.46 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.684 1.135 . . . . 74.0 110.733 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -104.65 152.84 21.98 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.712 1.605 . . . . 74.44 109.447 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -147.45 126.47 12.84 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.845 1.258 . . . . 71.1 110.231 -170.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.6 t -135.66 166.89 22.19 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.89 0.876 . . . . 75.43 110.117 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.451 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 15.3 t -114.23 -13.96 12.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.76 1.624 . . . . 73.44 111.438 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.09 -174.9 41.7 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.704 -1.358 . . . . 60.02 109.704 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.0 pt -132.51 28.17 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.9 1.68 . . . . 75.02 110.165 -177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -129.39 175.48 8.72 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.454 1.102 . . . . 72.43 109.568 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.45 -107.79 0.57 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 125.927 1.727 . . . . 74.21 111.872 161.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.3 m -139.02 94.78 2.85 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.408 -1.701 . . . . 62.34 106.408 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -125.48 168.21 13.94 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 122.151 0.977 . . . . 61.1 111.653 -172.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -137.56 145.41 42.85 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.233 0.613 . . . . 63.5 109.839 -161.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.61 127.94 48.13 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.807 1.643 . . . . 62.41 107.71 -172.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.0 mt -117.33 153.23 33.35 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.322 -1.362 . . . . 71.31 107.322 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.0 p -148.88 158.05 43.89 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.68 -0.236 . . . . 62.43 110.655 159.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -142.62 138.76 30.94 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.169 1.388 . . . . 64.32 107.298 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.49 156.57 17.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.067 0.947 . . . . 71.22 109.622 171.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.9 -21.09 44.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 63.12 111.857 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.96 -1.61 5.24 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.325 0.65 . . . . 74.3 112.431 -173.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.94 -129.96 4.36 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.256 1.408 . . . . 71.42 111.992 -166.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 p -137.04 172.45 13.0 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 127.302 2.241 . . . . 75.22 107.38 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.9 175.83 25.51 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.523 -0.735 . . . . 64.13 112.241 -176.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.37 152.08 50.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.904 1.282 . . . . 75.31 108.317 176.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -145.14 106.5 4.21 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.447 1.499 . . . . 75.43 108.693 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.78 149.66 18.64 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.785 -0.926 . . . . 75.12 110.785 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.3 mt -116.1 131.7 67.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.362 -2.088 . . . . 75.34 105.362 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -130.95 127.74 39.03 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.932 1.293 . . . . 74.33 109.006 -170.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.93 115.83 31.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.668 -1.975 . . . . 54.41 105.668 173.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.73 -65.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 129.602 3.161 . . . . 75.13 115.849 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -153.62 36.23 0.45 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.947 1.299 . . . . 75.14 111.785 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.1 m -136.85 133.92 19.01 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.953 1.301 . . . . 75.34 108.788 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.06 133.04 17.52 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.408 2.738 . . . . 75.22 110.656 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 mm -128.89 -6.72 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.231 1.012 . . . . 73.13 112.261 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.3 t -153.23 157.92 40.93 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 119.783 -1.823 . . . . 74.13 109.437 167.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -146.93 134.56 21.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.055 2.142 . . . . 73.12 107.936 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -141.45 160.28 40.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.184 -1.043 . . . . 71.11 108.184 162.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mtm -130.82 139.13 50.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.465 -2.05 . . . . 75.34 105.465 172.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -157.37 152.5 25.96 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.706 -1.22 . . . . 74.44 107.706 -173.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.9 p30 -79.32 -177.35 5.67 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.648 1.213 . . . . 75.3 111.003 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -173.16 135.04 0.56 Allowed 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.858 1.663 . . . . 75.2 111.461 -164.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.573 ' HE3' ' CE1' ' A' ' 63' ' ' TYR . 4.1 mttt -135.34 159.96 39.91 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 124.536 1.147 . . . . 74.33 109.239 159.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.0 mm -94.71 118.91 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.723 -1.954 . . . . 75.23 105.723 149.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -136.93 25.09 3.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.769 0.828 . . . . 63.42 110.062 162.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.6 14.92 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 115.377 1.621 . . . . 74.24 115.377 -174.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.99 20.47 64.66 Favored Glycine 0 CA--C 1.531 1.094 0 O-C-N 120.299 -1.501 . . . . 64.13 110.951 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -148.41 156.68 42.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.63 2.772 . . . . 63.1 105.007 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.1 mt -84.06 115.73 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 105.318 -2.104 . . . . 75.44 105.318 -176.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -90.26 116.87 28.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 117.918 -1.039 . . . . 73.2 109.236 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.5 mm -95.82 148.83 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 107.162 -1.421 . . . . 72.54 107.162 172.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.573 ' CE1' ' HE3' ' A' ' 54' ' ' LYS . 13.1 p90 -158.26 -0.19 0.1 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.755 1.761 . . . . 75.4 115.755 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -152.95 124.97 7.95 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.762 -2.31 . . . . 64.54 104.762 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.832 ' CG1' ' H ' ' A' ' 70' ' ' LYS . 7.2 p -139.23 158.21 28.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 125.139 1.376 . . . . 74.44 109.948 173.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.89 158.72 48.64 Favored Pre-proline 0 C--O 1.24 0.577 0 C-N-CA 126.839 2.056 . . . . 71.0 106.894 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -80.64 -10.96 39.95 Favored 'Cis proline' 0 N--CA 1.463 -0.321 0 N-CA-C 113.863 0.678 . . . . 72.52 113.863 0.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.11 124.35 50.65 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 103.555 -2.757 . . . . 70.51 103.555 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.68 148.15 38.88 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.382 -0.599 . . . . 74.24 109.382 172.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.832 ' H ' ' CG1' ' A' ' 65' ' ' VAL . 23.2 mtpt -128.05 158.66 37.33 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.574 -0.528 . . . . 74.34 109.574 169.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -53.26 149.28 13.91 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.283 1.433 . . . . 74.54 111.727 -178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.68 140.37 42.8 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.352 2.035 . . . . 73.53 111.482 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -159.31 174.58 14.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.708 1.203 . . . . 73.44 110.24 175.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.81 125.49 54.06 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.779 1.632 . . . . 73.3 110.248 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.0 mt -89.44 112.53 23.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.608 1.163 . . . . 74.21 109.146 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.09 114.08 3.51 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.377 -1.342 . . . . 73.52 107.377 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.9 p -152.6 157.92 41.71 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.876 0.845 . . . . 72.42 110.429 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -129.31 152.95 48.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.916 1.687 . . . . 74.53 108.827 -175.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.6 tt -146.92 152.75 12.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.466 -0.568 . . . . 73.52 109.466 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 t -159.26 45.75 0.27 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 122.945 1.355 . . . . 74.32 110.779 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.52 -127.89 9.28 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 106.811 -2.515 . . . . 54.13 106.811 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.5 p -71.36 -11.41 60.88 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.383 -1.77 . . . . 64.14 114.16 -167.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.5 m -95.05 119.74 34.07 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 121.664 2.029 . . . . 52.21 108.822 173.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.9 tp -92.56 131.56 37.58 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.748 1.619 . . . . 75.43 108.13 160.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -119.48 100.59 7.38 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 125.246 1.418 . . . . 73.31 108.175 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.9 t -94.25 131.48 41.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.807 -1.183 . . . . 73.3 107.807 174.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -92.14 -29.22 16.62 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.579 0.752 . . . . 53.23 112.652 -172.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.9 t -140.78 173.17 11.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.003 1.721 . . . . 72.34 110.04 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.09 -176.15 45.29 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 122.976 1.32 . . . . 45.22 112.311 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.59 -32.09 73.6 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.056 -0.673 . . . . 71.21 110.572 172.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.72 7.36 39.97 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.725 -0.609 . . . . 75.53 112.391 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.6 104.99 0.21 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.252 2.221 . . . . 71.52 111.584 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.96 -158.84 29.0 Favored Glycine 0 N--CA 1.451 -0.312 0 O-C-N 121.656 -0.652 . . . . 61.31 112.444 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.6 p -115.85 120.48 39.37 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.481 1.912 . . . . 72.43 107.327 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.451 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 67.1 m-85 -135.67 148.05 48.79 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.04 -0.726 . . . . 75.14 109.04 -174.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -111.86 146.2 38.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.068 -1.086 . . . . 72.41 108.068 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -55.6 144.79 25.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.91 0.884 . . . . 74.41 108.891 172.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 105.743 -1.947 . . . . 73.2 105.743 179.531 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 106.285 -1.746 . . . . 74.22 106.285 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -120.78 161.15 21.97 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.684 1.193 . . . . 72.02 110.502 172.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.47 178.43 7.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.049 2.14 . . . . 73.2 109.966 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -67.07 135.36 53.52 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.633 -1.167 . . . . 73.21 110.359 161.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.89 129.73 38.48 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 126.143 1.777 . . . . 72.25 108.097 158.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -141.3 179.57 6.69 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 119.64 -0.824 . . . . 74.12 110.132 161.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -69.27 25.1 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.386 1.875 . . . . 74.32 112.65 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.63 -53.64 0.82 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 119.873 -1.767 . . . . 65.12 109.317 -171.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -65.65 -28.5 69.14 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.451 -1.262 . . . . 74.12 112.517 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.19 -18.64 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 121.366 1.894 . . . . 71.34 114.002 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.4 mm -62.89 121.19 11.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 O-C-N 121.375 -0.828 . . . . 74.04 110.247 -169.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.98 -174.05 26.93 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.085 1.802 . . . . 74.15 111.12 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -88.74 163.27 15.81 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.003 1.321 . . . . 73.24 109.513 171.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -150.22 133.85 16.65 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.925 -1.109 . . . . 73.14 111.116 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 t -138.2 162.75 33.47 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.292 1.437 . . . . 73.2 109.596 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.455 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 8.9 t -126.73 -14.79 5.62 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.496 1.118 . . . . 70.34 112.234 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.3 170.53 30.37 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 107.159 -2.376 . . . . 72.24 107.159 -169.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.0 pt -138.76 34.87 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.493 1.117 . . . . 73.22 108.746 -161.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -148.79 -176.14 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.8 1.64 . . . . 74.4 109.908 -165.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 44.97 -99.84 0.02 OUTLIER Glycine 0 CA--C 1.525 0.702 0 C-N-CA 126.603 2.049 . . . . 73.22 113.18 158.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 m -134.83 115.98 14.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.424 -1.695 . . . . 72.22 106.424 165.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -127.34 168.55 14.64 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.679 0.752 . . . . 74.1 109.699 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -139.79 137.16 34.8 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.746 -1.576 . . . . 74.42 106.746 -164.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.32 143.3 50.18 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.214 1.406 . . . . 72.42 107.686 -172.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 mt -138.95 158.99 43.2 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.785 1.634 . . . . 74.12 107.823 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.6 p -150.56 157.08 42.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.765 0.826 . . . . 71.44 109.747 163.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -144.16 135.64 25.78 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.53 1.532 . . . . 74.01 107.798 174.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -110.53 150.56 28.74 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.295 1.038 . . . . 74.41 109.216 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -25.54 56.16 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.879 -0.513 . . . . 75.24 110.937 -174.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.6 -3.36 5.39 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.503 0.721 . . . . 72.03 111.12 -172.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.33 -140.47 6.64 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 126.085 1.803 . . . . 74.22 110.272 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 74.7 p -122.89 158.68 29.83 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.806 1.242 . . . . 75.01 109.17 -176.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.89 165.56 43.89 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 109.889 -1.285 . . . . 74.22 109.889 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.16 161.54 37.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.393 -0.595 . . . . 72.21 109.393 173.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -140.56 150.17 43.32 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.086 -1.079 . . . . 72.21 108.086 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.81 155.69 26.39 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.069 -1.212 . . . . 70.41 110.069 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.5 mt -125.66 136.88 59.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.508 -2.034 . . . . 72.31 105.508 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -119.9 155.45 32.68 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.837 1.255 . . . . 74.11 108.278 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.05 130.93 56.45 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.254 -1.758 . . . . 71.33 106.254 162.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 44.85 -81.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 128.369 2.668 . . . . 72.34 114.653 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.01 54.25 1.37 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.928 1.691 . . . . 72.32 110.433 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.2 m -155.15 124.11 3.05 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 125.604 1.562 . . . . 73.42 108.544 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.69 139.74 41.22 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.891 2.394 . . . . 73.13 109.999 171.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.9 mm -129.79 -16.66 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.208 1.403 . . . . 72.34 111.416 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.5 t -139.94 161.91 36.45 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.995 -1.691 . . . . 73.14 108.966 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -160.48 145.17 14.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 126.282 1.833 . . . . 75.15 107.983 -176.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.13 168.41 25.55 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 125.765 1.626 . . . . 64.35 107.512 167.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.7 mtm -133.03 138.07 46.68 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.921 -1.511 . . . . 75.31 106.921 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.25 137.16 20.52 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.732 1.213 . . . . 71.41 110.409 -173.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -82.05 166.26 19.91 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.533 -0.914 . . . . 75.04 108.533 169.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.05 168.34 27.32 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.904 0.882 . . . . 72.03 111.914 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -139.99 158.13 44.55 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.036 0.935 . . . . 71.45 111.434 162.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.5 mm -113.2 83.1 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.382 1.473 . . . . 73.33 108.1 171.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -116.77 24.29 11.36 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.395 1.878 . . . . 72.35 111.204 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -164.74 14.7 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.284 1.216 . . . . 64.25 114.284 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.8 21.28 74.95 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.287 -0.883 . . . . 71.05 111.27 -170.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -145.46 166.06 26.74 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 127.011 2.124 . . . . 71.43 107.994 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.8 mt -99.31 115.54 40.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.517 -1.66 . . . . 72.44 106.517 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -89.53 122.72 32.97 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.55 1.54 . . . . 74.15 107.912 172.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.8 mm -98.79 143.36 13.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.185 -1.413 . . . . 74.33 107.185 173.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -160.63 2.34 0.07 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.333 1.235 . . . . 72.05 114.333 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -153.75 112.49 3.68 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 104.388 -2.449 . . . . 73.01 104.388 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.779 ' CG1' ' H ' ' A' ' 70' ' ' LYS . 11.8 p -138.62 157.82 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.575 -1.268 . . . . 75.04 107.575 171.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.87 165.99 23.13 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 124.889 1.276 . . . . 75.03 108.465 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.09 -44.36 0.46 Allowed 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 125.334 -0.694 . . . . 74.43 111.684 -10.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.62 125.28 26.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.892 -1.522 . . . . 74.35 106.892 167.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.426 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 1.2 pt-20 -75.5 158.01 33.18 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 124.285 0.991 . . . . 73.31 108.678 168.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.779 ' H ' ' CG1' ' A' ' 65' ' ' VAL . 9.4 mmpt? -115.14 158.73 21.8 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.509 -1.369 . . . . 72.25 108.068 164.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.73 145.91 20.08 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.624 -1.25 . . . . 74.02 107.624 168.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.4 139.8 32.36 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.852 1.701 . . . . 74.42 109.611 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -153.28 173.37 15.67 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.992 1.317 . . . . 74.11 108.554 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -107.09 153.5 22.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.93 -1.137 . . . . 74.12 107.93 171.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.3 mt -124.04 116.07 22.21 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 125.943 1.697 . . . . 63.43 107.218 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.51 121.08 9.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.211 1.404 . . . . 70.21 109.188 166.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.0 168.63 21.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 125.211 1.404 . . . . 65.43 108.415 172.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.54 165.76 26.05 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.789 1.636 . . . . 74.05 111.04 163.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.2 tt -157.38 159.46 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.453 -1.314 . . . . 71.33 107.453 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 t -137.48 -2.57 1.97 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.726 1.21 . . . . 72.13 112.612 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.73 -152.38 20.08 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 107.664 -2.175 . . . . 71.2 107.664 -149.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.0 p -51.97 7.4 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 119.554 3.168 . . . . 72.34 119.554 -173.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.9 m -130.1 110.71 11.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.528 2.731 . . . . 73.23 108.059 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.09 128.32 35.42 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.946 -1.502 . . . . 74.32 106.946 170.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -117.78 82.87 1.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.61 0.764 . . . . 72.41 110.687 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.74 128.77 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.101 -1.074 . . . . 73.44 108.101 170.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -77.45 -42.99 33.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.661 1.184 . . . . 74.14 110.008 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.4 t -130.22 -173.77 3.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.205 1.002 . . . . 73.21 112.523 -170.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.7 -172.48 39.04 Favored Glycine 0 C--N 1.335 0.494 0 O-C-N 120.337 -1.477 . . . . 72.21 110.592 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.2 m -62.92 -28.24 69.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.849 -0.795 . . . . 64.14 109.814 158.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.59 -1.12 57.39 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.387 1.475 . . . . 74.02 112.131 -167.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.71 108.03 0.24 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.395 2.278 . . . . 72.12 109.34 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.6 -154.9 19.96 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 122.192 0.884 . . . . 73.2 112.692 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 t -140.44 97.83 3.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.759 -1.941 . . . . 61.1 105.759 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.455 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 52.0 m-85 -110.38 151.3 27.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.503 -1.295 . . . . 63.31 107.503 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -104.96 148.04 27.14 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.26 -1.385 . . . . 74.32 107.26 174.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -54.79 139.6 39.05 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 106.66 -1.607 . . . . 71.11 106.66 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 . . . . . 0 N--CA 1.438 -1.042 0 N-CA-C 104.831 -2.285 . . . . 73.33 104.831 160.395 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 107.568 -1.271 . . . . 73.04 107.568 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -61.0 144.52 53.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.876 -1.057 . . . . 75.32 111.149 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.6 172.39 12.67 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.263 1.03 . . . . 73.32 110.652 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.72 140.87 55.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 122.169 0.985 . . . . 62.35 110.036 167.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.6 tp -78.85 133.68 36.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.55 -1.278 . . . . 74.43 107.55 168.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -143.22 167.99 20.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.741 0.816 . . . . 54.41 109.032 173.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 t -75.95 43.16 0.27 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.573 1.549 . . . . 72.03 109.877 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.21 -50.83 0.14 Allowed 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 119.85 -1.781 . . . . 74.32 110.609 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -70.49 -29.98 66.65 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 119.092 -0.48 . . . . 73.25 111.251 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.1 tp -64.46 -26.16 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.344 0.974 . . . . 73.21 112.941 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mm -62.85 132.56 28.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.774 1.23 . . . . 75.33 110.242 -168.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.13 -178.8 17.09 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.796 1.665 . . . . 73.43 112.08 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -76.24 157.36 32.69 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.404 0.682 . . . . 71.33 110.323 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -143.33 110.38 5.66 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.544 -0.909 . . . . 62.44 108.544 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.9 t -115.02 151.62 33.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.759 0.824 . . . . 75.21 109.332 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 t -105.32 -17.31 14.49 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.864 0.866 . . . . 73.21 111.888 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.93 179.95 35.07 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.896 -1.682 . . . . 75.31 108.896 -174.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 pt -131.86 9.15 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 117.708 0.754 . . . . 75.44 112.819 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.9 163.65 12.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.358 0.981 . . . . 74.4 110.295 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.57 -90.23 0.02 OUTLIER Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.167 1.365 . . . . 62.43 114.956 155.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 m -134.07 123.41 24.44 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.15 1.975 . . . . 74.54 107.683 163.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -140.91 176.47 8.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.562 1.145 . . . . 74.11 109.385 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -143.23 140.78 30.84 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.943 1.297 . . . . 74.14 108.68 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.56 147.01 38.78 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 126.243 1.817 . . . . 74.32 108.621 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.59 168.2 19.69 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.121 0.969 . . . . 75.13 111.29 161.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 t -143.86 156.49 44.48 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.288 1.835 . . . . 75.54 108.845 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -146.12 111.91 5.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.508 2.723 . . . . 74.02 106.525 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.73 163.33 20.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.854 0.752 . . . . 73.32 109.308 166.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -88.87 -27.12 21.24 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.309 0.643 . . . . 75.34 112.095 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -130.98 12.94 5.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.631 1.172 . . . . 72.24 111.871 -172.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -126.92 -129.61 3.28 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 126.7 2.095 . . . . 74.42 108.989 -176.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 p -132.63 -166.6 1.77 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.244 1.818 . . . . 61.44 107.906 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -129.58 -175.26 13.97 Favored Glycine 0 CA--C 1.505 -0.552 0 O-C-N 119.823 -1.798 . . . . 74.11 112.058 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -144.84 154.38 42.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 118.281 -0.866 . . . . 72.13 110.057 -166.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -136.72 135.11 37.86 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.788 1.235 . . . . 74.24 109.493 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.39 158.01 24.74 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.573 -1.011 . . . . 51.41 110.573 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.8 mt -128.01 133.05 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 105.515 -2.031 . . . . 63.35 105.515 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -129.4 124.43 34.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.402 -0.962 . . . . 73.54 108.402 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.8 m -86.09 106.74 17.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.204 -2.147 . . . . 72.33 105.204 166.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 61.96 -75.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 127.371 2.268 . . . . 74.54 113.039 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.08 34.57 0.9 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.283 1.033 . . . . 72.44 112.495 172.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -137.59 118.44 10.58 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.498 1.919 . . . . 73.52 108.018 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.31 133.58 23.03 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.243 2.629 . . . . 74.34 111.125 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 mm -122.05 1.71 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 126.501 1.92 . . . . 71.52 111.046 -175.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.7 t -160.39 153.04 21.02 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 119.867 -1.771 . . . . 51.03 109.335 166.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -148.66 136.04 20.34 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.332 1.853 . . . . 73.52 109.302 172.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -158.57 163.22 37.22 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.746 1.618 . . . . 75.24 107.677 169.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.7 mtm -138.68 151.12 46.91 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.091 0.956 . . . . 74.42 108.808 170.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -159.0 155.09 26.88 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.949 0.9 . . . . 63.32 109.752 -176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -83.23 167.25 17.87 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.657 -0.497 . . . . 73.14 109.657 173.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.08 159.87 42.69 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.01 -1.107 . . . . 75.44 108.01 169.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -125.27 163.31 22.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.675 0.671 . . . . 75.14 109.826 162.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.6 mm -120.77 82.34 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.464 1.505 . . . . 74.05 106.956 174.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -117.45 24.11 11.33 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.795 1.238 . . . . 74.41 110.097 -172.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.71 14.56 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.434 1.894 . . . . 72.14 112.842 -164.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.78 10.02 53.95 Favored Glycine 0 CA--C 1.534 1.257 0 O-C-N 120.483 -1.385 . . . . 74.33 112.965 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.69 169.05 18.44 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 127.707 2.403 . . . . 74.35 106.739 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.8 mt -81.27 150.63 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 106.972 -1.492 . . . . 73.14 106.972 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -132.1 111.63 11.63 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.412 1.885 . . . . 75.24 108.501 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.0 mm -85.43 148.89 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.519 -1.289 . . . . 75.34 107.519 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -158.08 -5.51 0.09 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 116.132 1.901 . . . . 75.12 116.132 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -156.36 107.48 2.44 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 106.087 -1.82 . . . . 75.14 106.087 -164.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.884 ' CG1' ' H ' ' A' ' 70' ' ' LYS . 4.0 p -137.62 150.67 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 125.149 1.379 . . . . 75.12 110.741 -175.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.06 161.75 61.85 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.286 1.035 . . . . 75.52 108.388 167.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.48 -24.61 9.98 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 N-CA-C 114.493 0.92 . . . . 72.55 114.493 1.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -121.27 111.8 17.82 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.698 -0.852 . . . . 73.55 108.698 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.403 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 42.4 mt-10 -60.57 123.34 17.1 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 128.199 2.599 . . . . 75.45 109.057 -174.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.884 ' H ' ' CG1' ' A' ' 65' ' ' VAL . 3.6 mtpp -103.35 152.25 21.8 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.405 -0.961 . . . . 73.01 108.405 174.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.0 t -56.72 147.56 51.52 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.064 -0.717 . . . . 71.13 109.064 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.8 158.92 35.41 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.855 2.37 . . . . 72.21 112.272 170.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -172.44 168.58 5.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.791 2.436 . . . . 74.33 107.648 170.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -95.86 154.42 17.24 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.587 -0.894 . . . . 74.24 108.587 171.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.8 mt -131.93 134.36 45.57 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.956 1.302 . . . . 74.21 108.987 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -96.07 125.22 40.46 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.869 1.667 . . . . 64.44 108.716 -169.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 p -158.3 165.42 34.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.685 1.194 . . . . 73.14 109.723 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HZ1' ' CD ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -125.19 160.27 29.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 124.376 1.071 . . . . 74.44 111.866 170.5 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 tt -144.99 151.98 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 124.996 1.318 . . . . 72.31 107.71 177.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.9 t -147.75 19.58 1.15 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.663 0.986 . . . . 74.42 113.663 161.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.11 -102.46 0.26 Allowed Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.634 -1.786 . . . . 73.22 108.634 173.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.1 p -87.61 -12.94 44.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.332 0.566 . . . . 72.21 112.298 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 m -89.26 126.69 35.61 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.137 -1.431 . . . . 62.24 107.137 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.7 tp -113.42 132.8 55.5 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.649 1.579 . . . . 75.35 108.342 160.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.5 93.76 4.0 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.938 2.095 . . . . 71.43 108.005 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.95 138.55 19.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.274 -1.38 . . . . 74.35 107.274 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.442 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 7.3 mt-10 -101.96 -31.49 10.65 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.737 -0.649 . . . . 74.24 112.289 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -145.9 171.24 15.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.405 1.002 . . . . 75.34 110.84 -175.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.77 174.02 38.07 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 108.924 -1.67 . . . . 52.24 108.924 -174.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.0 m -61.0 -22.02 64.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.295 -1.12 . . . . 75.01 112.011 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -84.11 -5.56 59.26 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.634 0.976 . . . . 74.44 113.634 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -46.52 108.81 0.15 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 127.22 2.208 . . . . 75.42 110.616 -170.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.03 -172.75 44.94 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 122.284 0.935 . . . . 54.32 113.277 -159.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.1 p -137.61 104.98 5.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.614 1.966 . . . . 71.11 107.287 -156.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -124.36 167.3 14.56 Favored 'General case' 0 C--O 1.239 0.545 0 O-C-N 120.929 -1.107 . . . . 75.14 112.368 -165.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -124.02 127.38 47.79 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 129.311 3.045 . . . . 74.44 107.894 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -57.57 135.13 56.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.122 1.369 . . . . 72.21 109.005 171.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 114.248 1.203 . . . . 75.32 114.248 176.526 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.841 0 N-CA-C 109.884 -1.287 . . . . 51.32 109.884 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.79 100.21 11.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.779 -1.563 . . . . 42.01 106.779 164.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -104.74 95.88 6.19 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.205 -2.146 . . . . 42.01 105.205 -175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -93.27 160.43 14.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.598 1.159 . . . . 75.22 109.838 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.8 p -91.17 167.7 12.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.559 0.618 . . . . 73.42 110.276 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.79 116.87 4.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.884 0.849 . . . . 63.4 109.663 160.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.1 tp -54.18 125.63 19.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.651 -1.24 . . . . 74.14 107.651 157.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -145.42 172.52 13.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.169 0.985 . . . . 74.53 110.07 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -1.06 0.69 Allowed 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 126.954 2.102 . . . . 64.42 115.331 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -122.95 -36.99 2.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 120.17 1.35 . . . . 71.52 112.66 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -73.94 -30.71 62.7 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.358 0.981 . . . . 60.33 112.884 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.0 tp -66.58 -22.9 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.62 1.1 . . . . 73.13 112.903 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.37 126.23 24.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.134 1.374 . . . . 72.32 110.905 -164.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 131.28 -172.74 20.65 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.783 2.135 . . . . 74.4 110.59 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -91.09 162.85 14.51 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.435 1.094 . . . . 75.41 111.567 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -148.84 122.44 9.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.506 0.722 . . . . 71.53 111.045 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 t -127.35 160.73 30.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.954 1.301 . . . . 75.3 112.474 -174.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.58 -66.17 0.94 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.566 1.946 . . . . 75.24 107.1 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.12 -179.44 48.0 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 129.37 3.366 . . . . 71.11 106.578 -170.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.1 pt -111.61 16.26 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 113.746 1.017 . . . . 74.51 113.746 -158.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -115.79 -178.82 3.48 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.682 1.193 . . . . 71.44 113.098 -166.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.33 -93.5 0.01 OUTLIER Glycine 0 C--N 1.34 0.79 0 C-N-CA 127.547 2.499 . . . . 73.23 114.976 157.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.3 m -140.76 92.86 2.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.865 -1.902 . . . . 72.41 105.865 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -100.17 168.44 9.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.214 1.007 . . . . 64.31 110.473 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -134.95 145.29 48.03 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.192 1.797 . . . . 62.12 106.817 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.57 146.07 50.66 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.869 0.868 . . . . 73.44 108.852 -177.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.0 mt -134.71 158.77 43.26 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 125.041 1.336 . . . . 72.44 109.87 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t -144.12 155.53 43.98 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.843 2.057 . . . . 63.11 108.552 164.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -144.69 126.89 15.69 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 127.161 2.185 . . . . 64.12 107.611 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -101.59 159.45 15.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.959 1.704 . . . . 74.54 108.491 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.01 -38.02 28.2 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.823 -0.171 . . . . 74.52 110.634 -175.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -129.15 21.86 5.71 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.503 0.668 . . . . 71.11 110.815 -170.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.68 -112.85 1.6 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.745 1.64 . . . . 44.42 109.413 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 p -141.39 175.85 9.34 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.157 1.783 . . . . 73.2 109.555 -164.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -98.75 170.02 23.73 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.611 -0.995 . . . . 54.14 110.611 161.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.7 m -144.84 144.13 30.97 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.78 -0.835 . . . . 74.12 109.18 167.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -130.9 126.13 35.32 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.09 1.356 . . . . 73.31 107.69 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.69 159.07 17.36 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.047 0.832 . . . . 72.23 111.315 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 mt -136.99 136.01 47.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.347 -2.094 . . . . 75.33 105.347 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.42 167.24 14.1 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.015 1.326 . . . . 72.55 108.988 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.32 127.57 33.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.12 -1.437 . . . . 75.35 107.12 160.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 44.95 -73.07 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 131.446 3.898 . . . . 74.53 113.923 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.16 43.71 1.43 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.292 1.437 . . . . 54.11 112.55 175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.7 m -144.51 135.61 12.47 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.809 1.243 . . . . 74.11 109.579 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.51 129.3 12.66 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.291 3.327 . . . . 75.25 111.17 168.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.3 mm -122.31 -22.48 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.903 0.881 . . . . 74.45 112.093 -173.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 t -130.54 170.2 14.56 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 120.545 -1.347 . . . . 74.25 109.048 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -159.6 144.33 15.23 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 127.765 2.426 . . . . 62.22 105.31 165.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -152.08 162.55 40.93 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.731 1.612 . . . . 72.31 106.707 162.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.9 mtm -130.0 162.84 27.78 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.84 -1.17 . . . . 73.13 107.84 167.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -157.15 145.79 19.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 123.877 0.736 . . . . 72.44 109.276 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.64 159.65 31.65 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.168 -1.419 . . . . 75.21 107.168 161.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -148.73 166.87 27.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 121.645 -0.659 . . . . 75.43 110.239 166.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -134.46 167.1 21.39 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.507 1.123 . . . . 74.34 108.571 167.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.8 mm -121.92 86.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.373 -1.714 . . . . 75.44 106.373 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.7 23.49 8.75 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.364 0.666 . . . . 71.13 110.105 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.73 14.04 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 114.68 1.363 . . . . 63.5 114.68 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.39 27.58 65.89 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 120.889 -1.132 . . . . 75.14 111.31 -168.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -139.39 161.31 37.77 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 127.209 2.204 . . . . 75.2 105.935 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mt -71.05 133.27 32.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 105.761 -1.94 . . . . 75.51 105.761 164.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -101.58 120.3 40.11 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.432 -1.692 . . . . 73.3 106.432 163.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.4 mm -105.31 137.49 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.308 -1.738 . . . . 75.2 106.308 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -160.6 1.31 0.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.424 0.898 . . . . 75.12 113.424 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -148.36 117.62 6.88 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 104.937 -2.246 . . . . 72.31 104.937 171.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.0 t -128.54 155.49 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 105.816 -1.92 . . . . 74.43 105.816 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.64 162.29 39.6 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.574 -0.898 . . . . 74.53 108.574 174.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.74 -21.75 15.37 Favored 'Cis proline' 0 CA--C 1.535 0.567 0 N-CA-C 113.872 0.681 . . . . 71.14 113.872 -8.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 93.57 6.96 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 104.942 -2.244 . . . . 64.22 104.942 174.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.16 140.76 58.91 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.091 0.956 . . . . 53.1 109.589 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -127.44 168.05 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.833 1.253 . . . . 75.14 110.094 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 t -55.64 148.04 37.45 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 123.844 0.715 . . . . 75.41 109.938 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.29 139.81 42.83 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.175 1.916 . . . . 75.53 111.261 169.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -152.36 174.11 14.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.919 1.287 . . . . 71.1 109.874 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -112.74 158.98 19.41 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.546 0.738 . . . . 75.33 109.439 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.8 mt -130.32 112.24 13.12 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.165 1.386 . . . . 75.53 109.679 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -62.55 122.06 14.86 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.876 1.27 . . . . 72.1 108.06 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.3 p -154.72 163.67 39.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.599 0.36 . . . . 71.32 110.738 174.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -126.74 158.42 36.54 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.055 0.942 . . . . 75.51 109.298 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.1 tt -151.54 154.15 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.144 -1.058 . . . . 72.51 108.144 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -141.44 -9.35 0.96 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.84 1.793 . . . . 75.23 115.84 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.82 -73.53 0.21 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.378 -1.889 . . . . 75.31 108.378 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 p -117.52 1.64 12.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.851 1.056 . . . . 72.34 113.851 -169.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.6 m -119.74 106.79 12.47 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.846 2.058 . . . . 54.3 110.469 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -75.07 128.32 35.27 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.639 -1.288 . . . . 75.12 108.333 164.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -117.25 95.09 4.82 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 119.039 -0.505 . . . . 74.52 110.681 164.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 66.1 t -86.11 132.5 31.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.038 0.835 . . . . 72.34 109.407 169.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -91.41 -31.71 15.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.923 0.889 . . . . 73.32 112.212 -176.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 t -139.67 163.74 31.78 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.71 1.604 . . . . 71.42 110.556 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.58 -179.86 30.62 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 122.628 1.127 . . . . 73.2 112.662 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.1 m -58.08 -31.05 66.72 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.687 1.595 . . . . 54.23 112.52 173.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -103.69 11.99 35.3 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.169 0.588 . . . . 71.33 109.887 -167.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.01 117.14 5.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.4 2.28 . . . . 71.43 110.591 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.12 -123.39 1.1 Allowed Glycine 0 C--O 1.237 0.324 0 C-N-CA 124.381 0.991 . . . . 74.43 111.6 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.4 t -145.0 142.41 29.77 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.152 1.781 . . . . 75.5 107.747 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -142.91 152.18 41.79 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.164 0.438 . . . . 75.43 111.762 167.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -91.4 147.89 22.71 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.476 -0.565 . . . . 72.33 109.476 167.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -58.55 147.53 31.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.995 0.918 . . . . 75.54 108.653 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -134.61 52.74 2.03 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.776 1.63 . . . . 72.33 109.0 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.3 mttp . . . . . 0 C--O 1.256 1.398 0 N-CA-C 105.916 -1.883 . . . . 62.33 105.916 151.814 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.62 0 N-CA-C 109.78 -1.328 . . . . 71.01 109.78 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -153.95 87.12 1.2 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 122.203 1.001 . . . . 71.44 108.368 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -78.37 104.66 9.11 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.64 -1.985 . . . . 65.0 105.64 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -101.14 163.25 12.37 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 124.604 1.162 . . . . 65.31 111.02 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.3 p -101.06 162.13 13.11 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.595 -0.521 . . . . 65.23 109.595 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.1 117.51 4.44 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.035 1.334 . . . . 74.13 110.551 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.0 tp -66.4 105.64 1.51 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.629 -1.249 . . . . 73.21 107.629 165.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -126.56 172.8 9.94 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.951 -1.022 . . . . 70.31 111.123 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.89 -5.68 22.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.901 2.48 . . . . 73.31 112.764 -169.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -109.81 -28.64 8.68 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.223 0.92 . . . . 73.0 110.352 171.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -66.43 -35.41 80.23 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.887 0.875 . . . . 74.04 112.71 -169.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.77 -15.24 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 113.133 0.79 . . . . 72.43 113.133 -173.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.8 mm -68.79 122.19 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.121 0.968 . . . . 74.04 111.218 -161.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.78 -168.91 24.35 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.624 1.583 . . . . 64.32 111.319 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -88.66 159.95 17.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.463 1.105 . . . . 74.44 110.284 176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -142.36 125.94 16.84 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.435 1.494 . . . . 74.43 109.756 176.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.7 t -123.58 164.02 19.84 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.191 0.997 . . . . 74.1 112.394 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.418 ' HB ' ' CE2' ' A' ' 95' ' ' TYR . 3.2 t -129.43 -5.96 4.76 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.856 1.663 . . . . 63.1 112.967 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.23 176.01 14.7 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 108.099 -2.0 . . . . 73.42 108.099 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 pt -135.65 7.44 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.46 0.911 . . . . 71.13 113.46 -160.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.26 165.04 15.37 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.877 1.671 . . . . 74.13 110.109 -174.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.81 -84.47 0.02 OUTLIER Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.063 1.316 . . . . 74.25 113.167 169.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -148.25 95.42 2.46 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.212 1.405 . . . . 74.53 108.081 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -114.34 177.52 4.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.152 -0.967 . . . . 72.41 110.109 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -132.66 172.63 12.29 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.251 1.421 . . . . 73.54 107.369 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.04 136.3 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.802 -1.555 . . . . 74.23 106.802 173.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.1 mt -115.85 152.74 32.78 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.327 -0.99 . . . . 73.32 108.327 165.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 p -144.62 143.41 30.76 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.633 1.173 . . . . 61.2 108.554 173.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -138.89 124.66 19.71 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.012 0.925 . . . . 74.4 108.759 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.32 156.71 20.79 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.164 -1.421 . . . . 71.23 107.164 164.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -72.19 -47.83 47.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.868 0.842 . . . . 72.23 109.197 165.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.88 -1.45 24.17 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.87 2.068 . . . . 72.23 111.439 -161.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -114.78 -122.35 3.62 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.297 -1.921 . . . . 70.11 108.297 176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 p -133.0 -175.45 3.79 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.503 2.321 . . . . 74.14 107.741 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -107.12 164.27 13.17 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.123 -1.191 . . . . 70.04 110.123 164.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.97 147.59 35.43 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.659 1.184 . . . . 72.04 108.73 -175.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -134.88 140.64 45.95 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.373 -1.343 . . . . 65.51 107.373 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.15 160.42 25.83 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 111.264 -0.734 . . . . 74.2 111.264 164.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 52.0 mt -122.79 145.4 29.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 105.3 -2.111 . . . . 71.43 105.3 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -133.89 166.34 22.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.992 1.317 . . . . 71.31 109.014 -173.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.99 139.42 39.67 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.304 -0.998 . . . . 74.41 108.304 157.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 44.48 -75.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 130.358 3.463 . . . . 73.54 115.975 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.31 47.77 1.29 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.6 0.636 . . . . 72.42 112.069 167.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 m -144.06 132.67 11.11 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.459 1.504 . . . . 74.35 109.324 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.31 132.24 16.15 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.604 2.869 . . . . 74.32 110.333 165.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.48 -23.58 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.774 0.829 . . . . 65.32 111.835 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.4 t -141.44 162.76 34.69 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.065 -1.647 . . . . 72.25 109.864 169.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -160.74 137.56 8.88 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.348 2.259 . . . . 71.43 107.428 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -161.28 165.49 29.1 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.537 1.535 . . . . 73.14 107.661 168.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.3 mtm -134.31 163.33 29.87 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.897 -1.149 . . . . 73.3 107.897 170.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -163.09 146.88 10.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.8 0.84 . . . . 71.42 110.231 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.31 161.01 31.44 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.205 -1.035 . . . . 73.11 108.205 162.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -144.02 171.38 14.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.784 -0.573 . . . . 72.4 109.594 165.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -137.01 161.8 35.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.863 0.865 . . . . 74.34 109.718 167.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.0 mm -105.18 103.68 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.922 -1.51 . . . . 73.43 106.922 165.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -134.67 24.48 3.69 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.329 -0.857 . . . . 73.31 113.193 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -163.72 14.1 0.06 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.604 1.962 . . . . 74.4 116.053 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.33 18.21 57.79 Favored Glycine 0 CA--C 1.539 1.558 0 O-C-N 120.119 -1.613 . . . . 72.31 113.069 -168.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -134.12 -171.48 2.76 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.4 3.08 . . . . 70.0 107.208 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.17 113.49 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 121.242 1.837 . . . . 74.04 107.515 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -82.74 102.55 11.62 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.766 -1.198 . . . . 73.43 107.766 171.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 mm -81.32 137.57 21.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 105.898 -1.89 . . . . 74.44 105.898 168.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -151.15 -8.94 0.23 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.03 1.493 . . . . 71.3 115.03 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -144.77 112.71 6.36 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.361 -1.348 . . . . 73.33 107.361 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.2 t -122.47 154.28 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.776 1.63 . . . . 71.02 107.749 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.49 162.21 52.66 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.44 1.096 . . . . 73.42 108.393 172.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -83.75 -14.17 35.86 Favored 'Cis proline' 0 CA--C 1.536 0.624 0 N-CA-C 113.78 0.646 . . . . 70.23 113.78 -9.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.76 115.89 31.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 103.72 -2.696 . . . . 74.22 103.72 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -93.5 143.82 25.93 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.0 0.812 . . . . 70.42 109.571 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -132.81 172.4 12.62 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.276 1.43 . . . . 73.11 109.878 -171.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 t -54.41 146.36 33.3 Favored Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 123.61 0.569 . . . . 62.1 109.564 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.97 144.7 77.38 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.937 1.758 . . . . 53.2 109.799 165.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -154.92 164.44 38.87 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.998 0.919 . . . . 73.04 110.501 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.3 127.54 49.24 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.707 0.803 . . . . 74.34 109.333 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.28 112.68 24.34 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.452 1.501 . . . . 74.33 108.77 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.29 123.25 17.72 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.778 -1.193 . . . . 70.41 107.778 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.13 156.84 33.4 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.225 0.61 . . . . 74.02 110.458 175.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -129.57 156.25 44.5 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.802 1.241 . . . . 74.43 111.056 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.3 tt -151.25 146.54 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 122.491 0.316 . . . . 74.43 110.844 -171.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -149.31 43.51 0.94 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.303 1.841 . . . . 73.23 111.435 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.63 -89.74 1.63 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 110.385 -1.086 . . . . 72.01 110.385 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -20.26 24.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.099 -1.429 . . . . 72.21 114.823 -171.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -102.74 108.14 19.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 122.017 2.19 . . . . 71.43 111.278 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 33.0 tp -87.6 123.81 32.86 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.335 -1.478 . . . . 65.3 108.53 168.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -118.67 91.04 3.46 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.02 0.928 . . . . 74.22 109.931 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.2 t -86.1 130.94 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.934 -1.136 . . . . 73.0 107.934 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -85.39 -32.65 22.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.957 -0.544 . . . . 74.02 111.946 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.5 t -143.32 167.89 21.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.68 1.192 . . . . 74.32 110.774 -169.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.71 178.86 43.62 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-O 122.432 1.018 . . . . 65.22 112.624 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 m -51.87 -27.93 14.34 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.719 1.608 . . . . 74.44 112.65 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -101.16 10.89 40.37 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.209 0.818 . . . . 72.02 113.209 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.02 105.21 0.3 Allowed 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.375 -0.828 . . . . 74.14 110.084 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.84 -136.71 2.48 Favored Glycine 0 CA--C 1.519 0.302 0 O-C-N 121.169 -0.957 . . . . 70.23 112.57 -172.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.2 t -153.29 116.77 4.67 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.33 1.052 . . . . 73.22 109.367 -171.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.418 ' CE2' ' HB ' ' A' ' 18' ' ' THR . 88.4 m-85 -139.78 152.44 46.59 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 121.466 -0.771 . . . . 71.32 110.561 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -116.74 146.28 42.91 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 118.647 -0.692 . . . . 74.44 110.393 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -54.7 148.15 13.28 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.932 -1.136 . . . . 72.32 107.932 173.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -129.43 148.74 51.38 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.407 -1.701 . . . . 72.22 106.407 166.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 C--O 1.257 1.477 0 C-N-CA 126.275 1.83 . . . . 73.1 110.336 -179.488 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.465 0 N-CA-C 110.958 -0.857 . . . . 43.42 110.958 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -134.35 142.75 47.32 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 105.25 -2.13 . . . . 51.03 105.25 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -131.83 81.46 1.97 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.25 -1.019 . . . . 72.54 108.25 -155.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -118.03 147.84 42.83 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.462 0.305 . . . . 74.23 111.775 -170.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.8 p -83.39 171.05 13.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.465 0.706 . . . . 71.34 110.3 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -56.88 123.38 14.86 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.303 -0.862 . . . . 73.13 109.768 155.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.24 134.01 53.93 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 124.879 1.272 . . . . 72.34 110.524 157.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -140.48 174.74 10.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.468 -0.938 . . . . 71.55 108.468 163.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -69.31 40.99 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.8 1.64 . . . . 74.34 110.289 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -134.26 -59.61 0.82 Allowed 'General case' 0 N--CA 1.466 0.374 0 O-C-N 118.269 -2.77 . . . . 64.32 108.212 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -73.2 -26.27 61.09 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.572 0.749 . . . . 63.54 111.47 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.04 -20.02 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 119.459 1.027 . . . . 71.44 112.506 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.2 mm -68.66 144.41 14.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 121.23 -0.918 . . . . 73.51 109.521 -169.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.23 -153.82 17.36 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 124.944 1.259 . . . . 64.15 110.296 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -120.79 154.16 36.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.279 1.431 . . . . 73.55 109.494 -168.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -152.13 117.1 5.17 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.006 0.922 . . . . 74.45 109.593 -161.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.2 t -122.81 166.76 14.46 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.21 1.368 . . . . 73.43 112.024 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -125.19 2.75 7.88 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.661 1.584 . . . . 72.55 111.829 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.08 -177.37 36.57 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 120.503 1.501 . . . . 65.15 111.667 176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.6 pt -128.78 5.31 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.391 1.476 . . . . 75.13 111.387 -175.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -147.15 -173.23 4.19 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.52 1.528 . . . . 71.11 110.237 -164.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 48.48 -104.19 0.08 OUTLIER Glycine 0 C--N 1.339 0.734 0 C-N-CA 126.25 1.881 . . . . 43.34 111.763 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -138.39 97.66 3.42 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.593 -1.632 . . . . 74.34 106.593 172.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -111.78 177.76 4.54 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.77 0.828 . . . . 72.51 110.712 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -154.57 155.76 35.35 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.005 0.922 . . . . 74.41 108.934 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.01 131.0 36.58 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.846 1.659 . . . . 63.24 108.298 -168.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.9 mt -115.38 153.68 30.59 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.769 1.628 . . . . 73.13 108.895 170.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 p -147.19 153.39 39.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.31 -0.996 . . . . 74.42 108.31 167.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -144.63 141.97 29.77 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.948 1.299 . . . . 73.33 108.85 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -110.69 158.93 18.07 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.272 1.429 . . . . 71.34 108.147 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.84 -29.42 40.14 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.909 -0.316 . . . . 71.43 111.683 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.36 10.59 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.108 1.363 . . . . 74.42 110.139 -164.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.33 -124.02 2.82 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 125.017 1.294 . . . . 73.43 110.127 -169.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -140.31 167.14 22.85 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.822 -1.177 . . . . 73.31 107.822 168.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -93.36 176.25 36.83 Favored Glycine 0 CA--C 1.523 0.551 0 O-C-N 121.53 -0.732 . . . . 73.23 112.057 170.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.85 161.65 33.62 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.108 0.963 . . . . 63.24 109.828 171.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -141.99 151.06 42.15 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.274 -1.01 . . . . 70.42 108.274 168.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.77 161.76 32.53 Favored Glycine 0 CA--C 1.525 0.662 0 O-C-N 121.524 -0.735 . . . . 64.12 111.621 163.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.5 mt -124.83 149.58 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 127.047 2.139 . . . . 73.51 105.356 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -134.0 164.78 26.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.271 1.428 . . . . 74.21 110.149 -170.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.2 m -133.9 120.42 20.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.977 2.111 . . . . 70.34 106.006 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.254 0.9 OUTLIER 45.02 -81.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 130.016 3.326 . . . . 74.33 114.582 -173.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.67 43.54 1.73 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.786 1.635 . . . . 74.43 109.335 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.3 m -137.4 129.22 16.55 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.059 1.744 . . . . 64.4 107.635 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.37 136.92 32.52 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.747 2.298 . . . . 73.21 109.435 168.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.6 mm -120.56 -22.23 3.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 118.658 -0.687 . . . . 70.13 111.279 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.3 p -139.02 169.81 17.11 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.884 1.22 . . . . 72.33 110.782 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -159.15 153.27 23.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.827 -1.079 . . . . 74.21 108.307 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -166.61 161.49 15.93 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 105.649 -1.982 . . . . 74.43 105.649 165.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.8 mtm -122.57 159.01 28.68 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.389 -1.708 . . . . 74.24 106.389 160.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.18 141.01 17.13 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 123.991 0.807 . . . . 72.53 109.503 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -78.7 156.48 28.92 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 123.079 1.419 . . . . 73.33 108.391 166.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -151.84 169.05 23.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.171 -1.377 . . . . 72.41 110.021 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -141.44 163.17 33.65 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.113 0.965 . . . . 65.13 109.475 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.6 mm -120.05 89.33 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.791 -1.559 . . . . 65.55 106.791 170.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -123.42 25.81 8.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.598 1.159 . . . . 72.31 110.529 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -164.41 14.35 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.785 1.234 . . . . 74.22 112.604 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 26.69 69.86 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 120.451 -0.88 . . . . 72.31 111.219 -172.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -151.22 164.47 36.5 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.466 3.106 . . . . 65.34 106.817 -168.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.9 mt -100.27 109.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.404 -1.702 . . . . 74.11 106.404 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -80.9 106.17 12.7 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.065 -1.457 . . . . 70.51 107.065 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.1 mm -85.54 140.21 16.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.968 -1.493 . . . . 74.4 106.968 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -156.52 -2.69 0.12 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 115.868 1.803 . . . . 72.14 115.868 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -148.03 120.99 8.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 103.618 -2.734 . . . . 71.32 103.618 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.8 t -133.47 154.09 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 125.314 1.446 . . . . 62.53 107.436 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.94 163.54 37.48 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.651 1.181 . . . . 74.23 109.055 172.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.24 -21.39 13.66 Favored 'Cis proline' 0 C--N 1.345 0.374 0 N-CA-C 113.968 0.719 . . . . 62.24 113.968 -7.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -100.78 101.05 11.81 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.329 -2.1 . . . . 71.44 105.329 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -61.64 139.08 58.33 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.775 1.23 . . . . 74.44 110.417 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.0 mmpt? -114.56 158.42 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.072 1.749 . . . . 72.21 109.095 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -65.04 148.87 97.52 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.657 -0.868 . . . . 74.33 108.657 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.63 145.58 52.52 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.567 2.178 . . . . 74.23 112.478 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -156.15 167.88 29.05 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.887 1.275 . . . . 74.34 110.307 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -106.51 130.55 54.27 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.917 -1.142 . . . . 74.11 107.917 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.0 mt -106.39 132.64 52.18 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 125.956 1.702 . . . . 70.52 109.103 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.65 128.12 34.79 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.672 1.189 . . . . 72.53 110.694 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 p -150.29 164.98 34.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.499 1.519 . . . . 71.14 109.47 169.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -127.8 164.1 22.92 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.906 2.082 . . . . 62.51 112.239 159.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.8 tt -155.3 160.24 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.556 -1.275 . . . . 73.35 107.556 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.6 m -128.38 -66.1 0.86 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.493 2.317 . . . . 74.53 109.914 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.68 -83.76 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 106.998 -2.441 . . . . 73.33 106.998 170.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 p -95.08 -8.5 36.4 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.082 1.882 . . . . 72.55 116.082 -167.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.2 m -101.63 98.86 9.1 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 121.342 1.883 . . . . 73.51 109.34 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.03 119.11 19.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.005 -1.85 . . . . 73.55 106.005 165.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -108.05 88.88 2.83 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.618 -0.882 . . . . 71.31 108.618 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 t -80.23 128.32 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.858 -1.164 . . . . 74.21 107.858 169.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.65 -46.58 16.92 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.4 -0.81 . . . . 73.32 112.078 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 t -126.12 -172.85 2.71 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.575 1.08 . . . . 74.54 111.584 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.8 177.98 51.91 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.99 -1.244 . . . . 73.34 109.99 -171.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.5 m -60.49 -19.22 56.13 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.659 -0.906 . . . . 65.33 111.803 164.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -89.78 0.63 56.89 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.299 0.64 . . . . 65.55 112.371 -170.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.96 108.45 0.4 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.083 2.153 . . . . 74.44 110.261 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.79 -150.12 6.52 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 121.833 0.685 . . . . 72.53 112.583 -167.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 t -144.86 125.76 14.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.852 -1.907 . . . . 74.24 105.852 165.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -122.9 124.65 43.7 Favored 'General case' 0 C--O 1.226 -0.168 0 O-C-N 121.641 -0.662 . . . . 74.45 110.606 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -88.09 18.17 4.48 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.335 1.606 . . . . 75.25 115.335 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 26.3 tttt 62.43 156.03 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 127.172 2.189 . . . . 72.41 110.677 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -143.11 47.2 1.52 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.059 2.144 . . . . 71.45 106.8 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.8 tttt . . . . . 0 C--O 1.254 1.337 0 C-N-CA 124.253 1.021 . . . . 73.33 110.648 175.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.806 0 N-CA-C 109.297 -1.521 . . . . 50.12 109.297 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.24 76.18 1.54 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.973 -1.491 . . . . 73.43 106.973 172.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -89.07 103.17 15.81 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.494 -1.298 . . . . 72.15 107.494 -162.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -108.29 161.26 15.17 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.906 2.082 . . . . 74.34 109.989 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.4 p -90.4 167.65 12.46 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.569 0.622 . . . . 74.34 109.896 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -51.63 125.18 14.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.132 0.968 . . . . 73.23 108.77 159.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.4 tp -67.66 118.99 11.67 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.29 -1.374 . . . . 73.31 107.29 161.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.442 HD21 ' ND2' ' A' ' 11' ' ' ASN . 21.2 m-80 -119.45 162.78 18.27 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 105.273 -2.121 . . . . 71.04 105.273 168.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -61.12 -44.91 96.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.16 -1.052 . . . . 62.25 108.16 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -53.83 -21.81 8.34 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.781 1.632 . . . . 75.54 113.918 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.442 ' ND2' HD21 ' A' ' 8' ' ' ASN . 93.0 m-20 -90.27 -29.78 17.94 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.283 0.947 . . . . 73.24 113.085 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.2 tp -87.66 -10.92 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.24 1.016 . . . . 73.23 111.923 -168.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mm -60.31 135.56 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.303 1.041 . . . . 71.23 111.523 -175.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.1 175.59 14.14 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.31 1.91 . . . . 61.13 110.847 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -78.17 159.09 28.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.972 -0.751 . . . . 74.3 108.972 164.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -149.59 146.15 27.17 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.588 1.155 . . . . 74.32 109.261 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.8 p -134.96 175.4 9.61 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.247 1.385 . . . . 73.23 112.851 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.2 t -133.8 12.94 4.03 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.451 1.1 . . . . 73.42 113.217 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.03 176.97 14.86 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.839 -1.704 . . . . 52.1 108.839 -175.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.0 pt -130.88 15.24 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.857 0.863 . . . . 74.41 112.612 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -108.91 165.1 11.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.118 1.367 . . . . 73.33 111.456 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.0 -101.35 0.72 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.561 -1.016 . . . . 73.1 110.561 162.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.3 m -141.7 117.3 10.31 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.455 -2.054 . . . . 73.22 105.455 162.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -114.99 179.23 4.01 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.689 1.595 . . . . 74.23 109.295 -176.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -142.81 139.85 31.1 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.165 1.386 . . . . 74.44 108.918 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.0 144.6 48.44 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.82 1.648 . . . . 73.5 108.306 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mt -124.76 155.62 39.03 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.358 1.863 . . . . 74.51 109.261 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.7 t -143.78 152.23 40.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.31 1.444 . . . . 75.13 107.735 163.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -149.13 127.68 12.34 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 127.128 2.171 . . . . 74.12 107.002 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.54 163.32 12.55 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.576 0.75 . . . . 71.11 111.386 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.37 -30.19 37.88 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.982 0.734 . . . . 60.55 112.982 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.75 2.26 3.14 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.271 0.357 . . . . 72.21 110.975 -172.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.11 -129.41 5.68 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.678 1.609 . . . . 71.34 109.827 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.8 p -138.71 -175.42 4.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.328 2.251 . . . . 74.5 106.175 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.67 -177.81 22.4 Favored Glycine 0 C--O 1.238 0.385 0 N-CA-C 109.862 -1.295 . . . . 72.14 109.862 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.7 p -159.77 152.16 21.03 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.797 1.036 . . . . 72.1 113.797 -163.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -129.55 112.82 14.11 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.364 1.866 . . . . 73.34 107.299 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.17 109.21 0.95 Allowed Glycine 0 C--N 1.341 0.857 0 C-N-CA 124.376 0.988 . . . . 54.52 112.053 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.6 mt -76.61 143.06 13.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.463 1.105 . . . . 74.43 108.239 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -131.73 125.12 31.21 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.031 1.333 . . . . 71.22 109.301 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -88.31 112.69 23.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.597 -1.261 . . . . 74.31 107.597 166.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 53.06 -78.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.995 2.518 . . . . 72.13 112.342 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.94 21.09 2.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.423 1.889 . . . . 74.22 112.492 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 m -116.76 118.02 37.08 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.393 1.477 . . . . 53.13 107.675 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.61 125.69 14.81 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.576 2.184 . . . . 73.11 108.702 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.4 mm -117.24 -3.9 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.672 0.789 . . . . 74.13 110.907 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.4 t -152.17 163.7 38.84 Favored 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 120.169 -1.582 . . . . 62.34 108.998 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -157.7 144.92 18.3 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.022 1.729 . . . . 75.5 106.939 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -167.77 153.59 7.39 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 105.629 -1.989 . . . . 71.21 105.629 165.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 mtm -132.32 153.9 50.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.564 1.146 . . . . 74.43 108.83 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -163.2 154.37 16.97 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.747 0.819 . . . . 74.2 109.527 -174.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.92 169.09 16.42 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.143 2.177 . . . . 75.12 109.601 172.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.68 162.02 36.55 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.258 1.023 . . . . 72.01 110.261 171.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -134.11 131.31 38.58 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.49 -1.3 . . . . 74.12 107.49 160.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.48 107.66 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 105.597 -2.001 . . . . 75.05 105.597 163.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -152.66 45.9 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.463 0.705 . . . . 61.43 109.137 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.95 14.49 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.811 2.444 . . . . 73.14 111.966 162.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.94 25.24 71.93 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.393 -1.442 . . . . 71.32 110.822 -160.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.416 ' HE ' ' CG ' ' A' ' 76' ' ' ASP . 76.4 mtt85 -140.05 158.75 43.57 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 126.724 2.009 . . . . 72.44 106.512 176.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.08 138.77 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.168 -1.79 . . . . 73.25 106.168 172.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -117.49 115.96 26.19 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.81 2.044 . . . . 72.11 107.111 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.4 mm -97.71 143.05 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.979 -1.489 . . . . 74.23 106.979 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -159.36 -2.62 0.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.067 1.506 . . . . 73.14 115.067 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -148.42 125.19 11.18 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.084 -2.562 . . . . 73.42 104.084 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.2 t -132.14 152.33 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 125.212 1.405 . . . . 71.23 107.787 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.4 151.94 48.7 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 125.833 1.653 . . . . 75.1 106.678 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.52 -6.74 50.3 Favored 'Cis proline' 0 CA--C 1.534 0.513 0 CA-C-N 119.378 0.814 . . . . 61.01 113.983 4.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.28 108.61 18.77 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.791 -1.929 . . . . 73.21 105.791 172.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.63 127.97 34.28 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.097 1.359 . . . . 74.32 108.142 169.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -125.16 160.38 29.27 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.635 0.774 . . . . 71.11 110.078 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -56.89 147.05 55.89 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.051 0.941 . . . . 70.02 109.437 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.93 147.19 89.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.979 1.786 . . . . 70.31 111.07 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -157.56 151.41 24.24 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.269 1.828 . . . . 54.23 108.17 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -81.22 160.23 24.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.637 -1.165 . . . . 72.25 107.931 165.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.83 127.28 38.3 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.467 1.107 . . . . 74.13 108.711 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.416 ' CG ' ' HE ' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -81.22 115.2 20.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.621 -1.622 . . . . 74.33 106.621 175.035 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -146.1 151.7 38.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.717 1.207 . . . . 65.21 107.773 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -117.8 157.99 25.58 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.253 1.021 . . . . 73.32 109.373 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 tt -151.65 151.78 11.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 118.689 -0.672 . . . . 71.15 109.537 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.4 m -141.68 -6.98 0.99 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.339 1.607 . . . . 73.12 115.339 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.23 -82.35 0.17 Allowed Glycine 0 N--CA 1.461 0.308 0 O-C-N 120.363 -1.46 . . . . 63.31 109.552 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.5 p -104.32 -13.54 16.1 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.534 -0.746 . . . . 73.22 112.057 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 m -90.01 101.63 14.34 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.45 1.477 . . . . 74.0 109.784 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 tp -81.58 138.94 35.32 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.419 -1.326 . . . . 72.43 107.419 159.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -127.66 144.43 51.08 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.617 -0.883 . . . . 74.13 108.617 163.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 t -127.99 127.21 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.793 -1.558 . . . . 74.4 106.793 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -96.45 -20.84 18.12 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.436 0.902 . . . . 70.02 113.436 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -155.48 172.89 17.49 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.62 1.568 . . . . 70.24 108.655 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.92 177.93 49.11 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-O 122.285 0.936 . . . . 73.34 111.383 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 t -60.84 -26.99 67.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.24 -0.565 . . . . 74.22 111.724 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.81 6.26 49.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.397 -0.811 . . . . 70.2 113.042 -172.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -46.4 101.61 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.926 1.691 . . . . 74.22 110.651 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.95 -174.14 39.88 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.067 0.841 . . . . 70.03 112.382 -158.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.7 p -140.43 100.75 3.95 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.551 1.541 . . . . 71.33 107.716 -169.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -115.78 150.94 36.1 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.721 0.408 . . . . 73.42 110.629 -169.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -120.59 16.87 12.05 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.331 1.234 . . . . 73.31 114.331 -167.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.5 tttt 68.16 142.42 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 129.891 3.277 . . . . 71.24 111.629 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -132.75 47.67 2.49 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.708 2.403 . . . . 72.43 107.581 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? . . . . . 0 C--O 1.245 0.863 0 N-CA-C 105.072 -2.196 . . . . 75.12 105.072 170.935 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.128 0 CA-C-O 119.491 -0.616 . . . . 75.15 111.849 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -69.73 75.54 0.44 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 123.712 1.72 . . . . 73.41 107.947 167.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -137.81 112.2 8.67 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.683 -1.969 . . . . 72.24 105.683 -157.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -135.5 156.5 48.8 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 128.34 2.656 . . . . 75.15 108.077 -171.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -76.81 168.5 19.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.132 0.492 . . . . 71.43 111.304 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -55.45 143.95 27.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.993 1.317 . . . . 74.52 109.055 164.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.3 tp -83.73 121.96 27.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.244 -1.391 . . . . 73.53 107.244 164.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -131.17 172.7 11.82 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.363 1.065 . . . . 75.11 109.762 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -10.36 23.05 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.92 -1.038 . . . . 74.42 113.103 173.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -107.42 -31.61 8.09 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 121.094 1.77 . . . . 75.12 113.073 -168.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -86.18 -27.76 24.34 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.008 -0.996 . . . . 52.32 112.452 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 tp -65.76 -27.7 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.791 1.632 . . . . 75.11 111.534 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.6 mm -54.09 121.79 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 C-N-CA 125.854 1.661 . . . . 75.13 110.744 -169.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.95 176.31 14.42 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 123.964 0.792 . . . . 72.44 111.255 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.45 157.94 24.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.706 0.803 . . . . 75.21 109.433 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -147.02 143.68 28.57 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.87 0.868 . . . . 73.22 109.346 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.8 t -140.01 166.0 25.82 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.53 0.732 . . . . 72.34 110.82 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.466 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 14.2 t -119.34 -6.51 10.32 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.952 2.101 . . . . 73.55 111.393 176.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.66 175.8 43.37 Favored Glycine 0 C--N 1.337 0.593 0 O-C-N 120.503 -1.373 . . . . 60.44 110.978 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.7 pt -133.47 15.02 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.169 1.387 . . . . 74.13 110.046 -173.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -148.94 -175.8 5.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.145 1.778 . . . . 73.41 109.703 -165.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.69 -99.9 0.04 OUTLIER Glycine 0 C--N 1.337 0.592 0 C-N-CA 126.789 2.138 . . . . 71.34 112.823 165.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.9 m -148.14 129.24 14.55 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 104.364 -2.458 . . . . 74.22 104.364 167.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -143.47 -174.78 4.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.373 1.069 . . . . 75.55 109.342 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -136.39 164.67 27.58 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.284 1.434 . . . . 75.11 109.549 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.33 133.06 23.83 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.243 1.417 . . . . 75.45 108.63 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 mt -121.07 160.41 23.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.953 0.901 . . . . 74.34 109.86 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 t -137.12 154.12 50.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.041 1.736 . . . . 62.45 106.631 159.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -145.03 130.26 18.58 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.566 1.546 . . . . 74.01 108.24 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.87 152.18 23.59 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.507 1.123 . . . . 64.35 109.822 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.82 -37.46 73.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.91 1.284 . . . . 73.25 110.516 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.67 21.26 4.65 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.31 1.044 . . . . 64.05 110.753 -171.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -130.36 -129.08 3.06 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.482 1.039 . . . . 75.42 110.599 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 p -124.19 -175.05 3.14 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.421 1.888 . . . . 74.24 108.442 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.79 167.13 13.04 Favored Glycine 0 C--O 1.237 0.322 0 N-CA-C 109.252 -1.539 . . . . 73.32 109.252 162.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.04 153.24 49.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.701 0.801 . . . . 74.01 108.859 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -137.73 121.54 17.58 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.127 1.371 . . . . 72.41 107.761 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.61 162.53 19.83 Favored Glycine 0 C--N 1.331 0.297 0 N-CA-C 110.293 -1.123 . . . . 75.32 110.293 174.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.0 mt -127.15 143.36 40.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.962 -1.866 . . . . 73.31 105.962 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -136.01 124.65 23.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.417 1.087 . . . . 75.43 108.687 -166.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.2 m -84.69 124.27 31.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.837 -1.542 . . . . 72.43 106.837 166.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 44.64 -78.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 129.059 2.943 . . . . 74.44 115.127 176.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.2 68.03 1.09 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.64 1.576 . . . . 62.01 107.612 165.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.7 m -152.97 130.96 6.2 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 126.591 1.957 . . . . 75.3 107.089 170.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.01 135.85 26.12 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.563 2.842 . . . . 75.12 110.509 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.7 mm -130.89 -21.25 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.007 0.923 . . . . 75.42 111.729 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.1 m -142.01 155.58 45.43 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 120.551 -1.343 . . . . 71.33 109.105 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -155.98 143.27 19.22 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.751 1.22 . . . . 72.34 109.629 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -159.75 159.59 32.97 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.1 1.76 . . . . 71.32 106.94 166.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.9 mtm -133.5 148.46 51.69 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.564 -1.643 . . . . 73.3 106.564 172.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -158.5 142.52 15.56 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.474 -0.565 . . . . 73.12 109.474 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.47 157.16 30.61 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.591 -1.263 . . . . 73.31 107.591 170.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -151.08 164.53 36.26 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.629 -0.67 . . . . 74.31 109.953 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -132.1 158.3 41.96 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.614 1.166 . . . . 73.35 108.235 164.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.9 mm -113.63 87.11 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.552 -2.018 . . . . 73.23 105.552 166.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -126.25 23.04 7.08 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 122.424 1.107 . . . . 74.23 110.759 -170.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.76 14.28 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.317 1.847 . . . . 74.14 113.606 -170.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.61 15.55 61.99 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 121.368 -0.833 . . . . 54.13 111.338 -172.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -145.43 162.05 38.24 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 128.847 2.859 . . . . 74.42 105.893 -170.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 mt -91.27 109.46 21.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.612 -1.625 . . . . 74.21 106.612 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -78.86 104.78 9.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.77 -1.567 . . . . 75.54 106.77 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.0 mm -88.89 131.39 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.152 -2.166 . . . . 73.35 105.152 170.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -154.74 -1.14 0.17 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 115.93 1.826 . . . . 75.42 115.93 -175.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -148.86 123.5 9.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.761 -1.94 . . . . 72.22 105.761 162.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.5 t -129.14 141.45 46.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 125.823 1.649 . . . . 71.14 107.827 -174.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.41 164.06 46.68 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.327 1.051 . . . . 75.12 108.246 173.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.23 -19.76 15.33 Favored 'Cis proline' 0 N--CA 1.454 -0.84 0 CA-C-N 119.285 0.78 . . . . 74.11 111.98 -14.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -98.27 102.21 13.89 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.912 -1.514 . . . . 64.54 106.912 -176.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -88.41 131.8 34.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.022 -0.99 . . . . 71.53 110.493 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -127.39 174.7 8.78 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.676 1.19 . . . . 74.43 110.382 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 t -61.02 154.89 58.05 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.152 1.381 . . . . 71.43 111.625 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.51 147.3 57.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.359 2.706 . . . . 71.13 112.593 171.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -161.01 164.59 30.85 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.648 1.179 . . . . 74.52 110.441 171.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -91.68 148.54 22.18 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.956 -0.757 . . . . 74.14 108.956 169.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -124.39 137.43 54.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.178 1.791 . . . . 74.43 108.474 175.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -98.71 133.22 43.34 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.766 -0.827 . . . . 61.24 108.766 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 2.1 p -151.68 165.64 33.73 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.091 1.356 . . . . 71.52 109.433 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.44 161.18 19.48 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.404 -0.591 . . . . 72.42 109.404 160.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.4 tt -137.47 146.94 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.462 -1.31 . . . . 75.22 107.462 174.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.3 p -111.7 -10.74 14.05 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.579 0.751 . . . . 64.52 112.037 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 125.69 -63.09 0.59 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 107.452 -2.259 . . . . 72.12 107.452 -169.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 p -112.55 -15.57 13.02 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.575 -1.202 . . . . 73.31 114.155 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.1 m -104.45 137.0 42.96 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.599 1.545 . . . . 75.54 107.878 168.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.76 143.4 29.14 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.898 -1.519 . . . . 74.51 106.898 161.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -133.07 85.65 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.154 -1.054 . . . . 74.24 108.154 170.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.41 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 44.4 t -75.65 124.75 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.3 -0.63 . . . . 73.34 109.3 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -92.94 -24.95 18.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.147 0.979 . . . . 65.23 112.547 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.0 t -152.52 160.86 43.2 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.013 0.824 . . . . 70.33 110.285 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.26 176.17 19.39 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.956 1.741 . . . . 65.24 111.134 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.1 m -55.62 -26.98 47.07 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.619 0.768 . . . . 53.35 111.548 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -101.89 11.79 38.02 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.022 0.929 . . . . 73.13 113.046 -174.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.6 108.73 0.37 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.207 1.403 . . . . 64.52 110.929 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.59 -169.8 41.51 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 122.113 0.841 . . . . 70.21 113.03 -169.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -118.65 126.29 51.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.929 2.092 . . . . 65.45 107.473 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.466 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 23.9 m-85 -140.07 159.33 42.42 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.789 0.328 . . . . 73.45 110.499 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -120.57 149.55 42.27 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.487 1.115 . . . . 74.45 109.154 170.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -61.17 143.19 55.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.99 -1.115 . . . . 71.01 107.99 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -116.5 56.67 0.79 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.685 -1.969 . . . . 74.12 105.685 175.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? . . . . . 0 C--O 1.248 0.998 0 C-N-CA 128.366 2.666 . . . . 73.31 105.68 -176.285 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.629 0 N-CA-C 108.485 -1.846 . . . . 73.43 108.485 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -153.3 75.46 1.06 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 104.219 -2.512 . . . . 74.4 104.219 170.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -117.47 65.57 0.73 Allowed 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.36 -1.348 . . . . 75.13 107.36 -149.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -87.57 147.79 25.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.187 -1.824 . . . . 75.04 109.936 -174.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.22 167.59 17.58 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.884 0.874 . . . . 71.31 110.528 168.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -55.58 136.26 50.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.882 1.325 . . . . 73.24 109.65 157.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.7 tp -66.96 139.24 57.69 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.363 -1.347 . . . . 74.44 107.363 154.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -140.11 170.42 15.88 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.713 -1.588 . . . . 75.41 106.713 163.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 p -44.25 -60.62 1.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.248 2.619 . . . . 74.05 109.809 171.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -71.69 -17.24 62.24 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.259 -1.337 . . . . 73.43 110.245 -170.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -82.64 -37.16 25.3 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 117.763 -1.113 . . . . 73.12 110.596 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 tp -74.98 -15.87 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 121.381 1.901 . . . . 73.21 113.363 -170.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mm -56.35 136.32 19.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.448 1.099 . . . . 64.52 110.762 -173.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 131.45 -175.08 19.79 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.777 1.18 . . . . 74.22 112.727 170.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.54 146.08 25.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.093 1.757 . . . . 73.21 108.612 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -140.3 111.61 7.19 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.789 0.836 . . . . 75.1 110.221 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -118.18 143.59 46.39 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.257 1.023 . . . . 73.0 108.971 -175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 t -82.35 -43.99 16.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.251 0.621 . . . . 73.03 109.419 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.5 172.8 44.7 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.74 1.638 . . . . 64.33 110.335 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.9 pt -115.94 45.37 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 122.924 1.345 . . . . 72.22 109.854 -164.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -131.06 178.81 6.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.251 1.42 . . . . 53.4 111.619 -156.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.79 -24.34 18.63 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 127.228 2.347 . . . . 75.34 115.597 -163.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.2 m -150.2 119.94 7.05 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.596 -1.631 . . . . 71.14 106.596 170.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -146.41 -178.95 6.43 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.043 0.838 . . . . 73.1 110.918 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -143.26 146.08 33.31 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.289 1.436 . . . . 74.0 108.39 -171.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.31 135.02 45.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.698 -1.223 . . . . 74.3 107.698 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 mt -123.13 155.75 36.38 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.201 1.401 . . . . 75.41 108.275 172.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.9 p -146.85 152.42 38.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.695 0.798 . . . . 55.12 109.567 167.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.62 119.84 12.19 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.602 -1.629 . . . . 75.04 106.602 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -84.94 169.51 13.98 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.694 -0.854 . . . . 64.15 108.694 169.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -93.58 -25.61 17.47 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.599 1.16 . . . . 62.54 112.92 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.09 32.09 1.24 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.416 1.086 . . . . 75.51 108.714 -174.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.19 -112.57 1.1 Allowed Glycine 0 C--N 1.339 0.698 0 N-CA-C 109.02 -1.632 . . . . 71.31 109.02 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.4 p -139.92 -165.66 1.93 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.735 1.214 . . . . 75.15 109.346 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.09 171.18 14.77 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.423 1.011 . . . . 55.25 110.852 166.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.53 148.94 35.08 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.907 -0.775 . . . . 62.45 108.907 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -138.83 124.25 19.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.472 1.109 . . . . 73.45 108.572 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.62 165.49 21.46 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.808 -0.917 . . . . 71.2 110.808 175.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -124.49 148.49 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 104.862 -2.273 . . . . 75.4 104.862 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -141.84 165.1 28.41 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.449 1.1 . . . . 75.22 108.716 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.3 m -136.24 112.69 9.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.91 2.084 . . . . 75.44 107.866 171.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 54.13 -78.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 127.51 2.324 . . . . 71.43 114.374 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.21 47.97 1.49 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.202 1.801 . . . . 75.33 110.457 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.2 m -154.83 137.66 10.3 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.024 1.73 . . . . 73.23 108.669 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.68 142.21 22.72 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 124.057 3.172 . . . . 71.41 110.593 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.6 mm -130.69 -7.48 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 126.028 1.731 . . . . 63.3 110.843 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.9 t -153.7 164.76 37.76 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 119.721 -1.862 . . . . 72.41 109.117 163.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -157.31 123.07 4.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.71 2.404 . . . . 73.22 106.837 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -139.0 164.22 30.33 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.381 1.472 . . . . 64.13 107.152 164.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mtm -135.87 156.28 49.02 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.967 1.307 . . . . 74.05 107.673 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -159.39 151.94 21.44 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.575 0.75 . . . . 75.03 110.27 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -82.4 166.85 19.05 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.349 -0.612 . . . . 75.25 109.349 166.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -148.23 160.9 42.48 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.238 0.615 . . . . 74.44 111.787 172.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -131.39 154.99 48.06 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.215 -1.402 . . . . 73.42 107.215 164.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.3 mm -104.16 107.72 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 106.018 -1.845 . . . . 74.33 106.018 164.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.75 24.62 2.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.946 1.461 . . . . 73.35 114.946 171.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.88 14.66 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.631 1.573 . . . . 73.05 114.835 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.43 11.84 84.02 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 120.114 -1.616 . . . . 74.05 115.12 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -121.37 -165.73 1.27 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.292 1.837 . . . . 74.45 107.765 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.6 mt -114.84 110.18 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.753 1.615 . . . . 55.15 107.179 172.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -76.88 103.17 6.67 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 107.363 -1.347 . . . . 75.25 107.363 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.5 mm -90.49 140.12 16.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 105.697 -1.964 . . . . 74.01 105.697 170.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -158.31 -5.01 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 115.131 1.53 . . . . 75.23 115.131 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -144.87 112.75 6.34 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.224 -2.88 . . . . 73.14 103.224 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.1 t -132.29 152.69 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.949 -1.501 . . . . 71.11 106.949 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.83 162.11 34.73 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.482 1.513 . . . . 75.44 107.18 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.84 -26.47 9.61 Favored 'Cis proline' 0 N--CA 1.459 -0.536 0 CA-C-N 119.833 0.976 . . . . 65.32 112.396 -9.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -87.16 107.7 18.58 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 104.789 -2.3 . . . . 74.24 104.789 167.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -70.74 159.66 34.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.954 0.407 . . . . 74.35 110.479 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.93 153.7 48.26 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.828 1.251 . . . . 73.14 108.778 171.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.4 t -50.89 151.13 4.64 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.559 1.944 . . . . 71.12 111.643 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.03 154.05 67.08 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.521 2.147 . . . . 74.13 113.335 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -168.45 166.04 12.38 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.142 1.377 . . . . 74.23 109.847 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -103.08 111.33 23.64 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.492 -1.299 . . . . 70.12 107.492 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.1 mt -77.61 113.99 16.0 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.956 0.903 . . . . 70.41 108.866 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.44 116.29 4.96 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.119 1.768 . . . . 70.23 108.697 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 9.5 p -151.13 158.77 44.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.658 -0.651 . . . . 74.44 112.637 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 163.0 16.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.316 -0.856 . . . . 75.41 110.972 174.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 tt -141.31 149.98 20.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.518 1.127 . . . . 72.33 108.425 170.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.6 p -129.02 -6.67 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.354 1.242 . . . . 75.04 114.354 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.6 -71.51 0.37 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.304 -1.519 . . . . 73.04 109.304 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.1 p -121.4 4.12 10.23 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.537 -0.745 . . . . 73.44 112.987 175.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.9 m -107.6 133.31 52.23 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.282 -1.377 . . . . 62.41 107.282 170.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.1 tp -108.6 130.57 55.31 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.258 2.223 . . . . 75.03 107.299 166.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -125.69 99.71 6.11 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.009 1.324 . . . . 75.1 110.009 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.8 t -93.61 131.81 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.854 -0.795 . . . . 75.32 108.854 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -87.56 -23.42 24.35 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.844 1.258 . . . . 75.42 113.329 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -153.12 166.39 32.63 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.129 -0.982 . . . . 65.11 109.849 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.67 175.44 36.92 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.709 -0.956 . . . . 54.42 110.709 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.1 m -60.05 -21.61 61.63 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.253 1.021 . . . . 75.22 112.016 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -101.85 6.34 41.45 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.914 1.686 . . . . 64.44 112.776 -172.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.65 110.66 0.83 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.509 1.924 . . . . 73.2 109.337 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.52 -136.31 2.64 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 123.451 0.548 . . . . 73.01 112.527 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.5 t -154.92 113.45 3.54 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.289 -1.745 . . . . 74.0 106.289 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -133.07 152.76 51.93 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.165 -0.959 . . . . 74.42 109.446 -168.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -118.98 141.42 48.68 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.282 1.033 . . . . 75.13 108.331 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -58.37 134.74 56.88 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.263 -1.384 . . . . 74.34 107.263 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -134.9 70.55 1.44 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.741 -1.207 . . . . 73.3 107.741 175.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 53.7 tttt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.5 -1.238 . . . . 74.01 108.695 -167.354 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.177 0 N-CA-C 109.687 -1.365 . . . . 60.41 109.687 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -128.15 98.69 5.19 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 118.934 1.367 . . . . 61.41 107.79 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -98.9 124.74 44.03 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.198 -2.149 . . . . 72.52 105.198 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -111.15 166.49 11.03 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.263 -1.79 . . . . 74.52 110.625 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -84.65 163.93 18.95 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.055 -0.72 . . . . 62.14 109.055 168.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -51.71 124.33 12.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.109 0.957 . . . . 74.44 109.283 153.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.17 134.3 55.76 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.529 0.681 . . . . 64.3 109.538 157.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -139.02 169.14 18.34 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.624 -1.621 . . . . 71.32 106.624 163.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -49.85 -57.19 7.9 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.944 0.498 . . . . 74.43 109.687 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -64.34 -17.33 63.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.843 0.683 . . . . 74.14 112.843 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -78.87 -44.39 22.94 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.854 0.861 . . . . 74.34 110.496 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.9 tp -74.96 -24.56 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 O-C-N 120.329 -1.482 . . . . 70.42 112.225 -170.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 mm -47.88 125.46 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.573 1.949 . . . . 73.53 112.53 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.17 -178.57 18.87 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.11 0.862 . . . . 70.43 112.828 168.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -72.78 147.89 45.1 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 125.675 1.59 . . . . 73.55 110.534 171.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.48 ' CH2' ' HE3' ' A' ' 97' ' ' LYS . 93.7 m95 -137.76 117.84 13.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.257 1.423 . . . . 74.31 108.669 176.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t -116.61 174.2 6.21 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.785 1.234 . . . . 71.31 110.038 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -142.98 1.31 1.26 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.315 1.446 . . . . 72.51 111.363 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.49 176.91 14.6 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 126.477 1.989 . . . . 74.24 108.465 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.75 11.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 113.123 0.786 . . . . 65.34 113.123 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -113.06 -171.35 1.85 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 125.426 1.49 . . . . 73.44 110.184 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 48.43 -90.42 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 126.495 1.998 . . . . 70.23 114.51 153.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.8 m -144.93 100.48 3.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.734 -1.95 . . . . 72.35 105.734 169.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -115.44 171.68 7.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.15 -0.685 . . . . 73.11 109.15 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -146.46 151.84 38.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.145 -1.798 . . . . 73.53 106.145 -175.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.67 146.83 50.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.815 -1.921 . . . . 70.44 105.815 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.03 159.97 35.98 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.479 -0.934 . . . . 70.44 108.479 161.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.2 p -133.36 154.55 50.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.498 0.719 . . . . 65.55 109.772 164.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -139.69 125.09 19.07 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.428 -2.064 . . . . 64.41 105.428 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -109.99 161.4 15.55 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.138 -1.43 . . . . 64.42 107.138 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -97.13 -21.04 17.56 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.586 -0.696 . . . . 72.13 112.518 -168.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -124.41 -5.78 7.67 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 122.853 0.461 . . . . 74.5 111.835 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.96 -120.38 4.36 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.01 1.767 . . . . 61.31 109.819 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.3 p -148.27 175.37 11.13 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 128.481 2.712 . . . . 73.43 106.535 -172.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.86 -166.87 23.33 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 119.392 0.996 . . . . 72.23 112.32 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 m -148.8 164.9 33.07 Favored 'General case' 0 CA--C 1.521 -0.144 0 O-C-N 121.214 -1.168 . . . . 71.51 109.674 168.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -143.15 125.33 15.44 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.488 -1.301 . . . . 73.12 107.488 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.14 159.04 20.49 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.064 -0.815 . . . . 72.53 111.064 170.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.6 mt -133.31 140.61 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 105.843 -1.91 . . . . 73.53 105.843 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -132.02 157.11 44.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.161 0.985 . . . . 74.51 110.022 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -125.86 116.88 22.24 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.19 2.196 . . . . 63.15 106.172 167.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 48.75 -76.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 129.182 2.993 . . . . 71.42 114.169 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.21 29.61 2.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.775 1.63 . . . . 72.13 112.969 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.0 m -137.22 130.46 17.28 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 124.911 1.284 . . . . 72.11 109.541 -174.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.38 133.63 21.22 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.997 3.132 . . . . 70.41 110.857 170.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.4 mm -128.44 -3.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 125.899 1.68 . . . . 71.31 111.275 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 t -145.63 171.28 14.94 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 119.277 -2.139 . . . . 70.52 107.837 165.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -166.37 140.89 4.32 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.729 1.612 . . . . 73.41 107.54 168.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -157.82 162.29 38.41 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.668 1.587 . . . . 73.44 107.074 169.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.6 mtm -130.44 155.42 46.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.237 -1.394 . . . . 74.33 107.237 166.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -163.35 156.22 18.67 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.206 1.002 . . . . 74.11 109.486 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -91.89 167.66 11.97 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.599 0.76 . . . . 72.22 109.385 170.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -135.97 164.71 27.36 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.642 1.177 . . . . 73.44 110.185 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -130.1 126.38 37.44 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.649 -1.611 . . . . 74.5 106.649 160.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mm -92.88 94.58 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 104.643 -2.354 . . . . 73.41 104.643 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -135.54 22.99 3.41 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.78 0.8 . . . . 72.32 112.237 -168.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -170.43 13.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.696 1.199 . . . . 50.23 112.696 171.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.17 13.4 82.94 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 121.6 -0.688 . . . . 72.23 112.33 -169.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -130.87 166.5 20.76 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.33 2.252 . . . . 74.54 106.828 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.6 mt -105.32 104.38 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.694 -1.595 . . . . 74.52 106.694 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -84.44 123.1 29.86 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.079 1.352 . . . . 74.42 107.865 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.6 mm -99.64 150.95 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.873 1.669 . . . . 74.43 107.82 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -160.97 -17.51 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 116.36 1.985 . . . . 73.53 116.36 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -135.66 109.4 8.07 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 105.318 -2.104 . . . . 71.14 105.318 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.74 149.99 25.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.975 1.71 . . . . 70.43 107.54 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.4 160.8 65.42 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.357 1.063 . . . . 72.24 108.203 173.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.46 -11.02 42.51 Favored 'Cis proline' 0 C--N 1.345 0.362 0 N-CA-C 114.222 0.816 . . . . 71.12 114.222 -2.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -108.14 109.39 20.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.053 -2.203 . . . . 74.25 105.053 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.38 145.61 55.5 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.387 0.429 . . . . 73.52 110.106 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -129.66 164.34 24.13 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.675 1.19 . . . . 74.35 110.554 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -62.25 149.76 86.34 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.713 0.805 . . . . 74.5 109.944 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.99 147.37 49.05 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.188 2.592 . . . . 62.11 111.618 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -162.06 157.03 22.87 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.277 2.231 . . . . 72.41 110.2 174.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -94.74 119.5 33.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.001 0.921 . . . . 74.12 109.085 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -91.12 138.75 31.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.573 1.149 . . . . 72.42 109.815 171.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -81.88 123.2 28.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.694 -1.225 . . . . 74.42 107.694 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.6 p -148.49 168.54 22.43 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.41 0.684 . . . . 63.42 109.515 165.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.69 163.7 25.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.825 1.65 . . . . 73.51 112.604 159.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 tt -145.66 160.14 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.477 1.511 . . . . 64.11 107.058 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.2 t -126.71 -35.57 2.31 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.32 3.048 . . . . 73.34 109.413 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.79 -52.72 0.09 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 127.31 2.386 . . . . 72.33 110.177 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.7 p -138.73 7.75 2.54 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.565 1.32 . . . . 70.23 114.565 -158.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.1 m -131.25 105.41 7.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 129.26 3.024 . . . . 65.22 107.712 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.48 121.41 23.81 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.701 -1.963 . . . . 71.23 105.701 173.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 ttmm -101.87 86.62 2.94 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.87 -1.159 . . . . 65.13 107.87 165.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.9 t -79.17 129.95 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.307 -1.368 . . . . 73.1 107.307 167.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -96.77 -30.57 13.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.956 0.902 . . . . 55.24 112.053 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -150.99 173.43 14.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.297 1.039 . . . . 71.11 110.291 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.48 -178.69 25.36 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 109.849 -1.3 . . . . 72.34 109.849 -172.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 t -64.23 -25.12 67.92 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 122.119 -0.636 . . . . 71.53 110.718 172.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -101.44 10.26 40.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.241 1.417 . . . . 63.22 112.22 -168.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.45 0.28 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 127.001 2.121 . . . . 74.14 112.122 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 -162.94 31.1 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 121.616 -0.677 . . . . 74.12 112.578 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.4 p -119.23 106.25 12.16 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.582 1.553 . . . . 72.34 107.978 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -120.81 130.8 54.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.849 0.75 . . . . 65.12 111.44 -168.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -81.39 127.96 33.33 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.971 0.908 . . . . 74.52 108.91 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.48 ' HE3' ' CH2' ' A' ' 16' ' ' TRP . 31.2 ttmt -60.94 135.29 57.74 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.917 -1.142 . . . . 73.52 107.917 165.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -113.76 65.14 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.283 1.04 . . . . 74.11 109.117 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.255 1.382 0 N-CA-C 106.613 -1.625 . . . . 74.5 106.613 163.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.657 0 N-CA-C 110.885 -0.886 . . . . 63.11 110.885 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -123.69 75.69 1.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 105.224 -2.139 . . . . 73.24 105.224 171.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -108.52 60.64 0.61 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.923 0.868 . . . . 72.0 109.194 -154.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -85.1 157.76 20.6 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.832 1.653 . . . . 73.4 111.045 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.14 176.29 8.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.705 0.802 . . . . 64.02 111.574 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -56.73 134.14 54.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.947 0.899 . . . . 74.11 109.772 156.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 tp -74.45 138.21 43.12 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.331 -1.359 . . . . 74.3 107.331 159.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -143.45 163.67 32.45 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.352 -1.721 . . . . 73.4 106.352 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.12 -51.33 54.58 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.746 0.654 . . . . 73.43 109.502 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -71.34 -16.22 62.43 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 117.933 -1.032 . . . . 73.22 113.36 -170.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -80.14 -41.87 24.57 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.456 1.025 . . . . 75.43 109.678 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.45 41.58 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.77 0.828 . . . . 75.22 110.568 -176.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.3 mm -112.21 125.5 69.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 O-C-N 119.939 -1.726 . . . . 74.4 108.48 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.46 179.69 16.47 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.651 1.119 . . . . 75.4 111.883 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -79.95 164.82 23.2 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.912 1.285 . . . . 72.22 109.474 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -142.35 145.65 34.14 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.176 0.99 . . . . 63.42 110.462 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.6 t -134.09 165.27 25.44 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.448 -1.407 . . . . 64.21 110.237 164.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.406 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 12.0 t -112.68 -12.21 13.43 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.587 1.555 . . . . 64.13 111.556 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.27 178.05 23.09 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 107.931 -2.068 . . . . 75.31 107.931 -166.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.3 pt -134.43 22.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.526 1.13 . . . . 64.4 110.827 -167.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 154.72 49.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.398 1.479 . . . . 72.01 107.238 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.49 -160.04 10.89 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.12 -0.491 . . . . 75.24 112.561 -172.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.8 m -79.95 88.59 5.32 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.678 1.191 . . . . 71.24 108.906 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -96.34 172.05 8.2 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 122.367 1.079 . . . . 72.44 110.843 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -141.15 118.26 11.27 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.184 -1.413 . . . . 74.32 107.184 -151.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.94 106.62 14.93 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.777 2.031 . . . . 64.51 109.226 -173.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 mt -90.81 158.26 16.92 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.509 1.124 . . . . 74.01 108.751 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.1 t -143.2 163.18 33.64 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.822 -0.807 . . . . 61.31 108.822 155.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -149.01 128.51 13.09 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.126 1.77 . . . . 75.23 109.34 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -104.38 144.77 31.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.084 1.354 . . . . 54.14 109.626 171.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.71 -27.41 63.96 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.37 1.068 . . . . 73.4 112.014 -174.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -128.15 0.7 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 129.248 3.019 . . . . 54.32 110.93 -164.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.94 -116.61 2.17 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 125.229 1.395 . . . . 72.44 110.047 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.3 p -140.23 177.75 7.77 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.352 2.261 . . . . 73.44 107.188 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -103.96 176.72 23.95 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 124.07 0.843 . . . . 73.53 111.183 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -140.86 158.67 43.62 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.448 1.499 . . . . 74.2 108.813 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -141.56 120.08 12.43 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.195 1.398 . . . . 75.22 107.267 164.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.83 114.48 1.42 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.891 1.71 . . . . 75.31 110.103 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.0 mt -78.27 140.59 16.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.46 -1.311 . . . . 74.01 107.46 171.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -124.96 154.51 41.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.943 -1.503 . . . . 62.42 106.943 170.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.63 118.11 24.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.286 -1.375 . . . . 75.11 107.286 174.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m120 68.63 -64.68 0.3 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 126.421 1.888 . . . . 71.43 113.675 162.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -158.06 49.75 0.4 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.048 1.295 . . . . 43.32 110.937 158.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 m -150.85 134.69 9.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.149 1.38 . . . . 71.42 109.109 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.19 131.19 21.49 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.12 2.547 . . . . 73.4 110.541 168.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.7 mm -126.85 4.7 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.024 0.93 . . . . 74.42 110.816 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.9 t -152.48 172.84 15.92 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 119.883 -1.761 . . . . 75.41 109.922 166.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -174.74 118.15 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.665 1.986 . . . . 75.02 108.113 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -142.48 158.04 44.11 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.281 1.432 . . . . 71.12 107.694 165.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.8 mtm -134.03 150.19 51.21 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.138 -1.43 . . . . 74.42 107.138 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.5 151.38 20.55 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 122.892 0.477 . . . . 75.32 110.985 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.76 167.21 22.22 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.838 -0.801 . . . . 74.33 108.838 166.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -146.79 166.86 25.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.677 0.791 . . . . 75.1 109.878 167.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -133.54 155.77 49.0 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.442 -1.688 . . . . 75.22 106.442 161.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.0 mm -114.02 98.56 7.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.844 -1.91 . . . . 74.32 105.844 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -130.03 23.13 5.29 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.029 0.752 . . . . 72.33 113.029 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -170.01 14.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.09 1.356 . . . . 71.34 114.07 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.43 18.61 75.47 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.272 -0.892 . . . . 75.31 112.461 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -140.36 173.29 11.65 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 128.586 2.754 . . . . 75.34 105.963 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.0 mt -102.72 117.81 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.866 -1.161 . . . . 75.01 107.866 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -84.51 122.17 28.63 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.686 1.194 . . . . 73.43 108.154 170.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mm -109.95 132.88 57.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.92 1.688 . . . . 74.44 106.626 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -160.87 6.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.777 1.399 . . . . 75.43 114.777 -169.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -148.68 123.15 9.71 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.024 -2.584 . . . . 75.41 104.024 163.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.8 t -136.27 148.85 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.467 -1.308 . . . . 74.15 107.467 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.68 163.31 32.12 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 107.364 -1.347 . . . . 75.35 107.364 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.63 -11.21 31.97 Favored 'Cis proline' 0 CA--C 1.534 0.487 0 CA-C-N 118.713 0.576 . . . . 74.33 113.378 -2.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.38 132.58 36.1 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.296 -1.742 . . . . 52.24 106.296 167.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.41 135.75 38.85 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 118.755 0.707 . . . . 73.32 109.335 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -124.14 168.4 12.95 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 124.169 0.987 . . . . 75.34 110.744 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 t -47.84 143.42 6.22 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.83 2.052 . . . . 75.35 110.675 166.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 159.0 53.78 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.253 1.969 . . . . 74.44 110.963 172.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -168.13 177.15 5.66 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.5 1.52 . . . . 74.3 108.349 172.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -106.99 155.94 19.27 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.708 -0.849 . . . . 75.02 108.708 171.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.8 mt -123.56 129.54 51.34 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.161 1.784 . . . . 73.32 109.298 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.09 123.25 29.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.177 1.391 . . . . 73.21 109.522 174.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 p -148.84 168.38 23.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.582 1.953 . . . . 75.34 108.033 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.08 154.88 50.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.887 1.275 . . . . 74.43 108.482 169.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 tt -136.95 156.54 34.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.362 -1.347 . . . . 75.34 107.362 173.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.45 26.06 0.68 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.692 0.997 . . . . 74.42 113.692 166.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.47 -94.28 0.18 Allowed Glycine 0 C--O 1.228 -0.229 0 N-CA-C 107.849 -2.1 . . . . 74.11 107.849 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.273 36.1 p -105.88 1.27 26.63 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.397 -0.811 . . . . 71.31 112.539 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.6 m -98.13 135.71 39.4 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.926 1.239 . . . . 75.02 109.207 168.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.43 137.0 45.2 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.824 -1.547 . . . . 75.43 106.824 162.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -121.37 85.05 2.34 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.356 1.062 . . . . 73.1 108.688 169.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.8 t -76.77 125.88 36.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.132 -1.062 . . . . 75.22 108.132 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -80.49 -53.27 6.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.148 0.579 . . . . 73.1 110.977 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.4 t -128.85 176.35 7.92 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.391 0.996 . . . . 60.01 112.251 -168.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.18 -175.81 44.89 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 125.622 1.582 . . . . 72.44 110.819 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.59 -27.9 65.07 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.083 -0.657 . . . . 74.12 111.583 176.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -101.17 14.26 32.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.983 -0.532 . . . . 72.44 112.128 -170.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.47 111.09 0.58 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.756 1.222 . . . . 72.02 110.385 172.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.49 -169.35 42.31 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.545 0.593 . . . . 73.2 113.885 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.9 p -113.8 118.15 33.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.479 1.911 . . . . 74.22 108.179 -174.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.406 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 47.2 m-85 -127.77 167.45 16.49 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.79 0.723 . . . . 75.24 112.879 -171.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -125.75 128.94 48.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 129.809 3.244 . . . . 74.0 106.932 -175.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -61.78 152.0 32.56 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.889 -0.782 . . . . 75.44 108.889 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -148.11 154.54 40.33 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 128.598 2.759 . . . . 73.2 109.621 171.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? . . . . . 0 C--O 1.254 1.297 0 CA-C-O 114.301 -2.761 . . . . 74.23 111.332 178.873 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.347 0 N-CA-C 109.778 -1.329 . . . . 73.33 109.778 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.414 ' CD ' ' HZ3' ' A' ' 85' ' ' LYS . 5.1 mt-10 -133.79 174.71 10.16 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.209 1.804 . . . . 71.14 107.689 -172.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -116.54 51.64 0.97 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.789 1.281 . . . . 72.52 109.145 -151.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -76.11 152.34 36.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.082 -1.417 . . . . 73.54 110.925 -170.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 p -73.32 173.09 10.03 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.716 0.77 . . . . 70.24 110.635 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -49.6 133.63 20.67 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.238 -1.346 . . . . 72.05 109.676 160.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.9 tp -74.92 127.87 34.23 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.054 -1.461 . . . . 73.45 107.054 156.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -137.24 162.14 34.31 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.165 -1.42 . . . . 72.35 107.165 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -53.68 -48.46 69.47 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.775 1.23 . . . . 54.44 109.689 -176.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -26.36 61.88 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.748 1.619 . . . . 72.14 111.133 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -68.09 -37.36 81.13 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.949 0.795 . . . . 73.32 111.002 -174.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.26 -9.72 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.842 0.682 . . . . 74.52 112.842 -171.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.2 mm -61.65 124.76 16.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.788 1.235 . . . . 72.31 110.488 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.63 -177.24 27.0 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.58 1.086 . . . . 73.54 110.556 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -92.89 156.21 17.1 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.432 -0.951 . . . . 74.14 108.432 163.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -126.6 178.49 5.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.913 2.485 . . . . 64.5 108.473 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 t -167.72 169.41 11.77 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.012 1.725 . . . . 72.53 108.601 160.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.531 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 10.0 t -132.36 -1.26 3.57 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.089 1.756 . . . . 74.42 112.463 172.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.77 -178.17 30.86 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 120.922 -1.111 . . . . 73.23 110.556 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.8 pt -140.26 13.78 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.44 1.496 . . . . 70.43 111.146 -166.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -126.75 179.26 5.45 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.01 1.324 . . . . 64.3 111.518 -168.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 44.79 -93.81 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.693 1.616 . . . . 63.32 114.881 153.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 93.6 m -134.68 127.39 30.99 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.245 -1.391 . . . . 63.23 107.245 157.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -136.66 -179.77 5.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.21 1.804 . . . . 71.42 108.813 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -154.0 153.71 32.45 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.132 1.373 . . . . 74.1 109.008 -171.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.05 124.46 23.4 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.191 1.797 . . . . 73.42 108.66 -171.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.425 ' CD1' ' HD1' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -114.52 137.94 51.23 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.511 1.524 . . . . 72.11 109.336 176.503 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -139.66 134.63 32.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.215 -1.031 . . . . 53.33 108.215 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -133.12 106.75 7.79 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.919 1.688 . . . . 70.34 107.352 -170.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -77.03 152.54 35.09 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.231 -1.025 . . . . 71.44 108.231 169.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.35 -27.67 56.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.471 0.915 . . . . 71.31 113.471 -174.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -135.2 13.65 3.55 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 122.817 0.447 . . . . 75.3 111.16 -166.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.36 -112.2 1.57 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.246 1.403 . . . . 52.34 111.21 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.5 p -139.31 -173.96 3.74 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.555 1.542 . . . . 74.3 108.006 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.57 176.3 20.45 Favored Glycine 0 C--O 1.239 0.446 0 O-C-N 120.817 -1.177 . . . . 72.12 111.437 167.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.2 p -136.69 159.06 42.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.088 -0.654 . . . . 73.31 111.616 -166.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.425 ' HD1' ' CD1' ' A' ' 27' ' ' LEU . 29.1 t80 -134.8 113.14 11.31 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.768 1.227 . . . . 71.44 108.841 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -124.71 112.6 1.79 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 109.64 -1.384 . . . . 72.4 109.64 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.3 mt -86.47 144.54 9.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 105.36 -2.089 . . . . 70.42 105.36 170.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -131.56 158.5 40.8 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.585 1.554 . . . . 73.5 108.022 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.45 126.77 50.09 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.361 1.464 . . . . 72.14 107.595 167.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 53.36 -78.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.024 2.529 . . . . 73.44 113.026 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.35 34.8 0.97 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.723 1.609 . . . . 64.23 111.871 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.8 m -141.7 131.67 12.73 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 127.345 2.258 . . . . 71.32 109.301 -170.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.24 132.99 10.59 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.997 3.132 . . . . 72.41 111.436 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.4 mm -124.48 -21.35 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 112.809 0.67 . . . . 72.42 112.809 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -150.13 154.24 37.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 120.92 1.691 . . . . 61.13 108.308 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -160.69 128.88 4.54 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.715 1.206 . . . . 74.41 108.028 -169.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -162.23 160.02 26.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.179 -1.415 . . . . 74.3 107.179 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.2 mtm -134.13 154.02 51.46 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.939 0.896 . . . . 71.42 108.622 173.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -163.56 153.79 15.54 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.757 0.823 . . . . 71.1 111.117 -176.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -84.6 169.51 14.31 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.951 0.881 . . . . 73.21 109.868 171.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -137.37 160.5 38.89 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.371 1.468 . . . . 72.44 110.53 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -132.96 153.84 51.05 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.751 -1.574 . . . . 73.04 106.751 154.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.1 mm -108.87 100.06 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 105.739 -1.948 . . . . 74.31 105.739 170.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.42 23.65 4.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.257 0.551 . . . . 64.13 112.045 -171.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.27 14.93 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.206 1.802 . . . . 74.01 113.351 -170.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.4 17.98 71.07 Favored Glycine 0 CA--C 1.535 1.296 0 O-C-N 120.465 -1.397 . . . . 65.05 110.901 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -144.09 164.42 30.72 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 129.359 3.064 . . . . 72.41 106.474 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.6 mt -95.48 121.26 45.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.963 -1.495 . . . . 74.34 106.963 -176.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -87.1 111.56 21.04 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.923 1.289 . . . . 72.54 107.606 167.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mm -86.14 140.7 15.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.013 -1.847 . . . . 74.52 106.013 167.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -156.51 -5.24 0.11 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 115.794 1.776 . . . . 75.53 115.794 -176.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -151.55 103.25 2.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.931 -1.137 . . . . 73.42 107.931 -171.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 t -129.11 141.9 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.019 0.928 . . . . 73.44 109.692 -167.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.08 163.87 48.0 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 126.126 1.77 . . . . 75.34 107.271 175.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.37 -17.79 20.14 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 119.096 0.713 . . . . 73.32 113.479 -4.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -102.2 130.55 48.88 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.137 -1.431 . . . . 72.42 107.137 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -72.8 145.15 47.21 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 123.601 0.563 . . . . 74.14 110.41 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -137.54 144.51 42.15 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.708 1.203 . . . . 73.51 108.734 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.0 t -52.14 148.33 11.52 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 118.202 -0.904 . . . . 72.32 110.167 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.57 153.78 75.5 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.148 2.565 . . . . 71.44 111.476 172.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -160.18 164.61 32.73 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.947 1.299 . . . . 71.24 109.39 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -97.43 158.14 15.63 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.084 -0.71 . . . . 70.11 109.084 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 mt -134.17 116.9 15.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.849 2.059 . . . . 73.22 108.516 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -73.51 117.63 15.5 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.761 1.624 . . . . 61.22 107.577 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.8 161.95 39.61 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.232 -0.918 . . . . 71.31 109.566 168.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.458 ' HZ1' ' CD ' ' A' ' 87' ' ' GLU . 5.6 mptt -115.62 161.48 18.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.817 -1.083 . . . . 74.34 110.08 161.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 tt -147.8 151.83 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.0 -1.111 . . . . 73.23 108.0 170.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.9 m -128.14 -1.96 5.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.471 1.108 . . . . 73.24 112.427 171.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.68 -74.68 0.43 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 108.316 -1.914 . . . . 71.41 108.316 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.0 p -93.7 -1.55 55.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.661 0.986 . . . . 70.33 113.661 -174.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -125.42 134.61 52.05 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.895 1.278 . . . . 73.35 108.423 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.54 131.67 49.12 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.152 -1.795 . . . . 74.31 106.152 166.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.414 ' HZ3' ' CD ' ' A' ' 2' ' ' GLU . 50.7 tttt -120.39 84.38 2.21 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.313 -0.995 . . . . 74.54 108.313 171.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.3 t -77.4 128.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.362 -0.977 . . . . 70.3 108.362 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.458 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 17.6 mt-10 -96.23 -22.41 17.27 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.227 1.195 . . . . 73.34 114.227 -174.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.8 t -150.21 179.0 8.46 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.311 1.444 . . . . 73.33 109.651 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.52 -177.96 52.3 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 122.706 1.17 . . . . 71.31 110.567 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.4 m -63.74 -11.83 29.7 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.155 1.782 . . . . 71.53 114.085 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -107.97 9.17 28.65 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.528 1.131 . . . . 71.5 113.18 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.22 105.84 0.23 Allowed 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.126 -1.609 . . . . 74.31 110.633 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 173.32 -159.29 29.31 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.81 0.719 . . . . 50.42 113.042 -163.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -133.18 128.91 37.02 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 125.33 1.452 . . . . 72.41 109.003 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.531 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 16.6 m-85 -134.88 149.38 50.3 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 123.871 0.868 . . . . 71.4 108.996 -173.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -118.57 151.05 38.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.099 -1.074 . . . . 73.35 108.099 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -68.62 151.65 46.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.091 -1.077 . . . . 74.54 108.091 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -128.7 66.23 1.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 123.434 1.588 . . . . 73.51 106.944 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.016 1.726 . . . . 73.54 108.338 171.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.619 0 N-CA-C 109.546 -1.422 . . . . 53.33 109.546 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -143.45 69.42 1.29 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 123.458 1.599 . . . . 72.42 106.698 171.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.94 102.37 2.91 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 129.153 2.981 . . . . 64.04 108.786 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.506 ' CD1' ' HE3' ' A' ' 78' ' ' LYS . 98.1 m95 -126.78 157.16 39.92 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.925 1.69 . . . . 70.4 110.647 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -82.73 175.24 10.28 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.037 0.835 . . . . 74.03 110.853 168.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -53.48 156.72 2.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.179 1.392 . . . . 75.11 110.345 163.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.0 tp -103.58 132.66 49.65 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.738 -1.574 . . . . 75.44 107.23 162.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -143.61 -175.3 4.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 127.323 2.249 . . . . 75.44 108.577 -175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 p -78.65 9.29 4.22 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.431 1.092 . . . . 74.4 113.673 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -130.38 -40.28 1.28 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.56 1.527 . . . . 54.21 112.184 -162.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -72.3 -31.65 65.9 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.948 1.299 . . . . 75.11 110.272 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.9 tp -75.76 -24.83 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.836 1.198 . . . . 73.2 111.864 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.6 mm -55.74 97.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 127.835 2.454 . . . . 74.24 111.974 -174.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.65 179.91 44.62 Favored Glycine 0 N--CA 1.445 -0.731 0 O-C-N 122.27 -0.269 . . . . 73.5 113.085 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -100.0 148.68 24.26 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.53 1.932 . . . . 75.14 108.531 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -146.55 135.34 22.29 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.753 0.821 . . . . 73.2 110.036 -171.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -140.44 170.9 14.93 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.941 -1.099 . . . . 74.54 108.841 166.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 t -118.8 -18.04 9.01 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.469 1.108 . . . . 74.12 111.559 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.84 -168.15 38.14 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 107.501 -2.24 . . . . 63.33 107.501 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.5 pt -139.98 -5.52 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.018 0.927 . . . . 72.13 112.742 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -93.21 173.59 7.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 120.077 1.308 . . . . 74.21 110.746 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.33 -94.56 0.01 OUTLIER Glycine 0 C--N 1.338 0.676 0 C-N-CA 126.528 2.014 . . . . 51.12 113.268 155.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.67 133.2 39.79 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.925 -1.139 . . . . 71.34 107.925 164.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -143.42 179.76 6.91 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.99 1.716 . . . . 75.44 107.67 174.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -143.28 133.5 24.49 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.962 -1.125 . . . . 74.44 107.962 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.8 155.17 18.98 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.996 1.718 . . . . 75.53 107.923 171.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 mt -145.9 141.81 28.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.552 -2.018 . . . . 75.34 105.552 164.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.0 m -138.24 147.83 44.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.156 -1.053 . . . . 74.44 108.156 173.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -141.85 121.31 13.23 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.087 1.755 . . . . 74.53 107.84 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -96.88 157.98 15.64 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.833 0.853 . . . . 74.41 109.579 167.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -78.87 -33.05 46.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.729 -0.669 . . . . 75.51 111.723 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -119.61 5.18 11.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.788 0.435 . . . . 71.32 111.4 -163.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.08 -111.09 0.95 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 125.448 1.499 . . . . 40.13 110.544 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.0 p -137.25 178.64 6.93 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.477 1.911 . . . . 72.31 108.797 -163.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -133.97 -174.78 13.63 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.493 -1.043 . . . . 73.31 110.493 164.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 t -148.28 160.02 43.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.609 -0.886 . . . . 62.3 108.609 -168.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -140.7 137.71 33.7 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.252 2.221 . . . . 72.32 105.695 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.53 147.35 16.66 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.402 -1.079 . . . . 43.31 110.402 166.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.1 mt -97.45 140.33 17.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 105.783 -1.932 . . . . 73.34 105.783 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -133.92 133.34 41.32 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.577 0.703 . . . . 75.51 109.867 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.2 t -79.75 -172.58 3.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.108 2.163 . . . . 64.53 108.439 169.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -44.68 -42.47 7.59 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 126.689 1.996 . . . . 60.31 113.422 -172.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -159.74 49.32 0.3 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.097 -0.705 . . . . 75.13 109.097 162.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.7 m -146.92 136.07 11.44 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.517 -0.754 . . . . 75.52 109.268 -173.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.56 142.27 18.23 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 124.295 3.33 . . . . 72.34 113.147 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.3 -8.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 114.137 1.162 . . . . 62.33 114.137 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.04 145.53 15.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.021 -1.675 . . . . 72.44 107.751 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -159.2 129.28 5.7 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.022 -1.473 . . . . 75.41 107.022 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -153.77 167.69 28.8 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.129 1.372 . . . . 74.31 108.436 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.9 mtm -135.13 158.34 44.6 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 123.479 0.712 . . . . 75.14 109.93 165.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -155.1 160.05 40.69 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.235 -0.893 . . . . 73.52 108.909 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.14 164.05 15.18 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.304 -1.369 . . . . 74.42 107.304 168.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -136.27 165.66 25.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.962 -0.563 . . . . 74.01 109.758 170.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -131.37 159.2 38.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.024 -0.732 . . . . 73.21 109.024 158.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.3 mm -118.38 89.55 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 104.522 -2.399 . . . . 73.24 104.522 171.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -118.95 23.48 11.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.907 1.283 . . . . 62.02 111.474 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.33 21.59 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.339 1.456 . . . . 75.01 113.317 -173.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.95 22.65 70.58 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 120.554 -1.341 . . . . 63.32 112.082 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -148.44 163.0 38.45 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 127.374 2.269 . . . . 74.4 107.02 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 71.0 mt -87.92 130.33 37.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.924 -1.51 . . . . 61.41 106.924 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -108.56 107.54 18.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.198 1.399 . . . . 75.43 108.829 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 mm -78.67 138.9 19.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.655 -1.609 . . . . 75.32 106.655 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -158.25 -5.43 0.08 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 116.375 1.991 . . . . 75.02 116.375 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -150.78 110.06 3.96 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 103.959 -2.608 . . . . 73.02 103.959 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.4 t -128.74 141.9 45.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.137 -1.06 . . . . 75.21 108.137 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.41 164.29 45.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.172 1.389 . . . . 73.13 107.806 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -75.62 -7.87 25.45 Favored 'Cis proline' 0 CA--C 1.538 0.697 0 CA-C-N 119.259 0.771 . . . . 73.11 112.325 -11.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.1 109.63 20.23 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.183 0.993 . . . . 74.52 110.548 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.55 128.63 36.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 122.488 1.137 . . . . 64.05 110.365 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -107.92 177.79 4.71 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.684 1.594 . . . . 74.31 109.509 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -76.66 149.14 80.59 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.842 -0.799 . . . . 72.44 108.842 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.75 149.53 83.58 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.347 2.031 . . . . 54.22 111.037 171.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -168.39 167.35 11.96 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.072 0.949 . . . . 75.04 110.248 172.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -98.29 156.94 16.47 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.134 0.574 . . . . 74.15 109.849 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.69 128.9 35.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.7 2.0 . . . . 75.3 107.824 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.521 ' H ' ' CG2' ' A' ' 88' ' ' THR . 5.1 m-20 -84.68 129.63 34.81 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.037 -1.838 . . . . 74.02 106.037 174.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.42 150.47 23.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.371 1.868 . . . . 73.14 107.558 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HE3' ' CD1' ' A' ' 4' ' ' TRP . 23.6 mtmt -128.55 145.46 51.12 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.069 -1.456 . . . . 75.22 107.069 -171.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.3 tt -143.93 152.4 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.02 -1.474 . . . . 74.1 107.02 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.9 t -128.64 -61.92 1.04 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.54 -1.282 . . . . 75.23 107.54 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.7 -102.0 0.27 Allowed Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 106.384 -2.686 . . . . 60.11 106.384 166.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.3 p -79.4 10.92 3.3 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.431 1.271 . . . . 75.34 114.431 -173.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.8 m -118.76 127.62 53.72 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 121.084 1.765 . . . . 73.04 109.7 171.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.15 125.64 41.79 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.085 1.354 . . . . 75.32 107.383 165.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.5 tttm -111.88 87.94 2.68 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.082 0.953 . . . . 74.44 109.065 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.9 t -72.03 134.5 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.777 -1.194 . . . . 64.31 107.777 174.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -97.11 -37.94 9.93 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.577 0.751 . . . . 63.23 110.292 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.521 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.0 t -137.7 161.41 36.59 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.054 1.741 . . . . 74.41 110.004 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.38 179.08 19.37 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.284 1.421 . . . . 72.43 112.639 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.8 m -57.24 -24.02 51.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.36 0.664 . . . . 74.42 111.444 166.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -100.83 5.04 43.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.399 1.88 . . . . 72.02 111.545 -169.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.1 103.53 0.15 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.438 1.495 . . . . 75.2 111.235 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.25 -164.74 33.1 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 123.793 0.711 . . . . 60.32 112.64 -169.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 54.3 p -130.08 120.61 24.93 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.512 1.125 . . . . 74.21 109.589 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -127.74 152.09 48.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.715 0.806 . . . . 60.23 109.226 -170.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -111.37 140.86 45.59 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.3 1.04 . . . . 75.2 108.458 175.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -66.59 125.87 27.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.772 -1.196 . . . . 75.51 107.772 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -101.26 55.16 0.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.833 1.253 . . . . 72.21 107.827 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 127.63 2.372 . . . . 74.5 105.819 167.389 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.649 0 N-CA-C 108.541 -1.824 . . . . 74.45 108.541 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -109.75 106.45 16.08 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 107.937 -1.135 . . . . 73.45 107.937 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -100.03 127.71 46.22 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 105.645 -1.983 . . . . 74.13 105.645 170.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -125.61 150.33 47.63 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.798 1.639 . . . . 64.55 109.733 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -72.07 171.86 11.15 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.469 0.652 . . . . 75.24 110.219 170.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -51.79 130.97 30.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.244 -0.889 . . . . 75.45 108.75 158.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.14 124.56 21.98 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.898 -1.149 . . . . 72.23 107.898 151.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -137.65 171.08 14.98 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 118.772 -1.171 . . . . 74.12 111.358 160.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p -69.08 36.02 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.142 2.577 . . . . 74.24 112.387 172.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -137.78 -58.18 0.67 Allowed 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 125.051 1.34 . . . . 63.15 109.006 -170.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -77.03 -21.53 54.4 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 118.563 -0.732 . . . . 74.44 112.107 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.7 -19.02 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.43 1.092 . . . . 75.44 113.57 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.3 mm -65.67 118.85 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.449 -0.945 . . . . 73.51 108.449 -171.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.75 173.69 23.88 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.336 0.97 . . . . 74.14 111.544 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -80.46 156.39 26.61 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.803 -1.184 . . . . 71.11 107.803 162.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -141.67 135.12 29.59 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.737 -0.602 . . . . 75.51 109.689 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -137.76 150.66 47.44 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.956 1.703 . . . . 74.13 109.627 -167.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.0 p -89.84 -77.16 0.4 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.933 -1.506 . . . . 75.31 106.933 161.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.87 -168.48 14.23 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 126.682 2.087 . . . . 75.44 109.879 -177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.0 pt -118.21 20.37 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.397 1.479 . . . . 73.42 110.792 -171.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -137.15 157.34 46.9 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.376 1.87 . . . . 63.13 108.478 -168.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.31 -172.09 7.69 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 121.633 0.574 . . . . 64.23 113.586 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.3 m -79.76 90.2 5.23 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.458 -1.312 . . . . 73.0 107.458 175.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.1 p-80 -110.54 -179.48 3.77 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.498 1.519 . . . . 75.05 110.371 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -140.89 157.6 45.14 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.073 1.349 . . . . 73.35 110.271 -169.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.95 140.94 32.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.702 1.601 . . . . 74.24 107.993 -173.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -123.87 169.48 11.54 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.981 0.913 . . . . 73.42 109.689 168.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.0 t -140.29 160.48 39.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.806 -1.553 . . . . 64.55 106.806 158.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -147.81 121.63 9.31 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.682 1.993 . . . . 63.33 106.271 168.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -95.33 156.23 16.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.829 0.851 . . . . 73.11 109.048 172.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.48 -23.96 37.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 61.11 111.957 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -133.16 10.68 4.18 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.046 0.758 . . . . 73.34 113.046 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.44 -119.98 3.92 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.588 -1.405 . . . . 34.23 109.588 173.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 p -141.33 -169.9 2.96 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.831 2.452 . . . . 74.13 106.505 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.6 179.05 19.21 Favored Glycine 0 CA--C 1.522 0.49 0 O-C-N 120.936 -1.102 . . . . 73.42 110.905 167.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -136.47 165.32 26.1 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.57 1.548 . . . . 73.11 109.284 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -152.44 109.62 3.54 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.551 1.541 . . . . 74.25 109.813 171.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.99 147.48 16.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.232 -1.147 . . . . 74.35 110.232 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.6 mt -119.87 139.85 45.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 105.828 -1.916 . . . . 74.24 105.828 169.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -122.41 165.82 15.71 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.942 1.297 . . . . 75.42 109.449 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 m -131.22 112.98 13.29 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.482 1.913 . . . . 73.2 106.869 160.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 m120 55.24 -73.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 130.161 3.384 . . . . 73.01 113.892 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.24 44.24 1.54 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.95 1.3 . . . . 73.12 109.649 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.5 m -150.17 123.01 4.27 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 107.758 -1.201 . . . . 75.03 107.758 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.6 137.73 36.65 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.342 2.028 . . . . 60.4 108.967 167.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.3 mm -126.35 -25.42 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.442 1.097 . . . . 74.33 110.791 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.5 t -141.12 157.85 44.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 120.63 -1.294 . . . . 73.5 109.194 169.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -151.0 135.84 17.32 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 129.166 2.987 . . . . 74.32 105.139 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.58 163.19 40.09 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.454 -2.054 . . . . 70.44 105.454 165.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.9 mtm -130.28 167.98 17.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.431 -0.952 . . . . 74.52 108.431 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -160.6 148.85 16.35 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.585 0.754 . . . . 63.54 109.132 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.67 163.9 20.45 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.953 -1.129 . . . . 74.34 107.953 163.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -150.88 161.84 41.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.889 -0.507 . . . . 74.51 109.935 172.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -129.32 159.48 36.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.072 -1.084 . . . . 74.14 108.072 156.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 25.3 mm -105.02 102.43 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 103.638 -2.727 . . . . 73.45 103.638 162.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.94 27.22 2.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.093 0.949 . . . . 73.13 109.655 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.52 15.1 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 114.206 1.187 . . . . 74.23 114.206 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.93 23.72 66.01 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.564 -1.415 . . . . 73.51 109.564 -168.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -149.56 163.06 38.89 Favored 'General case' 0 N--CA 1.445 -0.712 1 C-N-CA 132.143 4.177 . . . . 73.53 103.843 -171.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.23 155.23 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.635 -1.617 . . . . 73.35 106.635 172.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -124.12 124.36 42.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.649 2.379 . . . . 74.45 106.911 164.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 mm -114.04 137.17 48.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.541 1.936 . . . . 74.44 106.458 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -160.08 6.96 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.281 1.215 . . . . 72.23 114.281 -172.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -151.96 123.81 8.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.17 -2.53 . . . . 71.11 104.17 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.3 t -132.57 144.81 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.943 -1.503 . . . . 74.11 106.943 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.21 159.95 68.9 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 108.165 -1.05 . . . . 73.51 108.165 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.58 -7.5 47.5 Favored 'Cis proline' 0 CA--C 1.534 0.485 0 N-CA-C 113.815 0.66 . . . . 74.33 113.815 -3.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -116.71 120.66 39.28 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.318 -1.734 . . . . 52.23 106.318 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -76.57 124.47 27.66 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.633 1.173 . . . . 72.5 108.686 -174.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 mttm -97.5 166.04 11.71 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.581 -0.896 . . . . 72.24 108.581 169.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.82 149.88 15.67 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.577 1.151 . . . . 64.11 109.315 171.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -68.9 142.84 53.01 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.217 1.944 . . . . 73.52 110.499 169.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -150.79 165.39 33.68 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 120.898 -1.126 . . . . 73.13 109.864 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -99.61 159.06 15.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.668 -0.864 . . . . 74.43 108.668 167.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.1 mt -131.54 118.9 20.76 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.373 1.069 . . . . 72.52 109.272 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -59.67 112.35 1.78 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.109 -1.441 . . . . 64.52 107.109 167.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.2 168.63 19.29 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 107.042 -1.466 . . . . 75.31 107.042 166.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.38 170.54 15.58 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.838 1.255 . . . . 73.11 111.49 163.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 tt -154.4 147.98 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 123.478 0.711 . . . . 75.41 109.303 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 m -151.39 48.81 0.82 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 129.473 3.109 . . . . 73.25 110.412 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.68 -66.9 3.32 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 126.207 1.86 . . . . 61.51 112.19 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -124.7 2.57 8.21 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.82 1.415 . . . . 75.34 114.82 -168.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 m -118.9 100.88 7.65 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.698 1.599 . . . . 72.55 107.806 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.3 tp -77.52 125.15 28.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.933 -1.506 . . . . 75.52 106.933 166.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -119.06 92.64 3.85 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 123.988 0.915 . . . . 72.43 108.973 177.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.78 137.35 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.669 -1.234 . . . . 75.35 107.669 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -100.58 -14.68 18.09 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.209 1.188 . . . . 75.32 114.209 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.1 t -151.6 163.87 38.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.429 1.013 . . . . 70.55 112.525 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.79 -175.79 53.28 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-O 122.832 1.24 . . . . 72.25 110.314 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.3 m -49.22 -27.62 3.85 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.802 1.641 . . . . 71.23 113.362 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -95.83 2.06 53.52 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.191 1.182 . . . . 62.55 114.191 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.68 105.17 0.14 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.347 1.059 . . . . 65.51 111.211 -173.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 173.47 -138.54 4.65 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.91 0.767 . . . . 72.35 112.62 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.8 t -150.5 132.14 14.89 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.416 1.486 . . . . 75.34 107.934 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -134.36 134.22 41.51 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 123.721 0.808 . . . . 73.54 109.323 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -75.98 153.93 36.19 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.428 -0.953 . . . . 72.11 108.428 167.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -69.84 154.97 41.25 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.555 -0.905 . . . . 75.15 108.555 168.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -139.5 165.21 27.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.224 1.81 . . . . 74.51 107.461 163.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm . . . . . 0 C--O 1.25 1.115 0 C-N-CA 125.919 1.688 . . . . 73.05 111.115 -178.407 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.784 0 N-CA-C 107.559 -2.217 . . . . 54.11 107.559 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -94.25 85.05 4.53 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.655 -1.609 . . . . 64.4 106.655 -170.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -99.7 122.8 43.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.546 -2.02 . . . . 75.13 105.546 -173.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -114.55 155.17 26.96 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 126.447 1.899 . . . . 75.1 110.778 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 p -72.27 175.64 5.93 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.35 -0.611 . . . . 64.42 109.35 164.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -56.92 150.23 17.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.337 1.065 . . . . 73.44 110.114 155.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.1 tp -84.76 129.23 34.85 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 125.722 1.609 . . . . 75.43 107.159 155.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -135.44 166.23 23.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.363 -1.347 . . . . 74.32 107.363 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 t -67.29 -2.61 6.24 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.574 1.15 . . . . 75.24 112.788 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -108.01 -36.8 6.24 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.131 -0.981 . . . . 73.33 109.436 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.82 -23.92 66.54 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.39 1.076 . . . . 74.21 112.895 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.3 tp -90.12 -16.1 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.0 1.32 . . . . 75.44 113.101 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.3 mm -69.75 130.5 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.952 1.301 . . . . 62.13 110.983 -163.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.34 -175.24 20.82 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.783 1.658 . . . . 63.51 110.324 175.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -82.17 169.97 16.0 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.403 -0.962 . . . . 73.33 108.403 167.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -132.58 -175.86 3.9 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.556 -1.276 . . . . 74.2 107.556 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 t -169.05 167.04 10.81 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.722 1.601 . . . . 75.21 109.745 162.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.513 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 2.3 t -136.98 -19.43 1.3 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.506 1.122 . . . . 62.22 112.799 -177.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.78 171.27 38.77 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.666 -1.774 . . . . 63.01 108.666 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.81 19.11 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.972 1.309 . . . . 75.01 110.578 -169.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.76 -179.65 6.59 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 127.195 2.198 . . . . 64.31 108.33 -174.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.02 -117.58 6.94 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.108 0.861 . . . . 74.02 111.964 170.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.2 m -132.13 98.95 4.56 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.664 -1.235 . . . . 71.3 107.664 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -114.56 171.11 7.83 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.471 1.108 . . . . 73.14 110.21 -175.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -138.92 136.05 35.07 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.854 -1.165 . . . . 74.44 107.854 -165.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.51 96.17 4.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.028 1.331 . . . . 75.25 109.392 -171.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.0 mt -77.89 153.24 32.8 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.633 1.573 . . . . 72.44 110.811 164.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.0 p -141.16 158.77 43.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.871 1.268 . . . . 75.55 109.267 162.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -141.12 124.65 16.75 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.015 1.326 . . . . 75.45 108.415 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.5 159.91 16.26 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.206 1.402 . . . . 61.51 107.746 170.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -83.96 -32.95 24.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.802 0.841 . . . . 73.33 112.239 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -138.87 30.32 2.27 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.641 1.176 . . . . 63.32 109.836 -172.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -127.86 -110.92 1.61 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.448 -1.461 . . . . 71.55 109.448 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.2 p -146.01 -170.66 3.53 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.049 2.14 . . . . 73.45 107.361 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.0 167.92 12.93 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.846 -1.302 . . . . 51.32 109.846 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -144.29 155.86 44.01 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.826 -0.808 . . . . 63.44 110.199 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -139.93 120.48 14.17 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.164 1.385 . . . . 63.32 107.764 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.85 157.18 15.13 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.752 -1.339 . . . . 72.33 109.752 168.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.3 mt -122.28 146.59 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 105.835 -1.913 . . . . 60.25 105.835 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -134.82 144.68 47.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.227 1.411 . . . . 72.31 108.449 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.9 125.87 48.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.192 -2.151 . . . . 71.34 105.192 158.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.2 m120 62.86 -83.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.582 1.553 . . . . 75.32 112.977 160.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.4 59.98 0.96 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.642 1.177 . . . . 74.5 108.651 163.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.0 m -144.89 130.19 9.36 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 127.137 2.175 . . . . 75.13 106.316 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.94 141.48 48.76 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.452 2.101 . . . . 74.03 109.651 167.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.3 mm -131.73 -22.26 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.763 1.225 . . . . 75.14 110.998 -174.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.9 t -143.47 167.66 21.67 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.576 -1.328 . . . . 75.01 110.251 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -160.09 146.88 16.03 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.551 1.94 . . . . 75.34 108.726 -175.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -159.05 164.05 35.78 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.386 1.874 . . . . 74.32 107.573 163.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.5 mtm -121.18 156.84 31.52 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.744 1.618 . . . . 73.33 107.149 162.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -161.3 138.01 8.53 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.141 0.976 . . . . 63.11 109.711 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -75.11 163.24 27.77 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.705 0.764 . . . . 74.24 109.262 166.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -153.08 158.15 41.49 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.799 0.84 . . . . 75.13 111.064 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -137.06 158.28 44.81 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.562 -0.711 . . . . 73.31 110.485 169.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.5 mm -111.14 90.85 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 106.81 -1.552 . . . . 73.01 106.81 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -121.5 22.86 10.55 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.381 1.252 . . . . 71.25 114.381 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -174.9 14.98 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 116.341 1.978 . . . . 64.05 116.341 -173.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.27 16.23 77.06 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 119.475 -2.016 . . . . 62.25 114.39 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -130.69 -170.7 2.39 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.796 2.038 . . . . 71.04 108.269 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.4 mt -113.2 106.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.802 1.637 . . . . 74.31 107.263 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -72.12 124.13 24.33 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.539 -1.282 . . . . 73.43 107.539 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.8 mm -111.15 139.07 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.406 -2.072 . . . . 74.21 105.406 170.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -157.49 8.57 0.17 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.954 0.902 . . . . 75.34 112.306 -175.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -152.6 118.9 5.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 103.18 -2.896 . . . . 75.44 103.18 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -135.65 152.23 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.223 -2.14 . . . . 75.23 105.223 169.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.05 161.64 54.61 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 125.34 1.456 . . . . 73.15 107.583 173.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -81.86 -6.81 46.39 Favored 'Cis proline' 0 CA--C 1.54 0.789 0 N-CA-C 114.319 0.854 . . . . 71.21 114.319 -6.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.92 104.78 14.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 104.731 -2.322 . . . . 63.42 104.731 168.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -64.01 155.2 31.86 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.814 0.696 . . . . 72.45 110.495 170.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -129.67 162.29 28.67 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.109 1.364 . . . . 73.05 107.854 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 t -54.92 149.26 24.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 109.072 -0.714 . . . . 73.21 109.072 171.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.12 147.19 53.7 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.241 1.961 . . . . 61.34 110.992 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -156.52 174.05 16.01 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.825 1.25 . . . . 71.15 109.755 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -117.05 131.08 57.02 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.811 -1.181 . . . . 74.45 107.811 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.5 mt -101.06 116.4 32.75 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.649 1.179 . . . . 74.22 108.578 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.9 116.28 5.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.844 1.258 . . . . 72.05 108.045 172.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.1 p -139.42 156.77 46.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.757 0.789 . . . . 71.44 110.045 161.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HZ2' ' CD ' ' A' ' 87' ' ' GLU . 25.5 mttt -116.28 159.34 22.01 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.279 -1.328 . . . . 74.04 108.964 168.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 tt -152.89 154.35 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.671 -1.603 . . . . 75.23 106.671 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.8 p -133.37 -11.22 2.83 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.836 1.421 . . . . 62.0 114.836 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.32 -91.17 0.15 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 107.098 -2.401 . . . . 74.43 107.098 -165.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.5 p -106.7 -0.42 23.62 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.454 1.65 . . . . 71.02 115.454 -167.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.6 m -114.16 109.93 19.18 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.568 1.947 . . . . 74.31 109.878 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.89 136.1 40.12 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 119.837 -1.789 . . . . 64.42 107.39 167.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -119.2 88.63 2.97 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.602 -0.518 . . . . 74.3 109.602 162.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.0 t -81.5 133.03 30.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.859 -0.793 . . . . 71.35 108.859 170.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.42 ' CD ' ' HZ2' ' A' ' 78' ' ' LYS . 33.0 mt-10 -106.43 -18.59 13.94 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.708 1.203 . . . . 74.23 112.872 -171.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.4 t -155.75 171.66 19.64 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.244 1.417 . . . . 64.01 109.298 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.81 178.28 40.78 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 122.836 1.242 . . . . 64.23 110.378 -173.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.1 m -59.55 -21.37 60.18 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 113.706 1.002 . . . . 74.43 113.706 174.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -109.96 19.48 18.99 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.342 1.608 . . . . 73.11 115.342 -176.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.14 109.24 0.56 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.171 0.988 . . . . 74.31 111.484 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.83 -156.15 26.7 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.184 1.374 . . . . 54.41 112.912 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -119.81 125.48 48.67 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.979 1.312 . . . . 64.03 110.158 -173.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.513 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 6.1 m-85 -133.3 152.23 51.92 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.003 0.43 . . . . 74.01 110.848 -174.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -103.53 138.3 40.41 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.352 1.461 . . . . 73.24 107.473 172.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -52.78 149.23 6.43 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.295 0.952 . . . . 74.24 109.408 166.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -137.63 155.99 48.55 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.52 1.928 . . . . 74.43 108.208 169.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 79.5 mttt . . . . . 0 C--O 1.252 1.2 0 C-N-CA 125.761 1.624 . . . . 75.33 110.805 -175.832 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.45 0 N-CA-C 109.541 -1.424 . . . . 73.53 109.541 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.4 150.78 1.15 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.948 2.099 . . . . 74.34 106.245 167.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -135.71 105.54 6.19 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.172 -1.788 . . . . 75.23 106.172 -168.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -106.51 -174.09 2.45 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.755 2.022 . . . . 75.53 111.592 -173.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.7 p -110.4 160.67 16.37 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.597 0.759 . . . . 74.53 110.126 168.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.56 127.16 26.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.11 2.164 . . . . 73.43 109.288 173.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 tp -79.7 92.04 5.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.893 -1.151 . . . . 74.11 107.893 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -94.56 164.36 13.01 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 125.33 1.452 . . . . 65.21 107.581 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.45 -45.89 73.19 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.241 1.016 . . . . 74.12 109.873 172.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -76.51 -19.35 58.07 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 119.454 -0.898 . . . . 70.2 112.425 -170.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.2 -40.5 62.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.914 -0.491 . . . . 71.3 111.003 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.1 tp -76.61 -13.32 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 120.91 -1.119 . . . . 74.41 113.695 -170.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 mm -52.28 136.0 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.032 1.333 . . . . 74.44 112.655 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.58 178.85 15.66 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 125.855 1.693 . . . . 72.24 110.739 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -84.87 167.06 16.33 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.405 -0.961 . . . . 73.53 108.405 165.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -147.41 139.86 24.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.417 -1.327 . . . . 74.24 107.417 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 t -141.71 170.09 16.37 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.569 -1.332 . . . . 71.2 110.203 166.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.3 t -132.71 0.43 3.57 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.462 2.305 . . . . 75.33 111.546 -173.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.93 179.28 38.12 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.175 -1.17 . . . . 75.52 110.175 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.2 pt -130.8 22.87 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.711 1.604 . . . . 73.22 109.571 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -142.53 -175.88 4.64 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.328 1.451 . . . . 74.24 109.654 -169.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.84 -119.38 16.08 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.534 -1.026 . . . . 55.34 110.534 156.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -131.79 101.69 5.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.979 -1.86 . . . . 73.34 105.979 161.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -114.34 172.5 6.97 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.641 0.734 . . . . 74.41 109.061 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -143.14 144.58 32.27 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.418 -0.956 . . . . 74.42 108.418 -160.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.84 103.13 5.93 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 122.994 0.518 . . . . 73.23 109.671 -167.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.5 mt -94.64 154.45 17.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.467 1.107 . . . . 71.55 110.068 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 p -146.12 125.16 12.82 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.425 1.09 . . . . 74.35 109.769 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -124.03 114.96 20.43 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 120.166 1.348 . . . . 74.21 109.793 -174.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -92.42 152.76 19.54 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 124.151 0.907 . . . . 73.3 110.033 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -81.26 -20.48 40.85 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 114.268 1.21 . . . . 73.11 114.268 -174.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -133.48 1.11 3.39 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.328 0.513 . . . . 74.22 112.245 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.83 -123.17 5.2 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.435 -1.466 . . . . 43.15 109.435 173.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.3 p -134.74 -171.1 2.7 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.858 1.663 . . . . 72.32 108.542 -164.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.37 165.65 12.15 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.99 -0.844 . . . . 64.13 110.99 165.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -142.56 166.38 24.82 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.846 0.859 . . . . 65.53 110.832 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -146.99 133.0 19.18 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.492 -1.299 . . . . 73.52 107.492 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.45 161.62 24.48 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.184 -1.167 . . . . 62.11 110.184 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.3 mt -131.94 121.51 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.109 -1.811 . . . . 71.24 106.109 -174.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -118.49 132.53 56.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.72 1.208 . . . . 71.11 109.016 -171.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 m -97.68 119.24 35.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.554 -1.276 . . . . 73.13 107.554 166.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 46.77 -85.2 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 127.844 2.457 . . . . 75.22 113.72 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.51 56.68 1.65 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.827 1.251 . . . . 72.04 109.402 170.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 m -143.58 122.57 7.32 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.154 1.782 . . . . 72.44 107.84 171.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.44 137.6 36.77 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.842 2.362 . . . . 73.13 109.847 165.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.0 mm -128.17 -15.27 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.187 0.995 . . . . 71.33 111.164 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.4 t -135.56 167.41 21.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 119.775 -1.828 . . . . 71.24 110.059 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -163.47 147.27 10.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.303 -0.862 . . . . 74.42 108.921 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -167.99 165.96 13.41 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.444 1.498 . . . . 63.15 108.311 166.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.3 mtm -133.48 161.29 34.97 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.089 1.356 . . . . 72.23 108.048 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -162.6 140.11 8.17 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.992 1.317 . . . . 71.32 109.155 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.42 161.81 26.8 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.271 -1.011 . . . . 74.34 108.271 163.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -144.14 164.56 30.33 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.669 -0.644 . . . . 74.53 109.344 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -136.7 156.42 48.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.806 -0.813 . . . . 74.34 108.806 166.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.0 mm -107.04 99.81 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 106.173 -1.788 . . . . 74.22 106.173 168.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.2 28.52 3.75 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.885 0.874 . . . . 72.44 112.353 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -163.14 14.01 0.07 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.003 1.721 . . . . 74.33 115.129 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.49 21.03 47.92 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.254 -1.529 . . . . 74.54 113.111 -168.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -132.69 -168.45 2.07 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.86 2.864 . . . . 74.44 106.875 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.7 mt -118.32 110.89 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.897 -1.52 . . . . 72.32 106.897 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -80.78 120.24 24.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.332 -1.359 . . . . 72.32 107.332 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.0 mm -108.02 135.0 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 105.356 -2.09 . . . . 71.14 105.356 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -154.06 8.29 0.35 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.809 0.843 . . . . 64.22 112.494 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -151.6 121.08 6.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 104.168 -2.53 . . . . 74.41 104.168 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.5 t -136.26 149.91 27.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.051 -1.833 . . . . 74.52 106.051 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.99 160.29 53.32 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.6 1.56 . . . . 72.53 108.04 177.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.78 -13.66 27.89 Favored 'Cis proline' 0 CA--C 1.535 0.555 0 CA-C-N 119.539 0.871 . . . . 74.24 113.802 -10.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.76 103.1 15.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 104.022 -2.584 . . . . 62.24 104.022 171.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -66.82 160.07 26.75 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.307 -0.627 . . . . 73.22 109.307 167.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -137.9 174.7 10.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.118 1.367 . . . . 74.43 108.315 168.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.5 t -51.32 150.76 5.86 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 108.861 -0.792 . . . . 71.35 108.861 168.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -65.2 153.23 79.27 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.077 1.851 . . . . 74.25 109.333 163.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -159.3 172.07 18.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.555 1.542 . . . . 74.43 109.008 175.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -114.15 146.01 40.89 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.846 -1.168 . . . . 71.54 107.846 172.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.3 mt -123.9 115.98 22.16 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.769 1.228 . . . . 74.54 107.94 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.06 127.53 33.46 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.205 1.002 . . . . 73.53 108.353 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.9 m -144.73 160.66 40.86 Favored 'General case' 0 CA--C 1.522 -0.124 0 O-C-N 121.787 -0.57 . . . . 72.41 109.803 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -121.41 155.72 34.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.333 1.453 . . . . 72.53 108.695 173.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 tt -145.75 148.23 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 119.095 0.862 . . . . 70.1 110.532 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.0 p -152.37 77.53 1.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.552 1.141 . . . . 64.33 109.913 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.4 -59.63 0.17 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 127.838 2.637 . . . . 74.23 115.385 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 p -132.6 22.16 4.3 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.479 1.111 . . . . 72.13 112.294 174.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.7 m -127.68 131.89 49.74 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.682 1.193 . . . . 72.24 107.989 167.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.98 131.96 56.44 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.524 1.929 . . . . 75.12 107.885 167.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -120.14 98.57 6.13 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.489 1.516 . . . . 73.23 108.183 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.6 t -75.89 125.59 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.436 -1.69 . . . . 63.32 106.436 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -83.15 -33.86 26.16 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.512 0.596 . . . . 64.2 111.474 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.0 t -146.76 155.77 42.64 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.446 1.498 . . . . 74.2 109.127 -170.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.07 -175.42 15.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 124.978 1.275 . . . . 53.21 111.414 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -24.61 63.29 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.895 -1.05 . . . . 63.43 112.432 169.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.487 ' CD ' ' HH ' ' A' ' 95' ' ' TYR . 11.1 mm-40 -111.68 24.19 13.01 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.406 1.003 . . . . 72.14 112.342 -168.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.39 102.41 0.23 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.341 1.456 . . . . 75.03 112.659 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.74 -124.97 0.92 Allowed Glycine 0 N--CA 1.463 0.498 0 C-N-CA 124.23 0.919 . . . . 75.14 112.557 -173.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -152.2 147.48 26.45 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.691 1.196 . . . . 63.33 111.186 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.487 ' HH ' ' CD ' ' A' ' 91' ' ' GLU . 61.7 m-85 -143.51 146.7 33.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.336 1.454 . . . . 71.24 110.0 176.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -115.19 27.24 9.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.522 1.129 . . . . 73.52 113.69 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttt 61.76 159.28 0.06 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.692 1.997 . . . . 63.24 111.255 -170.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -144.22 163.05 34.78 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 127.786 2.434 . . . . 73.14 106.083 163.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt . . . . . 0 C--O 1.251 1.153 0 C-N-CA 125.949 1.699 . . . . 74.11 108.071 -173.183 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.563 0 N-CA-C 109.402 -1.479 . . . . 74.53 109.402 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -137.24 96.08 3.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.479 1.133 . . . . 74.51 109.532 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -85.75 117.21 24.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 104.1 -2.556 . . . . 61.04 104.1 173.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -121.81 -178.63 3.88 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 125.755 1.622 . . . . 71.22 108.624 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.6 p -111.42 170.19 8.29 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.588 0.631 . . . . 73.45 111.072 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.36 119.07 5.42 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.548 1.139 . . . . 70.05 109.669 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.9 tp -70.84 123.24 21.51 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.528 -1.656 . . . . 73.44 106.528 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -136.85 175.2 9.83 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.053 0.941 . . . . 65.33 108.903 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.3 p -58.51 -41.07 84.55 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.56 1.544 . . . . 73.34 111.821 -174.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.89 -30.14 35.53 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.384 0.674 . . . . 61.22 109.857 -174.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.6 -38.51 91.38 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.394 0.543 . . . . 74.22 111.021 -170.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.5 tp -74.43 -24.81 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.616 1.166 . . . . 70.51 112.636 -172.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm -57.02 109.58 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.91 1.684 . . . . 74.14 111.21 -168.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.97 172.89 32.99 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.784 -0.926 . . . . 54.12 110.784 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -86.51 160.02 19.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.42 -0.956 . . . . 72.43 108.42 159.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -146.89 140.86 26.0 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.475 1.51 . . . . 74.11 108.894 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.0 t -138.09 179.42 6.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.238 1.415 . . . . 65.43 107.874 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 t -137.27 -40.03 0.59 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.647 -1.283 . . . . 71.21 112.034 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.86 179.6 30.79 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 106.652 -2.579 . . . . 74.22 106.652 167.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.8 pt -130.41 36.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.304 1.041 . . . . 65.44 109.678 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -139.61 174.39 10.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.947 1.299 . . . . 71.44 109.606 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.68 -95.22 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.991 1.758 . . . . 52.11 114.024 169.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -139.44 141.89 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 105.688 -1.967 . . . . 74.52 105.688 162.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -151.45 -179.47 7.41 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.487 1.115 . . . . 73.23 108.112 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -142.47 140.86 32.04 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.131 0.973 . . . . 72.43 108.767 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.32 154.08 17.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.859 2.064 . . . . 74.33 107.032 170.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.0 mt -145.02 147.76 32.97 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.39 1.876 . . . . 73.43 105.951 169.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 p -151.02 154.71 37.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.015 0.825 . . . . 73.2 110.516 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -143.56 118.12 9.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.257 1.023 . . . . 71.23 108.782 -174.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.5 158.76 25.76 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.61 -0.885 . . . . 52.04 108.61 164.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -79.6 -39.04 32.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.023 0.529 . . . . 71.31 110.427 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.29 8.79 7.88 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.897 0.879 . . . . 75.02 110.678 -166.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.27 -133.21 5.36 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 126.694 2.092 . . . . 74.54 108.062 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -126.35 -177.89 4.14 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.299 1.44 . . . . 75.14 108.441 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.27 160.1 15.27 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.667 1.603 . . . . 62.22 110.461 171.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 m -133.63 158.2 43.83 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.326 1.051 . . . . 71.54 109.871 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -149.1 129.11 13.49 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.464 1.906 . . . . 72.43 107.082 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.87 119.21 1.11 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.226 -1.15 . . . . 71.53 110.226 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.463 ' H ' ' HB3' ' A' ' 47' ' ' SER . 35.9 mt -75.95 150.63 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.558 -0.905 . . . . 74.22 108.558 174.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -132.09 133.58 44.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.443 1.497 . . . . 73.2 108.222 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 m -83.17 135.34 34.83 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 105.792 -1.929 . . . . 73.23 105.792 159.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 43.42 -80.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.785 2.434 . . . . 72.51 115.825 156.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.07 64.42 1.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.073 0.949 . . . . 73.43 111.597 162.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 m -157.65 135.83 7.48 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 128.469 2.707 . . . . 71.23 108.875 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.25 119.89 5.76 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.312 3.341 . . . . 74.11 111.927 170.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 mm -122.8 17.12 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.611 1.564 . . . . 73.53 111.071 -173.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.463 ' HB3' ' H ' ' A' ' 39' ' ' ILE . 30.4 t -158.03 164.26 36.91 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 119.492 -2.005 . . . . 63.52 108.117 157.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -158.72 127.86 5.53 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.898 2.079 . . . . 73.2 106.122 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -143.4 169.31 17.9 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.145 1.778 . . . . 71.44 107.604 163.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.0 mtm -145.92 160.43 41.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.44 1.096 . . . . 75.32 110.302 170.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -161.89 147.55 13.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.626 1.57 . . . . 73.41 108.23 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.59 176.18 7.87 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.447 1.476 . . . . 73.53 108.614 170.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -157.43 161.96 38.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.266 -0.896 . . . . 65.5 111.139 168.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -131.15 165.0 24.26 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.454 0.702 . . . . 74.04 109.338 163.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.8 mm -123.8 83.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 105.753 -1.943 . . . . 73.4 105.753 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.28 24.14 10.89 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.064 1.346 . . . . 65.44 110.074 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -164.25 13.51 0.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.963 1.305 . . . . 73.04 114.092 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.65 14.6 65.22 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 120.977 -1.077 . . . . 73.34 111.843 -171.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -137.19 170.94 15.25 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.143 2.177 . . . . 73.41 106.625 173.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 mt -75.27 165.61 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.446 -1.316 . . . . 73.44 107.446 176.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -136.52 108.62 7.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.976 2.11 . . . . 71.2 106.179 162.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mm -93.46 145.59 7.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 106.02 -1.845 . . . . 65.54 106.02 168.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -150.25 -1.45 0.41 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.131 1.16 . . . . 75.03 114.131 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.36 115.92 3.84 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.079 -2.563 . . . . 75.44 104.079 -167.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.34 149.43 32.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.295 1.038 . . . . 74.44 108.459 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.64 164.41 32.88 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.998 2.119 . . . . 63.32 106.094 168.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.03 -16.09 19.67 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.412 0.826 . . . . 70.4 113.69 -5.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.09 119.89 34.37 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.683 -1.599 . . . . 72.31 106.683 172.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -79.4 141.66 36.67 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 118.668 0.667 . . . . 73.52 110.281 177.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -136.61 160.16 39.65 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.605 1.162 . . . . 73.3 111.315 -177.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 t -57.69 151.62 40.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.588 1.955 . . . . 65.34 111.464 170.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.88 158.05 38.88 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.665 2.91 . . . . 74.42 112.484 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -171.04 172.4 5.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.664 1.186 . . . . 73.43 111.176 173.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -115.93 96.89 5.8 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.963 1.705 . . . . 71.51 110.052 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.2 mt -75.54 133.13 41.06 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 126.238 1.815 . . . . 64.4 109.258 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.1 130.49 34.48 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.776 1.23 . . . . 73.33 109.303 176.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.3 p -154.64 166.62 32.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.487 1.915 . . . . 72.52 109.306 170.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -131.57 155.33 47.69 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.643 1.577 . . . . 74.51 109.649 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.9 tt -146.89 147.92 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.411 1.084 . . . . 65.54 108.122 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 m -138.74 -5.37 1.53 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.185 1.394 . . . . 74.11 114.626 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.02 -89.89 0.11 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 107.978 -2.049 . . . . 73.1 107.978 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.0 p -119.8 -4.35 10.2 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.676 1.361 . . . . 73.21 114.676 -172.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -99.08 114.14 26.7 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 121.039 1.745 . . . . 73.54 110.582 172.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.5 tp -85.49 116.17 23.64 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 119.441 -2.037 . . . . 63.12 108.297 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.87 105.51 15.73 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.011 0.924 . . . . 63.43 109.792 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.426 ' HB ' ' H ' ' A' ' 93' ' ' GLY . 18.5 t -90.12 127.68 42.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.132 -0.692 . . . . 71.22 109.132 -179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -85.53 -38.2 18.79 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 118.662 0.664 . . . . 64.14 110.699 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.4 t -148.54 173.35 13.23 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.092 0.86 . . . . 74.34 110.962 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.42 177.07 23.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 125.088 1.328 . . . . 64.13 110.361 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.8 m -53.48 -30.94 43.51 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.589 1.155 . . . . 74.22 110.252 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -89.51 0.52 56.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.713 1.005 . . . . 73.5 113.713 -174.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.48 109.87 0.26 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.801 1.64 . . . . 71.41 109.651 -175.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.426 ' H ' ' HB ' ' A' ' 86' ' ' VAL . . . 166.15 -167.97 39.6 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 109.024 -1.63 . . . . 71.44 109.024 -167.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.8 t -135.13 147.98 49.64 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.108 -1.071 . . . . 72.53 108.108 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -146.68 160.53 42.09 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.17 1.388 . . . . 73.43 109.97 -167.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.78 140.25 49.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.441 1.496 . . . . 74.21 109.405 175.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -60.77 144.47 52.35 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.776 1.231 . . . . 74.32 109.952 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -125.94 34.05 4.95 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.861 2.064 . . . . 74.52 109.11 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp . . . . . 0 C--O 1.253 1.257 0 C-N-CA 128.471 2.709 . . . . 74.54 104.959 162.345 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.458 0 N-CA-C 108.85 -1.7 . . . . 72.44 108.85 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -138.86 160.09 40.54 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.439 1.096 . . . . 73.31 108.828 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -126.25 98.27 5.4 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.579 1.952 . . . . 65.15 105.745 -174.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -117.42 154.01 32.11 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.581 1.153 . . . . 71.53 110.48 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.2 p -75.32 165.85 24.52 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.28 -0.637 . . . . 73.25 109.28 172.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -64.19 130.93 45.86 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.755 1.264 . . . . 75.14 108.873 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.04 133.83 55.16 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 114.597 -1.183 . . . . 75.55 109.184 164.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.31 166.7 23.85 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.157 -1.383 . . . . 71.12 109.428 166.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -44.9 78.09 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 124.328 1.017 . . . . 71.34 108.957 167.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -60.83 -24.82 66.17 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.963 -1.086 . . . . 73.12 112.152 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -85.96 -26.86 25.25 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 118.432 -0.794 . . . . 71.44 112.457 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.0 tp -88.07 -7.52 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.54 1.064 . . . . 75.12 112.168 -171.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.406 ' O ' ' HE3' ' A' ' 97' ' ' LYS . 18.3 mm -62.23 114.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.218 1.407 . . . . 75.51 110.445 -172.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.6 173.92 25.71 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.435 -1.066 . . . . 63.11 110.435 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -85.62 151.55 23.81 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.369 -1.345 . . . . 74.54 107.369 162.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -138.58 123.84 19.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.108 1.363 . . . . 73.44 108.772 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -129.1 170.13 13.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.327 0.651 . . . . 74.15 109.403 173.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.43 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 12.5 t -126.82 -6.07 6.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.77 1.628 . . . . 71.15 111.369 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.07 177.46 19.9 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 108.665 -1.774 . . . . 63.12 108.665 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 pt -131.65 -11.04 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.702 0.801 . . . . 73.53 112.655 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -72.05 153.72 41.56 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 120.104 -1.623 . . . . 73.51 110.409 173.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.18 -111.64 3.31 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.698 -1.057 . . . . 72.52 111.237 165.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.6 m -141.78 107.49 5.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.966 -1.494 . . . . 74.12 106.966 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -103.11 175.43 5.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 122.229 1.014 . . . . 73.42 110.779 -174.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -126.89 140.08 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.461 1.905 . . . . 71.33 106.826 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.45 143.51 51.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.94 1.296 . . . . 75.54 108.428 -176.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.0 mt -132.12 156.75 45.81 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.034 -1.469 . . . . 75.14 107.034 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.0 p -154.92 97.64 1.97 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.689 1.596 . . . . 75.52 112.311 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -91.59 132.42 36.33 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.243 1.417 . . . . 75.53 110.289 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' A' ' 34' ' ' THR . 2.7 p30 -94.11 165.33 12.68 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 127.77 2.428 . . . . 60.35 108.949 159.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -104.26 6.64 35.57 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.059 1.744 . . . . 73.52 110.549 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -149.94 7.3 0.62 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 115.162 1.541 . . . . 75.31 115.162 175.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.06 -110.97 1.51 Allowed Glycine 0 C--N 1.337 0.632 0 CA-C-N 118.498 0.59 . . . . 72.54 112.132 -170.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.425 ' H ' ' CG ' ' A' ' 30' ' ' ASP . 35.4 p -147.16 131.83 17.86 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.418 1.487 . . . . 74.44 107.927 -174.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.95 175.96 34.06 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.137 -0.785 . . . . 71.42 111.137 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m -145.04 164.27 31.69 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.817 -1.402 . . . . 75.41 111.943 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -141.63 120.5 12.73 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.024 -0.732 . . . . 63.41 109.024 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -121.35 161.65 15.35 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.553 1.073 . . . . 64.14 111.097 177.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.4 mt -137.7 133.62 45.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.962 -1.866 . . . . 73.22 105.962 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -125.93 127.03 45.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.593 1.557 . . . . 75.22 108.965 -170.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -86.01 112.83 21.59 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.149 -1.056 . . . . 55.2 108.149 166.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.24 -85.95 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.921 2.089 . . . . 74.3 110.307 -169.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.92 -0.42 3.41 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.155 0.982 . . . . 60.1 112.264 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.5 m -84.11 119.65 73.61 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.267 1.427 . . . . 74.43 108.161 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.36 140.19 57.26 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.862 2.375 . . . . 64.51 109.778 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.8 mm -124.42 -41.61 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 124.213 1.005 . . . . 75.11 109.655 -177.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.2 t -124.63 156.18 37.91 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 121.495 -0.753 . . . . 73.31 109.641 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -154.82 152.99 30.47 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.987 1.715 . . . . 75.41 108.235 172.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -161.48 161.07 29.92 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 127.723 2.409 . . . . 75.4 107.286 168.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.6 mtm -124.3 163.3 21.95 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.199 1.0 . . . . 75.23 110.048 166.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -164.57 141.7 6.38 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.433 1.093 . . . . 71.35 111.035 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.8 158.83 20.83 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.151 0.98 . . . . 72.54 108.961 164.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -151.33 166.73 30.07 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.158 -0.964 . . . . 75.21 110.556 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -138.07 149.3 45.88 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.187 -1.042 . . . . 75.43 108.187 165.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.2 mm -116.61 92.98 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 106.888 -1.523 . . . . 74.33 106.888 172.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -134.31 23.32 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.648 0.779 . . . . 74.51 112.484 -173.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -166.71 14.13 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.805 0.842 . . . . 75.12 111.791 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.77 5.59 57.39 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.342 -0.848 . . . . 72.15 111.947 -171.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.453 ' HB3' ' HA ' ' A' ' 76' ' ' ASP . 0.6 OUTLIER -121.51 145.01 48.39 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 130.458 3.503 . . . . 74.25 109.551 173.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.98 121.04 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.583 -1.636 . . . . 74.33 106.583 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -88.75 112.36 23.08 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.474 -1.676 . . . . 75.55 106.474 169.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 mm -103.92 138.4 28.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 106.304 -1.739 . . . . 74.22 106.304 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -158.62 2.59 0.1 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.767 1.025 . . . . 75.44 113.767 -172.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -153.43 125.15 7.72 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 103.544 -2.762 . . . . 64.53 103.544 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.9 t -135.49 152.23 31.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.973 -1.491 . . . . 73.23 106.973 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.78 160.66 52.59 Favored Pre-proline 0 C--O 1.239 0.549 0 C-N-CA 123.855 0.862 . . . . 74.42 109.046 175.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.78 -8.01 16.91 Favored 'Cis proline' 0 CA--C 1.534 0.523 0 CA-C-N 118.794 0.605 . . . . 62.43 113.45 -8.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -108.09 107.05 17.55 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.643 -1.244 . . . . 71.51 107.643 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -67.35 140.67 57.25 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.966 -0.753 . . . . 75.12 108.966 169.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -130.89 172.8 11.63 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.143 1.377 . . . . 75.32 109.146 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.7 t -49.81 150.53 3.77 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.422 1.489 . . . . 72.44 110.798 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -66.1 154.23 74.89 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.874 1.716 . . . . 63.44 110.009 163.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -160.82 153.02 20.22 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.471 1.908 . . . . 74.31 109.767 170.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -98.11 140.38 32.51 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.185 -1.042 . . . . 74.24 108.185 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.1 mt -119.76 109.22 15.36 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 126.53 1.932 . . . . 74.12 108.683 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.453 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 5.0 m-20 -62.58 131.56 49.48 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.828 -1.175 . . . . 63.21 107.828 174.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.8 p -150.8 173.0 14.72 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.483 1.513 . . . . 73.55 109.831 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -139.23 158.43 44.19 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.227 0.611 . . . . 70.52 110.233 178.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 tt -151.06 144.02 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 118.227 0.467 . . . . 73.21 110.528 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.0 t -133.23 33.46 3.61 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.662 1.585 . . . . 74.41 108.244 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.4 -56.85 4.22 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 120.912 -1.118 . . . . 74.31 111.962 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.85 -25.25 11.32 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.043 1.127 . . . . 73.11 114.043 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.0 m -102.29 127.76 49.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.827 1.194 . . . . 75.51 108.056 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.8 tp -94.81 137.7 33.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.875 2.07 . . . . 64.22 108.808 159.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -136.15 87.91 2.34 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.6 1.16 . . . . 70.45 110.221 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.64 128.5 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.189 -1.041 . . . . 63.34 108.189 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -86.35 -25.72 25.23 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.607 0.763 . . . . 74.22 111.367 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 t -153.71 158.36 40.89 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.181 1.392 . . . . 72.22 110.579 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.18 177.47 20.93 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 124.664 1.126 . . . . 74.44 111.17 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.3 m -60.69 -16.82 43.4 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.204 1.402 . . . . 62.24 113.694 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -109.32 8.81 25.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.8 1.64 . . . . 64.52 112.844 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.12 116.34 2.73 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.311 1.844 . . . . 74.44 109.5 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.15 -153.26 21.76 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 122.158 0.866 . . . . 74.45 113.204 -172.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.7 t -135.43 123.93 23.5 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 126.191 1.796 . . . . 64.54 106.503 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.43 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 60.9 m-85 -141.01 157.72 44.94 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.556 1.169 . . . . 75.42 109.481 -175.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -127.62 138.06 52.73 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.356 -1.35 . . . . 73.32 107.356 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HE3' ' O ' ' A' ' 13' ' ' ILE . 25.5 tttt -51.39 145.88 7.87 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.641 1.576 . . . . 62.34 109.32 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -122.54 20.1 10.36 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.469 2.708 . . . . 75.52 109.463 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp . . . . . 0 C--O 1.246 0.918 0 C-N-CA 130.007 3.323 . . . . 75.54 103.817 171.942 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.62 0 N-CA-C 110.155 -1.178 . . . . 54.24 110.155 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -133.55 146.49 51.07 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.202 -1.036 . . . . 70.03 108.202 170.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -82.77 117.82 22.95 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 104.814 -2.291 . . . . 65.11 104.814 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -115.15 157.2 23.95 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 125.056 1.343 . . . . 72.44 110.157 172.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.59 173.08 12.95 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.18 0.514 . . . . 74.03 109.877 169.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -59.21 151.65 22.48 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.948 -1.023 . . . . 74.13 109.754 167.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 tp -90.89 130.0 36.88 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.872 -1.529 . . . . 73.25 106.872 165.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -139.2 168.02 20.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.694 1.198 . . . . 74.45 109.259 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -74.04 33.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.945 0.898 . . . . 72.11 111.482 175.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.76 -32.44 0.44 Allowed 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 119.875 -1.765 . . . . 74.01 113.178 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -82.82 -30.3 28.86 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 116.976 -1.488 . . . . 73.11 111.969 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 tp -70.43 -24.63 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 121.636 2.016 . . . . 73.35 113.136 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.83 104.57 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.778 2.031 . . . . 74.25 111.246 -174.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.99 171.2 32.82 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.089 0.852 . . . . 72.14 111.034 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -76.13 152.28 36.77 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.106 0.962 . . . . 65.21 109.066 163.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -146.41 153.5 40.55 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.601 1.16 . . . . 70.33 109.299 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 t -153.45 165.24 36.45 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.812 -1.18 . . . . 70.14 110.304 166.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 25' ' ' LYS . 4.4 t -115.79 -9.82 11.82 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.69 1.596 . . . . 65.12 111.413 -175.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.04 -172.6 44.85 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.489 -0.757 . . . . 72.23 111.209 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.5 pt -134.77 14.69 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.032 2.133 . . . . 65.44 110.71 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -144.34 179.35 7.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.861 1.664 . . . . 74.34 111.653 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.25 -104.98 0.23 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.038 1.78 . . . . 72.12 111.755 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.6 m -139.74 101.88 4.3 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 106.128 -1.804 . . . . 74.21 106.128 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -117.7 178.73 4.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.827 1.251 . . . . 72.05 109.423 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.403 ' H ' HG23 ' A' ' 18' ' ' THR . 1.5 mptt -144.8 154.38 42.63 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.072 0.949 . . . . 72.05 109.941 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.22 154.5 18.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.382 1.873 . . . . 72.01 107.529 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mt -138.31 144.82 40.6 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.855 -1.535 . . . . 73.12 106.855 160.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.9 p -139.03 155.03 48.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.814 1.188 . . . . 73.14 109.764 166.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.426 ' CD2' ' CE2' ' A' ' 53' ' ' TYR . 22.2 m-85 -143.09 125.19 15.33 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.549 1.94 . . . . 73.14 106.039 -175.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -101.35 154.04 19.13 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.467 -1.679 . . . . 72.12 106.467 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -74.87 -41.38 59.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.841 0.746 . . . . 53.31 111.38 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -108.59 -1.74 19.37 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.113 0.565 . . . . 65.41 111.672 -162.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.81 -112.22 1.54 Allowed Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.26 -0.736 . . . . 31.04 111.26 -169.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 80.3 p -145.3 172.67 12.82 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.022 1.329 . . . . 74.23 107.773 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.03 -166.46 14.64 Favored Glycine 0 CA--C 1.524 0.627 0 O-C-N 120.973 -1.08 . . . . 63.15 111.865 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -155.44 156.94 36.2 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 121.264 -1.139 . . . . 73.43 111.694 -170.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -135.52 145.54 47.17 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.325 1.45 . . . . 65.43 108.104 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.15 154.5 25.54 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 109.93 -1.268 . . . . 63.45 109.93 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.7 mt -113.29 143.77 22.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.034 -1.469 . . . . 73.14 107.034 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -132.22 119.27 20.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.499 1.52 . . . . 74.03 109.211 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -85.86 107.98 17.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.617 -1.994 . . . . 74.44 105.617 166.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.72 -57.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 129.749 3.219 . . . . 74.32 115.721 174.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -154.94 25.3 0.43 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.684 1.594 . . . . 62.41 112.307 167.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.5 m -131.51 125.16 20.51 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.89 1.276 . . . . 73.45 108.282 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.06 124.8 7.53 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.738 2.959 . . . . 74.31 112.159 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.2 mm -114.65 -13.17 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.264 1.426 . . . . 73.21 112.762 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.7 m -151.6 163.73 38.42 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.086 -1.009 . . . . 74.21 109.133 170.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -164.23 127.47 2.51 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.639 1.976 . . . . 74.31 108.057 -173.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.77 166.94 26.94 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.879 1.671 . . . . 73.44 108.354 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.8 mtm -137.93 151.25 47.79 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.545 -0.909 . . . . 72.12 108.545 170.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.74 146.76 18.11 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.327 1.451 . . . . 74.21 110.913 -171.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -81.22 176.24 9.94 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.301 -1.0 . . . . 74.44 108.301 167.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CE2' ' CD2' ' A' ' 29' ' ' PHE . 5.9 m-85 -141.97 159.19 42.73 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.87 -0.604 . . . . 74.13 110.2 171.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -130.78 132.21 45.14 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.296 -1.372 . . . . 71.04 107.296 161.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.42 106.88 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 105.939 -1.875 . . . . 74.33 105.939 164.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -127.94 23.98 6.08 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.401 0.62 . . . . 74.25 111.244 174.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.67 13.73 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.471 0.915 . . . . 72.44 113.471 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.32 13.43 62.59 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 120.892 -1.13 . . . . 71.03 111.286 -163.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.4 mmt85 -136.89 152.82 50.65 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.768 2.027 . . . . 73.12 105.917 -172.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.8 mt -88.06 115.24 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 107.147 -1.427 . . . . 74.04 107.147 -170.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -87.38 111.11 20.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.147 -1.057 . . . . 72.02 108.147 169.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.2 mm -79.51 138.99 18.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.021 -1.844 . . . . 72.23 106.021 163.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -145.79 2.84 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.859 1.429 . . . . 74.11 114.859 175.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.4 100.46 0.34 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.014 -1.476 . . . . 74.03 107.014 -156.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.9 t -130.34 143.27 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.401 1.08 . . . . 61.44 108.34 -176.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.04 158.91 71.32 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.371 1.869 . . . . 74.33 106.597 171.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -84.95 -6.41 53.31 Favored 'Cis proline' 0 CA--C 1.54 0.793 0 CA-C-N 119.533 0.869 . . . . 65.12 113.581 -6.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.09 102.79 10.73 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 105.973 -1.862 . . . . 72.02 105.973 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.43 151.97 43.53 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.234 1.016 . . . . 74.41 112.079 -174.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -128.48 164.66 22.27 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.35 1.86 . . . . 72.21 111.017 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 t -63.01 150.43 88.33 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.796 0.838 . . . . 73.44 109.292 165.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.77 137.66 25.07 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.696 2.264 . . . . 65.34 111.186 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -152.77 164.1 38.44 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.729 0.812 . . . . 74.15 111.451 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -93.39 154.37 17.99 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.244 0.617 . . . . 73.05 110.932 173.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -128.62 126.13 39.57 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.553 1.941 . . . . 74.22 107.728 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -76.77 116.08 17.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.669 -1.975 . . . . 63.21 105.669 172.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -142.46 159.24 42.62 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.157 -0.683 . . . . 63.23 109.157 169.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -132.01 156.97 45.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.444 1.498 . . . . 71.21 110.537 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 tt -146.85 156.81 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.495 -0.557 . . . . 73.33 109.495 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.4 46.5 0.66 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 123.482 1.61 . . . . 73.14 110.898 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.19 -73.13 0.33 Allowed Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 113.583 -1.644 . . . . 65.41 109.262 171.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.4 p -119.91 -2.77 10.26 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 114.152 1.168 . . . . 74.31 114.152 -173.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.3 m -106.62 130.11 54.43 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.264 -1.384 . . . . 73.31 107.264 164.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.91 136.42 38.23 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.177 1.791 . . . . 72.15 107.524 163.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -120.65 88.77 3.0 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.662 1.185 . . . . 71.32 109.329 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.6 t -77.07 118.85 24.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.922 -1.51 . . . . 73.44 106.922 172.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -78.14 -39.97 39.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.465 0.575 . . . . 65.44 111.142 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 t -144.0 174.73 10.6 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.123 0.874 . . . . 74.35 111.258 -166.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.55 -179.17 47.65 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 125.683 1.611 . . . . 42.55 111.272 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.4 m -58.92 -21.87 58.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.356 1.462 . . . . 72.44 113.101 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -106.62 10.28 31.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.938 1.295 . . . . 74.45 112.474 -177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.45 109.57 0.46 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.298 1.439 . . . . 71.42 110.738 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -175.74 -169.89 37.91 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.547 1.07 . . . . 71.31 111.269 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -129.61 121.58 27.37 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.481 -1.674 . . . . 72.31 106.481 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -126.29 145.45 50.41 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.048 0.539 . . . . 73.05 109.842 -165.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -97.38 148.95 22.65 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.448 -0.945 . . . . 70.33 108.448 164.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -59.7 150.13 28.69 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.435 1.494 . . . . 74.32 109.486 166.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -145.26 20.66 1.56 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.251 1.82 . . . . 73.23 113.076 -170.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.6 tttt . . . . . 0 C--O 1.255 1.371 0 C-N-CA 128.473 2.709 . . . . 72.41 112.839 -178.985 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.733 0 N-CA-C 109.395 -1.482 . . . . 74.32 109.395 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -87.41 87.18 7.34 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 105.874 -1.899 . . . . 72.51 105.874 156.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.8 85.98 5.41 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.56 -1.274 . . . . 74.22 107.56 -172.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -88.47 150.86 22.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.134 0.974 . . . . 75.41 110.283 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.64 175.99 7.64 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.619 1.568 . . . . 63.22 109.996 171.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -74.15 123.08 23.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.06 0.944 . . . . 73.43 111.164 172.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 24.7 tp -60.69 129.29 40.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.239 -0.652 . . . . 74.42 109.239 162.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -146.35 168.27 21.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.653 0.74 . . . . 72.44 109.709 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.07 21.14 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.814 3.245 . . . . 74.43 113.446 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.83 -52.13 0.63 Allowed 'General case' 0 C--O 1.232 0.177 0 O-C-N 119.904 -1.748 . . . . 74.1 110.916 176.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -64.19 -26.38 68.49 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.66 1.118 . . . . 72.1 113.015 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.8 tp -70.52 -25.09 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.417 1.487 . . . . 73.1 113.469 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.77 129.89 34.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 123.443 0.697 . . . . 65.42 110.08 -163.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.36 -172.42 18.72 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.12 1.819 . . . . 65.23 111.397 174.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -82.27 160.7 22.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.361 1.465 . . . . 74.22 111.264 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -141.13 158.28 44.13 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.702 1.601 . . . . 73.54 108.182 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 p -146.78 169.08 19.83 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.8 2.091 . . . . 71.14 112.733 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -132.78 -5.33 3.19 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.608 1.563 . . . . 75.44 112.704 -171.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.8 172.94 14.9 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.251 -1.939 . . . . 75.45 108.251 -171.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.9 pt -138.11 27.42 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.452 1.101 . . . . 74.34 110.79 -168.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -125.89 174.88 8.07 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 124.559 1.144 . . . . 74.15 112.063 -171.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 43.66 -88.47 0.01 OUTLIER Glycine 0 C--N 1.341 0.854 0 C-N-CA 127.505 2.479 . . . . 63.01 114.017 149.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.3 m -130.44 122.23 27.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.485 -1.672 . . . . 63.43 106.485 159.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -131.72 -167.54 1.88 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.822 1.649 . . . . 72.23 107.757 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.43 156.08 18.31 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.241 1.816 . . . . 64.01 107.522 -162.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.95 132.4 20.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.789 2.436 . . . . 72.11 109.812 -177.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.4 mt -116.71 156.75 26.61 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.218 2.207 . . . . 75.34 108.498 175.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 t -137.18 156.31 48.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.025 -1.842 . . . . 65.53 106.025 160.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -143.1 129.78 20.3 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.35 1.46 . . . . 72.22 107.704 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.21 167.04 11.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.569 0.748 . . . . 71.44 110.76 171.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -81.88 -33.41 30.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.237 0.615 . . . . 71.5 110.572 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -138.08 28.82 2.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.867 0.841 . . . . 70.14 110.927 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.31 -116.62 2.54 Favored Glycine 0 C--N 1.33 0.232 0 N-CA-C 108.565 -1.814 . . . . 71.21 108.565 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.2 p -146.11 -175.07 4.61 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.398 1.479 . . . . 65.52 107.173 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.82 170.52 17.09 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.881 -0.888 . . . . 73.55 110.881 162.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.1 p -135.42 166.85 22.2 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.322 1.049 . . . . 74.41 110.89 171.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -149.59 105.96 3.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.044 -1.465 . . . . 75.05 107.044 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.51 104.02 1.02 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.577 -1.009 . . . . 72.14 110.577 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 mt -73.83 134.26 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 106.42 -1.696 . . . . 74.02 106.42 170.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -123.56 135.85 54.22 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.257 1.423 . . . . 72.32 108.238 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.28 136.29 36.96 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 107.622 -1.251 . . . . 62.23 107.622 163.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 45.89 -78.91 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 129.065 2.946 . . . . 74.02 114.655 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.27 65.47 1.02 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.793 1.237 . . . . 75.34 110.335 163.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.0 m -155.32 132.84 6.5 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.562 1.945 . . . . 72.25 108.939 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.15 134.99 26.2 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.433 2.756 . . . . 64.45 110.357 172.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.3 mm -127.48 -20.78 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.146 0.578 . . . . 75.01 111.31 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.7 t -138.76 163.69 31.53 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 120.526 -1.359 . . . . 74.43 108.268 167.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -163.45 132.36 3.93 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 126.891 2.076 . . . . 74.04 106.694 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -148.96 159.22 44.4 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.474 -1.676 . . . . 75.35 106.474 162.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.9 mtm -130.78 145.56 52.0 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.643 -1.614 . . . . 74.15 106.643 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -164.09 140.13 6.35 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.955 -0.387 . . . . 74.51 109.955 -167.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.42 174.16 3.55 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.503 1.121 . . . . 64.14 109.671 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -154.13 172.12 18.06 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.302 -0.873 . . . . 73.43 110.941 162.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -133.31 153.77 51.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.407 -0.961 . . . . 72.3 108.407 158.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.1 mm -102.67 101.12 11.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.356 -1.72 . . . . 65.33 106.356 165.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -136.67 24.52 3.13 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.503 1.521 . . . . 73.11 110.363 -171.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -169.73 14.27 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.641 1.576 . . . . 62.52 114.045 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.47 18.88 68.23 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 120.773 -1.204 . . . . 74.43 112.129 -170.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 -136.48 166.56 23.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 128.704 2.802 . . . . 74.42 105.436 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.58 150.09 4.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.117 -1.438 . . . . 75.44 107.117 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -119.99 125.17 47.73 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.61 1.964 . . . . 75.41 105.757 165.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mm -113.44 132.7 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.479 -2.045 . . . . 72.14 105.479 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -156.41 -2.61 0.12 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.314 0.857 . . . . 71.52 113.314 -170.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -145.52 111.65 5.66 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 105.526 -2.027 . . . . 74.34 105.526 174.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.28 146.84 33.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.067 -1.827 . . . . 72.14 106.067 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.58 160.73 58.01 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 106.72 -1.585 . . . . 74.11 106.72 174.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.47 -10.0 38.23 Favored 'Cis proline' 0 CA--C 1.537 0.645 0 CA-C-N 119.085 0.709 . . . . 72.11 113.532 -7.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.96 97.23 7.12 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 104.563 -2.384 . . . . 71.43 104.563 172.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -65.76 140.53 58.44 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.547 -0.908 . . . . 71.22 108.547 168.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -126.59 171.15 11.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.308 1.043 . . . . 74.15 109.459 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -47.15 141.69 5.94 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.276 1.031 . . . . 72.34 108.719 171.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.45 139.72 42.0 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.518 1.478 . . . . 70.53 109.466 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -144.64 162.33 36.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.629 0.772 . . . . 75.12 110.397 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -99.28 156.61 16.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.467 -0.938 . . . . 72.2 108.467 170.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.4 mt -127.55 110.12 12.4 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.734 -1.21 . . . . 75.1 107.734 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -57.98 129.19 40.8 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.481 -1.303 . . . . 73.12 107.481 170.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.48 165.46 35.59 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.508 0.723 . . . . 75.51 109.359 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -126.86 167.94 15.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.506 1.522 . . . . 72.21 111.143 164.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.0 tt -157.71 154.79 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.796 -0.816 . . . . 75.53 108.796 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.8 m -138.48 -5.27 1.59 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 118.195 2.665 . . . . 72.11 118.195 168.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.2 -52.52 0.51 Allowed Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.956 -1.258 . . . . 75.23 109.956 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -121.22 -20.88 6.58 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 116.757 -1.592 . . . . 73.42 113.82 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.1 m -96.51 116.83 29.72 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 121.141 1.791 . . . . 63.44 110.124 168.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.45 140.13 29.84 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.645 1.178 . . . . 75.51 109.752 159.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -132.1 91.25 2.93 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.131 0.972 . . . . 75.3 110.968 170.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.4 t -80.67 133.24 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.106 -1.072 . . . . 75.11 108.106 173.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -89.84 -30.7 17.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.499 0.72 . . . . 74.21 112.675 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.5 t -143.38 171.59 13.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.571 1.078 . . . . 73.12 110.69 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.25 179.67 49.61 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-O 122.997 1.331 . . . . 73.14 110.787 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.3 m -58.13 -20.07 37.49 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.691 1.197 . . . . 43.52 113.757 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -110.46 16.49 21.54 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.386 0.513 . . . . 75.34 112.386 -174.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.15 105.37 0.58 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.787 0.835 . . . . 73.33 111.69 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.35 -135.18 2.16 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 118.836 0.744 . . . . 61.2 113.074 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.4 t -138.58 119.9 14.77 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.866 1.666 . . . . 74.11 109.12 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.59 152.06 51.1 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.354 -0.841 . . . . 74.2 109.24 -166.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -119.05 129.8 55.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 117.636 -1.173 . . . . 75.44 108.698 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -47.39 140.65 5.47 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.333 1.053 . . . . 74.53 109.297 172.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -120.77 45.06 2.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.107 1.763 . . . . 63.33 109.172 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt . . . . . 0 C--O 1.257 1.457 0 C-N-CA 128.673 2.789 . . . . 74.14 105.418 178.058 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.572 0 N-CA-C 109.897 -1.281 . . . . 73.52 109.897 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -142.08 66.37 1.34 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 122.861 1.315 . . . . 75.35 107.693 162.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.14 64.67 7.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.315 -1.311 . . . . 62.12 108.34 -166.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -72.73 152.55 41.59 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.064 1.346 . . . . 75.11 110.385 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -78.63 166.39 22.58 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.027 0.376 . . . . 64.45 110.356 167.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -51.58 132.49 30.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.269 1.033 . . . . 73.33 108.669 163.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.8 tp -72.41 122.97 22.12 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.454 -1.684 . . . . 61.44 106.454 157.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -135.43 165.24 25.94 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.015 -1.476 . . . . 74.53 107.015 174.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -57.91 -43.68 86.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 124.184 0.928 . . . . 73.23 110.732 -165.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -75.75 -24.03 56.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.784 0.834 . . . . 72.05 111.728 -171.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -71.15 -39.55 71.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.517 0.599 . . . . 75.23 111.806 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.7 tp -83.18 -14.72 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.214 1.006 . . . . 74.13 112.307 -167.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 mm -57.97 145.29 9.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.846 1.258 . . . . 74.11 109.755 -176.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.72 -170.09 13.46 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.684 1.135 . . . . 74.0 110.733 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -104.65 152.84 21.98 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.712 1.605 . . . . 74.44 109.447 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -147.45 126.47 12.84 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.845 1.258 . . . . 71.1 110.231 -170.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.6 t -135.66 166.89 22.19 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.89 0.876 . . . . 75.43 110.117 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.451 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 15.3 t -114.23 -13.96 12.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.76 1.624 . . . . 73.44 111.438 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.09 -174.9 41.7 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.704 -1.358 . . . . 60.02 109.704 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.0 pt -132.51 28.17 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.9 1.68 . . . . 75.02 110.165 -177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -129.39 175.48 8.72 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.454 1.102 . . . . 72.43 109.568 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.45 -107.79 0.57 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 125.927 1.727 . . . . 74.21 111.872 161.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.3 m -139.02 94.78 2.85 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.408 -1.701 . . . . 62.34 106.408 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -125.48 168.21 13.94 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 122.151 0.977 . . . . 61.1 111.653 -172.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -137.56 145.41 42.85 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.233 0.613 . . . . 63.5 109.839 -161.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.61 127.94 48.13 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.807 1.643 . . . . 62.41 107.71 -172.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.0 mt -117.33 153.23 33.35 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.322 -1.362 . . . . 71.31 107.322 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.0 p -148.88 158.05 43.89 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.68 -0.236 . . . . 62.43 110.655 159.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -142.62 138.76 30.94 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.169 1.388 . . . . 64.32 107.298 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.49 156.57 17.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.067 0.947 . . . . 71.22 109.622 171.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.9 -21.09 44.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 63.12 111.857 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.96 -1.61 5.24 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.325 0.65 . . . . 74.3 112.431 -173.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.94 -129.96 4.36 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.256 1.408 . . . . 71.42 111.992 -166.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 p -137.04 172.45 13.0 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 127.302 2.241 . . . . 75.22 107.38 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.9 175.83 25.51 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.523 -0.735 . . . . 64.13 112.241 -176.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.37 152.08 50.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.904 1.282 . . . . 75.31 108.317 176.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -145.14 106.5 4.21 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.447 1.499 . . . . 75.43 108.693 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.78 149.66 18.64 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.785 -0.926 . . . . 75.12 110.785 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.3 mt -116.1 131.7 67.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.362 -2.088 . . . . 75.34 105.362 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -130.95 127.74 39.03 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.932 1.293 . . . . 74.33 109.006 -170.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.93 115.83 31.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.668 -1.975 . . . . 54.41 105.668 173.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.73 -65.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 129.602 3.161 . . . . 75.13 115.849 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -153.62 36.23 0.45 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.947 1.299 . . . . 75.14 111.785 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.1 m -136.85 133.92 19.01 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.953 1.301 . . . . 75.34 108.788 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.06 133.04 17.52 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.408 2.738 . . . . 75.22 110.656 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 mm -128.89 -6.72 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.231 1.012 . . . . 73.13 112.261 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.3 t -153.23 157.92 40.93 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 119.783 -1.823 . . . . 74.13 109.437 167.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -146.93 134.56 21.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.055 2.142 . . . . 73.12 107.936 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -141.45 160.28 40.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.184 -1.043 . . . . 71.11 108.184 162.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mtm -130.82 139.13 50.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.465 -2.05 . . . . 75.34 105.465 172.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -157.37 152.5 25.96 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.706 -1.22 . . . . 74.44 107.706 -173.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.9 p30 -79.32 -177.35 5.67 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.648 1.213 . . . . 75.3 111.003 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -173.16 135.04 0.56 Allowed 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.858 1.663 . . . . 75.2 111.461 -164.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.573 ' HE3' ' CE1' ' A' ' 63' ' ' TYR . 4.1 mttt -135.34 159.96 39.91 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 124.536 1.147 . . . . 74.33 109.239 159.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.0 mm -94.71 118.91 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.723 -1.954 . . . . 75.23 105.723 149.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -136.93 25.09 3.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.769 0.828 . . . . 63.42 110.062 162.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.6 14.92 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 115.377 1.621 . . . . 74.24 115.377 -174.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.99 20.47 64.66 Favored Glycine 0 CA--C 1.531 1.094 0 O-C-N 120.299 -1.501 . . . . 64.13 110.951 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -148.41 156.68 42.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.63 2.772 . . . . 63.1 105.007 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 72.1 mt -84.06 115.73 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 105.318 -2.104 . . . . 75.44 105.318 -176.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -90.26 116.87 28.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 117.918 -1.039 . . . . 73.2 109.236 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.5 mm -95.82 148.83 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 107.162 -1.421 . . . . 72.54 107.162 172.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.573 ' CE1' ' HE3' ' A' ' 54' ' ' LYS . 13.1 p90 -158.26 -0.19 0.1 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.755 1.761 . . . . 75.4 115.755 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -152.95 124.97 7.95 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.762 -2.31 . . . . 64.54 104.762 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.832 ' CG1' ' H ' ' A' ' 70' ' ' LYS . 7.2 p -139.23 158.21 28.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 125.139 1.376 . . . . 74.44 109.948 173.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.89 158.72 48.64 Favored Pre-proline 0 C--O 1.24 0.577 0 C-N-CA 126.839 2.056 . . . . 71.0 106.894 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -80.64 -10.96 39.95 Favored 'Cis proline' 0 N--CA 1.463 -0.321 0 N-CA-C 113.863 0.678 . . . . 72.52 113.863 0.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.11 124.35 50.65 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 103.555 -2.757 . . . . 70.51 103.555 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.68 148.15 38.88 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.382 -0.599 . . . . 74.24 109.382 172.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.832 ' H ' ' CG1' ' A' ' 65' ' ' VAL . 23.2 mtpt -128.05 158.66 37.33 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.574 -0.528 . . . . 74.34 109.574 169.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -53.26 149.28 13.91 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.283 1.433 . . . . 74.54 111.727 -178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.68 140.37 42.8 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.352 2.035 . . . . 73.53 111.482 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -159.31 174.58 14.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.708 1.203 . . . . 73.44 110.24 175.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.81 125.49 54.06 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.779 1.632 . . . . 73.3 110.248 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.0 mt -89.44 112.53 23.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.608 1.163 . . . . 74.21 109.146 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.09 114.08 3.51 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.377 -1.342 . . . . 73.52 107.377 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.9 p -152.6 157.92 41.71 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.876 0.845 . . . . 72.42 110.429 175.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -129.31 152.95 48.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.916 1.687 . . . . 74.53 108.827 -175.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.6 tt -146.92 152.75 12.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.466 -0.568 . . . . 73.52 109.466 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 t -159.26 45.75 0.27 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 122.945 1.355 . . . . 74.32 110.779 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.52 -127.89 9.28 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 106.811 -2.515 . . . . 54.13 106.811 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.5 p -71.36 -11.41 60.88 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.383 -1.77 . . . . 64.14 114.16 -167.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.5 m -95.05 119.74 34.07 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 121.664 2.029 . . . . 52.21 108.822 173.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.9 tp -92.56 131.56 37.58 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.748 1.619 . . . . 75.43 108.13 160.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -119.48 100.59 7.38 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 125.246 1.418 . . . . 73.31 108.175 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.9 t -94.25 131.48 41.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.807 -1.183 . . . . 73.3 107.807 174.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -92.14 -29.22 16.62 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.579 0.752 . . . . 53.23 112.652 -172.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.9 t -140.78 173.17 11.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.003 1.721 . . . . 72.34 110.04 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.09 -176.15 45.29 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 122.976 1.32 . . . . 45.22 112.311 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.59 -32.09 73.6 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.056 -0.673 . . . . 71.21 110.572 172.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.72 7.36 39.97 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.725 -0.609 . . . . 75.53 112.391 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.6 104.99 0.21 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.252 2.221 . . . . 71.52 111.584 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.96 -158.84 29.0 Favored Glycine 0 N--CA 1.451 -0.312 0 O-C-N 121.656 -0.652 . . . . 61.31 112.444 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.6 p -115.85 120.48 39.37 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.481 1.912 . . . . 72.43 107.327 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.451 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 67.1 m-85 -135.67 148.05 48.79 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.04 -0.726 . . . . 75.14 109.04 -174.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -111.86 146.2 38.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.068 -1.086 . . . . 72.41 108.068 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -55.6 144.79 25.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.91 0.884 . . . . 74.41 108.891 172.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -126.6 86.6 2.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.743 -1.947 . . . . 73.2 105.743 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.5 mttt . . . . . 0 C--O 1.249 1.048 0 C-N-CA 126.897 2.079 . . . . 74.3 111.759 179.05 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.581 0 N-CA-C 110.386 -1.086 . . . . 71.23 110.386 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -106.02 156.73 18.1 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.724 0.762 . . . . 71.43 109.49 170.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -92.1 106.81 18.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.285 -1.746 . . . . 74.22 106.285 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -120.78 161.15 21.97 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.684 1.193 . . . . 72.02 110.502 172.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.47 178.43 7.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.049 2.14 . . . . 73.2 109.966 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -67.07 135.36 53.52 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.633 -1.167 . . . . 73.21 110.359 161.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.89 129.73 38.48 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 126.143 1.777 . . . . 72.25 108.097 158.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -141.3 179.57 6.69 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 119.64 -0.824 . . . . 74.12 110.132 161.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -69.27 25.1 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.386 1.875 . . . . 74.32 112.65 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.63 -53.64 0.82 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 119.873 -1.767 . . . . 65.12 109.317 -171.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -65.65 -28.5 69.14 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.451 -1.262 . . . . 74.12 112.517 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.19 -18.64 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 121.366 1.894 . . . . 71.34 114.002 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.4 mm -62.89 121.19 11.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 O-C-N 121.375 -0.828 . . . . 74.04 110.247 -169.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.98 -174.05 26.93 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.085 1.802 . . . . 74.15 111.12 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -88.74 163.27 15.81 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.003 1.321 . . . . 73.24 109.513 171.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -150.22 133.85 16.65 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.925 -1.109 . . . . 73.14 111.116 -175.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 t -138.2 162.75 33.47 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.292 1.437 . . . . 73.2 109.596 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.455 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 8.9 t -126.73 -14.79 5.62 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.496 1.118 . . . . 70.34 112.234 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.3 170.53 30.37 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 107.159 -2.376 . . . . 72.24 107.159 -169.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.0 pt -138.76 34.87 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.493 1.117 . . . . 73.22 108.746 -161.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -148.79 -176.14 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.8 1.64 . . . . 74.4 109.908 -165.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 44.97 -99.84 0.02 OUTLIER Glycine 0 CA--C 1.525 0.702 0 C-N-CA 126.603 2.049 . . . . 73.22 113.18 158.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 m -134.83 115.98 14.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.424 -1.695 . . . . 72.22 106.424 165.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -127.34 168.55 14.64 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.679 0.752 . . . . 74.1 109.699 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -139.79 137.16 34.8 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.746 -1.576 . . . . 74.42 106.746 -164.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.32 143.3 50.18 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.214 1.406 . . . . 72.42 107.686 -172.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 mt -138.95 158.99 43.2 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.785 1.634 . . . . 74.12 107.823 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.6 p -150.56 157.08 42.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.765 0.826 . . . . 71.44 109.747 163.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -144.16 135.64 25.78 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.53 1.532 . . . . 74.01 107.798 174.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -110.53 150.56 28.74 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.295 1.038 . . . . 74.41 109.216 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -25.54 56.16 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.879 -0.513 . . . . 75.24 110.937 -174.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.6 -3.36 5.39 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.503 0.721 . . . . 72.03 111.12 -172.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.33 -140.47 6.64 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 126.085 1.803 . . . . 74.22 110.272 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 74.7 p -122.89 158.68 29.83 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.806 1.242 . . . . 75.01 109.17 -176.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.89 165.56 43.89 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 109.889 -1.285 . . . . 74.22 109.889 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.16 161.54 37.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.393 -0.595 . . . . 72.21 109.393 173.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -140.56 150.17 43.32 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.086 -1.079 . . . . 72.21 108.086 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.81 155.69 26.39 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.069 -1.212 . . . . 70.41 110.069 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.5 mt -125.66 136.88 59.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.508 -2.034 . . . . 72.31 105.508 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -119.9 155.45 32.68 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.837 1.255 . . . . 74.11 108.278 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.05 130.93 56.45 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.254 -1.758 . . . . 71.33 106.254 162.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 44.85 -81.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 128.369 2.668 . . . . 72.34 114.653 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.01 54.25 1.37 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.928 1.691 . . . . 72.32 110.433 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.2 m -155.15 124.11 3.05 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 125.604 1.562 . . . . 73.42 108.544 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.69 139.74 41.22 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.891 2.394 . . . . 73.13 109.999 171.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.9 mm -129.79 -16.66 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.208 1.403 . . . . 72.34 111.416 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.5 t -139.94 161.91 36.45 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.995 -1.691 . . . . 73.14 108.966 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -160.48 145.17 14.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 126.282 1.833 . . . . 75.15 107.983 -176.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.13 168.41 25.55 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 125.765 1.626 . . . . 64.35 107.512 167.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.7 mtm -133.03 138.07 46.68 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.921 -1.511 . . . . 75.31 106.921 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.25 137.16 20.52 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.732 1.213 . . . . 71.41 110.409 -173.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -82.05 166.26 19.91 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.533 -0.914 . . . . 75.04 108.533 169.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.05 168.34 27.32 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.904 0.882 . . . . 72.03 111.914 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -139.99 158.13 44.55 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.036 0.935 . . . . 71.45 111.434 162.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.5 mm -113.2 83.1 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.382 1.473 . . . . 73.33 108.1 171.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -116.77 24.29 11.36 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.395 1.878 . . . . 72.35 111.204 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -164.74 14.7 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.284 1.216 . . . . 64.25 114.284 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.8 21.28 74.95 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.287 -0.883 . . . . 71.05 111.27 -170.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -145.46 166.06 26.74 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 127.011 2.124 . . . . 71.43 107.994 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.8 mt -99.31 115.54 40.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.517 -1.66 . . . . 72.44 106.517 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -89.53 122.72 32.97 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.55 1.54 . . . . 74.15 107.912 172.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.8 mm -98.79 143.36 13.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.185 -1.413 . . . . 74.33 107.185 173.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -160.63 2.34 0.07 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.333 1.235 . . . . 72.05 114.333 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -153.75 112.49 3.68 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 104.388 -2.449 . . . . 73.01 104.388 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.779 ' CG1' ' H ' ' A' ' 70' ' ' LYS . 11.8 p -138.62 157.82 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.575 -1.268 . . . . 75.04 107.575 171.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.87 165.99 23.13 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 124.889 1.276 . . . . 75.03 108.465 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.09 -44.36 0.46 Allowed 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 125.334 -0.694 . . . . 74.43 111.684 -10.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.62 125.28 26.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.892 -1.522 . . . . 74.35 106.892 167.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.426 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 1.2 pt-20 -75.5 158.01 33.18 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 124.285 0.991 . . . . 73.31 108.678 168.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.779 ' H ' ' CG1' ' A' ' 65' ' ' VAL . 9.4 mmpt? -115.14 158.73 21.8 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.509 -1.369 . . . . 72.25 108.068 164.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.73 145.91 20.08 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.624 -1.25 . . . . 74.02 107.624 168.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.4 139.8 32.36 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.852 1.701 . . . . 74.42 109.611 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -153.28 173.37 15.67 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.992 1.317 . . . . 74.11 108.554 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -107.09 153.5 22.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.93 -1.137 . . . . 74.12 107.93 171.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.3 mt -124.04 116.07 22.21 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 125.943 1.697 . . . . 63.43 107.218 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.51 121.08 9.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.211 1.404 . . . . 70.21 109.188 166.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.0 168.63 21.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 125.211 1.404 . . . . 65.43 108.415 172.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.54 165.76 26.05 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.789 1.636 . . . . 74.05 111.04 163.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.2 tt -157.38 159.46 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.453 -1.314 . . . . 71.33 107.453 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 t -137.48 -2.57 1.97 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.726 1.21 . . . . 72.13 112.612 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.73 -152.38 20.08 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 107.664 -2.175 . . . . 71.2 107.664 -149.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.0 p -51.97 7.4 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 119.554 3.168 . . . . 72.34 119.554 -173.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.9 m -130.1 110.71 11.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.528 2.731 . . . . 73.23 108.059 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.09 128.32 35.42 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.946 -1.502 . . . . 74.32 106.946 170.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -117.78 82.87 1.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.61 0.764 . . . . 72.41 110.687 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.74 128.77 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.101 -1.074 . . . . 73.44 108.101 170.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -77.45 -42.99 33.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.661 1.184 . . . . 74.14 110.008 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.4 t -130.22 -173.77 3.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.205 1.002 . . . . 73.21 112.523 -170.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.7 -172.48 39.04 Favored Glycine 0 C--N 1.335 0.494 0 O-C-N 120.337 -1.477 . . . . 72.21 110.592 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.2 m -62.92 -28.24 69.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.849 -0.795 . . . . 64.14 109.814 158.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.59 -1.12 57.39 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.387 1.475 . . . . 74.02 112.131 -167.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.71 108.03 0.24 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.395 2.278 . . . . 72.12 109.34 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.6 -154.9 19.96 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 122.192 0.884 . . . . 73.2 112.692 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 t -140.44 97.83 3.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.759 -1.941 . . . . 61.1 105.759 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.455 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 52.0 m-85 -110.38 151.3 27.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.503 -1.295 . . . . 63.31 107.503 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -104.96 148.04 27.14 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.26 -1.385 . . . . 74.32 107.26 174.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -54.79 139.6 39.05 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 106.66 -1.607 . . . . 71.11 106.66 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -116.85 122.76 45.31 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 104.831 -2.285 . . . . 73.33 104.831 160.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.3 mttt . . . . . 0 C--O 1.249 1.05 0 C-N-CA 126.035 1.734 . . . . 74.2 111.187 168.645 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.887 0 N-CA-C 109.672 -1.371 . . . . 62.32 109.672 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -110.0 133.3 53.34 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.868 -1.16 . . . . 71.03 107.868 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -90.69 68.84 6.57 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.555 1.942 . . . . 73.04 107.568 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -61.0 144.52 53.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.876 -1.057 . . . . 75.32 111.149 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.6 172.39 12.67 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.263 1.03 . . . . 73.32 110.652 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.72 140.87 55.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 122.169 0.985 . . . . 62.35 110.036 167.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.6 tp -78.85 133.68 36.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.55 -1.278 . . . . 74.43 107.55 168.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -143.22 167.99 20.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.741 0.816 . . . . 54.41 109.032 173.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 t -75.95 43.16 0.27 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.573 1.549 . . . . 72.03 109.877 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.21 -50.83 0.14 Allowed 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 119.85 -1.781 . . . . 74.32 110.609 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -70.49 -29.98 66.65 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 119.092 -0.48 . . . . 73.25 111.251 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.1 tp -64.46 -26.16 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.344 0.974 . . . . 73.21 112.941 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mm -62.85 132.56 28.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.774 1.23 . . . . 75.33 110.242 -168.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.13 -178.8 17.09 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.796 1.665 . . . . 73.43 112.08 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -76.24 157.36 32.69 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.404 0.682 . . . . 71.33 110.323 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -143.33 110.38 5.66 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.544 -0.909 . . . . 62.44 108.544 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.9 t -115.02 151.62 33.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.759 0.824 . . . . 75.21 109.332 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 t -105.32 -17.31 14.49 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.864 0.866 . . . . 73.21 111.888 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.93 179.95 35.07 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.896 -1.682 . . . . 75.31 108.896 -174.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 pt -131.86 9.15 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 117.708 0.754 . . . . 75.44 112.819 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.9 163.65 12.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.358 0.981 . . . . 74.4 110.295 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.57 -90.23 0.02 OUTLIER Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.167 1.365 . . . . 62.43 114.956 155.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 m -134.07 123.41 24.44 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.15 1.975 . . . . 74.54 107.683 163.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -140.91 176.47 8.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.562 1.145 . . . . 74.11 109.385 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -143.23 140.78 30.84 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.943 1.297 . . . . 74.14 108.68 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.56 147.01 38.78 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 126.243 1.817 . . . . 74.32 108.621 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.59 168.2 19.69 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.121 0.969 . . . . 75.13 111.29 161.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 t -143.86 156.49 44.48 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.288 1.835 . . . . 75.54 108.845 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -146.12 111.91 5.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.508 2.723 . . . . 74.02 106.525 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.73 163.33 20.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.854 0.752 . . . . 73.32 109.308 166.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -88.87 -27.12 21.24 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.309 0.643 . . . . 75.34 112.095 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -130.98 12.94 5.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.631 1.172 . . . . 72.24 111.871 -172.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -126.92 -129.61 3.28 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 126.7 2.095 . . . . 74.42 108.989 -176.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 p -132.63 -166.6 1.77 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.244 1.818 . . . . 61.44 107.906 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -129.58 -175.26 13.97 Favored Glycine 0 CA--C 1.505 -0.552 0 O-C-N 119.823 -1.798 . . . . 74.11 112.058 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -144.84 154.38 42.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 118.281 -0.866 . . . . 72.13 110.057 -166.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -136.72 135.11 37.86 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.788 1.235 . . . . 74.24 109.493 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.39 158.01 24.74 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.573 -1.011 . . . . 51.41 110.573 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.8 mt -128.01 133.05 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 105.515 -2.031 . . . . 63.35 105.515 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -129.4 124.43 34.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.402 -0.962 . . . . 73.54 108.402 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.8 m -86.09 106.74 17.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.204 -2.147 . . . . 72.33 105.204 166.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 61.96 -75.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 127.371 2.268 . . . . 74.54 113.039 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.08 34.57 0.9 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.283 1.033 . . . . 72.44 112.495 172.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -137.59 118.44 10.58 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.498 1.919 . . . . 73.52 108.018 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.31 133.58 23.03 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.243 2.629 . . . . 74.34 111.125 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 mm -122.05 1.71 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 126.501 1.92 . . . . 71.52 111.046 -175.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.7 t -160.39 153.04 21.02 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 119.867 -1.771 . . . . 51.03 109.335 166.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -148.66 136.04 20.34 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.332 1.853 . . . . 73.52 109.302 172.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -158.57 163.22 37.22 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.746 1.618 . . . . 75.24 107.677 169.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.7 mtm -138.68 151.12 46.91 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.091 0.956 . . . . 74.42 108.808 170.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -159.0 155.09 26.88 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.949 0.9 . . . . 63.32 109.752 -176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -83.23 167.25 17.87 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.657 -0.497 . . . . 73.14 109.657 173.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.08 159.87 42.69 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.01 -1.107 . . . . 75.44 108.01 169.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -125.27 163.31 22.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.675 0.671 . . . . 75.14 109.826 162.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.6 mm -120.77 82.34 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.464 1.505 . . . . 74.05 106.956 174.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -117.45 24.11 11.33 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.795 1.238 . . . . 74.41 110.097 -172.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.71 14.56 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.434 1.894 . . . . 72.14 112.842 -164.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.78 10.02 53.95 Favored Glycine 0 CA--C 1.534 1.257 0 O-C-N 120.483 -1.385 . . . . 74.33 112.965 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.69 169.05 18.44 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 127.707 2.403 . . . . 74.35 106.739 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.8 mt -81.27 150.63 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 106.972 -1.492 . . . . 73.14 106.972 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -132.1 111.63 11.63 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.412 1.885 . . . . 75.24 108.501 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.0 mm -85.43 148.89 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.519 -1.289 . . . . 75.34 107.519 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -158.08 -5.51 0.09 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 116.132 1.901 . . . . 75.12 116.132 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -156.36 107.48 2.44 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 106.087 -1.82 . . . . 75.14 106.087 -164.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.884 ' CG1' ' H ' ' A' ' 70' ' ' LYS . 4.0 p -137.62 150.67 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 125.149 1.379 . . . . 75.12 110.741 -175.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.06 161.75 61.85 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.286 1.035 . . . . 75.52 108.388 167.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.48 -24.61 9.98 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 N-CA-C 114.493 0.92 . . . . 72.55 114.493 1.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -121.27 111.8 17.82 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.698 -0.852 . . . . 73.55 108.698 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.403 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 42.4 mt-10 -60.57 123.34 17.1 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 128.199 2.599 . . . . 75.45 109.057 -174.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.884 ' H ' ' CG1' ' A' ' 65' ' ' VAL . 3.6 mtpp -103.35 152.25 21.8 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.405 -0.961 . . . . 73.01 108.405 174.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.0 t -56.72 147.56 51.52 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.064 -0.717 . . . . 71.13 109.064 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.8 158.92 35.41 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.855 2.37 . . . . 72.21 112.272 170.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -172.44 168.58 5.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.791 2.436 . . . . 74.33 107.648 170.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -95.86 154.42 17.24 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.587 -0.894 . . . . 74.24 108.587 171.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.8 mt -131.93 134.36 45.57 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.956 1.302 . . . . 74.21 108.987 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -96.07 125.22 40.46 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.869 1.667 . . . . 64.44 108.716 -169.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 p -158.3 165.42 34.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.685 1.194 . . . . 73.14 109.723 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HZ1' ' CD ' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -125.19 160.27 29.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 124.376 1.071 . . . . 74.44 111.866 170.5 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 tt -144.99 151.98 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 124.996 1.318 . . . . 72.31 107.71 177.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.9 t -147.75 19.58 1.15 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.663 0.986 . . . . 74.42 113.663 161.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.11 -102.46 0.26 Allowed Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.634 -1.786 . . . . 73.22 108.634 173.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.1 p -87.61 -12.94 44.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.332 0.566 . . . . 72.21 112.298 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 m -89.26 126.69 35.61 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.137 -1.431 . . . . 62.24 107.137 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.7 tp -113.42 132.8 55.5 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.649 1.579 . . . . 75.35 108.342 160.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.5 93.76 4.0 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.938 2.095 . . . . 71.43 108.005 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.95 138.55 19.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.274 -1.38 . . . . 74.35 107.274 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.442 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 7.3 mt-10 -101.96 -31.49 10.65 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.737 -0.649 . . . . 74.24 112.289 178.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -145.9 171.24 15.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.405 1.002 . . . . 75.34 110.84 -175.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.77 174.02 38.07 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 108.924 -1.67 . . . . 52.24 108.924 -174.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.0 m -61.0 -22.02 64.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.295 -1.12 . . . . 75.01 112.011 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -84.11 -5.56 59.26 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.634 0.976 . . . . 74.44 113.634 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -46.52 108.81 0.15 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 127.22 2.208 . . . . 75.42 110.616 -170.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.03 -172.75 44.94 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 122.284 0.935 . . . . 54.32 113.277 -159.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.1 p -137.61 104.98 5.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.614 1.966 . . . . 71.11 107.287 -156.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -124.36 167.3 14.56 Favored 'General case' 0 C--O 1.239 0.545 0 O-C-N 120.929 -1.107 . . . . 75.14 112.368 -165.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -124.02 127.38 47.79 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 129.311 3.045 . . . . 74.44 107.894 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -57.57 135.13 56.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.122 1.369 . . . . 72.21 109.005 171.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -143.81 38.27 1.33 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.248 1.203 . . . . 75.32 114.248 176.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.582 0 N-CA-C 108.823 -0.806 . . . . 63.42 108.823 163.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 105.205 -2.146 . . . . 40.32 105.205 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -93.27 160.43 14.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.598 1.159 . . . . 64.340000000000003 109.838 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.8 p -91.17 167.7 12.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.559 0.618 . . . . 73.420000000000002 110.276 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.79 116.87 4.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.884 0.849 . . . . 63.399999999999999 109.663 160.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.1 tp -54.18 125.63 19.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.651 -1.24 . . . . 71.230000000000004 107.651 157.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -145.42 172.52 13.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.169 0.985 . . . . 74.530000000000001 110.07 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -1.06 0.69 Allowed 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 126.954 2.102 . . . . 53.329999999999998 115.331 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -122.95 -36.99 2.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 120.17 1.35 . . . . 71.519999999999996 112.66 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -73.94 -30.71 62.7 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.358 0.981 . . . . 53.210000000000001 112.884 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.0 tp -66.58 -22.9 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.62 1.1 . . . . 62.100000000000001 112.903 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.37 126.23 24.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.134 1.374 . . . . 70.109999999999999 110.905 -164.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 131.28 -172.74 20.65 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.783 2.135 . . . . 42.219999999999999 110.59 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -91.09 162.85 14.51 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.435 1.094 . . . . 75.409999999999997 111.567 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -148.84 122.44 9.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.506 0.722 . . . . 63.409999999999997 111.045 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 t -127.35 160.73 30.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.954 1.301 . . . . 75.299999999999997 112.474 -174.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.58 -66.17 0.94 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.566 1.946 . . . . 55.43 107.1 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.12 -179.44 48.0 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 129.37 3.366 . . . . 64.530000000000001 106.578 -170.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.1 pt -111.61 16.26 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 113.746 1.017 . . . . 64.549999999999997 113.746 -158.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -115.79 -178.82 3.48 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.682 1.193 . . . . 71.439999999999998 113.098 -166.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.33 -93.5 0.01 OUTLIER Glycine 0 C--N 1.34 0.79 0 C-N-CA 127.547 2.499 . . . . 73.230000000000004 114.976 157.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.3 m -140.76 92.86 2.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.865 -1.902 . . . . 72.409999999999997 105.865 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -100.17 168.44 9.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.214 1.007 . . . . 64.219999999999999 110.473 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -134.95 145.29 48.03 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.192 1.797 . . . . 54.119999999999997 106.817 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.427 HD13 ' H ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -133.57 146.07 50.66 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.869 0.868 . . . . 71.129999999999995 108.852 -177.393 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.427 ' H ' HD13 ' A' ' 26' ' ' LEU . 10.0 mt -134.71 158.77 43.26 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 125.041 1.336 . . . . 72.439999999999998 109.87 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t -144.12 155.53 43.98 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.843 2.057 . . . . 61.43 108.552 164.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -144.69 126.89 15.69 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 127.161 2.185 . . . . 64.120000000000005 107.611 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -101.59 159.45 15.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.959 1.704 . . . . 62.520000000000003 108.491 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.01 -38.02 28.2 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.823 -0.171 . . . . 74.519999999999996 110.634 -175.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -129.15 21.86 5.71 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.503 0.668 . . . . 71.109999999999999 110.815 -170.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.68 -112.85 1.6 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.745 1.64 . . . . 44.420000000000002 109.413 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 p -141.39 175.85 9.34 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.157 1.783 . . . . 73.200000000000003 109.555 -164.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -98.75 170.02 23.73 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.611 -0.995 . . . . 51.0 110.611 161.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.7 m -144.84 144.13 30.97 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.78 -0.835 . . . . 64.129999999999995 109.18 167.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -130.9 126.13 35.32 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.09 1.356 . . . . 73.310000000000002 107.69 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.69 159.07 17.36 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.047 0.832 . . . . 72.230000000000004 111.315 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 mt -136.99 136.01 47.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.347 -2.094 . . . . 63.340000000000003 105.347 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.42 167.24 14.1 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.015 1.326 . . . . 72.549999999999997 108.988 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.32 127.57 33.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.12 -1.437 . . . . 75.349999999999994 107.12 160.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 44.95 -73.07 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 131.446 3.898 . . . . 74.409999999999997 113.923 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.16 43.71 1.43 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.292 1.437 . . . . 42.310000000000002 112.55 175.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.7 m -144.51 135.61 12.47 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.809 1.243 . . . . 74.109999999999999 109.579 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.51 129.3 12.66 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.291 3.327 . . . . 73.519999999999996 111.17 168.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.3 mm -122.31 -22.48 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.903 0.881 . . . . 74.450000000000003 112.093 -173.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 t -130.54 170.2 14.56 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 120.545 -1.347 . . . . 74.25 109.048 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -159.6 144.33 15.23 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 127.765 2.426 . . . . 62.219999999999999 105.31 165.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -152.08 162.55 40.93 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.731 1.612 . . . . 72.310000000000002 106.707 162.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.9 mtm -130.0 162.84 27.78 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.84 -1.17 . . . . 73.129999999999995 107.84 167.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -157.15 145.79 19.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 123.877 0.736 . . . . 61.420000000000002 109.276 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.64 159.65 31.65 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.168 -1.419 . . . . 75.209999999999994 107.168 161.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -148.73 166.87 27.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 121.645 -0.659 . . . . 75.120000000000005 110.239 166.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -134.46 167.1 21.39 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.507 1.123 . . . . 72.299999999999997 108.571 167.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.8 mm -121.92 86.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.373 -1.714 . . . . 75.439999999999998 106.373 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.7 23.49 8.75 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.364 0.666 . . . . 71.129999999999995 110.105 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.73 14.04 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 114.68 1.363 . . . . 63.5 114.68 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.39 27.58 65.89 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 120.889 -1.132 . . . . 75.140000000000001 111.31 -168.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -139.39 161.31 37.77 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 127.209 2.204 . . . . 75.200000000000003 105.935 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mt -71.05 133.27 32.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 105.761 -1.94 . . . . 75.510000000000005 105.761 164.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -101.58 120.3 40.11 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.432 -1.692 . . . . 73.299999999999997 106.432 163.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.4 mm -105.31 137.49 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.308 -1.738 . . . . 44.32 106.308 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -160.6 1.31 0.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.424 0.898 . . . . 75.120000000000005 113.424 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -148.36 117.62 6.88 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 104.937 -2.246 . . . . 54.210000000000001 104.937 171.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.0 t -128.54 155.49 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 105.816 -1.92 . . . . 71.329999999999998 105.816 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.64 162.29 39.6 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.574 -0.898 . . . . 74.530000000000001 108.574 174.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.74 -21.75 15.37 Favored 'Cis proline' 0 CA--C 1.535 0.567 0 N-CA-C 113.872 0.681 . . . . 42.039999999999999 113.872 -8.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 93.57 6.96 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 104.942 -2.244 . . . . 61.530000000000001 104.942 174.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.16 140.76 58.91 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.091 0.956 . . . . 53.100000000000001 109.589 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -127.44 168.05 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.833 1.253 . . . . 75.129999999999995 110.094 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 t -55.64 148.04 37.45 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 123.844 0.715 . . . . 75.409999999999997 109.938 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.29 139.81 42.83 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.175 1.916 . . . . 75.530000000000001 111.261 169.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -152.36 174.11 14.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.919 1.287 . . . . 64.209999999999994 109.874 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -112.74 158.98 19.41 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.546 0.738 . . . . 74.400000000000006 109.439 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.8 mt -130.32 112.24 13.12 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.165 1.386 . . . . 75.530000000000001 109.679 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -62.55 122.06 14.86 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.876 1.27 . . . . 72.099999999999994 108.06 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 2.3 p -154.72 163.67 39.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.599 0.36 . . . . 41.229999999999997 110.738 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.466 ' HE2' ' CD ' ' A' ' 87' ' ' GLU . 9.7 mttm -126.74 158.42 36.54 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.055 0.942 . . . . 75.510000000000005 109.298 176.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.1 tt -151.54 154.15 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.144 -1.058 . . . . 72.510000000000005 108.144 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -141.44 -9.35 0.96 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.84 1.793 . . . . 75.230000000000004 115.84 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.82 -73.53 0.21 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.378 -1.889 . . . . 75.310000000000002 108.378 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 p -117.52 1.64 12.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.851 1.056 . . . . 72.340000000000003 113.851 -169.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.6 m -119.74 106.79 12.47 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.846 2.058 . . . . 54.020000000000003 110.469 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -75.07 128.32 35.27 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.639 -1.288 . . . . 74.439999999999998 108.333 164.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -117.25 95.09 4.82 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 119.039 -0.505 . . . . 64.099999999999994 110.681 164.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.445 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 66.1 t -86.11 132.5 31.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.038 0.835 . . . . 72.340000000000003 109.407 169.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.466 ' CD ' ' HE2' ' A' ' 78' ' ' LYS . 23.6 mt-10 -91.41 -31.71 15.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.923 0.889 . . . . 73.319999999999993 112.212 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 t -139.67 163.74 31.78 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.71 1.604 . . . . 71.420000000000002 110.556 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.58 -179.86 30.62 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 122.628 1.127 . . . . 44.0 112.662 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.1 m -58.08 -31.05 66.72 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.687 1.595 . . . . 54.229999999999997 112.52 173.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.42 ' HB3' HD11 ' A' ' 27' ' ' LEU . 1.8 mp0 -103.69 11.99 35.3 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.169 0.588 . . . . 63.310000000000002 109.887 -167.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.01 117.14 5.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.4 2.28 . . . . 71.430000000000007 110.591 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.12 -123.39 1.1 Allowed Glycine 0 C--O 1.237 0.324 0 C-N-CA 124.381 0.991 . . . . 74.430000000000007 111.6 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.4 t -145.0 142.41 29.77 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.152 1.781 . . . . 73.540000000000006 107.747 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -142.91 152.18 41.79 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.164 0.438 . . . . 75.430000000000007 111.762 167.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -91.4 147.89 22.71 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.476 -0.565 . . . . 52.100000000000001 109.476 167.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -58.55 147.53 31.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.995 0.918 . . . . 75.540000000000006 108.653 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 . . . . . 0 N--CA 1.467 0.383 0 C-N-CA 125.776 1.63 . . . . 72.329999999999998 109.0 179.591 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 105.64 -1.985 . . . . 65.0 105.64 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.416 ' CG ' ' HB3' ' A' ' 78' ' ' LYS . 94.2 m95 -101.14 163.25 12.37 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 124.604 1.162 . . . . 65.310000000000002 111.02 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.3 p -101.06 162.13 13.11 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.595 -0.521 . . . . 65.230000000000004 109.595 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.1 117.51 4.44 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.035 1.334 . . . . 72.439999999999998 110.551 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.0 tp -66.4 105.64 1.51 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.629 -1.249 . . . . 73.209999999999994 107.629 165.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.437 ' HA ' HG21 ' A' ' 55' ' ' ILE . 22.0 p30 -126.56 172.8 9.94 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.951 -1.022 . . . . 70.310000000000002 111.123 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.89 -5.68 22.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.901 2.48 . . . . 73.310000000000002 112.764 -169.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -109.81 -28.64 8.68 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.223 0.92 . . . . 73.0 110.352 171.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -66.43 -35.41 80.23 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.887 0.875 . . . . 74.040000000000006 112.71 -169.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.77 -15.24 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 113.133 0.79 . . . . 70.140000000000001 113.133 -173.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.8 mm -68.79 122.19 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.121 0.968 . . . . 74.040000000000006 111.218 -161.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.78 -168.91 24.35 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.624 1.583 . . . . 64.230000000000004 111.319 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 28' ' ' SER . 1.9 m-85 -88.66 159.95 17.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.463 1.105 . . . . 72.230000000000004 110.284 176.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.417 ' CZ3' ' HB2' ' A' ' 84' ' ' LEU . 85.2 m95 -142.36 125.94 16.84 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.435 1.494 . . . . 74.430000000000007 109.756 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.7 t -123.58 164.02 19.84 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.191 0.997 . . . . 74.099999999999994 112.394 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.419 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 3.2 t -129.43 -5.96 4.76 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.856 1.663 . . . . 50.140000000000001 112.967 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.23 176.01 14.7 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 108.099 -2.0 . . . . 73.420000000000002 108.099 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 pt -135.65 7.44 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.46 0.911 . . . . 71.129999999999995 113.46 -160.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.26 165.04 15.37 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.877 1.671 . . . . 74.129999999999995 110.109 -174.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.81 -84.47 0.02 OUTLIER Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.063 1.316 . . . . 73.239999999999995 113.167 169.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -148.25 95.42 2.46 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.212 1.405 . . . . 74.530000000000001 108.081 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -114.34 177.52 4.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.152 -0.967 . . . . 71.219999999999999 110.109 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -132.66 172.63 12.29 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.251 1.421 . . . . 72.439999999999998 107.369 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.04 136.3 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.802 -1.555 . . . . 74.230000000000004 106.802 173.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.1 mt -115.85 152.74 32.78 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.327 -0.99 . . . . 63.109999999999999 108.327 165.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.435 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 1.3 p -144.62 143.41 30.76 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.633 1.173 . . . . 61.200000000000003 108.554 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -138.89 124.66 19.71 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.012 0.925 . . . . 74.400000000000006 108.759 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.407 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -85.32 156.71 20.79 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.164 -1.421 . . . . 71.230000000000004 107.164 164.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -72.19 -47.83 47.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.868 0.842 . . . . 72.230000000000004 109.197 165.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.88 -1.45 24.17 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.87 2.068 . . . . 61.130000000000003 111.439 -161.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 30' ' ' ASP . . . -114.78 -122.35 3.62 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.297 -1.921 . . . . 70.109999999999999 108.297 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 p -133.0 -175.45 3.79 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.503 2.321 . . . . 74.140000000000001 107.741 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -107.12 164.27 13.17 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.123 -1.191 . . . . 70.040000000000006 110.123 164.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.97 147.59 35.43 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.659 1.184 . . . . 54.399999999999999 108.73 -175.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -134.88 140.64 45.95 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.373 -1.343 . . . . 65.510000000000005 107.373 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.15 160.42 25.83 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 111.264 -0.734 . . . . 74.200000000000003 111.264 164.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 52.0 mt -122.79 145.4 29.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 105.3 -2.111 . . . . 71.430000000000007 105.3 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -133.89 166.34 22.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.992 1.317 . . . . 71.120000000000005 109.014 -173.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.99 139.42 39.67 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.304 -0.998 . . . . 41.140000000000001 108.304 157.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 44.48 -75.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 130.358 3.463 . . . . 73.540000000000006 115.975 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.31 47.77 1.29 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.6 0.636 . . . . 61.329999999999998 112.069 167.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 m -144.06 132.67 11.11 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.459 1.504 . . . . 74.349999999999994 109.324 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.31 132.24 16.15 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.604 2.869 . . . . 74.319999999999993 110.333 165.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.48 -23.58 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.774 0.829 . . . . 65.319999999999993 111.835 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.4 t -141.44 162.76 34.69 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.065 -1.647 . . . . 72.25 109.864 169.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -160.74 137.56 8.88 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.348 2.259 . . . . 71.430000000000007 107.428 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -161.28 165.49 29.1 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.537 1.535 . . . . 72.510000000000005 107.661 168.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.3 mtm -134.31 163.33 29.87 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.897 -1.149 . . . . 64.439999999999998 107.897 170.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -163.09 146.88 10.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.8 0.84 . . . . 70.430000000000007 110.231 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.31 161.01 31.44 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.205 -1.035 . . . . 73.109999999999999 108.205 162.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -144.02 171.38 14.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.784 -0.573 . . . . 72.400000000000006 109.594 165.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -137.01 161.8 35.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.863 0.865 . . . . 74.340000000000003 109.718 167.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.437 HG21 ' HA ' ' A' ' 8' ' ' ASN . 40.0 mm -105.18 103.68 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.922 -1.51 . . . . 73.430000000000007 106.922 165.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -134.67 24.48 3.69 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.329 -0.857 . . . . 73.310000000000002 113.193 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -163.72 14.1 0.06 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.604 1.962 . . . . 74.400000000000006 116.053 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.33 18.21 57.79 Favored Glycine 0 CA--C 1.539 1.558 0 O-C-N 120.119 -1.613 . . . . 72.310000000000002 113.069 -168.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -134.12 -171.48 2.76 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.4 3.08 . . . . 65.329999999999998 107.208 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.17 113.49 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 121.242 1.837 . . . . 70.129999999999995 107.515 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -82.74 102.55 11.62 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.766 -1.198 . . . . 73.400000000000006 107.766 171.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 mm -81.32 137.57 21.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 105.898 -1.89 . . . . 74.439999999999998 105.898 168.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -151.15 -8.94 0.23 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.03 1.493 . . . . 71.299999999999997 115.03 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -144.77 112.71 6.36 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.361 -1.348 . . . . 73.329999999999998 107.361 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.2 t -122.47 154.28 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.776 1.63 . . . . 53.210000000000001 107.749 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.49 162.21 52.66 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.44 1.096 . . . . 73.420000000000002 108.393 172.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -83.75 -14.17 35.86 Favored 'Cis proline' 0 CA--C 1.536 0.624 0 N-CA-C 113.78 0.646 . . . . 64.140000000000001 113.78 -9.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.76 115.89 31.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 103.72 -2.696 . . . . 74.219999999999999 103.72 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -93.5 143.82 25.93 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.0 0.812 . . . . 70.420000000000002 109.571 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -132.81 172.4 12.62 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.276 1.43 . . . . 64.030000000000001 109.878 -171.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 t -54.41 146.36 33.3 Favored Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 123.61 0.569 . . . . 62.100000000000001 109.564 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.97 144.7 77.38 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.937 1.758 . . . . 53.200000000000003 109.799 165.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -154.92 164.44 38.87 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.998 0.919 . . . . 61.109999999999999 110.501 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.3 127.54 49.24 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.707 0.803 . . . . 74.340000000000003 109.333 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.28 112.68 24.34 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.452 1.501 . . . . 73.409999999999997 108.77 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.29 123.25 17.72 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.778 -1.193 . . . . 70.409999999999997 107.778 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.495 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 1.8 p -157.13 156.84 33.4 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.225 0.61 . . . . 74.019999999999996 110.458 175.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 4' ' ' TRP . 1.5 mppt? -129.57 156.25 44.5 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.802 1.241 . . . . 74.200000000000003 111.056 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.3 tt -151.25 146.54 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 122.491 0.316 . . . . 72.340000000000003 110.844 -171.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -149.31 43.51 0.94 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.303 1.841 . . . . 73.230000000000004 111.435 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.63 -89.74 1.63 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 110.385 -1.086 . . . . 72.010000000000005 110.385 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -20.26 24.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.099 -1.429 . . . . 72.209999999999994 114.823 -171.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -102.74 108.14 19.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 122.017 2.19 . . . . 63.0 111.278 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.417 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 33.0 tp -87.6 123.81 32.86 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.335 -1.478 . . . . 65.299999999999997 108.53 168.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -118.67 91.04 3.46 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.02 0.928 . . . . 74.219999999999999 109.931 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.495 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 22.2 t -86.1 130.94 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.934 -1.136 . . . . 72.030000000000001 107.934 173.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -85.39 -32.65 22.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.957 -0.544 . . . . 70.230000000000004 111.946 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.5 t -143.32 167.89 21.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.68 1.192 . . . . 63.409999999999997 110.774 -169.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.71 178.86 43.62 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-O 122.432 1.018 . . . . 62.140000000000001 112.624 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 m -51.87 -27.93 14.34 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.719 1.608 . . . . 70.530000000000001 112.65 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -101.16 10.89 40.37 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.209 0.818 . . . . 64.340000000000003 113.209 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.02 105.21 0.3 Allowed 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.375 -0.828 . . . . 42.329999999999998 110.084 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.84 -136.71 2.48 Favored Glycine 0 CA--C 1.519 0.302 0 O-C-N 121.169 -0.957 . . . . 70.230000000000004 112.57 -172.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.2 t -153.29 116.77 4.67 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.33 1.052 . . . . 62.420000000000002 109.367 -171.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.419 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 88.4 m-85 -139.78 152.44 46.59 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 121.466 -0.771 . . . . 71.319999999999993 110.561 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -116.74 146.28 42.91 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 118.647 -0.692 . . . . 62.200000000000003 110.393 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -54.7 148.15 13.28 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.932 -1.136 . . . . 61.240000000000002 107.932 173.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 106.407 -1.701 . . . . 70.129999999999995 106.407 166.573 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 . . . . . 0 CA--C 1.517 -0.31 0 N-CA-C 108.25 -1.019 . . . . 72.540000000000006 108.25 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -118.03 147.84 42.83 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.462 0.305 . . . . 74.230000000000004 111.775 -170.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.8 p -83.39 171.05 13.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.465 0.706 . . . . 62.219999999999999 110.3 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -56.88 123.38 14.86 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.303 -0.862 . . . . 71.329999999999998 109.768 155.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.24 134.01 53.93 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 124.879 1.272 . . . . 72.310000000000002 110.524 157.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -140.48 174.74 10.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.468 -0.938 . . . . 64.430000000000007 108.468 163.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -69.31 40.99 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.8 1.64 . . . . 74.340000000000003 110.289 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -134.26 -59.61 0.82 Allowed 'General case' 0 N--CA 1.466 0.374 0 O-C-N 118.269 -2.77 . . . . 61.450000000000003 108.212 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -73.2 -26.27 61.09 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.572 0.749 . . . . 63.539999999999999 111.47 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.04 -20.02 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 119.459 1.027 . . . . 71.439999999999998 112.506 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.2 mm -68.66 144.41 14.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 121.23 -0.918 . . . . 73.510000000000005 109.521 -169.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.23 -153.82 17.36 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 124.944 1.259 . . . . 64.150000000000006 110.296 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -120.79 154.16 36.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.279 1.431 . . . . 73.549999999999997 109.494 -168.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 84' ' ' LEU . 97.2 m95 -152.13 117.1 5.17 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.006 0.922 . . . . 74.450000000000003 109.593 -161.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.2 t -122.81 166.76 14.46 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.21 1.368 . . . . 70.450000000000003 112.024 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -125.19 2.75 7.88 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.661 1.584 . . . . 72.549999999999997 111.829 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.08 -177.37 36.57 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 120.503 1.501 . . . . 61.32 111.667 176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.6 pt -128.78 5.31 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.391 1.476 . . . . 75.129999999999995 111.387 -175.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -147.15 -173.23 4.19 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.52 1.528 . . . . 71.109999999999999 110.237 -164.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 48.48 -104.19 0.08 OUTLIER Glycine 0 C--N 1.339 0.734 0 C-N-CA 126.25 1.881 . . . . 24.43 111.763 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -138.39 97.66 3.42 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.593 -1.632 . . . . 74.340000000000003 106.593 172.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -111.78 177.76 4.54 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.77 0.828 . . . . 72.510000000000005 110.712 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -154.57 155.76 35.35 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.005 0.922 . . . . 74.409999999999997 108.934 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.01 131.0 36.58 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.846 1.659 . . . . 63.240000000000002 108.298 -168.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.609 HD22 ' CZ ' ' A' ' 29' ' ' PHE . 3.9 mt -115.38 153.68 30.59 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.769 1.628 . . . . 73.129999999999995 108.895 170.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 p -147.19 153.39 39.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.31 -0.996 . . . . 74.420000000000002 108.31 167.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.609 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 68.4 m-85 -144.63 141.97 29.77 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.948 1.299 . . . . 73.310000000000002 108.85 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -110.69 158.93 18.07 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.272 1.429 . . . . 71.340000000000003 108.147 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.84 -29.42 40.14 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.909 -0.316 . . . . 71.430000000000007 111.683 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.36 10.59 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.108 1.363 . . . . 74.420000000000002 110.139 -164.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.33 -124.02 2.82 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 125.017 1.294 . . . . 73.430000000000007 110.127 -169.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -140.31 167.14 22.85 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.822 -1.177 . . . . 71.129999999999995 107.822 168.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -93.36 176.25 36.83 Favored Glycine 0 CA--C 1.523 0.551 0 O-C-N 121.53 -0.732 . . . . 70.5 112.057 170.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.85 161.65 33.62 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.108 0.963 . . . . 63.240000000000002 109.828 171.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -141.99 151.06 42.15 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.274 -1.01 . . . . 70.420000000000002 108.274 168.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.77 161.76 32.53 Favored Glycine 0 CA--C 1.525 0.662 0 O-C-N 121.524 -0.735 . . . . 63.109999999999999 111.621 163.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.5 mt -124.83 149.58 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 127.047 2.139 . . . . 73.510000000000005 105.356 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -134.0 164.78 26.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.271 1.428 . . . . 74.209999999999994 110.149 -170.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.2 m -133.9 120.42 20.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.977 2.111 . . . . 54.409999999999997 106.006 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.254 0.9 OUTLIER 45.02 -81.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 130.016 3.326 . . . . 70.299999999999997 114.582 -173.093 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.67 43.54 1.73 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.786 1.635 . . . . 74.099999999999994 109.335 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.3 m -137.4 129.22 16.55 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.059 1.744 . . . . 64.400000000000006 107.635 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.37 136.92 32.52 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.747 2.298 . . . . 72.019999999999996 109.435 168.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.6 mm -120.56 -22.23 3.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 118.658 -0.687 . . . . 63.520000000000003 111.279 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.3 p -139.02 169.81 17.11 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.884 1.22 . . . . 52.020000000000003 110.782 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -159.15 153.27 23.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.827 -1.079 . . . . 63.109999999999999 108.307 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -166.61 161.49 15.93 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 105.649 -1.982 . . . . 74.430000000000007 105.649 165.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.8 mtm -122.57 159.01 28.68 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.389 -1.708 . . . . 74.239999999999995 106.389 160.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.18 141.01 17.13 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 123.991 0.807 . . . . 71.310000000000002 109.503 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -78.7 156.48 28.92 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 123.079 1.419 . . . . 72.329999999999998 108.391 166.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -151.84 169.05 23.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.171 -1.377 . . . . 61.119999999999997 110.021 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -141.44 163.17 33.65 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.113 0.965 . . . . 65.129999999999995 109.475 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.6 mm -120.05 89.33 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.791 -1.559 . . . . 64.540000000000006 106.791 170.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -123.42 25.81 8.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.598 1.159 . . . . 72.310000000000002 110.529 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -164.41 14.35 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.785 1.234 . . . . 65.230000000000004 112.604 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 26.69 69.86 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 120.451 -0.88 . . . . 72.310000000000002 111.219 -172.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -151.22 164.47 36.5 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.466 3.106 . . . . 65.230000000000004 106.817 -168.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.9 mt -100.27 109.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.404 -1.702 . . . . 63.420000000000002 106.404 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -80.9 106.17 12.7 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.065 -1.457 . . . . 65.209999999999994 107.065 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.1 mm -85.54 140.21 16.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.968 -1.493 . . . . 53.210000000000001 106.968 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -156.52 -2.69 0.12 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 115.868 1.803 . . . . 72.140000000000001 115.868 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -148.03 120.99 8.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 103.618 -2.734 . . . . 71.319999999999993 103.618 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.8 t -133.47 154.09 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 125.314 1.446 . . . . 61.229999999999997 107.436 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.94 163.54 37.48 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.651 1.181 . . . . 72.430000000000007 109.055 172.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.24 -21.39 13.66 Favored 'Cis proline' 0 C--N 1.345 0.374 0 N-CA-C 113.968 0.719 . . . . 62.240000000000002 113.968 -7.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -100.78 101.05 11.81 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.329 -2.1 . . . . 71.439999999999998 105.329 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -61.64 139.08 58.33 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.775 1.23 . . . . 73.319999999999993 110.417 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 9.0 mmpt? -114.56 158.42 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.072 1.749 . . . . 70.299999999999997 109.095 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -65.04 148.87 97.52 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.657 -0.868 . . . . 74.329999999999998 108.657 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.63 145.58 52.52 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.567 2.178 . . . . 74.230000000000004 112.478 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -156.15 167.88 29.05 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.887 1.275 . . . . 72.519999999999996 110.307 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -106.51 130.55 54.27 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.917 -1.142 . . . . 74.109999999999999 107.917 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.0 mt -106.39 132.64 52.18 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 125.956 1.702 . . . . 70.099999999999994 109.103 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.65 128.12 34.79 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.672 1.189 . . . . 70.340000000000003 110.694 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 p -150.29 164.98 34.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.499 1.519 . . . . 62.43 109.47 169.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -127.8 164.1 22.92 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.906 2.082 . . . . 54.310000000000002 112.239 159.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.8 tt -155.3 160.24 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.556 -1.275 . . . . 71.310000000000002 107.556 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.6 m -128.38 -66.1 0.86 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.493 2.317 . . . . 55.409999999999997 109.914 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.68 -83.76 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 106.998 -2.441 . . . . 73.329999999999998 106.998 170.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 p -95.08 -8.5 36.4 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.082 1.882 . . . . 72.549999999999997 116.082 -167.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.2 m -101.63 98.86 9.1 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 121.342 1.883 . . . . 73.510000000000005 109.34 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.429 ' HB2' ' CE3' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -76.03 119.11 19.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.005 -1.85 . . . . 72.450000000000003 106.005 165.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -108.05 88.88 2.83 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.618 -0.882 . . . . 64.239999999999995 108.618 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 t -80.23 128.32 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.858 -1.164 . . . . 63.549999999999997 107.858 169.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.65 -46.58 16.92 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.4 -0.81 . . . . 73.25 112.078 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 t -126.12 -172.85 2.71 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.575 1.08 . . . . 64.140000000000001 111.584 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.8 177.98 51.91 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.99 -1.244 . . . . 30.34 109.99 -171.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.5 m -60.49 -19.22 56.13 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.659 -0.906 . . . . 65.329999999999998 111.803 164.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -89.78 0.63 56.89 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.299 0.64 . . . . 65.549999999999997 112.371 -170.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.96 108.45 0.4 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.083 2.153 . . . . 70.530000000000001 110.261 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.79 -150.12 6.52 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 121.833 0.685 . . . . 72.530000000000001 112.583 -167.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 t -144.86 125.76 14.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.852 -1.907 . . . . 74.140000000000001 105.852 165.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -122.9 124.65 43.7 Favored 'General case' 0 C--O 1.226 -0.168 0 O-C-N 121.641 -0.662 . . . . 74.450000000000003 110.606 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -88.09 18.17 4.48 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.335 1.606 . . . . 75.25 115.335 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 26.3 tttt 62.43 156.03 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 127.172 2.189 . . . . 72.120000000000005 110.677 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 127.059 2.144 . . . . 71.450000000000003 106.8 -175.409 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 . . . . . 0 C--O 1.237 0.403 0 N-CA-C 107.494 -1.298 . . . . 72.150000000000006 107.494 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -108.29 161.26 15.17 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.906 2.082 . . . . 74.340000000000003 109.989 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.4 p -90.4 167.65 12.46 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.569 0.622 . . . . 63.43 109.896 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -51.63 125.18 14.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.132 0.968 . . . . 72.049999999999997 108.77 159.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.4 tp -67.66 118.99 11.67 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.29 -1.374 . . . . 63.310000000000002 107.29 161.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -119.45 162.78 18.27 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 105.273 -2.121 . . . . 60.329999999999998 105.273 168.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -61.12 -44.91 96.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.16 -1.052 . . . . 53.25 108.16 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -53.83 -21.81 8.34 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.781 1.632 . . . . 75.540000000000006 113.918 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -90.27 -29.78 17.94 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.283 0.947 . . . . 73.239999999999995 113.085 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.2 tp -87.66 -10.92 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.24 1.016 . . . . 64.519999999999996 111.923 -168.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mm -60.31 135.56 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.303 1.041 . . . . 61.149999999999999 111.523 -175.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.1 175.59 14.14 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.31 1.91 . . . . 35.340000000000003 110.847 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -78.17 159.09 28.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.972 -0.751 . . . . 73.209999999999994 108.972 164.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -149.59 146.15 27.17 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.588 1.155 . . . . 74.319999999999993 109.261 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.8 p -134.96 175.4 9.61 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.247 1.385 . . . . 73.230000000000004 112.851 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.2 t -133.8 12.94 4.03 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.451 1.1 . . . . 73.420000000000002 113.217 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.03 176.97 14.86 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.839 -1.704 . . . . 52.100000000000001 108.839 -175.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.0 pt -130.88 15.24 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.857 0.863 . . . . 65.219999999999999 112.612 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -108.91 165.1 11.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.118 1.367 . . . . 73.329999999999998 111.456 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.0 -101.35 0.72 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.561 -1.016 . . . . 53.210000000000001 110.561 162.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.3 m -141.7 117.3 10.31 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.455 -2.054 . . . . 73.219999999999999 105.455 162.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -114.99 179.23 4.01 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.689 1.595 . . . . 74.230000000000004 109.295 -176.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -142.81 139.85 31.1 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.165 1.386 . . . . 74.439999999999998 108.918 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.0 144.6 48.44 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.82 1.648 . . . . 50.219999999999999 108.306 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.556 HD22 ' CZ ' ' A' ' 29' ' ' PHE . 7.9 mt -124.76 155.62 39.03 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.358 1.863 . . . . 74.510000000000005 109.261 175.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.7 t -143.78 152.23 40.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.31 1.444 . . . . 72.430000000000007 107.735 163.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.556 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 61.4 m-85 -149.13 127.68 12.34 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 127.128 2.171 . . . . 74.120000000000005 107.002 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.54 163.32 12.55 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.576 0.75 . . . . 71.109999999999999 111.386 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.37 -30.19 37.88 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.982 0.734 . . . . 60.549999999999997 112.982 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.75 2.26 3.14 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.271 0.357 . . . . 72.209999999999994 110.975 -172.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.11 -129.41 5.68 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.678 1.609 . . . . 71.340000000000003 109.827 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.8 p -138.71 -175.42 4.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.328 2.251 . . . . 74.5 106.175 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.67 -177.81 22.4 Favored Glycine 0 C--O 1.238 0.385 0 N-CA-C 109.862 -1.295 . . . . 62.539999999999999 109.862 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.7 p -159.77 152.16 21.03 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.797 1.036 . . . . 42.409999999999997 113.797 -163.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -129.55 112.82 14.11 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.364 1.866 . . . . 71.030000000000001 107.299 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.17 109.21 0.95 Allowed Glycine 0 C--N 1.341 0.857 0 C-N-CA 124.376 0.988 . . . . 54.520000000000003 112.053 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.6 mt -76.61 143.06 13.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.463 1.105 . . . . 65.030000000000001 108.239 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -131.73 125.12 31.21 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.031 1.333 . . . . 71.219999999999999 109.301 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -88.31 112.69 23.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.597 -1.261 . . . . 41.399999999999999 107.597 166.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 53.06 -78.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.995 2.518 . . . . 72.129999999999995 112.342 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.94 21.09 2.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.423 1.889 . . . . 54.43 112.492 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 m -116.76 118.02 37.08 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.393 1.477 . . . . 53.130000000000003 107.675 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.61 125.69 14.81 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.576 2.184 . . . . 73.109999999999999 108.702 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.4 mm -117.24 -3.9 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.672 0.789 . . . . 74.129999999999995 110.907 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.4 t -152.17 163.7 38.84 Favored 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 120.169 -1.582 . . . . 62.340000000000003 108.998 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -157.7 144.92 18.3 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.022 1.729 . . . . 75.5 106.939 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -167.77 153.59 7.39 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 105.629 -1.989 . . . . 71.209999999999994 105.629 165.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 mtm -132.32 153.9 50.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.564 1.146 . . . . 73.540000000000006 108.83 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -163.2 154.37 16.97 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.747 0.819 . . . . 71.450000000000003 109.527 -174.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.92 169.09 16.42 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.143 2.177 . . . . 75.120000000000005 109.601 172.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.68 162.02 36.55 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.258 1.023 . . . . 63.310000000000002 110.261 171.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -134.11 131.31 38.58 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.49 -1.3 . . . . 72.219999999999999 107.49 160.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.48 107.66 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 105.597 -2.001 . . . . 73.420000000000002 105.597 163.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -152.66 45.9 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.463 0.705 . . . . 61.329999999999998 109.137 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.95 14.49 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.811 2.444 . . . . 73.140000000000001 111.966 162.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.94 25.24 71.93 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.393 -1.442 . . . . 65.120000000000005 110.822 -160.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -140.05 158.75 43.57 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 126.724 2.009 . . . . 71.129999999999995 106.512 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.08 138.77 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.168 -1.79 . . . . 73.25 106.168 172.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -117.49 115.96 26.19 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.81 2.044 . . . . 72.109999999999999 107.111 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.4 mm -97.71 143.05 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.979 -1.489 . . . . 74.230000000000004 106.979 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -159.36 -2.62 0.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.067 1.506 . . . . 73.140000000000001 115.067 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -148.42 125.19 11.18 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.084 -2.562 . . . . 73.420000000000002 104.084 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.2 t -132.14 152.33 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 125.212 1.405 . . . . 63.119999999999997 107.787 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.4 151.94 48.7 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 125.833 1.653 . . . . 75.099999999999994 106.678 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.52 -6.74 50.3 Favored 'Cis proline' 0 CA--C 1.534 0.513 0 CA-C-N 119.378 0.814 . . . . 61.009999999999998 113.983 4.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.28 108.61 18.77 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.791 -1.929 . . . . 73.209999999999994 105.791 172.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.63 127.97 34.28 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.097 1.359 . . . . 74.230000000000004 108.142 169.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -125.16 160.38 29.27 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.635 0.774 . . . . 65.239999999999995 110.078 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -56.89 147.05 55.89 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.051 0.941 . . . . 63.149999999999999 109.437 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.93 147.19 89.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.979 1.786 . . . . 70.310000000000002 111.07 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -157.56 151.41 24.24 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.269 1.828 . . . . 53.109999999999999 108.17 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -81.22 160.23 24.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.637 -1.165 . . . . 72.25 107.931 165.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.83 127.28 38.3 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.467 1.107 . . . . 73.010000000000005 108.711 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.22 115.2 20.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.621 -1.622 . . . . 70.150000000000006 106.621 175.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -146.1 151.7 38.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.717 1.207 . . . . 63.420000000000002 107.773 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -117.8 157.99 25.58 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.253 1.021 . . . . 73.319999999999993 109.373 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 tt -151.65 151.78 11.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 118.689 -0.672 . . . . 64.049999999999997 109.537 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.4 m -141.68 -6.98 0.99 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.339 1.607 . . . . 73.120000000000005 115.339 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.23 -82.35 0.17 Allowed Glycine 0 N--CA 1.461 0.308 0 O-C-N 120.363 -1.46 . . . . 63.310000000000002 109.552 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.5 p -104.32 -13.54 16.1 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.534 -0.746 . . . . 44.32 112.057 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 m -90.01 101.63 14.34 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.45 1.477 . . . . 61.299999999999997 109.784 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 tp -81.58 138.94 35.32 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.419 -1.326 . . . . 72.430000000000007 107.419 159.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -127.66 144.43 51.08 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.617 -0.883 . . . . 74.129999999999995 108.617 163.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 t -127.99 127.21 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.793 -1.558 . . . . 73.120000000000005 106.793 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -96.45 -20.84 18.12 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.436 0.902 . . . . 70.019999999999996 113.436 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -155.48 172.89 17.49 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.62 1.568 . . . . 70.239999999999995 108.655 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.92 177.93 49.11 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-O 122.285 0.936 . . . . 63.200000000000003 111.383 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 t -60.84 -26.99 67.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.24 -0.565 . . . . 74.219999999999999 111.724 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.81 6.26 49.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.397 -0.811 . . . . 64.239999999999995 113.042 -172.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -46.4 101.61 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.926 1.691 . . . . 74.219999999999999 110.651 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.95 -174.14 39.88 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.067 0.841 . . . . 70.030000000000001 112.382 -158.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.7 p -140.43 100.75 3.95 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.551 1.541 . . . . 71.329999999999998 107.716 -169.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -115.78 150.94 36.1 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.721 0.408 . . . . 73.420000000000002 110.629 -169.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -120.59 16.87 12.05 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.331 1.234 . . . . 53.119999999999997 114.331 -167.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.5 tttt 68.16 142.42 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 129.891 3.277 . . . . 71.239999999999995 111.629 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 . . . . . 0 C--O 1.235 0.321 0 C-N-CA 127.708 2.403 . . . . 72.430000000000007 107.581 -179.958 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 105.683 -1.969 . . . . 72.239999999999995 105.683 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -135.5 156.5 48.8 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 128.34 2.656 . . . . 72.549999999999997 108.077 -171.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -76.81 168.5 19.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.132 0.492 . . . . 62.149999999999999 111.304 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -55.45 143.95 27.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.993 1.317 . . . . 74.519999999999996 109.055 164.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.3 tp -83.73 121.96 27.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.244 -1.391 . . . . 73.530000000000001 107.244 164.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -131.17 172.7 11.82 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.363 1.065 . . . . 75.109999999999999 109.762 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' HD11 ' A' ' 13' ' ' ILE . 0.5 OUTLIER -64.24 -10.36 23.05 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.92 -1.038 . . . . 74.420000000000002 113.103 173.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -107.42 -31.61 8.09 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 121.094 1.77 . . . . 75.120000000000005 113.073 -168.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -86.18 -27.76 24.34 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.008 -0.996 . . . . 34.32 112.452 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 tp -65.76 -27.7 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.791 1.632 . . . . 75.109999999999999 111.534 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 9' ' ' SER . 14.6 mm -54.09 121.79 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 C-N-CA 125.854 1.661 . . . . 60.049999999999997 110.744 -169.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.95 176.31 14.42 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 123.964 0.792 . . . . 72.439999999999998 111.255 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.45 157.94 24.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.706 0.803 . . . . 75.209999999999994 109.433 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -147.02 143.68 28.57 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.87 0.868 . . . . 73.150000000000006 109.346 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.8 t -140.01 166.0 25.82 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.53 0.732 . . . . 62.530000000000001 110.82 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.49 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 14.2 t -119.34 -6.51 10.32 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.952 2.101 . . . . 73.549999999999997 111.393 176.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.66 175.8 43.37 Favored Glycine 0 C--N 1.337 0.593 0 O-C-N 120.503 -1.373 . . . . 55.420000000000002 110.978 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.7 pt -133.47 15.02 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.169 1.387 . . . . 74.129999999999995 110.046 -173.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -148.94 -175.8 5.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.145 1.778 . . . . 73.409999999999997 109.703 -165.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.69 -99.9 0.04 OUTLIER Glycine 0 C--N 1.337 0.592 0 C-N-CA 126.789 2.138 . . . . 63.329999999999998 112.823 165.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.9 m -148.14 129.24 14.55 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 104.364 -2.458 . . . . 74.219999999999999 104.364 167.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -143.47 -174.78 4.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.373 1.069 . . . . 55.329999999999998 109.342 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -136.39 164.67 27.58 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.284 1.434 . . . . 75.109999999999999 109.549 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.33 133.06 23.83 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.243 1.417 . . . . 72.329999999999998 108.63 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 mt -121.07 160.41 23.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.953 0.901 . . . . 74.340000000000003 109.86 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 t -137.12 154.12 50.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.041 1.736 . . . . 62.450000000000003 106.631 159.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -145.03 130.26 18.58 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.566 1.546 . . . . 74.010000000000005 108.24 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.87 152.18 23.59 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.507 1.123 . . . . 64.349999999999994 109.822 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.82 -37.46 73.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.91 1.284 . . . . 73.25 110.516 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.67 21.26 4.65 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.31 1.044 . . . . 64.049999999999997 110.753 -171.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -130.36 -129.08 3.06 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.482 1.039 . . . . 71.230000000000004 110.599 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 p -124.19 -175.05 3.14 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.421 1.888 . . . . 73.109999999999999 108.442 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.79 167.13 13.04 Favored Glycine 0 C--O 1.237 0.322 0 N-CA-C 109.252 -1.539 . . . . 73.319999999999993 109.252 162.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.04 153.24 49.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.701 0.801 . . . . 74.010000000000005 108.859 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -137.73 121.54 17.58 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.127 1.371 . . . . 54.399999999999999 107.761 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.61 162.53 19.83 Favored Glycine 0 C--N 1.331 0.297 0 N-CA-C 110.293 -1.123 . . . . 74.230000000000004 110.293 174.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.0 mt -127.15 143.36 40.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.962 -1.866 . . . . 73.310000000000002 105.962 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -136.01 124.65 23.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.417 1.087 . . . . 75.430000000000007 108.687 -166.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.2 m -84.69 124.27 31.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.837 -1.542 . . . . 55.210000000000001 106.837 166.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 44.64 -78.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 129.059 2.943 . . . . 71.230000000000004 115.127 176.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.2 68.03 1.09 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.64 1.576 . . . . 35.130000000000003 107.612 165.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.7 m -152.97 130.96 6.2 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 126.591 1.957 . . . . 62.310000000000002 107.089 170.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.01 135.85 26.12 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.563 2.842 . . . . 75.120000000000005 110.509 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.7 mm -130.89 -21.25 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.007 0.923 . . . . 74.310000000000002 111.729 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.1 m -142.01 155.58 45.43 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 120.551 -1.343 . . . . 71.329999999999998 109.105 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -155.98 143.27 19.22 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.751 1.22 . . . . 64.409999999999997 109.629 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -159.75 159.59 32.97 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.1 1.76 . . . . 42.43 106.94 166.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.9 mtm -133.5 148.46 51.69 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.564 -1.643 . . . . 71.329999999999998 106.564 172.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -158.5 142.52 15.56 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.474 -0.565 . . . . 63.409999999999997 109.474 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.47 157.16 30.61 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.591 -1.263 . . . . 72.150000000000006 107.591 170.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -151.08 164.53 36.26 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.629 -0.67 . . . . 74.310000000000002 109.953 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -132.1 158.3 41.96 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.614 1.166 . . . . 73.349999999999994 108.235 164.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.9 mm -113.63 87.11 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.552 -2.018 . . . . 73.230000000000004 105.552 166.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -126.25 23.04 7.08 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 122.424 1.107 . . . . 73.329999999999998 110.759 -170.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.76 14.28 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.317 1.847 . . . . 74.140000000000001 113.606 -170.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.61 15.55 61.99 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 121.368 -0.833 . . . . 54.130000000000003 111.338 -172.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -145.43 162.05 38.24 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 128.847 2.859 . . . . 74.420000000000002 105.893 -170.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 mt -91.27 109.46 21.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.612 -1.625 . . . . 63.549999999999997 106.612 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -78.86 104.78 9.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.77 -1.567 . . . . 75.540000000000006 106.77 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.0 mm -88.89 131.39 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.152 -2.166 . . . . 64.120000000000005 105.152 170.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -154.74 -1.14 0.17 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 115.93 1.826 . . . . 75.420000000000002 115.93 -175.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -148.86 123.5 9.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.761 -1.94 . . . . 72.219999999999999 105.761 162.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.5 t -129.14 141.45 46.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 125.823 1.649 . . . . 71.140000000000001 107.827 -174.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.41 164.06 46.68 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.327 1.051 . . . . 74.329999999999998 108.246 173.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.23 -19.76 15.33 Favored 'Cis proline' 0 N--CA 1.454 -0.84 0 CA-C-N 119.285 0.78 . . . . 63.32 111.98 -14.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -98.27 102.21 13.89 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.912 -1.514 . . . . 64.540000000000006 106.912 -176.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -88.41 131.8 34.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.022 -0.99 . . . . 71.530000000000001 110.493 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -127.39 174.7 8.78 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.676 1.19 . . . . 74.400000000000006 110.382 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 t -61.02 154.89 58.05 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.152 1.381 . . . . 71.430000000000007 111.625 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.51 147.3 57.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.359 2.706 . . . . 71.129999999999995 112.593 171.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -161.01 164.59 30.85 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.648 1.179 . . . . 74.519999999999996 110.441 171.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -91.68 148.54 22.18 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.956 -0.757 . . . . 74.140000000000001 108.956 169.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -124.39 137.43 54.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.178 1.791 . . . . 74.430000000000007 108.474 175.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -98.71 133.22 43.34 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.766 -0.827 . . . . 61.240000000000002 108.766 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.469 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 2.1 p -151.68 165.64 33.73 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.091 1.356 . . . . 65.129999999999995 109.433 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.44 161.18 19.48 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.404 -0.591 . . . . 65.420000000000002 109.404 160.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.432 HG12 ' H ' ' A' ' 81' ' ' GLY . 16.4 tt -137.47 146.94 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.462 -1.31 . . . . 73.420000000000002 107.462 174.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.3 p -111.7 -10.74 14.05 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.579 0.751 . . . . 64.519999999999996 112.037 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 79' ' ' ILE . . . 125.69 -63.09 0.59 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 107.452 -2.259 . . . . 51.119999999999997 107.452 -169.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 p -112.55 -15.57 13.02 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.575 -1.202 . . . . 73.310000000000002 114.155 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.1 m -104.45 137.0 42.96 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.599 1.545 . . . . 74.519999999999996 107.878 168.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.526 HD22 HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -98.76 143.4 29.14 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.898 -1.519 . . . . 74.510000000000005 106.898 161.677 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -133.07 85.65 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.154 -1.054 . . . . 73.329999999999998 108.154 170.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.526 HG23 HD22 ' A' ' 84' ' ' LEU . 44.4 t -75.65 124.75 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.3 -0.63 . . . . 73.340000000000003 109.3 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -92.94 -24.95 18.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.147 0.979 . . . . 65.230000000000004 112.547 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.0 t -152.52 160.86 43.2 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.013 0.824 . . . . 70.329999999999998 110.285 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.26 176.17 19.39 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.956 1.741 . . . . 65.239999999999995 111.134 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.1 m -55.62 -26.98 47.07 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.619 0.768 . . . . 53.350000000000001 111.548 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -101.89 11.79 38.02 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.022 0.929 . . . . 71.129999999999995 113.046 -174.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.6 108.73 0.37 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.207 1.403 . . . . 52.229999999999997 110.929 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.59 -169.8 41.51 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 122.113 0.841 . . . . 70.209999999999994 113.03 -169.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -118.65 126.29 51.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.929 2.092 . . . . 65.450000000000003 107.473 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.49 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 23.9 m-85 -140.07 159.33 42.42 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.789 0.328 . . . . 73.120000000000005 110.499 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -120.57 149.55 42.27 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.487 1.115 . . . . 72.430000000000007 109.154 170.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -61.17 143.19 55.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.99 -1.115 . . . . 64.25 107.99 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 105.685 -1.969 . . . . 74.120000000000005 105.685 175.128 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 CA--C 1.512 -0.51 0 N-CA-C 107.36 -1.348 . . . . 75.099999999999994 107.36 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -87.57 147.79 25.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.187 -1.824 . . . . 75.040000000000006 109.936 -174.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.22 167.59 17.58 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.884 0.874 . . . . 71.310000000000002 110.528 168.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -55.58 136.26 50.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.882 1.325 . . . . 73.239999999999995 109.65 157.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.7 tp -66.96 139.24 57.69 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.363 -1.347 . . . . 73.420000000000002 107.363 154.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -140.11 170.42 15.88 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.713 -1.588 . . . . 63.229999999999997 106.713 163.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 p -44.25 -60.62 1.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.248 2.619 . . . . 74.049999999999997 109.809 171.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -71.69 -17.24 62.24 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.259 -1.337 . . . . 73.430000000000007 110.245 -170.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -82.64 -37.16 25.3 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 117.763 -1.113 . . . . 73.120000000000005 110.596 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 tp -74.98 -15.87 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 121.381 1.901 . . . . 63.329999999999998 113.363 -170.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mm -56.35 136.32 19.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.448 1.099 . . . . 62.130000000000003 110.762 -173.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 131.45 -175.08 19.79 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.777 1.18 . . . . 74.219999999999999 112.727 170.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.54 146.08 25.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.093 1.757 . . . . 71.409999999999997 108.612 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -140.3 111.61 7.19 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.789 0.836 . . . . 75.099999999999994 110.221 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -118.18 143.59 46.39 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.257 1.023 . . . . 61.420000000000002 108.971 -175.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 25' ' ' LYS . 10.4 t -82.35 -43.99 16.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.251 0.621 . . . . 73.030000000000001 109.419 174.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.5 172.8 44.7 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.74 1.638 . . . . 32.310000000000002 110.335 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.9 pt -115.94 45.37 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 122.924 1.345 . . . . 64.209999999999994 109.854 -164.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -131.06 178.81 6.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.251 1.42 . . . . 52.520000000000003 111.619 -156.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.79 -24.34 18.63 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 127.228 2.347 . . . . 22.02 115.597 -163.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.2 m -150.2 119.94 7.05 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.596 -1.631 . . . . 63.100000000000001 106.596 170.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -146.41 -178.95 6.43 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.043 0.838 . . . . 72.200000000000003 110.918 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.411 ' H ' HG22 ' A' ' 18' ' ' THR . 96.5 mttt -143.26 146.08 33.31 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.289 1.436 . . . . 73.439999999999998 108.39 -171.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.31 135.02 45.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.698 -1.223 . . . . 72.129999999999995 107.698 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 mt -123.13 155.75 36.38 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.201 1.401 . . . . 60.439999999999998 108.275 172.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.9 p -146.85 152.42 38.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.695 0.798 . . . . 52.340000000000003 109.567 167.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.62 119.84 12.19 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.602 -1.629 . . . . 75.040000000000006 106.602 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -84.94 169.51 13.98 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.694 -0.854 . . . . 64.150000000000006 108.694 169.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -93.58 -25.61 17.47 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.599 1.16 . . . . 62.539999999999999 112.92 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.09 32.09 1.24 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.416 1.086 . . . . 75.510000000000005 108.714 -174.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.19 -112.57 1.1 Allowed Glycine 0 C--N 1.339 0.698 0 N-CA-C 109.02 -1.632 . . . . 64.140000000000001 109.02 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.4 p -139.92 -165.66 1.93 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.735 1.214 . . . . 74.209999999999994 109.346 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.09 171.18 14.77 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.423 1.011 . . . . 55.229999999999997 110.852 166.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.53 148.94 35.08 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.907 -0.775 . . . . 62.020000000000003 108.907 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -138.83 124.25 19.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.472 1.109 . . . . 71.340000000000003 108.572 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.62 165.49 21.46 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.808 -0.917 . . . . 71.200000000000003 110.808 175.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -124.49 148.49 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 104.862 -2.273 . . . . 52.5 104.862 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -141.84 165.1 28.41 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.449 1.1 . . . . 74.319999999999993 108.716 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.3 m -136.24 112.69 9.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.91 2.084 . . . . 75.439999999999998 107.866 171.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 54.13 -78.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 127.51 2.324 . . . . 71.430000000000007 114.374 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.21 47.97 1.49 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.202 1.801 . . . . 75.329999999999998 110.457 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.2 m -154.83 137.66 10.3 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.024 1.73 . . . . 64.109999999999999 108.669 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.68 142.21 22.72 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 124.057 3.172 . . . . 71.409999999999997 110.593 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.6 mm -130.69 -7.48 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 126.028 1.731 . . . . 55.240000000000002 110.843 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.9 t -153.7 164.76 37.76 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 119.721 -1.862 . . . . 72.409999999999997 109.117 163.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -157.31 123.07 4.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.71 2.404 . . . . 71.409999999999997 106.837 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -139.0 164.22 30.33 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.381 1.472 . . . . 64.129999999999995 107.152 164.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mtm -135.87 156.28 49.02 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.967 1.307 . . . . 72.25 107.673 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -159.39 151.94 21.44 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.575 0.75 . . . . 75.030000000000001 110.27 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -82.4 166.85 19.05 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.349 -0.612 . . . . 75.25 109.349 166.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -148.23 160.9 42.48 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.238 0.615 . . . . 74.439999999999998 111.787 172.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -131.39 154.99 48.06 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.215 -1.402 . . . . 64.450000000000003 107.215 164.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.3 mm -104.16 107.72 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 106.018 -1.845 . . . . 74.329999999999998 106.018 164.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.75 24.62 2.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.946 1.461 . . . . 73.349999999999994 114.946 171.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.88 14.66 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.631 1.573 . . . . 73.049999999999997 114.835 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.43 11.84 84.02 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 120.114 -1.616 . . . . 74.049999999999997 115.12 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -121.37 -165.73 1.27 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.292 1.837 . . . . 74.450000000000003 107.765 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.6 mt -114.84 110.18 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.753 1.615 . . . . 55.149999999999999 107.179 172.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -76.88 103.17 6.67 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 107.363 -1.347 . . . . 75.25 107.363 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.5 mm -90.49 140.12 16.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 105.697 -1.964 . . . . 74.010000000000005 105.697 170.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -158.31 -5.01 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 115.131 1.53 . . . . 74.450000000000003 115.131 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -144.87 112.75 6.34 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.224 -2.88 . . . . 62.130000000000003 103.224 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.1 t -132.29 152.69 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.949 -1.501 . . . . 71.109999999999999 106.949 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.83 162.11 34.73 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.482 1.513 . . . . 75.439999999999998 107.18 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.84 -26.47 9.61 Favored 'Cis proline' 0 N--CA 1.459 -0.536 0 CA-C-N 119.833 0.976 . . . . 53.549999999999997 112.396 -9.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -87.16 107.7 18.58 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 104.789 -2.3 . . . . 50.109999999999999 104.789 167.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -70.74 159.66 34.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.954 0.407 . . . . 74.349999999999994 110.479 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.93 153.7 48.26 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.828 1.251 . . . . 73.140000000000001 108.778 171.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.4 t -50.89 151.13 4.64 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.559 1.944 . . . . 71.120000000000005 111.643 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.03 154.05 67.08 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.521 2.147 . . . . 74.129999999999995 113.335 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -168.45 166.04 12.38 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.142 1.377 . . . . 74.230000000000004 109.847 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -103.08 111.33 23.64 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.492 -1.299 . . . . 70.120000000000005 107.492 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.1 mt -77.61 113.99 16.0 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.956 0.903 . . . . 70.409999999999997 108.866 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.44 116.29 4.96 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.119 1.768 . . . . 70.230000000000004 108.697 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 9.5 p -151.13 158.77 44.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.658 -0.651 . . . . 74.439999999999998 112.637 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 163.0 16.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.316 -0.856 . . . . 71.319999999999993 110.972 174.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 tt -141.31 149.98 20.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.518 1.127 . . . . 72.329999999999998 108.425 170.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.6 p -129.02 -6.67 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.354 1.242 . . . . 74.420000000000002 114.354 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.6 -71.51 0.37 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.304 -1.519 . . . . 73.010000000000005 109.304 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.1 p -121.4 4.12 10.23 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.537 -0.745 . . . . 73.439999999999998 112.987 175.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.9 m -107.6 133.31 52.23 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.282 -1.377 . . . . 52.530000000000001 107.282 170.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.1 tp -108.6 130.57 55.31 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.258 2.223 . . . . 74.109999999999999 107.299 166.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -125.69 99.71 6.11 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.009 1.324 . . . . 75.099999999999994 110.009 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.8 t -93.61 131.81 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.854 -0.795 . . . . 73.019999999999996 108.854 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -87.56 -23.42 24.35 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.844 1.258 . . . . 75.420000000000002 113.329 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -153.12 166.39 32.63 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.129 -0.982 . . . . 64.040000000000006 109.849 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.67 175.44 36.92 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.709 -0.956 . . . . 54.420000000000002 110.709 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.1 m -60.05 -21.61 61.63 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.253 1.021 . . . . 75.219999999999999 112.016 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -101.85 6.34 41.45 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.914 1.686 . . . . 64.439999999999998 112.776 -172.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.65 110.66 0.83 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.509 1.924 . . . . 55.109999999999999 109.337 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.52 -136.31 2.64 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 123.451 0.548 . . . . 73.010000000000005 112.527 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.5 t -154.92 113.45 3.54 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.289 -1.745 . . . . 64.200000000000003 106.289 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -133.07 152.76 51.93 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.165 -0.959 . . . . 74.420000000000002 109.446 -168.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -118.98 141.42 48.68 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.282 1.033 . . . . 75.099999999999994 108.331 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -58.37 134.74 56.88 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.263 -1.384 . . . . 74.340000000000003 107.263 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 . . . . . 0 C--N 1.326 -0.439 0 N-CA-C 107.741 -1.207 . . . . 73.299999999999997 107.741 175.651 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 . . . . . 0 N--CA 1.441 -0.88 0 N-CA-C 105.198 -2.149 . . . . 72.519999999999996 105.198 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -111.15 166.49 11.03 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.263 -1.79 . . . . 74.519999999999996 110.625 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -84.65 163.93 18.95 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.055 -0.72 . . . . 53.109999999999999 109.055 168.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -51.71 124.33 12.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.109 0.957 . . . . 70.120000000000005 109.283 153.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.17 134.3 55.76 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.529 0.681 . . . . 45.119999999999997 109.538 157.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -139.02 169.14 18.34 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.624 -1.621 . . . . 71.319999999999993 106.624 163.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -49.85 -57.19 7.9 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.944 0.498 . . . . 72.420000000000002 109.687 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -64.34 -17.33 63.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.843 0.683 . . . . 61.140000000000001 112.843 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -78.87 -44.39 22.94 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.854 0.861 . . . . 71.219999999999999 110.496 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.9 tp -74.96 -24.56 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 O-C-N 120.329 -1.482 . . . . 70.420000000000002 112.225 -170.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 mm -47.88 125.46 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.573 1.949 . . . . 53.409999999999997 112.53 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.17 -178.57 18.87 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.11 0.862 . . . . 65.25 112.828 168.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -72.78 147.89 45.1 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 125.675 1.59 . . . . 73.549999999999997 110.534 171.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.493 ' CH2' ' HE3' ' A' ' 97' ' ' LYS . 93.7 m95 -137.76 117.84 13.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.257 1.423 . . . . 74.310000000000002 108.669 176.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t -116.61 174.2 6.21 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.785 1.234 . . . . 71.310000000000002 110.038 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -142.98 1.31 1.26 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.315 1.446 . . . . 72.510000000000005 111.363 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.49 176.91 14.6 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 126.477 1.989 . . . . 74.239999999999995 108.465 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.75 11.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 113.123 0.786 . . . . 65.340000000000003 113.123 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -113.06 -171.35 1.85 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 125.426 1.49 . . . . 73.439999999999998 110.184 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 48.43 -90.42 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 126.495 1.998 . . . . 70.230000000000004 114.51 153.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.8 m -144.93 100.48 3.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.734 -1.95 . . . . 70.120000000000005 105.734 169.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -115.44 171.68 7.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.15 -0.685 . . . . 65.420000000000002 109.15 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HE2' HG23 ' A' ' 39' ' ' ILE . 82.7 mttt -146.46 151.84 38.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.145 -1.798 . . . . 65.310000000000002 106.145 -175.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.67 146.83 50.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.815 -1.921 . . . . 61.25 105.815 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.03 159.97 35.98 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.479 -0.934 . . . . 63.509999999999998 108.479 161.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.2 p -133.36 154.55 50.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.498 0.719 . . . . 53.32 109.772 164.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -139.69 125.09 19.07 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.428 -2.064 . . . . 64.409999999999997 105.428 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -109.99 161.4 15.55 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.138 -1.43 . . . . 51.420000000000002 107.138 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -97.13 -21.04 17.56 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.586 -0.696 . . . . 71.239999999999995 112.518 -168.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -124.41 -5.78 7.67 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 122.853 0.461 . . . . 74.5 111.835 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.96 -120.38 4.36 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.01 1.767 . . . . 43.100000000000001 109.819 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.3 p -148.27 175.37 11.13 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 128.481 2.712 . . . . 73.430000000000007 106.535 -172.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.86 -166.87 23.33 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 119.392 0.996 . . . . 72.230000000000004 112.32 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 m -148.8 164.9 33.07 Favored 'General case' 0 CA--C 1.521 -0.144 0 O-C-N 121.214 -1.168 . . . . 71.510000000000005 109.674 168.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -143.15 125.33 15.44 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.488 -1.301 . . . . 70.209999999999994 107.488 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.14 159.04 20.49 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.064 -0.815 . . . . 72.530000000000001 111.064 170.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.5 HG23 ' HE2' ' A' ' 25' ' ' LYS . 69.6 mt -133.31 140.61 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 105.843 -1.91 . . . . 64.209999999999994 105.843 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -132.02 157.11 44.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.161 0.985 . . . . 71.549999999999997 110.022 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -125.86 116.88 22.24 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.19 2.196 . . . . 53.32 106.172 167.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 48.75 -76.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 129.182 2.993 . . . . 71.019999999999996 114.169 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.21 29.61 2.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.775 1.63 . . . . 72.129999999999995 112.969 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.0 m -137.22 130.46 17.28 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 124.911 1.284 . . . . 71.120000000000005 109.541 -174.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.38 133.63 21.22 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.997 3.132 . . . . 70.409999999999997 110.857 170.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.4 mm -128.44 -3.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 125.899 1.68 . . . . 70.219999999999999 111.275 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 t -145.63 171.28 14.94 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 119.277 -2.139 . . . . 65.129999999999995 107.837 165.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -166.37 140.89 4.32 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.729 1.612 . . . . 73.409999999999997 107.54 168.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -157.82 162.29 38.41 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.668 1.587 . . . . 64.450000000000003 107.074 169.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.6 mtm -130.44 155.42 46.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.237 -1.394 . . . . 74.329999999999998 107.237 166.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -163.35 156.22 18.67 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.206 1.002 . . . . 74.109999999999999 109.486 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -91.89 167.66 11.97 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.599 0.76 . . . . 72.219999999999999 109.385 170.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -135.97 164.71 27.36 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.642 1.177 . . . . 52.329999999999998 110.185 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -130.1 126.38 37.44 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.649 -1.611 . . . . 74.5 106.649 160.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mm -92.88 94.58 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 104.643 -2.354 . . . . 73.239999999999995 104.643 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -135.54 22.99 3.41 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.78 0.8 . . . . 72.319999999999993 112.237 -168.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -170.43 13.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.696 1.199 . . . . 44.100000000000001 112.696 171.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.17 13.4 82.94 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 121.6 -0.688 . . . . 72.230000000000004 112.33 -169.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -130.87 166.5 20.76 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.33 2.252 . . . . 74.239999999999995 106.828 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.6 mt -105.32 104.38 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.694 -1.595 . . . . 74.519999999999996 106.694 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -84.44 123.1 29.86 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.079 1.352 . . . . 74.129999999999995 107.865 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.6 mm -99.64 150.95 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.873 1.669 . . . . 74.430000000000007 107.82 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -160.97 -17.51 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 116.36 1.985 . . . . 73.530000000000001 116.36 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -135.66 109.4 8.07 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 105.318 -2.104 . . . . 71.140000000000001 105.318 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.74 149.99 25.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.975 1.71 . . . . 45.140000000000001 107.54 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.4 160.8 65.42 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.357 1.063 . . . . 72.239999999999995 108.203 173.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.46 -11.02 42.51 Favored 'Cis proline' 0 C--N 1.345 0.362 0 N-CA-C 114.222 0.816 . . . . 71.120000000000005 114.222 -2.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -108.14 109.39 20.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.053 -2.203 . . . . 74.25 105.053 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.38 145.61 55.5 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.387 0.429 . . . . 65.439999999999998 110.106 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -129.66 164.34 24.13 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.675 1.19 . . . . 72.120000000000005 110.554 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -62.25 149.76 86.34 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.713 0.805 . . . . 70.510000000000005 109.944 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.99 147.37 49.05 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.188 2.592 . . . . 62.109999999999999 111.618 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -162.06 157.03 22.87 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.277 2.231 . . . . 65.099999999999994 110.2 174.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -94.74 119.5 33.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.001 0.921 . . . . 72.140000000000001 109.085 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -91.12 138.75 31.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.573 1.149 . . . . 63.140000000000001 109.815 171.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -81.88 123.2 28.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.694 -1.225 . . . . 72.120000000000005 107.694 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.6 p -148.49 168.54 22.43 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.41 0.684 . . . . 61.530000000000001 109.515 165.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.69 163.7 25.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.825 1.65 . . . . 72.340000000000003 112.604 159.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 tt -145.66 160.14 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.477 1.511 . . . . 52.130000000000003 107.058 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.2 t -126.71 -35.57 2.31 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.32 3.048 . . . . 53.119999999999997 109.413 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.79 -52.72 0.09 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 127.31 2.386 . . . . 72.329999999999998 110.177 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.7 p -138.73 7.75 2.54 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.565 1.32 . . . . 44.409999999999997 114.565 -158.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.1 m -131.25 105.41 7.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 129.26 3.024 . . . . 65.219999999999999 107.712 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.474 HD22 HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -77.48 121.41 23.81 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.701 -1.963 . . . . 71.230000000000004 105.701 173.369 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 ttmm -101.87 86.62 2.94 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.87 -1.159 . . . . 65.129999999999995 107.87 165.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.474 HG23 HD22 ' A' ' 84' ' ' LEU . 22.9 t -79.17 129.95 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.307 -1.368 . . . . 73.099999999999994 107.307 167.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -96.77 -30.57 13.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.956 0.902 . . . . 51.100000000000001 112.053 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -150.99 173.43 14.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.297 1.039 . . . . 71.109999999999999 110.291 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.48 -178.69 25.36 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 109.849 -1.3 . . . . 52.200000000000003 109.849 -172.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 t -64.23 -25.12 67.92 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 122.119 -0.636 . . . . 71.530000000000001 110.718 172.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -101.44 10.26 40.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.241 1.417 . . . . 63.219999999999999 112.22 -168.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.45 0.28 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 127.001 2.121 . . . . 74.140000000000001 112.122 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 -162.94 31.1 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 121.616 -0.677 . . . . 23.32 112.578 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.4 p -119.23 106.25 12.16 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.582 1.553 . . . . 72.340000000000003 107.978 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -120.81 130.8 54.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.849 0.75 . . . . 64.510000000000005 111.44 -168.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -81.39 127.96 33.33 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.971 0.908 . . . . 73.420000000000002 108.91 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HE3' ' CH2' ' A' ' 16' ' ' TRP . 31.2 ttmt -60.94 135.29 57.74 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.917 -1.142 . . . . 65.510000000000005 107.917 165.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 122.283 1.04 . . . . 74.109999999999999 109.117 177.533 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 . . . . . 0 CA--C 1.515 -0.391 0 CA-C-O 121.923 0.868 . . . . 72.0 109.194 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -85.1 157.76 20.6 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.832 1.653 . . . . 73.109999999999999 111.045 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.14 176.29 8.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.705 0.802 . . . . 63.039999999999999 111.574 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -56.73 134.14 54.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.947 0.899 . . . . 74.109999999999999 109.772 156.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 tp -74.45 138.21 43.12 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.331 -1.359 . . . . 74.299999999999997 107.331 159.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -143.45 163.67 32.45 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.352 -1.721 . . . . 73.400000000000006 106.352 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.12 -51.33 54.58 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.746 0.654 . . . . 73.430000000000007 109.502 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -71.34 -16.22 62.43 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 117.933 -1.032 . . . . 73.219999999999999 113.36 -170.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -80.14 -41.87 24.57 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.456 1.025 . . . . 71.140000000000001 109.678 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.45 41.58 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.77 0.828 . . . . 73.530000000000001 110.568 -176.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.3 mm -112.21 125.5 69.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 O-C-N 119.939 -1.726 . . . . 73.329999999999998 108.48 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.46 179.69 16.47 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.651 1.119 . . . . 75.400000000000006 111.883 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -79.95 164.82 23.2 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.912 1.285 . . . . 72.219999999999999 109.474 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -142.35 145.65 34.14 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.176 0.99 . . . . 63.420000000000002 110.462 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.6 t -134.09 165.27 25.44 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.448 -1.407 . . . . 64.209999999999994 110.237 164.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.426 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 12.0 t -112.68 -12.21 13.43 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.587 1.555 . . . . 62.399999999999999 111.556 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.27 178.05 23.09 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 107.931 -2.068 . . . . 75.310000000000002 107.931 -166.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.3 pt -134.43 22.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.526 1.13 . . . . 61.399999999999999 110.827 -167.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 154.72 49.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.398 1.479 . . . . 72.010000000000005 107.238 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.49 -160.04 10.89 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.12 -0.491 . . . . 75.239999999999995 112.561 -172.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.8 m -79.95 88.59 5.32 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.678 1.191 . . . . 53.229999999999997 108.906 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -96.34 172.05 8.2 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 122.367 1.079 . . . . 71.030000000000001 110.843 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -141.15 118.26 11.27 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.184 -1.413 . . . . 74.319999999999993 107.184 -151.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.94 106.62 14.93 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.777 2.031 . . . . 55.130000000000003 109.226 -173.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 mt -90.81 158.26 16.92 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.509 1.124 . . . . 74.010000000000005 108.751 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.1 t -143.2 163.18 33.64 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.822 -0.807 . . . . 61.310000000000002 108.822 155.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -149.01 128.51 13.09 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.126 1.77 . . . . 75.230000000000004 109.34 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -104.38 144.77 31.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.084 1.354 . . . . 54.140000000000001 109.626 171.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.71 -27.41 63.96 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.37 1.068 . . . . 64.510000000000005 112.014 -174.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -128.15 0.7 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 129.248 3.019 . . . . 51.020000000000003 110.93 -164.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.94 -116.61 2.17 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 125.229 1.395 . . . . 43.109999999999999 110.047 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.3 p -140.23 177.75 7.77 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.352 2.261 . . . . 73.439999999999998 107.188 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -103.96 176.72 23.95 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 124.07 0.843 . . . . 73.530000000000001 111.183 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -140.86 158.67 43.62 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.448 1.499 . . . . 60.109999999999999 108.813 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -141.56 120.08 12.43 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.195 1.398 . . . . 75.219999999999999 107.267 164.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.83 114.48 1.42 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.891 1.71 . . . . 75.310000000000002 110.103 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.402 ' H ' ' HB3' ' A' ' 47' ' ' SER . 8.0 mt -78.27 140.59 16.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.46 -1.311 . . . . 64.0 107.46 171.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -124.96 154.51 41.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.943 -1.503 . . . . 54.399999999999999 106.943 170.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.401 ' HB2' HG13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -126.63 118.11 24.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.286 -1.375 . . . . 75.109999999999999 107.286 174.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m120 68.63 -64.68 0.3 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 126.421 1.888 . . . . 71.430000000000007 113.675 162.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -158.06 49.75 0.4 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.048 1.295 . . . . 43.210000000000001 110.937 158.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 m -150.85 134.69 9.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.149 1.38 . . . . 71.140000000000001 109.109 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.19 131.19 21.49 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.12 2.547 . . . . 73.400000000000006 110.541 168.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 41' ' ' SER . 10.7 mm -126.85 4.7 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.024 0.93 . . . . 74.0 110.816 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.402 ' HB3' ' H ' ' A' ' 39' ' ' ILE . 7.9 t -152.48 172.84 15.92 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 119.883 -1.761 . . . . 75.239999999999995 109.922 166.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -174.74 118.15 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.665 1.986 . . . . 75.019999999999996 108.113 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -142.48 158.04 44.11 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.281 1.432 . . . . 61.210000000000001 107.694 165.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.8 mtm -134.03 150.19 51.21 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.138 -1.43 . . . . 74.420000000000002 107.138 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.5 151.38 20.55 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 122.892 0.477 . . . . 75.319999999999993 110.985 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.76 167.21 22.22 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.838 -0.801 . . . . 63.140000000000001 108.838 166.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -146.79 166.86 25.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.677 0.791 . . . . 75.099999999999994 109.878 167.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -133.54 155.77 49.0 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.442 -1.688 . . . . 73.349999999999994 106.442 161.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.0 mm -114.02 98.56 7.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.844 -1.91 . . . . 63.299999999999997 105.844 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -130.03 23.13 5.29 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.029 0.752 . . . . 72.329999999999998 113.029 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -170.01 14.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.09 1.356 . . . . 55.229999999999997 114.07 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.43 18.61 75.47 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.272 -0.892 . . . . 64.239999999999995 112.461 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -140.36 173.29 11.65 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 128.586 2.754 . . . . 75.340000000000003 105.963 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.0 mt -102.72 117.81 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.866 -1.161 . . . . 75.010000000000005 107.866 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -84.51 122.17 28.63 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.686 1.194 . . . . 64.150000000000006 108.154 170.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mm -109.95 132.88 57.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.92 1.688 . . . . 74.439999999999998 106.626 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -160.87 6.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.777 1.399 . . . . 75.430000000000007 114.777 -169.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -148.68 123.15 9.71 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.024 -2.584 . . . . 73.329999999999998 104.024 163.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.8 t -136.27 148.85 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.467 -1.308 . . . . 74.150000000000006 107.467 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.68 163.31 32.12 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 107.364 -1.347 . . . . 75.349999999999994 107.364 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.63 -11.21 31.97 Favored 'Cis proline' 0 CA--C 1.534 0.487 0 CA-C-N 118.713 0.576 . . . . 74.329999999999998 113.378 -2.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.38 132.58 36.1 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.296 -1.742 . . . . 52.240000000000002 106.296 167.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.41 135.75 38.85 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 118.755 0.707 . . . . 73.319999999999993 109.335 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -124.14 168.4 12.95 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 124.169 0.987 . . . . 74.349999999999994 110.744 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 t -47.84 143.42 6.22 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.83 2.052 . . . . 72.319999999999993 110.675 166.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 159.0 53.78 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.253 1.969 . . . . 74.439999999999998 110.963 172.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -168.13 177.15 5.66 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.5 1.52 . . . . 74.299999999999997 108.349 172.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -106.99 155.94 19.27 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.708 -0.849 . . . . 75.019999999999996 108.708 171.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.8 mt -123.56 129.54 51.34 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.161 1.784 . . . . 73.319999999999993 109.298 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.09 123.25 29.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.177 1.391 . . . . 73.209999999999994 109.522 174.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 p -148.84 168.38 23.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.582 1.953 . . . . 75.340000000000003 108.033 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.08 154.88 50.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.887 1.275 . . . . 73.409999999999997 108.482 169.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 tt -136.95 156.54 34.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.362 -1.347 . . . . 75.340000000000003 107.362 173.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.45 26.06 0.68 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.692 0.997 . . . . 74.420000000000002 113.692 166.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.47 -94.28 0.18 Allowed Glycine 0 C--O 1.228 -0.229 0 N-CA-C 107.849 -2.1 . . . . 74.109999999999999 107.849 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.273 36.1 p -105.88 1.27 26.63 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.397 -0.811 . . . . 71.310000000000002 112.539 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.6 m -98.13 135.71 39.4 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.926 1.239 . . . . 75.019999999999996 109.207 168.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.43 137.0 45.2 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.824 -1.547 . . . . 74.230000000000004 106.824 162.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -121.37 85.05 2.34 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.356 1.062 . . . . 73.099999999999994 108.688 169.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.8 t -76.77 125.88 36.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.132 -1.062 . . . . 75.219999999999999 108.132 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -80.49 -53.27 6.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.148 0.579 . . . . 73.099999999999994 110.977 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.4 t -128.85 176.35 7.92 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.391 0.996 . . . . 60.009999999999998 112.251 -168.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.18 -175.81 44.89 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 125.622 1.582 . . . . 72.439999999999998 110.819 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.59 -27.9 65.07 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.083 -0.657 . . . . 74.120000000000005 111.583 176.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -101.17 14.26 32.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.983 -0.532 . . . . 72.439999999999998 112.128 -170.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.47 111.09 0.58 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.756 1.222 . . . . 55.5 110.385 172.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.49 -169.35 42.31 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.545 0.593 . . . . 42.229999999999997 113.885 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.9 p -113.8 118.15 33.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.479 1.911 . . . . 74.219999999999999 108.179 -174.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.426 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 47.2 m-85 -127.77 167.45 16.49 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.79 0.723 . . . . 62.210000000000001 112.879 -171.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -125.75 128.94 48.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 129.809 3.244 . . . . 74.0 106.932 -175.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -61.78 152.0 32.56 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.889 -0.782 . . . . 75.439999999999998 108.889 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.566 0 C-N-CA 128.598 2.759 . . . . 60.399999999999999 109.621 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 . . . . . 0 C--O 1.236 0.377 0 CA-C-O 122.789 1.281 . . . . 71.049999999999997 109.145 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -76.11 152.34 36.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.082 -1.417 . . . . 73.540000000000006 110.925 -170.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 p -73.32 173.09 10.03 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.716 0.77 . . . . 61.149999999999999 110.635 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -49.6 133.63 20.67 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.238 -1.346 . . . . 72.049999999999997 109.676 160.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.9 tp -74.92 127.87 34.23 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.054 -1.461 . . . . 73.450000000000003 107.054 156.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -137.24 162.14 34.31 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.165 -1.42 . . . . 52.43 107.165 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -53.68 -48.46 69.47 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.775 1.23 . . . . 53.299999999999997 109.689 -176.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -26.36 61.88 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.748 1.619 . . . . 65.25 111.133 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -68.09 -37.36 81.13 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.949 0.795 . . . . 73.319999999999993 111.002 -174.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.26 -9.72 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.842 0.682 . . . . 74.519999999999996 112.842 -171.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.2 mm -61.65 124.76 16.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.788 1.235 . . . . 72.310000000000002 110.488 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.63 -177.24 27.0 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.58 1.086 . . . . 62.109999999999999 110.556 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -92.89 156.21 17.1 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.432 -0.951 . . . . 74.140000000000001 108.432 163.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -126.6 178.49 5.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.913 2.485 . . . . 63.340000000000003 108.473 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 t -167.72 169.41 11.77 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.012 1.725 . . . . 71.420000000000002 108.601 160.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.55 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 10.0 t -132.36 -1.26 3.57 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.089 1.756 . . . . 74.420000000000002 112.463 172.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.77 -178.17 30.86 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 120.922 -1.111 . . . . 50.100000000000001 110.556 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.8 pt -140.26 13.78 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.44 1.496 . . . . 70.430000000000007 111.146 -166.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -126.75 179.26 5.45 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.01 1.324 . . . . 64.299999999999997 111.518 -168.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 44.79 -93.81 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.693 1.616 . . . . 44.32 114.881 153.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 93.6 m -134.68 127.39 30.99 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.245 -1.391 . . . . 63.229999999999997 107.245 157.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -136.66 -179.77 5.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.21 1.804 . . . . 71.420000000000002 108.813 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -154.0 153.71 32.45 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.132 1.373 . . . . 74.099999999999994 109.008 -171.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.05 124.46 23.4 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.191 1.797 . . . . 73.420000000000002 108.66 -171.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.423 ' CD1' ' HD1' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -114.52 137.94 51.23 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.511 1.524 . . . . 71.120000000000005 109.336 176.503 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -139.66 134.63 32.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.215 -1.031 . . . . 53.329999999999998 108.215 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -133.12 106.75 7.79 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.919 1.688 . . . . 63.520000000000003 107.352 -170.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -77.03 152.54 35.09 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.231 -1.025 . . . . 71.439999999999998 108.231 169.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.35 -27.67 56.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.471 0.915 . . . . 71.310000000000002 113.471 -174.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -135.2 13.65 3.55 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 122.817 0.447 . . . . 75.299999999999997 111.16 -166.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.36 -112.2 1.57 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.246 1.403 . . . . 52.340000000000003 111.21 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.5 p -139.31 -173.96 3.74 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.555 1.542 . . . . 74.299999999999997 108.006 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.57 176.3 20.45 Favored Glycine 0 C--O 1.239 0.446 0 O-C-N 120.817 -1.177 . . . . 71.400000000000006 111.437 167.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.2 p -136.69 159.06 42.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.088 -0.654 . . . . 72.120000000000005 111.616 -166.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.423 ' HD1' ' CD1' ' A' ' 27' ' ' LEU . 29.1 t80 -134.8 113.14 11.31 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.768 1.227 . . . . 65.109999999999999 108.841 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -124.71 112.6 1.79 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 109.64 -1.384 . . . . 71.540000000000006 109.64 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.3 mt -86.47 144.54 9.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 105.36 -2.089 . . . . 70.420000000000002 105.36 170.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -131.56 158.5 40.8 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.585 1.554 . . . . 64.400000000000006 108.022 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.45 126.77 50.09 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.361 1.464 . . . . 72.140000000000001 107.595 167.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 53.36 -78.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.024 2.529 . . . . 73.439999999999998 113.026 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.35 34.8 0.97 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.723 1.609 . . . . 61.130000000000003 111.871 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.8 m -141.7 131.67 12.73 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 127.345 2.258 . . . . 64.329999999999998 109.301 -170.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.24 132.99 10.59 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.997 3.132 . . . . 61.340000000000003 111.436 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.4 mm -124.48 -21.35 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 112.809 0.67 . . . . 71.140000000000001 112.809 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -150.13 154.24 37.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 120.92 1.691 . . . . 61.130000000000003 108.308 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -160.69 128.88 4.54 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.715 1.206 . . . . 74.409999999999997 108.028 -169.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -162.23 160.02 26.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.179 -1.415 . . . . 74.299999999999997 107.179 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.2 mtm -134.13 154.02 51.46 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.939 0.896 . . . . 71.420000000000002 108.622 173.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -163.56 153.79 15.54 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.757 0.823 . . . . 71.099999999999994 111.117 -176.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -84.6 169.51 14.31 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.951 0.881 . . . . 71.219999999999999 109.868 171.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' HE3' ' A' ' 54' ' ' LYS . 7.2 m-85 -137.37 160.5 38.89 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.371 1.468 . . . . 72.439999999999998 110.53 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 53' ' ' TYR . 9.2 mmpt? -132.96 153.84 51.05 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.751 -1.574 . . . . 63.119999999999997 106.751 154.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.1 mm -108.87 100.06 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 105.739 -1.948 . . . . 73.140000000000001 105.739 170.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.42 23.65 4.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.257 0.551 . . . . 42.119999999999997 112.045 -171.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.27 14.93 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.206 1.802 . . . . 74.010000000000005 113.351 -170.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.4 17.98 71.07 Favored Glycine 0 CA--C 1.535 1.296 0 O-C-N 120.465 -1.397 . . . . 43.450000000000003 110.901 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -144.09 164.42 30.72 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 129.359 3.064 . . . . 71.420000000000002 106.474 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.6 mt -95.48 121.26 45.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.963 -1.495 . . . . 74.340000000000003 106.963 -176.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -87.1 111.56 21.04 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.923 1.289 . . . . 72.540000000000006 107.606 167.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mm -86.14 140.7 15.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.013 -1.847 . . . . 74.5 106.013 167.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -156.51 -5.24 0.11 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 115.794 1.776 . . . . 75.530000000000001 115.794 -176.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -151.55 103.25 2.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.931 -1.137 . . . . 73.420000000000002 107.931 -171.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 t -129.11 141.9 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.019 0.928 . . . . 73.439999999999998 109.692 -167.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.08 163.87 48.0 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 126.126 1.77 . . . . 75.329999999999998 107.271 175.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.37 -17.79 20.14 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 119.096 0.713 . . . . 63.130000000000003 113.479 -4.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -102.2 130.55 48.88 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.137 -1.431 . . . . 72.420000000000002 107.137 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -72.8 145.15 47.21 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 123.601 0.563 . . . . 74.140000000000001 110.41 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -137.54 144.51 42.15 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.708 1.203 . . . . 73.510000000000005 108.734 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.0 t -52.14 148.33 11.52 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 118.202 -0.904 . . . . 72.319999999999993 110.167 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.57 153.78 75.5 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.148 2.565 . . . . 54.200000000000003 111.476 172.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -160.18 164.61 32.73 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.947 1.299 . . . . 70.420000000000002 109.39 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -97.43 158.14 15.63 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.084 -0.71 . . . . 61.329999999999998 109.084 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 mt -134.17 116.9 15.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.849 2.059 . . . . 73.219999999999999 108.516 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -73.51 117.63 15.5 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.761 1.624 . . . . 61.219999999999999 107.577 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.8 161.95 39.61 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.232 -0.918 . . . . 71.310000000000002 109.566 168.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -115.62 161.48 18.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.817 -1.083 . . . . 74.129999999999995 110.08 161.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 tt -147.8 151.83 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.0 -1.111 . . . . 73.230000000000004 108.0 170.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.9 m -128.14 -1.96 5.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.471 1.108 . . . . 73.239999999999995 112.427 171.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.68 -74.68 0.43 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 108.316 -1.914 . . . . 41.43 108.316 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.0 p -93.7 -1.55 55.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.661 0.986 . . . . 65.319999999999993 113.661 -174.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -125.42 134.61 52.05 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.895 1.278 . . . . 70.209999999999994 108.423 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.54 131.67 49.12 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.152 -1.795 . . . . 74.239999999999995 106.152 166.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -120.39 84.38 2.21 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.313 -0.995 . . . . 74.540000000000006 108.313 171.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.3 t -77.4 128.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.362 -0.977 . . . . 64.099999999999994 108.362 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -96.23 -22.41 17.27 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.227 1.195 . . . . 71.340000000000003 114.227 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.8 t -150.21 179.0 8.46 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.311 1.444 . . . . 71.530000000000001 109.651 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.52 -177.96 52.3 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 122.706 1.17 . . . . 71.310000000000002 110.567 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.4 m -63.74 -11.83 29.7 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.155 1.782 . . . . 71.530000000000001 114.085 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -107.97 9.17 28.65 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.528 1.131 . . . . 62.299999999999997 113.18 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.22 105.84 0.23 Allowed 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.126 -1.609 . . . . 74.310000000000002 110.633 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 173.32 -159.29 29.31 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.81 0.719 . . . . 42.439999999999998 113.042 -163.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -133.18 128.91 37.02 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 125.33 1.452 . . . . 72.409999999999997 109.003 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.55 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 16.6 m-85 -134.88 149.38 50.3 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 123.871 0.868 . . . . 61.140000000000001 108.996 -173.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -118.57 151.05 38.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.099 -1.074 . . . . 73.120000000000005 108.099 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -68.62 151.65 46.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.091 -1.077 . . . . 62.420000000000002 108.091 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 123.434 1.588 . . . . 71.400000000000006 106.944 176.68 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 108.786 -0.82 . . . . 64.040000000000006 108.786 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.508 ' CD1' ' HE3' ' A' ' 78' ' ' LYS . 98.1 m95 -126.78 157.16 39.92 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.925 1.69 . . . . 70.400000000000006 110.647 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -82.73 175.24 10.28 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.037 0.835 . . . . 63.140000000000001 110.853 168.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -53.48 156.72 2.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.179 1.392 . . . . 75.040000000000006 110.345 163.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.419 HD21 HG13 ' A' ' 60' ' ' ILE . 7.0 tp -103.58 132.66 49.65 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.738 -1.574 . . . . 75.010000000000005 107.23 162.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.446 ' HA ' HG21 ' A' ' 55' ' ' ILE . 23.0 p30 -143.61 -175.3 4.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 127.323 2.249 . . . . 74.310000000000002 108.577 -175.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 p -78.65 9.29 4.22 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.431 1.092 . . . . 61.340000000000003 113.673 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -130.38 -40.28 1.28 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.56 1.527 . . . . 34.439999999999998 112.184 -162.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -72.3 -31.65 65.9 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.948 1.299 . . . . 54.43 110.272 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.9 tp -75.76 -24.83 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.836 1.198 . . . . 73.200000000000003 111.864 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.6 mm -55.74 97.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 127.835 2.454 . . . . 74.239999999999995 111.974 -174.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.65 179.91 44.62 Favored Glycine 0 N--CA 1.445 -0.731 0 O-C-N 122.27 -0.269 . . . . 52.420000000000002 113.085 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -100.0 148.68 24.26 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.53 1.932 . . . . 75.140000000000001 108.531 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -146.55 135.34 22.29 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.753 0.821 . . . . 72.540000000000006 110.036 -171.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -140.44 170.9 14.93 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.941 -1.099 . . . . 74.540000000000006 108.841 166.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.409 ' HB ' ' CD1' ' A' ' 95' ' ' TYR . 14.5 t -118.8 -18.04 9.01 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.469 1.108 . . . . 61.509999999999998 111.559 -176.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.84 -168.15 38.14 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 107.501 -2.24 . . . . 53.039999999999999 107.501 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.5 pt -139.98 -5.52 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.018 0.927 . . . . 72.129999999999995 112.742 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -93.21 173.59 7.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 120.077 1.308 . . . . 74.209999999999994 110.746 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.33 -94.56 0.01 OUTLIER Glycine 0 C--N 1.338 0.676 0 C-N-CA 126.528 2.014 . . . . 51.119999999999997 113.268 155.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.67 133.2 39.79 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.925 -1.139 . . . . 63.119999999999997 107.925 164.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -143.42 179.76 6.91 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.99 1.716 . . . . 75.439999999999998 107.67 174.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -143.28 133.5 24.49 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.962 -1.125 . . . . 62.509999999999998 107.962 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.8 155.17 18.98 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.996 1.718 . . . . 75.530000000000001 107.923 171.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 mt -145.9 141.81 28.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.552 -2.018 . . . . 75.140000000000001 105.552 164.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.0 m -138.24 147.83 44.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.156 -1.053 . . . . 74.439999999999998 108.156 173.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -141.85 121.31 13.23 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.087 1.755 . . . . 74.420000000000002 107.84 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -96.88 157.98 15.64 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.833 0.853 . . . . 74.409999999999997 109.579 167.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -78.87 -33.05 46.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.729 -0.669 . . . . 75.510000000000005 111.723 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -119.61 5.18 11.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.788 0.435 . . . . 71.319999999999993 111.4 -163.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.08 -111.09 0.95 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 125.448 1.499 . . . . 32.130000000000003 110.544 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.0 p -137.25 178.64 6.93 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.477 1.911 . . . . 72.310000000000002 108.797 -163.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -133.97 -174.78 13.63 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.493 -1.043 . . . . 73.310000000000002 110.493 164.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 t -148.28 160.02 43.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.609 -0.886 . . . . 62.299999999999997 108.609 -168.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -140.7 137.71 33.7 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.252 2.221 . . . . 64.420000000000002 105.695 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.53 147.35 16.66 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.402 -1.079 . . . . 35.140000000000001 110.402 166.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.1 mt -97.45 140.33 17.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 105.783 -1.932 . . . . 53.310000000000002 105.783 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -133.92 133.34 41.32 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.577 0.703 . . . . 75.510000000000005 109.867 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.715 ' N ' HD11 ' A' ' 46' ' ' ILE . 24.2 t -79.75 -172.58 3.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.108 2.163 . . . . 51.020000000000003 108.439 169.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -44.68 -42.47 7.59 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 126.689 1.996 . . . . 60.310000000000002 113.422 -172.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -159.74 49.32 0.3 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.097 -0.705 . . . . 75.129999999999995 109.097 162.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.7 m -146.92 136.07 11.44 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.517 -0.754 . . . . 75.519999999999996 109.268 -173.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.56 142.27 18.23 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 124.295 3.33 . . . . 72.340000000000003 113.147 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.715 HD11 ' N ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -136.3 -8.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 114.137 1.162 . . . . 62.329999999999998 114.137 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.04 145.53 15.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.021 -1.675 . . . . 72.340000000000003 107.751 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -159.2 129.28 5.7 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.022 -1.473 . . . . 75.109999999999999 107.022 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -153.77 167.69 28.8 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.129 1.372 . . . . 74.310000000000002 108.436 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.9 mtm -135.13 158.34 44.6 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 123.479 0.712 . . . . 74.200000000000003 109.93 165.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -155.1 160.05 40.69 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.235 -0.893 . . . . 72.340000000000003 108.909 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.14 164.05 15.18 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.304 -1.369 . . . . 74.420000000000002 107.304 168.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -136.27 165.66 25.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.962 -0.563 . . . . 64.340000000000003 109.758 170.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -131.37 159.2 38.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.024 -0.732 . . . . 72.040000000000006 109.024 158.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.446 HG21 ' HA ' ' A' ' 8' ' ' ASN . 16.3 mm -118.38 89.55 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 104.522 -2.399 . . . . 71.420000000000002 104.522 171.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -118.95 23.48 11.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.907 1.283 . . . . 62.020000000000003 111.474 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.33 21.59 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.339 1.456 . . . . 72.120000000000005 113.317 -173.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.95 22.65 70.58 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 120.554 -1.341 . . . . 63.32 112.082 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -148.44 163.0 38.45 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 127.374 2.269 . . . . 74.400000000000006 107.02 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.419 HG13 HD21 ' A' ' 7' ' ' LEU . 71.0 mt -87.92 130.33 37.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.924 -1.51 . . . . 61.409999999999997 106.924 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -108.56 107.54 18.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.198 1.399 . . . . 75.430000000000007 108.829 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 mm -78.67 138.9 19.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.655 -1.609 . . . . 63.229999999999997 106.655 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -158.25 -5.43 0.08 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 116.375 1.991 . . . . 75.019999999999996 116.375 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -150.78 110.06 3.96 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 103.959 -2.608 . . . . 73.019999999999996 103.959 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.4 t -128.74 141.9 45.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.137 -1.06 . . . . 72.230000000000004 108.137 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.41 164.29 45.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.172 1.389 . . . . 72.549999999999997 107.806 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -75.62 -7.87 25.45 Favored 'Cis proline' 0 CA--C 1.538 0.697 0 CA-C-N 119.259 0.771 . . . . 73.109999999999999 112.325 -11.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.1 109.63 20.23 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.183 0.993 . . . . 74.519999999999996 110.548 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.55 128.63 36.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 122.488 1.137 . . . . 64.049999999999997 110.365 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -107.92 177.79 4.71 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.684 1.594 . . . . 73.150000000000006 109.509 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -76.66 149.14 80.59 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.842 -0.799 . . . . 72.150000000000006 108.842 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.75 149.53 83.58 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.347 2.031 . . . . 52.420000000000002 111.037 171.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -168.39 167.35 11.96 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.072 0.949 . . . . 75.040000000000006 110.248 172.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -98.29 156.94 16.47 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.134 0.574 . . . . 54.340000000000003 109.849 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.69 128.9 35.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.7 2.0 . . . . 75.299999999999997 107.824 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.494 ' H ' ' CG2' ' A' ' 88' ' ' THR . 5.1 m-20 -84.68 129.63 34.81 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.037 -1.838 . . . . 74.019999999999996 106.037 174.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.42 150.47 23.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.371 1.868 . . . . 64.430000000000007 107.558 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.508 ' HE3' ' CD1' ' A' ' 4' ' ' TRP . 23.6 mtmt -128.55 145.46 51.12 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.069 -1.456 . . . . 75.019999999999996 107.069 -171.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.3 tt -143.93 152.4 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.02 -1.474 . . . . 74.099999999999994 107.02 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.9 t -128.64 -61.92 1.04 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.54 -1.282 . . . . 61.439999999999998 107.54 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.7 -102.0 0.27 Allowed Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 106.384 -2.686 . . . . 55.32 106.384 166.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.3 p -79.4 10.92 3.3 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.431 1.271 . . . . 75.340000000000003 114.431 -173.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.8 m -118.76 127.62 53.72 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 121.084 1.765 . . . . 72.209999999999994 109.7 171.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.15 125.64 41.79 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.085 1.354 . . . . 62.100000000000001 107.383 165.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.5 tttm -111.88 87.94 2.68 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.082 0.953 . . . . 74.439999999999998 109.065 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.9 t -72.03 134.5 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.777 -1.194 . . . . 64.310000000000002 107.777 174.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -97.11 -37.94 9.93 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.577 0.751 . . . . 62.420000000000002 110.292 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.494 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.0 t -137.7 161.41 36.59 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.054 1.741 . . . . 73.239999999999995 110.004 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.38 179.08 19.37 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.284 1.421 . . . . 72.430000000000007 112.639 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.8 m -57.24 -24.02 51.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.36 0.664 . . . . 63.32 111.444 166.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -100.83 5.04 43.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.399 1.88 . . . . 72.019999999999996 111.545 -169.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.1 103.53 0.15 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.438 1.495 . . . . 74.230000000000004 111.235 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.25 -164.74 33.1 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 123.793 0.711 . . . . 60.32 112.64 -169.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 54.3 p -130.08 120.61 24.93 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.512 1.125 . . . . 74.209999999999994 109.589 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.409 ' CD1' ' HB ' ' A' ' 18' ' ' THR . 48.3 m-85 -127.74 152.09 48.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.715 0.806 . . . . 55.140000000000001 109.226 -170.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -111.37 140.86 45.59 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.3 1.04 . . . . 75.200000000000003 108.458 175.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -66.59 125.87 27.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.772 -1.196 . . . . 75.340000000000003 107.772 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--N 1.325 -0.474 0 C-N-CA 124.833 1.253 . . . . 72.209999999999994 107.827 179.819 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 CA--C 1.512 -0.498 0 N-CA-C 105.645 -1.983 . . . . 72.450000000000003 105.645 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -125.61 150.33 47.63 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.798 1.639 . . . . 64.549999999999997 109.733 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -72.07 171.86 11.15 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.469 0.652 . . . . 71.140000000000001 110.219 170.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -51.79 130.97 30.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.244 -0.889 . . . . 75.450000000000003 108.75 158.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.46 HD22 HD12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -64.14 124.56 21.98 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.898 -1.149 . . . . 72.230000000000004 107.898 151.491 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -137.65 171.08 14.98 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 118.772 -1.171 . . . . 63.520000000000003 111.358 160.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p -69.08 36.02 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.142 2.577 . . . . 74.239999999999995 112.387 172.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -137.78 -58.18 0.67 Allowed 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 125.051 1.34 . . . . 63.149999999999999 109.006 -170.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -77.03 -21.53 54.4 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 118.563 -0.732 . . . . 73.239999999999995 112.107 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.7 -19.02 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.43 1.092 . . . . 75.439999999999998 113.57 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.3 mm -65.67 118.85 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.449 -0.945 . . . . 73.510000000000005 108.449 -171.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.75 173.69 23.88 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.336 0.97 . . . . 73.209999999999994 111.544 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -80.46 156.39 26.61 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.803 -1.184 . . . . 71.109999999999999 107.803 162.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -141.67 135.12 29.59 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.737 -0.602 . . . . 75.510000000000005 109.689 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -137.76 150.66 47.44 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.956 1.703 . . . . 74.129999999999995 109.627 -167.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.522 HG23 ' CE2' ' A' ' 95' ' ' TYR . 31.0 p -89.84 -77.16 0.4 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.933 -1.506 . . . . 75.310000000000002 106.933 161.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.87 -168.48 14.23 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 126.682 2.087 . . . . 75.439999999999998 109.879 -177.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.0 pt -118.21 20.37 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.397 1.479 . . . . 73.420000000000002 110.792 -171.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -137.15 157.34 46.9 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.376 1.87 . . . . 63.130000000000003 108.478 -168.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.31 -172.09 7.69 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 121.633 0.574 . . . . 53.310000000000002 113.586 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.3 m -79.76 90.2 5.23 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.458 -1.312 . . . . 52.130000000000003 107.458 175.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.1 p-80 -110.54 -179.48 3.77 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.498 1.519 . . . . 53.340000000000003 110.371 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -140.89 157.6 45.14 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.073 1.349 . . . . 73.349999999999994 110.271 -169.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.95 140.94 32.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.702 1.601 . . . . 60.25 107.993 -173.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -123.87 169.48 11.54 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.981 0.913 . . . . 72.209999999999994 109.689 168.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.0 t -140.29 160.48 39.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.806 -1.553 . . . . 64.549999999999997 106.806 158.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -147.81 121.63 9.31 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.682 1.993 . . . . 63.329999999999998 106.271 168.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -95.33 156.23 16.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.829 0.851 . . . . 73.109999999999999 109.048 172.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.48 -23.96 37.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 61.109999999999999 111.957 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -133.16 10.68 4.18 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.046 0.758 . . . . 73.340000000000003 113.046 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.44 -119.98 3.92 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.588 -1.405 . . . . 21.41 109.588 173.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 p -141.33 -169.9 2.96 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.831 2.452 . . . . 74.129999999999995 106.505 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.6 179.05 19.21 Favored Glycine 0 CA--C 1.522 0.49 0 O-C-N 120.936 -1.102 . . . . 73.420000000000002 110.905 167.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -136.47 165.32 26.1 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.57 1.548 . . . . 73.109999999999999 109.284 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -152.44 109.62 3.54 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.551 1.541 . . . . 74.109999999999999 109.813 171.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.99 147.48 16.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.232 -1.147 . . . . 64.530000000000001 110.232 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.6 mt -119.87 139.85 45.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 105.828 -1.916 . . . . 65.129999999999995 105.828 169.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -122.41 165.82 15.71 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.942 1.297 . . . . 75.420000000000002 109.449 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 m -131.22 112.98 13.29 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.482 1.913 . . . . 73.200000000000003 106.869 160.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 55.24 -73.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 130.161 3.384 . . . . 73.010000000000005 113.892 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.24 44.24 1.54 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.95 1.3 . . . . 54.229999999999997 109.649 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.5 m -150.17 123.01 4.27 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 107.758 -1.201 . . . . 55.439999999999998 107.758 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.6 137.73 36.65 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.342 2.028 . . . . 60.399999999999999 108.967 167.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.3 mm -126.35 -25.42 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.442 1.097 . . . . 74.329999999999998 110.791 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.5 t -141.12 157.85 44.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 120.63 -1.294 . . . . 63.130000000000003 109.194 169.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -151.0 135.84 17.32 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 129.166 2.987 . . . . 74.319999999999993 105.139 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.58 163.19 40.09 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.454 -2.054 . . . . 53.149999999999999 105.454 165.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.9 mtm -130.28 167.98 17.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.431 -0.952 . . . . 74.519999999999996 108.431 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -160.6 148.85 16.35 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.585 0.754 . . . . 63.539999999999999 109.132 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.67 163.9 20.45 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.953 -1.129 . . . . 72.140000000000001 107.953 163.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -150.88 161.84 41.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.889 -0.507 . . . . 74.319999999999993 109.935 172.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -129.32 159.48 36.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.072 -1.084 . . . . 74.140000000000001 108.072 156.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.46 HD12 HD22 ' A' ' 7' ' ' LEU . 25.3 mm -105.02 102.43 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 103.638 -2.727 . . . . 73.450000000000003 103.638 162.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.94 27.22 2.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.093 0.949 . . . . 73.129999999999995 109.655 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.52 15.1 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 114.206 1.187 . . . . 70.409999999999997 114.206 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.93 23.72 66.01 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.564 -1.415 . . . . 73.510000000000005 109.564 -168.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -149.56 163.06 38.89 Favored 'General case' 0 N--CA 1.445 -0.712 1 C-N-CA 132.143 4.177 . . . . 73.530000000000001 103.843 -171.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.23 155.23 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.635 -1.617 . . . . 73.349999999999994 106.635 172.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -124.12 124.36 42.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.649 2.379 . . . . 61.450000000000003 106.911 164.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 mm -114.04 137.17 48.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.541 1.936 . . . . 63.350000000000001 106.458 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -160.08 6.96 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.281 1.215 . . . . 72.230000000000004 114.281 -172.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -151.96 123.81 8.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.17 -2.53 . . . . 71.109999999999999 104.17 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.3 t -132.57 144.81 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.943 -1.503 . . . . 74.109999999999999 106.943 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.21 159.95 68.9 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 108.165 -1.05 . . . . 73.510000000000005 108.165 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.58 -7.5 47.5 Favored 'Cis proline' 0 CA--C 1.534 0.485 0 N-CA-C 113.815 0.66 . . . . 74.329999999999998 113.815 -3.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -116.71 120.66 39.28 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.318 -1.734 . . . . 52.229999999999997 106.318 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -76.57 124.47 27.66 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.633 1.173 . . . . 71.430000000000007 108.686 -174.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 mttm -97.5 166.04 11.71 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.581 -0.896 . . . . 72.239999999999995 108.581 169.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.82 149.88 15.67 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.577 1.151 . . . . 50.32 109.315 171.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -68.9 142.84 53.01 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.217 1.944 . . . . 73.519999999999996 110.499 169.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -150.79 165.39 33.68 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 120.898 -1.126 . . . . 53.240000000000002 109.864 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -99.61 159.06 15.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.668 -0.864 . . . . 74.109999999999999 108.668 167.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.1 mt -131.54 118.9 20.76 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.373 1.069 . . . . 64.319999999999993 109.272 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -59.67 112.35 1.78 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.109 -1.441 . . . . 64.519999999999996 107.109 167.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.2 168.63 19.29 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 107.042 -1.466 . . . . 75.310000000000002 107.042 166.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.38 170.54 15.58 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.838 1.255 . . . . 73.109999999999999 111.49 163.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 tt -154.4 147.98 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 123.478 0.711 . . . . 75.409999999999997 109.303 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 m -151.39 48.81 0.82 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 129.473 3.109 . . . . 73.25 110.412 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.68 -66.9 3.32 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 126.207 1.86 . . . . 61.509999999999998 112.19 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -124.7 2.57 8.21 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.82 1.415 . . . . 75.340000000000003 114.82 -168.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 m -118.9 100.88 7.65 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.698 1.599 . . . . 63.530000000000001 107.806 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.3 tp -77.52 125.15 28.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.933 -1.506 . . . . 75.519999999999996 106.933 166.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -119.06 92.64 3.85 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 123.988 0.915 . . . . 72.430000000000007 108.973 177.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.78 137.35 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.669 -1.234 . . . . 75.349999999999994 107.669 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -100.58 -14.68 18.09 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.209 1.188 . . . . 75.319999999999993 114.209 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.1 t -151.6 163.87 38.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.429 1.013 . . . . 70.549999999999997 112.525 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.79 -175.79 53.28 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-O 122.832 1.24 . . . . 51.149999999999999 110.314 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.3 m -49.22 -27.62 3.85 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.802 1.641 . . . . 71.230000000000004 113.362 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -95.83 2.06 53.52 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.191 1.182 . . . . 62.25 114.191 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.68 105.17 0.14 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.347 1.059 . . . . 61.229999999999997 111.211 -173.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 173.47 -138.54 4.65 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.91 0.767 . . . . 72.349999999999994 112.62 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.8 t -150.5 132.14 14.89 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.416 1.486 . . . . 74.329999999999998 107.934 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.522 ' CE2' HG23 ' A' ' 18' ' ' THR . 36.7 m-85 -134.36 134.22 41.51 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 123.721 0.808 . . . . 73.540000000000006 109.323 -176.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -75.98 153.93 36.19 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.428 -0.953 . . . . 72.109999999999999 108.428 167.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -69.84 154.97 41.25 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.555 -0.905 . . . . 73.310000000000002 108.555 168.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 . . . . . 0 C--N 1.327 -0.386 0 C-N-CA 126.224 1.81 . . . . 74.510000000000005 107.461 163.819 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 105.546 -2.02 . . . . 75.129999999999995 105.546 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -114.55 155.17 26.96 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 126.447 1.899 . . . . 75.099999999999994 110.778 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 p -72.27 175.64 5.93 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.35 -0.611 . . . . 64.420000000000002 109.35 164.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -56.92 150.23 17.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.337 1.065 . . . . 73.439999999999998 110.114 155.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.1 tp -84.76 129.23 34.85 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 125.722 1.609 . . . . 75.430000000000007 107.159 155.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -135.44 166.23 23.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.363 -1.347 . . . . 74.319999999999993 107.363 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 t -67.29 -2.61 6.24 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.574 1.15 . . . . 61.149999999999999 112.788 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -108.01 -36.8 6.24 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.131 -0.981 . . . . 73.329999999999998 109.436 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.82 -23.92 66.54 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.39 1.076 . . . . 74.209999999999994 112.895 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.3 tp -90.12 -16.1 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.0 1.32 . . . . 72.129999999999995 113.101 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.3 mm -69.75 130.5 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.952 1.301 . . . . 62.130000000000003 110.983 -163.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.34 -175.24 20.82 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.783 1.658 . . . . 63.509999999999998 110.324 175.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -82.17 169.97 16.0 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.403 -0.962 . . . . 73.329999999999998 108.403 167.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -132.58 -175.86 3.9 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.556 -1.276 . . . . 74.200000000000003 107.556 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 t -169.05 167.04 10.81 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.722 1.601 . . . . 75.209999999999994 109.745 162.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.518 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 2.3 t -136.98 -19.43 1.3 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.506 1.122 . . . . 60.229999999999997 112.799 -177.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.78 171.27 38.77 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.666 -1.774 . . . . 60.119999999999997 108.666 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.81 19.11 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.972 1.309 . . . . 55.340000000000003 110.578 -169.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.76 -179.65 6.59 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 127.195 2.198 . . . . 64.310000000000002 108.33 -174.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.02 -117.58 6.94 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.108 0.861 . . . . 74.019999999999996 111.964 170.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.2 m -132.13 98.95 4.56 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.664 -1.235 . . . . 63.329999999999998 107.664 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -114.56 171.11 7.83 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.471 1.108 . . . . 73.140000000000001 110.21 -175.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -138.92 136.05 35.07 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.854 -1.165 . . . . 74.439999999999998 107.854 -165.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.51 96.17 4.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.028 1.331 . . . . 75.25 109.392 -171.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.0 mt -77.89 153.24 32.8 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.633 1.573 . . . . 72.439999999999998 110.811 164.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.0 p -141.16 158.77 43.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.871 1.268 . . . . 75.549999999999997 109.267 162.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -141.12 124.65 16.75 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.015 1.326 . . . . 75.450000000000003 108.415 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.5 159.91 16.26 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.206 1.402 . . . . 52.409999999999997 107.746 170.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -83.96 -32.95 24.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.802 0.841 . . . . 73.329999999999998 112.239 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -138.87 30.32 2.27 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.641 1.176 . . . . 63.240000000000002 109.836 -172.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -127.86 -110.92 1.61 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.448 -1.461 . . . . 71.549999999999997 109.448 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.2 p -146.01 -170.66 3.53 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.049 2.14 . . . . 72.140000000000001 107.361 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.0 167.92 12.93 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.846 -1.302 . . . . 32.030000000000001 109.846 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -144.29 155.86 44.01 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.826 -0.808 . . . . 54.43 110.199 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -139.93 120.48 14.17 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.164 1.385 . . . . 60.049999999999997 107.764 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.85 157.18 15.13 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.752 -1.339 . . . . 71.049999999999997 109.752 168.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.3 mt -122.28 146.59 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 105.835 -1.913 . . . . 40.350000000000001 105.835 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -134.82 144.68 47.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.227 1.411 . . . . 72.310000000000002 108.449 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.9 125.87 48.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.192 -2.151 . . . . 71.340000000000003 105.192 158.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.2 m120 62.86 -83.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.582 1.553 . . . . 72.019999999999996 112.977 160.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.4 59.98 0.96 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.642 1.177 . . . . 74.030000000000001 108.651 163.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.0 m -144.89 130.19 9.36 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 127.137 2.175 . . . . 75.129999999999995 106.316 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.94 141.48 48.76 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.452 2.101 . . . . 72.010000000000005 109.651 167.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.3 mm -131.73 -22.26 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.763 1.225 . . . . 62.109999999999999 110.998 -174.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.9 t -143.47 167.66 21.67 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.576 -1.328 . . . . 72.409999999999997 110.251 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -160.09 146.88 16.03 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.551 1.94 . . . . 75.340000000000003 108.726 -175.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -159.05 164.05 35.78 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.386 1.874 . . . . 74.319999999999993 107.573 163.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.5 mtm -121.18 156.84 31.52 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.744 1.618 . . . . 53.450000000000003 107.149 162.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -161.3 138.01 8.53 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.141 0.976 . . . . 63.109999999999999 109.711 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -75.11 163.24 27.77 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.705 0.764 . . . . 72.329999999999998 109.262 166.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -153.08 158.15 41.49 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.799 0.84 . . . . 75.040000000000006 111.064 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -137.06 158.28 44.81 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.562 -0.711 . . . . 72.439999999999998 110.485 169.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.5 mm -111.14 90.85 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 106.81 -1.552 . . . . 55.530000000000001 106.81 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -121.5 22.86 10.55 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.381 1.252 . . . . 62.32 114.381 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -174.9 14.98 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 116.341 1.978 . . . . 64.049999999999997 116.341 -173.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.27 16.23 77.06 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 119.475 -2.016 . . . . 31.140000000000001 114.39 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -130.69 -170.7 2.39 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.796 2.038 . . . . 71.040000000000006 108.269 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.4 mt -113.2 106.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.802 1.637 . . . . 74.310000000000002 107.263 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -72.12 124.13 24.33 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.539 -1.282 . . . . 73.430000000000007 107.539 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.8 mm -111.15 139.07 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.406 -2.072 . . . . 62.240000000000002 105.406 170.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -157.49 8.57 0.17 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.954 0.902 . . . . 75.340000000000003 112.306 -175.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -152.6 118.9 5.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 103.18 -2.896 . . . . 75.439999999999998 103.18 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -135.65 152.23 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.223 -2.14 . . . . 64.150000000000006 105.223 169.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.05 161.64 54.61 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 125.34 1.456 . . . . 73.150000000000006 107.583 173.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -81.86 -6.81 46.39 Favored 'Cis proline' 0 CA--C 1.54 0.789 0 N-CA-C 114.319 0.854 . . . . 71.209999999999994 114.319 -6.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.92 104.78 14.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 104.731 -2.322 . . . . 63.420000000000002 104.731 168.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -64.01 155.2 31.86 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.814 0.696 . . . . 62.340000000000003 110.495 170.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -129.67 162.29 28.67 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.109 1.364 . . . . 73.049999999999997 107.854 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 t -54.92 149.26 24.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 109.072 -0.714 . . . . 61.329999999999998 109.072 171.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.12 147.19 53.7 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.241 1.961 . . . . 61.340000000000003 110.992 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -156.52 174.05 16.01 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.825 1.25 . . . . 71.150000000000006 109.755 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -117.05 131.08 57.02 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.811 -1.181 . . . . 74.450000000000003 107.811 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.416 HD22 ' HA3' ' A' ' 89' ' ' GLY . 45.5 mt -101.06 116.4 32.75 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.649 1.179 . . . . 72.120000000000005 108.578 176.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.9 116.28 5.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.844 1.258 . . . . 72.049999999999997 108.045 172.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.1 p -139.42 156.77 46.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.757 0.789 . . . . 71.299999999999997 110.045 161.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -116.28 159.34 22.01 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.279 -1.328 . . . . 60.100000000000001 108.964 168.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 tt -152.89 154.35 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.671 -1.603 . . . . 55.240000000000002 106.671 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.8 p -133.37 -11.22 2.83 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.836 1.421 . . . . 62.0 114.836 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.32 -91.17 0.15 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 107.098 -2.401 . . . . 74.430000000000007 107.098 -165.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.5 p -106.7 -0.42 23.62 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.454 1.65 . . . . 64.040000000000006 115.454 -167.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.6 m -114.16 109.93 19.18 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.568 1.947 . . . . 74.310000000000002 109.878 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.493 HD22 HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -75.89 136.1 40.12 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 119.837 -1.789 . . . . 64.209999999999994 107.39 167.562 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -119.2 88.63 2.97 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.602 -0.518 . . . . 60.229999999999997 109.602 162.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.493 HG23 HD22 ' A' ' 84' ' ' LEU . 25.0 t -81.5 133.03 30.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.859 -0.793 . . . . 54.329999999999998 108.859 170.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -106.43 -18.59 13.94 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.708 1.203 . . . . 74.230000000000004 112.872 -171.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.4 t -155.75 171.66 19.64 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.244 1.417 . . . . 64.010000000000005 109.298 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.416 ' HA3' HD22 ' A' ' 75' ' ' LEU . . . 92.81 178.28 40.78 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 122.836 1.242 . . . . 61.109999999999999 110.378 -173.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.1 m -59.55 -21.37 60.18 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 113.706 1.002 . . . . 74.430000000000007 113.706 174.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -109.96 19.48 18.99 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.342 1.608 . . . . 73.109999999999999 115.342 -176.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.14 109.24 0.56 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.171 0.988 . . . . 62.140000000000001 111.484 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.83 -156.15 26.7 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.184 1.374 . . . . 53.409999999999997 112.912 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -119.81 125.48 48.67 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.979 1.312 . . . . 62.140000000000001 110.158 -173.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.518 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 6.1 m-85 -133.3 152.23 51.92 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.003 0.43 . . . . 73.319999999999993 110.848 -174.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -103.53 138.3 40.41 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.352 1.461 . . . . 71.219999999999999 107.473 172.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -52.78 149.23 6.43 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.295 0.952 . . . . 74.239999999999995 109.408 166.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 . . . . . 0 C--O 1.237 0.415 0 C-N-CA 126.52 1.928 . . . . 64.310000000000002 108.208 169.612 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 . . . . . 0 CA--C 1.511 -0.549 0 N-CA-C 106.172 -1.788 . . . . 75.099999999999994 106.172 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.416 ' CG ' ' HB3' ' A' ' 78' ' ' LYS . 93.4 m95 -106.51 -174.09 2.45 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.755 2.022 . . . . 73.200000000000003 111.592 -173.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.7 p -110.4 160.67 16.37 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.597 0.759 . . . . 74.530000000000001 110.126 168.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.56 127.16 26.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.11 2.164 . . . . 73.430000000000007 109.288 173.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 tp -79.7 92.04 5.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.893 -1.151 . . . . 73.219999999999999 107.893 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -94.56 164.36 13.01 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 125.33 1.452 . . . . 65.209999999999994 107.581 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.45 -45.89 73.19 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.241 1.016 . . . . 74.120000000000005 109.873 172.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -76.51 -19.35 58.07 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 119.454 -0.898 . . . . 63.310000000000002 112.425 -170.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.2 -40.5 62.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.914 -0.491 . . . . 71.299999999999997 111.003 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.1 tp -76.61 -13.32 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 120.91 -1.119 . . . . 74.409999999999997 113.695 -170.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 mm -52.28 136.0 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.032 1.333 . . . . 72.530000000000001 112.655 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.58 178.85 15.66 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 125.855 1.693 . . . . 72.239999999999995 110.739 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -84.87 167.06 16.33 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.405 -0.961 . . . . 73.299999999999997 108.405 165.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -147.41 139.86 24.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.417 -1.327 . . . . 73.530000000000001 107.417 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 t -141.71 170.09 16.37 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.569 -1.332 . . . . 71.200000000000003 110.203 166.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.3 t -132.71 0.43 3.57 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.462 2.305 . . . . 75.329999999999998 111.546 -173.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.93 179.28 38.12 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.175 -1.17 . . . . 60.219999999999999 110.175 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.2 pt -130.8 22.87 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.711 1.604 . . . . 35.509999999999998 109.571 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -142.53 -175.88 4.64 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.328 1.451 . . . . 74.239999999999995 109.654 -169.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.84 -119.38 16.08 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.534 -1.026 . . . . 55.340000000000003 110.534 156.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -131.79 101.69 5.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.979 -1.86 . . . . 73.019999999999996 105.979 161.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -114.34 172.5 6.97 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.641 0.734 . . . . 74.409999999999997 109.061 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -143.14 144.58 32.27 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.418 -0.956 . . . . 74.420000000000002 108.418 -160.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.84 103.13 5.93 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 122.994 0.518 . . . . 72.230000000000004 109.671 -167.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.5 mt -94.64 154.45 17.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.467 1.107 . . . . 71.549999999999997 110.068 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 p -146.12 125.16 12.82 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.425 1.09 . . . . 70.450000000000003 109.769 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -124.03 114.96 20.43 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 120.166 1.348 . . . . 72.120000000000005 109.793 -174.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -92.42 152.76 19.54 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 124.151 0.907 . . . . 73.299999999999997 110.033 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -81.26 -20.48 40.85 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 114.268 1.21 . . . . 73.109999999999999 114.268 -174.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -133.48 1.11 3.39 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.328 0.513 . . . . 74.219999999999999 112.245 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.83 -123.17 5.2 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.435 -1.466 . . . . 43.149999999999999 109.435 173.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.3 p -134.74 -171.1 2.7 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.858 1.663 . . . . 63.210000000000001 108.542 -164.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.37 165.65 12.15 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.99 -0.844 . . . . 64.129999999999995 110.99 165.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -142.56 166.38 24.82 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.846 0.859 . . . . 45.030000000000001 110.832 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -146.99 133.0 19.18 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.492 -1.299 . . . . 73.519999999999996 107.492 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.45 161.62 24.48 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.184 -1.167 . . . . 52.219999999999999 110.184 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.3 mt -131.94 121.51 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.109 -1.811 . . . . 71.239999999999995 106.109 -174.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -118.49 132.53 56.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.72 1.208 . . . . 71.109999999999999 109.016 -171.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 m -97.68 119.24 35.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.554 -1.276 . . . . 73.129999999999995 107.554 166.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 46.77 -85.2 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 127.844 2.457 . . . . 75.219999999999999 113.72 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.51 56.68 1.65 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.827 1.251 . . . . 72.040000000000006 109.402 170.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 m -143.58 122.57 7.32 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.154 1.782 . . . . 72.439999999999998 107.84 171.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.44 137.6 36.77 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.842 2.362 . . . . 73.129999999999995 109.847 165.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.0 mm -128.17 -15.27 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.187 0.995 . . . . 71.329999999999998 111.164 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.4 t -135.56 167.41 21.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 119.775 -1.828 . . . . 71.239999999999995 110.059 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -163.47 147.27 10.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.303 -0.862 . . . . 74.420000000000002 108.921 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -167.99 165.96 13.41 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.444 1.498 . . . . 63.149999999999999 108.311 166.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.3 mtm -133.48 161.29 34.97 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.089 1.356 . . . . 72.230000000000004 108.048 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -162.6 140.11 8.17 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.992 1.317 . . . . 71.319999999999993 109.155 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.42 161.81 26.8 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.271 -1.011 . . . . 74.340000000000003 108.271 163.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -144.14 164.56 30.33 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.669 -0.644 . . . . 74.530000000000001 109.344 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -136.7 156.42 48.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.806 -0.813 . . . . 74.120000000000005 108.806 166.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.0 mm -107.04 99.81 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 106.173 -1.788 . . . . 71.530000000000001 106.173 168.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.2 28.52 3.75 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.885 0.874 . . . . 61.43 112.353 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -163.14 14.01 0.07 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.003 1.721 . . . . 74.329999999999998 115.129 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.49 21.03 47.92 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.254 -1.529 . . . . 74.540000000000006 113.111 -168.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -132.69 -168.45 2.07 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.86 2.864 . . . . 74.439999999999998 106.875 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.7 mt -118.32 110.89 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.897 -1.52 . . . . 72.319999999999993 106.897 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -80.78 120.24 24.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.332 -1.359 . . . . 70.530000000000001 107.332 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.0 mm -108.02 135.0 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 105.356 -2.09 . . . . 71.140000000000001 105.356 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -154.06 8.29 0.35 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.809 0.843 . . . . 64.219999999999999 112.494 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -151.6 121.08 6.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 104.168 -2.53 . . . . 61.109999999999999 104.168 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.5 t -136.26 149.91 27.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.051 -1.833 . . . . 52.25 106.051 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.99 160.29 53.32 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.6 1.56 . . . . 72.530000000000001 108.04 177.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.78 -13.66 27.89 Favored 'Cis proline' 0 CA--C 1.535 0.555 0 CA-C-N 119.539 0.871 . . . . 71.140000000000001 113.802 -10.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.76 103.1 15.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 104.022 -2.584 . . . . 50.520000000000003 104.022 171.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -66.82 160.07 26.75 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.307 -0.627 . . . . 73.219999999999999 109.307 167.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -137.9 174.7 10.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.118 1.367 . . . . 74.430000000000007 108.315 168.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.5 t -51.32 150.76 5.86 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 108.861 -0.792 . . . . 71.349999999999994 108.861 168.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -65.2 153.23 79.27 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.077 1.851 . . . . 74.25 109.333 163.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -159.3 172.07 18.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.555 1.542 . . . . 74.430000000000007 109.008 175.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -114.15 146.01 40.89 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.846 -1.168 . . . . 53.109999999999999 107.846 172.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.3 mt -123.9 115.98 22.16 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.769 1.228 . . . . 73.409999999999997 107.94 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.06 127.53 33.46 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.205 1.002 . . . . 73.530000000000001 108.353 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.9 m -144.73 160.66 40.86 Favored 'General case' 0 CA--C 1.522 -0.124 0 O-C-N 121.787 -0.57 . . . . 72.409999999999997 109.803 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 4' ' ' TRP . 8.2 mttm -121.41 155.72 34.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.333 1.453 . . . . 55.140000000000001 108.695 173.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 tt -145.75 148.23 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 119.095 0.862 . . . . 45.32 110.532 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.0 p -152.37 77.53 1.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.552 1.141 . . . . 64.329999999999998 109.913 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.4 -59.63 0.17 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 127.838 2.637 . . . . 74.230000000000004 115.385 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 p -132.6 22.16 4.3 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.479 1.111 . . . . 71.430000000000007 112.294 174.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.7 m -127.68 131.89 49.74 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.682 1.193 . . . . 72.239999999999995 107.989 167.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.98 131.96 56.44 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.524 1.929 . . . . 75.120000000000005 107.885 167.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -120.14 98.57 6.13 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.489 1.516 . . . . 72.319999999999993 108.183 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.6 t -75.89 125.59 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.436 -1.69 . . . . 34.530000000000001 106.436 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -83.15 -33.86 26.16 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.512 0.596 . . . . 64.200000000000003 111.474 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.0 t -146.76 155.77 42.64 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.446 1.498 . . . . 74.200000000000003 109.127 -170.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.07 -175.42 15.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 124.978 1.275 . . . . 53.210000000000001 111.414 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -24.61 63.29 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.895 -1.05 . . . . 63.43 112.432 169.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -111.68 24.19 13.01 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.406 1.003 . . . . 64.109999999999999 112.342 -168.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.39 102.41 0.23 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.341 1.456 . . . . 55.310000000000002 112.659 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.74 -124.97 0.92 Allowed Glycine 0 N--CA 1.463 0.498 0 C-N-CA 124.23 0.919 . . . . 73.219999999999999 112.557 -173.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -152.2 147.48 26.45 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.691 1.196 . . . . 35.229999999999997 111.186 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -143.51 146.7 33.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.336 1.454 . . . . 71.239999999999995 110.0 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -115.19 27.24 9.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.522 1.129 . . . . 72.109999999999999 113.69 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttt 61.76 159.28 0.06 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.692 1.997 . . . . 61.539999999999999 111.255 -170.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 . . . . . 0 C--N 1.324 -0.522 0 C-N-CA 127.786 2.434 . . . . 73.140000000000001 106.083 163.345 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 104.1 -2.556 . . . . 61.039999999999999 104.1 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -121.81 -178.63 3.88 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 125.755 1.622 . . . . 71.219999999999999 108.624 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.6 p -111.42 170.19 8.29 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.588 0.631 . . . . 73.450000000000003 111.072 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.36 119.07 5.42 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.548 1.139 . . . . 70.049999999999997 109.669 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.9 tp -70.84 123.24 21.51 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.528 -1.656 . . . . 73.439999999999998 106.528 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -136.85 175.2 9.83 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.053 0.941 . . . . 65.329999999999998 108.903 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.3 p -58.51 -41.07 84.55 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.56 1.544 . . . . 73.340000000000003 111.821 -174.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -80.89 -30.14 35.53 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.384 0.674 . . . . 61.219999999999999 109.857 -174.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.6 -38.51 91.38 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.394 0.543 . . . . 74.219999999999999 111.021 -170.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.5 tp -74.43 -24.81 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.616 1.166 . . . . 70.510000000000005 112.636 -172.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm -57.02 109.58 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.91 1.684 . . . . 70.310000000000002 111.21 -168.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.97 172.89 32.99 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.784 -0.926 . . . . 54.119999999999997 110.784 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -86.51 160.02 19.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.42 -0.956 . . . . 70.209999999999994 108.42 159.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -146.89 140.86 26.0 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.475 1.51 . . . . 74.109999999999999 108.894 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.0 t -138.09 179.42 6.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.238 1.415 . . . . 51.130000000000003 107.874 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 t -137.27 -40.03 0.59 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.647 -1.283 . . . . 70.519999999999996 112.034 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.86 179.6 30.79 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 106.652 -2.579 . . . . 61.119999999999997 106.652 167.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.8 pt -130.41 36.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.304 1.041 . . . . 65.439999999999998 109.678 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -139.61 174.39 10.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.947 1.299 . . . . 71.439999999999998 109.606 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.68 -95.22 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.991 1.758 . . . . 50.310000000000002 114.024 169.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -139.44 141.89 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 105.688 -1.967 . . . . 73.209999999999994 105.688 162.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -151.45 -179.47 7.41 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.487 1.115 . . . . 72.420000000000002 108.112 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -142.47 140.86 32.04 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.131 0.973 . . . . 72.430000000000007 108.767 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.32 154.08 17.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.859 2.064 . . . . 71.540000000000006 107.032 170.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.479 HD21 ' HG2' ' A' ' 91' ' ' GLU . 5.0 mt -145.02 147.76 32.97 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.39 1.876 . . . . 73.430000000000007 105.951 169.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 p -151.02 154.71 37.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.015 0.825 . . . . 73.200000000000003 110.516 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CE1' HD22 ' A' ' 27' ' ' LEU . 93.2 m-85 -143.56 118.12 9.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.257 1.023 . . . . 71.230000000000004 108.782 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.5 158.76 25.76 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.61 -0.885 . . . . 43.130000000000003 108.61 164.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -79.6 -39.04 32.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.023 0.529 . . . . 71.310000000000002 110.427 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.29 8.79 7.88 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.897 0.879 . . . . 75.019999999999996 110.678 -166.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.27 -133.21 5.36 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 126.694 2.092 . . . . 74.540000000000006 108.062 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -126.35 -177.89 4.14 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.299 1.44 . . . . 75.140000000000001 108.441 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.27 160.1 15.27 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.667 1.603 . . . . 62.219999999999999 110.461 171.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 m -133.63 158.2 43.83 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.326 1.051 . . . . 31.219999999999999 109.871 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -149.1 129.11 13.49 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.464 1.906 . . . . 72.430000000000007 107.082 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.87 119.21 1.11 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.226 -1.15 . . . . 54.240000000000002 110.226 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.507 ' H ' ' HB3' ' A' ' 47' ' ' SER . 35.9 mt -75.95 150.63 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.558 -0.905 . . . . 73.129999999999995 108.558 174.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -132.09 133.58 44.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.443 1.497 . . . . 73.129999999999995 108.222 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 m -83.17 135.34 34.83 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 105.792 -1.929 . . . . 61.329999999999998 105.792 159.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 43.42 -80.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.785 2.434 . . . . 72.510000000000005 115.825 156.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.07 64.42 1.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.073 0.949 . . . . 22.440000000000001 111.597 162.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 m -157.65 135.83 7.48 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 128.469 2.707 . . . . 71.230000000000004 108.875 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.25 119.89 5.76 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.312 3.341 . . . . 74.109999999999999 111.927 170.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 mm -122.8 17.12 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.611 1.564 . . . . 73.530000000000001 111.071 -173.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 39' ' ' ILE . 30.4 t -158.03 164.26 36.91 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 119.492 -2.005 . . . . 63.520000000000003 108.117 157.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -158.72 127.86 5.53 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.898 2.079 . . . . 73.200000000000003 106.122 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -143.4 169.31 17.9 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.145 1.778 . . . . 71.439999999999998 107.604 163.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.0 mtm -145.92 160.43 41.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.44 1.096 . . . . 75.319999999999993 110.302 170.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -161.89 147.55 13.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.626 1.57 . . . . 71.219999999999999 108.23 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.59 176.18 7.87 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.447 1.476 . . . . 51.229999999999997 108.614 170.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -157.43 161.96 38.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.266 -0.896 . . . . 65.5 111.139 168.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -131.15 165.0 24.26 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.454 0.702 . . . . 74.040000000000006 109.338 163.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.8 mm -123.8 83.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 105.753 -1.943 . . . . 73.400000000000006 105.753 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.28 24.14 10.89 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.064 1.346 . . . . 65.439999999999998 110.074 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -164.25 13.51 0.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.963 1.305 . . . . 73.040000000000006 114.092 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.65 14.6 65.22 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 120.977 -1.077 . . . . 65.430000000000007 111.843 -171.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -137.19 170.94 15.25 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.143 2.177 . . . . 64.209999999999994 106.625 173.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 mt -75.27 165.61 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.446 -1.316 . . . . 64.409999999999997 107.446 176.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -136.52 108.62 7.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.976 2.11 . . . . 65.319999999999993 106.179 162.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mm -93.46 145.59 7.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 106.02 -1.845 . . . . 50.009999999999998 106.02 168.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -150.25 -1.45 0.41 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.131 1.16 . . . . 74.409999999999997 114.131 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.36 115.92 3.84 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.079 -2.563 . . . . 75.439999999999998 104.079 -167.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.34 149.43 32.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.295 1.038 . . . . 74.439999999999998 108.459 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.64 164.41 32.88 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.998 2.119 . . . . 63.32 106.094 168.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.03 -16.09 19.67 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.412 0.826 . . . . 64.219999999999999 113.69 -5.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.09 119.89 34.37 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.683 -1.599 . . . . 72.310000000000002 106.683 172.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -79.4 141.66 36.67 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 118.668 0.667 . . . . 73.519999999999996 110.281 177.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -136.61 160.16 39.65 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.605 1.162 . . . . 70.530000000000001 111.315 -177.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 t -57.69 151.62 40.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.588 1.955 . . . . 65.340000000000003 111.464 170.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.88 158.05 38.88 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.665 2.91 . . . . 74.420000000000002 112.484 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -171.04 172.4 5.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.664 1.186 . . . . 73.109999999999999 111.176 173.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -115.93 96.89 5.8 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.963 1.705 . . . . 71.510000000000005 110.052 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.2 mt -75.54 133.13 41.06 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 126.238 1.815 . . . . 62.119999999999997 109.258 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.418 ' H ' HG22 ' A' ' 88' ' ' THR . 0.0 OUTLIER -87.1 130.49 34.48 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.776 1.23 . . . . 73.329999999999998 109.303 176.767 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.3 p -154.64 166.62 32.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.487 1.915 . . . . 64.310000000000002 109.306 170.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -131.57 155.33 47.69 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.643 1.577 . . . . 74.510000000000005 109.649 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.9 tt -146.89 147.92 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.411 1.084 . . . . 65.540000000000006 108.122 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 m -138.74 -5.37 1.53 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.185 1.394 . . . . 74.109999999999999 114.626 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.02 -89.89 0.11 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 107.978 -2.049 . . . . 54.509999999999998 107.978 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.0 p -119.8 -4.35 10.2 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.676 1.361 . . . . 65.310000000000002 114.676 -172.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -99.08 114.14 26.7 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 121.039 1.745 . . . . 73.540000000000006 110.582 172.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.5 tp -85.49 116.17 23.64 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 119.441 -2.037 . . . . 50.240000000000002 108.297 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.87 105.51 15.73 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.011 0.924 . . . . 61.219999999999999 109.792 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.5 t -90.12 127.68 42.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.132 -0.692 . . . . 63.539999999999999 109.132 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -85.53 -38.2 18.79 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 118.662 0.664 . . . . 63.340000000000003 110.699 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 76' ' ' ASP . 1.4 t -148.54 173.35 13.23 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.092 0.86 . . . . 74.340000000000003 110.962 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.42 177.07 23.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 125.088 1.328 . . . . 64.129999999999995 110.361 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.8 m -53.48 -30.94 43.51 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.589 1.155 . . . . 74.219999999999999 110.252 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.479 ' HG2' HD21 ' A' ' 27' ' ' LEU . 1.4 mp0 -89.51 0.52 56.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.713 1.005 . . . . 73.5 113.713 -174.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.48 109.87 0.26 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.801 1.64 . . . . 71.409999999999997 109.651 -175.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.15 -167.97 39.6 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 109.024 -1.63 . . . . 71.439999999999998 109.024 -167.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.8 t -135.13 147.98 49.64 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.108 -1.071 . . . . 72.530000000000001 108.108 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -146.68 160.53 42.09 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.17 1.388 . . . . 73.430000000000007 109.97 -167.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.78 140.25 49.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.441 1.496 . . . . 70.209999999999994 109.405 175.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -60.77 144.47 52.35 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.776 1.231 . . . . 74.239999999999995 109.952 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 . . . . . 0 CA--C 1.534 0.365 0 C-N-CA 126.861 2.064 . . . . 74.519999999999996 109.11 178.235 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 . . . . . 0 C--O 1.236 0.379 0 N-CA-C 105.745 -1.946 . . . . 65.150000000000006 105.745 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.405 ' CD1' ' HE3' ' A' ' 78' ' ' LYS . 86.4 m95 -117.42 154.01 32.11 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.581 1.153 . . . . 65.140000000000001 110.48 -178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.2 p -75.32 165.85 24.52 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.28 -0.637 . . . . 73.25 109.28 172.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -64.19 130.93 45.86 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.755 1.264 . . . . 75.140000000000001 108.873 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.04 133.83 55.16 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 114.597 -1.183 . . . . 75.549999999999997 109.184 164.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.31 166.7 23.85 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.157 -1.383 . . . . 71.120000000000005 109.428 166.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -44.9 78.09 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 124.328 1.017 . . . . 71.340000000000003 108.957 167.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -60.83 -24.82 66.17 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.963 -1.086 . . . . 73.120000000000005 112.152 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.418 ' HB3' HG21 ' A' ' 79' ' ' ILE . 1.3 m-20 -85.96 -26.86 25.25 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 118.432 -0.794 . . . . 71.439999999999998 112.457 -172.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.0 tp -88.07 -7.52 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.54 1.064 . . . . 73.519999999999996 112.168 -171.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.442 ' O ' ' HE3' ' A' ' 97' ' ' LYS . 18.3 mm -62.23 114.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.218 1.407 . . . . 75.310000000000002 110.445 -172.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.6 173.92 25.71 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.435 -1.066 . . . . 53.350000000000001 110.435 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -85.62 151.55 23.81 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.369 -1.345 . . . . 54.009999999999998 107.369 162.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -138.58 123.84 19.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.108 1.363 . . . . 73.310000000000002 108.772 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -129.1 170.13 13.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.327 0.651 . . . . 60.420000000000002 109.403 173.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.455 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 12.5 t -126.82 -6.07 6.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.77 1.628 . . . . 61.240000000000002 111.369 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.07 177.46 19.9 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 108.665 -1.774 . . . . 61.149999999999999 108.665 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 pt -131.65 -11.04 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.702 0.801 . . . . 73.530000000000001 112.655 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -72.05 153.72 41.56 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 120.104 -1.623 . . . . 73.510000000000005 110.409 173.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.18 -111.64 3.31 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.698 -1.057 . . . . 70.230000000000004 111.237 165.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.6 m -141.78 107.49 5.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.966 -1.494 . . . . 62.100000000000001 106.966 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -103.11 175.43 5.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 122.229 1.014 . . . . 73.420000000000002 110.779 -174.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -126.89 140.08 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.461 1.905 . . . . 71.329999999999998 106.826 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.45 143.51 51.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.94 1.296 . . . . 52.130000000000003 108.428 -176.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.0 mt -132.12 156.75 45.81 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.034 -1.469 . . . . 75.140000000000001 107.034 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.0 p -154.92 97.64 1.97 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.689 1.596 . . . . 60.530000000000001 112.311 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -91.59 132.42 36.33 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.243 1.417 . . . . 75.530000000000001 110.289 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -94.11 165.33 12.68 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 127.77 2.428 . . . . 60.350000000000001 108.949 159.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -104.26 6.64 35.57 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.059 1.744 . . . . 60.310000000000002 110.549 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -149.94 7.3 0.62 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 115.162 1.541 . . . . 61.25 115.162 175.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.06 -110.97 1.51 Allowed Glycine 0 C--N 1.337 0.632 0 CA-C-N 118.498 0.59 . . . . 72.540000000000006 112.132 -170.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.4 p -147.16 131.83 17.86 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.418 1.487 . . . . 71.439999999999998 107.927 -174.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.95 175.96 34.06 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.137 -0.785 . . . . 71.420000000000002 111.137 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m -145.04 164.27 31.69 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.817 -1.402 . . . . 75.409999999999997 111.943 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -141.63 120.5 12.73 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.024 -0.732 . . . . 63.409999999999997 109.024 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -121.35 161.65 15.35 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.553 1.073 . . . . 44.219999999999999 111.097 177.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.4 mt -137.7 133.62 45.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.962 -1.866 . . . . 63.32 105.962 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -125.93 127.03 45.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.593 1.557 . . . . 43.140000000000001 108.965 -170.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -86.01 112.83 21.59 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.149 -1.056 . . . . 55.200000000000003 108.149 166.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.24 -85.95 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.921 2.089 . . . . 74.299999999999997 110.307 -169.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.92 -0.42 3.41 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.155 0.982 . . . . 60.100000000000001 112.264 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.5 m -84.11 119.65 73.61 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.267 1.427 . . . . 74.430000000000007 108.161 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.36 140.19 57.26 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.862 2.375 . . . . 64.510000000000005 109.778 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.8 mm -124.42 -41.61 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 124.213 1.005 . . . . 73.319999999999993 109.655 -177.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.2 t -124.63 156.18 37.91 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 121.495 -0.753 . . . . 73.310000000000002 109.641 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -154.82 152.99 30.47 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.987 1.715 . . . . 74.299999999999997 108.235 172.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -161.48 161.07 29.92 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 127.723 2.409 . . . . 51.329999999999998 107.286 168.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.6 mtm -124.3 163.3 21.95 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.199 1.0 . . . . 72.430000000000007 110.048 166.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -164.57 141.7 6.38 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.433 1.093 . . . . 71.349999999999994 111.035 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.8 158.83 20.83 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.151 0.98 . . . . 72.540000000000006 108.961 164.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -151.33 166.73 30.07 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.158 -0.964 . . . . 74.349999999999994 110.556 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -138.07 149.3 45.88 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.187 -1.042 . . . . 75.430000000000007 108.187 165.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.2 mm -116.61 92.98 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 106.888 -1.523 . . . . 74.329999999999998 106.888 172.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -134.31 23.32 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.648 0.779 . . . . 74.510000000000005 112.484 -173.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -166.71 14.13 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.805 0.842 . . . . 75.120000000000005 111.791 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.77 5.59 57.39 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.342 -0.848 . . . . 72.150000000000006 111.947 -171.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.542 ' HB3' ' HA ' ' A' ' 76' ' ' ASP . 0.6 OUTLIER -121.51 145.01 48.39 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 130.458 3.503 . . . . 73.109999999999999 109.551 173.616 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.98 121.04 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.583 -1.636 . . . . 71.140000000000001 106.583 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -88.75 112.36 23.08 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.474 -1.676 . . . . 74.140000000000001 106.474 169.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 mm -103.92 138.4 28.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 106.304 -1.739 . . . . 72.310000000000002 106.304 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -158.62 2.59 0.1 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.767 1.025 . . . . 73.319999999999993 113.767 -172.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -153.43 125.15 7.72 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 103.544 -2.762 . . . . 64.530000000000001 103.544 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.9 t -135.49 152.23 31.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.973 -1.491 . . . . 73.230000000000004 106.973 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.78 160.66 52.59 Favored Pre-proline 0 C--O 1.239 0.549 0 C-N-CA 123.855 0.862 . . . . 72.409999999999997 109.046 175.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.78 -8.01 16.91 Favored 'Cis proline' 0 CA--C 1.534 0.523 0 CA-C-N 118.794 0.605 . . . . 62.43 113.45 -8.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -108.09 107.05 17.55 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.643 -1.244 . . . . 71.510000000000005 107.643 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -67.35 140.67 57.25 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.966 -0.753 . . . . 73.230000000000004 108.966 169.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -130.89 172.8 11.63 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.143 1.377 . . . . 75.319999999999993 109.146 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.7 t -49.81 150.53 3.77 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.422 1.489 . . . . 72.439999999999998 110.798 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -66.1 154.23 74.89 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.874 1.716 . . . . 60.32 110.009 163.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -160.82 153.02 20.22 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.471 1.908 . . . . 74.310000000000002 109.767 170.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -98.11 140.38 32.51 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.185 -1.042 . . . . 74.239999999999995 108.185 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.1 mt -119.76 109.22 15.36 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 126.53 1.932 . . . . 70.230000000000004 108.683 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.542 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 5.0 m-20 -62.58 131.56 49.48 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.828 -1.175 . . . . 63.210000000000001 107.828 174.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.8 p -150.8 173.0 14.72 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.483 1.513 . . . . 71.519999999999996 109.831 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HE3' ' CD1' ' A' ' 4' ' ' TRP . 17.9 mtmt -139.23 158.43 44.19 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.227 0.611 . . . . 70.519999999999996 110.233 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.418 HG21 ' HB3' ' A' ' 11' ' ' ASN . 4.8 tt -151.06 144.02 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 118.227 0.467 . . . . 64.140000000000001 110.528 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.0 t -133.23 33.46 3.61 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.662 1.585 . . . . 74.409999999999997 108.244 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.4 -56.85 4.22 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 120.912 -1.118 . . . . 74.310000000000002 111.962 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.85 -25.25 11.32 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.043 1.127 . . . . 73.109999999999999 114.043 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.0 m -102.29 127.76 49.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.827 1.194 . . . . 75.510000000000005 108.056 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.8 tp -94.81 137.7 33.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.875 2.07 . . . . 63.32 108.808 159.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -136.15 87.91 2.34 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.6 1.16 . . . . 63.549999999999997 110.221 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.64 128.5 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.189 -1.041 . . . . 63.340000000000003 108.189 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -86.35 -25.72 25.23 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.607 0.763 . . . . 74.219999999999999 111.367 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 t -153.71 158.36 40.89 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.181 1.392 . . . . 72.219999999999999 110.579 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.18 177.47 20.93 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 124.664 1.126 . . . . 74.439999999999998 111.17 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.3 m -60.69 -16.82 43.4 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.204 1.402 . . . . 61.140000000000001 113.694 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -109.32 8.81 25.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.8 1.64 . . . . 64.519999999999996 112.844 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.12 116.34 2.73 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.311 1.844 . . . . 74.439999999999998 109.5 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.15 -153.26 21.76 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 122.158 0.866 . . . . 63.409999999999997 113.204 -172.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.7 t -135.43 123.93 23.5 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 126.191 1.796 . . . . 64.540000000000006 106.503 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.455 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 60.9 m-85 -141.01 157.72 44.94 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.556 1.169 . . . . 74.230000000000004 109.481 -175.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -127.62 138.06 52.73 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.356 -1.35 . . . . 72.340000000000003 107.356 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 13' ' ' ILE . 25.5 tttt -51.39 145.88 7.87 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.641 1.576 . . . . 62.25 109.32 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 CA--C 1.544 0.719 0 C-N-CA 128.469 2.708 . . . . 61.509999999999998 109.463 179.258 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 . . . . . 0 N--CA 1.443 -0.783 0 N-CA-C 104.814 -2.291 . . . . 65.109999999999999 104.814 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -115.15 157.2 23.95 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 125.056 1.343 . . . . 72.439999999999998 110.157 172.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.59 173.08 12.95 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.18 0.514 . . . . 64.310000000000002 109.877 169.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -59.21 151.65 22.48 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.948 -1.023 . . . . 74.129999999999995 109.754 167.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 tp -90.89 130.0 36.88 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.872 -1.529 . . . . 73.25 106.872 165.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -139.2 168.02 20.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.694 1.198 . . . . 74.450000000000003 109.259 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -74.04 33.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.945 0.898 . . . . 51.43 111.482 175.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.76 -32.44 0.44 Allowed 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 119.875 -1.765 . . . . 74.010000000000005 113.178 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -82.82 -30.3 28.86 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 116.976 -1.488 . . . . 65.219999999999999 111.969 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 tp -70.43 -24.63 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 121.636 2.016 . . . . 73.030000000000001 113.136 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.83 104.57 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.778 2.031 . . . . 74.25 111.246 -174.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.99 171.2 32.82 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.089 0.852 . . . . 72.140000000000001 111.034 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -76.13 152.28 36.77 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.106 0.962 . . . . 65.209999999999994 109.066 163.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -146.41 153.5 40.55 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.601 1.16 . . . . 70.329999999999998 109.299 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 t -153.45 165.24 36.45 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.812 -1.18 . . . . 70.140000000000001 110.304 166.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 25' ' ' LYS . 4.4 t -115.79 -9.82 11.82 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.69 1.596 . . . . 65.120000000000005 111.413 -175.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.04 -172.6 44.85 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.489 -0.757 . . . . 72.230000000000004 111.209 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.5 pt -134.77 14.69 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.032 2.133 . . . . 61.450000000000003 110.71 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -144.34 179.35 7.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.861 1.664 . . . . 74.340000000000003 111.653 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.25 -104.98 0.23 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.038 1.78 . . . . 63.549999999999997 111.755 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.6 m -139.74 101.88 4.3 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 106.128 -1.804 . . . . 74.209999999999994 106.128 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -117.7 178.73 4.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.827 1.251 . . . . 72.049999999999997 109.423 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.458 ' H ' HG22 ' A' ' 18' ' ' THR . 1.5 mptt -144.8 154.38 42.63 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.072 0.949 . . . . 71.430000000000007 109.941 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.22 154.5 18.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.382 1.873 . . . . 64.25 107.529 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mt -138.31 144.82 40.6 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.855 -1.535 . . . . 41.509999999999998 106.855 160.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.9 p -139.03 155.03 48.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.814 1.188 . . . . 73.140000000000001 109.764 166.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.426 ' CD2' ' CE2' ' A' ' 53' ' ' TYR . 22.2 m-85 -143.09 125.19 15.33 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.549 1.94 . . . . 72.239999999999995 106.039 -175.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -101.35 154.04 19.13 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.467 -1.679 . . . . 72.120000000000005 106.467 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -74.87 -41.38 59.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.841 0.746 . . . . 51.409999999999997 111.38 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -108.59 -1.74 19.37 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.113 0.565 . . . . 65.409999999999997 111.672 -162.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.81 -112.22 1.54 Allowed Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.26 -0.736 . . . . 31.039999999999999 111.26 -169.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 80.3 p -145.3 172.67 12.82 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.022 1.329 . . . . 51.329999999999998 107.773 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.03 -166.46 14.64 Favored Glycine 0 CA--C 1.524 0.627 0 O-C-N 120.973 -1.08 . . . . 43.219999999999999 111.865 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -155.44 156.94 36.2 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 121.264 -1.139 . . . . 71.319999999999993 111.694 -170.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -135.52 145.54 47.17 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.325 1.45 . . . . 65.430000000000007 108.104 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.15 154.5 25.54 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 109.93 -1.268 . . . . 54.219999999999999 109.93 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.7 mt -113.29 143.77 22.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.034 -1.469 . . . . 73.140000000000001 107.034 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -132.22 119.27 20.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.499 1.52 . . . . 73.239999999999995 109.211 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -85.86 107.98 17.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.617 -1.994 . . . . 74.439999999999998 105.617 166.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.72 -57.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 129.749 3.219 . . . . 74.319999999999993 115.721 174.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -154.94 25.3 0.43 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.684 1.594 . . . . 44.420000000000002 112.307 167.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.5 m -131.51 125.16 20.51 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.89 1.276 . . . . 54.240000000000002 108.282 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.06 124.8 7.53 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.738 2.959 . . . . 74.310000000000002 112.159 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.2 mm -114.65 -13.17 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.264 1.426 . . . . 73.109999999999999 112.762 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.7 m -151.6 163.73 38.42 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.086 -1.009 . . . . 74.209999999999994 109.133 170.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -164.23 127.47 2.51 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.639 1.976 . . . . 64.439999999999998 108.057 -173.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.77 166.94 26.94 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.879 1.671 . . . . 53.340000000000003 108.354 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.8 mtm -137.93 151.25 47.79 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.545 -0.909 . . . . 65.049999999999997 108.545 170.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.74 146.76 18.11 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.327 1.451 . . . . 74.209999999999994 110.913 -171.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -81.22 176.24 9.94 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.301 -1.0 . . . . 74.439999999999998 108.301 167.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CE2' ' CD2' ' A' ' 29' ' ' PHE . 5.9 m-85 -141.97 159.19 42.73 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.87 -0.604 . . . . 74.129999999999995 110.2 171.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -130.78 132.21 45.14 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.296 -1.372 . . . . 65.019999999999996 107.296 161.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.42 106.88 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 105.939 -1.875 . . . . 73.310000000000002 105.939 164.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -127.94 23.98 6.08 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.401 0.62 . . . . 74.25 111.244 174.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.67 13.73 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.471 0.915 . . . . 65.349999999999994 113.471 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.32 13.43 62.59 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 120.892 -1.13 . . . . 71.030000000000001 111.286 -163.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 76' ' ' ASP . 9.4 mmt85 -136.89 152.82 50.65 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.768 2.027 . . . . 73.120000000000005 105.917 -172.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.8 mt -88.06 115.24 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 107.147 -1.427 . . . . 72.219999999999999 107.147 -170.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -87.38 111.11 20.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.147 -1.057 . . . . 72.019999999999996 108.147 169.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.2 mm -79.51 138.99 18.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.021 -1.844 . . . . 65.129999999999995 106.021 163.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -145.79 2.84 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.859 1.429 . . . . 74.109999999999999 114.859 175.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.4 100.46 0.34 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.014 -1.476 . . . . 65.150000000000006 107.014 -156.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.9 t -130.34 143.27 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.401 1.08 . . . . 52.149999999999999 108.34 -176.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.04 158.91 71.32 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.371 1.869 . . . . 72.299999999999997 106.597 171.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -84.95 -6.41 53.31 Favored 'Cis proline' 0 CA--C 1.54 0.793 0 CA-C-N 119.533 0.869 . . . . 64.010000000000005 113.581 -6.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.09 102.79 10.73 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 105.973 -1.862 . . . . 72.019999999999996 105.973 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.43 151.97 43.53 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.234 1.016 . . . . 74.409999999999997 112.079 -174.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -128.48 164.66 22.27 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.35 1.86 . . . . 72.209999999999994 111.017 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 t -63.01 150.43 88.33 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.796 0.838 . . . . 73.439999999999998 109.292 165.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.77 137.66 25.07 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.696 2.264 . . . . 65.340000000000003 111.186 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -152.77 164.1 38.44 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.729 0.812 . . . . 74.150000000000006 111.451 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -93.39 154.37 17.99 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.244 0.617 . . . . 73.049999999999997 110.932 173.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -128.62 126.13 39.57 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.553 1.941 . . . . 70.450000000000003 107.728 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.426 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 48.0 m-20 -76.77 116.08 17.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.669 -1.975 . . . . 63.210000000000001 105.669 172.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -142.46 159.24 42.62 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.157 -0.683 . . . . 63.229999999999997 109.157 169.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -132.01 156.97 45.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.444 1.498 . . . . 71.209999999999994 110.537 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 tt -146.85 156.81 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.495 -0.557 . . . . 70.430000000000007 109.495 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.4 46.5 0.66 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 123.482 1.61 . . . . 73.140000000000001 110.898 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.19 -73.13 0.33 Allowed Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 113.583 -1.644 . . . . 65.409999999999997 109.262 171.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.4 p -119.91 -2.77 10.26 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 114.152 1.168 . . . . 74.310000000000002 114.152 -173.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.3 m -106.62 130.11 54.43 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.264 -1.384 . . . . 73.310000000000002 107.264 164.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.91 136.42 38.23 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.177 1.791 . . . . 61.25 107.524 163.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -120.65 88.77 3.0 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.662 1.185 . . . . 65.329999999999998 109.329 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.6 t -77.07 118.85 24.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.922 -1.51 . . . . 73.150000000000006 106.922 172.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -78.14 -39.97 39.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.465 0.575 . . . . 65.439999999999998 111.142 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 t -144.0 174.73 10.6 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.123 0.874 . . . . 73.310000000000002 111.258 -166.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.55 -179.17 47.65 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 125.683 1.611 . . . . 34.43 111.272 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.4 m -58.92 -21.87 58.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.356 1.462 . . . . 72.439999999999998 113.101 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -106.62 10.28 31.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.938 1.295 . . . . 73.409999999999997 112.474 -177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.45 109.57 0.46 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.298 1.439 . . . . 61.119999999999997 110.738 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -175.74 -169.89 37.91 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.547 1.07 . . . . 65.120000000000005 111.269 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -129.61 121.58 27.37 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.481 -1.674 . . . . 52.240000000000002 106.481 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -126.29 145.45 50.41 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.048 0.539 . . . . 73.049999999999997 109.842 -165.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -97.38 148.95 22.65 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.448 -0.945 . . . . 64.049999999999997 108.448 164.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -59.7 150.13 28.69 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.435 1.494 . . . . 74.319999999999993 109.486 166.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 126.251 1.82 . . . . 73.230000000000004 113.076 -170.641 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--O 1.236 0.371 0 N-CA-C 107.56 -1.274 . . . . 74.219999999999999 107.56 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -88.47 150.86 22.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.134 0.974 . . . . 75.409999999999997 110.283 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.64 175.99 7.64 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.619 1.568 . . . . 52.340000000000003 109.996 171.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -74.15 123.08 23.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.06 0.944 . . . . 72.340000000000003 111.164 172.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.431 HD22 ' SG ' ' A' ' 77' ' ' CYS . 24.7 tp -60.69 129.29 40.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.239 -0.652 . . . . 74.420000000000002 109.239 162.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -146.35 168.27 21.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.653 0.74 . . . . 72.439999999999998 109.709 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.07 21.14 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.814 3.245 . . . . 72.510000000000005 113.446 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.83 -52.13 0.63 Allowed 'General case' 0 C--O 1.232 0.177 0 O-C-N 119.904 -1.748 . . . . 74.099999999999994 110.916 176.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -64.19 -26.38 68.49 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.66 1.118 . . . . 53.030000000000001 113.015 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.429 HD13 HD11 ' A' ' 7' ' ' LEU . 10.8 tp -70.52 -25.09 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.417 1.487 . . . . 64.310000000000002 113.469 177.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.77 129.89 34.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 123.443 0.697 . . . . 45.039999999999999 110.08 -163.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.36 -172.42 18.72 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.12 1.819 . . . . 63.530000000000001 111.397 174.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -82.27 160.7 22.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.361 1.465 . . . . 72.530000000000001 111.264 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -141.13 158.28 44.13 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.702 1.601 . . . . 73.25 108.182 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 p -146.78 169.08 19.83 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.8 2.091 . . . . 71.140000000000001 112.733 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -132.78 -5.33 3.19 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.608 1.563 . . . . 61.310000000000002 112.704 -171.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.8 172.94 14.9 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.251 -1.939 . . . . 74.049999999999997 108.251 -171.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.9 pt -138.11 27.42 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.452 1.101 . . . . 62.43 110.79 -168.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -125.89 174.88 8.07 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 124.559 1.144 . . . . 74.019999999999996 112.063 -171.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 43.66 -88.47 0.01 OUTLIER Glycine 0 C--N 1.341 0.854 0 C-N-CA 127.505 2.479 . . . . 55.420000000000002 114.017 149.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.3 m -130.44 122.23 27.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.485 -1.672 . . . . 62.030000000000001 106.485 159.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -131.72 -167.54 1.88 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.822 1.649 . . . . 72.230000000000004 107.757 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.43 156.08 18.31 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.241 1.816 . . . . 64.010000000000005 107.522 -162.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.95 132.4 20.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.789 2.436 . . . . 54.229999999999997 109.812 -177.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.59 HD21 ' HG3' ' A' ' 91' ' ' GLU . 48.4 mt -116.71 156.75 26.61 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.218 2.207 . . . . 75.340000000000003 108.498 175.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 t -137.18 156.31 48.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.025 -1.842 . . . . 43.409999999999997 106.025 160.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -143.1 129.78 20.3 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.35 1.46 . . . . 64.319999999999993 107.704 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.21 167.04 11.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.569 0.748 . . . . 71.219999999999999 110.76 171.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -81.88 -33.41 30.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.237 0.615 . . . . 71.5 110.572 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -138.08 28.82 2.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.867 0.841 . . . . 70.140000000000001 110.927 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.31 -116.62 2.54 Favored Glycine 0 C--N 1.33 0.232 0 N-CA-C 108.565 -1.814 . . . . 65.510000000000005 108.565 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.2 p -146.11 -175.07 4.61 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.398 1.479 . . . . 65.519999999999996 107.173 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.82 170.52 17.09 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.881 -0.888 . . . . 65.530000000000001 110.881 162.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.1 p -135.42 166.85 22.2 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.322 1.049 . . . . 74.409999999999997 110.89 171.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -149.59 105.96 3.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.044 -1.465 . . . . 71.329999999999998 107.044 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.51 104.02 1.02 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.577 -1.009 . . . . 63.310000000000002 110.577 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 mt -73.83 134.26 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 106.42 -1.696 . . . . 52.439999999999998 106.42 170.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -123.56 135.85 54.22 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.257 1.423 . . . . 63.25 108.238 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.28 136.29 36.96 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 107.622 -1.251 . . . . 62.229999999999997 107.622 163.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 45.89 -78.91 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 129.065 2.946 . . . . 74.019999999999996 114.655 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.27 65.47 1.02 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.793 1.237 . . . . 74.329999999999998 110.335 163.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.0 m -155.32 132.84 6.5 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.562 1.945 . . . . 64.319999999999993 108.939 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.15 134.99 26.2 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.433 2.756 . . . . 63.439999999999998 110.357 172.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.3 mm -127.48 -20.78 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.146 0.578 . . . . 71.019999999999996 111.31 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.7 t -138.76 163.69 31.53 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 120.526 -1.359 . . . . 74.230000000000004 108.268 167.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -163.45 132.36 3.93 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 126.891 2.076 . . . . 53.43 106.694 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -148.96 159.22 44.4 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.474 -1.676 . . . . 75.349999999999994 106.474 162.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.9 mtm -130.78 145.56 52.0 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.643 -1.614 . . . . 74.150000000000006 106.643 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -164.09 140.13 6.35 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.955 -0.387 . . . . 62.420000000000002 109.955 -167.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.42 174.16 3.55 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.503 1.121 . . . . 62.530000000000001 109.671 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -154.13 172.12 18.06 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.302 -0.873 . . . . 73.430000000000007 110.941 162.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -133.31 153.77 51.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.407 -0.961 . . . . 72.239999999999995 108.407 158.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.1 mm -102.67 101.12 11.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.356 -1.72 . . . . 62.5 106.356 165.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -136.67 24.52 3.13 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.503 1.521 . . . . 73.109999999999999 110.363 -171.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -169.73 14.27 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.641 1.576 . . . . 54.409999999999997 114.045 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.47 18.88 68.23 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 120.773 -1.204 . . . . 71.140000000000001 112.129 -170.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 -136.48 166.56 23.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 128.704 2.802 . . . . 74.200000000000003 105.436 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.58 150.09 4.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.117 -1.438 . . . . 71.310000000000002 107.117 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -119.99 125.17 47.73 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.61 1.964 . . . . 75.409999999999997 105.757 165.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mm -113.44 132.7 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.479 -2.045 . . . . 72.140000000000001 105.479 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -156.41 -2.61 0.12 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.314 0.857 . . . . 71.519999999999996 113.314 -170.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -145.52 111.65 5.66 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 105.526 -2.027 . . . . 74.340000000000003 105.526 174.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.28 146.84 33.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.067 -1.827 . . . . 72.140000000000001 106.067 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.58 160.73 58.01 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 106.72 -1.585 . . . . 70.239999999999995 106.72 174.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.47 -10.0 38.23 Favored 'Cis proline' 0 CA--C 1.537 0.645 0 CA-C-N 119.085 0.709 . . . . 70.450000000000003 113.532 -7.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.96 97.23 7.12 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 104.563 -2.384 . . . . 71.430000000000007 104.563 172.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -65.76 140.53 58.44 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.547 -0.908 . . . . 71.219999999999999 108.547 168.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -126.59 171.15 11.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.308 1.043 . . . . 74.150000000000006 109.459 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -47.15 141.69 5.94 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.276 1.031 . . . . 63.240000000000002 108.719 171.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.45 139.72 42.0 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.518 1.478 . . . . 43.32 109.466 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -144.64 162.33 36.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.629 0.772 . . . . 75.120000000000005 110.397 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -99.28 156.61 16.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.467 -0.938 . . . . 71.420000000000002 108.467 170.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.4 mt -127.55 110.12 12.4 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.734 -1.21 . . . . 63.200000000000003 107.734 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -57.98 129.19 40.8 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.481 -1.303 . . . . 73.120000000000005 107.481 170.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 1.8 p -157.48 165.46 35.59 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.508 0.723 . . . . 75.510000000000005 109.359 173.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -126.86 167.94 15.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.506 1.522 . . . . 71.209999999999994 111.143 164.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.0 tt -157.71 154.79 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.796 -0.816 . . . . 75.530000000000001 108.796 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.8 m -138.48 -5.27 1.59 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 118.195 2.665 . . . . 64.530000000000001 118.195 168.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.2 -52.52 0.51 Allowed Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.956 -1.258 . . . . 73.409999999999997 109.956 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -121.22 -20.88 6.58 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 116.757 -1.592 . . . . 51.030000000000001 113.82 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.1 m -96.51 116.83 29.72 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 121.141 1.791 . . . . 53.100000000000001 110.124 168.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.45 140.13 29.84 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.645 1.178 . . . . 75.510000000000005 109.752 159.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -132.1 91.25 2.93 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.131 0.972 . . . . 74.540000000000006 110.968 170.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 29.4 t -80.67 133.24 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.106 -1.072 . . . . 75.109999999999999 108.106 173.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -89.84 -30.7 17.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.499 0.72 . . . . 74.209999999999994 112.675 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.5 t -143.38 171.59 13.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.571 1.078 . . . . 63.210000000000001 110.69 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.25 179.67 49.61 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-O 122.997 1.331 . . . . 73.140000000000001 110.787 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.3 m -58.13 -20.07 37.49 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.691 1.197 . . . . 35.439999999999998 113.757 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.59 ' HG3' HD21 ' A' ' 27' ' ' LEU . 5.4 mm-40 -110.46 16.49 21.54 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.386 0.513 . . . . 62.119999999999997 112.386 -174.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.15 105.37 0.58 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.787 0.835 . . . . 73.329999999999998 111.69 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.35 -135.18 2.16 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 118.836 0.744 . . . . 42.439999999999998 113.074 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.4 t -138.58 119.9 14.77 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.866 1.666 . . . . 74.109999999999999 109.12 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.59 152.06 51.1 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.354 -0.841 . . . . 74.200000000000003 109.24 -166.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -119.05 129.8 55.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 117.636 -1.173 . . . . 74.109999999999999 108.698 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -47.39 140.65 5.47 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.333 1.053 . . . . 74.530000000000001 109.297 172.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 . . . . . 0 N--CA 1.473 0.682 0 C-N-CA 126.107 1.763 . . . . 63.329999999999998 109.172 178.632 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 122.441 1.115 . . . . 53.119999999999997 108.34 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -72.73 152.55 41.59 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.064 1.346 . . . . 75.109999999999999 110.385 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -78.63 166.39 22.58 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.027 0.376 . . . . 54.039999999999999 110.356 167.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -51.58 132.49 30.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.269 1.033 . . . . 73.329999999999998 108.669 163.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.8 tp -72.41 122.97 22.12 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.454 -1.684 . . . . 60.329999999999998 106.454 157.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -135.43 165.24 25.94 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.015 -1.476 . . . . 74.530000000000001 107.015 174.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -57.91 -43.68 86.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 124.184 0.928 . . . . 53.399999999999999 110.732 -165.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -75.75 -24.03 56.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.784 0.834 . . . . 72.049999999999997 111.728 -171.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -71.15 -39.55 71.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.517 0.599 . . . . 75.230000000000004 111.806 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.7 tp -83.18 -14.72 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.214 1.006 . . . . 74.129999999999995 112.307 -167.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 mm -57.97 145.29 9.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.846 1.258 . . . . 73.109999999999999 109.755 -176.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.72 -170.09 13.46 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.684 1.135 . . . . 74.0 110.733 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -104.65 152.84 21.98 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.712 1.605 . . . . 74.439999999999998 109.447 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -147.45 126.47 12.84 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.845 1.258 . . . . 71.099999999999994 110.231 -170.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.6 t -135.66 166.89 22.19 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.89 0.876 . . . . 75.430000000000007 110.117 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.484 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 15.3 t -114.23 -13.96 12.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.76 1.624 . . . . 52.439999999999998 111.438 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.09 -174.9 41.7 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.704 -1.358 . . . . 60.020000000000003 109.704 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.0 pt -132.51 28.17 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.9 1.68 . . . . 63.140000000000001 110.165 -177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -129.39 175.48 8.72 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.454 1.102 . . . . 53.439999999999998 109.568 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.45 -107.79 0.57 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 125.927 1.727 . . . . 74.209999999999994 111.872 161.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.3 m -139.02 94.78 2.85 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.408 -1.701 . . . . 62.340000000000003 106.408 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -125.48 168.21 13.94 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 122.151 0.977 . . . . 61.100000000000001 111.653 -172.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -137.56 145.41 42.85 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.233 0.613 . . . . 63.5 109.839 -161.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.61 127.94 48.13 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.807 1.643 . . . . 55.299999999999997 107.71 -172.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.0 mt -117.33 153.23 33.35 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.322 -1.362 . . . . 62.200000000000003 107.322 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.0 p -148.88 158.05 43.89 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.68 -0.236 . . . . 62.43 110.655 159.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -142.62 138.76 30.94 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.169 1.388 . . . . 64.319999999999993 107.298 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.49 156.57 17.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.067 0.947 . . . . 71.219999999999999 109.622 171.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.9 -21.09 44.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 54.210000000000001 111.857 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.96 -1.61 5.24 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.325 0.65 . . . . 74.299999999999997 112.431 -173.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.94 -129.96 4.36 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.256 1.408 . . . . 55.409999999999997 111.992 -166.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 p -137.04 172.45 13.0 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 127.302 2.241 . . . . 75.099999999999994 107.38 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.9 175.83 25.51 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.523 -0.735 . . . . 35.340000000000003 112.241 -176.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.37 152.08 50.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.904 1.282 . . . . 75.310000000000002 108.317 176.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -145.14 106.5 4.21 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.447 1.499 . . . . 62.509999999999998 108.693 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.78 149.66 18.64 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.785 -0.926 . . . . 75.120000000000005 110.785 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.3 mt -116.1 131.7 67.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.362 -2.088 . . . . 71.409999999999997 105.362 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -130.95 127.74 39.03 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.932 1.293 . . . . 62.32 109.006 -170.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.93 115.83 31.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.668 -1.975 . . . . 44.119999999999997 105.668 173.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.73 -65.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 129.602 3.161 . . . . 75.129999999999995 115.849 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -153.62 36.23 0.45 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.947 1.299 . . . . 74.010000000000005 111.785 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.1 m -136.85 133.92 19.01 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.953 1.301 . . . . 75.340000000000003 108.788 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.06 133.04 17.52 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.408 2.738 . . . . 75.219999999999999 110.656 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 mm -128.89 -6.72 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.231 1.012 . . . . 73.129999999999995 112.261 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.3 t -153.23 157.92 40.93 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 119.783 -1.823 . . . . 74.129999999999995 109.437 167.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -146.93 134.56 21.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.055 2.142 . . . . 54.32 107.936 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -141.45 160.28 40.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.184 -1.043 . . . . 71.109999999999999 108.184 162.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mtm -130.82 139.13 50.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.465 -2.05 . . . . 75.340000000000003 105.465 172.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.616 ' HB3' HG23 ' A' ' 65' ' ' VAL . 7.7 p90 -157.37 152.5 25.96 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.706 -1.22 . . . . 73.010000000000005 107.706 -173.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.9 p30 -79.32 -177.35 5.67 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.648 1.213 . . . . 75.299999999999997 111.003 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.535 ' CD1' HG23 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -173.16 135.04 0.56 Allowed 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.858 1.663 . . . . 72.319999999999993 111.461 -164.717 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.582 ' HE3' ' CE1' ' A' ' 63' ' ' TYR . 4.1 mttt -135.34 159.96 39.91 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 124.536 1.147 . . . . 74.329999999999998 109.239 159.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.0 mm -94.71 118.91 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.723 -1.954 . . . . 75.230000000000004 105.723 149.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -136.93 25.09 3.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.769 0.828 . . . . 63.420000000000002 110.062 162.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.6 14.92 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 115.377 1.621 . . . . 74.239999999999995 115.377 -174.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.99 20.47 64.66 Favored Glycine 0 CA--C 1.531 1.094 0 O-C-N 120.299 -1.501 . . . . 64.129999999999995 110.951 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -148.41 156.68 42.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.63 2.772 . . . . 63.100000000000001 105.007 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.535 HG23 ' CD1' ' A' ' 53' ' ' TYR . 72.1 mt -84.06 115.73 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 105.318 -2.104 . . . . 72.310000000000002 105.318 -176.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -90.26 116.87 28.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 117.918 -1.039 . . . . 73.200000000000003 109.236 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.5 mm -95.82 148.83 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 107.162 -1.421 . . . . 71.099999999999994 107.162 172.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.582 ' CE1' ' HE3' ' A' ' 54' ' ' LYS . 13.1 p90 -158.26 -0.19 0.1 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.755 1.761 . . . . 73.5 115.755 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -152.95 124.97 7.95 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.762 -2.31 . . . . 64.540000000000006 104.762 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.746 ' CG1' ' H ' ' A' ' 70' ' ' LYS . 7.2 p -139.23 158.21 28.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 125.139 1.376 . . . . 74.439999999999998 109.948 173.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.89 158.72 48.64 Favored Pre-proline 0 C--O 1.24 0.577 0 C-N-CA 126.839 2.056 . . . . 71.0 106.894 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -80.64 -10.96 39.95 Favored 'Cis proline' 0 N--CA 1.463 -0.321 0 N-CA-C 113.863 0.678 . . . . 72.519999999999996 113.863 0.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.11 124.35 50.65 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 103.555 -2.757 . . . . 70.510000000000005 103.555 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.713 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -75.68 148.15 38.88 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.382 -0.599 . . . . 74.239999999999995 109.382 172.305 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.746 ' H ' ' CG1' ' A' ' 65' ' ' VAL . 23.2 mtpt -128.05 158.66 37.33 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.574 -0.528 . . . . 74.109999999999999 109.574 169.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -53.26 149.28 13.91 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.283 1.433 . . . . 74.540000000000006 111.727 -178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.68 140.37 42.8 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.352 2.035 . . . . 63.219999999999999 111.482 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -159.31 174.58 14.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.708 1.203 . . . . 73.439999999999998 110.24 175.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.81 125.49 54.06 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.779 1.632 . . . . 73.299999999999997 110.248 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.0 mt -89.44 112.53 23.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.608 1.163 . . . . 64.400000000000006 109.146 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.09 114.08 3.51 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.377 -1.342 . . . . 73.519999999999996 107.377 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' CYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 3.9 p -152.6 157.92 41.71 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.876 0.845 . . . . 53.009999999999998 110.429 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -129.31 152.95 48.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.916 1.687 . . . . 74.530000000000001 108.827 -175.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.6 tt -146.92 152.75 12.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.466 -0.568 . . . . 54.039999999999999 109.466 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 t -159.26 45.75 0.27 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 122.945 1.355 . . . . 74.319999999999993 110.779 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.52 -127.89 9.28 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 106.811 -2.515 . . . . 54.130000000000003 106.811 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.5 p -71.36 -11.41 60.88 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.383 -1.77 . . . . 64.140000000000001 114.16 -167.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.5 m -95.05 119.74 34.07 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 121.664 2.029 . . . . 42.030000000000001 108.822 173.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.9 tp -92.56 131.56 37.58 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.748 1.619 . . . . 72.120000000000005 108.13 160.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -119.48 100.59 7.38 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 125.246 1.418 . . . . 64.319999999999993 108.175 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.467 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 59.9 t -94.25 131.48 41.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.807 -1.183 . . . . 62.520000000000003 107.807 174.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -92.14 -29.22 16.62 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.579 0.752 . . . . 52.409999999999997 112.652 -172.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.9 t -140.78 173.17 11.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.003 1.721 . . . . 45.020000000000003 110.04 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.09 -176.15 45.29 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 122.976 1.32 . . . . 45.219999999999999 112.311 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.59 -32.09 73.6 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.056 -0.673 . . . . 71.209999999999994 110.572 172.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.72 7.36 39.97 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.725 -0.609 . . . . 73.310000000000002 112.391 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.6 104.99 0.21 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.252 2.221 . . . . 71.519999999999996 111.584 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.96 -158.84 29.0 Favored Glycine 0 N--CA 1.451 -0.312 0 O-C-N 121.656 -0.652 . . . . 61.310000000000002 112.444 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.6 p -115.85 120.48 39.37 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.481 1.912 . . . . 55.439999999999998 107.327 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.484 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 67.1 m-85 -135.67 148.05 48.79 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.04 -0.726 . . . . 75.140000000000001 109.04 -174.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -111.86 146.2 38.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.068 -1.086 . . . . 54.420000000000002 108.068 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -55.6 144.79 25.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.91 0.884 . . . . 72.439999999999998 108.891 172.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 105.743 -1.947 . . . . 73.200000000000003 105.743 179.531 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 106.285 -1.746 . . . . 74.219999999999999 106.285 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -120.78 161.15 21.97 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.684 1.193 . . . . 64.340000000000003 110.502 172.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.47 178.43 7.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.049 2.14 . . . . 73.200000000000003 109.966 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -67.07 135.36 53.52 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.633 -1.167 . . . . 73.209999999999994 110.359 161.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -73.89 129.73 38.48 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 126.143 1.777 . . . . 71.420000000000002 108.097 158.787 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -141.3 179.57 6.69 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 119.64 -0.824 . . . . 71.030000000000001 110.132 161.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -69.27 25.1 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.386 1.875 . . . . 74.219999999999999 112.65 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.63 -53.64 0.82 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 119.873 -1.767 . . . . 64.409999999999997 109.317 -171.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -65.65 -28.5 69.14 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.451 -1.262 . . . . 74.120000000000005 112.517 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.19 -18.64 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 121.366 1.894 . . . . 71.340000000000003 114.002 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.4 mm -62.89 121.19 11.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 O-C-N 121.375 -0.828 . . . . 74.040000000000006 110.247 -169.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.98 -174.05 26.93 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.085 1.802 . . . . 74.150000000000006 111.12 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 28' ' ' SER . 1.8 m-85 -88.74 163.27 15.81 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.003 1.321 . . . . 73.239999999999995 109.513 171.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 84' ' ' LEU . 94.9 m95 -150.22 133.85 16.65 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.925 -1.109 . . . . 73.140000000000001 111.116 -175.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 t -138.2 162.75 33.47 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.292 1.437 . . . . 64.120000000000005 109.596 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.482 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 8.9 t -126.73 -14.79 5.62 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.496 1.118 . . . . 70.340000000000003 112.234 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.3 170.53 30.37 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 107.159 -2.376 . . . . 72.239999999999995 107.159 -169.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.0 pt -138.76 34.87 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.493 1.117 . . . . 73.219999999999999 108.746 -161.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -148.79 -176.14 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.8 1.64 . . . . 74.400000000000006 109.908 -165.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 44.97 -99.84 0.02 OUTLIER Glycine 0 CA--C 1.525 0.702 0 C-N-CA 126.603 2.049 . . . . 52.240000000000002 113.18 158.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 m -134.83 115.98 14.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.424 -1.695 . . . . 72.219999999999999 106.424 165.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -127.34 168.55 14.64 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.679 0.752 . . . . 74.099999999999994 109.699 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -139.79 137.16 34.8 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.746 -1.576 . . . . 65.140000000000001 106.746 -164.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.43 HD13 ' H ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -123.32 143.3 50.18 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.214 1.406 . . . . 72.420000000000002 107.686 -172.098 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.447 HD22 ' CZ ' ' A' ' 29' ' ' PHE . 6.9 mt -138.95 158.99 43.2 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.785 1.634 . . . . 72.150000000000006 107.823 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 23.6 p -150.56 157.08 42.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.765 0.826 . . . . 65.219999999999999 109.747 163.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.447 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 92.4 m-85 -144.16 135.64 25.78 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.53 1.532 . . . . 74.010000000000005 107.798 174.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -110.53 150.56 28.74 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.295 1.038 . . . . 74.409999999999997 109.216 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -25.54 56.16 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.879 -0.513 . . . . 72.209999999999994 110.937 -174.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.6 -3.36 5.39 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.503 0.721 . . . . 72.030000000000001 111.12 -172.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.33 -140.47 6.64 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 126.085 1.803 . . . . 74.219999999999999 110.272 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 74.7 p -122.89 158.68 29.83 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.806 1.242 . . . . 72.310000000000002 109.17 -176.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.89 165.56 43.89 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 109.889 -1.285 . . . . 74.219999999999999 109.889 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.16 161.54 37.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.393 -0.595 . . . . 72.209999999999994 109.393 173.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -140.56 150.17 43.32 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.086 -1.079 . . . . 72.209999999999994 108.086 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.81 155.69 26.39 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.069 -1.212 . . . . 62.43 110.069 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.5 mt -125.66 136.88 59.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.508 -2.034 . . . . 72.310000000000002 105.508 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -119.9 155.45 32.68 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.837 1.255 . . . . 72.230000000000004 108.278 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.05 130.93 56.45 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.254 -1.758 . . . . 71.329999999999998 106.254 162.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 44.85 -81.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 128.369 2.668 . . . . 71.239999999999995 114.653 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.01 54.25 1.37 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.928 1.691 . . . . 72.319999999999993 110.433 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.2 m -155.15 124.11 3.05 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 125.604 1.562 . . . . 73.420000000000002 108.544 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.69 139.74 41.22 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.891 2.394 . . . . 73.129999999999995 109.999 171.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.9 mm -129.79 -16.66 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.208 1.403 . . . . 72.340000000000003 111.416 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.5 t -139.94 161.91 36.45 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.995 -1.691 . . . . 73.140000000000001 108.966 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -160.48 145.17 14.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 126.282 1.833 . . . . 74.430000000000007 107.983 -176.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.13 168.41 25.55 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 125.765 1.626 . . . . 61.439999999999998 107.512 167.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.7 mtm -133.03 138.07 46.68 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.921 -1.511 . . . . 75.310000000000002 106.921 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.555 ' HB3' HG23 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -149.25 137.16 20.52 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.732 1.213 . . . . 71.409999999999997 110.409 -173.907 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -82.05 166.26 19.91 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.533 -0.914 . . . . 64.239999999999995 108.533 169.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.05 168.34 27.32 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.904 0.882 . . . . 63.43 111.914 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -139.99 158.13 44.55 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.036 0.935 . . . . 65.019999999999996 111.434 162.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.5 mm -113.2 83.1 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.382 1.473 . . . . 61.149999999999999 108.1 171.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -116.77 24.29 11.36 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.395 1.878 . . . . 72.349999999999994 111.204 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -164.74 14.7 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.284 1.216 . . . . 64.25 114.284 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.8 21.28 74.95 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.287 -0.883 . . . . 54.310000000000002 111.27 -170.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -145.46 166.06 26.74 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 127.011 2.124 . . . . 63.109999999999999 107.994 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.8 mt -99.31 115.54 40.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.517 -1.66 . . . . 72.439999999999998 106.517 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -89.53 122.72 32.97 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.55 1.54 . . . . 63.149999999999999 107.912 172.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.8 mm -98.79 143.36 13.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.185 -1.413 . . . . 74.329999999999998 107.185 173.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -160.63 2.34 0.07 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.333 1.235 . . . . 71.150000000000006 114.333 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -153.75 112.49 3.68 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 104.388 -2.449 . . . . 52.509999999999998 104.388 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.727 HG13 ' HA ' ' A' ' 69' ' ' GLU . 11.8 p -138.62 157.82 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.575 -1.268 . . . . 74.129999999999995 107.575 171.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.87 165.99 23.13 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 124.889 1.276 . . . . 73.409999999999997 108.465 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.09 -44.36 0.46 Allowed 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 125.334 -0.694 . . . . 74.430000000000007 111.684 -10.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.62 125.28 26.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.892 -1.522 . . . . 61.049999999999997 106.892 167.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.727 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.2 pt-20 -75.5 158.01 33.18 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 124.285 0.991 . . . . 64.340000000000003 108.678 168.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.675 ' H ' HG12 ' A' ' 65' ' ' VAL . 9.4 mmpt? -115.14 158.73 21.8 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.509 -1.369 . . . . 72.25 108.068 164.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.73 145.91 20.08 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.624 -1.25 . . . . 51.539999999999999 107.624 168.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.4 139.8 32.36 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.852 1.701 . . . . 74.420000000000002 109.611 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -153.28 173.37 15.67 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.992 1.317 . . . . 74.109999999999999 108.554 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -107.09 153.5 22.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.93 -1.137 . . . . 74.120000000000005 107.93 171.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.3 mt -124.04 116.07 22.21 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 125.943 1.697 . . . . 63.43 107.218 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.51 121.08 9.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.211 1.404 . . . . 64.140000000000001 109.188 166.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.0 168.63 21.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 125.211 1.404 . . . . 65.430000000000007 108.415 172.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.54 165.76 26.05 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.789 1.636 . . . . 54.210000000000001 111.04 163.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.415 HG22 ' HG ' ' A' ' 7' ' ' LEU . 7.2 tt -157.38 159.46 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.453 -1.314 . . . . 71.329999999999998 107.453 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 t -137.48 -2.57 1.97 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.726 1.21 . . . . 72.129999999999995 112.612 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.73 -152.38 20.08 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 107.664 -2.175 . . . . 62.009999999999998 107.664 -149.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.0 p -51.97 7.4 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 119.554 3.168 . . . . 72.340000000000003 119.554 -173.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.9 m -130.1 110.71 11.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.528 2.731 . . . . 70.319999999999993 108.059 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.415 ' HB2' ' CE3' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -88.09 128.32 35.42 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.946 -1.502 . . . . 52.219999999999999 106.946 170.932 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -117.78 82.87 1.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.61 0.764 . . . . 72.409999999999997 110.687 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.74 128.77 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.101 -1.074 . . . . 73.040000000000006 108.101 170.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -77.45 -42.99 33.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.661 1.184 . . . . 72.129999999999995 110.008 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.4 t -130.22 -173.77 3.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.205 1.002 . . . . 73.209999999999994 112.523 -170.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.7 -172.48 39.04 Favored Glycine 0 C--N 1.335 0.494 0 O-C-N 120.337 -1.477 . . . . 72.209999999999994 110.592 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.2 m -62.92 -28.24 69.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.849 -0.795 . . . . 64.140000000000001 109.814 158.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.59 -1.12 57.39 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.387 1.475 . . . . 53.43 112.131 -167.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.71 108.03 0.24 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.395 2.278 . . . . 72.120000000000005 109.34 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.6 -154.9 19.96 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 122.192 0.884 . . . . 73.200000000000003 112.692 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 t -140.44 97.83 3.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.759 -1.941 . . . . 52.299999999999997 105.759 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.482 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 52.0 m-85 -110.38 151.3 27.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.503 -1.295 . . . . 63.310000000000002 107.503 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -104.96 148.04 27.14 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.26 -1.385 . . . . 65.109999999999999 107.26 174.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -54.79 139.6 39.05 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 106.66 -1.607 . . . . 71.109999999999999 106.66 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 . . . . . 0 N--CA 1.438 -1.042 0 N-CA-C 104.831 -2.285 . . . . 73.329999999999998 104.831 160.395 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 107.568 -1.271 . . . . 73.040000000000006 107.568 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -61.0 144.52 53.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.876 -1.057 . . . . 74.239999999999995 111.149 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.6 172.39 12.67 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.263 1.03 . . . . 73.319999999999993 110.652 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.72 140.87 55.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 122.169 0.985 . . . . 62.350000000000001 110.036 167.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.466 HD11 HD13 ' A' ' 12' ' ' ILE . 15.6 tp -78.85 133.68 36.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.55 -1.278 . . . . 74.430000000000007 107.55 168.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -143.22 167.99 20.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.741 0.816 . . . . 54.409999999999997 109.032 173.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 t -75.95 43.16 0.27 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.573 1.549 . . . . 72.030000000000001 109.877 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.21 -50.83 0.14 Allowed 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 119.85 -1.781 . . . . 62.439999999999998 110.609 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -70.49 -29.98 66.65 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 119.092 -0.48 . . . . 71.239999999999995 111.251 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.466 HD13 HD11 ' A' ' 7' ' ' LEU . 4.1 tp -64.46 -26.16 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.344 0.974 . . . . 73.120000000000005 112.941 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mm -62.85 132.56 28.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.774 1.23 . . . . 75.329999999999998 110.242 -168.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.13 -178.8 17.09 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.796 1.665 . . . . 73.430000000000007 112.08 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -76.24 157.36 32.69 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.404 0.682 . . . . 71.329999999999998 110.323 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -143.33 110.38 5.66 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.544 -0.909 . . . . 62.439999999999998 108.544 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.9 t -115.02 151.62 33.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.759 0.824 . . . . 75.209999999999994 109.332 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 t -105.32 -17.31 14.49 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.864 0.866 . . . . 52.350000000000001 111.888 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.93 179.95 35.07 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.896 -1.682 . . . . 64.319999999999993 108.896 -174.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 pt -131.86 9.15 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 117.708 0.754 . . . . 75.340000000000003 112.819 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.9 163.65 12.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.358 0.981 . . . . 74.400000000000006 110.295 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.57 -90.23 0.02 OUTLIER Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.167 1.365 . . . . 62.43 114.956 155.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 m -134.07 123.41 24.44 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.15 1.975 . . . . 74.540000000000006 107.683 163.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -140.91 176.47 8.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.562 1.145 . . . . 74.109999999999999 109.385 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -143.23 140.78 30.84 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.943 1.297 . . . . 64.340000000000003 108.68 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.56 147.01 38.78 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 126.243 1.817 . . . . 63.149999999999999 108.621 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.59 168.2 19.69 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.121 0.969 . . . . 75.129999999999995 111.29 161.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 t -143.86 156.49 44.48 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.288 1.835 . . . . 73.310000000000002 108.845 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -146.12 111.91 5.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.508 2.723 . . . . 74.010000000000005 106.525 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.73 163.33 20.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.854 0.752 . . . . 73.319999999999993 109.308 166.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -88.87 -27.12 21.24 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.309 0.643 . . . . 75.340000000000003 112.095 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -130.98 12.94 5.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.631 1.172 . . . . 72.239999999999995 111.871 -172.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -126.92 -129.61 3.28 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 126.7 2.095 . . . . 74.420000000000002 108.989 -176.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 p -132.63 -166.6 1.77 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.244 1.818 . . . . 61.439999999999998 107.906 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -129.58 -175.26 13.97 Favored Glycine 0 CA--C 1.505 -0.552 0 O-C-N 119.823 -1.798 . . . . 74.109999999999999 112.058 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -144.84 154.38 42.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 118.281 -0.866 . . . . 71.219999999999999 110.057 -166.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -136.72 135.11 37.86 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.788 1.235 . . . . 74.239999999999995 109.493 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.39 158.01 24.74 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.573 -1.011 . . . . 51.409999999999997 110.573 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.8 mt -128.01 133.05 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 105.515 -2.031 . . . . 63.350000000000001 105.515 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -129.4 124.43 34.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.402 -0.962 . . . . 73.540000000000006 108.402 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.8 m -86.09 106.74 17.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.204 -2.147 . . . . 72.329999999999998 105.204 166.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 61.96 -75.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 127.371 2.268 . . . . 72.409999999999997 113.039 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.08 34.57 0.9 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.283 1.033 . . . . 72.439999999999998 112.495 172.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -137.59 118.44 10.58 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.498 1.919 . . . . 73.519999999999996 108.018 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.31 133.58 23.03 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.243 2.629 . . . . 74.230000000000004 111.125 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 mm -122.05 1.71 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 126.501 1.92 . . . . 64.219999999999999 111.046 -175.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.7 t -160.39 153.04 21.02 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 119.867 -1.771 . . . . 32.43 109.335 166.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -148.66 136.04 20.34 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.332 1.853 . . . . 63.140000000000001 109.302 172.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -158.57 163.22 37.22 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.746 1.618 . . . . 75.239999999999995 107.677 169.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.7 mtm -138.68 151.12 46.91 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.091 0.956 . . . . 73.450000000000003 108.808 170.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -159.0 155.09 26.88 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.949 0.9 . . . . 63.030000000000001 109.752 -176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -83.23 167.25 17.87 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.657 -0.497 . . . . 73.140000000000001 109.657 173.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.08 159.87 42.69 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.01 -1.107 . . . . 61.43 108.01 169.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HA ' ' HE2' ' A' ' 54' ' ' LYS . 10.7 mmpt? -125.27 163.31 22.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.675 0.671 . . . . 75.140000000000001 109.826 162.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.6 mm -120.77 82.34 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.464 1.505 . . . . 51.240000000000002 106.956 174.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -117.45 24.11 11.33 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.795 1.238 . . . . 74.230000000000004 110.097 -172.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.71 14.56 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.434 1.894 . . . . 62.439999999999998 112.842 -164.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.78 10.02 53.95 Favored Glycine 0 CA--C 1.534 1.257 0 O-C-N 120.483 -1.385 . . . . 72.120000000000005 112.965 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.69 169.05 18.44 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 127.707 2.403 . . . . 74.349999999999994 106.739 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.8 mt -81.27 150.63 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 106.972 -1.492 . . . . 63.229999999999997 106.972 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -132.1 111.63 11.63 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.412 1.885 . . . . 75.239999999999995 108.501 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.0 mm -85.43 148.89 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.519 -1.289 . . . . 74.209999999999994 107.519 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -158.08 -5.51 0.09 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 116.132 1.901 . . . . 74.409999999999997 116.132 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -156.36 107.48 2.44 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 106.087 -1.82 . . . . 75.140000000000001 106.087 -164.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.9 ' CG1' ' H ' ' A' ' 70' ' ' LYS . 4.0 p -137.62 150.67 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 125.149 1.379 . . . . 75.120000000000005 110.741 -175.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.06 161.75 61.85 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.286 1.035 . . . . 75.519999999999996 108.388 167.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.48 -24.61 9.98 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 N-CA-C 114.493 0.92 . . . . 72.349999999999994 114.493 1.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -121.27 111.8 17.82 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.698 -0.852 . . . . 73.549999999999997 108.698 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.761 ' HA ' HG13 ' A' ' 65' ' ' VAL . 42.4 mt-10 -60.57 123.34 17.1 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 128.199 2.599 . . . . 63.43 109.057 -174.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.9 ' H ' ' CG1' ' A' ' 65' ' ' VAL . 3.6 mtpp -103.35 152.25 21.8 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.405 -0.961 . . . . 63.140000000000001 108.405 174.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.0 t -56.72 147.56 51.52 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.064 -0.717 . . . . 71.129999999999995 109.064 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.8 158.92 35.41 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.855 2.37 . . . . 62.140000000000001 112.272 170.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -172.44 168.58 5.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.791 2.436 . . . . 72.349999999999994 107.648 170.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -95.86 154.42 17.24 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.587 -0.894 . . . . 63.049999999999997 108.587 171.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.8 mt -131.93 134.36 45.57 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.956 1.302 . . . . 74.209999999999994 108.987 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -96.07 125.22 40.46 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.869 1.667 . . . . 64.439999999999998 108.716 -169.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 p -158.3 165.42 34.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.685 1.194 . . . . 73.140000000000001 109.723 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.19 160.27 29.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 124.376 1.071 . . . . 74.439999999999998 111.866 170.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 tt -144.99 151.98 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 124.996 1.318 . . . . 72.310000000000002 107.71 177.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.9 t -147.75 19.58 1.15 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.663 0.986 . . . . 74.420000000000002 113.663 161.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.11 -102.46 0.26 Allowed Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.634 -1.786 . . . . 73.219999999999999 108.634 173.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.1 p -87.61 -12.94 44.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.332 0.566 . . . . 72.209999999999994 112.298 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 m -89.26 126.69 35.61 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.137 -1.431 . . . . 62.240000000000002 107.137 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.7 tp -113.42 132.8 55.5 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.649 1.579 . . . . 75.349999999999994 108.342 160.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.5 93.76 4.0 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.938 2.095 . . . . 65.430000000000007 108.005 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.95 138.55 19.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.274 -1.38 . . . . 61.130000000000003 107.274 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -101.96 -31.49 10.65 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.737 -0.649 . . . . 74.239999999999995 112.289 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -145.9 171.24 15.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.405 1.002 . . . . 75.340000000000003 110.84 -175.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.77 174.02 38.07 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 108.924 -1.67 . . . . 52.240000000000002 108.924 -174.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.0 m -61.0 -22.02 64.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.295 -1.12 . . . . 72.049999999999997 112.011 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -84.11 -5.56 59.26 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.634 0.976 . . . . 74.439999999999998 113.634 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -46.52 108.81 0.15 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 127.22 2.208 . . . . 75.420000000000002 110.616 -170.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.03 -172.75 44.94 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 122.284 0.935 . . . . 52.140000000000001 113.277 -159.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.1 p -137.61 104.98 5.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.614 1.966 . . . . 64.329999999999998 107.287 -156.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -124.36 167.3 14.56 Favored 'General case' 0 C--O 1.239 0.545 0 O-C-N 120.929 -1.107 . . . . 75.120000000000005 112.368 -165.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -124.02 127.38 47.79 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 129.311 3.045 . . . . 64.310000000000002 107.894 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -57.57 135.13 56.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.122 1.369 . . . . 55.350000000000001 109.005 171.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 114.248 1.203 . . . . 75.319999999999993 114.248 176.526 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.841 0 N-CA-C 109.884 -1.287 . . . . 51.32 109.884 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.79 100.21 11.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.779 -1.563 . . . . 42.009999999999998 106.779 164.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -104.74 95.88 6.19 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.205 -2.146 . . . . 40.32 105.205 -175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -93.27 160.43 14.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.598 1.159 . . . . 64.340000000000003 109.838 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.8 p -91.17 167.7 12.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.559 0.618 . . . . 73.420000000000002 110.276 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.79 116.87 4.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.884 0.849 . . . . 63.399999999999999 109.663 160.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.1 tp -54.18 125.63 19.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.651 -1.24 . . . . 71.230000000000004 107.651 157.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -145.42 172.52 13.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.169 0.985 . . . . 74.530000000000001 110.07 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -1.06 0.69 Allowed 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 126.954 2.102 . . . . 53.329999999999998 115.331 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -122.95 -36.99 2.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 120.17 1.35 . . . . 71.519999999999996 112.66 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -73.94 -30.71 62.7 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.358 0.981 . . . . 53.210000000000001 112.884 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.0 tp -66.58 -22.9 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.62 1.1 . . . . 62.100000000000001 112.903 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.37 126.23 24.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.134 1.374 . . . . 70.109999999999999 110.905 -164.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 131.28 -172.74 20.65 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.783 2.135 . . . . 42.219999999999999 110.59 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -91.09 162.85 14.51 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.435 1.094 . . . . 75.409999999999997 111.567 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -148.84 122.44 9.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.506 0.722 . . . . 63.409999999999997 111.045 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 t -127.35 160.73 30.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.954 1.301 . . . . 75.299999999999997 112.474 -174.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.58 -66.17 0.94 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.566 1.946 . . . . 55.43 107.1 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.12 -179.44 48.0 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 129.37 3.366 . . . . 64.530000000000001 106.578 -170.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.1 pt -111.61 16.26 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 113.746 1.017 . . . . 64.549999999999997 113.746 -158.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -115.79 -178.82 3.48 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.682 1.193 . . . . 71.439999999999998 113.098 -166.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.33 -93.5 0.01 OUTLIER Glycine 0 C--N 1.34 0.79 0 C-N-CA 127.547 2.499 . . . . 73.230000000000004 114.976 157.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.3 m -140.76 92.86 2.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.865 -1.902 . . . . 72.409999999999997 105.865 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -100.17 168.44 9.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.214 1.007 . . . . 64.219999999999999 110.473 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -134.95 145.29 48.03 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.192 1.797 . . . . 54.119999999999997 106.817 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.427 HD13 ' H ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -133.57 146.07 50.66 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.869 0.868 . . . . 71.129999999999995 108.852 -177.393 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.427 ' H ' HD13 ' A' ' 26' ' ' LEU . 10.0 mt -134.71 158.77 43.26 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 125.041 1.336 . . . . 72.439999999999998 109.87 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t -144.12 155.53 43.98 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.843 2.057 . . . . 61.43 108.552 164.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -144.69 126.89 15.69 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 127.161 2.185 . . . . 64.120000000000005 107.611 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -101.59 159.45 15.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.959 1.704 . . . . 62.520000000000003 108.491 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.01 -38.02 28.2 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.823 -0.171 . . . . 74.519999999999996 110.634 -175.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -129.15 21.86 5.71 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.503 0.668 . . . . 71.109999999999999 110.815 -170.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.68 -112.85 1.6 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.745 1.64 . . . . 44.420000000000002 109.413 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 p -141.39 175.85 9.34 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.157 1.783 . . . . 73.200000000000003 109.555 -164.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -98.75 170.02 23.73 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.611 -0.995 . . . . 51.0 110.611 161.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.7 m -144.84 144.13 30.97 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.78 -0.835 . . . . 64.129999999999995 109.18 167.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -130.9 126.13 35.32 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.09 1.356 . . . . 73.310000000000002 107.69 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.69 159.07 17.36 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.047 0.832 . . . . 72.230000000000004 111.315 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 mt -136.99 136.01 47.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.347 -2.094 . . . . 63.340000000000003 105.347 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.42 167.24 14.1 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.015 1.326 . . . . 72.549999999999997 108.988 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.32 127.57 33.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.12 -1.437 . . . . 75.349999999999994 107.12 160.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 44.95 -73.07 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 131.446 3.898 . . . . 74.409999999999997 113.923 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.16 43.71 1.43 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.292 1.437 . . . . 42.310000000000002 112.55 175.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.7 m -144.51 135.61 12.47 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.809 1.243 . . . . 74.109999999999999 109.579 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.51 129.3 12.66 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.291 3.327 . . . . 73.519999999999996 111.17 168.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.3 mm -122.31 -22.48 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.903 0.881 . . . . 74.450000000000003 112.093 -173.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 t -130.54 170.2 14.56 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 120.545 -1.347 . . . . 74.25 109.048 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -159.6 144.33 15.23 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 127.765 2.426 . . . . 62.219999999999999 105.31 165.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -152.08 162.55 40.93 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.731 1.612 . . . . 72.310000000000002 106.707 162.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.9 mtm -130.0 162.84 27.78 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.84 -1.17 . . . . 73.129999999999995 107.84 167.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -157.15 145.79 19.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 123.877 0.736 . . . . 61.420000000000002 109.276 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.64 159.65 31.65 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.168 -1.419 . . . . 75.209999999999994 107.168 161.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -148.73 166.87 27.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 121.645 -0.659 . . . . 75.120000000000005 110.239 166.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -134.46 167.1 21.39 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.507 1.123 . . . . 72.299999999999997 108.571 167.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.8 mm -121.92 86.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.373 -1.714 . . . . 75.439999999999998 106.373 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.7 23.49 8.75 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.364 0.666 . . . . 71.129999999999995 110.105 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.73 14.04 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 114.68 1.363 . . . . 63.5 114.68 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.39 27.58 65.89 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 120.889 -1.132 . . . . 75.140000000000001 111.31 -168.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -139.39 161.31 37.77 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 127.209 2.204 . . . . 75.200000000000003 105.935 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mt -71.05 133.27 32.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 105.761 -1.94 . . . . 75.510000000000005 105.761 164.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -101.58 120.3 40.11 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.432 -1.692 . . . . 73.299999999999997 106.432 163.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.4 mm -105.31 137.49 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.308 -1.738 . . . . 44.32 106.308 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -160.6 1.31 0.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.424 0.898 . . . . 75.120000000000005 113.424 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -148.36 117.62 6.88 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 104.937 -2.246 . . . . 54.210000000000001 104.937 171.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.0 t -128.54 155.49 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 105.816 -1.92 . . . . 71.329999999999998 105.816 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.64 162.29 39.6 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.574 -0.898 . . . . 74.530000000000001 108.574 174.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.74 -21.75 15.37 Favored 'Cis proline' 0 CA--C 1.535 0.567 0 N-CA-C 113.872 0.681 . . . . 42.039999999999999 113.872 -8.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 93.57 6.96 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 104.942 -2.244 . . . . 61.530000000000001 104.942 174.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.16 140.76 58.91 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.091 0.956 . . . . 53.100000000000001 109.589 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -127.44 168.05 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.833 1.253 . . . . 75.129999999999995 110.094 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 t -55.64 148.04 37.45 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 123.844 0.715 . . . . 75.409999999999997 109.938 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.29 139.81 42.83 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.175 1.916 . . . . 75.530000000000001 111.261 169.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -152.36 174.11 14.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.919 1.287 . . . . 64.209999999999994 109.874 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -112.74 158.98 19.41 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.546 0.738 . . . . 74.400000000000006 109.439 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.8 mt -130.32 112.24 13.12 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.165 1.386 . . . . 75.530000000000001 109.679 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -62.55 122.06 14.86 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.876 1.27 . . . . 72.099999999999994 108.06 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 2.3 p -154.72 163.67 39.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.599 0.36 . . . . 41.229999999999997 110.738 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.466 ' HE2' ' CD ' ' A' ' 87' ' ' GLU . 9.7 mttm -126.74 158.42 36.54 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.055 0.942 . . . . 75.510000000000005 109.298 176.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.1 tt -151.54 154.15 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.144 -1.058 . . . . 72.510000000000005 108.144 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -141.44 -9.35 0.96 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.84 1.793 . . . . 75.230000000000004 115.84 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.82 -73.53 0.21 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.378 -1.889 . . . . 75.310000000000002 108.378 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 p -117.52 1.64 12.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.851 1.056 . . . . 72.340000000000003 113.851 -169.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.6 m -119.74 106.79 12.47 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.846 2.058 . . . . 54.020000000000003 110.469 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -75.07 128.32 35.27 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.639 -1.288 . . . . 74.439999999999998 108.333 164.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -117.25 95.09 4.82 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 119.039 -0.505 . . . . 64.099999999999994 110.681 164.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.445 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 66.1 t -86.11 132.5 31.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.038 0.835 . . . . 72.340000000000003 109.407 169.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.466 ' CD ' ' HE2' ' A' ' 78' ' ' LYS . 23.6 mt-10 -91.41 -31.71 15.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.923 0.889 . . . . 73.319999999999993 112.212 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 t -139.67 163.74 31.78 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.71 1.604 . . . . 71.420000000000002 110.556 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.58 -179.86 30.62 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 122.628 1.127 . . . . 44.0 112.662 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.1 m -58.08 -31.05 66.72 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.687 1.595 . . . . 54.229999999999997 112.52 173.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.42 ' HB3' HD11 ' A' ' 27' ' ' LEU . 1.8 mp0 -103.69 11.99 35.3 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.169 0.588 . . . . 63.310000000000002 109.887 -167.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.01 117.14 5.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.4 2.28 . . . . 71.430000000000007 110.591 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.12 -123.39 1.1 Allowed Glycine 0 C--O 1.237 0.324 0 C-N-CA 124.381 0.991 . . . . 74.430000000000007 111.6 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.4 t -145.0 142.41 29.77 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.152 1.781 . . . . 73.540000000000006 107.747 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -142.91 152.18 41.79 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.164 0.438 . . . . 75.430000000000007 111.762 167.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -91.4 147.89 22.71 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.476 -0.565 . . . . 52.100000000000001 109.476 167.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -58.55 147.53 31.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.995 0.918 . . . . 75.540000000000006 108.653 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -134.61 52.74 2.03 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.776 1.63 . . . . 72.329999999999998 109.0 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.3 mttp . . . . . 0 C--O 1.256 1.398 0 N-CA-C 105.916 -1.883 . . . . 62.200000000000003 105.916 151.814 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.62 0 N-CA-C 109.78 -1.328 . . . . 71.010000000000005 109.78 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -153.95 87.12 1.2 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 122.203 1.001 . . . . 64.019999999999996 108.368 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -78.37 104.66 9.11 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.64 -1.985 . . . . 65.0 105.64 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.416 ' CG ' ' HB3' ' A' ' 78' ' ' LYS . 94.2 m95 -101.14 163.25 12.37 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 124.604 1.162 . . . . 65.310000000000002 111.02 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.3 p -101.06 162.13 13.11 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.595 -0.521 . . . . 65.230000000000004 109.595 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.1 117.51 4.44 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.035 1.334 . . . . 72.439999999999998 110.551 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.0 tp -66.4 105.64 1.51 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.629 -1.249 . . . . 73.209999999999994 107.629 165.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.437 ' HA ' HG21 ' A' ' 55' ' ' ILE . 22.0 p30 -126.56 172.8 9.94 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.951 -1.022 . . . . 70.310000000000002 111.123 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.89 -5.68 22.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.901 2.48 . . . . 73.310000000000002 112.764 -169.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -109.81 -28.64 8.68 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.223 0.92 . . . . 73.0 110.352 171.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -66.43 -35.41 80.23 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.887 0.875 . . . . 74.040000000000006 112.71 -169.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.77 -15.24 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 113.133 0.79 . . . . 70.140000000000001 113.133 -173.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.8 mm -68.79 122.19 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.121 0.968 . . . . 74.040000000000006 111.218 -161.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.78 -168.91 24.35 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.624 1.583 . . . . 64.230000000000004 111.319 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 28' ' ' SER . 1.9 m-85 -88.66 159.95 17.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.463 1.105 . . . . 72.230000000000004 110.284 176.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.417 ' CZ3' ' HB2' ' A' ' 84' ' ' LEU . 85.2 m95 -142.36 125.94 16.84 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.435 1.494 . . . . 74.430000000000007 109.756 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.7 t -123.58 164.02 19.84 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.191 0.997 . . . . 74.099999999999994 112.394 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.419 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 3.2 t -129.43 -5.96 4.76 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.856 1.663 . . . . 50.140000000000001 112.967 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.23 176.01 14.7 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 108.099 -2.0 . . . . 73.420000000000002 108.099 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 pt -135.65 7.44 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.46 0.911 . . . . 71.129999999999995 113.46 -160.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.26 165.04 15.37 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.877 1.671 . . . . 74.129999999999995 110.109 -174.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.81 -84.47 0.02 OUTLIER Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.063 1.316 . . . . 73.239999999999995 113.167 169.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -148.25 95.42 2.46 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.212 1.405 . . . . 74.530000000000001 108.081 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -114.34 177.52 4.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.152 -0.967 . . . . 71.219999999999999 110.109 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -132.66 172.63 12.29 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.251 1.421 . . . . 72.439999999999998 107.369 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.04 136.3 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.802 -1.555 . . . . 74.230000000000004 106.802 173.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.1 mt -115.85 152.74 32.78 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.327 -0.99 . . . . 63.109999999999999 108.327 165.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.435 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 1.3 p -144.62 143.41 30.76 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.633 1.173 . . . . 61.200000000000003 108.554 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -138.89 124.66 19.71 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.012 0.925 . . . . 74.400000000000006 108.759 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.407 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -85.32 156.71 20.79 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.164 -1.421 . . . . 71.230000000000004 107.164 164.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -72.19 -47.83 47.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.868 0.842 . . . . 72.230000000000004 109.197 165.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.88 -1.45 24.17 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.87 2.068 . . . . 61.130000000000003 111.439 -161.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 30' ' ' ASP . . . -114.78 -122.35 3.62 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.297 -1.921 . . . . 70.109999999999999 108.297 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 p -133.0 -175.45 3.79 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.503 2.321 . . . . 74.140000000000001 107.741 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -107.12 164.27 13.17 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.123 -1.191 . . . . 70.040000000000006 110.123 164.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.97 147.59 35.43 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.659 1.184 . . . . 54.399999999999999 108.73 -175.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -134.88 140.64 45.95 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.373 -1.343 . . . . 65.510000000000005 107.373 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.15 160.42 25.83 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 111.264 -0.734 . . . . 74.200000000000003 111.264 164.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 52.0 mt -122.79 145.4 29.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 105.3 -2.111 . . . . 71.430000000000007 105.3 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -133.89 166.34 22.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.992 1.317 . . . . 71.120000000000005 109.014 -173.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.99 139.42 39.67 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.304 -0.998 . . . . 41.140000000000001 108.304 157.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 44.48 -75.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 130.358 3.463 . . . . 73.540000000000006 115.975 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.31 47.77 1.29 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.6 0.636 . . . . 61.329999999999998 112.069 167.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 m -144.06 132.67 11.11 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.459 1.504 . . . . 74.349999999999994 109.324 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.31 132.24 16.15 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.604 2.869 . . . . 74.319999999999993 110.333 165.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.48 -23.58 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.774 0.829 . . . . 65.319999999999993 111.835 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.4 t -141.44 162.76 34.69 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.065 -1.647 . . . . 72.25 109.864 169.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -160.74 137.56 8.88 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.348 2.259 . . . . 71.430000000000007 107.428 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -161.28 165.49 29.1 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.537 1.535 . . . . 72.510000000000005 107.661 168.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.3 mtm -134.31 163.33 29.87 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.897 -1.149 . . . . 64.439999999999998 107.897 170.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -163.09 146.88 10.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.8 0.84 . . . . 70.430000000000007 110.231 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.31 161.01 31.44 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.205 -1.035 . . . . 73.109999999999999 108.205 162.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -144.02 171.38 14.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.784 -0.573 . . . . 72.400000000000006 109.594 165.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -137.01 161.8 35.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.863 0.865 . . . . 74.340000000000003 109.718 167.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.437 HG21 ' HA ' ' A' ' 8' ' ' ASN . 40.0 mm -105.18 103.68 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.922 -1.51 . . . . 73.430000000000007 106.922 165.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -134.67 24.48 3.69 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.329 -0.857 . . . . 73.310000000000002 113.193 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -163.72 14.1 0.06 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.604 1.962 . . . . 74.400000000000006 116.053 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.33 18.21 57.79 Favored Glycine 0 CA--C 1.539 1.558 0 O-C-N 120.119 -1.613 . . . . 72.310000000000002 113.069 -168.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -134.12 -171.48 2.76 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.4 3.08 . . . . 65.329999999999998 107.208 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.17 113.49 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 121.242 1.837 . . . . 70.129999999999995 107.515 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -82.74 102.55 11.62 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.766 -1.198 . . . . 73.400000000000006 107.766 171.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 mm -81.32 137.57 21.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 105.898 -1.89 . . . . 74.439999999999998 105.898 168.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -151.15 -8.94 0.23 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.03 1.493 . . . . 71.299999999999997 115.03 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -144.77 112.71 6.36 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.361 -1.348 . . . . 73.329999999999998 107.361 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.2 t -122.47 154.28 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.776 1.63 . . . . 53.210000000000001 107.749 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.49 162.21 52.66 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.44 1.096 . . . . 73.420000000000002 108.393 172.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -83.75 -14.17 35.86 Favored 'Cis proline' 0 CA--C 1.536 0.624 0 N-CA-C 113.78 0.646 . . . . 64.140000000000001 113.78 -9.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.76 115.89 31.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 103.72 -2.696 . . . . 74.219999999999999 103.72 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -93.5 143.82 25.93 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.0 0.812 . . . . 70.420000000000002 109.571 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -132.81 172.4 12.62 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.276 1.43 . . . . 64.030000000000001 109.878 -171.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 t -54.41 146.36 33.3 Favored Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 123.61 0.569 . . . . 62.100000000000001 109.564 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.97 144.7 77.38 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.937 1.758 . . . . 53.200000000000003 109.799 165.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -154.92 164.44 38.87 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.998 0.919 . . . . 61.109999999999999 110.501 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.3 127.54 49.24 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.707 0.803 . . . . 74.340000000000003 109.333 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.28 112.68 24.34 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.452 1.501 . . . . 73.409999999999997 108.77 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.29 123.25 17.72 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.778 -1.193 . . . . 70.409999999999997 107.778 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.495 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 1.8 p -157.13 156.84 33.4 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.225 0.61 . . . . 74.019999999999996 110.458 175.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 4' ' ' TRP . 1.5 mppt? -129.57 156.25 44.5 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.802 1.241 . . . . 74.200000000000003 111.056 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.3 tt -151.25 146.54 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 122.491 0.316 . . . . 72.340000000000003 110.844 -171.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -149.31 43.51 0.94 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.303 1.841 . . . . 73.230000000000004 111.435 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.63 -89.74 1.63 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 110.385 -1.086 . . . . 72.010000000000005 110.385 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -20.26 24.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.099 -1.429 . . . . 72.209999999999994 114.823 -171.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -102.74 108.14 19.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 122.017 2.19 . . . . 63.0 111.278 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.417 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 33.0 tp -87.6 123.81 32.86 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.335 -1.478 . . . . 65.299999999999997 108.53 168.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -118.67 91.04 3.46 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.02 0.928 . . . . 74.219999999999999 109.931 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.495 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 22.2 t -86.1 130.94 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.934 -1.136 . . . . 72.030000000000001 107.934 173.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -85.39 -32.65 22.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.957 -0.544 . . . . 70.230000000000004 111.946 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.5 t -143.32 167.89 21.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.68 1.192 . . . . 63.409999999999997 110.774 -169.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.71 178.86 43.62 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-O 122.432 1.018 . . . . 62.140000000000001 112.624 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 m -51.87 -27.93 14.34 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.719 1.608 . . . . 70.530000000000001 112.65 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -101.16 10.89 40.37 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.209 0.818 . . . . 64.340000000000003 113.209 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.02 105.21 0.3 Allowed 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.375 -0.828 . . . . 42.329999999999998 110.084 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.84 -136.71 2.48 Favored Glycine 0 CA--C 1.519 0.302 0 O-C-N 121.169 -0.957 . . . . 70.230000000000004 112.57 -172.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.2 t -153.29 116.77 4.67 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.33 1.052 . . . . 62.420000000000002 109.367 -171.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.419 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 88.4 m-85 -139.78 152.44 46.59 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 121.466 -0.771 . . . . 71.319999999999993 110.561 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -116.74 146.28 42.91 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 118.647 -0.692 . . . . 62.200000000000003 110.393 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -54.7 148.15 13.28 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.932 -1.136 . . . . 61.240000000000002 107.932 173.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -129.43 148.74 51.38 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.407 -1.701 . . . . 70.129999999999995 106.407 166.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 C--O 1.257 1.477 0 C-N-CA 126.275 1.83 . . . . 41.299999999999997 110.336 -179.488 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.465 0 N-CA-C 110.958 -0.857 . . . . 43.420000000000002 110.958 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -134.35 142.75 47.32 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 105.25 -2.13 . . . . 51.030000000000001 105.25 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -131.83 81.46 1.97 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.25 -1.019 . . . . 72.540000000000006 108.25 -155.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -118.03 147.84 42.83 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.462 0.305 . . . . 74.230000000000004 111.775 -170.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.8 p -83.39 171.05 13.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.465 0.706 . . . . 62.219999999999999 110.3 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -56.88 123.38 14.86 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.303 -0.862 . . . . 71.329999999999998 109.768 155.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.24 134.01 53.93 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 124.879 1.272 . . . . 72.310000000000002 110.524 157.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -140.48 174.74 10.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.468 -0.938 . . . . 64.430000000000007 108.468 163.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -69.31 40.99 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.8 1.64 . . . . 74.340000000000003 110.289 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -134.26 -59.61 0.82 Allowed 'General case' 0 N--CA 1.466 0.374 0 O-C-N 118.269 -2.77 . . . . 61.450000000000003 108.212 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -73.2 -26.27 61.09 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.572 0.749 . . . . 63.539999999999999 111.47 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.04 -20.02 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 119.459 1.027 . . . . 71.439999999999998 112.506 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.2 mm -68.66 144.41 14.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 121.23 -0.918 . . . . 73.510000000000005 109.521 -169.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.23 -153.82 17.36 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 124.944 1.259 . . . . 64.150000000000006 110.296 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -120.79 154.16 36.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.279 1.431 . . . . 73.549999999999997 109.494 -168.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 84' ' ' LEU . 97.2 m95 -152.13 117.1 5.17 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.006 0.922 . . . . 74.450000000000003 109.593 -161.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.2 t -122.81 166.76 14.46 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.21 1.368 . . . . 70.450000000000003 112.024 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -125.19 2.75 7.88 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.661 1.584 . . . . 72.549999999999997 111.829 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.08 -177.37 36.57 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 120.503 1.501 . . . . 61.32 111.667 176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.6 pt -128.78 5.31 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.391 1.476 . . . . 75.129999999999995 111.387 -175.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -147.15 -173.23 4.19 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.52 1.528 . . . . 71.109999999999999 110.237 -164.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 48.48 -104.19 0.08 OUTLIER Glycine 0 C--N 1.339 0.734 0 C-N-CA 126.25 1.881 . . . . 24.43 111.763 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -138.39 97.66 3.42 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.593 -1.632 . . . . 74.340000000000003 106.593 172.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -111.78 177.76 4.54 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.77 0.828 . . . . 72.510000000000005 110.712 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -154.57 155.76 35.35 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.005 0.922 . . . . 74.409999999999997 108.934 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.01 131.0 36.58 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.846 1.659 . . . . 63.240000000000002 108.298 -168.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.609 HD22 ' CZ ' ' A' ' 29' ' ' PHE . 3.9 mt -115.38 153.68 30.59 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.769 1.628 . . . . 73.129999999999995 108.895 170.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 p -147.19 153.39 39.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.31 -0.996 . . . . 74.420000000000002 108.31 167.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.609 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 68.4 m-85 -144.63 141.97 29.77 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.948 1.299 . . . . 73.310000000000002 108.85 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -110.69 158.93 18.07 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.272 1.429 . . . . 71.340000000000003 108.147 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.84 -29.42 40.14 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.909 -0.316 . . . . 71.430000000000007 111.683 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.36 10.59 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.108 1.363 . . . . 74.420000000000002 110.139 -164.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.33 -124.02 2.82 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 125.017 1.294 . . . . 73.430000000000007 110.127 -169.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -140.31 167.14 22.85 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.822 -1.177 . . . . 71.129999999999995 107.822 168.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -93.36 176.25 36.83 Favored Glycine 0 CA--C 1.523 0.551 0 O-C-N 121.53 -0.732 . . . . 70.5 112.057 170.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.85 161.65 33.62 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.108 0.963 . . . . 63.240000000000002 109.828 171.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -141.99 151.06 42.15 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.274 -1.01 . . . . 70.420000000000002 108.274 168.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.77 161.76 32.53 Favored Glycine 0 CA--C 1.525 0.662 0 O-C-N 121.524 -0.735 . . . . 63.109999999999999 111.621 163.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.5 mt -124.83 149.58 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 127.047 2.139 . . . . 73.510000000000005 105.356 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -134.0 164.78 26.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.271 1.428 . . . . 74.209999999999994 110.149 -170.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.2 m -133.9 120.42 20.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.977 2.111 . . . . 54.409999999999997 106.006 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.254 0.9 OUTLIER 45.02 -81.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 130.016 3.326 . . . . 70.299999999999997 114.582 -173.093 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.67 43.54 1.73 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.786 1.635 . . . . 74.099999999999994 109.335 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.3 m -137.4 129.22 16.55 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.059 1.744 . . . . 64.400000000000006 107.635 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.37 136.92 32.52 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.747 2.298 . . . . 72.019999999999996 109.435 168.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.6 mm -120.56 -22.23 3.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 118.658 -0.687 . . . . 63.520000000000003 111.279 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.3 p -139.02 169.81 17.11 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.884 1.22 . . . . 52.020000000000003 110.782 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -159.15 153.27 23.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.827 -1.079 . . . . 63.109999999999999 108.307 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -166.61 161.49 15.93 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 105.649 -1.982 . . . . 74.430000000000007 105.649 165.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.8 mtm -122.57 159.01 28.68 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.389 -1.708 . . . . 74.239999999999995 106.389 160.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.18 141.01 17.13 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 123.991 0.807 . . . . 71.310000000000002 109.503 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -78.7 156.48 28.92 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 123.079 1.419 . . . . 72.329999999999998 108.391 166.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -151.84 169.05 23.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.171 -1.377 . . . . 61.119999999999997 110.021 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -141.44 163.17 33.65 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.113 0.965 . . . . 65.129999999999995 109.475 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.6 mm -120.05 89.33 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.791 -1.559 . . . . 64.540000000000006 106.791 170.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -123.42 25.81 8.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.598 1.159 . . . . 72.310000000000002 110.529 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -164.41 14.35 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.785 1.234 . . . . 65.230000000000004 112.604 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 26.69 69.86 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 120.451 -0.88 . . . . 72.310000000000002 111.219 -172.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -151.22 164.47 36.5 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.466 3.106 . . . . 65.230000000000004 106.817 -168.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.9 mt -100.27 109.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.404 -1.702 . . . . 63.420000000000002 106.404 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -80.9 106.17 12.7 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.065 -1.457 . . . . 65.209999999999994 107.065 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.1 mm -85.54 140.21 16.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.968 -1.493 . . . . 53.210000000000001 106.968 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -156.52 -2.69 0.12 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 115.868 1.803 . . . . 72.140000000000001 115.868 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -148.03 120.99 8.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 103.618 -2.734 . . . . 71.319999999999993 103.618 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.8 t -133.47 154.09 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 125.314 1.446 . . . . 61.229999999999997 107.436 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.94 163.54 37.48 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.651 1.181 . . . . 72.430000000000007 109.055 172.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.24 -21.39 13.66 Favored 'Cis proline' 0 C--N 1.345 0.374 0 N-CA-C 113.968 0.719 . . . . 62.240000000000002 113.968 -7.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -100.78 101.05 11.81 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.329 -2.1 . . . . 71.439999999999998 105.329 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -61.64 139.08 58.33 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.775 1.23 . . . . 73.319999999999993 110.417 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 9.0 mmpt? -114.56 158.42 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.072 1.749 . . . . 70.299999999999997 109.095 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -65.04 148.87 97.52 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.657 -0.868 . . . . 74.329999999999998 108.657 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.63 145.58 52.52 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.567 2.178 . . . . 74.230000000000004 112.478 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -156.15 167.88 29.05 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.887 1.275 . . . . 72.519999999999996 110.307 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -106.51 130.55 54.27 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.917 -1.142 . . . . 74.109999999999999 107.917 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.0 mt -106.39 132.64 52.18 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 125.956 1.702 . . . . 70.099999999999994 109.103 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.65 128.12 34.79 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.672 1.189 . . . . 70.340000000000003 110.694 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 p -150.29 164.98 34.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.499 1.519 . . . . 62.43 109.47 169.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -127.8 164.1 22.92 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.906 2.082 . . . . 54.310000000000002 112.239 159.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.8 tt -155.3 160.24 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.556 -1.275 . . . . 71.310000000000002 107.556 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.6 m -128.38 -66.1 0.86 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.493 2.317 . . . . 55.409999999999997 109.914 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.68 -83.76 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 106.998 -2.441 . . . . 73.329999999999998 106.998 170.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 p -95.08 -8.5 36.4 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.082 1.882 . . . . 72.549999999999997 116.082 -167.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.2 m -101.63 98.86 9.1 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 121.342 1.883 . . . . 73.510000000000005 109.34 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.429 ' HB2' ' CE3' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -76.03 119.11 19.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.005 -1.85 . . . . 72.450000000000003 106.005 165.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -108.05 88.88 2.83 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.618 -0.882 . . . . 64.239999999999995 108.618 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 t -80.23 128.32 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.858 -1.164 . . . . 63.549999999999997 107.858 169.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.65 -46.58 16.92 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.4 -0.81 . . . . 73.25 112.078 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 t -126.12 -172.85 2.71 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.575 1.08 . . . . 64.140000000000001 111.584 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.8 177.98 51.91 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.99 -1.244 . . . . 30.34 109.99 -171.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.5 m -60.49 -19.22 56.13 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.659 -0.906 . . . . 65.329999999999998 111.803 164.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -89.78 0.63 56.89 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.299 0.64 . . . . 65.549999999999997 112.371 -170.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.96 108.45 0.4 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.083 2.153 . . . . 70.530000000000001 110.261 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.79 -150.12 6.52 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 121.833 0.685 . . . . 72.530000000000001 112.583 -167.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 t -144.86 125.76 14.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.852 -1.907 . . . . 74.140000000000001 105.852 165.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -122.9 124.65 43.7 Favored 'General case' 0 C--O 1.226 -0.168 0 O-C-N 121.641 -0.662 . . . . 74.450000000000003 110.606 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -88.09 18.17 4.48 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.335 1.606 . . . . 75.25 115.335 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 26.3 tttt 62.43 156.03 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 127.172 2.189 . . . . 72.120000000000005 110.677 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -143.11 47.2 1.52 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.059 2.144 . . . . 71.450000000000003 106.8 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.8 tttt . . . . . 0 C--O 1.254 1.337 0 C-N-CA 124.253 1.021 . . . . 73.329999999999998 110.648 175.993 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.806 0 N-CA-C 109.297 -1.521 . . . . 50.119999999999997 109.297 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.24 76.18 1.54 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.973 -1.491 . . . . 71.230000000000004 106.973 172.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -89.07 103.17 15.81 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.494 -1.298 . . . . 72.150000000000006 107.494 -162.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -108.29 161.26 15.17 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.906 2.082 . . . . 74.340000000000003 109.989 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.4 p -90.4 167.65 12.46 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.569 0.622 . . . . 63.43 109.896 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -51.63 125.18 14.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.132 0.968 . . . . 72.049999999999997 108.77 159.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.4 tp -67.66 118.99 11.67 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.29 -1.374 . . . . 63.310000000000002 107.29 161.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -119.45 162.78 18.27 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 105.273 -2.121 . . . . 60.329999999999998 105.273 168.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -61.12 -44.91 96.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.16 -1.052 . . . . 53.25 108.16 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -53.83 -21.81 8.34 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.781 1.632 . . . . 75.540000000000006 113.918 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -90.27 -29.78 17.94 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.283 0.947 . . . . 73.239999999999995 113.085 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.2 tp -87.66 -10.92 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.24 1.016 . . . . 64.519999999999996 111.923 -168.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mm -60.31 135.56 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.303 1.041 . . . . 61.149999999999999 111.523 -175.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.1 175.59 14.14 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.31 1.91 . . . . 35.340000000000003 110.847 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -78.17 159.09 28.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.972 -0.751 . . . . 73.209999999999994 108.972 164.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -149.59 146.15 27.17 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.588 1.155 . . . . 74.319999999999993 109.261 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.8 p -134.96 175.4 9.61 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.247 1.385 . . . . 73.230000000000004 112.851 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.2 t -133.8 12.94 4.03 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.451 1.1 . . . . 73.420000000000002 113.217 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.03 176.97 14.86 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.839 -1.704 . . . . 52.100000000000001 108.839 -175.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.0 pt -130.88 15.24 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.857 0.863 . . . . 65.219999999999999 112.612 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -108.91 165.1 11.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.118 1.367 . . . . 73.329999999999998 111.456 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.0 -101.35 0.72 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.561 -1.016 . . . . 53.210000000000001 110.561 162.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.3 m -141.7 117.3 10.31 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.455 -2.054 . . . . 73.219999999999999 105.455 162.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -114.99 179.23 4.01 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.689 1.595 . . . . 74.230000000000004 109.295 -176.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -142.81 139.85 31.1 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.165 1.386 . . . . 74.439999999999998 108.918 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.0 144.6 48.44 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.82 1.648 . . . . 50.219999999999999 108.306 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.556 HD22 ' CZ ' ' A' ' 29' ' ' PHE . 7.9 mt -124.76 155.62 39.03 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.358 1.863 . . . . 74.510000000000005 109.261 175.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.7 t -143.78 152.23 40.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.31 1.444 . . . . 72.430000000000007 107.735 163.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.556 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 61.4 m-85 -149.13 127.68 12.34 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 127.128 2.171 . . . . 74.120000000000005 107.002 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.54 163.32 12.55 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.576 0.75 . . . . 71.109999999999999 111.386 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.37 -30.19 37.88 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.982 0.734 . . . . 60.549999999999997 112.982 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.75 2.26 3.14 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.271 0.357 . . . . 72.209999999999994 110.975 -172.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.11 -129.41 5.68 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.678 1.609 . . . . 71.340000000000003 109.827 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.8 p -138.71 -175.42 4.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.328 2.251 . . . . 74.5 106.175 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.67 -177.81 22.4 Favored Glycine 0 C--O 1.238 0.385 0 N-CA-C 109.862 -1.295 . . . . 62.539999999999999 109.862 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.7 p -159.77 152.16 21.03 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.797 1.036 . . . . 42.409999999999997 113.797 -163.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -129.55 112.82 14.11 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.364 1.866 . . . . 71.030000000000001 107.299 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.17 109.21 0.95 Allowed Glycine 0 C--N 1.341 0.857 0 C-N-CA 124.376 0.988 . . . . 54.520000000000003 112.053 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.6 mt -76.61 143.06 13.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.463 1.105 . . . . 65.030000000000001 108.239 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -131.73 125.12 31.21 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.031 1.333 . . . . 71.219999999999999 109.301 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -88.31 112.69 23.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.597 -1.261 . . . . 41.399999999999999 107.597 166.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 53.06 -78.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.995 2.518 . . . . 72.129999999999995 112.342 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.94 21.09 2.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.423 1.889 . . . . 54.43 112.492 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 m -116.76 118.02 37.08 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.393 1.477 . . . . 53.130000000000003 107.675 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.61 125.69 14.81 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.576 2.184 . . . . 73.109999999999999 108.702 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.4 mm -117.24 -3.9 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.672 0.789 . . . . 74.129999999999995 110.907 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.4 t -152.17 163.7 38.84 Favored 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 120.169 -1.582 . . . . 62.340000000000003 108.998 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -157.7 144.92 18.3 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.022 1.729 . . . . 75.5 106.939 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -167.77 153.59 7.39 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 105.629 -1.989 . . . . 71.209999999999994 105.629 165.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 mtm -132.32 153.9 50.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.564 1.146 . . . . 73.540000000000006 108.83 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -163.2 154.37 16.97 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.747 0.819 . . . . 71.450000000000003 109.527 -174.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.92 169.09 16.42 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.143 2.177 . . . . 75.120000000000005 109.601 172.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.68 162.02 36.55 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.258 1.023 . . . . 63.310000000000002 110.261 171.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -134.11 131.31 38.58 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.49 -1.3 . . . . 72.219999999999999 107.49 160.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.48 107.66 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 105.597 -2.001 . . . . 73.420000000000002 105.597 163.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -152.66 45.9 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.463 0.705 . . . . 61.329999999999998 109.137 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.95 14.49 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.811 2.444 . . . . 73.140000000000001 111.966 162.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.94 25.24 71.93 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.393 -1.442 . . . . 65.120000000000005 110.822 -160.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -140.05 158.75 43.57 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 126.724 2.009 . . . . 71.129999999999995 106.512 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.08 138.77 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.168 -1.79 . . . . 73.25 106.168 172.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -117.49 115.96 26.19 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.81 2.044 . . . . 72.109999999999999 107.111 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.4 mm -97.71 143.05 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.979 -1.489 . . . . 74.230000000000004 106.979 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -159.36 -2.62 0.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.067 1.506 . . . . 73.140000000000001 115.067 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -148.42 125.19 11.18 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.084 -2.562 . . . . 73.420000000000002 104.084 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.2 t -132.14 152.33 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 125.212 1.405 . . . . 63.119999999999997 107.787 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.4 151.94 48.7 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 125.833 1.653 . . . . 75.099999999999994 106.678 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.52 -6.74 50.3 Favored 'Cis proline' 0 CA--C 1.534 0.513 0 CA-C-N 119.378 0.814 . . . . 61.009999999999998 113.983 4.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.28 108.61 18.77 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.791 -1.929 . . . . 73.209999999999994 105.791 172.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.63 127.97 34.28 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.097 1.359 . . . . 74.230000000000004 108.142 169.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -125.16 160.38 29.27 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.635 0.774 . . . . 65.239999999999995 110.078 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -56.89 147.05 55.89 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.051 0.941 . . . . 63.149999999999999 109.437 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.93 147.19 89.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.979 1.786 . . . . 70.310000000000002 111.07 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -157.56 151.41 24.24 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.269 1.828 . . . . 53.109999999999999 108.17 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -81.22 160.23 24.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.637 -1.165 . . . . 72.25 107.931 165.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.83 127.28 38.3 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.467 1.107 . . . . 73.010000000000005 108.711 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.22 115.2 20.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.621 -1.622 . . . . 70.150000000000006 106.621 175.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -146.1 151.7 38.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.717 1.207 . . . . 63.420000000000002 107.773 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -117.8 157.99 25.58 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.253 1.021 . . . . 73.319999999999993 109.373 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 tt -151.65 151.78 11.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 118.689 -0.672 . . . . 64.049999999999997 109.537 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.4 m -141.68 -6.98 0.99 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.339 1.607 . . . . 73.120000000000005 115.339 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.23 -82.35 0.17 Allowed Glycine 0 N--CA 1.461 0.308 0 O-C-N 120.363 -1.46 . . . . 63.310000000000002 109.552 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.5 p -104.32 -13.54 16.1 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.534 -0.746 . . . . 44.32 112.057 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 m -90.01 101.63 14.34 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.45 1.477 . . . . 61.299999999999997 109.784 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 tp -81.58 138.94 35.32 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.419 -1.326 . . . . 72.430000000000007 107.419 159.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -127.66 144.43 51.08 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.617 -0.883 . . . . 74.129999999999995 108.617 163.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 t -127.99 127.21 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.793 -1.558 . . . . 73.120000000000005 106.793 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -96.45 -20.84 18.12 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.436 0.902 . . . . 70.019999999999996 113.436 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -155.48 172.89 17.49 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.62 1.568 . . . . 70.239999999999995 108.655 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.92 177.93 49.11 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-O 122.285 0.936 . . . . 63.200000000000003 111.383 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 t -60.84 -26.99 67.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.24 -0.565 . . . . 74.219999999999999 111.724 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.81 6.26 49.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.397 -0.811 . . . . 64.239999999999995 113.042 -172.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -46.4 101.61 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.926 1.691 . . . . 74.219999999999999 110.651 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.95 -174.14 39.88 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.067 0.841 . . . . 70.030000000000001 112.382 -158.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.7 p -140.43 100.75 3.95 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.551 1.541 . . . . 71.329999999999998 107.716 -169.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -115.78 150.94 36.1 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.721 0.408 . . . . 73.420000000000002 110.629 -169.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -120.59 16.87 12.05 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.331 1.234 . . . . 53.119999999999997 114.331 -167.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.5 tttt 68.16 142.42 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 129.891 3.277 . . . . 71.239999999999995 111.629 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -132.75 47.67 2.49 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.708 2.403 . . . . 72.430000000000007 107.581 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? . . . . . 0 C--O 1.245 0.863 0 N-CA-C 105.072 -2.196 . . . . 75.120000000000005 105.072 170.935 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.128 0 CA-C-O 119.491 -0.616 . . . . 71.519999999999996 111.849 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -69.73 75.54 0.44 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 123.712 1.72 . . . . 72.430000000000007 107.947 167.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -137.81 112.2 8.67 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.683 -1.969 . . . . 72.239999999999995 105.683 -157.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -135.5 156.5 48.8 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 128.34 2.656 . . . . 72.549999999999997 108.077 -171.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -76.81 168.5 19.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.132 0.492 . . . . 62.149999999999999 111.304 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -55.45 143.95 27.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.993 1.317 . . . . 74.519999999999996 109.055 164.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.3 tp -83.73 121.96 27.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.244 -1.391 . . . . 73.530000000000001 107.244 164.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -131.17 172.7 11.82 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.363 1.065 . . . . 75.109999999999999 109.762 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' HD11 ' A' ' 13' ' ' ILE . 0.5 OUTLIER -64.24 -10.36 23.05 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.92 -1.038 . . . . 74.420000000000002 113.103 173.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -107.42 -31.61 8.09 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 121.094 1.77 . . . . 75.120000000000005 113.073 -168.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -86.18 -27.76 24.34 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.008 -0.996 . . . . 34.32 112.452 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 tp -65.76 -27.7 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.791 1.632 . . . . 75.109999999999999 111.534 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 9' ' ' SER . 14.6 mm -54.09 121.79 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 C-N-CA 125.854 1.661 . . . . 60.049999999999997 110.744 -169.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.95 176.31 14.42 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 123.964 0.792 . . . . 72.439999999999998 111.255 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.45 157.94 24.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.706 0.803 . . . . 75.209999999999994 109.433 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -147.02 143.68 28.57 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.87 0.868 . . . . 73.150000000000006 109.346 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.8 t -140.01 166.0 25.82 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.53 0.732 . . . . 62.530000000000001 110.82 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.49 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 14.2 t -119.34 -6.51 10.32 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.952 2.101 . . . . 73.549999999999997 111.393 176.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.66 175.8 43.37 Favored Glycine 0 C--N 1.337 0.593 0 O-C-N 120.503 -1.373 . . . . 55.420000000000002 110.978 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.7 pt -133.47 15.02 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.169 1.387 . . . . 74.129999999999995 110.046 -173.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -148.94 -175.8 5.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.145 1.778 . . . . 73.409999999999997 109.703 -165.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.69 -99.9 0.04 OUTLIER Glycine 0 C--N 1.337 0.592 0 C-N-CA 126.789 2.138 . . . . 63.329999999999998 112.823 165.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.9 m -148.14 129.24 14.55 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 104.364 -2.458 . . . . 74.219999999999999 104.364 167.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -143.47 -174.78 4.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.373 1.069 . . . . 55.329999999999998 109.342 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -136.39 164.67 27.58 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.284 1.434 . . . . 75.109999999999999 109.549 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.33 133.06 23.83 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.243 1.417 . . . . 72.329999999999998 108.63 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 mt -121.07 160.41 23.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.953 0.901 . . . . 74.340000000000003 109.86 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 t -137.12 154.12 50.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.041 1.736 . . . . 62.450000000000003 106.631 159.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -145.03 130.26 18.58 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.566 1.546 . . . . 74.010000000000005 108.24 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.87 152.18 23.59 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.507 1.123 . . . . 64.349999999999994 109.822 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.82 -37.46 73.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.91 1.284 . . . . 73.25 110.516 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.67 21.26 4.65 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.31 1.044 . . . . 64.049999999999997 110.753 -171.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -130.36 -129.08 3.06 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.482 1.039 . . . . 71.230000000000004 110.599 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 p -124.19 -175.05 3.14 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.421 1.888 . . . . 73.109999999999999 108.442 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.79 167.13 13.04 Favored Glycine 0 C--O 1.237 0.322 0 N-CA-C 109.252 -1.539 . . . . 73.319999999999993 109.252 162.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.04 153.24 49.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.701 0.801 . . . . 74.010000000000005 108.859 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -137.73 121.54 17.58 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.127 1.371 . . . . 54.399999999999999 107.761 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.61 162.53 19.83 Favored Glycine 0 C--N 1.331 0.297 0 N-CA-C 110.293 -1.123 . . . . 74.230000000000004 110.293 174.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.0 mt -127.15 143.36 40.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.962 -1.866 . . . . 73.310000000000002 105.962 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -136.01 124.65 23.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.417 1.087 . . . . 75.430000000000007 108.687 -166.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.2 m -84.69 124.27 31.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.837 -1.542 . . . . 55.210000000000001 106.837 166.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 44.64 -78.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 129.059 2.943 . . . . 71.230000000000004 115.127 176.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.2 68.03 1.09 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.64 1.576 . . . . 35.130000000000003 107.612 165.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.7 m -152.97 130.96 6.2 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 126.591 1.957 . . . . 62.310000000000002 107.089 170.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.01 135.85 26.12 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.563 2.842 . . . . 75.120000000000005 110.509 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.7 mm -130.89 -21.25 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.007 0.923 . . . . 74.310000000000002 111.729 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.1 m -142.01 155.58 45.43 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 120.551 -1.343 . . . . 71.329999999999998 109.105 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -155.98 143.27 19.22 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.751 1.22 . . . . 64.409999999999997 109.629 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -159.75 159.59 32.97 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.1 1.76 . . . . 42.43 106.94 166.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.9 mtm -133.5 148.46 51.69 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.564 -1.643 . . . . 71.329999999999998 106.564 172.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -158.5 142.52 15.56 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.474 -0.565 . . . . 63.409999999999997 109.474 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.47 157.16 30.61 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.591 -1.263 . . . . 72.150000000000006 107.591 170.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -151.08 164.53 36.26 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.629 -0.67 . . . . 74.310000000000002 109.953 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -132.1 158.3 41.96 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.614 1.166 . . . . 73.349999999999994 108.235 164.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.9 mm -113.63 87.11 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.552 -2.018 . . . . 73.230000000000004 105.552 166.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -126.25 23.04 7.08 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 122.424 1.107 . . . . 73.329999999999998 110.759 -170.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.76 14.28 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.317 1.847 . . . . 74.140000000000001 113.606 -170.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.61 15.55 61.99 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 121.368 -0.833 . . . . 54.130000000000003 111.338 -172.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -145.43 162.05 38.24 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 128.847 2.859 . . . . 74.420000000000002 105.893 -170.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 mt -91.27 109.46 21.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.612 -1.625 . . . . 63.549999999999997 106.612 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -78.86 104.78 9.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.77 -1.567 . . . . 75.540000000000006 106.77 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.0 mm -88.89 131.39 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.152 -2.166 . . . . 64.120000000000005 105.152 170.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -154.74 -1.14 0.17 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 115.93 1.826 . . . . 75.420000000000002 115.93 -175.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -148.86 123.5 9.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.761 -1.94 . . . . 72.219999999999999 105.761 162.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.5 t -129.14 141.45 46.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 125.823 1.649 . . . . 71.140000000000001 107.827 -174.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.41 164.06 46.68 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.327 1.051 . . . . 74.329999999999998 108.246 173.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.23 -19.76 15.33 Favored 'Cis proline' 0 N--CA 1.454 -0.84 0 CA-C-N 119.285 0.78 . . . . 63.32 111.98 -14.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -98.27 102.21 13.89 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.912 -1.514 . . . . 64.540000000000006 106.912 -176.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -88.41 131.8 34.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.022 -0.99 . . . . 71.530000000000001 110.493 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -127.39 174.7 8.78 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.676 1.19 . . . . 74.400000000000006 110.382 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 t -61.02 154.89 58.05 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.152 1.381 . . . . 71.430000000000007 111.625 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.51 147.3 57.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.359 2.706 . . . . 71.129999999999995 112.593 171.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -161.01 164.59 30.85 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.648 1.179 . . . . 74.519999999999996 110.441 171.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -91.68 148.54 22.18 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.956 -0.757 . . . . 74.140000000000001 108.956 169.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -124.39 137.43 54.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.178 1.791 . . . . 74.430000000000007 108.474 175.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -98.71 133.22 43.34 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.766 -0.827 . . . . 61.240000000000002 108.766 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.469 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 2.1 p -151.68 165.64 33.73 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.091 1.356 . . . . 65.129999999999995 109.433 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.44 161.18 19.48 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.404 -0.591 . . . . 65.420000000000002 109.404 160.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.432 HG12 ' H ' ' A' ' 81' ' ' GLY . 16.4 tt -137.47 146.94 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.462 -1.31 . . . . 73.420000000000002 107.462 174.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.3 p -111.7 -10.74 14.05 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.579 0.751 . . . . 64.519999999999996 112.037 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 79' ' ' ILE . . . 125.69 -63.09 0.59 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 107.452 -2.259 . . . . 51.119999999999997 107.452 -169.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 p -112.55 -15.57 13.02 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.575 -1.202 . . . . 73.310000000000002 114.155 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.1 m -104.45 137.0 42.96 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.599 1.545 . . . . 74.519999999999996 107.878 168.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.526 HD22 HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -98.76 143.4 29.14 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.898 -1.519 . . . . 74.510000000000005 106.898 161.677 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -133.07 85.65 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.154 -1.054 . . . . 73.329999999999998 108.154 170.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.526 HG23 HD22 ' A' ' 84' ' ' LEU . 44.4 t -75.65 124.75 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.3 -0.63 . . . . 73.340000000000003 109.3 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -92.94 -24.95 18.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.147 0.979 . . . . 65.230000000000004 112.547 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.0 t -152.52 160.86 43.2 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.013 0.824 . . . . 70.329999999999998 110.285 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.26 176.17 19.39 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.956 1.741 . . . . 65.239999999999995 111.134 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.1 m -55.62 -26.98 47.07 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.619 0.768 . . . . 53.350000000000001 111.548 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -101.89 11.79 38.02 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.022 0.929 . . . . 71.129999999999995 113.046 -174.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.6 108.73 0.37 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.207 1.403 . . . . 52.229999999999997 110.929 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.59 -169.8 41.51 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 122.113 0.841 . . . . 70.209999999999994 113.03 -169.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -118.65 126.29 51.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.929 2.092 . . . . 65.450000000000003 107.473 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.49 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 23.9 m-85 -140.07 159.33 42.42 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.789 0.328 . . . . 73.120000000000005 110.499 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -120.57 149.55 42.27 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.487 1.115 . . . . 72.430000000000007 109.154 170.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -61.17 143.19 55.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.99 -1.115 . . . . 64.25 107.99 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -116.5 56.67 0.79 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.685 -1.969 . . . . 74.120000000000005 105.685 175.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? . . . . . 0 C--O 1.248 0.998 0 C-N-CA 128.366 2.666 . . . . 55.509999999999998 105.68 -176.285 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.629 0 N-CA-C 108.485 -1.846 . . . . 35.140000000000001 108.485 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -153.3 75.46 1.06 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 104.219 -2.512 . . . . 74.010000000000005 104.219 170.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -117.47 65.57 0.73 Allowed 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.36 -1.348 . . . . 75.099999999999994 107.36 -149.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -87.57 147.79 25.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.187 -1.824 . . . . 75.040000000000006 109.936 -174.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.22 167.59 17.58 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.884 0.874 . . . . 71.310000000000002 110.528 168.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -55.58 136.26 50.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.882 1.325 . . . . 73.239999999999995 109.65 157.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.7 tp -66.96 139.24 57.69 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.363 -1.347 . . . . 73.420000000000002 107.363 154.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -140.11 170.42 15.88 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.713 -1.588 . . . . 63.229999999999997 106.713 163.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 p -44.25 -60.62 1.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.248 2.619 . . . . 74.049999999999997 109.809 171.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -71.69 -17.24 62.24 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.259 -1.337 . . . . 73.430000000000007 110.245 -170.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -82.64 -37.16 25.3 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 117.763 -1.113 . . . . 73.120000000000005 110.596 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 tp -74.98 -15.87 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 121.381 1.901 . . . . 63.329999999999998 113.363 -170.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mm -56.35 136.32 19.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.448 1.099 . . . . 62.130000000000003 110.762 -173.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 131.45 -175.08 19.79 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.777 1.18 . . . . 74.219999999999999 112.727 170.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.54 146.08 25.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.093 1.757 . . . . 71.409999999999997 108.612 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -140.3 111.61 7.19 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.789 0.836 . . . . 75.099999999999994 110.221 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -118.18 143.59 46.39 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.257 1.023 . . . . 61.420000000000002 108.971 -175.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 25' ' ' LYS . 10.4 t -82.35 -43.99 16.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.251 0.621 . . . . 73.030000000000001 109.419 174.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.5 172.8 44.7 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.74 1.638 . . . . 32.310000000000002 110.335 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.9 pt -115.94 45.37 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 122.924 1.345 . . . . 64.209999999999994 109.854 -164.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -131.06 178.81 6.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.251 1.42 . . . . 52.520000000000003 111.619 -156.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.79 -24.34 18.63 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 127.228 2.347 . . . . 22.02 115.597 -163.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.2 m -150.2 119.94 7.05 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.596 -1.631 . . . . 63.100000000000001 106.596 170.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -146.41 -178.95 6.43 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.043 0.838 . . . . 72.200000000000003 110.918 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' H ' HG22 ' A' ' 18' ' ' THR . 96.5 mttt -143.26 146.08 33.31 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.289 1.436 . . . . 73.439999999999998 108.39 -171.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.31 135.02 45.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.698 -1.223 . . . . 72.129999999999995 107.698 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 mt -123.13 155.75 36.38 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.201 1.401 . . . . 60.439999999999998 108.275 172.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.9 p -146.85 152.42 38.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.695 0.798 . . . . 52.340000000000003 109.567 167.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.62 119.84 12.19 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.602 -1.629 . . . . 75.040000000000006 106.602 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -84.94 169.51 13.98 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.694 -0.854 . . . . 64.150000000000006 108.694 169.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -93.58 -25.61 17.47 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.599 1.16 . . . . 62.539999999999999 112.92 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.09 32.09 1.24 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.416 1.086 . . . . 75.510000000000005 108.714 -174.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.19 -112.57 1.1 Allowed Glycine 0 C--N 1.339 0.698 0 N-CA-C 109.02 -1.632 . . . . 64.140000000000001 109.02 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.4 p -139.92 -165.66 1.93 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.735 1.214 . . . . 74.209999999999994 109.346 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.09 171.18 14.77 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.423 1.011 . . . . 55.229999999999997 110.852 166.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.53 148.94 35.08 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.907 -0.775 . . . . 62.020000000000003 108.907 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -138.83 124.25 19.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.472 1.109 . . . . 71.340000000000003 108.572 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.62 165.49 21.46 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.808 -0.917 . . . . 71.200000000000003 110.808 175.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -124.49 148.49 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 104.862 -2.273 . . . . 52.5 104.862 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -141.84 165.1 28.41 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.449 1.1 . . . . 74.319999999999993 108.716 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.3 m -136.24 112.69 9.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.91 2.084 . . . . 75.439999999999998 107.866 171.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 54.13 -78.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 127.51 2.324 . . . . 71.430000000000007 114.374 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.21 47.97 1.49 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.202 1.801 . . . . 75.329999999999998 110.457 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.2 m -154.83 137.66 10.3 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.024 1.73 . . . . 64.109999999999999 108.669 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.68 142.21 22.72 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 124.057 3.172 . . . . 71.409999999999997 110.593 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.6 mm -130.69 -7.48 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 126.028 1.731 . . . . 55.240000000000002 110.843 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.9 t -153.7 164.76 37.76 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 119.721 -1.862 . . . . 72.409999999999997 109.117 163.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -157.31 123.07 4.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.71 2.404 . . . . 71.409999999999997 106.837 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -139.0 164.22 30.33 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.381 1.472 . . . . 64.129999999999995 107.152 164.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mtm -135.87 156.28 49.02 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.967 1.307 . . . . 72.25 107.673 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -159.39 151.94 21.44 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.575 0.75 . . . . 75.030000000000001 110.27 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -82.4 166.85 19.05 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.349 -0.612 . . . . 75.25 109.349 166.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -148.23 160.9 42.48 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.238 0.615 . . . . 74.439999999999998 111.787 172.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -131.39 154.99 48.06 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.215 -1.402 . . . . 64.450000000000003 107.215 164.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.3 mm -104.16 107.72 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 106.018 -1.845 . . . . 74.329999999999998 106.018 164.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.75 24.62 2.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.946 1.461 . . . . 73.349999999999994 114.946 171.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.88 14.66 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.631 1.573 . . . . 73.049999999999997 114.835 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.43 11.84 84.02 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 120.114 -1.616 . . . . 74.049999999999997 115.12 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -121.37 -165.73 1.27 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.292 1.837 . . . . 74.450000000000003 107.765 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.6 mt -114.84 110.18 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.753 1.615 . . . . 55.149999999999999 107.179 172.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -76.88 103.17 6.67 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 107.363 -1.347 . . . . 75.25 107.363 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.5 mm -90.49 140.12 16.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 105.697 -1.964 . . . . 74.010000000000005 105.697 170.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -158.31 -5.01 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 115.131 1.53 . . . . 74.450000000000003 115.131 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -144.87 112.75 6.34 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.224 -2.88 . . . . 62.130000000000003 103.224 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.1 t -132.29 152.69 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.949 -1.501 . . . . 71.109999999999999 106.949 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.83 162.11 34.73 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.482 1.513 . . . . 75.439999999999998 107.18 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.84 -26.47 9.61 Favored 'Cis proline' 0 N--CA 1.459 -0.536 0 CA-C-N 119.833 0.976 . . . . 53.549999999999997 112.396 -9.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -87.16 107.7 18.58 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 104.789 -2.3 . . . . 50.109999999999999 104.789 167.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -70.74 159.66 34.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.954 0.407 . . . . 74.349999999999994 110.479 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.93 153.7 48.26 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.828 1.251 . . . . 73.140000000000001 108.778 171.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.4 t -50.89 151.13 4.64 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.559 1.944 . . . . 71.120000000000005 111.643 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.03 154.05 67.08 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.521 2.147 . . . . 74.129999999999995 113.335 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -168.45 166.04 12.38 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.142 1.377 . . . . 74.230000000000004 109.847 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -103.08 111.33 23.64 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.492 -1.299 . . . . 70.120000000000005 107.492 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.1 mt -77.61 113.99 16.0 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.956 0.903 . . . . 70.409999999999997 108.866 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.44 116.29 4.96 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.119 1.768 . . . . 70.230000000000004 108.697 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 9.5 p -151.13 158.77 44.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.658 -0.651 . . . . 74.439999999999998 112.637 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 163.0 16.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.316 -0.856 . . . . 71.319999999999993 110.972 174.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 tt -141.31 149.98 20.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.518 1.127 . . . . 72.329999999999998 108.425 170.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.6 p -129.02 -6.67 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.354 1.242 . . . . 74.420000000000002 114.354 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.6 -71.51 0.37 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.304 -1.519 . . . . 73.010000000000005 109.304 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.1 p -121.4 4.12 10.23 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.537 -0.745 . . . . 73.439999999999998 112.987 175.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.9 m -107.6 133.31 52.23 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.282 -1.377 . . . . 52.530000000000001 107.282 170.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.1 tp -108.6 130.57 55.31 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.258 2.223 . . . . 74.109999999999999 107.299 166.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -125.69 99.71 6.11 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.009 1.324 . . . . 75.099999999999994 110.009 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.8 t -93.61 131.81 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.854 -0.795 . . . . 73.019999999999996 108.854 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -87.56 -23.42 24.35 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.844 1.258 . . . . 75.420000000000002 113.329 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -153.12 166.39 32.63 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.129 -0.982 . . . . 64.040000000000006 109.849 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.67 175.44 36.92 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.709 -0.956 . . . . 54.420000000000002 110.709 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.1 m -60.05 -21.61 61.63 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.253 1.021 . . . . 75.219999999999999 112.016 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -101.85 6.34 41.45 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.914 1.686 . . . . 64.439999999999998 112.776 -172.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.65 110.66 0.83 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.509 1.924 . . . . 55.109999999999999 109.337 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.52 -136.31 2.64 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 123.451 0.548 . . . . 73.010000000000005 112.527 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.5 t -154.92 113.45 3.54 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.289 -1.745 . . . . 64.200000000000003 106.289 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -133.07 152.76 51.93 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.165 -0.959 . . . . 74.420000000000002 109.446 -168.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -118.98 141.42 48.68 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.282 1.033 . . . . 75.099999999999994 108.331 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -58.37 134.74 56.88 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.263 -1.384 . . . . 74.340000000000003 107.263 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -134.9 70.55 1.44 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.741 -1.207 . . . . 73.299999999999997 107.741 175.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 53.7 tttt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.5 -1.238 . . . . 61.140000000000001 108.695 -167.354 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.177 0 N-CA-C 109.687 -1.365 . . . . 60.409999999999997 109.687 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -128.15 98.69 5.19 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 118.934 1.367 . . . . 61.409999999999997 107.79 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -98.9 124.74 44.03 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.198 -2.149 . . . . 72.519999999999996 105.198 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -111.15 166.49 11.03 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.263 -1.79 . . . . 74.519999999999996 110.625 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -84.65 163.93 18.95 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.055 -0.72 . . . . 53.109999999999999 109.055 168.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -51.71 124.33 12.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.109 0.957 . . . . 70.120000000000005 109.283 153.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.17 134.3 55.76 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.529 0.681 . . . . 45.119999999999997 109.538 157.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -139.02 169.14 18.34 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.624 -1.621 . . . . 71.319999999999993 106.624 163.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -49.85 -57.19 7.9 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.944 0.498 . . . . 72.420000000000002 109.687 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -64.34 -17.33 63.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.843 0.683 . . . . 61.140000000000001 112.843 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -78.87 -44.39 22.94 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.854 0.861 . . . . 71.219999999999999 110.496 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.9 tp -74.96 -24.56 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 O-C-N 120.329 -1.482 . . . . 70.420000000000002 112.225 -170.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 mm -47.88 125.46 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.573 1.949 . . . . 53.409999999999997 112.53 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.17 -178.57 18.87 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.11 0.862 . . . . 65.25 112.828 168.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -72.78 147.89 45.1 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 125.675 1.59 . . . . 73.549999999999997 110.534 171.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.493 ' CH2' ' HE3' ' A' ' 97' ' ' LYS . 93.7 m95 -137.76 117.84 13.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.257 1.423 . . . . 74.310000000000002 108.669 176.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t -116.61 174.2 6.21 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.785 1.234 . . . . 71.310000000000002 110.038 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -142.98 1.31 1.26 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.315 1.446 . . . . 72.510000000000005 111.363 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.49 176.91 14.6 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 126.477 1.989 . . . . 74.239999999999995 108.465 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.75 11.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 113.123 0.786 . . . . 65.340000000000003 113.123 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -113.06 -171.35 1.85 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 125.426 1.49 . . . . 73.439999999999998 110.184 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 48.43 -90.42 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 126.495 1.998 . . . . 70.230000000000004 114.51 153.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.8 m -144.93 100.48 3.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.734 -1.95 . . . . 70.120000000000005 105.734 169.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -115.44 171.68 7.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.15 -0.685 . . . . 65.420000000000002 109.15 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HE2' HG23 ' A' ' 39' ' ' ILE . 82.7 mttt -146.46 151.84 38.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.145 -1.798 . . . . 65.310000000000002 106.145 -175.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.67 146.83 50.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.815 -1.921 . . . . 61.25 105.815 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.03 159.97 35.98 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.479 -0.934 . . . . 63.509999999999998 108.479 161.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.2 p -133.36 154.55 50.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.498 0.719 . . . . 53.32 109.772 164.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -139.69 125.09 19.07 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.428 -2.064 . . . . 64.409999999999997 105.428 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -109.99 161.4 15.55 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.138 -1.43 . . . . 51.420000000000002 107.138 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -97.13 -21.04 17.56 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.586 -0.696 . . . . 71.239999999999995 112.518 -168.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -124.41 -5.78 7.67 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 122.853 0.461 . . . . 74.5 111.835 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.96 -120.38 4.36 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.01 1.767 . . . . 43.100000000000001 109.819 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.3 p -148.27 175.37 11.13 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 128.481 2.712 . . . . 73.430000000000007 106.535 -172.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.86 -166.87 23.33 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 119.392 0.996 . . . . 72.230000000000004 112.32 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 m -148.8 164.9 33.07 Favored 'General case' 0 CA--C 1.521 -0.144 0 O-C-N 121.214 -1.168 . . . . 71.510000000000005 109.674 168.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -143.15 125.33 15.44 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.488 -1.301 . . . . 70.209999999999994 107.488 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.14 159.04 20.49 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.064 -0.815 . . . . 72.530000000000001 111.064 170.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.5 HG23 ' HE2' ' A' ' 25' ' ' LYS . 69.6 mt -133.31 140.61 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 105.843 -1.91 . . . . 64.209999999999994 105.843 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -132.02 157.11 44.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.161 0.985 . . . . 71.549999999999997 110.022 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -125.86 116.88 22.24 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.19 2.196 . . . . 53.32 106.172 167.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 48.75 -76.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 129.182 2.993 . . . . 71.019999999999996 114.169 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.21 29.61 2.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.775 1.63 . . . . 72.129999999999995 112.969 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.0 m -137.22 130.46 17.28 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 124.911 1.284 . . . . 71.120000000000005 109.541 -174.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.38 133.63 21.22 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.997 3.132 . . . . 70.409999999999997 110.857 170.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.4 mm -128.44 -3.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 125.899 1.68 . . . . 70.219999999999999 111.275 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 t -145.63 171.28 14.94 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 119.277 -2.139 . . . . 65.129999999999995 107.837 165.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -166.37 140.89 4.32 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.729 1.612 . . . . 73.409999999999997 107.54 168.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -157.82 162.29 38.41 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.668 1.587 . . . . 64.450000000000003 107.074 169.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.6 mtm -130.44 155.42 46.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.237 -1.394 . . . . 74.329999999999998 107.237 166.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -163.35 156.22 18.67 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.206 1.002 . . . . 74.109999999999999 109.486 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -91.89 167.66 11.97 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.599 0.76 . . . . 72.219999999999999 109.385 170.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -135.97 164.71 27.36 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.642 1.177 . . . . 52.329999999999998 110.185 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -130.1 126.38 37.44 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.649 -1.611 . . . . 74.5 106.649 160.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mm -92.88 94.58 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 104.643 -2.354 . . . . 73.239999999999995 104.643 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -135.54 22.99 3.41 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.78 0.8 . . . . 72.319999999999993 112.237 -168.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -170.43 13.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.696 1.199 . . . . 44.100000000000001 112.696 171.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.17 13.4 82.94 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 121.6 -0.688 . . . . 72.230000000000004 112.33 -169.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -130.87 166.5 20.76 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.33 2.252 . . . . 74.239999999999995 106.828 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.6 mt -105.32 104.38 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.694 -1.595 . . . . 74.519999999999996 106.694 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -84.44 123.1 29.86 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.079 1.352 . . . . 74.129999999999995 107.865 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.6 mm -99.64 150.95 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.873 1.669 . . . . 74.430000000000007 107.82 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -160.97 -17.51 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 116.36 1.985 . . . . 73.530000000000001 116.36 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -135.66 109.4 8.07 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 105.318 -2.104 . . . . 71.140000000000001 105.318 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.74 149.99 25.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.975 1.71 . . . . 45.140000000000001 107.54 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.4 160.8 65.42 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.357 1.063 . . . . 72.239999999999995 108.203 173.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.46 -11.02 42.51 Favored 'Cis proline' 0 C--N 1.345 0.362 0 N-CA-C 114.222 0.816 . . . . 71.120000000000005 114.222 -2.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -108.14 109.39 20.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.053 -2.203 . . . . 74.25 105.053 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.38 145.61 55.5 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.387 0.429 . . . . 65.439999999999998 110.106 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -129.66 164.34 24.13 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.675 1.19 . . . . 72.120000000000005 110.554 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -62.25 149.76 86.34 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.713 0.805 . . . . 70.510000000000005 109.944 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.99 147.37 49.05 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.188 2.592 . . . . 62.109999999999999 111.618 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -162.06 157.03 22.87 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.277 2.231 . . . . 65.099999999999994 110.2 174.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -94.74 119.5 33.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.001 0.921 . . . . 72.140000000000001 109.085 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -91.12 138.75 31.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.573 1.149 . . . . 63.140000000000001 109.815 171.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -81.88 123.2 28.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.694 -1.225 . . . . 72.120000000000005 107.694 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.6 p -148.49 168.54 22.43 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.41 0.684 . . . . 61.530000000000001 109.515 165.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.69 163.7 25.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.825 1.65 . . . . 72.340000000000003 112.604 159.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 tt -145.66 160.14 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.477 1.511 . . . . 52.130000000000003 107.058 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.2 t -126.71 -35.57 2.31 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.32 3.048 . . . . 53.119999999999997 109.413 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.79 -52.72 0.09 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 127.31 2.386 . . . . 72.329999999999998 110.177 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.7 p -138.73 7.75 2.54 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.565 1.32 . . . . 44.409999999999997 114.565 -158.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.1 m -131.25 105.41 7.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 129.26 3.024 . . . . 65.219999999999999 107.712 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.474 HD22 HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -77.48 121.41 23.81 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.701 -1.963 . . . . 71.230000000000004 105.701 173.369 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 ttmm -101.87 86.62 2.94 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.87 -1.159 . . . . 65.129999999999995 107.87 165.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.474 HG23 HD22 ' A' ' 84' ' ' LEU . 22.9 t -79.17 129.95 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.307 -1.368 . . . . 73.099999999999994 107.307 167.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -96.77 -30.57 13.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.956 0.902 . . . . 51.100000000000001 112.053 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -150.99 173.43 14.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.297 1.039 . . . . 71.109999999999999 110.291 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.48 -178.69 25.36 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 109.849 -1.3 . . . . 52.200000000000003 109.849 -172.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 t -64.23 -25.12 67.92 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 122.119 -0.636 . . . . 71.530000000000001 110.718 172.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -101.44 10.26 40.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.241 1.417 . . . . 63.219999999999999 112.22 -168.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.45 0.28 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 127.001 2.121 . . . . 74.140000000000001 112.122 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 -162.94 31.1 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 121.616 -0.677 . . . . 23.32 112.578 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.4 p -119.23 106.25 12.16 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.582 1.553 . . . . 72.340000000000003 107.978 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -120.81 130.8 54.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.849 0.75 . . . . 64.510000000000005 111.44 -168.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -81.39 127.96 33.33 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.971 0.908 . . . . 73.420000000000002 108.91 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HE3' ' CH2' ' A' ' 16' ' ' TRP . 31.2 ttmt -60.94 135.29 57.74 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.917 -1.142 . . . . 65.510000000000005 107.917 165.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -113.76 65.14 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.283 1.04 . . . . 74.109999999999999 109.117 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.255 1.382 0 N-CA-C 106.613 -1.625 . . . . 73.239999999999995 106.613 163.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.657 0 N-CA-C 110.885 -0.886 . . . . 63.109999999999999 110.885 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -123.69 75.69 1.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 105.224 -2.139 . . . . 73.239999999999995 105.224 171.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -108.52 60.64 0.61 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.923 0.868 . . . . 72.0 109.194 -154.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -85.1 157.76 20.6 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.832 1.653 . . . . 73.109999999999999 111.045 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.14 176.29 8.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.705 0.802 . . . . 63.039999999999999 111.574 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -56.73 134.14 54.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.947 0.899 . . . . 74.109999999999999 109.772 156.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 tp -74.45 138.21 43.12 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.331 -1.359 . . . . 74.299999999999997 107.331 159.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -143.45 163.67 32.45 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.352 -1.721 . . . . 73.400000000000006 106.352 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.12 -51.33 54.58 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.746 0.654 . . . . 73.430000000000007 109.502 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -71.34 -16.22 62.43 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 117.933 -1.032 . . . . 73.219999999999999 113.36 -170.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -80.14 -41.87 24.57 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.456 1.025 . . . . 71.140000000000001 109.678 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.45 41.58 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.77 0.828 . . . . 73.530000000000001 110.568 -176.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.3 mm -112.21 125.5 69.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 O-C-N 119.939 -1.726 . . . . 73.329999999999998 108.48 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.46 179.69 16.47 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.651 1.119 . . . . 75.400000000000006 111.883 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -79.95 164.82 23.2 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.912 1.285 . . . . 72.219999999999999 109.474 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -142.35 145.65 34.14 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.176 0.99 . . . . 63.420000000000002 110.462 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.6 t -134.09 165.27 25.44 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.448 -1.407 . . . . 64.209999999999994 110.237 164.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.426 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 12.0 t -112.68 -12.21 13.43 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.587 1.555 . . . . 62.399999999999999 111.556 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.27 178.05 23.09 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 107.931 -2.068 . . . . 75.310000000000002 107.931 -166.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.3 pt -134.43 22.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.526 1.13 . . . . 61.399999999999999 110.827 -167.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 154.72 49.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.398 1.479 . . . . 72.010000000000005 107.238 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.49 -160.04 10.89 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.12 -0.491 . . . . 75.239999999999995 112.561 -172.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.8 m -79.95 88.59 5.32 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.678 1.191 . . . . 53.229999999999997 108.906 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -96.34 172.05 8.2 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 122.367 1.079 . . . . 71.030000000000001 110.843 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -141.15 118.26 11.27 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.184 -1.413 . . . . 74.319999999999993 107.184 -151.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.94 106.62 14.93 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.777 2.031 . . . . 55.130000000000003 109.226 -173.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 mt -90.81 158.26 16.92 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.509 1.124 . . . . 74.010000000000005 108.751 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.1 t -143.2 163.18 33.64 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.822 -0.807 . . . . 61.310000000000002 108.822 155.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -149.01 128.51 13.09 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.126 1.77 . . . . 75.230000000000004 109.34 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -104.38 144.77 31.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.084 1.354 . . . . 54.140000000000001 109.626 171.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.71 -27.41 63.96 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.37 1.068 . . . . 64.510000000000005 112.014 -174.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -128.15 0.7 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 129.248 3.019 . . . . 51.020000000000003 110.93 -164.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.94 -116.61 2.17 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 125.229 1.395 . . . . 43.109999999999999 110.047 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.3 p -140.23 177.75 7.77 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.352 2.261 . . . . 73.439999999999998 107.188 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -103.96 176.72 23.95 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 124.07 0.843 . . . . 73.530000000000001 111.183 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -140.86 158.67 43.62 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.448 1.499 . . . . 60.109999999999999 108.813 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -141.56 120.08 12.43 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.195 1.398 . . . . 75.219999999999999 107.267 164.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.83 114.48 1.42 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.891 1.71 . . . . 75.310000000000002 110.103 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.402 ' H ' ' HB3' ' A' ' 47' ' ' SER . 8.0 mt -78.27 140.59 16.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.46 -1.311 . . . . 64.0 107.46 171.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -124.96 154.51 41.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.943 -1.503 . . . . 54.399999999999999 106.943 170.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.401 ' HB2' HG13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -126.63 118.11 24.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.286 -1.375 . . . . 75.109999999999999 107.286 174.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m120 68.63 -64.68 0.3 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 126.421 1.888 . . . . 71.430000000000007 113.675 162.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -158.06 49.75 0.4 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.048 1.295 . . . . 43.210000000000001 110.937 158.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 m -150.85 134.69 9.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.149 1.38 . . . . 71.140000000000001 109.109 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.19 131.19 21.49 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.12 2.547 . . . . 73.400000000000006 110.541 168.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 41' ' ' SER . 10.7 mm -126.85 4.7 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.024 0.93 . . . . 74.0 110.816 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.402 ' HB3' ' H ' ' A' ' 39' ' ' ILE . 7.9 t -152.48 172.84 15.92 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 119.883 -1.761 . . . . 75.239999999999995 109.922 166.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -174.74 118.15 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.665 1.986 . . . . 75.019999999999996 108.113 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -142.48 158.04 44.11 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.281 1.432 . . . . 61.210000000000001 107.694 165.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.8 mtm -134.03 150.19 51.21 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.138 -1.43 . . . . 74.420000000000002 107.138 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.5 151.38 20.55 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 122.892 0.477 . . . . 75.319999999999993 110.985 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.76 167.21 22.22 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.838 -0.801 . . . . 63.140000000000001 108.838 166.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -146.79 166.86 25.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.677 0.791 . . . . 75.099999999999994 109.878 167.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -133.54 155.77 49.0 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.442 -1.688 . . . . 73.349999999999994 106.442 161.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.0 mm -114.02 98.56 7.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.844 -1.91 . . . . 63.299999999999997 105.844 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -130.03 23.13 5.29 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.029 0.752 . . . . 72.329999999999998 113.029 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -170.01 14.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.09 1.356 . . . . 55.229999999999997 114.07 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.43 18.61 75.47 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.272 -0.892 . . . . 64.239999999999995 112.461 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -140.36 173.29 11.65 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 128.586 2.754 . . . . 75.340000000000003 105.963 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.0 mt -102.72 117.81 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.866 -1.161 . . . . 75.010000000000005 107.866 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -84.51 122.17 28.63 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.686 1.194 . . . . 64.150000000000006 108.154 170.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mm -109.95 132.88 57.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.92 1.688 . . . . 74.439999999999998 106.626 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -160.87 6.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.777 1.399 . . . . 75.430000000000007 114.777 -169.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -148.68 123.15 9.71 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.024 -2.584 . . . . 73.329999999999998 104.024 163.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.8 t -136.27 148.85 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.467 -1.308 . . . . 74.150000000000006 107.467 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.68 163.31 32.12 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 107.364 -1.347 . . . . 75.349999999999994 107.364 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.63 -11.21 31.97 Favored 'Cis proline' 0 CA--C 1.534 0.487 0 CA-C-N 118.713 0.576 . . . . 74.329999999999998 113.378 -2.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.38 132.58 36.1 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.296 -1.742 . . . . 52.240000000000002 106.296 167.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.41 135.75 38.85 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 118.755 0.707 . . . . 73.319999999999993 109.335 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -124.14 168.4 12.95 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 124.169 0.987 . . . . 74.349999999999994 110.744 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 t -47.84 143.42 6.22 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.83 2.052 . . . . 72.319999999999993 110.675 166.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 159.0 53.78 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.253 1.969 . . . . 74.439999999999998 110.963 172.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -168.13 177.15 5.66 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.5 1.52 . . . . 74.299999999999997 108.349 172.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -106.99 155.94 19.27 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.708 -0.849 . . . . 75.019999999999996 108.708 171.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.8 mt -123.56 129.54 51.34 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.161 1.784 . . . . 73.319999999999993 109.298 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.09 123.25 29.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.177 1.391 . . . . 73.209999999999994 109.522 174.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 p -148.84 168.38 23.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.582 1.953 . . . . 75.340000000000003 108.033 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.08 154.88 50.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.887 1.275 . . . . 73.409999999999997 108.482 169.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 tt -136.95 156.54 34.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.362 -1.347 . . . . 75.340000000000003 107.362 173.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.45 26.06 0.68 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.692 0.997 . . . . 74.420000000000002 113.692 166.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.47 -94.28 0.18 Allowed Glycine 0 C--O 1.228 -0.229 0 N-CA-C 107.849 -2.1 . . . . 74.109999999999999 107.849 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.273 36.1 p -105.88 1.27 26.63 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.397 -0.811 . . . . 71.310000000000002 112.539 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.6 m -98.13 135.71 39.4 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.926 1.239 . . . . 75.019999999999996 109.207 168.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.43 137.0 45.2 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.824 -1.547 . . . . 74.230000000000004 106.824 162.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -121.37 85.05 2.34 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.356 1.062 . . . . 73.099999999999994 108.688 169.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.8 t -76.77 125.88 36.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.132 -1.062 . . . . 75.219999999999999 108.132 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -80.49 -53.27 6.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.148 0.579 . . . . 73.099999999999994 110.977 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.4 t -128.85 176.35 7.92 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.391 0.996 . . . . 60.009999999999998 112.251 -168.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.18 -175.81 44.89 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 125.622 1.582 . . . . 72.439999999999998 110.819 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.59 -27.9 65.07 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.083 -0.657 . . . . 74.120000000000005 111.583 176.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -101.17 14.26 32.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.983 -0.532 . . . . 72.439999999999998 112.128 -170.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.47 111.09 0.58 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.756 1.222 . . . . 55.5 110.385 172.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.49 -169.35 42.31 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.545 0.593 . . . . 42.229999999999997 113.885 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.9 p -113.8 118.15 33.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.479 1.911 . . . . 74.219999999999999 108.179 -174.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.426 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 47.2 m-85 -127.77 167.45 16.49 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.79 0.723 . . . . 62.210000000000001 112.879 -171.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -125.75 128.94 48.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 129.809 3.244 . . . . 74.0 106.932 -175.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -61.78 152.0 32.56 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.889 -0.782 . . . . 75.439999999999998 108.889 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -148.11 154.54 40.33 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 128.598 2.759 . . . . 60.399999999999999 109.621 171.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? . . . . . 0 C--O 1.254 1.297 0 CA-C-O 114.301 -2.761 . . . . 63.299999999999997 111.332 178.873 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.347 0 N-CA-C 109.778 -1.329 . . . . 73.329999999999998 109.778 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -133.79 174.71 10.16 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.209 1.804 . . . . 71.140000000000001 107.689 -172.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -116.54 51.64 0.97 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.789 1.281 . . . . 71.049999999999997 109.145 -151.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -76.11 152.34 36.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.082 -1.417 . . . . 73.540000000000006 110.925 -170.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 p -73.32 173.09 10.03 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.716 0.77 . . . . 61.149999999999999 110.635 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -49.6 133.63 20.67 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.238 -1.346 . . . . 72.049999999999997 109.676 160.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.9 tp -74.92 127.87 34.23 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.054 -1.461 . . . . 73.450000000000003 107.054 156.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -137.24 162.14 34.31 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.165 -1.42 . . . . 52.43 107.165 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -53.68 -48.46 69.47 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.775 1.23 . . . . 53.299999999999997 109.689 -176.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -26.36 61.88 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.748 1.619 . . . . 65.25 111.133 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -68.09 -37.36 81.13 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.949 0.795 . . . . 73.319999999999993 111.002 -174.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.26 -9.72 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.842 0.682 . . . . 74.519999999999996 112.842 -171.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.2 mm -61.65 124.76 16.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.788 1.235 . . . . 72.310000000000002 110.488 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.63 -177.24 27.0 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.58 1.086 . . . . 62.109999999999999 110.556 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -92.89 156.21 17.1 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.432 -0.951 . . . . 74.140000000000001 108.432 163.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -126.6 178.49 5.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.913 2.485 . . . . 63.340000000000003 108.473 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 t -167.72 169.41 11.77 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.012 1.725 . . . . 71.420000000000002 108.601 160.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.55 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 10.0 t -132.36 -1.26 3.57 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.089 1.756 . . . . 74.420000000000002 112.463 172.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.77 -178.17 30.86 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 120.922 -1.111 . . . . 50.100000000000001 110.556 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.8 pt -140.26 13.78 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.44 1.496 . . . . 70.430000000000007 111.146 -166.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -126.75 179.26 5.45 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.01 1.324 . . . . 64.299999999999997 111.518 -168.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 44.79 -93.81 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.693 1.616 . . . . 44.32 114.881 153.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 93.6 m -134.68 127.39 30.99 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.245 -1.391 . . . . 63.229999999999997 107.245 157.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -136.66 -179.77 5.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.21 1.804 . . . . 71.420000000000002 108.813 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -154.0 153.71 32.45 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.132 1.373 . . . . 74.099999999999994 109.008 -171.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.05 124.46 23.4 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.191 1.797 . . . . 73.420000000000002 108.66 -171.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.423 ' CD1' ' HD1' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -114.52 137.94 51.23 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.511 1.524 . . . . 71.120000000000005 109.336 176.503 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -139.66 134.63 32.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.215 -1.031 . . . . 53.329999999999998 108.215 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -133.12 106.75 7.79 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.919 1.688 . . . . 63.520000000000003 107.352 -170.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -77.03 152.54 35.09 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.231 -1.025 . . . . 71.439999999999998 108.231 169.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.35 -27.67 56.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.471 0.915 . . . . 71.310000000000002 113.471 -174.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -135.2 13.65 3.55 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 122.817 0.447 . . . . 75.299999999999997 111.16 -166.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.36 -112.2 1.57 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.246 1.403 . . . . 52.340000000000003 111.21 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.5 p -139.31 -173.96 3.74 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.555 1.542 . . . . 74.299999999999997 108.006 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.57 176.3 20.45 Favored Glycine 0 C--O 1.239 0.446 0 O-C-N 120.817 -1.177 . . . . 71.400000000000006 111.437 167.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.2 p -136.69 159.06 42.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.088 -0.654 . . . . 72.120000000000005 111.616 -166.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.423 ' HD1' ' CD1' ' A' ' 27' ' ' LEU . 29.1 t80 -134.8 113.14 11.31 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.768 1.227 . . . . 65.109999999999999 108.841 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -124.71 112.6 1.79 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 109.64 -1.384 . . . . 71.540000000000006 109.64 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.3 mt -86.47 144.54 9.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 105.36 -2.089 . . . . 70.420000000000002 105.36 170.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -131.56 158.5 40.8 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.585 1.554 . . . . 64.400000000000006 108.022 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.45 126.77 50.09 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.361 1.464 . . . . 72.140000000000001 107.595 167.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 53.36 -78.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.024 2.529 . . . . 73.439999999999998 113.026 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.35 34.8 0.97 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.723 1.609 . . . . 61.130000000000003 111.871 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.8 m -141.7 131.67 12.73 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 127.345 2.258 . . . . 64.329999999999998 109.301 -170.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.24 132.99 10.59 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.997 3.132 . . . . 61.340000000000003 111.436 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.4 mm -124.48 -21.35 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 112.809 0.67 . . . . 71.140000000000001 112.809 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -150.13 154.24 37.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 120.92 1.691 . . . . 61.130000000000003 108.308 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -160.69 128.88 4.54 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.715 1.206 . . . . 74.409999999999997 108.028 -169.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -162.23 160.02 26.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.179 -1.415 . . . . 74.299999999999997 107.179 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.2 mtm -134.13 154.02 51.46 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.939 0.896 . . . . 71.420000000000002 108.622 173.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -163.56 153.79 15.54 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.757 0.823 . . . . 71.099999999999994 111.117 -176.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -84.6 169.51 14.31 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.951 0.881 . . . . 71.219999999999999 109.868 171.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' HE3' ' A' ' 54' ' ' LYS . 7.2 m-85 -137.37 160.5 38.89 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.371 1.468 . . . . 72.439999999999998 110.53 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 53' ' ' TYR . 9.2 mmpt? -132.96 153.84 51.05 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.751 -1.574 . . . . 63.119999999999997 106.751 154.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.1 mm -108.87 100.06 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 105.739 -1.948 . . . . 73.140000000000001 105.739 170.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.42 23.65 4.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.257 0.551 . . . . 42.119999999999997 112.045 -171.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.27 14.93 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.206 1.802 . . . . 74.010000000000005 113.351 -170.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.4 17.98 71.07 Favored Glycine 0 CA--C 1.535 1.296 0 O-C-N 120.465 -1.397 . . . . 43.450000000000003 110.901 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -144.09 164.42 30.72 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 129.359 3.064 . . . . 71.420000000000002 106.474 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.6 mt -95.48 121.26 45.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.963 -1.495 . . . . 74.340000000000003 106.963 -176.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -87.1 111.56 21.04 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.923 1.289 . . . . 72.540000000000006 107.606 167.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mm -86.14 140.7 15.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.013 -1.847 . . . . 74.5 106.013 167.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -156.51 -5.24 0.11 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 115.794 1.776 . . . . 75.530000000000001 115.794 -176.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -151.55 103.25 2.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.931 -1.137 . . . . 73.420000000000002 107.931 -171.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 t -129.11 141.9 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.019 0.928 . . . . 73.439999999999998 109.692 -167.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.08 163.87 48.0 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 126.126 1.77 . . . . 75.329999999999998 107.271 175.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.37 -17.79 20.14 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 119.096 0.713 . . . . 63.130000000000003 113.479 -4.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -102.2 130.55 48.88 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.137 -1.431 . . . . 72.420000000000002 107.137 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -72.8 145.15 47.21 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 123.601 0.563 . . . . 74.140000000000001 110.41 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -137.54 144.51 42.15 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.708 1.203 . . . . 73.510000000000005 108.734 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.0 t -52.14 148.33 11.52 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 118.202 -0.904 . . . . 72.319999999999993 110.167 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.57 153.78 75.5 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.148 2.565 . . . . 54.200000000000003 111.476 172.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -160.18 164.61 32.73 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.947 1.299 . . . . 70.420000000000002 109.39 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -97.43 158.14 15.63 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.084 -0.71 . . . . 61.329999999999998 109.084 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 mt -134.17 116.9 15.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.849 2.059 . . . . 73.219999999999999 108.516 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -73.51 117.63 15.5 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.761 1.624 . . . . 61.219999999999999 107.577 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.8 161.95 39.61 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.232 -0.918 . . . . 71.310000000000002 109.566 168.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -115.62 161.48 18.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.817 -1.083 . . . . 74.129999999999995 110.08 161.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 tt -147.8 151.83 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.0 -1.111 . . . . 73.230000000000004 108.0 170.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.9 m -128.14 -1.96 5.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.471 1.108 . . . . 73.239999999999995 112.427 171.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.68 -74.68 0.43 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 108.316 -1.914 . . . . 41.43 108.316 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.0 p -93.7 -1.55 55.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.661 0.986 . . . . 65.319999999999993 113.661 -174.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -125.42 134.61 52.05 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.895 1.278 . . . . 70.209999999999994 108.423 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.54 131.67 49.12 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.152 -1.795 . . . . 74.239999999999995 106.152 166.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -120.39 84.38 2.21 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.313 -0.995 . . . . 74.540000000000006 108.313 171.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.3 t -77.4 128.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.362 -0.977 . . . . 64.099999999999994 108.362 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -96.23 -22.41 17.27 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.227 1.195 . . . . 71.340000000000003 114.227 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.8 t -150.21 179.0 8.46 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.311 1.444 . . . . 71.530000000000001 109.651 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.52 -177.96 52.3 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 122.706 1.17 . . . . 71.310000000000002 110.567 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.4 m -63.74 -11.83 29.7 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.155 1.782 . . . . 71.530000000000001 114.085 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -107.97 9.17 28.65 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.528 1.131 . . . . 62.299999999999997 113.18 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.22 105.84 0.23 Allowed 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.126 -1.609 . . . . 74.310000000000002 110.633 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 173.32 -159.29 29.31 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.81 0.719 . . . . 42.439999999999998 113.042 -163.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -133.18 128.91 37.02 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 125.33 1.452 . . . . 72.409999999999997 109.003 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.55 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 16.6 m-85 -134.88 149.38 50.3 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 123.871 0.868 . . . . 61.140000000000001 108.996 -173.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -118.57 151.05 38.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.099 -1.074 . . . . 73.120000000000005 108.099 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -68.62 151.65 46.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.091 -1.077 . . . . 62.420000000000002 108.091 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -128.7 66.23 1.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 123.434 1.588 . . . . 71.400000000000006 106.944 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.016 1.726 . . . . 72.519999999999996 108.338 171.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.619 0 N-CA-C 109.546 -1.422 . . . . 50.329999999999998 109.546 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -143.45 69.42 1.29 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 123.458 1.599 . . . . 65.0 106.698 171.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.94 102.37 2.91 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 129.153 2.981 . . . . 64.040000000000006 108.786 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.508 ' CD1' ' HE3' ' A' ' 78' ' ' LYS . 98.1 m95 -126.78 157.16 39.92 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.925 1.69 . . . . 70.400000000000006 110.647 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -82.73 175.24 10.28 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.037 0.835 . . . . 63.140000000000001 110.853 168.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -53.48 156.72 2.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.179 1.392 . . . . 75.040000000000006 110.345 163.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.419 HD21 HG13 ' A' ' 60' ' ' ILE . 7.0 tp -103.58 132.66 49.65 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.738 -1.574 . . . . 75.010000000000005 107.23 162.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.446 ' HA ' HG21 ' A' ' 55' ' ' ILE . 23.0 p30 -143.61 -175.3 4.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 127.323 2.249 . . . . 74.310000000000002 108.577 -175.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 p -78.65 9.29 4.22 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.431 1.092 . . . . 61.340000000000003 113.673 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -130.38 -40.28 1.28 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.56 1.527 . . . . 34.439999999999998 112.184 -162.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -72.3 -31.65 65.9 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.948 1.299 . . . . 54.43 110.272 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.9 tp -75.76 -24.83 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.836 1.198 . . . . 73.200000000000003 111.864 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.6 mm -55.74 97.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 127.835 2.454 . . . . 74.239999999999995 111.974 -174.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.65 179.91 44.62 Favored Glycine 0 N--CA 1.445 -0.731 0 O-C-N 122.27 -0.269 . . . . 52.420000000000002 113.085 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -100.0 148.68 24.26 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.53 1.932 . . . . 75.140000000000001 108.531 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -146.55 135.34 22.29 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.753 0.821 . . . . 72.540000000000006 110.036 -171.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -140.44 170.9 14.93 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.941 -1.099 . . . . 74.540000000000006 108.841 166.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.409 ' HB ' ' CD1' ' A' ' 95' ' ' TYR . 14.5 t -118.8 -18.04 9.01 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.469 1.108 . . . . 61.509999999999998 111.559 -176.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.84 -168.15 38.14 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 107.501 -2.24 . . . . 53.039999999999999 107.501 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.5 pt -139.98 -5.52 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.018 0.927 . . . . 72.129999999999995 112.742 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -93.21 173.59 7.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 120.077 1.308 . . . . 74.209999999999994 110.746 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.33 -94.56 0.01 OUTLIER Glycine 0 C--N 1.338 0.676 0 C-N-CA 126.528 2.014 . . . . 51.119999999999997 113.268 155.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.67 133.2 39.79 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.925 -1.139 . . . . 63.119999999999997 107.925 164.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -143.42 179.76 6.91 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.99 1.716 . . . . 75.439999999999998 107.67 174.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -143.28 133.5 24.49 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.962 -1.125 . . . . 62.509999999999998 107.962 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.8 155.17 18.98 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.996 1.718 . . . . 75.530000000000001 107.923 171.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 mt -145.9 141.81 28.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.552 -2.018 . . . . 75.140000000000001 105.552 164.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.0 m -138.24 147.83 44.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.156 -1.053 . . . . 74.439999999999998 108.156 173.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -141.85 121.31 13.23 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.087 1.755 . . . . 74.420000000000002 107.84 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -96.88 157.98 15.64 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.833 0.853 . . . . 74.409999999999997 109.579 167.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -78.87 -33.05 46.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.729 -0.669 . . . . 75.510000000000005 111.723 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -119.61 5.18 11.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.788 0.435 . . . . 71.319999999999993 111.4 -163.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.08 -111.09 0.95 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 125.448 1.499 . . . . 32.130000000000003 110.544 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.0 p -137.25 178.64 6.93 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.477 1.911 . . . . 72.310000000000002 108.797 -163.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -133.97 -174.78 13.63 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.493 -1.043 . . . . 73.310000000000002 110.493 164.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 t -148.28 160.02 43.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.609 -0.886 . . . . 62.299999999999997 108.609 -168.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -140.7 137.71 33.7 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.252 2.221 . . . . 64.420000000000002 105.695 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.53 147.35 16.66 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.402 -1.079 . . . . 35.140000000000001 110.402 166.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.1 mt -97.45 140.33 17.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 105.783 -1.932 . . . . 53.310000000000002 105.783 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -133.92 133.34 41.32 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.577 0.703 . . . . 75.510000000000005 109.867 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.715 ' N ' HD11 ' A' ' 46' ' ' ILE . 24.2 t -79.75 -172.58 3.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.108 2.163 . . . . 51.020000000000003 108.439 169.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -44.68 -42.47 7.59 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 126.689 1.996 . . . . 60.310000000000002 113.422 -172.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -159.74 49.32 0.3 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.097 -0.705 . . . . 75.129999999999995 109.097 162.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.7 m -146.92 136.07 11.44 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.517 -0.754 . . . . 75.519999999999996 109.268 -173.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.56 142.27 18.23 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 124.295 3.33 . . . . 72.340000000000003 113.147 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.715 HD11 ' N ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -136.3 -8.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 114.137 1.162 . . . . 62.329999999999998 114.137 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.04 145.53 15.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.021 -1.675 . . . . 72.340000000000003 107.751 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -159.2 129.28 5.7 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.022 -1.473 . . . . 75.109999999999999 107.022 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -153.77 167.69 28.8 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.129 1.372 . . . . 74.310000000000002 108.436 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.9 mtm -135.13 158.34 44.6 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 123.479 0.712 . . . . 74.200000000000003 109.93 165.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -155.1 160.05 40.69 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.235 -0.893 . . . . 72.340000000000003 108.909 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.14 164.05 15.18 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.304 -1.369 . . . . 74.420000000000002 107.304 168.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -136.27 165.66 25.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.962 -0.563 . . . . 64.340000000000003 109.758 170.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -131.37 159.2 38.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.024 -0.732 . . . . 72.040000000000006 109.024 158.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.446 HG21 ' HA ' ' A' ' 8' ' ' ASN . 16.3 mm -118.38 89.55 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 104.522 -2.399 . . . . 71.420000000000002 104.522 171.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -118.95 23.48 11.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.907 1.283 . . . . 62.020000000000003 111.474 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.33 21.59 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.339 1.456 . . . . 72.120000000000005 113.317 -173.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.95 22.65 70.58 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 120.554 -1.341 . . . . 63.32 112.082 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -148.44 163.0 38.45 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 127.374 2.269 . . . . 74.400000000000006 107.02 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.419 HG13 HD21 ' A' ' 7' ' ' LEU . 71.0 mt -87.92 130.33 37.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.924 -1.51 . . . . 61.409999999999997 106.924 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -108.56 107.54 18.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.198 1.399 . . . . 75.430000000000007 108.829 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 mm -78.67 138.9 19.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.655 -1.609 . . . . 63.229999999999997 106.655 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -158.25 -5.43 0.08 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 116.375 1.991 . . . . 75.019999999999996 116.375 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -150.78 110.06 3.96 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 103.959 -2.608 . . . . 73.019999999999996 103.959 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.4 t -128.74 141.9 45.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.137 -1.06 . . . . 72.230000000000004 108.137 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.41 164.29 45.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.172 1.389 . . . . 72.549999999999997 107.806 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -75.62 -7.87 25.45 Favored 'Cis proline' 0 CA--C 1.538 0.697 0 CA-C-N 119.259 0.771 . . . . 73.109999999999999 112.325 -11.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.1 109.63 20.23 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.183 0.993 . . . . 74.519999999999996 110.548 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.55 128.63 36.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 122.488 1.137 . . . . 64.049999999999997 110.365 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -107.92 177.79 4.71 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.684 1.594 . . . . 73.150000000000006 109.509 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -76.66 149.14 80.59 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.842 -0.799 . . . . 72.150000000000006 108.842 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.75 149.53 83.58 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.347 2.031 . . . . 52.420000000000002 111.037 171.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -168.39 167.35 11.96 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.072 0.949 . . . . 75.040000000000006 110.248 172.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -98.29 156.94 16.47 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.134 0.574 . . . . 54.340000000000003 109.849 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.69 128.9 35.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.7 2.0 . . . . 75.299999999999997 107.824 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.494 ' H ' ' CG2' ' A' ' 88' ' ' THR . 5.1 m-20 -84.68 129.63 34.81 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.037 -1.838 . . . . 74.019999999999996 106.037 174.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.42 150.47 23.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.371 1.868 . . . . 64.430000000000007 107.558 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.508 ' HE3' ' CD1' ' A' ' 4' ' ' TRP . 23.6 mtmt -128.55 145.46 51.12 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.069 -1.456 . . . . 75.019999999999996 107.069 -171.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.3 tt -143.93 152.4 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.02 -1.474 . . . . 74.099999999999994 107.02 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.9 t -128.64 -61.92 1.04 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.54 -1.282 . . . . 61.439999999999998 107.54 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.7 -102.0 0.27 Allowed Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 106.384 -2.686 . . . . 55.32 106.384 166.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.3 p -79.4 10.92 3.3 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.431 1.271 . . . . 75.340000000000003 114.431 -173.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.8 m -118.76 127.62 53.72 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 121.084 1.765 . . . . 72.209999999999994 109.7 171.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.15 125.64 41.79 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.085 1.354 . . . . 62.100000000000001 107.383 165.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.5 tttm -111.88 87.94 2.68 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.082 0.953 . . . . 74.439999999999998 109.065 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.9 t -72.03 134.5 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.777 -1.194 . . . . 64.310000000000002 107.777 174.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -97.11 -37.94 9.93 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.577 0.751 . . . . 62.420000000000002 110.292 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.494 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.0 t -137.7 161.41 36.59 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.054 1.741 . . . . 73.239999999999995 110.004 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.38 179.08 19.37 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.284 1.421 . . . . 72.430000000000007 112.639 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.8 m -57.24 -24.02 51.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.36 0.664 . . . . 63.32 111.444 166.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -100.83 5.04 43.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.399 1.88 . . . . 72.019999999999996 111.545 -169.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.1 103.53 0.15 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.438 1.495 . . . . 74.230000000000004 111.235 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.25 -164.74 33.1 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 123.793 0.711 . . . . 60.32 112.64 -169.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 54.3 p -130.08 120.61 24.93 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.512 1.125 . . . . 74.209999999999994 109.589 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.409 ' CD1' ' HB ' ' A' ' 18' ' ' THR . 48.3 m-85 -127.74 152.09 48.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.715 0.806 . . . . 55.140000000000001 109.226 -170.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -111.37 140.86 45.59 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.3 1.04 . . . . 75.200000000000003 108.458 175.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -66.59 125.87 27.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.772 -1.196 . . . . 75.340000000000003 107.772 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -101.26 55.16 0.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.833 1.253 . . . . 72.209999999999994 107.827 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 127.63 2.372 . . . . 64.299999999999997 105.819 167.389 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.649 0 N-CA-C 108.541 -1.824 . . . . 74.450000000000003 108.541 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -109.75 106.45 16.08 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 107.937 -1.135 . . . . 71.450000000000003 107.937 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -100.03 127.71 46.22 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 105.645 -1.983 . . . . 72.450000000000003 105.645 170.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -125.61 150.33 47.63 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.798 1.639 . . . . 64.549999999999997 109.733 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -72.07 171.86 11.15 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.469 0.652 . . . . 71.140000000000001 110.219 170.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -51.79 130.97 30.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.244 -0.889 . . . . 75.450000000000003 108.75 158.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.46 HD22 HD12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -64.14 124.56 21.98 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.898 -1.149 . . . . 72.230000000000004 107.898 151.491 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -137.65 171.08 14.98 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 118.772 -1.171 . . . . 63.520000000000003 111.358 160.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p -69.08 36.02 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.142 2.577 . . . . 74.239999999999995 112.387 172.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -137.78 -58.18 0.67 Allowed 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 125.051 1.34 . . . . 63.149999999999999 109.006 -170.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -77.03 -21.53 54.4 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 118.563 -0.732 . . . . 73.239999999999995 112.107 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.7 -19.02 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.43 1.092 . . . . 75.439999999999998 113.57 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.3 mm -65.67 118.85 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.449 -0.945 . . . . 73.510000000000005 108.449 -171.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.75 173.69 23.88 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.336 0.97 . . . . 73.209999999999994 111.544 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -80.46 156.39 26.61 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.803 -1.184 . . . . 71.109999999999999 107.803 162.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -141.67 135.12 29.59 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.737 -0.602 . . . . 75.510000000000005 109.689 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -137.76 150.66 47.44 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.956 1.703 . . . . 74.129999999999995 109.627 -167.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.522 HG23 ' CE2' ' A' ' 95' ' ' TYR . 31.0 p -89.84 -77.16 0.4 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.933 -1.506 . . . . 75.310000000000002 106.933 161.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.87 -168.48 14.23 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 126.682 2.087 . . . . 75.439999999999998 109.879 -177.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.0 pt -118.21 20.37 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.397 1.479 . . . . 73.420000000000002 110.792 -171.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -137.15 157.34 46.9 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.376 1.87 . . . . 63.130000000000003 108.478 -168.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.31 -172.09 7.69 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 121.633 0.574 . . . . 53.310000000000002 113.586 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.3 m -79.76 90.2 5.23 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.458 -1.312 . . . . 52.130000000000003 107.458 175.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.1 p-80 -110.54 -179.48 3.77 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.498 1.519 . . . . 53.340000000000003 110.371 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -140.89 157.6 45.14 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.073 1.349 . . . . 73.349999999999994 110.271 -169.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.95 140.94 32.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.702 1.601 . . . . 60.25 107.993 -173.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -123.87 169.48 11.54 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.981 0.913 . . . . 72.209999999999994 109.689 168.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.0 t -140.29 160.48 39.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.806 -1.553 . . . . 64.549999999999997 106.806 158.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -147.81 121.63 9.31 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.682 1.993 . . . . 63.329999999999998 106.271 168.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -95.33 156.23 16.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.829 0.851 . . . . 73.109999999999999 109.048 172.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.48 -23.96 37.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 61.109999999999999 111.957 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -133.16 10.68 4.18 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.046 0.758 . . . . 73.340000000000003 113.046 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.44 -119.98 3.92 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.588 -1.405 . . . . 21.41 109.588 173.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 p -141.33 -169.9 2.96 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.831 2.452 . . . . 74.129999999999995 106.505 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.6 179.05 19.21 Favored Glycine 0 CA--C 1.522 0.49 0 O-C-N 120.936 -1.102 . . . . 73.420000000000002 110.905 167.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -136.47 165.32 26.1 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.57 1.548 . . . . 73.109999999999999 109.284 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -152.44 109.62 3.54 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.551 1.541 . . . . 74.109999999999999 109.813 171.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.99 147.48 16.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.232 -1.147 . . . . 64.530000000000001 110.232 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.6 mt -119.87 139.85 45.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 105.828 -1.916 . . . . 65.129999999999995 105.828 169.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -122.41 165.82 15.71 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.942 1.297 . . . . 75.420000000000002 109.449 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 m -131.22 112.98 13.29 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.482 1.913 . . . . 73.200000000000003 106.869 160.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 55.24 -73.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 130.161 3.384 . . . . 73.010000000000005 113.892 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.24 44.24 1.54 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.95 1.3 . . . . 54.229999999999997 109.649 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.5 m -150.17 123.01 4.27 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 107.758 -1.201 . . . . 55.439999999999998 107.758 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.6 137.73 36.65 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.342 2.028 . . . . 60.399999999999999 108.967 167.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.3 mm -126.35 -25.42 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.442 1.097 . . . . 74.329999999999998 110.791 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.5 t -141.12 157.85 44.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 120.63 -1.294 . . . . 63.130000000000003 109.194 169.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -151.0 135.84 17.32 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 129.166 2.987 . . . . 74.319999999999993 105.139 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.58 163.19 40.09 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.454 -2.054 . . . . 53.149999999999999 105.454 165.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.9 mtm -130.28 167.98 17.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.431 -0.952 . . . . 74.519999999999996 108.431 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -160.6 148.85 16.35 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.585 0.754 . . . . 63.539999999999999 109.132 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.67 163.9 20.45 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.953 -1.129 . . . . 72.140000000000001 107.953 163.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -150.88 161.84 41.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.889 -0.507 . . . . 74.319999999999993 109.935 172.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -129.32 159.48 36.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.072 -1.084 . . . . 74.140000000000001 108.072 156.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.46 HD12 HD22 ' A' ' 7' ' ' LEU . 25.3 mm -105.02 102.43 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 103.638 -2.727 . . . . 73.450000000000003 103.638 162.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.94 27.22 2.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.093 0.949 . . . . 73.129999999999995 109.655 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.52 15.1 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 114.206 1.187 . . . . 70.409999999999997 114.206 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.93 23.72 66.01 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.564 -1.415 . . . . 73.510000000000005 109.564 -168.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -149.56 163.06 38.89 Favored 'General case' 0 N--CA 1.445 -0.712 1 C-N-CA 132.143 4.177 . . . . 73.530000000000001 103.843 -171.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.23 155.23 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.635 -1.617 . . . . 73.349999999999994 106.635 172.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -124.12 124.36 42.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.649 2.379 . . . . 61.450000000000003 106.911 164.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 mm -114.04 137.17 48.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.541 1.936 . . . . 63.350000000000001 106.458 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -160.08 6.96 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.281 1.215 . . . . 72.230000000000004 114.281 -172.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -151.96 123.81 8.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.17 -2.53 . . . . 71.109999999999999 104.17 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.3 t -132.57 144.81 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.943 -1.503 . . . . 74.109999999999999 106.943 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.21 159.95 68.9 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 108.165 -1.05 . . . . 73.510000000000005 108.165 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.58 -7.5 47.5 Favored 'Cis proline' 0 CA--C 1.534 0.485 0 N-CA-C 113.815 0.66 . . . . 74.329999999999998 113.815 -3.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -116.71 120.66 39.28 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.318 -1.734 . . . . 52.229999999999997 106.318 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -76.57 124.47 27.66 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.633 1.173 . . . . 71.430000000000007 108.686 -174.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 mttm -97.5 166.04 11.71 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.581 -0.896 . . . . 72.239999999999995 108.581 169.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.82 149.88 15.67 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.577 1.151 . . . . 50.32 109.315 171.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -68.9 142.84 53.01 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.217 1.944 . . . . 73.519999999999996 110.499 169.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -150.79 165.39 33.68 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 120.898 -1.126 . . . . 53.240000000000002 109.864 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -99.61 159.06 15.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.668 -0.864 . . . . 74.109999999999999 108.668 167.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.1 mt -131.54 118.9 20.76 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.373 1.069 . . . . 64.319999999999993 109.272 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -59.67 112.35 1.78 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.109 -1.441 . . . . 64.519999999999996 107.109 167.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.2 168.63 19.29 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 107.042 -1.466 . . . . 75.310000000000002 107.042 166.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.38 170.54 15.58 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.838 1.255 . . . . 73.109999999999999 111.49 163.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 tt -154.4 147.98 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 123.478 0.711 . . . . 75.409999999999997 109.303 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 m -151.39 48.81 0.82 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 129.473 3.109 . . . . 73.25 110.412 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.68 -66.9 3.32 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 126.207 1.86 . . . . 61.509999999999998 112.19 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -124.7 2.57 8.21 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.82 1.415 . . . . 75.340000000000003 114.82 -168.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 m -118.9 100.88 7.65 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.698 1.599 . . . . 63.530000000000001 107.806 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.3 tp -77.52 125.15 28.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.933 -1.506 . . . . 75.519999999999996 106.933 166.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -119.06 92.64 3.85 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 123.988 0.915 . . . . 72.430000000000007 108.973 177.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.78 137.35 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.669 -1.234 . . . . 75.349999999999994 107.669 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -100.58 -14.68 18.09 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.209 1.188 . . . . 75.319999999999993 114.209 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.1 t -151.6 163.87 38.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.429 1.013 . . . . 70.549999999999997 112.525 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.79 -175.79 53.28 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-O 122.832 1.24 . . . . 51.149999999999999 110.314 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.3 m -49.22 -27.62 3.85 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.802 1.641 . . . . 71.230000000000004 113.362 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -95.83 2.06 53.52 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.191 1.182 . . . . 62.25 114.191 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.68 105.17 0.14 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.347 1.059 . . . . 61.229999999999997 111.211 -173.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 173.47 -138.54 4.65 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.91 0.767 . . . . 72.349999999999994 112.62 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.8 t -150.5 132.14 14.89 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.416 1.486 . . . . 74.329999999999998 107.934 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.522 ' CE2' HG23 ' A' ' 18' ' ' THR . 36.7 m-85 -134.36 134.22 41.51 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 123.721 0.808 . . . . 73.540000000000006 109.323 -176.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -75.98 153.93 36.19 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.428 -0.953 . . . . 72.109999999999999 108.428 167.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -69.84 154.97 41.25 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.555 -0.905 . . . . 73.310000000000002 108.555 168.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -139.5 165.21 27.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.224 1.81 . . . . 74.510000000000005 107.461 163.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm . . . . . 0 C--O 1.25 1.115 0 C-N-CA 125.919 1.688 . . . . 61.240000000000002 111.115 -178.407 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.784 0 N-CA-C 107.559 -2.217 . . . . 32.329999999999998 107.559 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -94.25 85.05 4.53 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.655 -1.609 . . . . 64.400000000000006 106.655 -170.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -99.7 122.8 43.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.546 -2.02 . . . . 75.129999999999995 105.546 -173.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -114.55 155.17 26.96 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 126.447 1.899 . . . . 75.099999999999994 110.778 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 p -72.27 175.64 5.93 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.35 -0.611 . . . . 64.420000000000002 109.35 164.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -56.92 150.23 17.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.337 1.065 . . . . 73.439999999999998 110.114 155.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.1 tp -84.76 129.23 34.85 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 125.722 1.609 . . . . 75.430000000000007 107.159 155.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -135.44 166.23 23.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.363 -1.347 . . . . 74.319999999999993 107.363 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 t -67.29 -2.61 6.24 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.574 1.15 . . . . 61.149999999999999 112.788 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -108.01 -36.8 6.24 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.131 -0.981 . . . . 73.329999999999998 109.436 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.82 -23.92 66.54 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.39 1.076 . . . . 74.209999999999994 112.895 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.3 tp -90.12 -16.1 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.0 1.32 . . . . 72.129999999999995 113.101 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.3 mm -69.75 130.5 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.952 1.301 . . . . 62.130000000000003 110.983 -163.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.34 -175.24 20.82 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.783 1.658 . . . . 63.509999999999998 110.324 175.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -82.17 169.97 16.0 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.403 -0.962 . . . . 73.329999999999998 108.403 167.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -132.58 -175.86 3.9 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.556 -1.276 . . . . 74.200000000000003 107.556 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 t -169.05 167.04 10.81 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.722 1.601 . . . . 75.209999999999994 109.745 162.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.518 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 2.3 t -136.98 -19.43 1.3 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.506 1.122 . . . . 60.229999999999997 112.799 -177.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.78 171.27 38.77 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.666 -1.774 . . . . 60.119999999999997 108.666 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.81 19.11 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.972 1.309 . . . . 55.340000000000003 110.578 -169.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.76 -179.65 6.59 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 127.195 2.198 . . . . 64.310000000000002 108.33 -174.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.02 -117.58 6.94 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.108 0.861 . . . . 74.019999999999996 111.964 170.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.2 m -132.13 98.95 4.56 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.664 -1.235 . . . . 63.329999999999998 107.664 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -114.56 171.11 7.83 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.471 1.108 . . . . 73.140000000000001 110.21 -175.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -138.92 136.05 35.07 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.854 -1.165 . . . . 74.439999999999998 107.854 -165.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.51 96.17 4.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.028 1.331 . . . . 75.25 109.392 -171.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.0 mt -77.89 153.24 32.8 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.633 1.573 . . . . 72.439999999999998 110.811 164.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.0 p -141.16 158.77 43.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.871 1.268 . . . . 75.549999999999997 109.267 162.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -141.12 124.65 16.75 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.015 1.326 . . . . 75.450000000000003 108.415 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.5 159.91 16.26 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.206 1.402 . . . . 52.409999999999997 107.746 170.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -83.96 -32.95 24.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.802 0.841 . . . . 73.329999999999998 112.239 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -138.87 30.32 2.27 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.641 1.176 . . . . 63.240000000000002 109.836 -172.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -127.86 -110.92 1.61 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.448 -1.461 . . . . 71.549999999999997 109.448 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.2 p -146.01 -170.66 3.53 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.049 2.14 . . . . 72.140000000000001 107.361 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.0 167.92 12.93 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.846 -1.302 . . . . 32.030000000000001 109.846 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -144.29 155.86 44.01 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.826 -0.808 . . . . 54.43 110.199 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -139.93 120.48 14.17 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.164 1.385 . . . . 60.049999999999997 107.764 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.85 157.18 15.13 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.752 -1.339 . . . . 71.049999999999997 109.752 168.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.3 mt -122.28 146.59 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 105.835 -1.913 . . . . 40.350000000000001 105.835 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -134.82 144.68 47.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.227 1.411 . . . . 72.310000000000002 108.449 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.9 125.87 48.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.192 -2.151 . . . . 71.340000000000003 105.192 158.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.2 m120 62.86 -83.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.582 1.553 . . . . 72.019999999999996 112.977 160.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.4 59.98 0.96 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.642 1.177 . . . . 74.030000000000001 108.651 163.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.0 m -144.89 130.19 9.36 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 127.137 2.175 . . . . 75.129999999999995 106.316 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.94 141.48 48.76 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.452 2.101 . . . . 72.010000000000005 109.651 167.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.3 mm -131.73 -22.26 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.763 1.225 . . . . 62.109999999999999 110.998 -174.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.9 t -143.47 167.66 21.67 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.576 -1.328 . . . . 72.409999999999997 110.251 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -160.09 146.88 16.03 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.551 1.94 . . . . 75.340000000000003 108.726 -175.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -159.05 164.05 35.78 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.386 1.874 . . . . 74.319999999999993 107.573 163.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.5 mtm -121.18 156.84 31.52 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.744 1.618 . . . . 53.450000000000003 107.149 162.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -161.3 138.01 8.53 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.141 0.976 . . . . 63.109999999999999 109.711 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -75.11 163.24 27.77 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.705 0.764 . . . . 72.329999999999998 109.262 166.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -153.08 158.15 41.49 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.799 0.84 . . . . 75.040000000000006 111.064 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -137.06 158.28 44.81 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.562 -0.711 . . . . 72.439999999999998 110.485 169.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.5 mm -111.14 90.85 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 106.81 -1.552 . . . . 55.530000000000001 106.81 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -121.5 22.86 10.55 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.381 1.252 . . . . 62.32 114.381 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -174.9 14.98 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 116.341 1.978 . . . . 64.049999999999997 116.341 -173.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.27 16.23 77.06 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 119.475 -2.016 . . . . 31.140000000000001 114.39 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -130.69 -170.7 2.39 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.796 2.038 . . . . 71.040000000000006 108.269 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.4 mt -113.2 106.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.802 1.637 . . . . 74.310000000000002 107.263 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -72.12 124.13 24.33 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.539 -1.282 . . . . 73.430000000000007 107.539 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.8 mm -111.15 139.07 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.406 -2.072 . . . . 62.240000000000002 105.406 170.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -157.49 8.57 0.17 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.954 0.902 . . . . 75.340000000000003 112.306 -175.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -152.6 118.9 5.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 103.18 -2.896 . . . . 75.439999999999998 103.18 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -135.65 152.23 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.223 -2.14 . . . . 64.150000000000006 105.223 169.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.05 161.64 54.61 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 125.34 1.456 . . . . 73.150000000000006 107.583 173.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -81.86 -6.81 46.39 Favored 'Cis proline' 0 CA--C 1.54 0.789 0 N-CA-C 114.319 0.854 . . . . 71.209999999999994 114.319 -6.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.92 104.78 14.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 104.731 -2.322 . . . . 63.420000000000002 104.731 168.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -64.01 155.2 31.86 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.814 0.696 . . . . 62.340000000000003 110.495 170.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -129.67 162.29 28.67 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.109 1.364 . . . . 73.049999999999997 107.854 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 t -54.92 149.26 24.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 109.072 -0.714 . . . . 61.329999999999998 109.072 171.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.12 147.19 53.7 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.241 1.961 . . . . 61.340000000000003 110.992 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -156.52 174.05 16.01 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.825 1.25 . . . . 71.150000000000006 109.755 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -117.05 131.08 57.02 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.811 -1.181 . . . . 74.450000000000003 107.811 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.416 HD22 ' HA3' ' A' ' 89' ' ' GLY . 45.5 mt -101.06 116.4 32.75 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.649 1.179 . . . . 72.120000000000005 108.578 176.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.9 116.28 5.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.844 1.258 . . . . 72.049999999999997 108.045 172.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.1 p -139.42 156.77 46.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.757 0.789 . . . . 71.299999999999997 110.045 161.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -116.28 159.34 22.01 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.279 -1.328 . . . . 60.100000000000001 108.964 168.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 tt -152.89 154.35 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.671 -1.603 . . . . 55.240000000000002 106.671 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.8 p -133.37 -11.22 2.83 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.836 1.421 . . . . 62.0 114.836 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.32 -91.17 0.15 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 107.098 -2.401 . . . . 74.430000000000007 107.098 -165.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.5 p -106.7 -0.42 23.62 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.454 1.65 . . . . 64.040000000000006 115.454 -167.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.6 m -114.16 109.93 19.18 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.568 1.947 . . . . 74.310000000000002 109.878 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.493 HD22 HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -75.89 136.1 40.12 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 119.837 -1.789 . . . . 64.209999999999994 107.39 167.562 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -119.2 88.63 2.97 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.602 -0.518 . . . . 60.229999999999997 109.602 162.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.493 HG23 HD22 ' A' ' 84' ' ' LEU . 25.0 t -81.5 133.03 30.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.859 -0.793 . . . . 54.329999999999998 108.859 170.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -106.43 -18.59 13.94 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.708 1.203 . . . . 74.230000000000004 112.872 -171.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.4 t -155.75 171.66 19.64 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.244 1.417 . . . . 64.010000000000005 109.298 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.416 ' HA3' HD22 ' A' ' 75' ' ' LEU . . . 92.81 178.28 40.78 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 122.836 1.242 . . . . 61.109999999999999 110.378 -173.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.1 m -59.55 -21.37 60.18 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 113.706 1.002 . . . . 74.430000000000007 113.706 174.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -109.96 19.48 18.99 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.342 1.608 . . . . 73.109999999999999 115.342 -176.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.14 109.24 0.56 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.171 0.988 . . . . 62.140000000000001 111.484 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.83 -156.15 26.7 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.184 1.374 . . . . 53.409999999999997 112.912 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -119.81 125.48 48.67 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.979 1.312 . . . . 62.140000000000001 110.158 -173.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.518 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 6.1 m-85 -133.3 152.23 51.92 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.003 0.43 . . . . 73.319999999999993 110.848 -174.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -103.53 138.3 40.41 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.352 1.461 . . . . 71.219999999999999 107.473 172.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -52.78 149.23 6.43 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.295 0.952 . . . . 74.239999999999995 109.408 166.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -137.63 155.99 48.55 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.52 1.928 . . . . 64.310000000000002 108.208 169.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 79.5 mttt . . . . . 0 C--O 1.252 1.2 0 C-N-CA 125.761 1.624 . . . . 64.5 110.805 -175.832 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.45 0 N-CA-C 109.541 -1.424 . . . . 73.530000000000001 109.541 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.4 150.78 1.15 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.948 2.099 . . . . 74.340000000000003 106.245 167.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -135.71 105.54 6.19 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.172 -1.788 . . . . 75.099999999999994 106.172 -168.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.416 ' CG ' ' HB3' ' A' ' 78' ' ' LYS . 93.4 m95 -106.51 -174.09 2.45 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.755 2.022 . . . . 73.200000000000003 111.592 -173.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.7 p -110.4 160.67 16.37 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.597 0.759 . . . . 74.530000000000001 110.126 168.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.56 127.16 26.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.11 2.164 . . . . 73.430000000000007 109.288 173.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 tp -79.7 92.04 5.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.893 -1.151 . . . . 73.219999999999999 107.893 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -94.56 164.36 13.01 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 125.33 1.452 . . . . 65.209999999999994 107.581 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.45 -45.89 73.19 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.241 1.016 . . . . 74.120000000000005 109.873 172.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -76.51 -19.35 58.07 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 119.454 -0.898 . . . . 63.310000000000002 112.425 -170.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.2 -40.5 62.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.914 -0.491 . . . . 71.299999999999997 111.003 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.1 tp -76.61 -13.32 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 120.91 -1.119 . . . . 74.409999999999997 113.695 -170.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 mm -52.28 136.0 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.032 1.333 . . . . 72.530000000000001 112.655 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.58 178.85 15.66 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 125.855 1.693 . . . . 72.239999999999995 110.739 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -84.87 167.06 16.33 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.405 -0.961 . . . . 73.299999999999997 108.405 165.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -147.41 139.86 24.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.417 -1.327 . . . . 73.530000000000001 107.417 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 t -141.71 170.09 16.37 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.569 -1.332 . . . . 71.200000000000003 110.203 166.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.3 t -132.71 0.43 3.57 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.462 2.305 . . . . 75.329999999999998 111.546 -173.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.93 179.28 38.12 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.175 -1.17 . . . . 60.219999999999999 110.175 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.2 pt -130.8 22.87 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.711 1.604 . . . . 35.509999999999998 109.571 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -142.53 -175.88 4.64 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.328 1.451 . . . . 74.239999999999995 109.654 -169.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.84 -119.38 16.08 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.534 -1.026 . . . . 55.340000000000003 110.534 156.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -131.79 101.69 5.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.979 -1.86 . . . . 73.019999999999996 105.979 161.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -114.34 172.5 6.97 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.641 0.734 . . . . 74.409999999999997 109.061 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -143.14 144.58 32.27 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.418 -0.956 . . . . 74.420000000000002 108.418 -160.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.84 103.13 5.93 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 122.994 0.518 . . . . 72.230000000000004 109.671 -167.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.5 mt -94.64 154.45 17.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.467 1.107 . . . . 71.549999999999997 110.068 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 p -146.12 125.16 12.82 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.425 1.09 . . . . 70.450000000000003 109.769 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -124.03 114.96 20.43 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 120.166 1.348 . . . . 72.120000000000005 109.793 -174.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -92.42 152.76 19.54 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 124.151 0.907 . . . . 73.299999999999997 110.033 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -81.26 -20.48 40.85 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 114.268 1.21 . . . . 73.109999999999999 114.268 -174.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -133.48 1.11 3.39 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.328 0.513 . . . . 74.219999999999999 112.245 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.83 -123.17 5.2 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.435 -1.466 . . . . 43.149999999999999 109.435 173.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.3 p -134.74 -171.1 2.7 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.858 1.663 . . . . 63.210000000000001 108.542 -164.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.37 165.65 12.15 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.99 -0.844 . . . . 64.129999999999995 110.99 165.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -142.56 166.38 24.82 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.846 0.859 . . . . 45.030000000000001 110.832 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -146.99 133.0 19.18 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.492 -1.299 . . . . 73.519999999999996 107.492 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.45 161.62 24.48 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.184 -1.167 . . . . 52.219999999999999 110.184 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.3 mt -131.94 121.51 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.109 -1.811 . . . . 71.239999999999995 106.109 -174.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -118.49 132.53 56.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.72 1.208 . . . . 71.109999999999999 109.016 -171.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 m -97.68 119.24 35.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.554 -1.276 . . . . 73.129999999999995 107.554 166.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 46.77 -85.2 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 127.844 2.457 . . . . 75.219999999999999 113.72 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.51 56.68 1.65 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.827 1.251 . . . . 72.040000000000006 109.402 170.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 m -143.58 122.57 7.32 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.154 1.782 . . . . 72.439999999999998 107.84 171.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.44 137.6 36.77 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.842 2.362 . . . . 73.129999999999995 109.847 165.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.0 mm -128.17 -15.27 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.187 0.995 . . . . 71.329999999999998 111.164 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.4 t -135.56 167.41 21.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 119.775 -1.828 . . . . 71.239999999999995 110.059 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -163.47 147.27 10.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.303 -0.862 . . . . 74.420000000000002 108.921 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -167.99 165.96 13.41 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.444 1.498 . . . . 63.149999999999999 108.311 166.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.3 mtm -133.48 161.29 34.97 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.089 1.356 . . . . 72.230000000000004 108.048 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -162.6 140.11 8.17 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.992 1.317 . . . . 71.319999999999993 109.155 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.42 161.81 26.8 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.271 -1.011 . . . . 74.340000000000003 108.271 163.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -144.14 164.56 30.33 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.669 -0.644 . . . . 74.530000000000001 109.344 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -136.7 156.42 48.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.806 -0.813 . . . . 74.120000000000005 108.806 166.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.0 mm -107.04 99.81 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 106.173 -1.788 . . . . 71.530000000000001 106.173 168.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.2 28.52 3.75 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.885 0.874 . . . . 61.43 112.353 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -163.14 14.01 0.07 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.003 1.721 . . . . 74.329999999999998 115.129 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.49 21.03 47.92 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.254 -1.529 . . . . 74.540000000000006 113.111 -168.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -132.69 -168.45 2.07 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.86 2.864 . . . . 74.439999999999998 106.875 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.7 mt -118.32 110.89 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.897 -1.52 . . . . 72.319999999999993 106.897 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -80.78 120.24 24.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.332 -1.359 . . . . 70.530000000000001 107.332 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.0 mm -108.02 135.0 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 105.356 -2.09 . . . . 71.140000000000001 105.356 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -154.06 8.29 0.35 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.809 0.843 . . . . 64.219999999999999 112.494 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -151.6 121.08 6.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 104.168 -2.53 . . . . 61.109999999999999 104.168 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.5 t -136.26 149.91 27.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.051 -1.833 . . . . 52.25 106.051 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.99 160.29 53.32 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.6 1.56 . . . . 72.530000000000001 108.04 177.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.78 -13.66 27.89 Favored 'Cis proline' 0 CA--C 1.535 0.555 0 CA-C-N 119.539 0.871 . . . . 71.140000000000001 113.802 -10.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.76 103.1 15.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 104.022 -2.584 . . . . 50.520000000000003 104.022 171.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -66.82 160.07 26.75 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.307 -0.627 . . . . 73.219999999999999 109.307 167.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -137.9 174.7 10.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.118 1.367 . . . . 74.430000000000007 108.315 168.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.5 t -51.32 150.76 5.86 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 108.861 -0.792 . . . . 71.349999999999994 108.861 168.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -65.2 153.23 79.27 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.077 1.851 . . . . 74.25 109.333 163.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -159.3 172.07 18.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.555 1.542 . . . . 74.430000000000007 109.008 175.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -114.15 146.01 40.89 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.846 -1.168 . . . . 53.109999999999999 107.846 172.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.3 mt -123.9 115.98 22.16 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.769 1.228 . . . . 73.409999999999997 107.94 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.06 127.53 33.46 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.205 1.002 . . . . 73.530000000000001 108.353 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.9 m -144.73 160.66 40.86 Favored 'General case' 0 CA--C 1.522 -0.124 0 O-C-N 121.787 -0.57 . . . . 72.409999999999997 109.803 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 4' ' ' TRP . 8.2 mttm -121.41 155.72 34.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.333 1.453 . . . . 55.140000000000001 108.695 173.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 tt -145.75 148.23 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 119.095 0.862 . . . . 45.32 110.532 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.0 p -152.37 77.53 1.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.552 1.141 . . . . 64.329999999999998 109.913 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.4 -59.63 0.17 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 127.838 2.637 . . . . 74.230000000000004 115.385 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 p -132.6 22.16 4.3 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.479 1.111 . . . . 71.430000000000007 112.294 174.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.7 m -127.68 131.89 49.74 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.682 1.193 . . . . 72.239999999999995 107.989 167.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.98 131.96 56.44 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.524 1.929 . . . . 75.120000000000005 107.885 167.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -120.14 98.57 6.13 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.489 1.516 . . . . 72.319999999999993 108.183 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.6 t -75.89 125.59 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.436 -1.69 . . . . 34.530000000000001 106.436 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -83.15 -33.86 26.16 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.512 0.596 . . . . 64.200000000000003 111.474 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.0 t -146.76 155.77 42.64 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.446 1.498 . . . . 74.200000000000003 109.127 -170.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.07 -175.42 15.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 124.978 1.275 . . . . 53.210000000000001 111.414 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -24.61 63.29 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.895 -1.05 . . . . 63.43 112.432 169.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -111.68 24.19 13.01 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.406 1.003 . . . . 64.109999999999999 112.342 -168.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.39 102.41 0.23 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.341 1.456 . . . . 55.310000000000002 112.659 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.74 -124.97 0.92 Allowed Glycine 0 N--CA 1.463 0.498 0 C-N-CA 124.23 0.919 . . . . 73.219999999999999 112.557 -173.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -152.2 147.48 26.45 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.691 1.196 . . . . 35.229999999999997 111.186 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -143.51 146.7 33.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.336 1.454 . . . . 71.239999999999995 110.0 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -115.19 27.24 9.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.522 1.129 . . . . 72.109999999999999 113.69 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttt 61.76 159.28 0.06 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.692 1.997 . . . . 61.539999999999999 111.255 -170.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -144.22 163.05 34.78 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 127.786 2.434 . . . . 73.140000000000001 106.083 163.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt . . . . . 0 C--O 1.251 1.153 0 C-N-CA 125.949 1.699 . . . . 71.420000000000002 108.071 -173.183 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.563 0 N-CA-C 109.402 -1.479 . . . . 74.530000000000001 109.402 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -137.24 96.08 3.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.479 1.133 . . . . 74.510000000000005 109.532 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -85.75 117.21 24.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 104.1 -2.556 . . . . 61.039999999999999 104.1 173.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -121.81 -178.63 3.88 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 125.755 1.622 . . . . 71.219999999999999 108.624 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.6 p -111.42 170.19 8.29 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.588 0.631 . . . . 73.450000000000003 111.072 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.36 119.07 5.42 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.548 1.139 . . . . 70.049999999999997 109.669 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.9 tp -70.84 123.24 21.51 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.528 -1.656 . . . . 73.439999999999998 106.528 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -136.85 175.2 9.83 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.053 0.941 . . . . 65.329999999999998 108.903 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.3 p -58.51 -41.07 84.55 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.56 1.544 . . . . 73.340000000000003 111.821 -174.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -80.89 -30.14 35.53 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.384 0.674 . . . . 61.219999999999999 109.857 -174.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.6 -38.51 91.38 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.394 0.543 . . . . 74.219999999999999 111.021 -170.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.5 tp -74.43 -24.81 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.616 1.166 . . . . 70.510000000000005 112.636 -172.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm -57.02 109.58 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.91 1.684 . . . . 70.310000000000002 111.21 -168.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.97 172.89 32.99 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.784 -0.926 . . . . 54.119999999999997 110.784 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -86.51 160.02 19.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.42 -0.956 . . . . 70.209999999999994 108.42 159.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -146.89 140.86 26.0 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.475 1.51 . . . . 74.109999999999999 108.894 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.0 t -138.09 179.42 6.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.238 1.415 . . . . 51.130000000000003 107.874 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 t -137.27 -40.03 0.59 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.647 -1.283 . . . . 70.519999999999996 112.034 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.86 179.6 30.79 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 106.652 -2.579 . . . . 61.119999999999997 106.652 167.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.8 pt -130.41 36.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.304 1.041 . . . . 65.439999999999998 109.678 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -139.61 174.39 10.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.947 1.299 . . . . 71.439999999999998 109.606 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.68 -95.22 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.991 1.758 . . . . 50.310000000000002 114.024 169.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -139.44 141.89 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 105.688 -1.967 . . . . 73.209999999999994 105.688 162.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -151.45 -179.47 7.41 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.487 1.115 . . . . 72.420000000000002 108.112 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -142.47 140.86 32.04 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.131 0.973 . . . . 72.430000000000007 108.767 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.32 154.08 17.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.859 2.064 . . . . 71.540000000000006 107.032 170.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.479 HD21 ' HG2' ' A' ' 91' ' ' GLU . 5.0 mt -145.02 147.76 32.97 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.39 1.876 . . . . 73.430000000000007 105.951 169.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 p -151.02 154.71 37.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.015 0.825 . . . . 73.200000000000003 110.516 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CE1' HD22 ' A' ' 27' ' ' LEU . 93.2 m-85 -143.56 118.12 9.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.257 1.023 . . . . 71.230000000000004 108.782 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.5 158.76 25.76 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.61 -0.885 . . . . 43.130000000000003 108.61 164.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -79.6 -39.04 32.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.023 0.529 . . . . 71.310000000000002 110.427 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.29 8.79 7.88 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.897 0.879 . . . . 75.019999999999996 110.678 -166.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.27 -133.21 5.36 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 126.694 2.092 . . . . 74.540000000000006 108.062 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -126.35 -177.89 4.14 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.299 1.44 . . . . 75.140000000000001 108.441 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.27 160.1 15.27 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.667 1.603 . . . . 62.219999999999999 110.461 171.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 m -133.63 158.2 43.83 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.326 1.051 . . . . 31.219999999999999 109.871 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -149.1 129.11 13.49 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.464 1.906 . . . . 72.430000000000007 107.082 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.87 119.21 1.11 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.226 -1.15 . . . . 54.240000000000002 110.226 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.507 ' H ' ' HB3' ' A' ' 47' ' ' SER . 35.9 mt -75.95 150.63 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.558 -0.905 . . . . 73.129999999999995 108.558 174.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -132.09 133.58 44.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.443 1.497 . . . . 73.129999999999995 108.222 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 m -83.17 135.34 34.83 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 105.792 -1.929 . . . . 61.329999999999998 105.792 159.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 43.42 -80.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.785 2.434 . . . . 72.510000000000005 115.825 156.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.07 64.42 1.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.073 0.949 . . . . 22.440000000000001 111.597 162.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 m -157.65 135.83 7.48 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 128.469 2.707 . . . . 71.230000000000004 108.875 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.25 119.89 5.76 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.312 3.341 . . . . 74.109999999999999 111.927 170.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 mm -122.8 17.12 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.611 1.564 . . . . 73.530000000000001 111.071 -173.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 39' ' ' ILE . 30.4 t -158.03 164.26 36.91 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 119.492 -2.005 . . . . 63.520000000000003 108.117 157.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -158.72 127.86 5.53 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.898 2.079 . . . . 73.200000000000003 106.122 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -143.4 169.31 17.9 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.145 1.778 . . . . 71.439999999999998 107.604 163.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.0 mtm -145.92 160.43 41.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.44 1.096 . . . . 75.319999999999993 110.302 170.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -161.89 147.55 13.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.626 1.57 . . . . 71.219999999999999 108.23 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.59 176.18 7.87 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.447 1.476 . . . . 51.229999999999997 108.614 170.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -157.43 161.96 38.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.266 -0.896 . . . . 65.5 111.139 168.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -131.15 165.0 24.26 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.454 0.702 . . . . 74.040000000000006 109.338 163.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.8 mm -123.8 83.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 105.753 -1.943 . . . . 73.400000000000006 105.753 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.28 24.14 10.89 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.064 1.346 . . . . 65.439999999999998 110.074 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -164.25 13.51 0.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.963 1.305 . . . . 73.040000000000006 114.092 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.65 14.6 65.22 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 120.977 -1.077 . . . . 65.430000000000007 111.843 -171.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -137.19 170.94 15.25 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.143 2.177 . . . . 64.209999999999994 106.625 173.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 mt -75.27 165.61 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.446 -1.316 . . . . 64.409999999999997 107.446 176.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -136.52 108.62 7.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.976 2.11 . . . . 65.319999999999993 106.179 162.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mm -93.46 145.59 7.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 106.02 -1.845 . . . . 50.009999999999998 106.02 168.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -150.25 -1.45 0.41 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.131 1.16 . . . . 74.409999999999997 114.131 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.36 115.92 3.84 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.079 -2.563 . . . . 75.439999999999998 104.079 -167.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.34 149.43 32.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.295 1.038 . . . . 74.439999999999998 108.459 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.64 164.41 32.88 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.998 2.119 . . . . 63.32 106.094 168.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.03 -16.09 19.67 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.412 0.826 . . . . 64.219999999999999 113.69 -5.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.09 119.89 34.37 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.683 -1.599 . . . . 72.310000000000002 106.683 172.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -79.4 141.66 36.67 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 118.668 0.667 . . . . 73.519999999999996 110.281 177.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -136.61 160.16 39.65 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.605 1.162 . . . . 70.530000000000001 111.315 -177.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 t -57.69 151.62 40.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.588 1.955 . . . . 65.340000000000003 111.464 170.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.88 158.05 38.88 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.665 2.91 . . . . 74.420000000000002 112.484 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -171.04 172.4 5.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.664 1.186 . . . . 73.109999999999999 111.176 173.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -115.93 96.89 5.8 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.963 1.705 . . . . 71.510000000000005 110.052 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.2 mt -75.54 133.13 41.06 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 126.238 1.815 . . . . 62.119999999999997 109.258 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.418 ' H ' HG22 ' A' ' 88' ' ' THR . 0.0 OUTLIER -87.1 130.49 34.48 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.776 1.23 . . . . 73.329999999999998 109.303 176.767 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.3 p -154.64 166.62 32.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.487 1.915 . . . . 64.310000000000002 109.306 170.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -131.57 155.33 47.69 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.643 1.577 . . . . 74.510000000000005 109.649 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.9 tt -146.89 147.92 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.411 1.084 . . . . 65.540000000000006 108.122 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 m -138.74 -5.37 1.53 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.185 1.394 . . . . 74.109999999999999 114.626 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.02 -89.89 0.11 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 107.978 -2.049 . . . . 54.509999999999998 107.978 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.0 p -119.8 -4.35 10.2 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.676 1.361 . . . . 65.310000000000002 114.676 -172.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -99.08 114.14 26.7 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 121.039 1.745 . . . . 73.540000000000006 110.582 172.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.5 tp -85.49 116.17 23.64 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 119.441 -2.037 . . . . 50.240000000000002 108.297 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.87 105.51 15.73 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.011 0.924 . . . . 61.219999999999999 109.792 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.5 t -90.12 127.68 42.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.132 -0.692 . . . . 63.539999999999999 109.132 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -85.53 -38.2 18.79 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 118.662 0.664 . . . . 63.340000000000003 110.699 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 76' ' ' ASP . 1.4 t -148.54 173.35 13.23 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.092 0.86 . . . . 74.340000000000003 110.962 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.42 177.07 23.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 125.088 1.328 . . . . 64.129999999999995 110.361 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.8 m -53.48 -30.94 43.51 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.589 1.155 . . . . 74.219999999999999 110.252 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.479 ' HG2' HD21 ' A' ' 27' ' ' LEU . 1.4 mp0 -89.51 0.52 56.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.713 1.005 . . . . 73.5 113.713 -174.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.48 109.87 0.26 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.801 1.64 . . . . 71.409999999999997 109.651 -175.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.15 -167.97 39.6 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 109.024 -1.63 . . . . 71.439999999999998 109.024 -167.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.8 t -135.13 147.98 49.64 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.108 -1.071 . . . . 72.530000000000001 108.108 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -146.68 160.53 42.09 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.17 1.388 . . . . 73.430000000000007 109.97 -167.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.78 140.25 49.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.441 1.496 . . . . 70.209999999999994 109.405 175.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.503 ' HG2' ' H ' ' A' ' 99' ' ' LYS . 67.5 tttt -60.77 144.47 52.35 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.776 1.231 . . . . 74.239999999999995 109.952 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -125.94 34.05 4.95 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.861 2.064 . . . . 74.519999999999996 109.11 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.503 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 11.4 mtpp . . . . . 0 C--O 1.253 1.257 0 C-N-CA 128.471 2.709 . . . . 74.109999999999999 104.959 162.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.458 0 N-CA-C 108.85 -1.7 . . . . 72.439999999999998 108.85 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -138.86 160.09 40.54 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.439 1.096 . . . . 73.310000000000002 108.828 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -126.25 98.27 5.4 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.579 1.952 . . . . 65.150000000000006 105.745 -174.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.405 ' CD1' ' HE3' ' A' ' 78' ' ' LYS . 86.4 m95 -117.42 154.01 32.11 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.581 1.153 . . . . 65.140000000000001 110.48 -178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.2 p -75.32 165.85 24.52 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.28 -0.637 . . . . 73.25 109.28 172.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -64.19 130.93 45.86 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.755 1.264 . . . . 75.140000000000001 108.873 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.04 133.83 55.16 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 114.597 -1.183 . . . . 75.549999999999997 109.184 164.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.31 166.7 23.85 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.157 -1.383 . . . . 71.120000000000005 109.428 166.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -44.9 78.09 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 124.328 1.017 . . . . 71.340000000000003 108.957 167.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -60.83 -24.82 66.17 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.963 -1.086 . . . . 73.120000000000005 112.152 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.418 ' HB3' HG21 ' A' ' 79' ' ' ILE . 1.3 m-20 -85.96 -26.86 25.25 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 118.432 -0.794 . . . . 71.439999999999998 112.457 -172.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.0 tp -88.07 -7.52 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.54 1.064 . . . . 73.519999999999996 112.168 -171.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.442 ' O ' ' HE3' ' A' ' 97' ' ' LYS . 18.3 mm -62.23 114.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.218 1.407 . . . . 75.310000000000002 110.445 -172.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.6 173.92 25.71 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.435 -1.066 . . . . 53.350000000000001 110.435 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -85.62 151.55 23.81 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.369 -1.345 . . . . 54.009999999999998 107.369 162.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -138.58 123.84 19.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.108 1.363 . . . . 73.310000000000002 108.772 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -129.1 170.13 13.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.327 0.651 . . . . 60.420000000000002 109.403 173.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.455 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 12.5 t -126.82 -6.07 6.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.77 1.628 . . . . 61.240000000000002 111.369 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.07 177.46 19.9 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 108.665 -1.774 . . . . 61.149999999999999 108.665 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 pt -131.65 -11.04 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.702 0.801 . . . . 73.530000000000001 112.655 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -72.05 153.72 41.56 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 120.104 -1.623 . . . . 73.510000000000005 110.409 173.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.18 -111.64 3.31 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.698 -1.057 . . . . 70.230000000000004 111.237 165.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.6 m -141.78 107.49 5.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.966 -1.494 . . . . 62.100000000000001 106.966 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -103.11 175.43 5.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 122.229 1.014 . . . . 73.420000000000002 110.779 -174.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -126.89 140.08 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.461 1.905 . . . . 71.329999999999998 106.826 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.45 143.51 51.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.94 1.296 . . . . 52.130000000000003 108.428 -176.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.0 mt -132.12 156.75 45.81 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.034 -1.469 . . . . 75.140000000000001 107.034 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.0 p -154.92 97.64 1.97 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.689 1.596 . . . . 60.530000000000001 112.311 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -91.59 132.42 36.33 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.243 1.417 . . . . 75.530000000000001 110.289 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -94.11 165.33 12.68 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 127.77 2.428 . . . . 60.350000000000001 108.949 159.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -104.26 6.64 35.57 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.059 1.744 . . . . 60.310000000000002 110.549 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -149.94 7.3 0.62 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 115.162 1.541 . . . . 61.25 115.162 175.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.06 -110.97 1.51 Allowed Glycine 0 C--N 1.337 0.632 0 CA-C-N 118.498 0.59 . . . . 72.540000000000006 112.132 -170.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.4 p -147.16 131.83 17.86 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.418 1.487 . . . . 71.439999999999998 107.927 -174.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.95 175.96 34.06 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.137 -0.785 . . . . 71.420000000000002 111.137 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m -145.04 164.27 31.69 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.817 -1.402 . . . . 75.409999999999997 111.943 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -141.63 120.5 12.73 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.024 -0.732 . . . . 63.409999999999997 109.024 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -121.35 161.65 15.35 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.553 1.073 . . . . 44.219999999999999 111.097 177.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.4 mt -137.7 133.62 45.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.962 -1.866 . . . . 63.32 105.962 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -125.93 127.03 45.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.593 1.557 . . . . 43.140000000000001 108.965 -170.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -86.01 112.83 21.59 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.149 -1.056 . . . . 55.200000000000003 108.149 166.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.24 -85.95 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.921 2.089 . . . . 74.299999999999997 110.307 -169.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.92 -0.42 3.41 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.155 0.982 . . . . 60.100000000000001 112.264 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.5 m -84.11 119.65 73.61 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.267 1.427 . . . . 74.430000000000007 108.161 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.36 140.19 57.26 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.862 2.375 . . . . 64.510000000000005 109.778 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.8 mm -124.42 -41.61 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 124.213 1.005 . . . . 73.319999999999993 109.655 -177.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.2 t -124.63 156.18 37.91 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 121.495 -0.753 . . . . 73.310000000000002 109.641 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -154.82 152.99 30.47 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.987 1.715 . . . . 74.299999999999997 108.235 172.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -161.48 161.07 29.92 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 127.723 2.409 . . . . 51.329999999999998 107.286 168.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.6 mtm -124.3 163.3 21.95 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.199 1.0 . . . . 72.430000000000007 110.048 166.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -164.57 141.7 6.38 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.433 1.093 . . . . 71.349999999999994 111.035 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.8 158.83 20.83 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.151 0.98 . . . . 72.540000000000006 108.961 164.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -151.33 166.73 30.07 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.158 -0.964 . . . . 74.349999999999994 110.556 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -138.07 149.3 45.88 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.187 -1.042 . . . . 75.430000000000007 108.187 165.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.2 mm -116.61 92.98 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 106.888 -1.523 . . . . 74.329999999999998 106.888 172.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -134.31 23.32 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.648 0.779 . . . . 74.510000000000005 112.484 -173.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -166.71 14.13 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.805 0.842 . . . . 75.120000000000005 111.791 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.77 5.59 57.39 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.342 -0.848 . . . . 72.150000000000006 111.947 -171.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.542 ' HB3' ' HA ' ' A' ' 76' ' ' ASP . 0.6 OUTLIER -121.51 145.01 48.39 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 130.458 3.503 . . . . 73.109999999999999 109.551 173.616 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.98 121.04 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.583 -1.636 . . . . 71.140000000000001 106.583 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -88.75 112.36 23.08 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.474 -1.676 . . . . 74.140000000000001 106.474 169.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 mm -103.92 138.4 28.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 106.304 -1.739 . . . . 72.310000000000002 106.304 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -158.62 2.59 0.1 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.767 1.025 . . . . 73.319999999999993 113.767 -172.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -153.43 125.15 7.72 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 103.544 -2.762 . . . . 64.530000000000001 103.544 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.9 t -135.49 152.23 31.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.973 -1.491 . . . . 73.230000000000004 106.973 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.78 160.66 52.59 Favored Pre-proline 0 C--O 1.239 0.549 0 C-N-CA 123.855 0.862 . . . . 72.409999999999997 109.046 175.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.78 -8.01 16.91 Favored 'Cis proline' 0 CA--C 1.534 0.523 0 CA-C-N 118.794 0.605 . . . . 62.43 113.45 -8.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -108.09 107.05 17.55 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.643 -1.244 . . . . 71.510000000000005 107.643 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -67.35 140.67 57.25 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.966 -0.753 . . . . 73.230000000000004 108.966 169.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -130.89 172.8 11.63 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.143 1.377 . . . . 75.319999999999993 109.146 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.7 t -49.81 150.53 3.77 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.422 1.489 . . . . 72.439999999999998 110.798 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -66.1 154.23 74.89 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.874 1.716 . . . . 60.32 110.009 163.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -160.82 153.02 20.22 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.471 1.908 . . . . 74.310000000000002 109.767 170.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -98.11 140.38 32.51 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.185 -1.042 . . . . 74.239999999999995 108.185 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.1 mt -119.76 109.22 15.36 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 126.53 1.932 . . . . 70.230000000000004 108.683 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.542 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 5.0 m-20 -62.58 131.56 49.48 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.828 -1.175 . . . . 63.210000000000001 107.828 174.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.8 p -150.8 173.0 14.72 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.483 1.513 . . . . 71.519999999999996 109.831 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HE3' ' CD1' ' A' ' 4' ' ' TRP . 17.9 mtmt -139.23 158.43 44.19 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.227 0.611 . . . . 70.519999999999996 110.233 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.418 HG21 ' HB3' ' A' ' 11' ' ' ASN . 4.8 tt -151.06 144.02 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 118.227 0.467 . . . . 64.140000000000001 110.528 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.0 t -133.23 33.46 3.61 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.662 1.585 . . . . 74.409999999999997 108.244 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.4 -56.85 4.22 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 120.912 -1.118 . . . . 74.310000000000002 111.962 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.85 -25.25 11.32 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.043 1.127 . . . . 73.109999999999999 114.043 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.0 m -102.29 127.76 49.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.827 1.194 . . . . 75.510000000000005 108.056 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.8 tp -94.81 137.7 33.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.875 2.07 . . . . 63.32 108.808 159.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -136.15 87.91 2.34 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.6 1.16 . . . . 63.549999999999997 110.221 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.64 128.5 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.189 -1.041 . . . . 63.340000000000003 108.189 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -86.35 -25.72 25.23 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.607 0.763 . . . . 74.219999999999999 111.367 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 t -153.71 158.36 40.89 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.181 1.392 . . . . 72.219999999999999 110.579 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.18 177.47 20.93 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 124.664 1.126 . . . . 74.439999999999998 111.17 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.3 m -60.69 -16.82 43.4 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.204 1.402 . . . . 61.140000000000001 113.694 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -109.32 8.81 25.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.8 1.64 . . . . 64.519999999999996 112.844 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.12 116.34 2.73 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.311 1.844 . . . . 74.439999999999998 109.5 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.15 -153.26 21.76 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 122.158 0.866 . . . . 63.409999999999997 113.204 -172.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.7 t -135.43 123.93 23.5 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 126.191 1.796 . . . . 64.540000000000006 106.503 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.455 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 60.9 m-85 -141.01 157.72 44.94 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.556 1.169 . . . . 74.230000000000004 109.481 -175.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -127.62 138.06 52.73 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.356 -1.35 . . . . 72.340000000000003 107.356 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 13' ' ' ILE . 25.5 tttt -51.39 145.88 7.87 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.641 1.576 . . . . 62.25 109.32 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -122.54 20.1 10.36 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.469 2.708 . . . . 61.509999999999998 109.463 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp . . . . . 0 C--O 1.246 0.918 0 C-N-CA 130.007 3.323 . . . . 60.130000000000003 103.817 171.942 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.62 0 N-CA-C 110.155 -1.178 . . . . 54.240000000000002 110.155 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -133.55 146.49 51.07 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.202 -1.036 . . . . 62.329999999999998 108.202 170.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -82.77 117.82 22.95 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 104.814 -2.291 . . . . 65.109999999999999 104.814 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -115.15 157.2 23.95 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 125.056 1.343 . . . . 72.439999999999998 110.157 172.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.59 173.08 12.95 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.18 0.514 . . . . 64.310000000000002 109.877 169.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -59.21 151.65 22.48 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.948 -1.023 . . . . 74.129999999999995 109.754 167.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 tp -90.89 130.0 36.88 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.872 -1.529 . . . . 73.25 106.872 165.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -139.2 168.02 20.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.694 1.198 . . . . 74.450000000000003 109.259 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -74.04 33.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.945 0.898 . . . . 51.43 111.482 175.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.76 -32.44 0.44 Allowed 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 119.875 -1.765 . . . . 74.010000000000005 113.178 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -82.82 -30.3 28.86 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 116.976 -1.488 . . . . 65.219999999999999 111.969 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 tp -70.43 -24.63 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 121.636 2.016 . . . . 73.030000000000001 113.136 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.83 104.57 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.778 2.031 . . . . 74.25 111.246 -174.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.99 171.2 32.82 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.089 0.852 . . . . 72.140000000000001 111.034 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -76.13 152.28 36.77 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.106 0.962 . . . . 65.209999999999994 109.066 163.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -146.41 153.5 40.55 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.601 1.16 . . . . 70.329999999999998 109.299 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 t -153.45 165.24 36.45 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.812 -1.18 . . . . 70.140000000000001 110.304 166.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 25' ' ' LYS . 4.4 t -115.79 -9.82 11.82 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.69 1.596 . . . . 65.120000000000005 111.413 -175.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.04 -172.6 44.85 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.489 -0.757 . . . . 72.230000000000004 111.209 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.5 pt -134.77 14.69 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.032 2.133 . . . . 61.450000000000003 110.71 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -144.34 179.35 7.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.861 1.664 . . . . 74.340000000000003 111.653 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.25 -104.98 0.23 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.038 1.78 . . . . 63.549999999999997 111.755 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.6 m -139.74 101.88 4.3 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 106.128 -1.804 . . . . 74.209999999999994 106.128 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -117.7 178.73 4.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.827 1.251 . . . . 72.049999999999997 109.423 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.458 ' H ' HG22 ' A' ' 18' ' ' THR . 1.5 mptt -144.8 154.38 42.63 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.072 0.949 . . . . 71.430000000000007 109.941 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.22 154.5 18.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.382 1.873 . . . . 64.25 107.529 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mt -138.31 144.82 40.6 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.855 -1.535 . . . . 41.509999999999998 106.855 160.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.9 p -139.03 155.03 48.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.814 1.188 . . . . 73.140000000000001 109.764 166.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.426 ' CD2' ' CE2' ' A' ' 53' ' ' TYR . 22.2 m-85 -143.09 125.19 15.33 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.549 1.94 . . . . 72.239999999999995 106.039 -175.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -101.35 154.04 19.13 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.467 -1.679 . . . . 72.120000000000005 106.467 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -74.87 -41.38 59.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.841 0.746 . . . . 51.409999999999997 111.38 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -108.59 -1.74 19.37 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.113 0.565 . . . . 65.409999999999997 111.672 -162.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.81 -112.22 1.54 Allowed Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.26 -0.736 . . . . 31.039999999999999 111.26 -169.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 80.3 p -145.3 172.67 12.82 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.022 1.329 . . . . 51.329999999999998 107.773 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.03 -166.46 14.64 Favored Glycine 0 CA--C 1.524 0.627 0 O-C-N 120.973 -1.08 . . . . 43.219999999999999 111.865 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -155.44 156.94 36.2 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 121.264 -1.139 . . . . 71.319999999999993 111.694 -170.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -135.52 145.54 47.17 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.325 1.45 . . . . 65.430000000000007 108.104 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.15 154.5 25.54 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 109.93 -1.268 . . . . 54.219999999999999 109.93 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.7 mt -113.29 143.77 22.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.034 -1.469 . . . . 73.140000000000001 107.034 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -132.22 119.27 20.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.499 1.52 . . . . 73.239999999999995 109.211 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -85.86 107.98 17.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.617 -1.994 . . . . 74.439999999999998 105.617 166.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.72 -57.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 129.749 3.219 . . . . 74.319999999999993 115.721 174.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -154.94 25.3 0.43 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.684 1.594 . . . . 44.420000000000002 112.307 167.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.5 m -131.51 125.16 20.51 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.89 1.276 . . . . 54.240000000000002 108.282 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.06 124.8 7.53 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.738 2.959 . . . . 74.310000000000002 112.159 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.2 mm -114.65 -13.17 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.264 1.426 . . . . 73.109999999999999 112.762 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.7 m -151.6 163.73 38.42 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.086 -1.009 . . . . 74.209999999999994 109.133 170.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -164.23 127.47 2.51 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.639 1.976 . . . . 64.439999999999998 108.057 -173.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.77 166.94 26.94 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.879 1.671 . . . . 53.340000000000003 108.354 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.8 mtm -137.93 151.25 47.79 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.545 -0.909 . . . . 65.049999999999997 108.545 170.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.74 146.76 18.11 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.327 1.451 . . . . 74.209999999999994 110.913 -171.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -81.22 176.24 9.94 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.301 -1.0 . . . . 74.439999999999998 108.301 167.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CE2' ' CD2' ' A' ' 29' ' ' PHE . 5.9 m-85 -141.97 159.19 42.73 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.87 -0.604 . . . . 74.129999999999995 110.2 171.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -130.78 132.21 45.14 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.296 -1.372 . . . . 65.019999999999996 107.296 161.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.42 106.88 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 105.939 -1.875 . . . . 73.310000000000002 105.939 164.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -127.94 23.98 6.08 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.401 0.62 . . . . 74.25 111.244 174.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.67 13.73 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.471 0.915 . . . . 65.349999999999994 113.471 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.32 13.43 62.59 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 120.892 -1.13 . . . . 71.030000000000001 111.286 -163.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 76' ' ' ASP . 9.4 mmt85 -136.89 152.82 50.65 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.768 2.027 . . . . 73.120000000000005 105.917 -172.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.8 mt -88.06 115.24 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 107.147 -1.427 . . . . 72.219999999999999 107.147 -170.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -87.38 111.11 20.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.147 -1.057 . . . . 72.019999999999996 108.147 169.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.2 mm -79.51 138.99 18.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.021 -1.844 . . . . 65.129999999999995 106.021 163.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -145.79 2.84 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.859 1.429 . . . . 74.109999999999999 114.859 175.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.4 100.46 0.34 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.014 -1.476 . . . . 65.150000000000006 107.014 -156.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.9 t -130.34 143.27 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.401 1.08 . . . . 52.149999999999999 108.34 -176.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.04 158.91 71.32 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.371 1.869 . . . . 72.299999999999997 106.597 171.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -84.95 -6.41 53.31 Favored 'Cis proline' 0 CA--C 1.54 0.793 0 CA-C-N 119.533 0.869 . . . . 64.010000000000005 113.581 -6.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.09 102.79 10.73 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 105.973 -1.862 . . . . 72.019999999999996 105.973 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.43 151.97 43.53 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.234 1.016 . . . . 74.409999999999997 112.079 -174.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -128.48 164.66 22.27 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.35 1.86 . . . . 72.209999999999994 111.017 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 t -63.01 150.43 88.33 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.796 0.838 . . . . 73.439999999999998 109.292 165.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.77 137.66 25.07 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.696 2.264 . . . . 65.340000000000003 111.186 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -152.77 164.1 38.44 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.729 0.812 . . . . 74.150000000000006 111.451 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -93.39 154.37 17.99 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.244 0.617 . . . . 73.049999999999997 110.932 173.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -128.62 126.13 39.57 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.553 1.941 . . . . 70.450000000000003 107.728 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.426 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 48.0 m-20 -76.77 116.08 17.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.669 -1.975 . . . . 63.210000000000001 105.669 172.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -142.46 159.24 42.62 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.157 -0.683 . . . . 63.229999999999997 109.157 169.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -132.01 156.97 45.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.444 1.498 . . . . 71.209999999999994 110.537 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 tt -146.85 156.81 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.495 -0.557 . . . . 70.430000000000007 109.495 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.4 46.5 0.66 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 123.482 1.61 . . . . 73.140000000000001 110.898 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.19 -73.13 0.33 Allowed Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 113.583 -1.644 . . . . 65.409999999999997 109.262 171.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.4 p -119.91 -2.77 10.26 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 114.152 1.168 . . . . 74.310000000000002 114.152 -173.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.3 m -106.62 130.11 54.43 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.264 -1.384 . . . . 73.310000000000002 107.264 164.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.91 136.42 38.23 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.177 1.791 . . . . 61.25 107.524 163.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -120.65 88.77 3.0 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.662 1.185 . . . . 65.329999999999998 109.329 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.6 t -77.07 118.85 24.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.922 -1.51 . . . . 73.150000000000006 106.922 172.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -78.14 -39.97 39.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.465 0.575 . . . . 65.439999999999998 111.142 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 t -144.0 174.73 10.6 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.123 0.874 . . . . 73.310000000000002 111.258 -166.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.55 -179.17 47.65 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 125.683 1.611 . . . . 34.43 111.272 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.4 m -58.92 -21.87 58.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.356 1.462 . . . . 72.439999999999998 113.101 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -106.62 10.28 31.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.938 1.295 . . . . 73.409999999999997 112.474 -177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.45 109.57 0.46 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.298 1.439 . . . . 61.119999999999997 110.738 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -175.74 -169.89 37.91 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.547 1.07 . . . . 65.120000000000005 111.269 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -129.61 121.58 27.37 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.481 -1.674 . . . . 52.240000000000002 106.481 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -126.29 145.45 50.41 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.048 0.539 . . . . 73.049999999999997 109.842 -165.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -97.38 148.95 22.65 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.448 -0.945 . . . . 64.049999999999997 108.448 164.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -59.7 150.13 28.69 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.435 1.494 . . . . 74.319999999999993 109.486 166.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -145.26 20.66 1.56 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.251 1.82 . . . . 73.230000000000004 113.076 -170.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.6 tttt . . . . . 0 C--O 1.255 1.371 0 C-N-CA 128.473 2.709 . . . . 72.409999999999997 112.839 -178.985 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.733 0 N-CA-C 109.395 -1.482 . . . . 74.319999999999993 109.395 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -87.41 87.18 7.34 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 105.874 -1.899 . . . . 61.200000000000003 105.874 156.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.8 85.98 5.41 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.56 -1.274 . . . . 74.219999999999999 107.56 -172.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -88.47 150.86 22.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.134 0.974 . . . . 75.409999999999997 110.283 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.64 175.99 7.64 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.619 1.568 . . . . 52.340000000000003 109.996 171.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -74.15 123.08 23.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.06 0.944 . . . . 72.340000000000003 111.164 172.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.431 HD22 ' SG ' ' A' ' 77' ' ' CYS . 24.7 tp -60.69 129.29 40.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.239 -0.652 . . . . 74.420000000000002 109.239 162.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -146.35 168.27 21.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.653 0.74 . . . . 72.439999999999998 109.709 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.07 21.14 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.814 3.245 . . . . 72.510000000000005 113.446 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.83 -52.13 0.63 Allowed 'General case' 0 C--O 1.232 0.177 0 O-C-N 119.904 -1.748 . . . . 74.099999999999994 110.916 176.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -64.19 -26.38 68.49 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.66 1.118 . . . . 53.030000000000001 113.015 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.429 HD13 HD11 ' A' ' 7' ' ' LEU . 10.8 tp -70.52 -25.09 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.417 1.487 . . . . 64.310000000000002 113.469 177.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.77 129.89 34.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 123.443 0.697 . . . . 45.039999999999999 110.08 -163.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.36 -172.42 18.72 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.12 1.819 . . . . 63.530000000000001 111.397 174.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -82.27 160.7 22.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.361 1.465 . . . . 72.530000000000001 111.264 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -141.13 158.28 44.13 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.702 1.601 . . . . 73.25 108.182 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 p -146.78 169.08 19.83 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.8 2.091 . . . . 71.140000000000001 112.733 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -132.78 -5.33 3.19 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.608 1.563 . . . . 61.310000000000002 112.704 -171.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.8 172.94 14.9 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.251 -1.939 . . . . 74.049999999999997 108.251 -171.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.9 pt -138.11 27.42 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.452 1.101 . . . . 62.43 110.79 -168.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -125.89 174.88 8.07 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 124.559 1.144 . . . . 74.019999999999996 112.063 -171.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 43.66 -88.47 0.01 OUTLIER Glycine 0 C--N 1.341 0.854 0 C-N-CA 127.505 2.479 . . . . 55.420000000000002 114.017 149.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.3 m -130.44 122.23 27.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.485 -1.672 . . . . 62.030000000000001 106.485 159.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -131.72 -167.54 1.88 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.822 1.649 . . . . 72.230000000000004 107.757 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.43 156.08 18.31 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.241 1.816 . . . . 64.010000000000005 107.522 -162.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.95 132.4 20.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.789 2.436 . . . . 54.229999999999997 109.812 -177.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.59 HD21 ' HG3' ' A' ' 91' ' ' GLU . 48.4 mt -116.71 156.75 26.61 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.218 2.207 . . . . 75.340000000000003 108.498 175.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 t -137.18 156.31 48.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.025 -1.842 . . . . 43.409999999999997 106.025 160.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -143.1 129.78 20.3 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.35 1.46 . . . . 64.319999999999993 107.704 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.21 167.04 11.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.569 0.748 . . . . 71.219999999999999 110.76 171.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -81.88 -33.41 30.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.237 0.615 . . . . 71.5 110.572 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -138.08 28.82 2.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.867 0.841 . . . . 70.140000000000001 110.927 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.31 -116.62 2.54 Favored Glycine 0 C--N 1.33 0.232 0 N-CA-C 108.565 -1.814 . . . . 65.510000000000005 108.565 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.2 p -146.11 -175.07 4.61 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.398 1.479 . . . . 65.519999999999996 107.173 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.82 170.52 17.09 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.881 -0.888 . . . . 65.530000000000001 110.881 162.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.1 p -135.42 166.85 22.2 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.322 1.049 . . . . 74.409999999999997 110.89 171.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -149.59 105.96 3.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.044 -1.465 . . . . 71.329999999999998 107.044 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.51 104.02 1.02 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.577 -1.009 . . . . 63.310000000000002 110.577 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 mt -73.83 134.26 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 106.42 -1.696 . . . . 52.439999999999998 106.42 170.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -123.56 135.85 54.22 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.257 1.423 . . . . 63.25 108.238 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.28 136.29 36.96 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 107.622 -1.251 . . . . 62.229999999999997 107.622 163.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 45.89 -78.91 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 129.065 2.946 . . . . 74.019999999999996 114.655 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.27 65.47 1.02 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.793 1.237 . . . . 74.329999999999998 110.335 163.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.0 m -155.32 132.84 6.5 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.562 1.945 . . . . 64.319999999999993 108.939 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.15 134.99 26.2 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.433 2.756 . . . . 63.439999999999998 110.357 172.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.3 mm -127.48 -20.78 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.146 0.578 . . . . 71.019999999999996 111.31 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.7 t -138.76 163.69 31.53 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 120.526 -1.359 . . . . 74.230000000000004 108.268 167.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -163.45 132.36 3.93 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 126.891 2.076 . . . . 53.43 106.694 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -148.96 159.22 44.4 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.474 -1.676 . . . . 75.349999999999994 106.474 162.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.9 mtm -130.78 145.56 52.0 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.643 -1.614 . . . . 74.150000000000006 106.643 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -164.09 140.13 6.35 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.955 -0.387 . . . . 62.420000000000002 109.955 -167.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.42 174.16 3.55 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.503 1.121 . . . . 62.530000000000001 109.671 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -154.13 172.12 18.06 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.302 -0.873 . . . . 73.430000000000007 110.941 162.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -133.31 153.77 51.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.407 -0.961 . . . . 72.239999999999995 108.407 158.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.1 mm -102.67 101.12 11.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.356 -1.72 . . . . 62.5 106.356 165.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -136.67 24.52 3.13 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.503 1.521 . . . . 73.109999999999999 110.363 -171.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -169.73 14.27 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.641 1.576 . . . . 54.409999999999997 114.045 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.47 18.88 68.23 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 120.773 -1.204 . . . . 71.140000000000001 112.129 -170.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 -136.48 166.56 23.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 128.704 2.802 . . . . 74.200000000000003 105.436 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.58 150.09 4.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.117 -1.438 . . . . 71.310000000000002 107.117 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -119.99 125.17 47.73 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.61 1.964 . . . . 75.409999999999997 105.757 165.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mm -113.44 132.7 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.479 -2.045 . . . . 72.140000000000001 105.479 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -156.41 -2.61 0.12 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.314 0.857 . . . . 71.519999999999996 113.314 -170.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -145.52 111.65 5.66 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 105.526 -2.027 . . . . 74.340000000000003 105.526 174.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.28 146.84 33.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.067 -1.827 . . . . 72.140000000000001 106.067 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.58 160.73 58.01 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 106.72 -1.585 . . . . 70.239999999999995 106.72 174.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.47 -10.0 38.23 Favored 'Cis proline' 0 CA--C 1.537 0.645 0 CA-C-N 119.085 0.709 . . . . 70.450000000000003 113.532 -7.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.96 97.23 7.12 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 104.563 -2.384 . . . . 71.430000000000007 104.563 172.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -65.76 140.53 58.44 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.547 -0.908 . . . . 71.219999999999999 108.547 168.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -126.59 171.15 11.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.308 1.043 . . . . 74.150000000000006 109.459 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -47.15 141.69 5.94 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.276 1.031 . . . . 63.240000000000002 108.719 171.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.45 139.72 42.0 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.518 1.478 . . . . 43.32 109.466 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -144.64 162.33 36.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.629 0.772 . . . . 75.120000000000005 110.397 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -99.28 156.61 16.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.467 -0.938 . . . . 71.420000000000002 108.467 170.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.4 mt -127.55 110.12 12.4 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.734 -1.21 . . . . 63.200000000000003 107.734 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -57.98 129.19 40.8 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.481 -1.303 . . . . 73.120000000000005 107.481 170.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 1.8 p -157.48 165.46 35.59 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.508 0.723 . . . . 75.510000000000005 109.359 173.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -126.86 167.94 15.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.506 1.522 . . . . 71.209999999999994 111.143 164.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.0 tt -157.71 154.79 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.796 -0.816 . . . . 75.530000000000001 108.796 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.8 m -138.48 -5.27 1.59 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 118.195 2.665 . . . . 64.530000000000001 118.195 168.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.2 -52.52 0.51 Allowed Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.956 -1.258 . . . . 73.409999999999997 109.956 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -121.22 -20.88 6.58 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 116.757 -1.592 . . . . 51.030000000000001 113.82 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.1 m -96.51 116.83 29.72 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 121.141 1.791 . . . . 53.100000000000001 110.124 168.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.45 140.13 29.84 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.645 1.178 . . . . 75.510000000000005 109.752 159.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -132.1 91.25 2.93 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.131 0.972 . . . . 74.540000000000006 110.968 170.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 29.4 t -80.67 133.24 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.106 -1.072 . . . . 75.109999999999999 108.106 173.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -89.84 -30.7 17.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.499 0.72 . . . . 74.209999999999994 112.675 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.5 t -143.38 171.59 13.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.571 1.078 . . . . 63.210000000000001 110.69 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.25 179.67 49.61 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-O 122.997 1.331 . . . . 73.140000000000001 110.787 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.3 m -58.13 -20.07 37.49 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.691 1.197 . . . . 35.439999999999998 113.757 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.59 ' HG3' HD21 ' A' ' 27' ' ' LEU . 5.4 mm-40 -110.46 16.49 21.54 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.386 0.513 . . . . 62.119999999999997 112.386 -174.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.15 105.37 0.58 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.787 0.835 . . . . 73.329999999999998 111.69 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.35 -135.18 2.16 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 118.836 0.744 . . . . 42.439999999999998 113.074 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.4 t -138.58 119.9 14.77 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.866 1.666 . . . . 74.109999999999999 109.12 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.59 152.06 51.1 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.354 -0.841 . . . . 74.200000000000003 109.24 -166.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -119.05 129.8 55.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 117.636 -1.173 . . . . 74.109999999999999 108.698 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -47.39 140.65 5.47 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.333 1.053 . . . . 74.530000000000001 109.297 172.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -120.77 45.06 2.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.107 1.763 . . . . 63.329999999999998 109.172 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt . . . . . 0 C--O 1.257 1.457 0 C-N-CA 128.673 2.789 . . . . 74.140000000000001 105.418 178.058 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.572 0 N-CA-C 109.897 -1.281 . . . . 63.240000000000002 109.897 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -142.08 66.37 1.34 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 122.861 1.315 . . . . 75.349999999999994 107.693 162.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.14 64.67 7.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.315 -1.311 . . . . 53.119999999999997 108.34 -166.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -72.73 152.55 41.59 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.064 1.346 . . . . 75.109999999999999 110.385 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -78.63 166.39 22.58 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.027 0.376 . . . . 54.039999999999999 110.356 167.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -51.58 132.49 30.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.269 1.033 . . . . 73.329999999999998 108.669 163.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.8 tp -72.41 122.97 22.12 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.454 -1.684 . . . . 60.329999999999998 106.454 157.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -135.43 165.24 25.94 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.015 -1.476 . . . . 74.530000000000001 107.015 174.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -57.91 -43.68 86.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 124.184 0.928 . . . . 53.399999999999999 110.732 -165.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -75.75 -24.03 56.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.784 0.834 . . . . 72.049999999999997 111.728 -171.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -71.15 -39.55 71.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.517 0.599 . . . . 75.230000000000004 111.806 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.7 tp -83.18 -14.72 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.214 1.006 . . . . 74.129999999999995 112.307 -167.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 mm -57.97 145.29 9.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.846 1.258 . . . . 73.109999999999999 109.755 -176.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.72 -170.09 13.46 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.684 1.135 . . . . 74.0 110.733 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -104.65 152.84 21.98 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.712 1.605 . . . . 74.439999999999998 109.447 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -147.45 126.47 12.84 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.845 1.258 . . . . 71.099999999999994 110.231 -170.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.6 t -135.66 166.89 22.19 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.89 0.876 . . . . 75.430000000000007 110.117 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.484 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 15.3 t -114.23 -13.96 12.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.76 1.624 . . . . 52.439999999999998 111.438 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.09 -174.9 41.7 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.704 -1.358 . . . . 60.020000000000003 109.704 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.0 pt -132.51 28.17 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.9 1.68 . . . . 63.140000000000001 110.165 -177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -129.39 175.48 8.72 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.454 1.102 . . . . 53.439999999999998 109.568 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.45 -107.79 0.57 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 125.927 1.727 . . . . 74.209999999999994 111.872 161.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.3 m -139.02 94.78 2.85 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.408 -1.701 . . . . 62.340000000000003 106.408 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -125.48 168.21 13.94 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 122.151 0.977 . . . . 61.100000000000001 111.653 -172.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -137.56 145.41 42.85 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.233 0.613 . . . . 63.5 109.839 -161.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.61 127.94 48.13 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.807 1.643 . . . . 55.299999999999997 107.71 -172.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.0 mt -117.33 153.23 33.35 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.322 -1.362 . . . . 62.200000000000003 107.322 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.0 p -148.88 158.05 43.89 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.68 -0.236 . . . . 62.43 110.655 159.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -142.62 138.76 30.94 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.169 1.388 . . . . 64.319999999999993 107.298 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.49 156.57 17.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.067 0.947 . . . . 71.219999999999999 109.622 171.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.9 -21.09 44.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 54.210000000000001 111.857 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.96 -1.61 5.24 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.325 0.65 . . . . 74.299999999999997 112.431 -173.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.94 -129.96 4.36 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.256 1.408 . . . . 55.409999999999997 111.992 -166.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 p -137.04 172.45 13.0 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 127.302 2.241 . . . . 75.099999999999994 107.38 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.9 175.83 25.51 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.523 -0.735 . . . . 35.340000000000003 112.241 -176.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.37 152.08 50.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.904 1.282 . . . . 75.310000000000002 108.317 176.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -145.14 106.5 4.21 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.447 1.499 . . . . 62.509999999999998 108.693 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.78 149.66 18.64 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.785 -0.926 . . . . 75.120000000000005 110.785 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.3 mt -116.1 131.7 67.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.362 -2.088 . . . . 71.409999999999997 105.362 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -130.95 127.74 39.03 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.932 1.293 . . . . 62.32 109.006 -170.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.93 115.83 31.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.668 -1.975 . . . . 44.119999999999997 105.668 173.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.73 -65.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 129.602 3.161 . . . . 75.129999999999995 115.849 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -153.62 36.23 0.45 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.947 1.299 . . . . 74.010000000000005 111.785 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.1 m -136.85 133.92 19.01 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.953 1.301 . . . . 75.340000000000003 108.788 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.06 133.04 17.52 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.408 2.738 . . . . 75.219999999999999 110.656 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 mm -128.89 -6.72 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.231 1.012 . . . . 73.129999999999995 112.261 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.3 t -153.23 157.92 40.93 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 119.783 -1.823 . . . . 74.129999999999995 109.437 167.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -146.93 134.56 21.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.055 2.142 . . . . 54.32 107.936 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -141.45 160.28 40.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.184 -1.043 . . . . 71.109999999999999 108.184 162.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mtm -130.82 139.13 50.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.465 -2.05 . . . . 75.340000000000003 105.465 172.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.616 ' HB3' HG23 ' A' ' 65' ' ' VAL . 7.7 p90 -157.37 152.5 25.96 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.706 -1.22 . . . . 73.010000000000005 107.706 -173.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.9 p30 -79.32 -177.35 5.67 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.648 1.213 . . . . 75.299999999999997 111.003 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.535 ' CD1' HG23 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -173.16 135.04 0.56 Allowed 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.858 1.663 . . . . 72.319999999999993 111.461 -164.717 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.582 ' HE3' ' CE1' ' A' ' 63' ' ' TYR . 4.1 mttt -135.34 159.96 39.91 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 124.536 1.147 . . . . 74.329999999999998 109.239 159.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.0 mm -94.71 118.91 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.723 -1.954 . . . . 75.230000000000004 105.723 149.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -136.93 25.09 3.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.769 0.828 . . . . 63.420000000000002 110.062 162.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.6 14.92 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 115.377 1.621 . . . . 74.239999999999995 115.377 -174.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.99 20.47 64.66 Favored Glycine 0 CA--C 1.531 1.094 0 O-C-N 120.299 -1.501 . . . . 64.129999999999995 110.951 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -148.41 156.68 42.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.63 2.772 . . . . 63.100000000000001 105.007 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.535 HG23 ' CD1' ' A' ' 53' ' ' TYR . 72.1 mt -84.06 115.73 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 105.318 -2.104 . . . . 72.310000000000002 105.318 -176.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -90.26 116.87 28.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 117.918 -1.039 . . . . 73.200000000000003 109.236 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.5 mm -95.82 148.83 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 107.162 -1.421 . . . . 71.099999999999994 107.162 172.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.582 ' CE1' ' HE3' ' A' ' 54' ' ' LYS . 13.1 p90 -158.26 -0.19 0.1 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.755 1.761 . . . . 73.5 115.755 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -152.95 124.97 7.95 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.762 -2.31 . . . . 64.540000000000006 104.762 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.746 ' CG1' ' H ' ' A' ' 70' ' ' LYS . 7.2 p -139.23 158.21 28.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 125.139 1.376 . . . . 74.439999999999998 109.948 173.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.89 158.72 48.64 Favored Pre-proline 0 C--O 1.24 0.577 0 C-N-CA 126.839 2.056 . . . . 71.0 106.894 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -80.64 -10.96 39.95 Favored 'Cis proline' 0 N--CA 1.463 -0.321 0 N-CA-C 113.863 0.678 . . . . 72.519999999999996 113.863 0.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.11 124.35 50.65 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 103.555 -2.757 . . . . 70.510000000000005 103.555 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.713 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -75.68 148.15 38.88 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.382 -0.599 . . . . 74.239999999999995 109.382 172.305 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.746 ' H ' ' CG1' ' A' ' 65' ' ' VAL . 23.2 mtpt -128.05 158.66 37.33 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.574 -0.528 . . . . 74.109999999999999 109.574 169.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -53.26 149.28 13.91 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.283 1.433 . . . . 74.540000000000006 111.727 -178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.68 140.37 42.8 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.352 2.035 . . . . 63.219999999999999 111.482 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -159.31 174.58 14.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.708 1.203 . . . . 73.439999999999998 110.24 175.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.81 125.49 54.06 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.779 1.632 . . . . 73.299999999999997 110.248 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.0 mt -89.44 112.53 23.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.608 1.163 . . . . 64.400000000000006 109.146 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.09 114.08 3.51 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.377 -1.342 . . . . 73.519999999999996 107.377 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 3.9 p -152.6 157.92 41.71 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.876 0.845 . . . . 53.009999999999998 110.429 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -129.31 152.95 48.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.916 1.687 . . . . 74.530000000000001 108.827 -175.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.6 tt -146.92 152.75 12.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.466 -0.568 . . . . 54.039999999999999 109.466 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 t -159.26 45.75 0.27 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 122.945 1.355 . . . . 74.319999999999993 110.779 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.52 -127.89 9.28 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 106.811 -2.515 . . . . 54.130000000000003 106.811 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.5 p -71.36 -11.41 60.88 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.383 -1.77 . . . . 64.140000000000001 114.16 -167.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.5 m -95.05 119.74 34.07 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 121.664 2.029 . . . . 42.030000000000001 108.822 173.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.9 tp -92.56 131.56 37.58 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.748 1.619 . . . . 72.120000000000005 108.13 160.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -119.48 100.59 7.38 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 125.246 1.418 . . . . 64.319999999999993 108.175 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.467 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 59.9 t -94.25 131.48 41.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.807 -1.183 . . . . 62.520000000000003 107.807 174.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -92.14 -29.22 16.62 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.579 0.752 . . . . 52.409999999999997 112.652 -172.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.9 t -140.78 173.17 11.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.003 1.721 . . . . 45.020000000000003 110.04 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.09 -176.15 45.29 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 122.976 1.32 . . . . 45.219999999999999 112.311 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.59 -32.09 73.6 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.056 -0.673 . . . . 71.209999999999994 110.572 172.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.72 7.36 39.97 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.725 -0.609 . . . . 73.310000000000002 112.391 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.6 104.99 0.21 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.252 2.221 . . . . 71.519999999999996 111.584 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.96 -158.84 29.0 Favored Glycine 0 N--CA 1.451 -0.312 0 O-C-N 121.656 -0.652 . . . . 61.310000000000002 112.444 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.6 p -115.85 120.48 39.37 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.481 1.912 . . . . 55.439999999999998 107.327 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.484 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 67.1 m-85 -135.67 148.05 48.79 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.04 -0.726 . . . . 75.140000000000001 109.04 -174.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -111.86 146.2 38.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.068 -1.086 . . . . 54.420000000000002 108.068 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -55.6 144.79 25.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.91 0.884 . . . . 72.439999999999998 108.891 172.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -126.6 86.6 2.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.743 -1.947 . . . . 73.200000000000003 105.743 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.5 mttt . . . . . 0 C--O 1.249 1.048 0 C-N-CA 126.897 2.079 . . . . 64.030000000000001 111.759 179.05 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.581 0 N-CA-C 110.386 -1.086 . . . . 71.230000000000004 110.386 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -106.02 156.73 18.1 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.724 0.762 . . . . 71.430000000000007 109.49 170.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -92.1 106.81 18.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.285 -1.746 . . . . 74.219999999999999 106.285 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -120.78 161.15 21.97 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.684 1.193 . . . . 64.340000000000003 110.502 172.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.47 178.43 7.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.049 2.14 . . . . 73.200000000000003 109.966 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -67.07 135.36 53.52 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.633 -1.167 . . . . 73.209999999999994 110.359 161.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -73.89 129.73 38.48 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 126.143 1.777 . . . . 71.420000000000002 108.097 158.787 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -141.3 179.57 6.69 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 119.64 -0.824 . . . . 71.030000000000001 110.132 161.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -69.27 25.1 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.386 1.875 . . . . 74.219999999999999 112.65 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.63 -53.64 0.82 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 119.873 -1.767 . . . . 64.409999999999997 109.317 -171.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -65.65 -28.5 69.14 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.451 -1.262 . . . . 74.120000000000005 112.517 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.19 -18.64 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 121.366 1.894 . . . . 71.340000000000003 114.002 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.4 mm -62.89 121.19 11.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 O-C-N 121.375 -0.828 . . . . 74.040000000000006 110.247 -169.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.98 -174.05 26.93 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.085 1.802 . . . . 74.150000000000006 111.12 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 28' ' ' SER . 1.8 m-85 -88.74 163.27 15.81 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.003 1.321 . . . . 73.239999999999995 109.513 171.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 84' ' ' LEU . 94.9 m95 -150.22 133.85 16.65 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.925 -1.109 . . . . 73.140000000000001 111.116 -175.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 t -138.2 162.75 33.47 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.292 1.437 . . . . 64.120000000000005 109.596 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.482 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 8.9 t -126.73 -14.79 5.62 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.496 1.118 . . . . 70.340000000000003 112.234 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.3 170.53 30.37 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 107.159 -2.376 . . . . 72.239999999999995 107.159 -169.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.0 pt -138.76 34.87 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.493 1.117 . . . . 73.219999999999999 108.746 -161.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -148.79 -176.14 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.8 1.64 . . . . 74.400000000000006 109.908 -165.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 44.97 -99.84 0.02 OUTLIER Glycine 0 CA--C 1.525 0.702 0 C-N-CA 126.603 2.049 . . . . 52.240000000000002 113.18 158.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 m -134.83 115.98 14.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.424 -1.695 . . . . 72.219999999999999 106.424 165.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -127.34 168.55 14.64 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.679 0.752 . . . . 74.099999999999994 109.699 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -139.79 137.16 34.8 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.746 -1.576 . . . . 65.140000000000001 106.746 -164.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.43 HD13 ' H ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -123.32 143.3 50.18 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.214 1.406 . . . . 72.420000000000002 107.686 -172.098 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.447 HD22 ' CZ ' ' A' ' 29' ' ' PHE . 6.9 mt -138.95 158.99 43.2 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.785 1.634 . . . . 72.150000000000006 107.823 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 23.6 p -150.56 157.08 42.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.765 0.826 . . . . 65.219999999999999 109.747 163.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.447 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 92.4 m-85 -144.16 135.64 25.78 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.53 1.532 . . . . 74.010000000000005 107.798 174.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -110.53 150.56 28.74 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.295 1.038 . . . . 74.409999999999997 109.216 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -25.54 56.16 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.879 -0.513 . . . . 72.209999999999994 110.937 -174.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.6 -3.36 5.39 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.503 0.721 . . . . 72.030000000000001 111.12 -172.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.33 -140.47 6.64 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 126.085 1.803 . . . . 74.219999999999999 110.272 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 74.7 p -122.89 158.68 29.83 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.806 1.242 . . . . 72.310000000000002 109.17 -176.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.89 165.56 43.89 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 109.889 -1.285 . . . . 74.219999999999999 109.889 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.16 161.54 37.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.393 -0.595 . . . . 72.209999999999994 109.393 173.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -140.56 150.17 43.32 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.086 -1.079 . . . . 72.209999999999994 108.086 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.81 155.69 26.39 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.069 -1.212 . . . . 62.43 110.069 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.5 mt -125.66 136.88 59.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.508 -2.034 . . . . 72.310000000000002 105.508 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -119.9 155.45 32.68 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.837 1.255 . . . . 72.230000000000004 108.278 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.05 130.93 56.45 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.254 -1.758 . . . . 71.329999999999998 106.254 162.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 44.85 -81.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 128.369 2.668 . . . . 71.239999999999995 114.653 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.01 54.25 1.37 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.928 1.691 . . . . 72.319999999999993 110.433 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.2 m -155.15 124.11 3.05 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 125.604 1.562 . . . . 73.420000000000002 108.544 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.69 139.74 41.22 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.891 2.394 . . . . 73.129999999999995 109.999 171.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.9 mm -129.79 -16.66 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.208 1.403 . . . . 72.340000000000003 111.416 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.5 t -139.94 161.91 36.45 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.995 -1.691 . . . . 73.140000000000001 108.966 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -160.48 145.17 14.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 126.282 1.833 . . . . 74.430000000000007 107.983 -176.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.13 168.41 25.55 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 125.765 1.626 . . . . 61.439999999999998 107.512 167.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.7 mtm -133.03 138.07 46.68 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.921 -1.511 . . . . 75.310000000000002 106.921 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.555 ' HB3' HG23 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -149.25 137.16 20.52 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.732 1.213 . . . . 71.409999999999997 110.409 -173.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -82.05 166.26 19.91 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.533 -0.914 . . . . 64.239999999999995 108.533 169.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.05 168.34 27.32 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.904 0.882 . . . . 63.43 111.914 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -139.99 158.13 44.55 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.036 0.935 . . . . 65.019999999999996 111.434 162.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.5 mm -113.2 83.1 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.382 1.473 . . . . 61.149999999999999 108.1 171.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -116.77 24.29 11.36 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.395 1.878 . . . . 72.349999999999994 111.204 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -164.74 14.7 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.284 1.216 . . . . 64.25 114.284 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.8 21.28 74.95 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.287 -0.883 . . . . 54.310000000000002 111.27 -170.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -145.46 166.06 26.74 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 127.011 2.124 . . . . 63.109999999999999 107.994 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.8 mt -99.31 115.54 40.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.517 -1.66 . . . . 72.439999999999998 106.517 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -89.53 122.72 32.97 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.55 1.54 . . . . 63.149999999999999 107.912 172.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.8 mm -98.79 143.36 13.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.185 -1.413 . . . . 74.329999999999998 107.185 173.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -160.63 2.34 0.07 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.333 1.235 . . . . 71.150000000000006 114.333 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -153.75 112.49 3.68 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 104.388 -2.449 . . . . 52.509999999999998 104.388 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.727 HG13 ' HA ' ' A' ' 69' ' ' GLU . 11.8 p -138.62 157.82 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.575 -1.268 . . . . 74.129999999999995 107.575 171.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.87 165.99 23.13 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 124.889 1.276 . . . . 73.409999999999997 108.465 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.09 -44.36 0.46 Allowed 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 125.334 -0.694 . . . . 74.430000000000007 111.684 -10.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.62 125.28 26.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.892 -1.522 . . . . 61.049999999999997 106.892 167.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.727 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.2 pt-20 -75.5 158.01 33.18 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 124.285 0.991 . . . . 64.340000000000003 108.678 168.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.675 ' H ' HG12 ' A' ' 65' ' ' VAL . 9.4 mmpt? -115.14 158.73 21.8 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.509 -1.369 . . . . 72.25 108.068 164.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.73 145.91 20.08 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.624 -1.25 . . . . 51.539999999999999 107.624 168.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.4 139.8 32.36 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.852 1.701 . . . . 74.420000000000002 109.611 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -153.28 173.37 15.67 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.992 1.317 . . . . 74.109999999999999 108.554 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -107.09 153.5 22.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.93 -1.137 . . . . 74.120000000000005 107.93 171.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.3 mt -124.04 116.07 22.21 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 125.943 1.697 . . . . 63.43 107.218 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.51 121.08 9.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.211 1.404 . . . . 64.140000000000001 109.188 166.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.0 168.63 21.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 125.211 1.404 . . . . 65.430000000000007 108.415 172.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.54 165.76 26.05 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.789 1.636 . . . . 54.210000000000001 111.04 163.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.415 HG22 ' HG ' ' A' ' 7' ' ' LEU . 7.2 tt -157.38 159.46 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.453 -1.314 . . . . 71.329999999999998 107.453 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 t -137.48 -2.57 1.97 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.726 1.21 . . . . 72.129999999999995 112.612 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.73 -152.38 20.08 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 107.664 -2.175 . . . . 62.009999999999998 107.664 -149.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.0 p -51.97 7.4 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 119.554 3.168 . . . . 72.340000000000003 119.554 -173.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.9 m -130.1 110.71 11.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.528 2.731 . . . . 70.319999999999993 108.059 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.415 ' HB2' ' CE3' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -88.09 128.32 35.42 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.946 -1.502 . . . . 52.219999999999999 106.946 170.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -117.78 82.87 1.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.61 0.764 . . . . 72.409999999999997 110.687 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.74 128.77 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.101 -1.074 . . . . 73.040000000000006 108.101 170.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -77.45 -42.99 33.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.661 1.184 . . . . 72.129999999999995 110.008 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.4 t -130.22 -173.77 3.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.205 1.002 . . . . 73.209999999999994 112.523 -170.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.7 -172.48 39.04 Favored Glycine 0 C--N 1.335 0.494 0 O-C-N 120.337 -1.477 . . . . 72.209999999999994 110.592 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.2 m -62.92 -28.24 69.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.849 -0.795 . . . . 64.140000000000001 109.814 158.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.59 -1.12 57.39 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.387 1.475 . . . . 53.43 112.131 -167.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.71 108.03 0.24 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.395 2.278 . . . . 72.120000000000005 109.34 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.6 -154.9 19.96 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 122.192 0.884 . . . . 73.200000000000003 112.692 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 t -140.44 97.83 3.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.759 -1.941 . . . . 52.299999999999997 105.759 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.482 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 52.0 m-85 -110.38 151.3 27.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.503 -1.295 . . . . 63.310000000000002 107.503 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -104.96 148.04 27.14 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.26 -1.385 . . . . 65.109999999999999 107.26 174.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -54.79 139.6 39.05 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 106.66 -1.607 . . . . 71.109999999999999 106.66 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -116.85 122.76 45.31 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 104.831 -2.285 . . . . 73.329999999999998 104.831 160.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.3 mttt . . . . . 0 C--O 1.249 1.05 0 C-N-CA 126.035 1.734 . . . . 74.200000000000003 111.187 168.645 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.887 0 N-CA-C 109.672 -1.371 . . . . 62.009999999999998 109.672 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -110.0 133.3 53.34 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.868 -1.16 . . . . 71.030000000000001 107.868 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -90.69 68.84 6.57 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.555 1.942 . . . . 73.040000000000006 107.568 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -61.0 144.52 53.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.876 -1.057 . . . . 74.239999999999995 111.149 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.6 172.39 12.67 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.263 1.03 . . . . 73.319999999999993 110.652 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.72 140.87 55.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 122.169 0.985 . . . . 62.350000000000001 110.036 167.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.466 HD11 HD13 ' A' ' 12' ' ' ILE . 15.6 tp -78.85 133.68 36.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.55 -1.278 . . . . 74.430000000000007 107.55 168.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -143.22 167.99 20.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.741 0.816 . . . . 54.409999999999997 109.032 173.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 t -75.95 43.16 0.27 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.573 1.549 . . . . 72.030000000000001 109.877 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.21 -50.83 0.14 Allowed 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 119.85 -1.781 . . . . 62.439999999999998 110.609 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -70.49 -29.98 66.65 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 119.092 -0.48 . . . . 71.239999999999995 111.251 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.466 HD13 HD11 ' A' ' 7' ' ' LEU . 4.1 tp -64.46 -26.16 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.344 0.974 . . . . 73.120000000000005 112.941 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mm -62.85 132.56 28.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.774 1.23 . . . . 75.329999999999998 110.242 -168.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.13 -178.8 17.09 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.796 1.665 . . . . 73.430000000000007 112.08 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -76.24 157.36 32.69 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.404 0.682 . . . . 71.329999999999998 110.323 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -143.33 110.38 5.66 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.544 -0.909 . . . . 62.439999999999998 108.544 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.9 t -115.02 151.62 33.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.759 0.824 . . . . 75.209999999999994 109.332 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 t -105.32 -17.31 14.49 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.864 0.866 . . . . 52.350000000000001 111.888 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.93 179.95 35.07 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.896 -1.682 . . . . 64.319999999999993 108.896 -174.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 pt -131.86 9.15 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 117.708 0.754 . . . . 75.340000000000003 112.819 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.9 163.65 12.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.358 0.981 . . . . 74.400000000000006 110.295 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.57 -90.23 0.02 OUTLIER Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.167 1.365 . . . . 62.43 114.956 155.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 m -134.07 123.41 24.44 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.15 1.975 . . . . 74.540000000000006 107.683 163.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -140.91 176.47 8.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.562 1.145 . . . . 74.109999999999999 109.385 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -143.23 140.78 30.84 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.943 1.297 . . . . 64.340000000000003 108.68 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.56 147.01 38.78 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 126.243 1.817 . . . . 63.149999999999999 108.621 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.59 168.2 19.69 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.121 0.969 . . . . 75.129999999999995 111.29 161.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 t -143.86 156.49 44.48 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.288 1.835 . . . . 73.310000000000002 108.845 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -146.12 111.91 5.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.508 2.723 . . . . 74.010000000000005 106.525 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.73 163.33 20.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.854 0.752 . . . . 73.319999999999993 109.308 166.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -88.87 -27.12 21.24 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.309 0.643 . . . . 75.340000000000003 112.095 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -130.98 12.94 5.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.631 1.172 . . . . 72.239999999999995 111.871 -172.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -126.92 -129.61 3.28 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 126.7 2.095 . . . . 74.420000000000002 108.989 -176.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 p -132.63 -166.6 1.77 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.244 1.818 . . . . 61.439999999999998 107.906 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -129.58 -175.26 13.97 Favored Glycine 0 CA--C 1.505 -0.552 0 O-C-N 119.823 -1.798 . . . . 74.109999999999999 112.058 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -144.84 154.38 42.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 118.281 -0.866 . . . . 71.219999999999999 110.057 -166.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -136.72 135.11 37.86 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.788 1.235 . . . . 74.239999999999995 109.493 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.39 158.01 24.74 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.573 -1.011 . . . . 51.409999999999997 110.573 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.8 mt -128.01 133.05 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 105.515 -2.031 . . . . 63.350000000000001 105.515 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -129.4 124.43 34.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.402 -0.962 . . . . 73.540000000000006 108.402 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.8 m -86.09 106.74 17.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.204 -2.147 . . . . 72.329999999999998 105.204 166.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 61.96 -75.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 127.371 2.268 . . . . 72.409999999999997 113.039 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.08 34.57 0.9 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.283 1.033 . . . . 72.439999999999998 112.495 172.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -137.59 118.44 10.58 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.498 1.919 . . . . 73.519999999999996 108.018 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.31 133.58 23.03 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.243 2.629 . . . . 74.230000000000004 111.125 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 mm -122.05 1.71 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 126.501 1.92 . . . . 64.219999999999999 111.046 -175.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.7 t -160.39 153.04 21.02 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 119.867 -1.771 . . . . 32.43 109.335 166.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -148.66 136.04 20.34 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.332 1.853 . . . . 63.140000000000001 109.302 172.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -158.57 163.22 37.22 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.746 1.618 . . . . 75.239999999999995 107.677 169.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.7 mtm -138.68 151.12 46.91 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.091 0.956 . . . . 73.450000000000003 108.808 170.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -159.0 155.09 26.88 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.949 0.9 . . . . 63.030000000000001 109.752 -176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -83.23 167.25 17.87 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.657 -0.497 . . . . 73.140000000000001 109.657 173.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.08 159.87 42.69 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.01 -1.107 . . . . 61.43 108.01 169.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HA ' ' HE2' ' A' ' 54' ' ' LYS . 10.7 mmpt? -125.27 163.31 22.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.675 0.671 . . . . 75.140000000000001 109.826 162.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.6 mm -120.77 82.34 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.464 1.505 . . . . 51.240000000000002 106.956 174.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -117.45 24.11 11.33 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.795 1.238 . . . . 74.230000000000004 110.097 -172.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.71 14.56 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.434 1.894 . . . . 62.439999999999998 112.842 -164.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.78 10.02 53.95 Favored Glycine 0 CA--C 1.534 1.257 0 O-C-N 120.483 -1.385 . . . . 72.120000000000005 112.965 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.69 169.05 18.44 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 127.707 2.403 . . . . 74.349999999999994 106.739 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.8 mt -81.27 150.63 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 106.972 -1.492 . . . . 63.229999999999997 106.972 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -132.1 111.63 11.63 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.412 1.885 . . . . 75.239999999999995 108.501 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.0 mm -85.43 148.89 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.519 -1.289 . . . . 74.209999999999994 107.519 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -158.08 -5.51 0.09 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 116.132 1.901 . . . . 74.409999999999997 116.132 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -156.36 107.48 2.44 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 106.087 -1.82 . . . . 75.140000000000001 106.087 -164.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.9 ' CG1' ' H ' ' A' ' 70' ' ' LYS . 4.0 p -137.62 150.67 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 125.149 1.379 . . . . 75.120000000000005 110.741 -175.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.06 161.75 61.85 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.286 1.035 . . . . 75.519999999999996 108.388 167.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.48 -24.61 9.98 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 N-CA-C 114.493 0.92 . . . . 72.349999999999994 114.493 1.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -121.27 111.8 17.82 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.698 -0.852 . . . . 73.549999999999997 108.698 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.761 ' HA ' HG13 ' A' ' 65' ' ' VAL . 42.4 mt-10 -60.57 123.34 17.1 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 128.199 2.599 . . . . 63.43 109.057 -174.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.9 ' H ' ' CG1' ' A' ' 65' ' ' VAL . 3.6 mtpp -103.35 152.25 21.8 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.405 -0.961 . . . . 63.140000000000001 108.405 174.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.0 t -56.72 147.56 51.52 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.064 -0.717 . . . . 71.129999999999995 109.064 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.8 158.92 35.41 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.855 2.37 . . . . 62.140000000000001 112.272 170.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -172.44 168.58 5.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.791 2.436 . . . . 72.349999999999994 107.648 170.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -95.86 154.42 17.24 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.587 -0.894 . . . . 63.049999999999997 108.587 171.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.8 mt -131.93 134.36 45.57 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.956 1.302 . . . . 74.209999999999994 108.987 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -96.07 125.22 40.46 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.869 1.667 . . . . 64.439999999999998 108.716 -169.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 p -158.3 165.42 34.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.685 1.194 . . . . 73.140000000000001 109.723 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.19 160.27 29.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 124.376 1.071 . . . . 74.439999999999998 111.866 170.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 tt -144.99 151.98 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 124.996 1.318 . . . . 72.310000000000002 107.71 177.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.9 t -147.75 19.58 1.15 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.663 0.986 . . . . 74.420000000000002 113.663 161.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.11 -102.46 0.26 Allowed Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.634 -1.786 . . . . 73.219999999999999 108.634 173.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.1 p -87.61 -12.94 44.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.332 0.566 . . . . 72.209999999999994 112.298 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 m -89.26 126.69 35.61 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.137 -1.431 . . . . 62.240000000000002 107.137 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.7 tp -113.42 132.8 55.5 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.649 1.579 . . . . 75.349999999999994 108.342 160.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.5 93.76 4.0 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.938 2.095 . . . . 65.430000000000007 108.005 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.95 138.55 19.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.274 -1.38 . . . . 61.130000000000003 107.274 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -101.96 -31.49 10.65 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.737 -0.649 . . . . 74.239999999999995 112.289 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -145.9 171.24 15.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.405 1.002 . . . . 75.340000000000003 110.84 -175.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.77 174.02 38.07 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 108.924 -1.67 . . . . 52.240000000000002 108.924 -174.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.0 m -61.0 -22.02 64.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.295 -1.12 . . . . 72.049999999999997 112.011 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -84.11 -5.56 59.26 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.634 0.976 . . . . 74.439999999999998 113.634 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -46.52 108.81 0.15 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 127.22 2.208 . . . . 75.420000000000002 110.616 -170.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.03 -172.75 44.94 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 122.284 0.935 . . . . 52.140000000000001 113.277 -159.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.1 p -137.61 104.98 5.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.614 1.966 . . . . 64.329999999999998 107.287 -156.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -124.36 167.3 14.56 Favored 'General case' 0 C--O 1.239 0.545 0 O-C-N 120.929 -1.107 . . . . 75.120000000000005 112.368 -165.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -124.02 127.38 47.79 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 129.311 3.045 . . . . 64.310000000000002 107.894 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -57.57 135.13 56.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.122 1.369 . . . . 55.350000000000001 109.005 171.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -143.81 38.27 1.33 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.248 1.203 . . . . 75.319999999999993 114.248 176.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.582 0 N-CA-C 108.823 -0.806 . . . . 62.109999999999999 108.823 163.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 105.205 -2.146 . . . . 40.32 105.205 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -93.27 160.43 14.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.598 1.159 . . . . 64.340000000000003 109.838 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.8 p -91.17 167.7 12.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.559 0.618 . . . . 73.420000000000002 110.276 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.79 116.87 4.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.884 0.849 . . . . 63.399999999999999 109.663 160.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.1 tp -54.18 125.63 19.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.651 -1.24 . . . . 71.230000000000004 107.651 157.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -145.42 172.52 13.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.169 0.985 . . . . 74.530000000000001 110.07 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -1.06 0.69 Allowed 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 126.954 2.102 . . . . 53.329999999999998 115.331 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -122.95 -36.99 2.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 120.17 1.35 . . . . 71.519999999999996 112.66 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -73.94 -30.71 62.7 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.358 0.981 . . . . 53.210000000000001 112.884 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.0 tp -66.58 -22.9 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.62 1.1 . . . . 62.100000000000001 112.903 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.37 126.23 24.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.134 1.374 . . . . 70.109999999999999 110.905 -164.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 131.28 -172.74 20.65 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.783 2.135 . . . . 42.219999999999999 110.59 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -91.09 162.85 14.51 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.435 1.094 . . . . 75.409999999999997 111.567 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -148.84 122.44 9.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.506 0.722 . . . . 63.409999999999997 111.045 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 t -127.35 160.73 30.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.954 1.301 . . . . 75.299999999999997 112.474 -174.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.58 -66.17 0.94 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.566 1.946 . . . . 55.43 107.1 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.12 -179.44 48.0 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 129.37 3.366 . . . . 64.530000000000001 106.578 -170.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.1 pt -111.61 16.26 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 113.746 1.017 . . . . 64.549999999999997 113.746 -158.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -115.79 -178.82 3.48 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.682 1.193 . . . . 71.439999999999998 113.098 -166.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.33 -93.5 0.01 OUTLIER Glycine 0 C--N 1.34 0.79 0 C-N-CA 127.547 2.499 . . . . 73.230000000000004 114.976 157.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.3 m -140.76 92.86 2.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.865 -1.902 . . . . 72.409999999999997 105.865 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -100.17 168.44 9.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.214 1.007 . . . . 64.219999999999999 110.473 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -134.95 145.29 48.03 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.192 1.797 . . . . 54.119999999999997 106.817 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.427 HD13 ' H ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -133.57 146.07 50.66 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.869 0.868 . . . . 71.129999999999995 108.852 -177.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.427 ' H ' HD13 ' A' ' 26' ' ' LEU . 10.0 mt -134.71 158.77 43.26 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 125.041 1.336 . . . . 72.439999999999998 109.87 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t -144.12 155.53 43.98 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.843 2.057 . . . . 61.43 108.552 164.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -144.69 126.89 15.69 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 127.161 2.185 . . . . 64.120000000000005 107.611 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -101.59 159.45 15.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.959 1.704 . . . . 62.520000000000003 108.491 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.01 -38.02 28.2 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.823 -0.171 . . . . 74.519999999999996 110.634 -175.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -129.15 21.86 5.71 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.503 0.668 . . . . 71.109999999999999 110.815 -170.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.68 -112.85 1.6 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.745 1.64 . . . . 44.420000000000002 109.413 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 p -141.39 175.85 9.34 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.157 1.783 . . . . 73.200000000000003 109.555 -164.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -98.75 170.02 23.73 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.611 -0.995 . . . . 51.0 110.611 161.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.7 m -144.84 144.13 30.97 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.78 -0.835 . . . . 64.129999999999995 109.18 167.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -130.9 126.13 35.32 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.09 1.356 . . . . 73.310000000000002 107.69 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.69 159.07 17.36 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.047 0.832 . . . . 72.230000000000004 111.315 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 mt -136.99 136.01 47.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.347 -2.094 . . . . 63.340000000000003 105.347 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.42 167.24 14.1 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.015 1.326 . . . . 72.549999999999997 108.988 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.32 127.57 33.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.12 -1.437 . . . . 75.349999999999994 107.12 160.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 44.95 -73.07 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 131.446 3.898 . . . . 74.409999999999997 113.923 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.16 43.71 1.43 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.292 1.437 . . . . 42.310000000000002 112.55 175.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.7 m -144.51 135.61 12.47 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.809 1.243 . . . . 74.109999999999999 109.579 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.51 129.3 12.66 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.291 3.327 . . . . 73.519999999999996 111.17 168.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.3 mm -122.31 -22.48 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.903 0.881 . . . . 74.450000000000003 112.093 -173.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 t -130.54 170.2 14.56 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 120.545 -1.347 . . . . 74.25 109.048 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -159.6 144.33 15.23 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 127.765 2.426 . . . . 62.219999999999999 105.31 165.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -152.08 162.55 40.93 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.731 1.612 . . . . 72.310000000000002 106.707 162.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.9 mtm -130.0 162.84 27.78 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.84 -1.17 . . . . 73.129999999999995 107.84 167.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -157.15 145.79 19.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 123.877 0.736 . . . . 61.420000000000002 109.276 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.64 159.65 31.65 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.168 -1.419 . . . . 75.209999999999994 107.168 161.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -148.73 166.87 27.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 121.645 -0.659 . . . . 75.120000000000005 110.239 166.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -134.46 167.1 21.39 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.507 1.123 . . . . 72.299999999999997 108.571 167.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.8 mm -121.92 86.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.373 -1.714 . . . . 75.439999999999998 106.373 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.7 23.49 8.75 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.364 0.666 . . . . 71.129999999999995 110.105 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.73 14.04 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 114.68 1.363 . . . . 63.5 114.68 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.39 27.58 65.89 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 120.889 -1.132 . . . . 75.140000000000001 111.31 -168.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -139.39 161.31 37.77 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 127.209 2.204 . . . . 75.200000000000003 105.935 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mt -71.05 133.27 32.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 105.761 -1.94 . . . . 75.510000000000005 105.761 164.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -101.58 120.3 40.11 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.432 -1.692 . . . . 73.299999999999997 106.432 163.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.4 mm -105.31 137.49 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.308 -1.738 . . . . 44.32 106.308 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -160.6 1.31 0.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.424 0.898 . . . . 75.120000000000005 113.424 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -148.36 117.62 6.88 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 104.937 -2.246 . . . . 54.210000000000001 104.937 171.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.0 t -128.54 155.49 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 105.816 -1.92 . . . . 71.329999999999998 105.816 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.64 162.29 39.6 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.574 -0.898 . . . . 74.530000000000001 108.574 174.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.74 -21.75 15.37 Favored 'Cis proline' 0 CA--C 1.535 0.567 0 N-CA-C 113.872 0.681 . . . . 42.039999999999999 113.872 -8.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 93.57 6.96 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 104.942 -2.244 . . . . 61.530000000000001 104.942 174.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.16 140.76 58.91 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.091 0.956 . . . . 53.100000000000001 109.589 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -127.44 168.05 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.833 1.253 . . . . 75.129999999999995 110.094 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 t -55.64 148.04 37.45 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 123.844 0.715 . . . . 75.409999999999997 109.938 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.29 139.81 42.83 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.175 1.916 . . . . 75.530000000000001 111.261 169.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -152.36 174.11 14.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.919 1.287 . . . . 64.209999999999994 109.874 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -112.74 158.98 19.41 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.546 0.738 . . . . 74.400000000000006 109.439 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.8 mt -130.32 112.24 13.12 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.165 1.386 . . . . 75.530000000000001 109.679 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -62.55 122.06 14.86 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.876 1.27 . . . . 72.099999999999994 108.06 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 2.3 p -154.72 163.67 39.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.599 0.36 . . . . 41.229999999999997 110.738 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.466 ' HE2' ' CD ' ' A' ' 87' ' ' GLU . 9.7 mttm -126.74 158.42 36.54 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.055 0.942 . . . . 75.510000000000005 109.298 176.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.1 tt -151.54 154.15 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.144 -1.058 . . . . 72.510000000000005 108.144 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -141.44 -9.35 0.96 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.84 1.793 . . . . 75.230000000000004 115.84 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.82 -73.53 0.21 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.378 -1.889 . . . . 75.310000000000002 108.378 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 p -117.52 1.64 12.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.851 1.056 . . . . 72.340000000000003 113.851 -169.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.6 m -119.74 106.79 12.47 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.846 2.058 . . . . 54.020000000000003 110.469 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -75.07 128.32 35.27 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.639 -1.288 . . . . 74.439999999999998 108.333 164.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -117.25 95.09 4.82 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 119.039 -0.505 . . . . 64.099999999999994 110.681 164.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.445 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 66.1 t -86.11 132.5 31.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.038 0.835 . . . . 72.340000000000003 109.407 169.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.466 ' CD ' ' HE2' ' A' ' 78' ' ' LYS . 23.6 mt-10 -91.41 -31.71 15.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.923 0.889 . . . . 73.319999999999993 112.212 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 t -139.67 163.74 31.78 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.71 1.604 . . . . 71.420000000000002 110.556 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.58 -179.86 30.62 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 122.628 1.127 . . . . 44.0 112.662 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.1 m -58.08 -31.05 66.72 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.687 1.595 . . . . 54.229999999999997 112.52 173.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.42 ' HB3' HD11 ' A' ' 27' ' ' LEU . 1.8 mp0 -103.69 11.99 35.3 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.169 0.588 . . . . 63.310000000000002 109.887 -167.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.01 117.14 5.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.4 2.28 . . . . 71.430000000000007 110.591 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.12 -123.39 1.1 Allowed Glycine 0 C--O 1.237 0.324 0 C-N-CA 124.381 0.991 . . . . 74.430000000000007 111.6 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.4 t -145.0 142.41 29.77 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.152 1.781 . . . . 73.540000000000006 107.747 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -142.91 152.18 41.79 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.164 0.438 . . . . 75.430000000000007 111.762 167.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -91.4 147.89 22.71 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.476 -0.565 . . . . 52.100000000000001 109.476 167.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -58.55 147.53 31.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.995 0.918 . . . . 75.540000000000006 108.653 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 . . . . . 0 N--CA 1.467 0.383 0 C-N-CA 125.776 1.63 . . . . 72.329999999999998 109.0 179.591 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 105.64 -1.985 . . . . 65.0 105.64 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.416 ' CG ' ' HB3' ' A' ' 78' ' ' LYS . 94.2 m95 -101.14 163.25 12.37 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 124.604 1.162 . . . . 65.310000000000002 111.02 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.3 p -101.06 162.13 13.11 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.595 -0.521 . . . . 65.230000000000004 109.595 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.1 117.51 4.44 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.035 1.334 . . . . 72.439999999999998 110.551 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.0 tp -66.4 105.64 1.51 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.629 -1.249 . . . . 73.209999999999994 107.629 165.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.437 ' HA ' HG21 ' A' ' 55' ' ' ILE . 22.0 p30 -126.56 172.8 9.94 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.951 -1.022 . . . . 70.310000000000002 111.123 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.89 -5.68 22.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.901 2.48 . . . . 73.310000000000002 112.764 -169.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -109.81 -28.64 8.68 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.223 0.92 . . . . 73.0 110.352 171.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -66.43 -35.41 80.23 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.887 0.875 . . . . 74.040000000000006 112.71 -169.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.77 -15.24 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 113.133 0.79 . . . . 70.140000000000001 113.133 -173.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.8 mm -68.79 122.19 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.121 0.968 . . . . 74.040000000000006 111.218 -161.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.78 -168.91 24.35 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.624 1.583 . . . . 64.230000000000004 111.319 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 28' ' ' SER . 1.9 m-85 -88.66 159.95 17.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.463 1.105 . . . . 72.230000000000004 110.284 176.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.417 ' CZ3' ' HB2' ' A' ' 84' ' ' LEU . 85.2 m95 -142.36 125.94 16.84 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.435 1.494 . . . . 74.430000000000007 109.756 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.7 t -123.58 164.02 19.84 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.191 0.997 . . . . 74.099999999999994 112.394 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.419 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 3.2 t -129.43 -5.96 4.76 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.856 1.663 . . . . 50.140000000000001 112.967 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.23 176.01 14.7 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 108.099 -2.0 . . . . 73.420000000000002 108.099 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 pt -135.65 7.44 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.46 0.911 . . . . 71.129999999999995 113.46 -160.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.26 165.04 15.37 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.877 1.671 . . . . 74.129999999999995 110.109 -174.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.81 -84.47 0.02 OUTLIER Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.063 1.316 . . . . 73.239999999999995 113.167 169.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -148.25 95.42 2.46 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.212 1.405 . . . . 74.530000000000001 108.081 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -114.34 177.52 4.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.152 -0.967 . . . . 71.219999999999999 110.109 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -132.66 172.63 12.29 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.251 1.421 . . . . 72.439999999999998 107.369 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.04 136.3 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.802 -1.555 . . . . 74.230000000000004 106.802 173.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.1 mt -115.85 152.74 32.78 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.327 -0.99 . . . . 63.109999999999999 108.327 165.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.435 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 1.3 p -144.62 143.41 30.76 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.633 1.173 . . . . 61.200000000000003 108.554 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -138.89 124.66 19.71 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.012 0.925 . . . . 74.400000000000006 108.759 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.407 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -85.32 156.71 20.79 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.164 -1.421 . . . . 71.230000000000004 107.164 164.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -72.19 -47.83 47.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.868 0.842 . . . . 72.230000000000004 109.197 165.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.88 -1.45 24.17 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.87 2.068 . . . . 61.130000000000003 111.439 -161.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 30' ' ' ASP . . . -114.78 -122.35 3.62 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.297 -1.921 . . . . 70.109999999999999 108.297 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 p -133.0 -175.45 3.79 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.503 2.321 . . . . 74.140000000000001 107.741 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -107.12 164.27 13.17 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.123 -1.191 . . . . 70.040000000000006 110.123 164.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.97 147.59 35.43 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.659 1.184 . . . . 54.399999999999999 108.73 -175.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -134.88 140.64 45.95 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.373 -1.343 . . . . 65.510000000000005 107.373 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.15 160.42 25.83 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 111.264 -0.734 . . . . 74.200000000000003 111.264 164.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 52.0 mt -122.79 145.4 29.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 105.3 -2.111 . . . . 71.430000000000007 105.3 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -133.89 166.34 22.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.992 1.317 . . . . 71.120000000000005 109.014 -173.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.99 139.42 39.67 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.304 -0.998 . . . . 41.140000000000001 108.304 157.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 44.48 -75.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 130.358 3.463 . . . . 73.540000000000006 115.975 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.31 47.77 1.29 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.6 0.636 . . . . 61.329999999999998 112.069 167.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 m -144.06 132.67 11.11 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.459 1.504 . . . . 74.349999999999994 109.324 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.31 132.24 16.15 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.604 2.869 . . . . 74.319999999999993 110.333 165.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.48 -23.58 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.774 0.829 . . . . 65.319999999999993 111.835 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.4 t -141.44 162.76 34.69 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.065 -1.647 . . . . 72.25 109.864 169.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -160.74 137.56 8.88 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.348 2.259 . . . . 71.430000000000007 107.428 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -161.28 165.49 29.1 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.537 1.535 . . . . 72.510000000000005 107.661 168.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.3 mtm -134.31 163.33 29.87 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.897 -1.149 . . . . 64.439999999999998 107.897 170.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -163.09 146.88 10.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.8 0.84 . . . . 70.430000000000007 110.231 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.31 161.01 31.44 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.205 -1.035 . . . . 73.109999999999999 108.205 162.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -144.02 171.38 14.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.784 -0.573 . . . . 72.400000000000006 109.594 165.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -137.01 161.8 35.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.863 0.865 . . . . 74.340000000000003 109.718 167.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.437 HG21 ' HA ' ' A' ' 8' ' ' ASN . 40.0 mm -105.18 103.68 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.922 -1.51 . . . . 73.430000000000007 106.922 165.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -134.67 24.48 3.69 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.329 -0.857 . . . . 73.310000000000002 113.193 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -163.72 14.1 0.06 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.604 1.962 . . . . 74.400000000000006 116.053 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.33 18.21 57.79 Favored Glycine 0 CA--C 1.539 1.558 0 O-C-N 120.119 -1.613 . . . . 72.310000000000002 113.069 -168.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -134.12 -171.48 2.76 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.4 3.08 . . . . 65.329999999999998 107.208 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.17 113.49 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 121.242 1.837 . . . . 70.129999999999995 107.515 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -82.74 102.55 11.62 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.766 -1.198 . . . . 73.400000000000006 107.766 171.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 mm -81.32 137.57 21.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 105.898 -1.89 . . . . 74.439999999999998 105.898 168.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -151.15 -8.94 0.23 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.03 1.493 . . . . 71.299999999999997 115.03 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -144.77 112.71 6.36 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.361 -1.348 . . . . 73.329999999999998 107.361 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.2 t -122.47 154.28 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.776 1.63 . . . . 53.210000000000001 107.749 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.49 162.21 52.66 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.44 1.096 . . . . 73.420000000000002 108.393 172.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -83.75 -14.17 35.86 Favored 'Cis proline' 0 CA--C 1.536 0.624 0 N-CA-C 113.78 0.646 . . . . 64.140000000000001 113.78 -9.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.76 115.89 31.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 103.72 -2.696 . . . . 74.219999999999999 103.72 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -93.5 143.82 25.93 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.0 0.812 . . . . 70.420000000000002 109.571 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -132.81 172.4 12.62 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.276 1.43 . . . . 64.030000000000001 109.878 -171.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 t -54.41 146.36 33.3 Favored Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 123.61 0.569 . . . . 62.100000000000001 109.564 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.97 144.7 77.38 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.937 1.758 . . . . 53.200000000000003 109.799 165.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -154.92 164.44 38.87 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.998 0.919 . . . . 61.109999999999999 110.501 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.3 127.54 49.24 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.707 0.803 . . . . 74.340000000000003 109.333 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.28 112.68 24.34 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.452 1.501 . . . . 73.409999999999997 108.77 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.29 123.25 17.72 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.778 -1.193 . . . . 70.409999999999997 107.778 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.495 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 1.8 p -157.13 156.84 33.4 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.225 0.61 . . . . 74.019999999999996 110.458 175.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 4' ' ' TRP . 1.5 mppt? -129.57 156.25 44.5 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.802 1.241 . . . . 74.200000000000003 111.056 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.3 tt -151.25 146.54 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 122.491 0.316 . . . . 72.340000000000003 110.844 -171.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -149.31 43.51 0.94 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.303 1.841 . . . . 73.230000000000004 111.435 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.63 -89.74 1.63 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 110.385 -1.086 . . . . 72.010000000000005 110.385 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -20.26 24.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.099 -1.429 . . . . 72.209999999999994 114.823 -171.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -102.74 108.14 19.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 122.017 2.19 . . . . 63.0 111.278 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.417 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 33.0 tp -87.6 123.81 32.86 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.335 -1.478 . . . . 65.299999999999997 108.53 168.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -118.67 91.04 3.46 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.02 0.928 . . . . 74.219999999999999 109.931 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.495 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 22.2 t -86.1 130.94 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.934 -1.136 . . . . 72.030000000000001 107.934 173.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -85.39 -32.65 22.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.957 -0.544 . . . . 70.230000000000004 111.946 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.5 t -143.32 167.89 21.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.68 1.192 . . . . 63.409999999999997 110.774 -169.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.71 178.86 43.62 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-O 122.432 1.018 . . . . 62.140000000000001 112.624 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 m -51.87 -27.93 14.34 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.719 1.608 . . . . 70.530000000000001 112.65 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -101.16 10.89 40.37 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.209 0.818 . . . . 64.340000000000003 113.209 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.02 105.21 0.3 Allowed 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.375 -0.828 . . . . 42.329999999999998 110.084 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.84 -136.71 2.48 Favored Glycine 0 CA--C 1.519 0.302 0 O-C-N 121.169 -0.957 . . . . 70.230000000000004 112.57 -172.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.2 t -153.29 116.77 4.67 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.33 1.052 . . . . 62.420000000000002 109.367 -171.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.419 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 88.4 m-85 -139.78 152.44 46.59 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 121.466 -0.771 . . . . 71.319999999999993 110.561 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -116.74 146.28 42.91 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 118.647 -0.692 . . . . 62.200000000000003 110.393 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -54.7 148.15 13.28 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.932 -1.136 . . . . 61.240000000000002 107.932 173.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 106.407 -1.701 . . . . 70.129999999999995 106.407 166.573 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 . . . . . 0 CA--C 1.517 -0.31 0 N-CA-C 108.25 -1.019 . . . . 72.540000000000006 108.25 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -118.03 147.84 42.83 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.462 0.305 . . . . 74.230000000000004 111.775 -170.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.8 p -83.39 171.05 13.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.465 0.706 . . . . 62.219999999999999 110.3 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -56.88 123.38 14.86 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.303 -0.862 . . . . 71.329999999999998 109.768 155.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.24 134.01 53.93 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 124.879 1.272 . . . . 72.310000000000002 110.524 157.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -140.48 174.74 10.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.468 -0.938 . . . . 64.430000000000007 108.468 163.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -69.31 40.99 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.8 1.64 . . . . 74.340000000000003 110.289 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -134.26 -59.61 0.82 Allowed 'General case' 0 N--CA 1.466 0.374 0 O-C-N 118.269 -2.77 . . . . 61.450000000000003 108.212 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -73.2 -26.27 61.09 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.572 0.749 . . . . 63.539999999999999 111.47 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.04 -20.02 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 119.459 1.027 . . . . 71.439999999999998 112.506 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.2 mm -68.66 144.41 14.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 121.23 -0.918 . . . . 73.510000000000005 109.521 -169.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.23 -153.82 17.36 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 124.944 1.259 . . . . 64.150000000000006 110.296 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -120.79 154.16 36.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.279 1.431 . . . . 73.549999999999997 109.494 -168.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 84' ' ' LEU . 97.2 m95 -152.13 117.1 5.17 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.006 0.922 . . . . 74.450000000000003 109.593 -161.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.2 t -122.81 166.76 14.46 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.21 1.368 . . . . 70.450000000000003 112.024 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -125.19 2.75 7.88 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.661 1.584 . . . . 72.549999999999997 111.829 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.08 -177.37 36.57 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 120.503 1.501 . . . . 61.32 111.667 176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.6 pt -128.78 5.31 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.391 1.476 . . . . 75.129999999999995 111.387 -175.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -147.15 -173.23 4.19 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.52 1.528 . . . . 71.109999999999999 110.237 -164.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 48.48 -104.19 0.08 OUTLIER Glycine 0 C--N 1.339 0.734 0 C-N-CA 126.25 1.881 . . . . 24.43 111.763 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -138.39 97.66 3.42 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.593 -1.632 . . . . 74.340000000000003 106.593 172.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -111.78 177.76 4.54 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.77 0.828 . . . . 72.510000000000005 110.712 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -154.57 155.76 35.35 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.005 0.922 . . . . 74.409999999999997 108.934 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.01 131.0 36.58 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.846 1.659 . . . . 63.240000000000002 108.298 -168.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.609 HD22 ' CZ ' ' A' ' 29' ' ' PHE . 3.9 mt -115.38 153.68 30.59 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.769 1.628 . . . . 73.129999999999995 108.895 170.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 p -147.19 153.39 39.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.31 -0.996 . . . . 74.420000000000002 108.31 167.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.609 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 68.4 m-85 -144.63 141.97 29.77 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.948 1.299 . . . . 73.310000000000002 108.85 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -110.69 158.93 18.07 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.272 1.429 . . . . 71.340000000000003 108.147 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.84 -29.42 40.14 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.909 -0.316 . . . . 71.430000000000007 111.683 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.36 10.59 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.108 1.363 . . . . 74.420000000000002 110.139 -164.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.33 -124.02 2.82 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 125.017 1.294 . . . . 73.430000000000007 110.127 -169.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -140.31 167.14 22.85 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.822 -1.177 . . . . 71.129999999999995 107.822 168.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -93.36 176.25 36.83 Favored Glycine 0 CA--C 1.523 0.551 0 O-C-N 121.53 -0.732 . . . . 70.5 112.057 170.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.85 161.65 33.62 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.108 0.963 . . . . 63.240000000000002 109.828 171.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -141.99 151.06 42.15 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.274 -1.01 . . . . 70.420000000000002 108.274 168.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.77 161.76 32.53 Favored Glycine 0 CA--C 1.525 0.662 0 O-C-N 121.524 -0.735 . . . . 63.109999999999999 111.621 163.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.5 mt -124.83 149.58 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 127.047 2.139 . . . . 73.510000000000005 105.356 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -134.0 164.78 26.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.271 1.428 . . . . 74.209999999999994 110.149 -170.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.2 m -133.9 120.42 20.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.977 2.111 . . . . 54.409999999999997 106.006 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.254 0.9 OUTLIER 45.02 -81.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 130.016 3.326 . . . . 70.299999999999997 114.582 -173.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.67 43.54 1.73 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.786 1.635 . . . . 74.099999999999994 109.335 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.3 m -137.4 129.22 16.55 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.059 1.744 . . . . 64.400000000000006 107.635 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.37 136.92 32.52 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.747 2.298 . . . . 72.019999999999996 109.435 168.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.6 mm -120.56 -22.23 3.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 118.658 -0.687 . . . . 63.520000000000003 111.279 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.3 p -139.02 169.81 17.11 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.884 1.22 . . . . 52.020000000000003 110.782 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -159.15 153.27 23.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.827 -1.079 . . . . 63.109999999999999 108.307 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -166.61 161.49 15.93 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 105.649 -1.982 . . . . 74.430000000000007 105.649 165.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.8 mtm -122.57 159.01 28.68 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.389 -1.708 . . . . 74.239999999999995 106.389 160.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.18 141.01 17.13 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 123.991 0.807 . . . . 71.310000000000002 109.503 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -78.7 156.48 28.92 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 123.079 1.419 . . . . 72.329999999999998 108.391 166.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -151.84 169.05 23.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.171 -1.377 . . . . 61.119999999999997 110.021 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -141.44 163.17 33.65 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.113 0.965 . . . . 65.129999999999995 109.475 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.6 mm -120.05 89.33 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.791 -1.559 . . . . 64.540000000000006 106.791 170.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -123.42 25.81 8.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.598 1.159 . . . . 72.310000000000002 110.529 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -164.41 14.35 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.785 1.234 . . . . 65.230000000000004 112.604 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 26.69 69.86 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 120.451 -0.88 . . . . 72.310000000000002 111.219 -172.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -151.22 164.47 36.5 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.466 3.106 . . . . 65.230000000000004 106.817 -168.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.9 mt -100.27 109.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.404 -1.702 . . . . 63.420000000000002 106.404 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -80.9 106.17 12.7 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.065 -1.457 . . . . 65.209999999999994 107.065 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.1 mm -85.54 140.21 16.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.968 -1.493 . . . . 53.210000000000001 106.968 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -156.52 -2.69 0.12 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 115.868 1.803 . . . . 72.140000000000001 115.868 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -148.03 120.99 8.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 103.618 -2.734 . . . . 71.319999999999993 103.618 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.8 t -133.47 154.09 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 125.314 1.446 . . . . 61.229999999999997 107.436 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.94 163.54 37.48 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.651 1.181 . . . . 72.430000000000007 109.055 172.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.24 -21.39 13.66 Favored 'Cis proline' 0 C--N 1.345 0.374 0 N-CA-C 113.968 0.719 . . . . 62.240000000000002 113.968 -7.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -100.78 101.05 11.81 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.329 -2.1 . . . . 71.439999999999998 105.329 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -61.64 139.08 58.33 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.775 1.23 . . . . 73.319999999999993 110.417 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 9.0 mmpt? -114.56 158.42 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.072 1.749 . . . . 70.299999999999997 109.095 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -65.04 148.87 97.52 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.657 -0.868 . . . . 74.329999999999998 108.657 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.63 145.58 52.52 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.567 2.178 . . . . 74.230000000000004 112.478 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -156.15 167.88 29.05 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.887 1.275 . . . . 72.519999999999996 110.307 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -106.51 130.55 54.27 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.917 -1.142 . . . . 74.109999999999999 107.917 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.0 mt -106.39 132.64 52.18 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 125.956 1.702 . . . . 70.099999999999994 109.103 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.65 128.12 34.79 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.672 1.189 . . . . 70.340000000000003 110.694 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 p -150.29 164.98 34.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.499 1.519 . . . . 62.43 109.47 169.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -127.8 164.1 22.92 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.906 2.082 . . . . 54.310000000000002 112.239 159.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.8 tt -155.3 160.24 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.556 -1.275 . . . . 71.310000000000002 107.556 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.6 m -128.38 -66.1 0.86 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.493 2.317 . . . . 55.409999999999997 109.914 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.68 -83.76 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 106.998 -2.441 . . . . 73.329999999999998 106.998 170.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 p -95.08 -8.5 36.4 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.082 1.882 . . . . 72.549999999999997 116.082 -167.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.2 m -101.63 98.86 9.1 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 121.342 1.883 . . . . 73.510000000000005 109.34 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.429 ' HB2' ' CE3' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -76.03 119.11 19.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.005 -1.85 . . . . 72.450000000000003 106.005 165.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -108.05 88.88 2.83 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.618 -0.882 . . . . 64.239999999999995 108.618 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 t -80.23 128.32 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.858 -1.164 . . . . 63.549999999999997 107.858 169.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.65 -46.58 16.92 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.4 -0.81 . . . . 73.25 112.078 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 t -126.12 -172.85 2.71 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.575 1.08 . . . . 64.140000000000001 111.584 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.8 177.98 51.91 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.99 -1.244 . . . . 30.34 109.99 -171.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.5 m -60.49 -19.22 56.13 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.659 -0.906 . . . . 65.329999999999998 111.803 164.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -89.78 0.63 56.89 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.299 0.64 . . . . 65.549999999999997 112.371 -170.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.96 108.45 0.4 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.083 2.153 . . . . 70.530000000000001 110.261 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.79 -150.12 6.52 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 121.833 0.685 . . . . 72.530000000000001 112.583 -167.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 t -144.86 125.76 14.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.852 -1.907 . . . . 74.140000000000001 105.852 165.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -122.9 124.65 43.7 Favored 'General case' 0 C--O 1.226 -0.168 0 O-C-N 121.641 -0.662 . . . . 74.450000000000003 110.606 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -88.09 18.17 4.48 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.335 1.606 . . . . 75.25 115.335 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 26.3 tttt 62.43 156.03 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 127.172 2.189 . . . . 72.120000000000005 110.677 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 . . . . . 0 C--N 1.328 -0.357 0 C-N-CA 127.059 2.144 . . . . 71.450000000000003 106.8 -175.409 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 . . . . . 0 C--O 1.237 0.403 0 N-CA-C 107.494 -1.298 . . . . 72.150000000000006 107.494 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -108.29 161.26 15.17 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.906 2.082 . . . . 74.340000000000003 109.989 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.4 p -90.4 167.65 12.46 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.569 0.622 . . . . 63.43 109.896 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -51.63 125.18 14.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.132 0.968 . . . . 72.049999999999997 108.77 159.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.4 tp -67.66 118.99 11.67 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.29 -1.374 . . . . 63.310000000000002 107.29 161.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.449 HD22 ' ND2' ' A' ' 11' ' ' ASN . 21.2 m-80 -119.45 162.78 18.27 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 105.273 -2.121 . . . . 60.329999999999998 105.273 168.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -61.12 -44.91 96.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.16 -1.052 . . . . 53.25 108.16 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -53.83 -21.81 8.34 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.781 1.632 . . . . 75.540000000000006 113.918 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.449 ' ND2' HD22 ' A' ' 8' ' ' ASN . 93.0 m-20 -90.27 -29.78 17.94 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.283 0.947 . . . . 73.239999999999995 113.085 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.2 tp -87.66 -10.92 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.24 1.016 . . . . 64.519999999999996 111.923 -168.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mm -60.31 135.56 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.303 1.041 . . . . 61.149999999999999 111.523 -175.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.1 175.59 14.14 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.31 1.91 . . . . 35.340000000000003 110.847 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -78.17 159.09 28.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.972 -0.751 . . . . 73.209999999999994 108.972 164.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -149.59 146.15 27.17 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.588 1.155 . . . . 74.319999999999993 109.261 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.8 p -134.96 175.4 9.61 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.247 1.385 . . . . 73.230000000000004 112.851 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.2 t -133.8 12.94 4.03 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.451 1.1 . . . . 73.420000000000002 113.217 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.03 176.97 14.86 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.839 -1.704 . . . . 52.100000000000001 108.839 -175.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.0 pt -130.88 15.24 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.857 0.863 . . . . 65.219999999999999 112.612 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -108.91 165.1 11.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.118 1.367 . . . . 73.329999999999998 111.456 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.0 -101.35 0.72 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.561 -1.016 . . . . 53.210000000000001 110.561 162.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.3 m -141.7 117.3 10.31 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.455 -2.054 . . . . 73.219999999999999 105.455 162.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -114.99 179.23 4.01 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.689 1.595 . . . . 74.230000000000004 109.295 -176.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -142.81 139.85 31.1 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.165 1.386 . . . . 74.439999999999998 108.918 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.0 144.6 48.44 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.82 1.648 . . . . 50.219999999999999 108.306 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.556 HD22 ' CZ ' ' A' ' 29' ' ' PHE . 7.9 mt -124.76 155.62 39.03 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.358 1.863 . . . . 74.510000000000005 109.261 175.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.7 t -143.78 152.23 40.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.31 1.444 . . . . 72.430000000000007 107.735 163.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.556 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 61.4 m-85 -149.13 127.68 12.34 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 127.128 2.171 . . . . 74.120000000000005 107.002 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.54 163.32 12.55 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.576 0.75 . . . . 71.109999999999999 111.386 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.37 -30.19 37.88 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.982 0.734 . . . . 60.549999999999997 112.982 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.75 2.26 3.14 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.271 0.357 . . . . 72.209999999999994 110.975 -172.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.11 -129.41 5.68 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.678 1.609 . . . . 71.340000000000003 109.827 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.8 p -138.71 -175.42 4.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.328 2.251 . . . . 74.5 106.175 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.67 -177.81 22.4 Favored Glycine 0 C--O 1.238 0.385 0 N-CA-C 109.862 -1.295 . . . . 62.539999999999999 109.862 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.7 p -159.77 152.16 21.03 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.797 1.036 . . . . 42.409999999999997 113.797 -163.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -129.55 112.82 14.11 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.364 1.866 . . . . 71.030000000000001 107.299 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.17 109.21 0.95 Allowed Glycine 0 C--N 1.341 0.857 0 C-N-CA 124.376 0.988 . . . . 54.520000000000003 112.053 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.6 mt -76.61 143.06 13.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.463 1.105 . . . . 65.030000000000001 108.239 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -131.73 125.12 31.21 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.031 1.333 . . . . 71.219999999999999 109.301 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -88.31 112.69 23.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.597 -1.261 . . . . 41.399999999999999 107.597 166.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 53.06 -78.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.995 2.518 . . . . 72.129999999999995 112.342 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.94 21.09 2.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.423 1.889 . . . . 54.43 112.492 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 m -116.76 118.02 37.08 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.393 1.477 . . . . 53.130000000000003 107.675 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.61 125.69 14.81 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.576 2.184 . . . . 73.109999999999999 108.702 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.4 mm -117.24 -3.9 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.672 0.789 . . . . 74.129999999999995 110.907 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.4 t -152.17 163.7 38.84 Favored 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 120.169 -1.582 . . . . 62.340000000000003 108.998 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -157.7 144.92 18.3 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.022 1.729 . . . . 75.5 106.939 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -167.77 153.59 7.39 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 105.629 -1.989 . . . . 71.209999999999994 105.629 165.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 mtm -132.32 153.9 50.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.564 1.146 . . . . 73.540000000000006 108.83 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -163.2 154.37 16.97 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.747 0.819 . . . . 71.450000000000003 109.527 -174.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.92 169.09 16.42 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.143 2.177 . . . . 75.120000000000005 109.601 172.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.68 162.02 36.55 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.258 1.023 . . . . 63.310000000000002 110.261 171.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -134.11 131.31 38.58 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.49 -1.3 . . . . 72.219999999999999 107.49 160.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.48 107.66 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 105.597 -2.001 . . . . 73.420000000000002 105.597 163.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -152.66 45.9 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.463 0.705 . . . . 61.329999999999998 109.137 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.95 14.49 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.811 2.444 . . . . 73.140000000000001 111.966 162.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.94 25.24 71.93 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.393 -1.442 . . . . 65.120000000000005 110.822 -160.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -140.05 158.75 43.57 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 126.724 2.009 . . . . 71.129999999999995 106.512 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.08 138.77 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.168 -1.79 . . . . 73.25 106.168 172.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -117.49 115.96 26.19 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.81 2.044 . . . . 72.109999999999999 107.111 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.4 mm -97.71 143.05 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.979 -1.489 . . . . 74.230000000000004 106.979 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -159.36 -2.62 0.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.067 1.506 . . . . 73.140000000000001 115.067 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -148.42 125.19 11.18 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.084 -2.562 . . . . 73.420000000000002 104.084 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.2 t -132.14 152.33 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 125.212 1.405 . . . . 63.119999999999997 107.787 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.4 151.94 48.7 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 125.833 1.653 . . . . 75.099999999999994 106.678 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.52 -6.74 50.3 Favored 'Cis proline' 0 CA--C 1.534 0.513 0 CA-C-N 119.378 0.814 . . . . 61.009999999999998 113.983 4.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.28 108.61 18.77 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.791 -1.929 . . . . 73.209999999999994 105.791 172.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.63 127.97 34.28 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.097 1.359 . . . . 74.230000000000004 108.142 169.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -125.16 160.38 29.27 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.635 0.774 . . . . 65.239999999999995 110.078 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -56.89 147.05 55.89 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.051 0.941 . . . . 63.149999999999999 109.437 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.93 147.19 89.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.979 1.786 . . . . 70.310000000000002 111.07 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -157.56 151.41 24.24 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.269 1.828 . . . . 53.109999999999999 108.17 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -81.22 160.23 24.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.637 -1.165 . . . . 72.25 107.931 165.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.83 127.28 38.3 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.467 1.107 . . . . 73.010000000000005 108.711 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.22 115.2 20.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.621 -1.622 . . . . 70.150000000000006 106.621 175.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -146.1 151.7 38.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.717 1.207 . . . . 63.420000000000002 107.773 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -117.8 157.99 25.58 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.253 1.021 . . . . 73.319999999999993 109.373 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 tt -151.65 151.78 11.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 118.689 -0.672 . . . . 64.049999999999997 109.537 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.4 m -141.68 -6.98 0.99 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.339 1.607 . . . . 73.120000000000005 115.339 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.23 -82.35 0.17 Allowed Glycine 0 N--CA 1.461 0.308 0 O-C-N 120.363 -1.46 . . . . 63.310000000000002 109.552 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.5 p -104.32 -13.54 16.1 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.534 -0.746 . . . . 44.32 112.057 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 m -90.01 101.63 14.34 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.45 1.477 . . . . 61.299999999999997 109.784 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 tp -81.58 138.94 35.32 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.419 -1.326 . . . . 72.430000000000007 107.419 159.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -127.66 144.43 51.08 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.617 -0.883 . . . . 74.129999999999995 108.617 163.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 t -127.99 127.21 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.793 -1.558 . . . . 73.120000000000005 106.793 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -96.45 -20.84 18.12 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.436 0.902 . . . . 70.019999999999996 113.436 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -155.48 172.89 17.49 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.62 1.568 . . . . 70.239999999999995 108.655 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.92 177.93 49.11 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-O 122.285 0.936 . . . . 63.200000000000003 111.383 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 t -60.84 -26.99 67.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.24 -0.565 . . . . 74.219999999999999 111.724 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.81 6.26 49.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.397 -0.811 . . . . 64.239999999999995 113.042 -172.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -46.4 101.61 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.926 1.691 . . . . 74.219999999999999 110.651 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.95 -174.14 39.88 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.067 0.841 . . . . 70.030000000000001 112.382 -158.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.7 p -140.43 100.75 3.95 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.551 1.541 . . . . 71.329999999999998 107.716 -169.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -115.78 150.94 36.1 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.721 0.408 . . . . 73.420000000000002 110.629 -169.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -120.59 16.87 12.05 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.331 1.234 . . . . 53.119999999999997 114.331 -167.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.5 tttt 68.16 142.42 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 129.891 3.277 . . . . 71.239999999999995 111.629 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 . . . . . 0 C--O 1.235 0.321 0 C-N-CA 127.708 2.403 . . . . 72.430000000000007 107.581 -179.958 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 105.683 -1.969 . . . . 72.239999999999995 105.683 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -135.5 156.5 48.8 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 128.34 2.656 . . . . 72.549999999999997 108.077 -171.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -76.81 168.5 19.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.132 0.492 . . . . 62.149999999999999 111.304 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -55.45 143.95 27.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.993 1.317 . . . . 74.519999999999996 109.055 164.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.3 tp -83.73 121.96 27.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.244 -1.391 . . . . 73.530000000000001 107.244 164.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -131.17 172.7 11.82 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.363 1.065 . . . . 75.109999999999999 109.762 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' HD11 ' A' ' 13' ' ' ILE . 0.5 OUTLIER -64.24 -10.36 23.05 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.92 -1.038 . . . . 74.420000000000002 113.103 173.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -107.42 -31.61 8.09 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 121.094 1.77 . . . . 75.120000000000005 113.073 -168.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -86.18 -27.76 24.34 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.008 -0.996 . . . . 34.32 112.452 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 tp -65.76 -27.7 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.791 1.632 . . . . 75.109999999999999 111.534 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 9' ' ' SER . 14.6 mm -54.09 121.79 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 C-N-CA 125.854 1.661 . . . . 60.049999999999997 110.744 -169.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.95 176.31 14.42 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 123.964 0.792 . . . . 72.439999999999998 111.255 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.45 157.94 24.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.706 0.803 . . . . 75.209999999999994 109.433 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -147.02 143.68 28.57 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.87 0.868 . . . . 73.150000000000006 109.346 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.8 t -140.01 166.0 25.82 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.53 0.732 . . . . 62.530000000000001 110.82 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.49 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 14.2 t -119.34 -6.51 10.32 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.952 2.101 . . . . 73.549999999999997 111.393 176.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.66 175.8 43.37 Favored Glycine 0 C--N 1.337 0.593 0 O-C-N 120.503 -1.373 . . . . 55.420000000000002 110.978 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.7 pt -133.47 15.02 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.169 1.387 . . . . 74.129999999999995 110.046 -173.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -148.94 -175.8 5.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.145 1.778 . . . . 73.409999999999997 109.703 -165.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.69 -99.9 0.04 OUTLIER Glycine 0 C--N 1.337 0.592 0 C-N-CA 126.789 2.138 . . . . 63.329999999999998 112.823 165.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.9 m -148.14 129.24 14.55 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 104.364 -2.458 . . . . 74.219999999999999 104.364 167.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -143.47 -174.78 4.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.373 1.069 . . . . 55.329999999999998 109.342 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -136.39 164.67 27.58 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.284 1.434 . . . . 75.109999999999999 109.549 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.33 133.06 23.83 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.243 1.417 . . . . 72.329999999999998 108.63 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 mt -121.07 160.41 23.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.953 0.901 . . . . 74.340000000000003 109.86 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 t -137.12 154.12 50.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.041 1.736 . . . . 62.450000000000003 106.631 159.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -145.03 130.26 18.58 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.566 1.546 . . . . 74.010000000000005 108.24 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.87 152.18 23.59 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.507 1.123 . . . . 64.349999999999994 109.822 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.82 -37.46 73.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.91 1.284 . . . . 73.25 110.516 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.67 21.26 4.65 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.31 1.044 . . . . 64.049999999999997 110.753 -171.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -130.36 -129.08 3.06 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.482 1.039 . . . . 71.230000000000004 110.599 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 p -124.19 -175.05 3.14 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.421 1.888 . . . . 73.109999999999999 108.442 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.79 167.13 13.04 Favored Glycine 0 C--O 1.237 0.322 0 N-CA-C 109.252 -1.539 . . . . 73.319999999999993 109.252 162.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.04 153.24 49.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.701 0.801 . . . . 74.010000000000005 108.859 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -137.73 121.54 17.58 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.127 1.371 . . . . 54.399999999999999 107.761 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.61 162.53 19.83 Favored Glycine 0 C--N 1.331 0.297 0 N-CA-C 110.293 -1.123 . . . . 74.230000000000004 110.293 174.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.0 mt -127.15 143.36 40.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.962 -1.866 . . . . 73.310000000000002 105.962 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -136.01 124.65 23.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.417 1.087 . . . . 75.430000000000007 108.687 -166.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.2 m -84.69 124.27 31.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.837 -1.542 . . . . 55.210000000000001 106.837 166.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 44.64 -78.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 129.059 2.943 . . . . 71.230000000000004 115.127 176.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.2 68.03 1.09 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.64 1.576 . . . . 35.130000000000003 107.612 165.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.7 m -152.97 130.96 6.2 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 126.591 1.957 . . . . 62.310000000000002 107.089 170.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.01 135.85 26.12 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.563 2.842 . . . . 75.120000000000005 110.509 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.7 mm -130.89 -21.25 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.007 0.923 . . . . 74.310000000000002 111.729 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.1 m -142.01 155.58 45.43 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 120.551 -1.343 . . . . 71.329999999999998 109.105 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -155.98 143.27 19.22 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.751 1.22 . . . . 64.409999999999997 109.629 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -159.75 159.59 32.97 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.1 1.76 . . . . 42.43 106.94 166.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.9 mtm -133.5 148.46 51.69 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.564 -1.643 . . . . 71.329999999999998 106.564 172.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -158.5 142.52 15.56 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.474 -0.565 . . . . 63.409999999999997 109.474 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.47 157.16 30.61 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.591 -1.263 . . . . 72.150000000000006 107.591 170.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -151.08 164.53 36.26 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.629 -0.67 . . . . 74.310000000000002 109.953 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -132.1 158.3 41.96 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.614 1.166 . . . . 73.349999999999994 108.235 164.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.9 mm -113.63 87.11 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.552 -2.018 . . . . 73.230000000000004 105.552 166.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -126.25 23.04 7.08 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 122.424 1.107 . . . . 73.329999999999998 110.759 -170.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.76 14.28 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.317 1.847 . . . . 74.140000000000001 113.606 -170.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.61 15.55 61.99 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 121.368 -0.833 . . . . 54.130000000000003 111.338 -172.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -145.43 162.05 38.24 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 128.847 2.859 . . . . 74.420000000000002 105.893 -170.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 mt -91.27 109.46 21.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.612 -1.625 . . . . 63.549999999999997 106.612 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -78.86 104.78 9.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.77 -1.567 . . . . 75.540000000000006 106.77 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.0 mm -88.89 131.39 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.152 -2.166 . . . . 64.120000000000005 105.152 170.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -154.74 -1.14 0.17 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 115.93 1.826 . . . . 75.420000000000002 115.93 -175.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -148.86 123.5 9.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.761 -1.94 . . . . 72.219999999999999 105.761 162.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.5 t -129.14 141.45 46.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 125.823 1.649 . . . . 71.140000000000001 107.827 -174.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.41 164.06 46.68 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.327 1.051 . . . . 74.329999999999998 108.246 173.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.23 -19.76 15.33 Favored 'Cis proline' 0 N--CA 1.454 -0.84 0 CA-C-N 119.285 0.78 . . . . 63.32 111.98 -14.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -98.27 102.21 13.89 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.912 -1.514 . . . . 64.540000000000006 106.912 -176.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -88.41 131.8 34.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.022 -0.99 . . . . 71.530000000000001 110.493 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -127.39 174.7 8.78 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.676 1.19 . . . . 74.400000000000006 110.382 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 t -61.02 154.89 58.05 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.152 1.381 . . . . 71.430000000000007 111.625 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.51 147.3 57.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.359 2.706 . . . . 71.129999999999995 112.593 171.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -161.01 164.59 30.85 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.648 1.179 . . . . 74.519999999999996 110.441 171.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -91.68 148.54 22.18 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.956 -0.757 . . . . 74.140000000000001 108.956 169.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -124.39 137.43 54.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.178 1.791 . . . . 74.430000000000007 108.474 175.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -98.71 133.22 43.34 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.766 -0.827 . . . . 61.240000000000002 108.766 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.469 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 2.1 p -151.68 165.64 33.73 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.091 1.356 . . . . 65.129999999999995 109.433 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.44 161.18 19.48 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.404 -0.591 . . . . 65.420000000000002 109.404 160.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.432 HG12 ' H ' ' A' ' 81' ' ' GLY . 16.4 tt -137.47 146.94 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.462 -1.31 . . . . 73.420000000000002 107.462 174.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.3 p -111.7 -10.74 14.05 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.579 0.751 . . . . 64.519999999999996 112.037 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 79' ' ' ILE . . . 125.69 -63.09 0.59 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 107.452 -2.259 . . . . 51.119999999999997 107.452 -169.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 p -112.55 -15.57 13.02 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.575 -1.202 . . . . 73.310000000000002 114.155 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.1 m -104.45 137.0 42.96 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.599 1.545 . . . . 74.519999999999996 107.878 168.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.526 HD22 HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -98.76 143.4 29.14 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.898 -1.519 . . . . 74.510000000000005 106.898 161.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -133.07 85.65 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.154 -1.054 . . . . 73.329999999999998 108.154 170.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.526 HG23 HD22 ' A' ' 84' ' ' LEU . 44.4 t -75.65 124.75 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.3 -0.63 . . . . 73.340000000000003 109.3 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -92.94 -24.95 18.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.147 0.979 . . . . 65.230000000000004 112.547 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.0 t -152.52 160.86 43.2 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.013 0.824 . . . . 70.329999999999998 110.285 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.26 176.17 19.39 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.956 1.741 . . . . 65.239999999999995 111.134 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.1 m -55.62 -26.98 47.07 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.619 0.768 . . . . 53.350000000000001 111.548 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -101.89 11.79 38.02 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.022 0.929 . . . . 71.129999999999995 113.046 -174.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.6 108.73 0.37 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.207 1.403 . . . . 52.229999999999997 110.929 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.59 -169.8 41.51 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 122.113 0.841 . . . . 70.209999999999994 113.03 -169.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -118.65 126.29 51.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.929 2.092 . . . . 65.450000000000003 107.473 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.49 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 23.9 m-85 -140.07 159.33 42.42 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.789 0.328 . . . . 73.120000000000005 110.499 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -120.57 149.55 42.27 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.487 1.115 . . . . 72.430000000000007 109.154 170.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -61.17 143.19 55.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.99 -1.115 . . . . 64.25 107.99 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 105.685 -1.969 . . . . 74.120000000000005 105.685 175.128 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 . . . . . 0 CA--C 1.512 -0.51 0 N-CA-C 107.36 -1.348 . . . . 75.099999999999994 107.36 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -87.57 147.79 25.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.187 -1.824 . . . . 75.040000000000006 109.936 -174.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.22 167.59 17.58 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.884 0.874 . . . . 71.310000000000002 110.528 168.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -55.58 136.26 50.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.882 1.325 . . . . 73.239999999999995 109.65 157.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.7 tp -66.96 139.24 57.69 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.363 -1.347 . . . . 73.420000000000002 107.363 154.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -140.11 170.42 15.88 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.713 -1.588 . . . . 63.229999999999997 106.713 163.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 p -44.25 -60.62 1.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.248 2.619 . . . . 74.049999999999997 109.809 171.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -71.69 -17.24 62.24 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.259 -1.337 . . . . 73.430000000000007 110.245 -170.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -82.64 -37.16 25.3 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 117.763 -1.113 . . . . 73.120000000000005 110.596 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 tp -74.98 -15.87 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 121.381 1.901 . . . . 63.329999999999998 113.363 -170.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mm -56.35 136.32 19.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.448 1.099 . . . . 62.130000000000003 110.762 -173.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 131.45 -175.08 19.79 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.777 1.18 . . . . 74.219999999999999 112.727 170.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.54 146.08 25.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.093 1.757 . . . . 71.409999999999997 108.612 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -140.3 111.61 7.19 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.789 0.836 . . . . 75.099999999999994 110.221 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -118.18 143.59 46.39 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.257 1.023 . . . . 61.420000000000002 108.971 -175.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 25' ' ' LYS . 10.4 t -82.35 -43.99 16.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.251 0.621 . . . . 73.030000000000001 109.419 174.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.5 172.8 44.7 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.74 1.638 . . . . 32.310000000000002 110.335 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.9 pt -115.94 45.37 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 122.924 1.345 . . . . 64.209999999999994 109.854 -164.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -131.06 178.81 6.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.251 1.42 . . . . 52.520000000000003 111.619 -156.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.79 -24.34 18.63 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 127.228 2.347 . . . . 22.02 115.597 -163.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.2 m -150.2 119.94 7.05 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.596 -1.631 . . . . 63.100000000000001 106.596 170.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -146.41 -178.95 6.43 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.043 0.838 . . . . 72.200000000000003 110.918 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.411 ' H ' HG22 ' A' ' 18' ' ' THR . 96.5 mttt -143.26 146.08 33.31 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.289 1.436 . . . . 73.439999999999998 108.39 -171.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.31 135.02 45.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.698 -1.223 . . . . 72.129999999999995 107.698 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 mt -123.13 155.75 36.38 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.201 1.401 . . . . 60.439999999999998 108.275 172.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.9 p -146.85 152.42 38.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.695 0.798 . . . . 52.340000000000003 109.567 167.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.62 119.84 12.19 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.602 -1.629 . . . . 75.040000000000006 106.602 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -84.94 169.51 13.98 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.694 -0.854 . . . . 64.150000000000006 108.694 169.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -93.58 -25.61 17.47 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.599 1.16 . . . . 62.539999999999999 112.92 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.09 32.09 1.24 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.416 1.086 . . . . 75.510000000000005 108.714 -174.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.19 -112.57 1.1 Allowed Glycine 0 C--N 1.339 0.698 0 N-CA-C 109.02 -1.632 . . . . 64.140000000000001 109.02 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.4 p -139.92 -165.66 1.93 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.735 1.214 . . . . 74.209999999999994 109.346 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.09 171.18 14.77 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.423 1.011 . . . . 55.229999999999997 110.852 166.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.53 148.94 35.08 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.907 -0.775 . . . . 62.020000000000003 108.907 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -138.83 124.25 19.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.472 1.109 . . . . 71.340000000000003 108.572 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.62 165.49 21.46 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.808 -0.917 . . . . 71.200000000000003 110.808 175.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -124.49 148.49 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 104.862 -2.273 . . . . 52.5 104.862 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -141.84 165.1 28.41 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.449 1.1 . . . . 74.319999999999993 108.716 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.3 m -136.24 112.69 9.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.91 2.084 . . . . 75.439999999999998 107.866 171.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 54.13 -78.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 127.51 2.324 . . . . 71.430000000000007 114.374 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.21 47.97 1.49 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.202 1.801 . . . . 75.329999999999998 110.457 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.2 m -154.83 137.66 10.3 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.024 1.73 . . . . 64.109999999999999 108.669 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.68 142.21 22.72 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 124.057 3.172 . . . . 71.409999999999997 110.593 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.6 mm -130.69 -7.48 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 126.028 1.731 . . . . 55.240000000000002 110.843 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.9 t -153.7 164.76 37.76 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 119.721 -1.862 . . . . 72.409999999999997 109.117 163.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -157.31 123.07 4.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.71 2.404 . . . . 71.409999999999997 106.837 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -139.0 164.22 30.33 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.381 1.472 . . . . 64.129999999999995 107.152 164.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mtm -135.87 156.28 49.02 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.967 1.307 . . . . 72.25 107.673 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -159.39 151.94 21.44 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.575 0.75 . . . . 75.030000000000001 110.27 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -82.4 166.85 19.05 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.349 -0.612 . . . . 75.25 109.349 166.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -148.23 160.9 42.48 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.238 0.615 . . . . 74.439999999999998 111.787 172.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -131.39 154.99 48.06 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.215 -1.402 . . . . 64.450000000000003 107.215 164.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.3 mm -104.16 107.72 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 106.018 -1.845 . . . . 74.329999999999998 106.018 164.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.75 24.62 2.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.946 1.461 . . . . 73.349999999999994 114.946 171.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.88 14.66 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.631 1.573 . . . . 73.049999999999997 114.835 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.43 11.84 84.02 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 120.114 -1.616 . . . . 74.049999999999997 115.12 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -121.37 -165.73 1.27 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.292 1.837 . . . . 74.450000000000003 107.765 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.6 mt -114.84 110.18 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.753 1.615 . . . . 55.149999999999999 107.179 172.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -76.88 103.17 6.67 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 107.363 -1.347 . . . . 75.25 107.363 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.5 mm -90.49 140.12 16.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 105.697 -1.964 . . . . 74.010000000000005 105.697 170.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -158.31 -5.01 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 115.131 1.53 . . . . 74.450000000000003 115.131 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -144.87 112.75 6.34 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.224 -2.88 . . . . 62.130000000000003 103.224 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.1 t -132.29 152.69 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.949 -1.501 . . . . 71.109999999999999 106.949 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.83 162.11 34.73 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.482 1.513 . . . . 75.439999999999998 107.18 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.84 -26.47 9.61 Favored 'Cis proline' 0 N--CA 1.459 -0.536 0 CA-C-N 119.833 0.976 . . . . 53.549999999999997 112.396 -9.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -87.16 107.7 18.58 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 104.789 -2.3 . . . . 50.109999999999999 104.789 167.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -70.74 159.66 34.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.954 0.407 . . . . 74.349999999999994 110.479 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.93 153.7 48.26 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.828 1.251 . . . . 73.140000000000001 108.778 171.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.4 t -50.89 151.13 4.64 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.559 1.944 . . . . 71.120000000000005 111.643 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.03 154.05 67.08 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.521 2.147 . . . . 74.129999999999995 113.335 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -168.45 166.04 12.38 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.142 1.377 . . . . 74.230000000000004 109.847 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -103.08 111.33 23.64 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.492 -1.299 . . . . 70.120000000000005 107.492 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.1 mt -77.61 113.99 16.0 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.956 0.903 . . . . 70.409999999999997 108.866 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.44 116.29 4.96 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.119 1.768 . . . . 70.230000000000004 108.697 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 9.5 p -151.13 158.77 44.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.658 -0.651 . . . . 74.439999999999998 112.637 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 163.0 16.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.316 -0.856 . . . . 71.319999999999993 110.972 174.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 tt -141.31 149.98 20.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.518 1.127 . . . . 72.329999999999998 108.425 170.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.6 p -129.02 -6.67 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.354 1.242 . . . . 74.420000000000002 114.354 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.6 -71.51 0.37 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.304 -1.519 . . . . 73.010000000000005 109.304 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.1 p -121.4 4.12 10.23 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.537 -0.745 . . . . 73.439999999999998 112.987 175.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.9 m -107.6 133.31 52.23 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.282 -1.377 . . . . 52.530000000000001 107.282 170.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.1 tp -108.6 130.57 55.31 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.258 2.223 . . . . 74.109999999999999 107.299 166.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -125.69 99.71 6.11 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.009 1.324 . . . . 75.099999999999994 110.009 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.8 t -93.61 131.81 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.854 -0.795 . . . . 73.019999999999996 108.854 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -87.56 -23.42 24.35 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.844 1.258 . . . . 75.420000000000002 113.329 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -153.12 166.39 32.63 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.129 -0.982 . . . . 64.040000000000006 109.849 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.67 175.44 36.92 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.709 -0.956 . . . . 54.420000000000002 110.709 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.1 m -60.05 -21.61 61.63 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.253 1.021 . . . . 75.219999999999999 112.016 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -101.85 6.34 41.45 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.914 1.686 . . . . 64.439999999999998 112.776 -172.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.65 110.66 0.83 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.509 1.924 . . . . 55.109999999999999 109.337 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.52 -136.31 2.64 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 123.451 0.548 . . . . 73.010000000000005 112.527 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.5 t -154.92 113.45 3.54 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.289 -1.745 . . . . 64.200000000000003 106.289 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -133.07 152.76 51.93 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.165 -0.959 . . . . 74.420000000000002 109.446 -168.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -118.98 141.42 48.68 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.282 1.033 . . . . 75.099999999999994 108.331 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -58.37 134.74 56.88 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.263 -1.384 . . . . 74.340000000000003 107.263 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 . . . . . 0 C--N 1.326 -0.439 0 N-CA-C 107.741 -1.207 . . . . 73.299999999999997 107.741 175.651 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 . . . . . 0 N--CA 1.441 -0.88 0 N-CA-C 105.198 -2.149 . . . . 72.519999999999996 105.198 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -111.15 166.49 11.03 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.263 -1.79 . . . . 74.519999999999996 110.625 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -84.65 163.93 18.95 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.055 -0.72 . . . . 53.109999999999999 109.055 168.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -51.71 124.33 12.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.109 0.957 . . . . 70.120000000000005 109.283 153.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.17 134.3 55.76 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.529 0.681 . . . . 45.119999999999997 109.538 157.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -139.02 169.14 18.34 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.624 -1.621 . . . . 71.319999999999993 106.624 163.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -49.85 -57.19 7.9 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.944 0.498 . . . . 72.420000000000002 109.687 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -64.34 -17.33 63.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.843 0.683 . . . . 61.140000000000001 112.843 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -78.87 -44.39 22.94 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.854 0.861 . . . . 71.219999999999999 110.496 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.9 tp -74.96 -24.56 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 O-C-N 120.329 -1.482 . . . . 70.420000000000002 112.225 -170.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 mm -47.88 125.46 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.573 1.949 . . . . 53.409999999999997 112.53 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.17 -178.57 18.87 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.11 0.862 . . . . 65.25 112.828 168.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -72.78 147.89 45.1 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 125.675 1.59 . . . . 73.549999999999997 110.534 171.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.493 ' CH2' ' HE3' ' A' ' 97' ' ' LYS . 93.7 m95 -137.76 117.84 13.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.257 1.423 . . . . 74.310000000000002 108.669 176.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t -116.61 174.2 6.21 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.785 1.234 . . . . 71.310000000000002 110.038 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -142.98 1.31 1.26 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.315 1.446 . . . . 72.510000000000005 111.363 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.49 176.91 14.6 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 126.477 1.989 . . . . 74.239999999999995 108.465 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.75 11.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 113.123 0.786 . . . . 65.340000000000003 113.123 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -113.06 -171.35 1.85 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 125.426 1.49 . . . . 73.439999999999998 110.184 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 48.43 -90.42 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 126.495 1.998 . . . . 70.230000000000004 114.51 153.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.8 m -144.93 100.48 3.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.734 -1.95 . . . . 70.120000000000005 105.734 169.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -115.44 171.68 7.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.15 -0.685 . . . . 65.420000000000002 109.15 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HE2' HG23 ' A' ' 39' ' ' ILE . 82.7 mttt -146.46 151.84 38.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.145 -1.798 . . . . 65.310000000000002 106.145 -175.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.67 146.83 50.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.815 -1.921 . . . . 61.25 105.815 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.03 159.97 35.98 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.479 -0.934 . . . . 63.509999999999998 108.479 161.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.2 p -133.36 154.55 50.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.498 0.719 . . . . 53.32 109.772 164.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -139.69 125.09 19.07 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.428 -2.064 . . . . 64.409999999999997 105.428 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -109.99 161.4 15.55 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.138 -1.43 . . . . 51.420000000000002 107.138 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -97.13 -21.04 17.56 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.586 -0.696 . . . . 71.239999999999995 112.518 -168.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -124.41 -5.78 7.67 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 122.853 0.461 . . . . 74.5 111.835 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.96 -120.38 4.36 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.01 1.767 . . . . 43.100000000000001 109.819 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.3 p -148.27 175.37 11.13 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 128.481 2.712 . . . . 73.430000000000007 106.535 -172.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.86 -166.87 23.33 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 119.392 0.996 . . . . 72.230000000000004 112.32 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 m -148.8 164.9 33.07 Favored 'General case' 0 CA--C 1.521 -0.144 0 O-C-N 121.214 -1.168 . . . . 71.510000000000005 109.674 168.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -143.15 125.33 15.44 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.488 -1.301 . . . . 70.209999999999994 107.488 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.14 159.04 20.49 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.064 -0.815 . . . . 72.530000000000001 111.064 170.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.5 HG23 ' HE2' ' A' ' 25' ' ' LYS . 69.6 mt -133.31 140.61 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 105.843 -1.91 . . . . 64.209999999999994 105.843 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -132.02 157.11 44.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.161 0.985 . . . . 71.549999999999997 110.022 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -125.86 116.88 22.24 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.19 2.196 . . . . 53.32 106.172 167.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 48.75 -76.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 129.182 2.993 . . . . 71.019999999999996 114.169 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.21 29.61 2.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.775 1.63 . . . . 72.129999999999995 112.969 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.0 m -137.22 130.46 17.28 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 124.911 1.284 . . . . 71.120000000000005 109.541 -174.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.38 133.63 21.22 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.997 3.132 . . . . 70.409999999999997 110.857 170.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.4 mm -128.44 -3.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 125.899 1.68 . . . . 70.219999999999999 111.275 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 t -145.63 171.28 14.94 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 119.277 -2.139 . . . . 65.129999999999995 107.837 165.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -166.37 140.89 4.32 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.729 1.612 . . . . 73.409999999999997 107.54 168.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -157.82 162.29 38.41 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.668 1.587 . . . . 64.450000000000003 107.074 169.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.6 mtm -130.44 155.42 46.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.237 -1.394 . . . . 74.329999999999998 107.237 166.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -163.35 156.22 18.67 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.206 1.002 . . . . 74.109999999999999 109.486 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -91.89 167.66 11.97 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.599 0.76 . . . . 72.219999999999999 109.385 170.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -135.97 164.71 27.36 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.642 1.177 . . . . 52.329999999999998 110.185 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -130.1 126.38 37.44 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.649 -1.611 . . . . 74.5 106.649 160.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mm -92.88 94.58 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 104.643 -2.354 . . . . 73.239999999999995 104.643 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -135.54 22.99 3.41 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.78 0.8 . . . . 72.319999999999993 112.237 -168.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -170.43 13.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.696 1.199 . . . . 44.100000000000001 112.696 171.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.17 13.4 82.94 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 121.6 -0.688 . . . . 72.230000000000004 112.33 -169.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -130.87 166.5 20.76 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.33 2.252 . . . . 74.239999999999995 106.828 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.6 mt -105.32 104.38 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.694 -1.595 . . . . 74.519999999999996 106.694 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -84.44 123.1 29.86 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.079 1.352 . . . . 74.129999999999995 107.865 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.6 mm -99.64 150.95 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.873 1.669 . . . . 74.430000000000007 107.82 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -160.97 -17.51 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 116.36 1.985 . . . . 73.530000000000001 116.36 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -135.66 109.4 8.07 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 105.318 -2.104 . . . . 71.140000000000001 105.318 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.74 149.99 25.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.975 1.71 . . . . 45.140000000000001 107.54 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.4 160.8 65.42 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.357 1.063 . . . . 72.239999999999995 108.203 173.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.46 -11.02 42.51 Favored 'Cis proline' 0 C--N 1.345 0.362 0 N-CA-C 114.222 0.816 . . . . 71.120000000000005 114.222 -2.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -108.14 109.39 20.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.053 -2.203 . . . . 74.25 105.053 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.38 145.61 55.5 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.387 0.429 . . . . 65.439999999999998 110.106 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -129.66 164.34 24.13 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.675 1.19 . . . . 72.120000000000005 110.554 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -62.25 149.76 86.34 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.713 0.805 . . . . 70.510000000000005 109.944 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.99 147.37 49.05 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.188 2.592 . . . . 62.109999999999999 111.618 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -162.06 157.03 22.87 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.277 2.231 . . . . 65.099999999999994 110.2 174.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -94.74 119.5 33.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.001 0.921 . . . . 72.140000000000001 109.085 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -91.12 138.75 31.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.573 1.149 . . . . 63.140000000000001 109.815 171.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -81.88 123.2 28.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.694 -1.225 . . . . 72.120000000000005 107.694 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.6 p -148.49 168.54 22.43 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.41 0.684 . . . . 61.530000000000001 109.515 165.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.69 163.7 25.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.825 1.65 . . . . 72.340000000000003 112.604 159.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 tt -145.66 160.14 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.477 1.511 . . . . 52.130000000000003 107.058 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.2 t -126.71 -35.57 2.31 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.32 3.048 . . . . 53.119999999999997 109.413 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.79 -52.72 0.09 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 127.31 2.386 . . . . 72.329999999999998 110.177 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.7 p -138.73 7.75 2.54 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.565 1.32 . . . . 44.409999999999997 114.565 -158.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.1 m -131.25 105.41 7.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 129.26 3.024 . . . . 65.219999999999999 107.712 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.474 HD22 HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -77.48 121.41 23.81 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.701 -1.963 . . . . 71.230000000000004 105.701 173.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 ttmm -101.87 86.62 2.94 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.87 -1.159 . . . . 65.129999999999995 107.87 165.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.474 HG23 HD22 ' A' ' 84' ' ' LEU . 22.9 t -79.17 129.95 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.307 -1.368 . . . . 73.099999999999994 107.307 167.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -96.77 -30.57 13.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.956 0.902 . . . . 51.100000000000001 112.053 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -150.99 173.43 14.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.297 1.039 . . . . 71.109999999999999 110.291 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.48 -178.69 25.36 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 109.849 -1.3 . . . . 52.200000000000003 109.849 -172.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 t -64.23 -25.12 67.92 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 122.119 -0.636 . . . . 71.530000000000001 110.718 172.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -101.44 10.26 40.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.241 1.417 . . . . 63.219999999999999 112.22 -168.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.45 0.28 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 127.001 2.121 . . . . 74.140000000000001 112.122 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 -162.94 31.1 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 121.616 -0.677 . . . . 23.32 112.578 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.4 p -119.23 106.25 12.16 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.582 1.553 . . . . 72.340000000000003 107.978 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -120.81 130.8 54.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.849 0.75 . . . . 64.510000000000005 111.44 -168.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -81.39 127.96 33.33 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.971 0.908 . . . . 73.420000000000002 108.91 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HE3' ' CH2' ' A' ' 16' ' ' TRP . 31.2 ttmt -60.94 135.29 57.74 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.917 -1.142 . . . . 65.510000000000005 107.917 165.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 122.283 1.04 . . . . 74.109999999999999 109.117 177.533 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 . . . . . 0 CA--C 1.515 -0.391 0 CA-C-O 121.923 0.868 . . . . 72.0 109.194 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -85.1 157.76 20.6 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.832 1.653 . . . . 73.109999999999999 111.045 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.14 176.29 8.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.705 0.802 . . . . 63.039999999999999 111.574 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -56.73 134.14 54.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.947 0.899 . . . . 74.109999999999999 109.772 156.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 tp -74.45 138.21 43.12 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.331 -1.359 . . . . 74.299999999999997 107.331 159.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -143.45 163.67 32.45 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.352 -1.721 . . . . 73.400000000000006 106.352 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.12 -51.33 54.58 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.746 0.654 . . . . 73.430000000000007 109.502 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -71.34 -16.22 62.43 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 117.933 -1.032 . . . . 73.219999999999999 113.36 -170.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -80.14 -41.87 24.57 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.456 1.025 . . . . 71.140000000000001 109.678 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.45 41.58 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.77 0.828 . . . . 73.530000000000001 110.568 -176.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.3 mm -112.21 125.5 69.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 O-C-N 119.939 -1.726 . . . . 73.329999999999998 108.48 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.46 179.69 16.47 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.651 1.119 . . . . 75.400000000000006 111.883 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -79.95 164.82 23.2 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.912 1.285 . . . . 72.219999999999999 109.474 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -142.35 145.65 34.14 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.176 0.99 . . . . 63.420000000000002 110.462 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.6 t -134.09 165.27 25.44 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.448 -1.407 . . . . 64.209999999999994 110.237 164.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.426 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 12.0 t -112.68 -12.21 13.43 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.587 1.555 . . . . 62.399999999999999 111.556 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.27 178.05 23.09 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 107.931 -2.068 . . . . 75.310000000000002 107.931 -166.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.3 pt -134.43 22.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.526 1.13 . . . . 61.399999999999999 110.827 -167.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 154.72 49.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.398 1.479 . . . . 72.010000000000005 107.238 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.49 -160.04 10.89 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.12 -0.491 . . . . 75.239999999999995 112.561 -172.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.8 m -79.95 88.59 5.32 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.678 1.191 . . . . 53.229999999999997 108.906 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -96.34 172.05 8.2 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 122.367 1.079 . . . . 71.030000000000001 110.843 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -141.15 118.26 11.27 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.184 -1.413 . . . . 74.319999999999993 107.184 -151.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.94 106.62 14.93 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.777 2.031 . . . . 55.130000000000003 109.226 -173.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 mt -90.81 158.26 16.92 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.509 1.124 . . . . 74.010000000000005 108.751 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.1 t -143.2 163.18 33.64 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.822 -0.807 . . . . 61.310000000000002 108.822 155.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -149.01 128.51 13.09 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.126 1.77 . . . . 75.230000000000004 109.34 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -104.38 144.77 31.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.084 1.354 . . . . 54.140000000000001 109.626 171.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.71 -27.41 63.96 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.37 1.068 . . . . 64.510000000000005 112.014 -174.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -128.15 0.7 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 129.248 3.019 . . . . 51.020000000000003 110.93 -164.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.94 -116.61 2.17 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 125.229 1.395 . . . . 43.109999999999999 110.047 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.3 p -140.23 177.75 7.77 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.352 2.261 . . . . 73.439999999999998 107.188 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -103.96 176.72 23.95 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 124.07 0.843 . . . . 73.530000000000001 111.183 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -140.86 158.67 43.62 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.448 1.499 . . . . 60.109999999999999 108.813 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -141.56 120.08 12.43 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.195 1.398 . . . . 75.219999999999999 107.267 164.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.83 114.48 1.42 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.891 1.71 . . . . 75.310000000000002 110.103 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.402 ' H ' ' HB3' ' A' ' 47' ' ' SER . 8.0 mt -78.27 140.59 16.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.46 -1.311 . . . . 64.0 107.46 171.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -124.96 154.51 41.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.943 -1.503 . . . . 54.399999999999999 106.943 170.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.401 ' HB2' HG13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -126.63 118.11 24.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.286 -1.375 . . . . 75.109999999999999 107.286 174.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m120 68.63 -64.68 0.3 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 126.421 1.888 . . . . 71.430000000000007 113.675 162.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -158.06 49.75 0.4 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.048 1.295 . . . . 43.210000000000001 110.937 158.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 m -150.85 134.69 9.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.149 1.38 . . . . 71.140000000000001 109.109 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.19 131.19 21.49 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.12 2.547 . . . . 73.400000000000006 110.541 168.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 41' ' ' SER . 10.7 mm -126.85 4.7 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.024 0.93 . . . . 74.0 110.816 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.402 ' HB3' ' H ' ' A' ' 39' ' ' ILE . 7.9 t -152.48 172.84 15.92 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 119.883 -1.761 . . . . 75.239999999999995 109.922 166.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -174.74 118.15 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.665 1.986 . . . . 75.019999999999996 108.113 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -142.48 158.04 44.11 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.281 1.432 . . . . 61.210000000000001 107.694 165.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.8 mtm -134.03 150.19 51.21 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.138 -1.43 . . . . 74.420000000000002 107.138 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.5 151.38 20.55 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 122.892 0.477 . . . . 75.319999999999993 110.985 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.76 167.21 22.22 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.838 -0.801 . . . . 63.140000000000001 108.838 166.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -146.79 166.86 25.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.677 0.791 . . . . 75.099999999999994 109.878 167.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -133.54 155.77 49.0 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.442 -1.688 . . . . 73.349999999999994 106.442 161.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.0 mm -114.02 98.56 7.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.844 -1.91 . . . . 63.299999999999997 105.844 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -130.03 23.13 5.29 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.029 0.752 . . . . 72.329999999999998 113.029 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -170.01 14.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.09 1.356 . . . . 55.229999999999997 114.07 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.43 18.61 75.47 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.272 -0.892 . . . . 64.239999999999995 112.461 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -140.36 173.29 11.65 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 128.586 2.754 . . . . 75.340000000000003 105.963 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.0 mt -102.72 117.81 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.866 -1.161 . . . . 75.010000000000005 107.866 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -84.51 122.17 28.63 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.686 1.194 . . . . 64.150000000000006 108.154 170.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mm -109.95 132.88 57.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.92 1.688 . . . . 74.439999999999998 106.626 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -160.87 6.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.777 1.399 . . . . 75.430000000000007 114.777 -169.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -148.68 123.15 9.71 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.024 -2.584 . . . . 73.329999999999998 104.024 163.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.8 t -136.27 148.85 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.467 -1.308 . . . . 74.150000000000006 107.467 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.68 163.31 32.12 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 107.364 -1.347 . . . . 75.349999999999994 107.364 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.63 -11.21 31.97 Favored 'Cis proline' 0 CA--C 1.534 0.487 0 CA-C-N 118.713 0.576 . . . . 74.329999999999998 113.378 -2.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.38 132.58 36.1 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.296 -1.742 . . . . 52.240000000000002 106.296 167.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.41 135.75 38.85 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 118.755 0.707 . . . . 73.319999999999993 109.335 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -124.14 168.4 12.95 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 124.169 0.987 . . . . 74.349999999999994 110.744 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 t -47.84 143.42 6.22 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.83 2.052 . . . . 72.319999999999993 110.675 166.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 159.0 53.78 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.253 1.969 . . . . 74.439999999999998 110.963 172.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -168.13 177.15 5.66 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.5 1.52 . . . . 74.299999999999997 108.349 172.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -106.99 155.94 19.27 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.708 -0.849 . . . . 75.019999999999996 108.708 171.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.8 mt -123.56 129.54 51.34 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.161 1.784 . . . . 73.319999999999993 109.298 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.09 123.25 29.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.177 1.391 . . . . 73.209999999999994 109.522 174.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 p -148.84 168.38 23.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.582 1.953 . . . . 75.340000000000003 108.033 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.08 154.88 50.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.887 1.275 . . . . 73.409999999999997 108.482 169.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 tt -136.95 156.54 34.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.362 -1.347 . . . . 75.340000000000003 107.362 173.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.45 26.06 0.68 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.692 0.997 . . . . 74.420000000000002 113.692 166.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.47 -94.28 0.18 Allowed Glycine 0 C--O 1.228 -0.229 0 N-CA-C 107.849 -2.1 . . . . 74.109999999999999 107.849 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.273 36.1 p -105.88 1.27 26.63 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.397 -0.811 . . . . 71.310000000000002 112.539 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.6 m -98.13 135.71 39.4 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.926 1.239 . . . . 75.019999999999996 109.207 168.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.43 137.0 45.2 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.824 -1.547 . . . . 74.230000000000004 106.824 162.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -121.37 85.05 2.34 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.356 1.062 . . . . 73.099999999999994 108.688 169.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.8 t -76.77 125.88 36.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.132 -1.062 . . . . 75.219999999999999 108.132 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -80.49 -53.27 6.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.148 0.579 . . . . 73.099999999999994 110.977 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.4 t -128.85 176.35 7.92 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.391 0.996 . . . . 60.009999999999998 112.251 -168.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.18 -175.81 44.89 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 125.622 1.582 . . . . 72.439999999999998 110.819 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.59 -27.9 65.07 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.083 -0.657 . . . . 74.120000000000005 111.583 176.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -101.17 14.26 32.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.983 -0.532 . . . . 72.439999999999998 112.128 -170.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.47 111.09 0.58 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.756 1.222 . . . . 55.5 110.385 172.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.49 -169.35 42.31 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.545 0.593 . . . . 42.229999999999997 113.885 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.9 p -113.8 118.15 33.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.479 1.911 . . . . 74.219999999999999 108.179 -174.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.426 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 47.2 m-85 -127.77 167.45 16.49 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.79 0.723 . . . . 62.210000000000001 112.879 -171.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -125.75 128.94 48.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 129.809 3.244 . . . . 74.0 106.932 -175.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -61.78 152.0 32.56 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.889 -0.782 . . . . 75.439999999999998 108.889 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.566 0 C-N-CA 128.598 2.759 . . . . 60.399999999999999 109.621 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 . . . . . 0 C--O 1.236 0.377 0 CA-C-O 122.789 1.281 . . . . 71.049999999999997 109.145 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -76.11 152.34 36.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.082 -1.417 . . . . 73.540000000000006 110.925 -170.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 p -73.32 173.09 10.03 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.716 0.77 . . . . 61.149999999999999 110.635 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -49.6 133.63 20.67 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.238 -1.346 . . . . 72.049999999999997 109.676 160.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.9 tp -74.92 127.87 34.23 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.054 -1.461 . . . . 73.450000000000003 107.054 156.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -137.24 162.14 34.31 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.165 -1.42 . . . . 52.43 107.165 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -53.68 -48.46 69.47 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.775 1.23 . . . . 53.299999999999997 109.689 -176.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -26.36 61.88 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.748 1.619 . . . . 65.25 111.133 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -68.09 -37.36 81.13 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.949 0.795 . . . . 73.319999999999993 111.002 -174.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.26 -9.72 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.842 0.682 . . . . 74.519999999999996 112.842 -171.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.2 mm -61.65 124.76 16.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.788 1.235 . . . . 72.310000000000002 110.488 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.63 -177.24 27.0 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.58 1.086 . . . . 62.109999999999999 110.556 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -92.89 156.21 17.1 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.432 -0.951 . . . . 74.140000000000001 108.432 163.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -126.6 178.49 5.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.913 2.485 . . . . 63.340000000000003 108.473 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 t -167.72 169.41 11.77 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.012 1.725 . . . . 71.420000000000002 108.601 160.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.55 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 10.0 t -132.36 -1.26 3.57 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.089 1.756 . . . . 74.420000000000002 112.463 172.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.77 -178.17 30.86 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 120.922 -1.111 . . . . 50.100000000000001 110.556 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.8 pt -140.26 13.78 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.44 1.496 . . . . 70.430000000000007 111.146 -166.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -126.75 179.26 5.45 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.01 1.324 . . . . 64.299999999999997 111.518 -168.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 44.79 -93.81 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.693 1.616 . . . . 44.32 114.881 153.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 93.6 m -134.68 127.39 30.99 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.245 -1.391 . . . . 63.229999999999997 107.245 157.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -136.66 -179.77 5.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.21 1.804 . . . . 71.420000000000002 108.813 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -154.0 153.71 32.45 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.132 1.373 . . . . 74.099999999999994 109.008 -171.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.05 124.46 23.4 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.191 1.797 . . . . 73.420000000000002 108.66 -171.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.423 ' CD1' ' HD1' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -114.52 137.94 51.23 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.511 1.524 . . . . 71.120000000000005 109.336 176.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -139.66 134.63 32.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.215 -1.031 . . . . 53.329999999999998 108.215 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -133.12 106.75 7.79 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.919 1.688 . . . . 63.520000000000003 107.352 -170.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -77.03 152.54 35.09 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.231 -1.025 . . . . 71.439999999999998 108.231 169.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.35 -27.67 56.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.471 0.915 . . . . 71.310000000000002 113.471 -174.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -135.2 13.65 3.55 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 122.817 0.447 . . . . 75.299999999999997 111.16 -166.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.36 -112.2 1.57 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.246 1.403 . . . . 52.340000000000003 111.21 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.5 p -139.31 -173.96 3.74 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.555 1.542 . . . . 74.299999999999997 108.006 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.57 176.3 20.45 Favored Glycine 0 C--O 1.239 0.446 0 O-C-N 120.817 -1.177 . . . . 71.400000000000006 111.437 167.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.2 p -136.69 159.06 42.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.088 -0.654 . . . . 72.120000000000005 111.616 -166.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.423 ' HD1' ' CD1' ' A' ' 27' ' ' LEU . 29.1 t80 -134.8 113.14 11.31 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.768 1.227 . . . . 65.109999999999999 108.841 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -124.71 112.6 1.79 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 109.64 -1.384 . . . . 71.540000000000006 109.64 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.3 mt -86.47 144.54 9.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 105.36 -2.089 . . . . 70.420000000000002 105.36 170.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -131.56 158.5 40.8 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.585 1.554 . . . . 64.400000000000006 108.022 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.45 126.77 50.09 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.361 1.464 . . . . 72.140000000000001 107.595 167.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 53.36 -78.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.024 2.529 . . . . 73.439999999999998 113.026 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.35 34.8 0.97 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.723 1.609 . . . . 61.130000000000003 111.871 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.8 m -141.7 131.67 12.73 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 127.345 2.258 . . . . 64.329999999999998 109.301 -170.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.24 132.99 10.59 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.997 3.132 . . . . 61.340000000000003 111.436 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.4 mm -124.48 -21.35 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 112.809 0.67 . . . . 71.140000000000001 112.809 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -150.13 154.24 37.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 120.92 1.691 . . . . 61.130000000000003 108.308 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -160.69 128.88 4.54 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.715 1.206 . . . . 74.409999999999997 108.028 -169.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -162.23 160.02 26.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.179 -1.415 . . . . 74.299999999999997 107.179 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.2 mtm -134.13 154.02 51.46 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.939 0.896 . . . . 71.420000000000002 108.622 173.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -163.56 153.79 15.54 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.757 0.823 . . . . 71.099999999999994 111.117 -176.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -84.6 169.51 14.31 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.951 0.881 . . . . 71.219999999999999 109.868 171.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' HE3' ' A' ' 54' ' ' LYS . 7.2 m-85 -137.37 160.5 38.89 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.371 1.468 . . . . 72.439999999999998 110.53 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 53' ' ' TYR . 9.2 mmpt? -132.96 153.84 51.05 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.751 -1.574 . . . . 63.119999999999997 106.751 154.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.1 mm -108.87 100.06 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 105.739 -1.948 . . . . 73.140000000000001 105.739 170.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.42 23.65 4.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.257 0.551 . . . . 42.119999999999997 112.045 -171.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.27 14.93 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.206 1.802 . . . . 74.010000000000005 113.351 -170.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.4 17.98 71.07 Favored Glycine 0 CA--C 1.535 1.296 0 O-C-N 120.465 -1.397 . . . . 43.450000000000003 110.901 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -144.09 164.42 30.72 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 129.359 3.064 . . . . 71.420000000000002 106.474 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.6 mt -95.48 121.26 45.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.963 -1.495 . . . . 74.340000000000003 106.963 -176.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -87.1 111.56 21.04 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.923 1.289 . . . . 72.540000000000006 107.606 167.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mm -86.14 140.7 15.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.013 -1.847 . . . . 74.5 106.013 167.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -156.51 -5.24 0.11 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 115.794 1.776 . . . . 75.530000000000001 115.794 -176.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -151.55 103.25 2.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.931 -1.137 . . . . 73.420000000000002 107.931 -171.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 t -129.11 141.9 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.019 0.928 . . . . 73.439999999999998 109.692 -167.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.08 163.87 48.0 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 126.126 1.77 . . . . 75.329999999999998 107.271 175.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.37 -17.79 20.14 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 119.096 0.713 . . . . 63.130000000000003 113.479 -4.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -102.2 130.55 48.88 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.137 -1.431 . . . . 72.420000000000002 107.137 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -72.8 145.15 47.21 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 123.601 0.563 . . . . 74.140000000000001 110.41 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -137.54 144.51 42.15 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.708 1.203 . . . . 73.510000000000005 108.734 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.0 t -52.14 148.33 11.52 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 118.202 -0.904 . . . . 72.319999999999993 110.167 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.57 153.78 75.5 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.148 2.565 . . . . 54.200000000000003 111.476 172.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -160.18 164.61 32.73 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.947 1.299 . . . . 70.420000000000002 109.39 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -97.43 158.14 15.63 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.084 -0.71 . . . . 61.329999999999998 109.084 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 mt -134.17 116.9 15.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.849 2.059 . . . . 73.219999999999999 108.516 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -73.51 117.63 15.5 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.761 1.624 . . . . 61.219999999999999 107.577 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.8 161.95 39.61 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.232 -0.918 . . . . 71.310000000000002 109.566 168.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -115.62 161.48 18.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.817 -1.083 . . . . 74.129999999999995 110.08 161.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 tt -147.8 151.83 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.0 -1.111 . . . . 73.230000000000004 108.0 170.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.9 m -128.14 -1.96 5.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.471 1.108 . . . . 73.239999999999995 112.427 171.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.68 -74.68 0.43 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 108.316 -1.914 . . . . 41.43 108.316 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.0 p -93.7 -1.55 55.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.661 0.986 . . . . 65.319999999999993 113.661 -174.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -125.42 134.61 52.05 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.895 1.278 . . . . 70.209999999999994 108.423 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.54 131.67 49.12 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.152 -1.795 . . . . 74.239999999999995 106.152 166.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -120.39 84.38 2.21 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.313 -0.995 . . . . 74.540000000000006 108.313 171.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.3 t -77.4 128.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.362 -0.977 . . . . 64.099999999999994 108.362 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -96.23 -22.41 17.27 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.227 1.195 . . . . 71.340000000000003 114.227 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.8 t -150.21 179.0 8.46 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.311 1.444 . . . . 71.530000000000001 109.651 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.52 -177.96 52.3 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 122.706 1.17 . . . . 71.310000000000002 110.567 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.4 m -63.74 -11.83 29.7 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.155 1.782 . . . . 71.530000000000001 114.085 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -107.97 9.17 28.65 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.528 1.131 . . . . 62.299999999999997 113.18 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.22 105.84 0.23 Allowed 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.126 -1.609 . . . . 74.310000000000002 110.633 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 173.32 -159.29 29.31 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.81 0.719 . . . . 42.439999999999998 113.042 -163.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -133.18 128.91 37.02 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 125.33 1.452 . . . . 72.409999999999997 109.003 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.55 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 16.6 m-85 -134.88 149.38 50.3 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 123.871 0.868 . . . . 61.140000000000001 108.996 -173.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -118.57 151.05 38.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.099 -1.074 . . . . 73.120000000000005 108.099 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -68.62 151.65 46.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.091 -1.077 . . . . 62.420000000000002 108.091 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 123.434 1.588 . . . . 71.400000000000006 106.944 176.68 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 108.786 -0.82 . . . . 64.040000000000006 108.786 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.508 ' CD1' ' HE3' ' A' ' 78' ' ' LYS . 98.1 m95 -126.78 157.16 39.92 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.925 1.69 . . . . 70.400000000000006 110.647 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -82.73 175.24 10.28 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.037 0.835 . . . . 63.140000000000001 110.853 168.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -53.48 156.72 2.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.179 1.392 . . . . 75.040000000000006 110.345 163.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.419 HD21 HG13 ' A' ' 60' ' ' ILE . 7.0 tp -103.58 132.66 49.65 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.738 -1.574 . . . . 75.010000000000005 107.23 162.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.446 ' HA ' HG21 ' A' ' 55' ' ' ILE . 23.0 p30 -143.61 -175.3 4.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 127.323 2.249 . . . . 74.310000000000002 108.577 -175.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 p -78.65 9.29 4.22 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.431 1.092 . . . . 61.340000000000003 113.673 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -130.38 -40.28 1.28 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.56 1.527 . . . . 34.439999999999998 112.184 -162.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -72.3 -31.65 65.9 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.948 1.299 . . . . 54.43 110.272 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.9 tp -75.76 -24.83 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.836 1.198 . . . . 73.200000000000003 111.864 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.6 mm -55.74 97.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 127.835 2.454 . . . . 74.239999999999995 111.974 -174.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.65 179.91 44.62 Favored Glycine 0 N--CA 1.445 -0.731 0 O-C-N 122.27 -0.269 . . . . 52.420000000000002 113.085 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -100.0 148.68 24.26 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.53 1.932 . . . . 75.140000000000001 108.531 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -146.55 135.34 22.29 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.753 0.821 . . . . 72.540000000000006 110.036 -171.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -140.44 170.9 14.93 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.941 -1.099 . . . . 74.540000000000006 108.841 166.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.409 ' HB ' ' CD1' ' A' ' 95' ' ' TYR . 14.5 t -118.8 -18.04 9.01 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.469 1.108 . . . . 61.509999999999998 111.559 -176.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.84 -168.15 38.14 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 107.501 -2.24 . . . . 53.039999999999999 107.501 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.5 pt -139.98 -5.52 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.018 0.927 . . . . 72.129999999999995 112.742 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -93.21 173.59 7.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 120.077 1.308 . . . . 74.209999999999994 110.746 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.433 ' H ' ' ND2' ' A' ' 42' ' ' ASN . . . 53.33 -94.56 0.01 OUTLIER Glycine 0 C--N 1.338 0.676 0 C-N-CA 126.528 2.014 . . . . 51.119999999999997 113.268 155.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.67 133.2 39.79 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.925 -1.139 . . . . 63.119999999999997 107.925 164.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -143.42 179.76 6.91 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.99 1.716 . . . . 75.439999999999998 107.67 174.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -143.28 133.5 24.49 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.962 -1.125 . . . . 62.509999999999998 107.962 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.8 155.17 18.98 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.996 1.718 . . . . 75.530000000000001 107.923 171.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 mt -145.9 141.81 28.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.552 -2.018 . . . . 75.140000000000001 105.552 164.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.0 m -138.24 147.83 44.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.156 -1.053 . . . . 74.439999999999998 108.156 173.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -141.85 121.31 13.23 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.087 1.755 . . . . 74.420000000000002 107.84 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -96.88 157.98 15.64 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.833 0.853 . . . . 74.409999999999997 109.579 167.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -78.87 -33.05 46.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.729 -0.669 . . . . 75.510000000000005 111.723 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -119.61 5.18 11.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.788 0.435 . . . . 71.319999999999993 111.4 -163.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.08 -111.09 0.95 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 125.448 1.499 . . . . 32.130000000000003 110.544 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.0 p -137.25 178.64 6.93 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.477 1.911 . . . . 72.310000000000002 108.797 -163.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -133.97 -174.78 13.63 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.493 -1.043 . . . . 73.310000000000002 110.493 164.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 t -148.28 160.02 43.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.609 -0.886 . . . . 62.299999999999997 108.609 -168.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -140.7 137.71 33.7 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.252 2.221 . . . . 64.420000000000002 105.695 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.53 147.35 16.66 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.402 -1.079 . . . . 35.140000000000001 110.402 166.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.1 mt -97.45 140.33 17.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 105.783 -1.932 . . . . 53.310000000000002 105.783 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -133.92 133.34 41.32 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.577 0.703 . . . . 75.510000000000005 109.867 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.715 ' N ' HD11 ' A' ' 46' ' ' ILE . 24.2 t -79.75 -172.58 3.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.108 2.163 . . . . 51.020000000000003 108.439 169.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 22' ' ' GLY . 4.6 m120 -44.68 -42.47 7.59 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 126.689 1.996 . . . . 60.310000000000002 113.422 -172.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -159.74 49.32 0.3 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.097 -0.705 . . . . 75.129999999999995 109.097 162.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.7 m -146.92 136.07 11.44 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.517 -0.754 . . . . 75.519999999999996 109.268 -173.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.56 142.27 18.23 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 124.295 3.33 . . . . 72.340000000000003 113.147 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.715 HD11 ' N ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -136.3 -8.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 114.137 1.162 . . . . 62.329999999999998 114.137 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.04 145.53 15.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.021 -1.675 . . . . 72.340000000000003 107.751 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -159.2 129.28 5.7 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.022 -1.473 . . . . 75.109999999999999 107.022 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -153.77 167.69 28.8 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.129 1.372 . . . . 74.310000000000002 108.436 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.9 mtm -135.13 158.34 44.6 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 123.479 0.712 . . . . 74.200000000000003 109.93 165.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -155.1 160.05 40.69 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.235 -0.893 . . . . 72.340000000000003 108.909 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.14 164.05 15.18 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.304 -1.369 . . . . 74.420000000000002 107.304 168.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -136.27 165.66 25.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.962 -0.563 . . . . 64.340000000000003 109.758 170.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -131.37 159.2 38.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.024 -0.732 . . . . 72.040000000000006 109.024 158.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.446 HG21 ' HA ' ' A' ' 8' ' ' ASN . 16.3 mm -118.38 89.55 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 104.522 -2.399 . . . . 71.420000000000002 104.522 171.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -118.95 23.48 11.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.907 1.283 . . . . 62.020000000000003 111.474 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.33 21.59 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.339 1.456 . . . . 72.120000000000005 113.317 -173.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.95 22.65 70.58 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 120.554 -1.341 . . . . 63.32 112.082 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -148.44 163.0 38.45 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 127.374 2.269 . . . . 74.400000000000006 107.02 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.419 HG13 HD21 ' A' ' 7' ' ' LEU . 71.0 mt -87.92 130.33 37.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.924 -1.51 . . . . 61.409999999999997 106.924 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -108.56 107.54 18.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.198 1.399 . . . . 75.430000000000007 108.829 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 mm -78.67 138.9 19.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.655 -1.609 . . . . 63.229999999999997 106.655 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -158.25 -5.43 0.08 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 116.375 1.991 . . . . 75.019999999999996 116.375 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -150.78 110.06 3.96 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 103.959 -2.608 . . . . 73.019999999999996 103.959 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.4 t -128.74 141.9 45.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.137 -1.06 . . . . 72.230000000000004 108.137 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.41 164.29 45.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.172 1.389 . . . . 72.549999999999997 107.806 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -75.62 -7.87 25.45 Favored 'Cis proline' 0 CA--C 1.538 0.697 0 CA-C-N 119.259 0.771 . . . . 73.109999999999999 112.325 -11.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.1 109.63 20.23 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.183 0.993 . . . . 74.519999999999996 110.548 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.55 128.63 36.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 122.488 1.137 . . . . 64.049999999999997 110.365 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -107.92 177.79 4.71 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.684 1.594 . . . . 73.150000000000006 109.509 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -76.66 149.14 80.59 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.842 -0.799 . . . . 72.150000000000006 108.842 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.75 149.53 83.58 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.347 2.031 . . . . 52.420000000000002 111.037 171.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -168.39 167.35 11.96 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.072 0.949 . . . . 75.040000000000006 110.248 172.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -98.29 156.94 16.47 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.134 0.574 . . . . 54.340000000000003 109.849 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.69 128.9 35.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.7 2.0 . . . . 75.299999999999997 107.824 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.494 ' H ' ' CG2' ' A' ' 88' ' ' THR . 5.1 m-20 -84.68 129.63 34.81 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.037 -1.838 . . . . 74.019999999999996 106.037 174.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.42 150.47 23.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.371 1.868 . . . . 64.430000000000007 107.558 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.508 ' HE3' ' CD1' ' A' ' 4' ' ' TRP . 23.6 mtmt -128.55 145.46 51.12 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.069 -1.456 . . . . 75.019999999999996 107.069 -171.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.3 tt -143.93 152.4 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.02 -1.474 . . . . 74.099999999999994 107.02 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.9 t -128.64 -61.92 1.04 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.54 -1.282 . . . . 61.439999999999998 107.54 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.7 -102.0 0.27 Allowed Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 106.384 -2.686 . . . . 55.32 106.384 166.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.3 p -79.4 10.92 3.3 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.431 1.271 . . . . 75.340000000000003 114.431 -173.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.8 m -118.76 127.62 53.72 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 121.084 1.765 . . . . 72.209999999999994 109.7 171.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.15 125.64 41.79 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.085 1.354 . . . . 62.100000000000001 107.383 165.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.5 tttm -111.88 87.94 2.68 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.082 0.953 . . . . 74.439999999999998 109.065 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.9 t -72.03 134.5 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.777 -1.194 . . . . 64.310000000000002 107.777 174.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -97.11 -37.94 9.93 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.577 0.751 . . . . 62.420000000000002 110.292 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.494 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.0 t -137.7 161.41 36.59 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.054 1.741 . . . . 73.239999999999995 110.004 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.38 179.08 19.37 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.284 1.421 . . . . 72.430000000000007 112.639 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.8 m -57.24 -24.02 51.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.36 0.664 . . . . 63.32 111.444 166.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -100.83 5.04 43.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.399 1.88 . . . . 72.019999999999996 111.545 -169.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.1 103.53 0.15 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.438 1.495 . . . . 74.230000000000004 111.235 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.25 -164.74 33.1 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 123.793 0.711 . . . . 60.32 112.64 -169.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 54.3 p -130.08 120.61 24.93 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.512 1.125 . . . . 74.209999999999994 109.589 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.409 ' CD1' ' HB ' ' A' ' 18' ' ' THR . 48.3 m-85 -127.74 152.09 48.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.715 0.806 . . . . 55.140000000000001 109.226 -170.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -111.37 140.86 45.59 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.3 1.04 . . . . 75.200000000000003 108.458 175.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -66.59 125.87 27.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.772 -1.196 . . . . 75.340000000000003 107.772 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--N 1.325 -0.474 0 C-N-CA 124.833 1.253 . . . . 72.209999999999994 107.827 179.819 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 CA--C 1.512 -0.498 0 N-CA-C 105.645 -1.983 . . . . 72.450000000000003 105.645 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -125.61 150.33 47.63 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.798 1.639 . . . . 64.549999999999997 109.733 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -72.07 171.86 11.15 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.469 0.652 . . . . 71.140000000000001 110.219 170.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -51.79 130.97 30.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.244 -0.889 . . . . 75.450000000000003 108.75 158.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.46 HD22 HD12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -64.14 124.56 21.98 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.898 -1.149 . . . . 72.230000000000004 107.898 151.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -137.65 171.08 14.98 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 118.772 -1.171 . . . . 63.520000000000003 111.358 160.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p -69.08 36.02 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.142 2.577 . . . . 74.239999999999995 112.387 172.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -137.78 -58.18 0.67 Allowed 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 125.051 1.34 . . . . 63.149999999999999 109.006 -170.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -77.03 -21.53 54.4 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 118.563 -0.732 . . . . 73.239999999999995 112.107 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.7 -19.02 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.43 1.092 . . . . 75.439999999999998 113.57 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.3 mm -65.67 118.85 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.449 -0.945 . . . . 73.510000000000005 108.449 -171.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.75 173.69 23.88 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.336 0.97 . . . . 73.209999999999994 111.544 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -80.46 156.39 26.61 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.803 -1.184 . . . . 71.109999999999999 107.803 162.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -141.67 135.12 29.59 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.737 -0.602 . . . . 75.510000000000005 109.689 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -137.76 150.66 47.44 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.956 1.703 . . . . 74.129999999999995 109.627 -167.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.522 HG23 ' CE2' ' A' ' 95' ' ' TYR . 31.0 p -89.84 -77.16 0.4 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.933 -1.506 . . . . 75.310000000000002 106.933 161.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.87 -168.48 14.23 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 126.682 2.087 . . . . 75.439999999999998 109.879 -177.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.0 pt -118.21 20.37 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.397 1.479 . . . . 73.420000000000002 110.792 -171.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -137.15 157.34 46.9 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.376 1.87 . . . . 63.130000000000003 108.478 -168.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.31 -172.09 7.69 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 121.633 0.574 . . . . 53.310000000000002 113.586 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.3 m -79.76 90.2 5.23 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.458 -1.312 . . . . 52.130000000000003 107.458 175.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.1 p-80 -110.54 -179.48 3.77 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.498 1.519 . . . . 53.340000000000003 110.371 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -140.89 157.6 45.14 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.073 1.349 . . . . 73.349999999999994 110.271 -169.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.95 140.94 32.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.702 1.601 . . . . 60.25 107.993 -173.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -123.87 169.48 11.54 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.981 0.913 . . . . 72.209999999999994 109.689 168.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.0 t -140.29 160.48 39.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.806 -1.553 . . . . 64.549999999999997 106.806 158.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -147.81 121.63 9.31 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.682 1.993 . . . . 63.329999999999998 106.271 168.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -95.33 156.23 16.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.829 0.851 . . . . 73.109999999999999 109.048 172.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.48 -23.96 37.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 61.109999999999999 111.957 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -133.16 10.68 4.18 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.046 0.758 . . . . 73.340000000000003 113.046 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.44 -119.98 3.92 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.588 -1.405 . . . . 21.41 109.588 173.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 p -141.33 -169.9 2.96 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.831 2.452 . . . . 74.129999999999995 106.505 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.6 179.05 19.21 Favored Glycine 0 CA--C 1.522 0.49 0 O-C-N 120.936 -1.102 . . . . 73.420000000000002 110.905 167.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -136.47 165.32 26.1 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.57 1.548 . . . . 73.109999999999999 109.284 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -152.44 109.62 3.54 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.551 1.541 . . . . 74.109999999999999 109.813 171.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.99 147.48 16.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.232 -1.147 . . . . 64.530000000000001 110.232 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.6 mt -119.87 139.85 45.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 105.828 -1.916 . . . . 65.129999999999995 105.828 169.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -122.41 165.82 15.71 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.942 1.297 . . . . 75.420000000000002 109.449 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 m -131.22 112.98 13.29 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.482 1.913 . . . . 73.200000000000003 106.869 160.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 m120 55.24 -73.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 130.161 3.384 . . . . 73.010000000000005 113.892 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.24 44.24 1.54 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.95 1.3 . . . . 54.229999999999997 109.649 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.5 m -150.17 123.01 4.27 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 107.758 -1.201 . . . . 55.439999999999998 107.758 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.6 137.73 36.65 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.342 2.028 . . . . 60.399999999999999 108.967 167.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.3 mm -126.35 -25.42 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.442 1.097 . . . . 74.329999999999998 110.791 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.5 t -141.12 157.85 44.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 120.63 -1.294 . . . . 63.130000000000003 109.194 169.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -151.0 135.84 17.32 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 129.166 2.987 . . . . 74.319999999999993 105.139 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.58 163.19 40.09 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.454 -2.054 . . . . 53.149999999999999 105.454 165.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.9 mtm -130.28 167.98 17.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.431 -0.952 . . . . 74.519999999999996 108.431 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -160.6 148.85 16.35 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.585 0.754 . . . . 63.539999999999999 109.132 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.67 163.9 20.45 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.953 -1.129 . . . . 72.140000000000001 107.953 163.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -150.88 161.84 41.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.889 -0.507 . . . . 74.319999999999993 109.935 172.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -129.32 159.48 36.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.072 -1.084 . . . . 74.140000000000001 108.072 156.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.46 HD12 HD22 ' A' ' 7' ' ' LEU . 25.3 mm -105.02 102.43 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 103.638 -2.727 . . . . 73.450000000000003 103.638 162.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.94 27.22 2.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.093 0.949 . . . . 73.129999999999995 109.655 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.52 15.1 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 114.206 1.187 . . . . 70.409999999999997 114.206 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.93 23.72 66.01 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.564 -1.415 . . . . 73.510000000000005 109.564 -168.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -149.56 163.06 38.89 Favored 'General case' 0 N--CA 1.445 -0.712 1 C-N-CA 132.143 4.177 . . . . 73.530000000000001 103.843 -171.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.23 155.23 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.635 -1.617 . . . . 73.349999999999994 106.635 172.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -124.12 124.36 42.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.649 2.379 . . . . 61.450000000000003 106.911 164.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 mm -114.04 137.17 48.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.541 1.936 . . . . 63.350000000000001 106.458 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -160.08 6.96 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.281 1.215 . . . . 72.230000000000004 114.281 -172.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -151.96 123.81 8.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.17 -2.53 . . . . 71.109999999999999 104.17 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.3 t -132.57 144.81 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.943 -1.503 . . . . 74.109999999999999 106.943 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.21 159.95 68.9 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 108.165 -1.05 . . . . 73.510000000000005 108.165 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.58 -7.5 47.5 Favored 'Cis proline' 0 CA--C 1.534 0.485 0 N-CA-C 113.815 0.66 . . . . 74.329999999999998 113.815 -3.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -116.71 120.66 39.28 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.318 -1.734 . . . . 52.229999999999997 106.318 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -76.57 124.47 27.66 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.633 1.173 . . . . 71.430000000000007 108.686 -174.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 mttm -97.5 166.04 11.71 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.581 -0.896 . . . . 72.239999999999995 108.581 169.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.82 149.88 15.67 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.577 1.151 . . . . 50.32 109.315 171.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -68.9 142.84 53.01 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.217 1.944 . . . . 73.519999999999996 110.499 169.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -150.79 165.39 33.68 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 120.898 -1.126 . . . . 53.240000000000002 109.864 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -99.61 159.06 15.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.668 -0.864 . . . . 74.109999999999999 108.668 167.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.1 mt -131.54 118.9 20.76 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.373 1.069 . . . . 64.319999999999993 109.272 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -59.67 112.35 1.78 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.109 -1.441 . . . . 64.519999999999996 107.109 167.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.2 168.63 19.29 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 107.042 -1.466 . . . . 75.310000000000002 107.042 166.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.38 170.54 15.58 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.838 1.255 . . . . 73.109999999999999 111.49 163.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 tt -154.4 147.98 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 123.478 0.711 . . . . 75.409999999999997 109.303 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 m -151.39 48.81 0.82 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 129.473 3.109 . . . . 73.25 110.412 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.68 -66.9 3.32 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 126.207 1.86 . . . . 61.509999999999998 112.19 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -124.7 2.57 8.21 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.82 1.415 . . . . 75.340000000000003 114.82 -168.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 m -118.9 100.88 7.65 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.698 1.599 . . . . 63.530000000000001 107.806 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.3 tp -77.52 125.15 28.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.933 -1.506 . . . . 75.519999999999996 106.933 166.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -119.06 92.64 3.85 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 123.988 0.915 . . . . 72.430000000000007 108.973 177.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.78 137.35 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.669 -1.234 . . . . 75.349999999999994 107.669 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -100.58 -14.68 18.09 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.209 1.188 . . . . 75.319999999999993 114.209 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.1 t -151.6 163.87 38.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.429 1.013 . . . . 70.549999999999997 112.525 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.79 -175.79 53.28 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-O 122.832 1.24 . . . . 51.149999999999999 110.314 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.3 m -49.22 -27.62 3.85 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.802 1.641 . . . . 71.230000000000004 113.362 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -95.83 2.06 53.52 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.191 1.182 . . . . 62.25 114.191 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.68 105.17 0.14 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.347 1.059 . . . . 61.229999999999997 111.211 -173.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 173.47 -138.54 4.65 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.91 0.767 . . . . 72.349999999999994 112.62 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.8 t -150.5 132.14 14.89 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.416 1.486 . . . . 74.329999999999998 107.934 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.522 ' CE2' HG23 ' A' ' 18' ' ' THR . 36.7 m-85 -134.36 134.22 41.51 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 123.721 0.808 . . . . 73.540000000000006 109.323 -176.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -75.98 153.93 36.19 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.428 -0.953 . . . . 72.109999999999999 108.428 167.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -69.84 154.97 41.25 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.555 -0.905 . . . . 73.310000000000002 108.555 168.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 . . . . . 0 C--N 1.327 -0.386 0 C-N-CA 126.224 1.81 . . . . 74.510000000000005 107.461 163.819 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 . . . . . 0 N--CA 1.443 -0.789 0 N-CA-C 105.546 -2.02 . . . . 75.129999999999995 105.546 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -114.55 155.17 26.96 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 126.447 1.899 . . . . 75.099999999999994 110.778 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 p -72.27 175.64 5.93 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.35 -0.611 . . . . 64.420000000000002 109.35 164.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -56.92 150.23 17.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.337 1.065 . . . . 73.439999999999998 110.114 155.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.1 tp -84.76 129.23 34.85 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 125.722 1.609 . . . . 75.430000000000007 107.159 155.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -135.44 166.23 23.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.363 -1.347 . . . . 74.319999999999993 107.363 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 t -67.29 -2.61 6.24 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.574 1.15 . . . . 61.149999999999999 112.788 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -108.01 -36.8 6.24 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.131 -0.981 . . . . 73.329999999999998 109.436 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.82 -23.92 66.54 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.39 1.076 . . . . 74.209999999999994 112.895 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.3 tp -90.12 -16.1 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.0 1.32 . . . . 72.129999999999995 113.101 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.3 mm -69.75 130.5 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.952 1.301 . . . . 62.130000000000003 110.983 -163.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.34 -175.24 20.82 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.783 1.658 . . . . 63.509999999999998 110.324 175.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -82.17 169.97 16.0 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.403 -0.962 . . . . 73.329999999999998 108.403 167.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -132.58 -175.86 3.9 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.556 -1.276 . . . . 74.200000000000003 107.556 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 t -169.05 167.04 10.81 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.722 1.601 . . . . 75.209999999999994 109.745 162.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.518 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 2.3 t -136.98 -19.43 1.3 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.506 1.122 . . . . 60.229999999999997 112.799 -177.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.78 171.27 38.77 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.666 -1.774 . . . . 60.119999999999997 108.666 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.81 19.11 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.972 1.309 . . . . 55.340000000000003 110.578 -169.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.76 -179.65 6.59 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 127.195 2.198 . . . . 64.310000000000002 108.33 -174.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.02 -117.58 6.94 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.108 0.861 . . . . 74.019999999999996 111.964 170.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.2 m -132.13 98.95 4.56 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.664 -1.235 . . . . 63.329999999999998 107.664 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -114.56 171.11 7.83 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.471 1.108 . . . . 73.140000000000001 110.21 -175.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -138.92 136.05 35.07 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.854 -1.165 . . . . 74.439999999999998 107.854 -165.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.51 96.17 4.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.028 1.331 . . . . 75.25 109.392 -171.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.0 mt -77.89 153.24 32.8 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.633 1.573 . . . . 72.439999999999998 110.811 164.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.0 p -141.16 158.77 43.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.871 1.268 . . . . 75.549999999999997 109.267 162.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -141.12 124.65 16.75 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.015 1.326 . . . . 75.450000000000003 108.415 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.5 159.91 16.26 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.206 1.402 . . . . 52.409999999999997 107.746 170.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -83.96 -32.95 24.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.802 0.841 . . . . 73.329999999999998 112.239 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -138.87 30.32 2.27 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.641 1.176 . . . . 63.240000000000002 109.836 -172.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -127.86 -110.92 1.61 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.448 -1.461 . . . . 71.549999999999997 109.448 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.2 p -146.01 -170.66 3.53 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.049 2.14 . . . . 72.140000000000001 107.361 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.0 167.92 12.93 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.846 -1.302 . . . . 32.030000000000001 109.846 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -144.29 155.86 44.01 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.826 -0.808 . . . . 54.43 110.199 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -139.93 120.48 14.17 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.164 1.385 . . . . 60.049999999999997 107.764 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.85 157.18 15.13 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.752 -1.339 . . . . 71.049999999999997 109.752 168.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.3 mt -122.28 146.59 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 105.835 -1.913 . . . . 40.350000000000001 105.835 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -134.82 144.68 47.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.227 1.411 . . . . 72.310000000000002 108.449 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.9 125.87 48.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.192 -2.151 . . . . 71.340000000000003 105.192 158.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.2 m120 62.86 -83.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.582 1.553 . . . . 72.019999999999996 112.977 160.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.4 59.98 0.96 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.642 1.177 . . . . 74.030000000000001 108.651 163.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.0 m -144.89 130.19 9.36 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 127.137 2.175 . . . . 75.129999999999995 106.316 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.94 141.48 48.76 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.452 2.101 . . . . 72.010000000000005 109.651 167.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.3 mm -131.73 -22.26 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.763 1.225 . . . . 62.109999999999999 110.998 -174.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.9 t -143.47 167.66 21.67 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.576 -1.328 . . . . 72.409999999999997 110.251 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -160.09 146.88 16.03 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.551 1.94 . . . . 75.340000000000003 108.726 -175.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -159.05 164.05 35.78 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.386 1.874 . . . . 74.319999999999993 107.573 163.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.5 mtm -121.18 156.84 31.52 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.744 1.618 . . . . 53.450000000000003 107.149 162.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -161.3 138.01 8.53 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.141 0.976 . . . . 63.109999999999999 109.711 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -75.11 163.24 27.77 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.705 0.764 . . . . 72.329999999999998 109.262 166.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -153.08 158.15 41.49 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.799 0.84 . . . . 75.040000000000006 111.064 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -137.06 158.28 44.81 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.562 -0.711 . . . . 72.439999999999998 110.485 169.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.5 mm -111.14 90.85 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 106.81 -1.552 . . . . 55.530000000000001 106.81 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -121.5 22.86 10.55 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.381 1.252 . . . . 62.32 114.381 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -174.9 14.98 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 116.341 1.978 . . . . 64.049999999999997 116.341 -173.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.27 16.23 77.06 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 119.475 -2.016 . . . . 31.140000000000001 114.39 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -130.69 -170.7 2.39 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.796 2.038 . . . . 71.040000000000006 108.269 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.4 mt -113.2 106.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.802 1.637 . . . . 74.310000000000002 107.263 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -72.12 124.13 24.33 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.539 -1.282 . . . . 73.430000000000007 107.539 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.8 mm -111.15 139.07 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.406 -2.072 . . . . 62.240000000000002 105.406 170.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -157.49 8.57 0.17 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.954 0.902 . . . . 75.340000000000003 112.306 -175.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -152.6 118.9 5.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 103.18 -2.896 . . . . 75.439999999999998 103.18 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -135.65 152.23 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.223 -2.14 . . . . 64.150000000000006 105.223 169.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.05 161.64 54.61 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 125.34 1.456 . . . . 73.150000000000006 107.583 173.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -81.86 -6.81 46.39 Favored 'Cis proline' 0 CA--C 1.54 0.789 0 N-CA-C 114.319 0.854 . . . . 71.209999999999994 114.319 -6.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.92 104.78 14.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 104.731 -2.322 . . . . 63.420000000000002 104.731 168.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -64.01 155.2 31.86 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.814 0.696 . . . . 62.340000000000003 110.495 170.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -129.67 162.29 28.67 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.109 1.364 . . . . 73.049999999999997 107.854 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 t -54.92 149.26 24.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 109.072 -0.714 . . . . 61.329999999999998 109.072 171.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.12 147.19 53.7 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.241 1.961 . . . . 61.340000000000003 110.992 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -156.52 174.05 16.01 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.825 1.25 . . . . 71.150000000000006 109.755 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -117.05 131.08 57.02 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.811 -1.181 . . . . 74.450000000000003 107.811 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.416 HD22 ' HA3' ' A' ' 89' ' ' GLY . 45.5 mt -101.06 116.4 32.75 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.649 1.179 . . . . 72.120000000000005 108.578 176.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.9 116.28 5.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.844 1.258 . . . . 72.049999999999997 108.045 172.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.1 p -139.42 156.77 46.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.757 0.789 . . . . 71.299999999999997 110.045 161.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -116.28 159.34 22.01 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.279 -1.328 . . . . 60.100000000000001 108.964 168.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 tt -152.89 154.35 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.671 -1.603 . . . . 55.240000000000002 106.671 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.8 p -133.37 -11.22 2.83 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.836 1.421 . . . . 62.0 114.836 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.32 -91.17 0.15 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 107.098 -2.401 . . . . 74.430000000000007 107.098 -165.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.5 p -106.7 -0.42 23.62 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.454 1.65 . . . . 64.040000000000006 115.454 -167.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.6 m -114.16 109.93 19.18 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.568 1.947 . . . . 74.310000000000002 109.878 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.493 HD22 HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -75.89 136.1 40.12 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 119.837 -1.789 . . . . 64.209999999999994 107.39 167.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -119.2 88.63 2.97 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.602 -0.518 . . . . 60.229999999999997 109.602 162.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.493 HG23 HD22 ' A' ' 84' ' ' LEU . 25.0 t -81.5 133.03 30.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.859 -0.793 . . . . 54.329999999999998 108.859 170.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -106.43 -18.59 13.94 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.708 1.203 . . . . 74.230000000000004 112.872 -171.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.4 t -155.75 171.66 19.64 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.244 1.417 . . . . 64.010000000000005 109.298 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.416 ' HA3' HD22 ' A' ' 75' ' ' LEU . . . 92.81 178.28 40.78 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 122.836 1.242 . . . . 61.109999999999999 110.378 -173.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.1 m -59.55 -21.37 60.18 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 113.706 1.002 . . . . 74.430000000000007 113.706 174.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -109.96 19.48 18.99 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.342 1.608 . . . . 73.109999999999999 115.342 -176.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.14 109.24 0.56 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.171 0.988 . . . . 62.140000000000001 111.484 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.83 -156.15 26.7 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.184 1.374 . . . . 53.409999999999997 112.912 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -119.81 125.48 48.67 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.979 1.312 . . . . 62.140000000000001 110.158 -173.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.518 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 6.1 m-85 -133.3 152.23 51.92 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.003 0.43 . . . . 73.319999999999993 110.848 -174.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -103.53 138.3 40.41 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.352 1.461 . . . . 71.219999999999999 107.473 172.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -52.78 149.23 6.43 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.295 0.952 . . . . 74.239999999999995 109.408 166.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 . . . . . 0 C--O 1.237 0.415 0 C-N-CA 126.52 1.928 . . . . 64.310000000000002 108.208 169.612 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 . . . . . 0 CA--C 1.511 -0.549 0 N-CA-C 106.172 -1.788 . . . . 75.099999999999994 106.172 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.416 ' CG ' ' HB3' ' A' ' 78' ' ' LYS . 93.4 m95 -106.51 -174.09 2.45 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.755 2.022 . . . . 73.200000000000003 111.592 -173.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.7 p -110.4 160.67 16.37 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.597 0.759 . . . . 74.530000000000001 110.126 168.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.56 127.16 26.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.11 2.164 . . . . 73.430000000000007 109.288 173.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 tp -79.7 92.04 5.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.893 -1.151 . . . . 73.219999999999999 107.893 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -94.56 164.36 13.01 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 125.33 1.452 . . . . 65.209999999999994 107.581 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.45 -45.89 73.19 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.241 1.016 . . . . 74.120000000000005 109.873 172.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -76.51 -19.35 58.07 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 119.454 -0.898 . . . . 63.310000000000002 112.425 -170.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.2 -40.5 62.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.914 -0.491 . . . . 71.299999999999997 111.003 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.1 tp -76.61 -13.32 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 120.91 -1.119 . . . . 74.409999999999997 113.695 -170.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 mm -52.28 136.0 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.032 1.333 . . . . 72.530000000000001 112.655 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.58 178.85 15.66 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 125.855 1.693 . . . . 72.239999999999995 110.739 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -84.87 167.06 16.33 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.405 -0.961 . . . . 73.299999999999997 108.405 165.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -147.41 139.86 24.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.417 -1.327 . . . . 73.530000000000001 107.417 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 t -141.71 170.09 16.37 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.569 -1.332 . . . . 71.200000000000003 110.203 166.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.3 t -132.71 0.43 3.57 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.462 2.305 . . . . 75.329999999999998 111.546 -173.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.93 179.28 38.12 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.175 -1.17 . . . . 60.219999999999999 110.175 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.2 pt -130.8 22.87 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.711 1.604 . . . . 35.509999999999998 109.571 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -142.53 -175.88 4.64 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.328 1.451 . . . . 74.239999999999995 109.654 -169.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.84 -119.38 16.08 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.534 -1.026 . . . . 55.340000000000003 110.534 156.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -131.79 101.69 5.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.979 -1.86 . . . . 73.019999999999996 105.979 161.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -114.34 172.5 6.97 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.641 0.734 . . . . 74.409999999999997 109.061 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -143.14 144.58 32.27 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.418 -0.956 . . . . 74.420000000000002 108.418 -160.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.84 103.13 5.93 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 122.994 0.518 . . . . 72.230000000000004 109.671 -167.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.5 mt -94.64 154.45 17.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.467 1.107 . . . . 71.549999999999997 110.068 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 p -146.12 125.16 12.82 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.425 1.09 . . . . 70.450000000000003 109.769 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -124.03 114.96 20.43 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 120.166 1.348 . . . . 72.120000000000005 109.793 -174.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -92.42 152.76 19.54 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 124.151 0.907 . . . . 73.299999999999997 110.033 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -81.26 -20.48 40.85 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 114.268 1.21 . . . . 73.109999999999999 114.268 -174.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -133.48 1.11 3.39 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.328 0.513 . . . . 74.219999999999999 112.245 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.83 -123.17 5.2 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.435 -1.466 . . . . 43.149999999999999 109.435 173.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.3 p -134.74 -171.1 2.7 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.858 1.663 . . . . 63.210000000000001 108.542 -164.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.37 165.65 12.15 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.99 -0.844 . . . . 64.129999999999995 110.99 165.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -142.56 166.38 24.82 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.846 0.859 . . . . 45.030000000000001 110.832 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -146.99 133.0 19.18 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.492 -1.299 . . . . 73.519999999999996 107.492 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.45 161.62 24.48 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.184 -1.167 . . . . 52.219999999999999 110.184 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.3 mt -131.94 121.51 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.109 -1.811 . . . . 71.239999999999995 106.109 -174.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -118.49 132.53 56.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.72 1.208 . . . . 71.109999999999999 109.016 -171.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 m -97.68 119.24 35.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.554 -1.276 . . . . 73.129999999999995 107.554 166.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 46.77 -85.2 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 127.844 2.457 . . . . 75.219999999999999 113.72 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.51 56.68 1.65 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.827 1.251 . . . . 72.040000000000006 109.402 170.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 m -143.58 122.57 7.32 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.154 1.782 . . . . 72.439999999999998 107.84 171.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.44 137.6 36.77 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.842 2.362 . . . . 73.129999999999995 109.847 165.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.0 mm -128.17 -15.27 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.187 0.995 . . . . 71.329999999999998 111.164 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.4 t -135.56 167.41 21.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 119.775 -1.828 . . . . 71.239999999999995 110.059 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -163.47 147.27 10.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.303 -0.862 . . . . 74.420000000000002 108.921 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -167.99 165.96 13.41 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.444 1.498 . . . . 63.149999999999999 108.311 166.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.3 mtm -133.48 161.29 34.97 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.089 1.356 . . . . 72.230000000000004 108.048 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -162.6 140.11 8.17 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.992 1.317 . . . . 71.319999999999993 109.155 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.42 161.81 26.8 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.271 -1.011 . . . . 74.340000000000003 108.271 163.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -144.14 164.56 30.33 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.669 -0.644 . . . . 74.530000000000001 109.344 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -136.7 156.42 48.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.806 -0.813 . . . . 74.120000000000005 108.806 166.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.0 mm -107.04 99.81 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 106.173 -1.788 . . . . 71.530000000000001 106.173 168.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.2 28.52 3.75 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.885 0.874 . . . . 61.43 112.353 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -163.14 14.01 0.07 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.003 1.721 . . . . 74.329999999999998 115.129 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.49 21.03 47.92 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.254 -1.529 . . . . 74.540000000000006 113.111 -168.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -132.69 -168.45 2.07 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.86 2.864 . . . . 74.439999999999998 106.875 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.7 mt -118.32 110.89 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.897 -1.52 . . . . 72.319999999999993 106.897 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -80.78 120.24 24.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.332 -1.359 . . . . 70.530000000000001 107.332 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.0 mm -108.02 135.0 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 105.356 -2.09 . . . . 71.140000000000001 105.356 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -154.06 8.29 0.35 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.809 0.843 . . . . 64.219999999999999 112.494 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -151.6 121.08 6.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 104.168 -2.53 . . . . 61.109999999999999 104.168 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.5 t -136.26 149.91 27.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.051 -1.833 . . . . 52.25 106.051 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.99 160.29 53.32 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.6 1.56 . . . . 72.530000000000001 108.04 177.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.78 -13.66 27.89 Favored 'Cis proline' 0 CA--C 1.535 0.555 0 CA-C-N 119.539 0.871 . . . . 71.140000000000001 113.802 -10.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.76 103.1 15.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 104.022 -2.584 . . . . 50.520000000000003 104.022 171.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -66.82 160.07 26.75 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.307 -0.627 . . . . 73.219999999999999 109.307 167.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -137.9 174.7 10.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.118 1.367 . . . . 74.430000000000007 108.315 168.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.5 t -51.32 150.76 5.86 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 108.861 -0.792 . . . . 71.349999999999994 108.861 168.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -65.2 153.23 79.27 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.077 1.851 . . . . 74.25 109.333 163.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -159.3 172.07 18.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.555 1.542 . . . . 74.430000000000007 109.008 175.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -114.15 146.01 40.89 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.846 -1.168 . . . . 53.109999999999999 107.846 172.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.3 mt -123.9 115.98 22.16 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.769 1.228 . . . . 73.409999999999997 107.94 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.06 127.53 33.46 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.205 1.002 . . . . 73.530000000000001 108.353 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.9 m -144.73 160.66 40.86 Favored 'General case' 0 CA--C 1.522 -0.124 0 O-C-N 121.787 -0.57 . . . . 72.409999999999997 109.803 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 4' ' ' TRP . 8.2 mttm -121.41 155.72 34.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.333 1.453 . . . . 55.140000000000001 108.695 173.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 tt -145.75 148.23 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 119.095 0.862 . . . . 45.32 110.532 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.0 p -152.37 77.53 1.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.552 1.141 . . . . 64.329999999999998 109.913 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.4 -59.63 0.17 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 127.838 2.637 . . . . 74.230000000000004 115.385 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 p -132.6 22.16 4.3 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.479 1.111 . . . . 71.430000000000007 112.294 174.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.7 m -127.68 131.89 49.74 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.682 1.193 . . . . 72.239999999999995 107.989 167.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.98 131.96 56.44 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.524 1.929 . . . . 75.120000000000005 107.885 167.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -120.14 98.57 6.13 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.489 1.516 . . . . 72.319999999999993 108.183 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.6 t -75.89 125.59 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.436 -1.69 . . . . 34.530000000000001 106.436 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -83.15 -33.86 26.16 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.512 0.596 . . . . 64.200000000000003 111.474 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.0 t -146.76 155.77 42.64 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.446 1.498 . . . . 74.200000000000003 109.127 -170.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.07 -175.42 15.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 124.978 1.275 . . . . 53.210000000000001 111.414 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -24.61 63.29 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.895 -1.05 . . . . 63.43 112.432 169.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -111.68 24.19 13.01 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.406 1.003 . . . . 64.109999999999999 112.342 -168.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.39 102.41 0.23 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.341 1.456 . . . . 55.310000000000002 112.659 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.74 -124.97 0.92 Allowed Glycine 0 N--CA 1.463 0.498 0 C-N-CA 124.23 0.919 . . . . 73.219999999999999 112.557 -173.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -152.2 147.48 26.45 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.691 1.196 . . . . 35.229999999999997 111.186 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -143.51 146.7 33.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.336 1.454 . . . . 71.239999999999995 110.0 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -115.19 27.24 9.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.522 1.129 . . . . 72.109999999999999 113.69 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttt 61.76 159.28 0.06 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.692 1.997 . . . . 61.539999999999999 111.255 -170.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 . . . . . 0 C--N 1.324 -0.522 0 C-N-CA 127.786 2.434 . . . . 73.140000000000001 106.083 163.345 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.443 -0.787 0 N-CA-C 104.1 -2.556 . . . . 61.039999999999999 104.1 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -121.81 -178.63 3.88 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 125.755 1.622 . . . . 71.219999999999999 108.624 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.6 p -111.42 170.19 8.29 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.588 0.631 . . . . 73.450000000000003 111.072 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.36 119.07 5.42 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.548 1.139 . . . . 70.049999999999997 109.669 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.9 tp -70.84 123.24 21.51 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.528 -1.656 . . . . 73.439999999999998 106.528 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -136.85 175.2 9.83 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.053 0.941 . . . . 65.329999999999998 108.903 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.3 p -58.51 -41.07 84.55 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.56 1.544 . . . . 73.340000000000003 111.821 -174.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.89 -30.14 35.53 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.384 0.674 . . . . 61.219999999999999 109.857 -174.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.6 -38.51 91.38 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.394 0.543 . . . . 74.219999999999999 111.021 -170.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.5 tp -74.43 -24.81 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.616 1.166 . . . . 70.510000000000005 112.636 -172.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm -57.02 109.58 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.91 1.684 . . . . 70.310000000000002 111.21 -168.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.97 172.89 32.99 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.784 -0.926 . . . . 54.119999999999997 110.784 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -86.51 160.02 19.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.42 -0.956 . . . . 70.209999999999994 108.42 159.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -146.89 140.86 26.0 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.475 1.51 . . . . 74.109999999999999 108.894 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.0 t -138.09 179.42 6.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.238 1.415 . . . . 51.130000000000003 107.874 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 t -137.27 -40.03 0.59 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.647 -1.283 . . . . 70.519999999999996 112.034 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.86 179.6 30.79 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 106.652 -2.579 . . . . 61.119999999999997 106.652 167.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.8 pt -130.41 36.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.304 1.041 . . . . 65.439999999999998 109.678 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -139.61 174.39 10.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.947 1.299 . . . . 71.439999999999998 109.606 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.68 -95.22 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.991 1.758 . . . . 50.310000000000002 114.024 169.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -139.44 141.89 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 105.688 -1.967 . . . . 73.209999999999994 105.688 162.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -151.45 -179.47 7.41 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.487 1.115 . . . . 72.420000000000002 108.112 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -142.47 140.86 32.04 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.131 0.973 . . . . 72.430000000000007 108.767 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.32 154.08 17.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.859 2.064 . . . . 71.540000000000006 107.032 170.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.479 HD21 ' HG2' ' A' ' 91' ' ' GLU . 5.0 mt -145.02 147.76 32.97 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.39 1.876 . . . . 73.430000000000007 105.951 169.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 p -151.02 154.71 37.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.015 0.825 . . . . 73.200000000000003 110.516 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CE1' HD22 ' A' ' 27' ' ' LEU . 93.2 m-85 -143.56 118.12 9.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.257 1.023 . . . . 71.230000000000004 108.782 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.5 158.76 25.76 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.61 -0.885 . . . . 43.130000000000003 108.61 164.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -79.6 -39.04 32.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.023 0.529 . . . . 71.310000000000002 110.427 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.29 8.79 7.88 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.897 0.879 . . . . 75.019999999999996 110.678 -166.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.27 -133.21 5.36 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 126.694 2.092 . . . . 74.540000000000006 108.062 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -126.35 -177.89 4.14 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.299 1.44 . . . . 75.140000000000001 108.441 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.27 160.1 15.27 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.667 1.603 . . . . 62.219999999999999 110.461 171.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 m -133.63 158.2 43.83 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.326 1.051 . . . . 31.219999999999999 109.871 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -149.1 129.11 13.49 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.464 1.906 . . . . 72.430000000000007 107.082 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.87 119.21 1.11 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.226 -1.15 . . . . 54.240000000000002 110.226 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.507 ' H ' ' HB3' ' A' ' 47' ' ' SER . 35.9 mt -75.95 150.63 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.558 -0.905 . . . . 73.129999999999995 108.558 174.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -132.09 133.58 44.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.443 1.497 . . . . 73.129999999999995 108.222 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 m -83.17 135.34 34.83 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 105.792 -1.929 . . . . 61.329999999999998 105.792 159.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 43.42 -80.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.785 2.434 . . . . 72.510000000000005 115.825 156.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.07 64.42 1.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.073 0.949 . . . . 22.440000000000001 111.597 162.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 m -157.65 135.83 7.48 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 128.469 2.707 . . . . 71.230000000000004 108.875 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.25 119.89 5.76 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.312 3.341 . . . . 74.109999999999999 111.927 170.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 mm -122.8 17.12 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.611 1.564 . . . . 73.530000000000001 111.071 -173.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 39' ' ' ILE . 30.4 t -158.03 164.26 36.91 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 119.492 -2.005 . . . . 63.520000000000003 108.117 157.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -158.72 127.86 5.53 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.898 2.079 . . . . 73.200000000000003 106.122 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -143.4 169.31 17.9 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.145 1.778 . . . . 71.439999999999998 107.604 163.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.0 mtm -145.92 160.43 41.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.44 1.096 . . . . 75.319999999999993 110.302 170.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -161.89 147.55 13.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.626 1.57 . . . . 71.219999999999999 108.23 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.59 176.18 7.87 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.447 1.476 . . . . 51.229999999999997 108.614 170.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -157.43 161.96 38.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.266 -0.896 . . . . 65.5 111.139 168.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -131.15 165.0 24.26 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.454 0.702 . . . . 74.040000000000006 109.338 163.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.8 mm -123.8 83.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 105.753 -1.943 . . . . 73.400000000000006 105.753 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.28 24.14 10.89 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.064 1.346 . . . . 65.439999999999998 110.074 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -164.25 13.51 0.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.963 1.305 . . . . 73.040000000000006 114.092 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.65 14.6 65.22 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 120.977 -1.077 . . . . 65.430000000000007 111.843 -171.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -137.19 170.94 15.25 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.143 2.177 . . . . 64.209999999999994 106.625 173.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 mt -75.27 165.61 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.446 -1.316 . . . . 64.409999999999997 107.446 176.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -136.52 108.62 7.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.976 2.11 . . . . 65.319999999999993 106.179 162.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mm -93.46 145.59 7.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 106.02 -1.845 . . . . 50.009999999999998 106.02 168.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -150.25 -1.45 0.41 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.131 1.16 . . . . 74.409999999999997 114.131 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.36 115.92 3.84 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.079 -2.563 . . . . 75.439999999999998 104.079 -167.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.34 149.43 32.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.295 1.038 . . . . 74.439999999999998 108.459 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.64 164.41 32.88 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.998 2.119 . . . . 63.32 106.094 168.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.03 -16.09 19.67 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.412 0.826 . . . . 64.219999999999999 113.69 -5.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.09 119.89 34.37 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.683 -1.599 . . . . 72.310000000000002 106.683 172.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -79.4 141.66 36.67 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 118.668 0.667 . . . . 73.519999999999996 110.281 177.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -136.61 160.16 39.65 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.605 1.162 . . . . 70.530000000000001 111.315 -177.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 t -57.69 151.62 40.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.588 1.955 . . . . 65.340000000000003 111.464 170.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.88 158.05 38.88 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.665 2.91 . . . . 74.420000000000002 112.484 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -171.04 172.4 5.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.664 1.186 . . . . 73.109999999999999 111.176 173.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -115.93 96.89 5.8 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.963 1.705 . . . . 71.510000000000005 110.052 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.2 mt -75.54 133.13 41.06 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 126.238 1.815 . . . . 62.119999999999997 109.258 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.418 ' H ' HG22 ' A' ' 88' ' ' THR . 0.0 OUTLIER -87.1 130.49 34.48 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.776 1.23 . . . . 73.329999999999998 109.303 176.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.3 p -154.64 166.62 32.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.487 1.915 . . . . 64.310000000000002 109.306 170.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -131.57 155.33 47.69 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.643 1.577 . . . . 74.510000000000005 109.649 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.9 tt -146.89 147.92 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.411 1.084 . . . . 65.540000000000006 108.122 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 m -138.74 -5.37 1.53 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.185 1.394 . . . . 74.109999999999999 114.626 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.02 -89.89 0.11 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 107.978 -2.049 . . . . 54.509999999999998 107.978 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.0 p -119.8 -4.35 10.2 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.676 1.361 . . . . 65.310000000000002 114.676 -172.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -99.08 114.14 26.7 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 121.039 1.745 . . . . 73.540000000000006 110.582 172.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.5 tp -85.49 116.17 23.64 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 119.441 -2.037 . . . . 50.240000000000002 108.297 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.87 105.51 15.73 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.011 0.924 . . . . 61.219999999999999 109.792 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.5 t -90.12 127.68 42.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.132 -0.692 . . . . 63.539999999999999 109.132 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -85.53 -38.2 18.79 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 118.662 0.664 . . . . 63.340000000000003 110.699 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 76' ' ' ASP . 1.4 t -148.54 173.35 13.23 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.092 0.86 . . . . 74.340000000000003 110.962 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.42 177.07 23.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 125.088 1.328 . . . . 64.129999999999995 110.361 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.8 m -53.48 -30.94 43.51 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.589 1.155 . . . . 74.219999999999999 110.252 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.479 ' HG2' HD21 ' A' ' 27' ' ' LEU . 1.4 mp0 -89.51 0.52 56.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.713 1.005 . . . . 73.5 113.713 -174.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.48 109.87 0.26 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.801 1.64 . . . . 71.409999999999997 109.651 -175.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.15 -167.97 39.6 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 109.024 -1.63 . . . . 71.439999999999998 109.024 -167.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.8 t -135.13 147.98 49.64 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.108 -1.071 . . . . 72.530000000000001 108.108 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -146.68 160.53 42.09 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.17 1.388 . . . . 73.430000000000007 109.97 -167.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.78 140.25 49.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.441 1.496 . . . . 70.209999999999994 109.405 175.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -60.77 144.47 52.35 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.776 1.231 . . . . 74.239999999999995 109.952 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 . . . . . 0 CA--C 1.534 0.365 0 C-N-CA 126.861 2.064 . . . . 74.519999999999996 109.11 178.235 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 . . . . . 0 C--O 1.236 0.379 0 N-CA-C 105.745 -1.946 . . . . 65.150000000000006 105.745 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.405 ' CD1' ' HE3' ' A' ' 78' ' ' LYS . 86.4 m95 -117.42 154.01 32.11 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.581 1.153 . . . . 65.140000000000001 110.48 -178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.2 p -75.32 165.85 24.52 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.28 -0.637 . . . . 73.25 109.28 172.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -64.19 130.93 45.86 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.755 1.264 . . . . 75.140000000000001 108.873 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.04 133.83 55.16 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 114.597 -1.183 . . . . 75.549999999999997 109.184 164.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.31 166.7 23.85 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.157 -1.383 . . . . 71.120000000000005 109.428 166.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -44.9 78.09 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 124.328 1.017 . . . . 71.340000000000003 108.957 167.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -60.83 -24.82 66.17 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.963 -1.086 . . . . 73.120000000000005 112.152 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.418 ' HB3' HG21 ' A' ' 79' ' ' ILE . 1.3 m-20 -85.96 -26.86 25.25 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 118.432 -0.794 . . . . 71.439999999999998 112.457 -172.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.0 tp -88.07 -7.52 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.54 1.064 . . . . 73.519999999999996 112.168 -171.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.442 ' O ' ' HE3' ' A' ' 97' ' ' LYS . 18.3 mm -62.23 114.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.218 1.407 . . . . 75.310000000000002 110.445 -172.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.6 173.92 25.71 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.435 -1.066 . . . . 53.350000000000001 110.435 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -85.62 151.55 23.81 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.369 -1.345 . . . . 54.009999999999998 107.369 162.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -138.58 123.84 19.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.108 1.363 . . . . 73.310000000000002 108.772 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -129.1 170.13 13.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.327 0.651 . . . . 60.420000000000002 109.403 173.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.455 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 12.5 t -126.82 -6.07 6.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.77 1.628 . . . . 61.240000000000002 111.369 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.07 177.46 19.9 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 108.665 -1.774 . . . . 61.149999999999999 108.665 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 pt -131.65 -11.04 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.702 0.801 . . . . 73.530000000000001 112.655 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -72.05 153.72 41.56 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 120.104 -1.623 . . . . 73.510000000000005 110.409 173.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.18 -111.64 3.31 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.698 -1.057 . . . . 70.230000000000004 111.237 165.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.6 m -141.78 107.49 5.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.966 -1.494 . . . . 62.100000000000001 106.966 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -103.11 175.43 5.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 122.229 1.014 . . . . 73.420000000000002 110.779 -174.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -126.89 140.08 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.461 1.905 . . . . 71.329999999999998 106.826 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.45 143.51 51.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.94 1.296 . . . . 52.130000000000003 108.428 -176.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.0 mt -132.12 156.75 45.81 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.034 -1.469 . . . . 75.140000000000001 107.034 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.0 p -154.92 97.64 1.97 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.689 1.596 . . . . 60.530000000000001 112.311 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -91.59 132.42 36.33 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.243 1.417 . . . . 75.530000000000001 110.289 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -94.11 165.33 12.68 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 127.77 2.428 . . . . 60.350000000000001 108.949 159.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -104.26 6.64 35.57 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.059 1.744 . . . . 60.310000000000002 110.549 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -149.94 7.3 0.62 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 115.162 1.541 . . . . 61.25 115.162 175.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.06 -110.97 1.51 Allowed Glycine 0 C--N 1.337 0.632 0 CA-C-N 118.498 0.59 . . . . 72.540000000000006 112.132 -170.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.4 p -147.16 131.83 17.86 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.418 1.487 . . . . 71.439999999999998 107.927 -174.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.95 175.96 34.06 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.137 -0.785 . . . . 71.420000000000002 111.137 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m -145.04 164.27 31.69 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.817 -1.402 . . . . 75.409999999999997 111.943 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -141.63 120.5 12.73 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.024 -0.732 . . . . 63.409999999999997 109.024 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -121.35 161.65 15.35 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.553 1.073 . . . . 44.219999999999999 111.097 177.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.4 mt -137.7 133.62 45.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.962 -1.866 . . . . 63.32 105.962 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -125.93 127.03 45.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.593 1.557 . . . . 43.140000000000001 108.965 -170.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -86.01 112.83 21.59 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.149 -1.056 . . . . 55.200000000000003 108.149 166.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.24 -85.95 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.921 2.089 . . . . 74.299999999999997 110.307 -169.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.92 -0.42 3.41 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.155 0.982 . . . . 60.100000000000001 112.264 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.5 m -84.11 119.65 73.61 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.267 1.427 . . . . 74.430000000000007 108.161 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.36 140.19 57.26 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.862 2.375 . . . . 64.510000000000005 109.778 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.8 mm -124.42 -41.61 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 124.213 1.005 . . . . 73.319999999999993 109.655 -177.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.2 t -124.63 156.18 37.91 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 121.495 -0.753 . . . . 73.310000000000002 109.641 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -154.82 152.99 30.47 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.987 1.715 . . . . 74.299999999999997 108.235 172.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -161.48 161.07 29.92 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 127.723 2.409 . . . . 51.329999999999998 107.286 168.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.6 mtm -124.3 163.3 21.95 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.199 1.0 . . . . 72.430000000000007 110.048 166.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -164.57 141.7 6.38 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.433 1.093 . . . . 71.349999999999994 111.035 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.8 158.83 20.83 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.151 0.98 . . . . 72.540000000000006 108.961 164.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -151.33 166.73 30.07 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.158 -0.964 . . . . 74.349999999999994 110.556 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -138.07 149.3 45.88 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.187 -1.042 . . . . 75.430000000000007 108.187 165.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.2 mm -116.61 92.98 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 106.888 -1.523 . . . . 74.329999999999998 106.888 172.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -134.31 23.32 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.648 0.779 . . . . 74.510000000000005 112.484 -173.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -166.71 14.13 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.805 0.842 . . . . 75.120000000000005 111.791 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.77 5.59 57.39 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.342 -0.848 . . . . 72.150000000000006 111.947 -171.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.542 ' HB3' ' HA ' ' A' ' 76' ' ' ASP . 0.6 OUTLIER -121.51 145.01 48.39 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 130.458 3.503 . . . . 73.109999999999999 109.551 173.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.98 121.04 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.583 -1.636 . . . . 71.140000000000001 106.583 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -88.75 112.36 23.08 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.474 -1.676 . . . . 74.140000000000001 106.474 169.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 mm -103.92 138.4 28.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 106.304 -1.739 . . . . 72.310000000000002 106.304 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -158.62 2.59 0.1 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.767 1.025 . . . . 73.319999999999993 113.767 -172.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -153.43 125.15 7.72 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 103.544 -2.762 . . . . 64.530000000000001 103.544 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.9 t -135.49 152.23 31.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.973 -1.491 . . . . 73.230000000000004 106.973 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.78 160.66 52.59 Favored Pre-proline 0 C--O 1.239 0.549 0 C-N-CA 123.855 0.862 . . . . 72.409999999999997 109.046 175.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.78 -8.01 16.91 Favored 'Cis proline' 0 CA--C 1.534 0.523 0 CA-C-N 118.794 0.605 . . . . 62.43 113.45 -8.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -108.09 107.05 17.55 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.643 -1.244 . . . . 71.510000000000005 107.643 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -67.35 140.67 57.25 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.966 -0.753 . . . . 73.230000000000004 108.966 169.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -130.89 172.8 11.63 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.143 1.377 . . . . 75.319999999999993 109.146 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.7 t -49.81 150.53 3.77 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.422 1.489 . . . . 72.439999999999998 110.798 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -66.1 154.23 74.89 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.874 1.716 . . . . 60.32 110.009 163.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -160.82 153.02 20.22 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.471 1.908 . . . . 74.310000000000002 109.767 170.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -98.11 140.38 32.51 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.185 -1.042 . . . . 74.239999999999995 108.185 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.1 mt -119.76 109.22 15.36 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 126.53 1.932 . . . . 70.230000000000004 108.683 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.542 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 5.0 m-20 -62.58 131.56 49.48 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.828 -1.175 . . . . 63.210000000000001 107.828 174.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.8 p -150.8 173.0 14.72 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.483 1.513 . . . . 71.519999999999996 109.831 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HE3' ' CD1' ' A' ' 4' ' ' TRP . 17.9 mtmt -139.23 158.43 44.19 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.227 0.611 . . . . 70.519999999999996 110.233 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.418 HG21 ' HB3' ' A' ' 11' ' ' ASN . 4.8 tt -151.06 144.02 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 118.227 0.467 . . . . 64.140000000000001 110.528 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.0 t -133.23 33.46 3.61 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.662 1.585 . . . . 74.409999999999997 108.244 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.4 -56.85 4.22 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 120.912 -1.118 . . . . 74.310000000000002 111.962 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.85 -25.25 11.32 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.043 1.127 . . . . 73.109999999999999 114.043 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.0 m -102.29 127.76 49.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.827 1.194 . . . . 75.510000000000005 108.056 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.8 tp -94.81 137.7 33.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.875 2.07 . . . . 63.32 108.808 159.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -136.15 87.91 2.34 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.6 1.16 . . . . 63.549999999999997 110.221 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.64 128.5 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.189 -1.041 . . . . 63.340000000000003 108.189 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -86.35 -25.72 25.23 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.607 0.763 . . . . 74.219999999999999 111.367 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 t -153.71 158.36 40.89 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.181 1.392 . . . . 72.219999999999999 110.579 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.18 177.47 20.93 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 124.664 1.126 . . . . 74.439999999999998 111.17 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.3 m -60.69 -16.82 43.4 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.204 1.402 . . . . 61.140000000000001 113.694 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -109.32 8.81 25.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.8 1.64 . . . . 64.519999999999996 112.844 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.12 116.34 2.73 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.311 1.844 . . . . 74.439999999999998 109.5 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.15 -153.26 21.76 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 122.158 0.866 . . . . 63.409999999999997 113.204 -172.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.7 t -135.43 123.93 23.5 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 126.191 1.796 . . . . 64.540000000000006 106.503 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.455 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 60.9 m-85 -141.01 157.72 44.94 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.556 1.169 . . . . 74.230000000000004 109.481 -175.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -127.62 138.06 52.73 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.356 -1.35 . . . . 72.340000000000003 107.356 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 13' ' ' ILE . 25.5 tttt -51.39 145.88 7.87 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.641 1.576 . . . . 62.25 109.32 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 CA--C 1.544 0.719 0 C-N-CA 128.469 2.708 . . . . 61.509999999999998 109.463 179.258 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 . . . . . 0 N--CA 1.443 -0.783 0 N-CA-C 104.814 -2.291 . . . . 65.109999999999999 104.814 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -115.15 157.2 23.95 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 125.056 1.343 . . . . 72.439999999999998 110.157 172.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.59 173.08 12.95 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.18 0.514 . . . . 64.310000000000002 109.877 169.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -59.21 151.65 22.48 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.948 -1.023 . . . . 74.129999999999995 109.754 167.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 tp -90.89 130.0 36.88 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.872 -1.529 . . . . 73.25 106.872 165.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -139.2 168.02 20.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.694 1.198 . . . . 74.450000000000003 109.259 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -74.04 33.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.945 0.898 . . . . 51.43 111.482 175.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.76 -32.44 0.44 Allowed 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 119.875 -1.765 . . . . 74.010000000000005 113.178 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -82.82 -30.3 28.86 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 116.976 -1.488 . . . . 65.219999999999999 111.969 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 tp -70.43 -24.63 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 121.636 2.016 . . . . 73.030000000000001 113.136 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.83 104.57 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.778 2.031 . . . . 74.25 111.246 -174.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.99 171.2 32.82 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.089 0.852 . . . . 72.140000000000001 111.034 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -76.13 152.28 36.77 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.106 0.962 . . . . 65.209999999999994 109.066 163.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -146.41 153.5 40.55 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.601 1.16 . . . . 70.329999999999998 109.299 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 t -153.45 165.24 36.45 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.812 -1.18 . . . . 70.140000000000001 110.304 166.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 25' ' ' LYS . 4.4 t -115.79 -9.82 11.82 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.69 1.596 . . . . 65.120000000000005 111.413 -175.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.04 -172.6 44.85 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.489 -0.757 . . . . 72.230000000000004 111.209 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.5 pt -134.77 14.69 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.032 2.133 . . . . 61.450000000000003 110.71 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -144.34 179.35 7.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.861 1.664 . . . . 74.340000000000003 111.653 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.25 -104.98 0.23 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.038 1.78 . . . . 63.549999999999997 111.755 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.6 m -139.74 101.88 4.3 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 106.128 -1.804 . . . . 74.209999999999994 106.128 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -117.7 178.73 4.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.827 1.251 . . . . 72.049999999999997 109.423 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.458 ' H ' HG22 ' A' ' 18' ' ' THR . 1.5 mptt -144.8 154.38 42.63 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.072 0.949 . . . . 71.430000000000007 109.941 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.22 154.5 18.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.382 1.873 . . . . 64.25 107.529 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mt -138.31 144.82 40.6 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.855 -1.535 . . . . 41.509999999999998 106.855 160.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.9 p -139.03 155.03 48.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.814 1.188 . . . . 73.140000000000001 109.764 166.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.426 ' CD2' ' CE2' ' A' ' 53' ' ' TYR . 22.2 m-85 -143.09 125.19 15.33 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.549 1.94 . . . . 72.239999999999995 106.039 -175.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -101.35 154.04 19.13 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.467 -1.679 . . . . 72.120000000000005 106.467 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -74.87 -41.38 59.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.841 0.746 . . . . 51.409999999999997 111.38 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -108.59 -1.74 19.37 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.113 0.565 . . . . 65.409999999999997 111.672 -162.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.81 -112.22 1.54 Allowed Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.26 -0.736 . . . . 31.039999999999999 111.26 -169.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 80.3 p -145.3 172.67 12.82 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.022 1.329 . . . . 51.329999999999998 107.773 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.03 -166.46 14.64 Favored Glycine 0 CA--C 1.524 0.627 0 O-C-N 120.973 -1.08 . . . . 43.219999999999999 111.865 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -155.44 156.94 36.2 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 121.264 -1.139 . . . . 71.319999999999993 111.694 -170.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -135.52 145.54 47.17 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.325 1.45 . . . . 65.430000000000007 108.104 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.15 154.5 25.54 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 109.93 -1.268 . . . . 54.219999999999999 109.93 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.7 mt -113.29 143.77 22.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.034 -1.469 . . . . 73.140000000000001 107.034 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -132.22 119.27 20.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.499 1.52 . . . . 73.239999999999995 109.211 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -85.86 107.98 17.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.617 -1.994 . . . . 74.439999999999998 105.617 166.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.72 -57.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 129.749 3.219 . . . . 74.319999999999993 115.721 174.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -154.94 25.3 0.43 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.684 1.594 . . . . 44.420000000000002 112.307 167.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.5 m -131.51 125.16 20.51 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.89 1.276 . . . . 54.240000000000002 108.282 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.06 124.8 7.53 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.738 2.959 . . . . 74.310000000000002 112.159 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.2 mm -114.65 -13.17 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.264 1.426 . . . . 73.109999999999999 112.762 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.7 m -151.6 163.73 38.42 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.086 -1.009 . . . . 74.209999999999994 109.133 170.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -164.23 127.47 2.51 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.639 1.976 . . . . 64.439999999999998 108.057 -173.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.77 166.94 26.94 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.879 1.671 . . . . 53.340000000000003 108.354 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.8 mtm -137.93 151.25 47.79 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.545 -0.909 . . . . 65.049999999999997 108.545 170.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.74 146.76 18.11 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.327 1.451 . . . . 74.209999999999994 110.913 -171.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -81.22 176.24 9.94 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.301 -1.0 . . . . 74.439999999999998 108.301 167.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CE2' ' CD2' ' A' ' 29' ' ' PHE . 5.9 m-85 -141.97 159.19 42.73 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.87 -0.604 . . . . 74.129999999999995 110.2 171.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -130.78 132.21 45.14 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.296 -1.372 . . . . 65.019999999999996 107.296 161.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.42 106.88 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 105.939 -1.875 . . . . 73.310000000000002 105.939 164.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -127.94 23.98 6.08 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.401 0.62 . . . . 74.25 111.244 174.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.67 13.73 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.471 0.915 . . . . 65.349999999999994 113.471 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.32 13.43 62.59 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 120.892 -1.13 . . . . 71.030000000000001 111.286 -163.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 76' ' ' ASP . 9.4 mmt85 -136.89 152.82 50.65 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.768 2.027 . . . . 73.120000000000005 105.917 -172.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.8 mt -88.06 115.24 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 107.147 -1.427 . . . . 72.219999999999999 107.147 -170.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -87.38 111.11 20.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.147 -1.057 . . . . 72.019999999999996 108.147 169.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.2 mm -79.51 138.99 18.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.021 -1.844 . . . . 65.129999999999995 106.021 163.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -145.79 2.84 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.859 1.429 . . . . 74.109999999999999 114.859 175.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.4 100.46 0.34 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.014 -1.476 . . . . 65.150000000000006 107.014 -156.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.9 t -130.34 143.27 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.401 1.08 . . . . 52.149999999999999 108.34 -176.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.04 158.91 71.32 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.371 1.869 . . . . 72.299999999999997 106.597 171.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -84.95 -6.41 53.31 Favored 'Cis proline' 0 CA--C 1.54 0.793 0 CA-C-N 119.533 0.869 . . . . 64.010000000000005 113.581 -6.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.09 102.79 10.73 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 105.973 -1.862 . . . . 72.019999999999996 105.973 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.43 151.97 43.53 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.234 1.016 . . . . 74.409999999999997 112.079 -174.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -128.48 164.66 22.27 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.35 1.86 . . . . 72.209999999999994 111.017 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 t -63.01 150.43 88.33 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.796 0.838 . . . . 73.439999999999998 109.292 165.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.77 137.66 25.07 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.696 2.264 . . . . 65.340000000000003 111.186 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -152.77 164.1 38.44 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.729 0.812 . . . . 74.150000000000006 111.451 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -93.39 154.37 17.99 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.244 0.617 . . . . 73.049999999999997 110.932 173.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -128.62 126.13 39.57 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.553 1.941 . . . . 70.450000000000003 107.728 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.426 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 48.0 m-20 -76.77 116.08 17.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.669 -1.975 . . . . 63.210000000000001 105.669 172.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -142.46 159.24 42.62 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.157 -0.683 . . . . 63.229999999999997 109.157 169.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -132.01 156.97 45.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.444 1.498 . . . . 71.209999999999994 110.537 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 tt -146.85 156.81 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.495 -0.557 . . . . 70.430000000000007 109.495 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.4 46.5 0.66 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 123.482 1.61 . . . . 73.140000000000001 110.898 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.19 -73.13 0.33 Allowed Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 113.583 -1.644 . . . . 65.409999999999997 109.262 171.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.4 p -119.91 -2.77 10.26 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 114.152 1.168 . . . . 74.310000000000002 114.152 -173.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.3 m -106.62 130.11 54.43 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.264 -1.384 . . . . 73.310000000000002 107.264 164.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.91 136.42 38.23 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.177 1.791 . . . . 61.25 107.524 163.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -120.65 88.77 3.0 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.662 1.185 . . . . 65.329999999999998 109.329 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.6 t -77.07 118.85 24.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.922 -1.51 . . . . 73.150000000000006 106.922 172.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -78.14 -39.97 39.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.465 0.575 . . . . 65.439999999999998 111.142 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 t -144.0 174.73 10.6 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.123 0.874 . . . . 73.310000000000002 111.258 -166.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.55 -179.17 47.65 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 125.683 1.611 . . . . 34.43 111.272 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.4 m -58.92 -21.87 58.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.356 1.462 . . . . 72.439999999999998 113.101 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -106.62 10.28 31.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.938 1.295 . . . . 73.409999999999997 112.474 -177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.45 109.57 0.46 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.298 1.439 . . . . 61.119999999999997 110.738 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -175.74 -169.89 37.91 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.547 1.07 . . . . 65.120000000000005 111.269 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -129.61 121.58 27.37 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.481 -1.674 . . . . 52.240000000000002 106.481 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -126.29 145.45 50.41 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.048 0.539 . . . . 73.049999999999997 109.842 -165.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -97.38 148.95 22.65 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.448 -0.945 . . . . 64.049999999999997 108.448 164.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -59.7 150.13 28.69 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.435 1.494 . . . . 74.319999999999993 109.486 166.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 126.251 1.82 . . . . 73.230000000000004 113.076 -170.641 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--O 1.236 0.371 0 N-CA-C 107.56 -1.274 . . . . 74.219999999999999 107.56 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -88.47 150.86 22.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.134 0.974 . . . . 75.409999999999997 110.283 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.64 175.99 7.64 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.619 1.568 . . . . 52.340000000000003 109.996 171.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -74.15 123.08 23.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.06 0.944 . . . . 72.340000000000003 111.164 172.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.431 HD22 ' SG ' ' A' ' 77' ' ' CYS . 24.7 tp -60.69 129.29 40.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.239 -0.652 . . . . 74.420000000000002 109.239 162.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -146.35 168.27 21.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.653 0.74 . . . . 72.439999999999998 109.709 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.07 21.14 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.814 3.245 . . . . 72.510000000000005 113.446 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.83 -52.13 0.63 Allowed 'General case' 0 C--O 1.232 0.177 0 O-C-N 119.904 -1.748 . . . . 74.099999999999994 110.916 176.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -64.19 -26.38 68.49 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.66 1.118 . . . . 53.030000000000001 113.015 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.429 HD13 HD11 ' A' ' 7' ' ' LEU . 10.8 tp -70.52 -25.09 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.417 1.487 . . . . 64.310000000000002 113.469 177.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.77 129.89 34.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 123.443 0.697 . . . . 45.039999999999999 110.08 -163.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.36 -172.42 18.72 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.12 1.819 . . . . 63.530000000000001 111.397 174.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -82.27 160.7 22.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.361 1.465 . . . . 72.530000000000001 111.264 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -141.13 158.28 44.13 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.702 1.601 . . . . 73.25 108.182 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 p -146.78 169.08 19.83 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.8 2.091 . . . . 71.140000000000001 112.733 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -132.78 -5.33 3.19 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.608 1.563 . . . . 61.310000000000002 112.704 -171.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.8 172.94 14.9 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.251 -1.939 . . . . 74.049999999999997 108.251 -171.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.9 pt -138.11 27.42 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.452 1.101 . . . . 62.43 110.79 -168.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -125.89 174.88 8.07 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 124.559 1.144 . . . . 74.019999999999996 112.063 -171.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 43.66 -88.47 0.01 OUTLIER Glycine 0 C--N 1.341 0.854 0 C-N-CA 127.505 2.479 . . . . 55.420000000000002 114.017 149.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.3 m -130.44 122.23 27.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.485 -1.672 . . . . 62.030000000000001 106.485 159.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -131.72 -167.54 1.88 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.822 1.649 . . . . 72.230000000000004 107.757 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.43 156.08 18.31 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.241 1.816 . . . . 64.010000000000005 107.522 -162.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.95 132.4 20.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.789 2.436 . . . . 54.229999999999997 109.812 -177.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.59 HD21 ' HG3' ' A' ' 91' ' ' GLU . 48.4 mt -116.71 156.75 26.61 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.218 2.207 . . . . 75.340000000000003 108.498 175.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 t -137.18 156.31 48.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.025 -1.842 . . . . 43.409999999999997 106.025 160.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -143.1 129.78 20.3 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.35 1.46 . . . . 64.319999999999993 107.704 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.21 167.04 11.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.569 0.748 . . . . 71.219999999999999 110.76 171.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -81.88 -33.41 30.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.237 0.615 . . . . 71.5 110.572 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -138.08 28.82 2.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.867 0.841 . . . . 70.140000000000001 110.927 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.31 -116.62 2.54 Favored Glycine 0 C--N 1.33 0.232 0 N-CA-C 108.565 -1.814 . . . . 65.510000000000005 108.565 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.2 p -146.11 -175.07 4.61 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.398 1.479 . . . . 65.519999999999996 107.173 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.82 170.52 17.09 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.881 -0.888 . . . . 65.530000000000001 110.881 162.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.1 p -135.42 166.85 22.2 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.322 1.049 . . . . 74.409999999999997 110.89 171.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -149.59 105.96 3.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.044 -1.465 . . . . 71.329999999999998 107.044 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.51 104.02 1.02 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.577 -1.009 . . . . 63.310000000000002 110.577 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 mt -73.83 134.26 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 106.42 -1.696 . . . . 52.439999999999998 106.42 170.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -123.56 135.85 54.22 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.257 1.423 . . . . 63.25 108.238 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.28 136.29 36.96 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 107.622 -1.251 . . . . 62.229999999999997 107.622 163.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 45.89 -78.91 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 129.065 2.946 . . . . 74.019999999999996 114.655 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.27 65.47 1.02 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.793 1.237 . . . . 74.329999999999998 110.335 163.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.0 m -155.32 132.84 6.5 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.562 1.945 . . . . 64.319999999999993 108.939 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.15 134.99 26.2 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.433 2.756 . . . . 63.439999999999998 110.357 172.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.3 mm -127.48 -20.78 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.146 0.578 . . . . 71.019999999999996 111.31 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.7 t -138.76 163.69 31.53 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 120.526 -1.359 . . . . 74.230000000000004 108.268 167.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -163.45 132.36 3.93 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 126.891 2.076 . . . . 53.43 106.694 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -148.96 159.22 44.4 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.474 -1.676 . . . . 75.349999999999994 106.474 162.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.9 mtm -130.78 145.56 52.0 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.643 -1.614 . . . . 74.150000000000006 106.643 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -164.09 140.13 6.35 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.955 -0.387 . . . . 62.420000000000002 109.955 -167.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.42 174.16 3.55 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.503 1.121 . . . . 62.530000000000001 109.671 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -154.13 172.12 18.06 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.302 -0.873 . . . . 73.430000000000007 110.941 162.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -133.31 153.77 51.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.407 -0.961 . . . . 72.239999999999995 108.407 158.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.1 mm -102.67 101.12 11.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.356 -1.72 . . . . 62.5 106.356 165.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -136.67 24.52 3.13 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.503 1.521 . . . . 73.109999999999999 110.363 -171.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -169.73 14.27 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.641 1.576 . . . . 54.409999999999997 114.045 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.47 18.88 68.23 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 120.773 -1.204 . . . . 71.140000000000001 112.129 -170.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 -136.48 166.56 23.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 128.704 2.802 . . . . 74.200000000000003 105.436 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.58 150.09 4.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.117 -1.438 . . . . 71.310000000000002 107.117 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -119.99 125.17 47.73 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.61 1.964 . . . . 75.409999999999997 105.757 165.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mm -113.44 132.7 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.479 -2.045 . . . . 72.140000000000001 105.479 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -156.41 -2.61 0.12 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.314 0.857 . . . . 71.519999999999996 113.314 -170.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -145.52 111.65 5.66 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 105.526 -2.027 . . . . 74.340000000000003 105.526 174.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.28 146.84 33.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.067 -1.827 . . . . 72.140000000000001 106.067 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.58 160.73 58.01 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 106.72 -1.585 . . . . 70.239999999999995 106.72 174.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.47 -10.0 38.23 Favored 'Cis proline' 0 CA--C 1.537 0.645 0 CA-C-N 119.085 0.709 . . . . 70.450000000000003 113.532 -7.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.96 97.23 7.12 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 104.563 -2.384 . . . . 71.430000000000007 104.563 172.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -65.76 140.53 58.44 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.547 -0.908 . . . . 71.219999999999999 108.547 168.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -126.59 171.15 11.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.308 1.043 . . . . 74.150000000000006 109.459 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -47.15 141.69 5.94 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.276 1.031 . . . . 63.240000000000002 108.719 171.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.45 139.72 42.0 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.518 1.478 . . . . 43.32 109.466 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -144.64 162.33 36.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.629 0.772 . . . . 75.120000000000005 110.397 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -99.28 156.61 16.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.467 -0.938 . . . . 71.420000000000002 108.467 170.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.4 mt -127.55 110.12 12.4 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.734 -1.21 . . . . 63.200000000000003 107.734 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -57.98 129.19 40.8 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.481 -1.303 . . . . 73.120000000000005 107.481 170.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 1.8 p -157.48 165.46 35.59 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.508 0.723 . . . . 75.510000000000005 109.359 173.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -126.86 167.94 15.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.506 1.522 . . . . 71.209999999999994 111.143 164.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.0 tt -157.71 154.79 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.796 -0.816 . . . . 75.530000000000001 108.796 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.8 m -138.48 -5.27 1.59 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 118.195 2.665 . . . . 64.530000000000001 118.195 168.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.2 -52.52 0.51 Allowed Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.956 -1.258 . . . . 73.409999999999997 109.956 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -121.22 -20.88 6.58 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 116.757 -1.592 . . . . 51.030000000000001 113.82 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.1 m -96.51 116.83 29.72 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 121.141 1.791 . . . . 53.100000000000001 110.124 168.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.45 140.13 29.84 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.645 1.178 . . . . 75.510000000000005 109.752 159.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -132.1 91.25 2.93 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.131 0.972 . . . . 74.540000000000006 110.968 170.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 29.4 t -80.67 133.24 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.106 -1.072 . . . . 75.109999999999999 108.106 173.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -89.84 -30.7 17.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.499 0.72 . . . . 74.209999999999994 112.675 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.5 t -143.38 171.59 13.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.571 1.078 . . . . 63.210000000000001 110.69 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.25 179.67 49.61 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-O 122.997 1.331 . . . . 73.140000000000001 110.787 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.3 m -58.13 -20.07 37.49 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.691 1.197 . . . . 35.439999999999998 113.757 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.59 ' HG3' HD21 ' A' ' 27' ' ' LEU . 5.4 mm-40 -110.46 16.49 21.54 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.386 0.513 . . . . 62.119999999999997 112.386 -174.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.15 105.37 0.58 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.787 0.835 . . . . 73.329999999999998 111.69 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.35 -135.18 2.16 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 118.836 0.744 . . . . 42.439999999999998 113.074 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.4 t -138.58 119.9 14.77 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.866 1.666 . . . . 74.109999999999999 109.12 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.59 152.06 51.1 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.354 -0.841 . . . . 74.200000000000003 109.24 -166.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -119.05 129.8 55.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 117.636 -1.173 . . . . 74.109999999999999 108.698 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -47.39 140.65 5.47 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.333 1.053 . . . . 74.530000000000001 109.297 172.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 . . . . . 0 N--CA 1.473 0.682 0 C-N-CA 126.107 1.763 . . . . 63.329999999999998 109.172 178.632 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 122.441 1.115 . . . . 53.119999999999997 108.34 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -72.73 152.55 41.59 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.064 1.346 . . . . 75.109999999999999 110.385 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -78.63 166.39 22.58 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.027 0.376 . . . . 54.039999999999999 110.356 167.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -51.58 132.49 30.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.269 1.033 . . . . 73.329999999999998 108.669 163.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.8 tp -72.41 122.97 22.12 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.454 -1.684 . . . . 60.329999999999998 106.454 157.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -135.43 165.24 25.94 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.015 -1.476 . . . . 74.530000000000001 107.015 174.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -57.91 -43.68 86.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 124.184 0.928 . . . . 53.399999999999999 110.732 -165.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -75.75 -24.03 56.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.784 0.834 . . . . 72.049999999999997 111.728 -171.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -71.15 -39.55 71.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.517 0.599 . . . . 75.230000000000004 111.806 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.7 tp -83.18 -14.72 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.214 1.006 . . . . 74.129999999999995 112.307 -167.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 mm -57.97 145.29 9.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.846 1.258 . . . . 73.109999999999999 109.755 -176.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.72 -170.09 13.46 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.684 1.135 . . . . 74.0 110.733 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -104.65 152.84 21.98 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.712 1.605 . . . . 74.439999999999998 109.447 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -147.45 126.47 12.84 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.845 1.258 . . . . 71.099999999999994 110.231 -170.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.6 t -135.66 166.89 22.19 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.89 0.876 . . . . 75.430000000000007 110.117 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.484 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 15.3 t -114.23 -13.96 12.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.76 1.624 . . . . 52.439999999999998 111.438 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.09 -174.9 41.7 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.704 -1.358 . . . . 60.020000000000003 109.704 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.0 pt -132.51 28.17 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.9 1.68 . . . . 63.140000000000001 110.165 -177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -129.39 175.48 8.72 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.454 1.102 . . . . 53.439999999999998 109.568 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.45 -107.79 0.57 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 125.927 1.727 . . . . 74.209999999999994 111.872 161.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.3 m -139.02 94.78 2.85 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.408 -1.701 . . . . 62.340000000000003 106.408 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -125.48 168.21 13.94 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 122.151 0.977 . . . . 61.100000000000001 111.653 -172.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -137.56 145.41 42.85 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.233 0.613 . . . . 63.5 109.839 -161.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.61 127.94 48.13 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.807 1.643 . . . . 55.299999999999997 107.71 -172.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.0 mt -117.33 153.23 33.35 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.322 -1.362 . . . . 62.200000000000003 107.322 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.0 p -148.88 158.05 43.89 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.68 -0.236 . . . . 62.43 110.655 159.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -142.62 138.76 30.94 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.169 1.388 . . . . 64.319999999999993 107.298 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.49 156.57 17.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.067 0.947 . . . . 71.219999999999999 109.622 171.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.9 -21.09 44.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 54.210000000000001 111.857 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.96 -1.61 5.24 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.325 0.65 . . . . 74.299999999999997 112.431 -173.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.94 -129.96 4.36 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.256 1.408 . . . . 55.409999999999997 111.992 -166.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 p -137.04 172.45 13.0 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 127.302 2.241 . . . . 75.099999999999994 107.38 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.9 175.83 25.51 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.523 -0.735 . . . . 35.340000000000003 112.241 -176.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.37 152.08 50.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.904 1.282 . . . . 75.310000000000002 108.317 176.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -145.14 106.5 4.21 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.447 1.499 . . . . 62.509999999999998 108.693 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.78 149.66 18.64 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.785 -0.926 . . . . 75.120000000000005 110.785 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.3 mt -116.1 131.7 67.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.362 -2.088 . . . . 71.409999999999997 105.362 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -130.95 127.74 39.03 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.932 1.293 . . . . 62.32 109.006 -170.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.93 115.83 31.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.668 -1.975 . . . . 44.119999999999997 105.668 173.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.73 -65.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 129.602 3.161 . . . . 75.129999999999995 115.849 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -153.62 36.23 0.45 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.947 1.299 . . . . 74.010000000000005 111.785 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.1 m -136.85 133.92 19.01 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.953 1.301 . . . . 75.340000000000003 108.788 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.06 133.04 17.52 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.408 2.738 . . . . 75.219999999999999 110.656 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 mm -128.89 -6.72 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.231 1.012 . . . . 73.129999999999995 112.261 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.3 t -153.23 157.92 40.93 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 119.783 -1.823 . . . . 74.129999999999995 109.437 167.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -146.93 134.56 21.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.055 2.142 . . . . 54.32 107.936 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -141.45 160.28 40.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.184 -1.043 . . . . 71.109999999999999 108.184 162.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mtm -130.82 139.13 50.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.465 -2.05 . . . . 75.340000000000003 105.465 172.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.616 ' HB3' HG23 ' A' ' 65' ' ' VAL . 7.7 p90 -157.37 152.5 25.96 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.706 -1.22 . . . . 73.010000000000005 107.706 -173.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.9 p30 -79.32 -177.35 5.67 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.648 1.213 . . . . 75.299999999999997 111.003 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.535 ' CD1' HG23 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -173.16 135.04 0.56 Allowed 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.858 1.663 . . . . 72.319999999999993 111.461 -164.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.582 ' HE3' ' CE1' ' A' ' 63' ' ' TYR . 4.1 mttt -135.34 159.96 39.91 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 124.536 1.147 . . . . 74.329999999999998 109.239 159.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.0 mm -94.71 118.91 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.723 -1.954 . . . . 75.230000000000004 105.723 149.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -136.93 25.09 3.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.769 0.828 . . . . 63.420000000000002 110.062 162.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.6 14.92 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 115.377 1.621 . . . . 74.239999999999995 115.377 -174.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.99 20.47 64.66 Favored Glycine 0 CA--C 1.531 1.094 0 O-C-N 120.299 -1.501 . . . . 64.129999999999995 110.951 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -148.41 156.68 42.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.63 2.772 . . . . 63.100000000000001 105.007 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.535 HG23 ' CD1' ' A' ' 53' ' ' TYR . 72.1 mt -84.06 115.73 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 105.318 -2.104 . . . . 72.310000000000002 105.318 -176.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -90.26 116.87 28.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 117.918 -1.039 . . . . 73.200000000000003 109.236 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.5 mm -95.82 148.83 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 107.162 -1.421 . . . . 71.099999999999994 107.162 172.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.582 ' CE1' ' HE3' ' A' ' 54' ' ' LYS . 13.1 p90 -158.26 -0.19 0.1 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.755 1.761 . . . . 73.5 115.755 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -152.95 124.97 7.95 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.762 -2.31 . . . . 64.540000000000006 104.762 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.746 ' CG1' ' H ' ' A' ' 70' ' ' LYS . 7.2 p -139.23 158.21 28.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 125.139 1.376 . . . . 74.439999999999998 109.948 173.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.89 158.72 48.64 Favored Pre-proline 0 C--O 1.24 0.577 0 C-N-CA 126.839 2.056 . . . . 71.0 106.894 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -80.64 -10.96 39.95 Favored 'Cis proline' 0 N--CA 1.463 -0.321 0 N-CA-C 113.863 0.678 . . . . 72.519999999999996 113.863 0.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.11 124.35 50.65 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 103.555 -2.757 . . . . 70.510000000000005 103.555 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.713 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -75.68 148.15 38.88 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.382 -0.599 . . . . 74.239999999999995 109.382 172.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.746 ' H ' ' CG1' ' A' ' 65' ' ' VAL . 23.2 mtpt -128.05 158.66 37.33 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.574 -0.528 . . . . 74.109999999999999 109.574 169.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -53.26 149.28 13.91 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.283 1.433 . . . . 74.540000000000006 111.727 -178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.68 140.37 42.8 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.352 2.035 . . . . 63.219999999999999 111.482 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -159.31 174.58 14.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.708 1.203 . . . . 73.439999999999998 110.24 175.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.81 125.49 54.06 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.779 1.632 . . . . 73.299999999999997 110.248 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.0 mt -89.44 112.53 23.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.608 1.163 . . . . 64.400000000000006 109.146 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.09 114.08 3.51 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.377 -1.342 . . . . 73.519999999999996 107.377 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 3.9 p -152.6 157.92 41.71 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.876 0.845 . . . . 53.009999999999998 110.429 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -129.31 152.95 48.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.916 1.687 . . . . 74.530000000000001 108.827 -175.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.6 tt -146.92 152.75 12.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.466 -0.568 . . . . 54.039999999999999 109.466 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 t -159.26 45.75 0.27 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 122.945 1.355 . . . . 74.319999999999993 110.779 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.52 -127.89 9.28 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 106.811 -2.515 . . . . 54.130000000000003 106.811 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.5 p -71.36 -11.41 60.88 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.383 -1.77 . . . . 64.140000000000001 114.16 -167.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.5 m -95.05 119.74 34.07 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 121.664 2.029 . . . . 42.030000000000001 108.822 173.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.9 tp -92.56 131.56 37.58 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.748 1.619 . . . . 72.120000000000005 108.13 160.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -119.48 100.59 7.38 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 125.246 1.418 . . . . 64.319999999999993 108.175 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.467 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 59.9 t -94.25 131.48 41.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.807 -1.183 . . . . 62.520000000000003 107.807 174.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -92.14 -29.22 16.62 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.579 0.752 . . . . 52.409999999999997 112.652 -172.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.9 t -140.78 173.17 11.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.003 1.721 . . . . 45.020000000000003 110.04 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.09 -176.15 45.29 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 122.976 1.32 . . . . 45.219999999999999 112.311 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.59 -32.09 73.6 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.056 -0.673 . . . . 71.209999999999994 110.572 172.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.72 7.36 39.97 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.725 -0.609 . . . . 73.310000000000002 112.391 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.6 104.99 0.21 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.252 2.221 . . . . 71.519999999999996 111.584 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.96 -158.84 29.0 Favored Glycine 0 N--CA 1.451 -0.312 0 O-C-N 121.656 -0.652 . . . . 61.310000000000002 112.444 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.6 p -115.85 120.48 39.37 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.481 1.912 . . . . 55.439999999999998 107.327 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.484 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 67.1 m-85 -135.67 148.05 48.79 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.04 -0.726 . . . . 75.140000000000001 109.04 -174.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -111.86 146.2 38.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.068 -1.086 . . . . 54.420000000000002 108.068 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -55.6 144.79 25.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.91 0.884 . . . . 72.439999999999998 108.891 172.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 105.743 -1.947 . . . . 73.200000000000003 105.743 179.531 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 106.285 -1.746 . . . . 74.219999999999999 106.285 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -120.78 161.15 21.97 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.684 1.193 . . . . 64.340000000000003 110.502 172.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.47 178.43 7.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.049 2.14 . . . . 73.200000000000003 109.966 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -67.07 135.36 53.52 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.633 -1.167 . . . . 73.209999999999994 110.359 161.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -73.89 129.73 38.48 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 126.143 1.777 . . . . 71.420000000000002 108.097 158.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -141.3 179.57 6.69 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 119.64 -0.824 . . . . 71.030000000000001 110.132 161.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -69.27 25.1 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.386 1.875 . . . . 74.219999999999999 112.65 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.63 -53.64 0.82 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 119.873 -1.767 . . . . 64.409999999999997 109.317 -171.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -65.65 -28.5 69.14 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.451 -1.262 . . . . 74.120000000000005 112.517 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.19 -18.64 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 121.366 1.894 . . . . 71.340000000000003 114.002 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.4 mm -62.89 121.19 11.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 O-C-N 121.375 -0.828 . . . . 74.040000000000006 110.247 -169.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.98 -174.05 26.93 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.085 1.802 . . . . 74.150000000000006 111.12 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 28' ' ' SER . 1.8 m-85 -88.74 163.27 15.81 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.003 1.321 . . . . 73.239999999999995 109.513 171.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 84' ' ' LEU . 94.9 m95 -150.22 133.85 16.65 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.925 -1.109 . . . . 73.140000000000001 111.116 -175.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 t -138.2 162.75 33.47 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.292 1.437 . . . . 64.120000000000005 109.596 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.482 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 8.9 t -126.73 -14.79 5.62 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.496 1.118 . . . . 70.340000000000003 112.234 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.3 170.53 30.37 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 107.159 -2.376 . . . . 72.239999999999995 107.159 -169.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.0 pt -138.76 34.87 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.493 1.117 . . . . 73.219999999999999 108.746 -161.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -148.79 -176.14 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.8 1.64 . . . . 74.400000000000006 109.908 -165.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 44.97 -99.84 0.02 OUTLIER Glycine 0 CA--C 1.525 0.702 0 C-N-CA 126.603 2.049 . . . . 52.240000000000002 113.18 158.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 m -134.83 115.98 14.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.424 -1.695 . . . . 72.219999999999999 106.424 165.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -127.34 168.55 14.64 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.679 0.752 . . . . 74.099999999999994 109.699 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -139.79 137.16 34.8 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.746 -1.576 . . . . 65.140000000000001 106.746 -164.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.43 HD13 ' H ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -123.32 143.3 50.18 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.214 1.406 . . . . 72.420000000000002 107.686 -172.098 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.447 HD22 ' CZ ' ' A' ' 29' ' ' PHE . 6.9 mt -138.95 158.99 43.2 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.785 1.634 . . . . 72.150000000000006 107.823 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 23.6 p -150.56 157.08 42.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.765 0.826 . . . . 65.219999999999999 109.747 163.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.447 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 92.4 m-85 -144.16 135.64 25.78 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.53 1.532 . . . . 74.010000000000005 107.798 174.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -110.53 150.56 28.74 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.295 1.038 . . . . 74.409999999999997 109.216 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -25.54 56.16 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.879 -0.513 . . . . 72.209999999999994 110.937 -174.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.6 -3.36 5.39 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.503 0.721 . . . . 72.030000000000001 111.12 -172.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.33 -140.47 6.64 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 126.085 1.803 . . . . 74.219999999999999 110.272 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 74.7 p -122.89 158.68 29.83 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.806 1.242 . . . . 72.310000000000002 109.17 -176.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.89 165.56 43.89 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 109.889 -1.285 . . . . 74.219999999999999 109.889 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.16 161.54 37.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.393 -0.595 . . . . 72.209999999999994 109.393 173.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -140.56 150.17 43.32 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.086 -1.079 . . . . 72.209999999999994 108.086 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.81 155.69 26.39 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.069 -1.212 . . . . 62.43 110.069 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.5 mt -125.66 136.88 59.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.508 -2.034 . . . . 72.310000000000002 105.508 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -119.9 155.45 32.68 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.837 1.255 . . . . 72.230000000000004 108.278 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.05 130.93 56.45 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.254 -1.758 . . . . 71.329999999999998 106.254 162.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 44.85 -81.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 128.369 2.668 . . . . 71.239999999999995 114.653 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.01 54.25 1.37 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.928 1.691 . . . . 72.319999999999993 110.433 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.2 m -155.15 124.11 3.05 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 125.604 1.562 . . . . 73.420000000000002 108.544 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.69 139.74 41.22 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.891 2.394 . . . . 73.129999999999995 109.999 171.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.9 mm -129.79 -16.66 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.208 1.403 . . . . 72.340000000000003 111.416 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.5 t -139.94 161.91 36.45 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.995 -1.691 . . . . 73.140000000000001 108.966 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -160.48 145.17 14.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 126.282 1.833 . . . . 74.430000000000007 107.983 -176.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.13 168.41 25.55 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 125.765 1.626 . . . . 61.439999999999998 107.512 167.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.7 mtm -133.03 138.07 46.68 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.921 -1.511 . . . . 75.310000000000002 106.921 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.555 ' HB3' HG23 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -149.25 137.16 20.52 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.732 1.213 . . . . 71.409999999999997 110.409 -173.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -82.05 166.26 19.91 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.533 -0.914 . . . . 64.239999999999995 108.533 169.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.05 168.34 27.32 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.904 0.882 . . . . 63.43 111.914 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -139.99 158.13 44.55 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.036 0.935 . . . . 65.019999999999996 111.434 162.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.5 mm -113.2 83.1 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.382 1.473 . . . . 61.149999999999999 108.1 171.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -116.77 24.29 11.36 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.395 1.878 . . . . 72.349999999999994 111.204 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -164.74 14.7 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.284 1.216 . . . . 64.25 114.284 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.8 21.28 74.95 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.287 -0.883 . . . . 54.310000000000002 111.27 -170.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -145.46 166.06 26.74 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 127.011 2.124 . . . . 63.109999999999999 107.994 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.8 mt -99.31 115.54 40.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.517 -1.66 . . . . 72.439999999999998 106.517 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -89.53 122.72 32.97 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.55 1.54 . . . . 63.149999999999999 107.912 172.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.8 mm -98.79 143.36 13.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.185 -1.413 . . . . 74.329999999999998 107.185 173.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -160.63 2.34 0.07 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.333 1.235 . . . . 71.150000000000006 114.333 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -153.75 112.49 3.68 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 104.388 -2.449 . . . . 52.509999999999998 104.388 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.727 HG13 ' HA ' ' A' ' 69' ' ' GLU . 11.8 p -138.62 157.82 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.575 -1.268 . . . . 74.129999999999995 107.575 171.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.87 165.99 23.13 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 124.889 1.276 . . . . 73.409999999999997 108.465 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.09 -44.36 0.46 Allowed 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 125.334 -0.694 . . . . 74.430000000000007 111.684 -10.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.62 125.28 26.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.892 -1.522 . . . . 61.049999999999997 106.892 167.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.727 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.2 pt-20 -75.5 158.01 33.18 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 124.285 0.991 . . . . 64.340000000000003 108.678 168.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.675 ' H ' HG12 ' A' ' 65' ' ' VAL . 9.4 mmpt? -115.14 158.73 21.8 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.509 -1.369 . . . . 72.25 108.068 164.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.73 145.91 20.08 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.624 -1.25 . . . . 51.539999999999999 107.624 168.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.4 139.8 32.36 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.852 1.701 . . . . 74.420000000000002 109.611 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -153.28 173.37 15.67 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.992 1.317 . . . . 74.109999999999999 108.554 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -107.09 153.5 22.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.93 -1.137 . . . . 74.120000000000005 107.93 171.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.3 mt -124.04 116.07 22.21 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 125.943 1.697 . . . . 63.43 107.218 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.51 121.08 9.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.211 1.404 . . . . 64.140000000000001 109.188 166.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.0 168.63 21.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 125.211 1.404 . . . . 65.430000000000007 108.415 172.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.54 165.76 26.05 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.789 1.636 . . . . 54.210000000000001 111.04 163.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.415 HG22 ' HG ' ' A' ' 7' ' ' LEU . 7.2 tt -157.38 159.46 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.453 -1.314 . . . . 71.329999999999998 107.453 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 t -137.48 -2.57 1.97 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.726 1.21 . . . . 72.129999999999995 112.612 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.73 -152.38 20.08 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 107.664 -2.175 . . . . 62.009999999999998 107.664 -149.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.0 p -51.97 7.4 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 119.554 3.168 . . . . 72.340000000000003 119.554 -173.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.9 m -130.1 110.71 11.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.528 2.731 . . . . 70.319999999999993 108.059 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.415 ' HB2' ' CE3' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -88.09 128.32 35.42 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.946 -1.502 . . . . 52.219999999999999 106.946 170.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -117.78 82.87 1.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.61 0.764 . . . . 72.409999999999997 110.687 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.74 128.77 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.101 -1.074 . . . . 73.040000000000006 108.101 170.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -77.45 -42.99 33.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.661 1.184 . . . . 72.129999999999995 110.008 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.4 t -130.22 -173.77 3.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.205 1.002 . . . . 73.209999999999994 112.523 -170.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.7 -172.48 39.04 Favored Glycine 0 C--N 1.335 0.494 0 O-C-N 120.337 -1.477 . . . . 72.209999999999994 110.592 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.2 m -62.92 -28.24 69.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.849 -0.795 . . . . 64.140000000000001 109.814 158.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.59 -1.12 57.39 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.387 1.475 . . . . 53.43 112.131 -167.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.71 108.03 0.24 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.395 2.278 . . . . 72.120000000000005 109.34 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.6 -154.9 19.96 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 122.192 0.884 . . . . 73.200000000000003 112.692 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 t -140.44 97.83 3.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.759 -1.941 . . . . 52.299999999999997 105.759 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.482 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 52.0 m-85 -110.38 151.3 27.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.503 -1.295 . . . . 63.310000000000002 107.503 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -104.96 148.04 27.14 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.26 -1.385 . . . . 65.109999999999999 107.26 174.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -54.79 139.6 39.05 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 106.66 -1.607 . . . . 71.109999999999999 106.66 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 . . . . . 0 N--CA 1.438 -1.042 0 N-CA-C 104.831 -2.285 . . . . 73.329999999999998 104.831 160.395 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 107.568 -1.271 . . . . 73.040000000000006 107.568 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -61.0 144.52 53.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.876 -1.057 . . . . 74.239999999999995 111.149 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.6 172.39 12.67 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.263 1.03 . . . . 73.319999999999993 110.652 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.72 140.87 55.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 122.169 0.985 . . . . 62.350000000000001 110.036 167.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.466 HD11 HD13 ' A' ' 12' ' ' ILE . 15.6 tp -78.85 133.68 36.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.55 -1.278 . . . . 74.430000000000007 107.55 168.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -143.22 167.99 20.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.741 0.816 . . . . 54.409999999999997 109.032 173.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 t -75.95 43.16 0.27 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.573 1.549 . . . . 72.030000000000001 109.877 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.21 -50.83 0.14 Allowed 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 119.85 -1.781 . . . . 62.439999999999998 110.609 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -70.49 -29.98 66.65 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 119.092 -0.48 . . . . 71.239999999999995 111.251 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.466 HD13 HD11 ' A' ' 7' ' ' LEU . 4.1 tp -64.46 -26.16 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.344 0.974 . . . . 73.120000000000005 112.941 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mm -62.85 132.56 28.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.774 1.23 . . . . 75.329999999999998 110.242 -168.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.13 -178.8 17.09 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.796 1.665 . . . . 73.430000000000007 112.08 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -76.24 157.36 32.69 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.404 0.682 . . . . 71.329999999999998 110.323 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -143.33 110.38 5.66 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.544 -0.909 . . . . 62.439999999999998 108.544 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.9 t -115.02 151.62 33.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.759 0.824 . . . . 75.209999999999994 109.332 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 t -105.32 -17.31 14.49 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.864 0.866 . . . . 52.350000000000001 111.888 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.93 179.95 35.07 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.896 -1.682 . . . . 64.319999999999993 108.896 -174.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 pt -131.86 9.15 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 117.708 0.754 . . . . 75.340000000000003 112.819 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.9 163.65 12.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.358 0.981 . . . . 74.400000000000006 110.295 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.57 -90.23 0.02 OUTLIER Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.167 1.365 . . . . 62.43 114.956 155.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 m -134.07 123.41 24.44 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.15 1.975 . . . . 74.540000000000006 107.683 163.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -140.91 176.47 8.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.562 1.145 . . . . 74.109999999999999 109.385 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -143.23 140.78 30.84 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.943 1.297 . . . . 64.340000000000003 108.68 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.56 147.01 38.78 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 126.243 1.817 . . . . 63.149999999999999 108.621 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.59 168.2 19.69 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.121 0.969 . . . . 75.129999999999995 111.29 161.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 t -143.86 156.49 44.48 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.288 1.835 . . . . 73.310000000000002 108.845 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -146.12 111.91 5.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.508 2.723 . . . . 74.010000000000005 106.525 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.73 163.33 20.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.854 0.752 . . . . 73.319999999999993 109.308 166.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -88.87 -27.12 21.24 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.309 0.643 . . . . 75.340000000000003 112.095 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -130.98 12.94 5.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.631 1.172 . . . . 72.239999999999995 111.871 -172.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -126.92 -129.61 3.28 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 126.7 2.095 . . . . 74.420000000000002 108.989 -176.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 p -132.63 -166.6 1.77 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.244 1.818 . . . . 61.439999999999998 107.906 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -129.58 -175.26 13.97 Favored Glycine 0 CA--C 1.505 -0.552 0 O-C-N 119.823 -1.798 . . . . 74.109999999999999 112.058 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -144.84 154.38 42.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 118.281 -0.866 . . . . 71.219999999999999 110.057 -166.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -136.72 135.11 37.86 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.788 1.235 . . . . 74.239999999999995 109.493 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.39 158.01 24.74 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.573 -1.011 . . . . 51.409999999999997 110.573 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.8 mt -128.01 133.05 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 105.515 -2.031 . . . . 63.350000000000001 105.515 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -129.4 124.43 34.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.402 -0.962 . . . . 73.540000000000006 108.402 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.8 m -86.09 106.74 17.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.204 -2.147 . . . . 72.329999999999998 105.204 166.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 61.96 -75.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 127.371 2.268 . . . . 72.409999999999997 113.039 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.08 34.57 0.9 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.283 1.033 . . . . 72.439999999999998 112.495 172.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -137.59 118.44 10.58 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.498 1.919 . . . . 73.519999999999996 108.018 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.31 133.58 23.03 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.243 2.629 . . . . 74.230000000000004 111.125 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 mm -122.05 1.71 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 126.501 1.92 . . . . 64.219999999999999 111.046 -175.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.7 t -160.39 153.04 21.02 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 119.867 -1.771 . . . . 32.43 109.335 166.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -148.66 136.04 20.34 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.332 1.853 . . . . 63.140000000000001 109.302 172.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -158.57 163.22 37.22 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.746 1.618 . . . . 75.239999999999995 107.677 169.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.7 mtm -138.68 151.12 46.91 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.091 0.956 . . . . 73.450000000000003 108.808 170.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -159.0 155.09 26.88 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.949 0.9 . . . . 63.030000000000001 109.752 -176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -83.23 167.25 17.87 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.657 -0.497 . . . . 73.140000000000001 109.657 173.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.08 159.87 42.69 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.01 -1.107 . . . . 61.43 108.01 169.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HA ' ' HE2' ' A' ' 54' ' ' LYS . 10.7 mmpt? -125.27 163.31 22.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.675 0.671 . . . . 75.140000000000001 109.826 162.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.6 mm -120.77 82.34 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.464 1.505 . . . . 51.240000000000002 106.956 174.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -117.45 24.11 11.33 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.795 1.238 . . . . 74.230000000000004 110.097 -172.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.71 14.56 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.434 1.894 . . . . 62.439999999999998 112.842 -164.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.78 10.02 53.95 Favored Glycine 0 CA--C 1.534 1.257 0 O-C-N 120.483 -1.385 . . . . 72.120000000000005 112.965 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.69 169.05 18.44 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 127.707 2.403 . . . . 74.349999999999994 106.739 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.8 mt -81.27 150.63 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 106.972 -1.492 . . . . 63.229999999999997 106.972 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -132.1 111.63 11.63 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.412 1.885 . . . . 75.239999999999995 108.501 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.0 mm -85.43 148.89 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.519 -1.289 . . . . 74.209999999999994 107.519 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -158.08 -5.51 0.09 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 116.132 1.901 . . . . 74.409999999999997 116.132 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -156.36 107.48 2.44 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 106.087 -1.82 . . . . 75.140000000000001 106.087 -164.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.9 ' CG1' ' H ' ' A' ' 70' ' ' LYS . 4.0 p -137.62 150.67 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 125.149 1.379 . . . . 75.120000000000005 110.741 -175.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.06 161.75 61.85 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.286 1.035 . . . . 75.519999999999996 108.388 167.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.48 -24.61 9.98 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 N-CA-C 114.493 0.92 . . . . 72.349999999999994 114.493 1.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -121.27 111.8 17.82 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.698 -0.852 . . . . 73.549999999999997 108.698 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.761 ' HA ' HG13 ' A' ' 65' ' ' VAL . 42.4 mt-10 -60.57 123.34 17.1 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 128.199 2.599 . . . . 63.43 109.057 -174.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.9 ' H ' ' CG1' ' A' ' 65' ' ' VAL . 3.6 mtpp -103.35 152.25 21.8 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.405 -0.961 . . . . 63.140000000000001 108.405 174.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.0 t -56.72 147.56 51.52 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.064 -0.717 . . . . 71.129999999999995 109.064 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.8 158.92 35.41 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.855 2.37 . . . . 62.140000000000001 112.272 170.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -172.44 168.58 5.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.791 2.436 . . . . 72.349999999999994 107.648 170.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -95.86 154.42 17.24 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.587 -0.894 . . . . 63.049999999999997 108.587 171.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.8 mt -131.93 134.36 45.57 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.956 1.302 . . . . 74.209999999999994 108.987 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -96.07 125.22 40.46 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.869 1.667 . . . . 64.439999999999998 108.716 -169.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 p -158.3 165.42 34.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.685 1.194 . . . . 73.140000000000001 109.723 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.19 160.27 29.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 124.376 1.071 . . . . 74.439999999999998 111.866 170.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 tt -144.99 151.98 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 124.996 1.318 . . . . 72.310000000000002 107.71 177.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.9 t -147.75 19.58 1.15 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.663 0.986 . . . . 74.420000000000002 113.663 161.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.11 -102.46 0.26 Allowed Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.634 -1.786 . . . . 73.219999999999999 108.634 173.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.1 p -87.61 -12.94 44.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.332 0.566 . . . . 72.209999999999994 112.298 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 m -89.26 126.69 35.61 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.137 -1.431 . . . . 62.240000000000002 107.137 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.7 tp -113.42 132.8 55.5 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.649 1.579 . . . . 75.349999999999994 108.342 160.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.5 93.76 4.0 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.938 2.095 . . . . 65.430000000000007 108.005 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.95 138.55 19.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.274 -1.38 . . . . 61.130000000000003 107.274 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -101.96 -31.49 10.65 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.737 -0.649 . . . . 74.239999999999995 112.289 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -145.9 171.24 15.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.405 1.002 . . . . 75.340000000000003 110.84 -175.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.77 174.02 38.07 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 108.924 -1.67 . . . . 52.240000000000002 108.924 -174.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.0 m -61.0 -22.02 64.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.295 -1.12 . . . . 72.049999999999997 112.011 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -84.11 -5.56 59.26 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.634 0.976 . . . . 74.439999999999998 113.634 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -46.52 108.81 0.15 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 127.22 2.208 . . . . 75.420000000000002 110.616 -170.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.03 -172.75 44.94 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 122.284 0.935 . . . . 52.140000000000001 113.277 -159.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.1 p -137.61 104.98 5.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.614 1.966 . . . . 64.329999999999998 107.287 -156.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -124.36 167.3 14.56 Favored 'General case' 0 C--O 1.239 0.545 0 O-C-N 120.929 -1.107 . . . . 75.120000000000005 112.368 -165.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -124.02 127.38 47.79 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 129.311 3.045 . . . . 64.310000000000002 107.894 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -57.57 135.13 56.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.122 1.369 . . . . 55.350000000000001 109.005 171.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 114.248 1.203 . . . . 75.319999999999993 114.248 176.526 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.841 0 N-CA-C 109.884 -1.287 . . . . 51.32 109.884 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.79 100.21 11.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 106.779 -1.563 . . . . 42.009999999999998 106.779 164.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -104.74 95.88 6.19 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.205 -2.146 . . . . 40.32 105.205 -175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -93.27 160.43 14.83 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.598 1.159 . . . . 64.340000000000003 109.838 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.8 p -91.17 167.7 12.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.559 0.618 . . . . 73.420000000000002 110.276 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.79 116.87 4.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.884 0.849 . . . . 63.399999999999999 109.663 160.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.1 tp -54.18 125.63 19.84 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.651 -1.24 . . . . 71.230000000000004 107.651 157.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -145.42 172.52 13.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 122.169 0.985 . . . . 74.530000000000001 110.07 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.49 -1.06 0.69 Allowed 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 126.954 2.102 . . . . 53.329999999999998 115.331 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -122.95 -36.99 2.79 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 120.17 1.35 . . . . 71.519999999999996 112.66 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.1 p30 -73.94 -30.71 62.7 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.358 0.981 . . . . 53.210000000000001 112.884 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.0 tp -66.58 -22.9 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 119.62 1.1 . . . . 62.100000000000001 112.903 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.6 mm -65.37 126.23 24.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.134 1.374 . . . . 70.109999999999999 110.905 -164.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 131.28 -172.74 20.65 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 126.783 2.135 . . . . 42.219999999999999 110.59 179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -91.09 162.85 14.51 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.435 1.094 . . . . 75.409999999999997 111.567 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -148.84 122.44 9.18 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.506 0.722 . . . . 63.409999999999997 111.045 -175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.2 t -127.35 160.73 30.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.954 1.301 . . . . 75.299999999999997 112.474 -174.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.58 -66.17 0.94 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.566 1.946 . . . . 55.43 107.1 172.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.12 -179.44 48.0 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 129.37 3.366 . . . . 64.530000000000001 106.578 -170.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.1 pt -111.61 16.26 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 113.746 1.017 . . . . 64.549999999999997 113.746 -158.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -115.79 -178.82 3.48 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.682 1.193 . . . . 71.439999999999998 113.098 -166.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 46.33 -93.5 0.01 OUTLIER Glycine 0 C--N 1.34 0.79 0 C-N-CA 127.547 2.499 . . . . 73.230000000000004 114.976 157.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.3 m -140.76 92.86 2.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.865 -1.902 . . . . 72.409999999999997 105.865 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -100.17 168.44 9.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 122.214 1.007 . . . . 64.219999999999999 110.473 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -134.95 145.29 48.03 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.192 1.797 . . . . 54.119999999999997 106.817 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.427 HD13 ' H ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -133.57 146.07 50.66 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.869 0.868 . . . . 71.129999999999995 108.852 -177.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.427 ' H ' HD13 ' A' ' 26' ' ' LEU . 10.0 mt -134.71 158.77 43.26 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 125.041 1.336 . . . . 72.439999999999998 109.87 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.8 t -144.12 155.53 43.98 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.843 2.057 . . . . 61.43 108.552 164.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -144.69 126.89 15.69 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 127.161 2.185 . . . . 64.120000000000005 107.611 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -101.59 159.45 15.29 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.959 1.704 . . . . 62.520000000000003 108.491 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.01 -38.02 28.2 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.823 -0.171 . . . . 74.519999999999996 110.634 -175.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -129.15 21.86 5.71 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.503 0.668 . . . . 71.109999999999999 110.815 -170.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.68 -112.85 1.6 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.745 1.64 . . . . 44.420000000000002 109.413 173.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.9 p -141.39 175.85 9.34 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.157 1.783 . . . . 73.200000000000003 109.555 -164.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -98.75 170.02 23.73 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.611 -0.995 . . . . 51.0 110.611 161.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.7 m -144.84 144.13 30.97 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.78 -0.835 . . . . 64.129999999999995 109.18 167.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -130.9 126.13 35.32 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.09 1.356 . . . . 73.310000000000002 107.69 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.69 159.07 17.36 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.047 0.832 . . . . 72.230000000000004 111.315 175.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 mt -136.99 136.01 47.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 105.347 -2.094 . . . . 63.340000000000003 105.347 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -123.42 167.24 14.1 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.015 1.326 . . . . 72.549999999999997 108.988 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.32 127.57 33.84 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.12 -1.437 . . . . 75.349999999999994 107.12 160.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 44.95 -73.07 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 131.446 3.898 . . . . 74.409999999999997 113.923 -176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.16 43.71 1.43 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.292 1.437 . . . . 42.310000000000002 112.55 175.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.7 m -144.51 135.61 12.47 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.809 1.243 . . . . 74.109999999999999 109.579 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.51 129.3 12.66 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 124.291 3.327 . . . . 73.519999999999996 111.17 168.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.3 mm -122.31 -22.48 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.903 0.881 . . . . 74.450000000000003 112.093 -173.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.9 t -130.54 170.2 14.56 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 120.545 -1.347 . . . . 74.25 109.048 169.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -159.6 144.33 15.23 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 127.765 2.426 . . . . 62.219999999999999 105.31 165.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -152.08 162.55 40.93 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.731 1.612 . . . . 72.310000000000002 106.707 162.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 39.9 mtm -130.0 162.84 27.78 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.84 -1.17 . . . . 73.129999999999995 107.84 167.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -157.15 145.79 19.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 123.877 0.736 . . . . 61.420000000000002 109.276 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.64 159.65 31.65 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.168 -1.419 . . . . 75.209999999999994 107.168 161.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -148.73 166.87 27.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 121.645 -0.659 . . . . 75.120000000000005 110.239 166.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -134.46 167.1 21.39 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.507 1.123 . . . . 72.299999999999997 108.571 167.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.8 mm -121.92 86.84 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.373 -1.714 . . . . 75.439999999999998 106.373 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -123.7 23.49 8.75 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.364 0.666 . . . . 71.129999999999995 110.105 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -165.73 14.04 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 114.68 1.363 . . . . 63.5 114.68 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 60.39 27.58 65.89 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 120.889 -1.132 . . . . 75.140000000000001 111.31 -168.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -139.39 161.31 37.77 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 127.209 2.204 . . . . 75.200000000000003 105.935 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mt -71.05 133.27 32.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 105.761 -1.94 . . . . 75.510000000000005 105.761 164.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -101.58 120.3 40.11 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.432 -1.692 . . . . 73.299999999999997 106.432 163.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.4 mm -105.31 137.49 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.308 -1.738 . . . . 44.32 106.308 174.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -160.6 1.31 0.07 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.424 0.898 . . . . 75.120000000000005 113.424 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -148.36 117.62 6.88 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 104.937 -2.246 . . . . 54.210000000000001 104.937 171.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.0 t -128.54 155.49 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 105.816 -1.92 . . . . 71.329999999999998 105.816 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.64 162.29 39.6 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 108.574 -0.898 . . . . 74.530000000000001 108.574 174.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.74 -21.75 15.37 Favored 'Cis proline' 0 CA--C 1.535 0.567 0 N-CA-C 113.872 0.681 . . . . 42.039999999999999 113.872 -8.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.29 93.57 6.96 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 104.942 -2.244 . . . . 61.530000000000001 104.942 174.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -63.16 140.76 58.91 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.091 0.956 . . . . 53.100000000000001 109.589 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -127.44 168.05 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.833 1.253 . . . . 75.129999999999995 110.094 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 t -55.64 148.04 37.45 Favored Pre-proline 0 CA--C 1.54 0.564 0 O-C-N 123.844 0.715 . . . . 75.409999999999997 109.938 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -69.29 139.81 42.83 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.175 1.916 . . . . 75.530000000000001 111.261 169.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -152.36 174.11 14.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.919 1.287 . . . . 64.209999999999994 109.874 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -112.74 158.98 19.41 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.546 0.738 . . . . 74.400000000000006 109.439 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.8 mt -130.32 112.24 13.12 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.165 1.386 . . . . 75.530000000000001 109.679 -175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -62.55 122.06 14.86 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.876 1.27 . . . . 72.099999999999994 108.06 173.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 2.3 p -154.72 163.67 39.9 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.599 0.36 . . . . 41.229999999999997 110.738 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.466 ' HE2' ' CD ' ' A' ' 87' ' ' GLU . 9.7 mttm -126.74 158.42 36.54 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.055 0.942 . . . . 75.510000000000005 109.298 176.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.1 tt -151.54 154.15 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 108.144 -1.058 . . . . 72.510000000000005 108.144 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -141.44 -9.35 0.96 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.84 1.793 . . . . 75.230000000000004 115.84 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.82 -73.53 0.21 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.378 -1.889 . . . . 75.310000000000002 108.378 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 p -117.52 1.64 12.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.851 1.056 . . . . 72.340000000000003 113.851 -169.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.6 m -119.74 106.79 12.47 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.846 2.058 . . . . 54.020000000000003 110.469 175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tp -75.07 128.32 35.27 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.639 -1.288 . . . . 74.439999999999998 108.333 164.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -117.25 95.09 4.82 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 119.039 -0.505 . . . . 64.099999999999994 110.681 164.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.445 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 66.1 t -86.11 132.5 31.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 119.038 0.835 . . . . 72.340000000000003 109.407 169.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.466 ' CD ' ' HE2' ' A' ' 78' ' ' LYS . 23.6 mt-10 -91.41 -31.71 15.92 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.923 0.889 . . . . 73.319999999999993 112.212 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 t -139.67 163.74 31.78 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.71 1.604 . . . . 71.420000000000002 110.556 -174.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.58 -179.86 30.62 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 122.628 1.127 . . . . 44.0 112.662 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.1 m -58.08 -31.05 66.72 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.687 1.595 . . . . 54.229999999999997 112.52 173.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.42 ' HB3' HD11 ' A' ' 27' ' ' LEU . 1.8 mp0 -103.69 11.99 35.3 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.169 0.588 . . . . 63.310000000000002 109.887 -167.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.01 117.14 5.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.4 2.28 . . . . 71.430000000000007 110.591 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.12 -123.39 1.1 Allowed Glycine 0 C--O 1.237 0.324 0 C-N-CA 124.381 0.991 . . . . 74.430000000000007 111.6 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.4 t -145.0 142.41 29.77 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 126.152 1.781 . . . . 73.540000000000006 107.747 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -142.91 152.18 41.79 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.164 0.438 . . . . 75.430000000000007 111.762 167.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -91.4 147.89 22.71 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.476 -0.565 . . . . 52.100000000000001 109.476 167.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -58.55 147.53 31.82 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.995 0.918 . . . . 75.540000000000006 108.653 169.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -134.61 52.74 2.03 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.776 1.63 . . . . 72.329999999999998 109.0 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.3 mttp . . . . . 0 C--O 1.256 1.398 0 N-CA-C 105.916 -1.883 . . . . 62.200000000000003 105.916 151.814 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.62 0 N-CA-C 109.78 -1.328 . . . . 71.010000000000005 109.78 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -153.95 87.12 1.2 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 122.203 1.001 . . . . 64.019999999999996 108.368 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -78.37 104.66 9.11 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.64 -1.985 . . . . 65.0 105.64 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.416 ' CG ' ' HB3' ' A' ' 78' ' ' LYS . 94.2 m95 -101.14 163.25 12.37 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 124.604 1.162 . . . . 65.310000000000002 111.02 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.3 p -101.06 162.13 13.11 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.595 -0.521 . . . . 65.230000000000004 109.595 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -58.1 117.51 4.44 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.035 1.334 . . . . 72.439999999999998 110.551 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.0 tp -66.4 105.64 1.51 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.629 -1.249 . . . . 73.209999999999994 107.629 165.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.437 ' HA ' HG21 ' A' ' 55' ' ' ILE . 22.0 p30 -126.56 172.8 9.94 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.951 -1.022 . . . . 70.310000000000002 111.123 175.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.89 -5.68 22.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.901 2.48 . . . . 73.310000000000002 112.764 -169.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -109.81 -28.64 8.68 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.223 0.92 . . . . 73.0 110.352 171.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -66.43 -35.41 80.23 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.887 0.875 . . . . 74.040000000000006 112.71 -169.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.77 -15.24 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 113.133 0.79 . . . . 70.140000000000001 113.133 -173.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.8 mm -68.79 122.19 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.121 0.968 . . . . 74.040000000000006 111.218 -161.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.78 -168.91 24.35 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.624 1.583 . . . . 64.230000000000004 111.319 -177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 28' ' ' SER . 1.9 m-85 -88.66 159.95 17.6 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.463 1.105 . . . . 72.230000000000004 110.284 176.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.417 ' CZ3' ' HB2' ' A' ' 84' ' ' LEU . 85.2 m95 -142.36 125.94 16.84 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 125.435 1.494 . . . . 74.430000000000007 109.756 176.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.7 t -123.58 164.02 19.84 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.191 0.997 . . . . 74.099999999999994 112.394 -174.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.419 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 3.2 t -129.43 -5.96 4.76 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.856 1.663 . . . . 50.140000000000001 112.967 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.23 176.01 14.7 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 108.099 -2.0 . . . . 73.420000000000002 108.099 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.5 pt -135.65 7.44 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 113.46 0.911 . . . . 71.129999999999995 113.46 -160.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.26 165.04 15.37 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.877 1.671 . . . . 74.129999999999995 110.109 -174.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.81 -84.47 0.02 OUTLIER Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.063 1.316 . . . . 73.239999999999995 113.167 169.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 m -148.25 95.42 2.46 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.212 1.405 . . . . 74.530000000000001 108.081 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -114.34 177.52 4.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.152 -0.967 . . . . 71.219999999999999 110.109 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -132.66 172.63 12.29 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.251 1.421 . . . . 72.439999999999998 107.369 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.04 136.3 22.61 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.802 -1.555 . . . . 74.230000000000004 106.802 173.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.1 mt -115.85 152.74 32.78 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.327 -0.99 . . . . 63.109999999999999 108.327 165.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.435 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 1.3 p -144.62 143.41 30.76 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.633 1.173 . . . . 61.200000000000003 108.554 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -138.89 124.66 19.71 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.012 0.925 . . . . 74.400000000000006 108.759 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.407 ' HB3' ' H ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -85.32 156.71 20.79 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 107.164 -1.421 . . . . 71.230000000000004 107.164 164.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -72.19 -47.83 47.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.868 0.842 . . . . 72.230000000000004 109.197 165.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.88 -1.45 24.17 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.87 2.068 . . . . 61.130000000000003 111.439 -161.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 30' ' ' ASP . . . -114.78 -122.35 3.62 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.297 -1.921 . . . . 70.109999999999999 108.297 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.0 p -133.0 -175.45 3.79 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.503 2.321 . . . . 74.140000000000001 107.741 -174.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -107.12 164.27 13.17 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.123 -1.191 . . . . 70.040000000000006 110.123 164.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.97 147.59 35.43 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.659 1.184 . . . . 54.399999999999999 108.73 -175.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -134.88 140.64 45.95 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 107.373 -1.343 . . . . 65.510000000000005 107.373 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.15 160.42 25.83 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 111.264 -0.734 . . . . 74.200000000000003 111.264 164.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 52.0 mt -122.79 145.4 29.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 105.3 -2.111 . . . . 71.430000000000007 105.3 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -133.89 166.34 22.92 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.992 1.317 . . . . 71.120000000000005 109.014 -173.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.99 139.42 39.67 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.304 -0.998 . . . . 41.140000000000001 108.304 157.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 44.48 -75.41 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 130.358 3.463 . . . . 73.540000000000006 115.975 175.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -145.31 47.77 1.29 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.6 0.636 . . . . 61.329999999999998 112.069 167.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.3 m -144.06 132.67 11.11 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.459 1.504 . . . . 74.349999999999994 109.324 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.31 132.24 16.15 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.604 2.869 . . . . 74.319999999999993 110.333 165.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.7 mm -123.48 -23.58 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.774 0.829 . . . . 65.319999999999993 111.835 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.4 t -141.44 162.76 34.69 Favored 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 120.065 -1.647 . . . . 72.25 109.864 169.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -160.74 137.56 8.88 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.348 2.259 . . . . 71.430000000000007 107.428 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -161.28 165.49 29.1 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.537 1.535 . . . . 72.510000000000005 107.661 168.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.3 mtm -134.31 163.33 29.87 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.897 -1.149 . . . . 64.439999999999998 107.897 170.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -163.09 146.88 10.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.8 0.84 . . . . 70.430000000000007 110.231 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.31 161.01 31.44 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.205 -1.035 . . . . 73.109999999999999 108.205 162.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -144.02 171.38 14.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 121.784 -0.573 . . . . 72.400000000000006 109.594 165.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -137.01 161.8 35.07 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.863 0.865 . . . . 74.340000000000003 109.718 167.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.437 HG21 ' HA ' ' A' ' 8' ' ' ASN . 40.0 mm -105.18 103.68 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.922 -1.51 . . . . 73.430000000000007 106.922 165.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -134.67 24.48 3.69 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.329 -0.857 . . . . 73.310000000000002 113.193 171.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -163.72 14.1 0.06 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.604 1.962 . . . . 74.400000000000006 116.053 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.33 18.21 57.79 Favored Glycine 0 CA--C 1.539 1.558 0 O-C-N 120.119 -1.613 . . . . 72.310000000000002 113.069 -168.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 79.9 mtt85 -134.12 -171.48 2.76 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.4 3.08 . . . . 65.329999999999998 107.208 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.17 113.49 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 121.242 1.837 . . . . 70.129999999999995 107.515 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -82.74 102.55 11.62 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.766 -1.198 . . . . 73.400000000000006 107.766 171.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.9 mm -81.32 137.57 21.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 105.898 -1.89 . . . . 74.439999999999998 105.898 168.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -151.15 -8.94 0.23 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.03 1.493 . . . . 71.299999999999997 115.03 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -144.77 112.71 6.36 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.361 -1.348 . . . . 73.329999999999998 107.361 175.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.2 t -122.47 154.28 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 125.776 1.63 . . . . 53.210000000000001 107.749 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.49 162.21 52.66 Favored Pre-proline 0 C--O 1.238 0.463 0 C-N-CA 124.44 1.096 . . . . 73.420000000000002 108.393 172.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -83.75 -14.17 35.86 Favored 'Cis proline' 0 CA--C 1.536 0.624 0 N-CA-C 113.78 0.646 . . . . 64.140000000000001 113.78 -9.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.76 115.89 31.36 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 103.72 -2.696 . . . . 74.219999999999999 103.72 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -93.5 143.82 25.93 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.0 0.812 . . . . 70.420000000000002 109.571 -177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -132.81 172.4 12.62 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.276 1.43 . . . . 64.030000000000001 109.878 -171.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 t -54.41 146.36 33.3 Favored Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 123.61 0.569 . . . . 62.100000000000001 109.564 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -65.97 144.7 77.38 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.937 1.758 . . . . 53.200000000000003 109.799 165.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -154.92 164.44 38.87 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.998 0.919 . . . . 61.109999999999999 110.501 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.3 127.54 49.24 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.707 0.803 . . . . 74.340000000000003 109.333 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.28 112.68 24.34 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.452 1.501 . . . . 73.409999999999997 108.77 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.29 123.25 17.72 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.778 -1.193 . . . . 70.409999999999997 107.778 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.495 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 1.8 p -157.13 156.84 33.4 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.225 0.61 . . . . 74.019999999999996 110.458 175.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 4' ' ' TRP . 1.5 mppt? -129.57 156.25 44.5 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.802 1.241 . . . . 74.200000000000003 111.056 -175.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.3 tt -151.25 146.54 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 122.491 0.316 . . . . 72.340000000000003 110.844 -171.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -149.31 43.51 0.94 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.303 1.841 . . . . 73.230000000000004 111.435 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.63 -89.74 1.63 Allowed Glycine 0 CA--C 1.52 0.349 0 N-CA-C 110.385 -1.086 . . . . 72.010000000000005 110.385 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -20.26 24.75 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.099 -1.429 . . . . 72.209999999999994 114.823 -171.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -102.74 108.14 19.27 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 122.017 2.19 . . . . 63.0 111.278 -174.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.417 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 33.0 tp -87.6 123.81 32.86 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 120.335 -1.478 . . . . 65.299999999999997 108.53 168.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -118.67 91.04 3.46 Favored 'General case' 0 CA--C 1.523 -0.095 0 C-N-CA 124.02 0.928 . . . . 74.219999999999999 109.931 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.495 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 22.2 t -86.1 130.94 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.934 -1.136 . . . . 72.030000000000001 107.934 173.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -85.39 -32.65 22.27 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 118.957 -0.544 . . . . 70.230000000000004 111.946 -175.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.5 t -143.32 167.89 21.09 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.68 1.192 . . . . 63.409999999999997 110.774 -169.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.71 178.86 43.62 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-O 122.432 1.018 . . . . 62.140000000000001 112.624 -178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.0 m -51.87 -27.93 14.34 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.719 1.608 . . . . 70.530000000000001 112.65 174.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -101.16 10.89 40.37 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.209 0.818 . . . . 64.340000000000003 113.209 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.02 105.21 0.3 Allowed 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.375 -0.828 . . . . 42.329999999999998 110.084 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.84 -136.71 2.48 Favored Glycine 0 CA--C 1.519 0.302 0 O-C-N 121.169 -0.957 . . . . 70.230000000000004 112.57 -172.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.2 t -153.29 116.77 4.67 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.33 1.052 . . . . 62.420000000000002 109.367 -171.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.419 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 88.4 m-85 -139.78 152.44 46.59 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 121.466 -0.771 . . . . 71.319999999999993 110.561 -167.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -116.74 146.28 42.91 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 118.647 -0.692 . . . . 62.200000000000003 110.393 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -54.7 148.15 13.28 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.932 -1.136 . . . . 61.240000000000002 107.932 173.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -129.43 148.74 51.38 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.407 -1.701 . . . . 70.129999999999995 106.407 166.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp . . . . . 0 C--O 1.257 1.477 0 C-N-CA 126.275 1.83 . . . . 41.299999999999997 110.336 -179.488 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.465 0 N-CA-C 110.958 -0.857 . . . . 43.420000000000002 110.958 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -134.35 142.75 47.32 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 105.25 -2.13 . . . . 51.030000000000001 105.25 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -131.83 81.46 1.97 Allowed 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 108.25 -1.019 . . . . 72.540000000000006 108.25 -155.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -118.03 147.84 42.83 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.462 0.305 . . . . 74.230000000000004 111.775 -170.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.8 p -83.39 171.05 13.88 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.465 0.706 . . . . 62.219999999999999 110.3 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -56.88 123.38 14.86 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.303 -0.862 . . . . 71.329999999999998 109.768 155.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.24 134.01 53.93 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 124.879 1.272 . . . . 72.310000000000002 110.524 157.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -140.48 174.74 10.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.468 -0.938 . . . . 64.430000000000007 108.468 163.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -69.31 40.99 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.8 1.64 . . . . 74.340000000000003 110.289 169.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -134.26 -59.61 0.82 Allowed 'General case' 0 N--CA 1.466 0.374 0 O-C-N 118.269 -2.77 . . . . 61.450000000000003 108.212 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -73.2 -26.27 61.09 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.572 0.749 . . . . 63.539999999999999 111.47 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.04 -20.02 17.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 119.459 1.027 . . . . 71.439999999999998 112.506 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.2 mm -68.66 144.41 14.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 O-C-N 121.23 -0.918 . . . . 73.510000000000005 109.521 -169.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.23 -153.82 17.36 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 124.944 1.259 . . . . 64.150000000000006 110.296 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -120.79 154.16 36.08 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.279 1.431 . . . . 73.549999999999997 109.494 -168.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.429 ' CE3' ' HB2' ' A' ' 84' ' ' LEU . 97.2 m95 -152.13 117.1 5.17 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.006 0.922 . . . . 74.450000000000003 109.593 -161.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.2 t -122.81 166.76 14.46 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.21 1.368 . . . . 70.450000000000003 112.024 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.7 t -125.19 2.75 7.88 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.661 1.584 . . . . 72.549999999999997 111.829 174.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.08 -177.37 36.57 Favored Glycine 0 C--N 1.339 0.71 0 CA-C-N 120.503 1.501 . . . . 61.32 111.667 176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 47.6 pt -128.78 5.31 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 125.391 1.476 . . . . 75.129999999999995 111.387 -175.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -147.15 -173.23 4.19 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.52 1.528 . . . . 71.109999999999999 110.237 -164.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 48.48 -104.19 0.08 OUTLIER Glycine 0 C--N 1.339 0.734 0 C-N-CA 126.25 1.881 . . . . 24.43 111.763 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -138.39 97.66 3.42 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.593 -1.632 . . . . 74.340000000000003 106.593 172.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -111.78 177.76 4.54 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.77 0.828 . . . . 72.510000000000005 110.712 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -154.57 155.76 35.35 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.005 0.922 . . . . 74.409999999999997 108.934 -175.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.01 131.0 36.58 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.846 1.659 . . . . 63.240000000000002 108.298 -168.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.609 HD22 ' CZ ' ' A' ' 29' ' ' PHE . 3.9 mt -115.38 153.68 30.59 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.769 1.628 . . . . 73.129999999999995 108.895 170.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.3 p -147.19 153.39 39.8 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.31 -0.996 . . . . 74.420000000000002 108.31 167.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.609 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 68.4 m-85 -144.63 141.97 29.77 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.948 1.299 . . . . 73.310000000000002 108.85 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -110.69 158.93 18.07 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.272 1.429 . . . . 71.340000000000003 108.147 173.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.84 -29.42 40.14 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 120.909 -0.316 . . . . 71.430000000000007 111.683 -177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.36 10.59 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 125.108 1.363 . . . . 74.420000000000002 110.139 -164.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.33 -124.02 2.82 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 125.017 1.294 . . . . 73.430000000000007 110.127 -169.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -140.31 167.14 22.85 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.822 -1.177 . . . . 71.129999999999995 107.822 168.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -93.36 176.25 36.83 Favored Glycine 0 CA--C 1.523 0.551 0 O-C-N 121.53 -0.732 . . . . 70.5 112.057 170.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.85 161.65 33.62 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.108 0.963 . . . . 63.240000000000002 109.828 171.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -141.99 151.06 42.15 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.274 -1.01 . . . . 70.420000000000002 108.274 168.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.77 161.76 32.53 Favored Glycine 0 CA--C 1.525 0.662 0 O-C-N 121.524 -0.735 . . . . 63.109999999999999 111.621 163.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.5 mt -124.83 149.58 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 127.047 2.139 . . . . 73.510000000000005 105.356 -177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -134.0 164.78 26.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.271 1.428 . . . . 74.209999999999994 110.149 -170.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.2 m -133.9 120.42 20.36 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.977 2.111 . . . . 54.409999999999997 106.006 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.254 0.9 OUTLIER 45.02 -81.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 130.016 3.326 . . . . 70.299999999999997 114.582 -173.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.67 43.54 1.73 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.786 1.635 . . . . 74.099999999999994 109.335 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.3 m -137.4 129.22 16.55 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 126.059 1.744 . . . . 64.400000000000006 107.635 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.37 136.92 32.52 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.747 2.298 . . . . 72.019999999999996 109.435 168.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.6 mm -120.56 -22.23 3.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 118.658 -0.687 . . . . 63.520000000000003 111.279 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 91.3 p -139.02 169.81 17.11 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 119.884 1.22 . . . . 52.020000000000003 110.782 173.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -159.15 153.27 23.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.827 -1.079 . . . . 63.109999999999999 108.307 172.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -166.61 161.49 15.93 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 105.649 -1.982 . . . . 74.430000000000007 105.649 165.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.8 mtm -122.57 159.01 28.68 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 106.389 -1.708 . . . . 74.239999999999995 106.389 160.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.18 141.01 17.13 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 123.991 0.807 . . . . 71.310000000000002 109.503 175.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -78.7 156.48 28.92 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 123.079 1.419 . . . . 72.329999999999998 108.391 166.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -151.84 169.05 23.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.171 -1.377 . . . . 61.119999999999997 110.021 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -141.44 163.17 33.65 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.113 0.965 . . . . 65.129999999999995 109.475 167.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.6 mm -120.05 89.33 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 106.791 -1.559 . . . . 64.540000000000006 106.791 170.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -123.42 25.81 8.14 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.598 1.159 . . . . 72.310000000000002 110.529 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -164.41 14.35 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.785 1.234 . . . . 65.230000000000004 112.604 -175.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.47 26.69 69.86 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 120.451 -0.88 . . . . 72.310000000000002 111.219 -172.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -151.22 164.47 36.5 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 129.466 3.106 . . . . 65.230000000000004 106.817 -168.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 65.9 mt -100.27 109.92 26.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.404 -1.702 . . . . 63.420000000000002 106.404 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -80.9 106.17 12.7 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.065 -1.457 . . . . 65.209999999999994 107.065 171.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.1 mm -85.54 140.21 16.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.968 -1.493 . . . . 53.210000000000001 106.968 171.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -156.52 -2.69 0.12 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 115.868 1.803 . . . . 72.140000000000001 115.868 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -148.03 120.99 8.77 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 103.618 -2.734 . . . . 71.319999999999993 103.618 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.8 t -133.47 154.09 38.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 125.314 1.446 . . . . 61.229999999999997 107.436 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.94 163.54 37.48 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.651 1.181 . . . . 72.430000000000007 109.055 172.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.24 -21.39 13.66 Favored 'Cis proline' 0 C--N 1.345 0.374 0 N-CA-C 113.968 0.719 . . . . 62.240000000000002 113.968 -7.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -100.78 101.05 11.81 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.329 -2.1 . . . . 71.439999999999998 105.329 177.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -61.64 139.08 58.33 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.775 1.23 . . . . 73.319999999999993 110.417 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 9.0 mmpt? -114.56 158.42 21.7 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.072 1.749 . . . . 70.299999999999997 109.095 -177.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 t -65.04 148.87 97.52 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.657 -0.868 . . . . 74.329999999999998 108.657 172.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.63 145.58 52.52 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.567 2.178 . . . . 74.230000000000004 112.478 178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -156.15 167.88 29.05 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.887 1.275 . . . . 72.519999999999996 110.307 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -106.51 130.55 54.27 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.917 -1.142 . . . . 74.109999999999999 107.917 175.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.0 mt -106.39 132.64 52.18 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 125.956 1.702 . . . . 70.099999999999994 109.103 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.65 128.12 34.79 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.672 1.189 . . . . 70.340000000000003 110.694 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 p -150.29 164.98 34.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.499 1.519 . . . . 62.43 109.47 169.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -127.8 164.1 22.92 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.906 2.082 . . . . 54.310000000000002 112.239 159.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.8 tt -155.3 160.24 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 107.556 -1.275 . . . . 71.310000000000002 107.556 174.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 69.6 m -128.38 -66.1 0.86 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.493 2.317 . . . . 55.409999999999997 109.914 170.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.68 -83.76 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 106.998 -2.441 . . . . 73.329999999999998 106.998 170.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 p -95.08 -8.5 36.4 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.082 1.882 . . . . 72.549999999999997 116.082 -167.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.2 m -101.63 98.86 9.1 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 121.342 1.883 . . . . 73.510000000000005 109.34 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.429 ' HB2' ' CE3' ' A' ' 16' ' ' TRP . 0.2 OUTLIER -76.03 119.11 19.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.005 -1.85 . . . . 72.450000000000003 106.005 165.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -108.05 88.88 2.83 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.618 -0.882 . . . . 64.239999999999995 108.618 173.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.3 t -80.23 128.32 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 107.858 -1.164 . . . . 63.549999999999997 107.858 169.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.65 -46.58 16.92 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 118.4 -0.81 . . . . 73.25 112.078 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.6 t -126.12 -172.85 2.71 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.575 1.08 . . . . 64.140000000000001 111.584 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.8 177.98 51.91 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 109.99 -1.244 . . . . 30.34 109.99 -171.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.5 m -60.49 -19.22 56.13 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.659 -0.906 . . . . 65.329999999999998 111.803 164.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -89.78 0.63 56.89 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.299 0.64 . . . . 65.549999999999997 112.371 -170.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.96 108.45 0.4 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 127.083 2.153 . . . . 70.530000000000001 110.261 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.79 -150.12 6.52 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 121.833 0.685 . . . . 72.530000000000001 112.583 -167.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 t -144.86 125.76 14.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.852 -1.907 . . . . 74.140000000000001 105.852 165.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -122.9 124.65 43.7 Favored 'General case' 0 C--O 1.226 -0.168 0 O-C-N 121.641 -0.662 . . . . 74.450000000000003 110.606 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -88.09 18.17 4.48 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 115.335 1.606 . . . . 75.25 115.335 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 26.3 tttt 62.43 156.03 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 127.172 2.189 . . . . 72.120000000000005 110.677 -170.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -143.11 47.2 1.52 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 127.059 2.144 . . . . 71.450000000000003 106.8 -175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.8 tttt . . . . . 0 C--O 1.254 1.337 0 C-N-CA 124.253 1.021 . . . . 73.329999999999998 110.648 175.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.806 0 N-CA-C 109.297 -1.521 . . . . 50.119999999999997 109.297 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.24 76.18 1.54 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 106.973 -1.491 . . . . 71.230000000000004 106.973 172.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -89.07 103.17 15.81 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.494 -1.298 . . . . 72.150000000000006 107.494 -162.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -108.29 161.26 15.17 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.906 2.082 . . . . 74.340000000000003 109.989 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.4 p -90.4 167.65 12.46 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 118.569 0.622 . . . . 63.43 109.896 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -51.63 125.18 14.06 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 122.132 0.968 . . . . 72.049999999999997 108.77 159.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.4 tp -67.66 118.99 11.67 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 107.29 -1.374 . . . . 63.310000000000002 107.29 161.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.449 HD22 ' ND2' ' A' ' 11' ' ' ASN . 21.2 m-80 -119.45 162.78 18.27 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 105.273 -2.121 . . . . 60.329999999999998 105.273 168.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 p -61.12 -44.91 96.62 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.16 -1.052 . . . . 53.25 108.16 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -53.83 -21.81 8.34 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.781 1.632 . . . . 75.540000000000006 113.918 177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.449 ' ND2' HD22 ' A' ' 8' ' ' ASN . 93.0 m-20 -90.27 -29.78 17.94 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.283 0.947 . . . . 73.239999999999995 113.085 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.2 tp -87.66 -10.92 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.24 1.016 . . . . 64.519999999999996 111.923 -168.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mm -60.31 135.56 24.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 124.303 1.041 . . . . 61.149999999999999 111.523 -175.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.1 175.59 14.14 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 126.31 1.91 . . . . 35.340000000000003 110.847 169.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -78.17 159.09 28.78 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.972 -0.751 . . . . 73.209999999999994 108.972 164.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -149.59 146.15 27.17 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.588 1.155 . . . . 74.319999999999993 109.261 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.8 p -134.96 175.4 9.61 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 120.247 1.385 . . . . 73.230000000000004 112.851 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.2 t -133.8 12.94 4.03 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.451 1.1 . . . . 73.420000000000002 113.217 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.03 176.97 14.86 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.839 -1.704 . . . . 52.100000000000001 108.839 -175.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 41.0 pt -130.88 15.24 2.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.857 0.863 . . . . 65.219999999999999 112.612 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -108.91 165.1 11.83 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.118 1.367 . . . . 73.329999999999998 111.456 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.0 -101.35 0.72 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.561 -1.016 . . . . 53.210000000000001 110.561 162.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.3 m -141.7 117.3 10.31 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.455 -2.054 . . . . 73.219999999999999 105.455 162.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -114.99 179.23 4.01 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.689 1.595 . . . . 74.230000000000004 109.295 -176.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -142.81 139.85 31.1 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.165 1.386 . . . . 74.439999999999998 108.918 -171.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.0 144.6 48.44 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.82 1.648 . . . . 50.219999999999999 108.306 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.556 HD22 ' CZ ' ' A' ' 29' ' ' PHE . 7.9 mt -124.76 155.62 39.03 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.358 1.863 . . . . 74.510000000000005 109.261 175.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.7 t -143.78 152.23 40.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.31 1.444 . . . . 72.430000000000007 107.735 163.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.556 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 61.4 m-85 -149.13 127.68 12.34 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 127.128 2.171 . . . . 74.120000000000005 107.002 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.54 163.32 12.55 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.576 0.75 . . . . 71.109999999999999 111.386 172.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.37 -30.19 37.88 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.982 0.734 . . . . 60.549999999999997 112.982 -174.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.75 2.26 3.14 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.271 0.357 . . . . 72.209999999999994 110.975 -172.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -110.11 -129.41 5.68 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.678 1.609 . . . . 71.340000000000003 109.827 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.8 p -138.71 -175.42 4.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.328 2.251 . . . . 74.5 106.175 -177.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.67 -177.81 22.4 Favored Glycine 0 C--O 1.238 0.385 0 N-CA-C 109.862 -1.295 . . . . 62.539999999999999 109.862 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.7 p -159.77 152.16 21.03 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.797 1.036 . . . . 42.409999999999997 113.797 -163.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -129.55 112.82 14.11 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.364 1.866 . . . . 71.030000000000001 107.299 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.17 109.21 0.95 Allowed Glycine 0 C--N 1.341 0.857 0 C-N-CA 124.376 0.988 . . . . 54.520000000000003 112.053 -177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.6 mt -76.61 143.06 13.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 124.463 1.105 . . . . 65.030000000000001 108.239 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -131.73 125.12 31.21 Favored 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 125.031 1.333 . . . . 71.219999999999999 109.301 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.8 m -88.31 112.69 23.12 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.597 -1.261 . . . . 41.399999999999999 107.597 166.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 53.06 -78.05 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 127.995 2.518 . . . . 72.129999999999995 112.342 -173.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.94 21.09 2.3 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.423 1.889 . . . . 54.43 112.492 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.2 m -116.76 118.02 37.08 Favored Pre-proline 0 CA--C 1.535 0.366 0 C-N-CA 125.393 1.477 . . . . 53.130000000000003 107.675 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.61 125.69 14.81 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.576 2.184 . . . . 73.109999999999999 108.702 171.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.4 mm -117.24 -3.9 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.672 0.789 . . . . 74.129999999999995 110.907 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.4 t -152.17 163.7 38.84 Favored 'General case' 0 CA--C 1.51 -0.565 0 O-C-N 120.169 -1.582 . . . . 62.340000000000003 108.998 172.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -157.7 144.92 18.3 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.022 1.729 . . . . 75.5 106.939 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -167.77 153.59 7.39 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 105.629 -1.989 . . . . 71.209999999999994 105.629 165.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 12.5 mtm -132.32 153.9 50.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.564 1.146 . . . . 73.540000000000006 108.83 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -163.2 154.37 16.97 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.747 0.819 . . . . 71.450000000000003 109.527 -174.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.92 169.09 16.42 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.143 2.177 . . . . 75.120000000000005 109.601 172.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.68 162.02 36.55 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 124.258 1.023 . . . . 63.310000000000002 110.261 171.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -134.11 131.31 38.58 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.49 -1.3 . . . . 72.219999999999999 107.49 160.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.48 107.66 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 105.597 -2.001 . . . . 73.420000000000002 105.597 163.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -152.66 45.9 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.463 0.705 . . . . 61.329999999999998 109.137 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -177.95 14.49 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.811 2.444 . . . . 73.140000000000001 111.966 162.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.94 25.24 71.93 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.393 -1.442 . . . . 65.120000000000005 110.822 -160.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 76.4 mtt85 -140.05 158.75 43.57 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 126.724 2.009 . . . . 71.129999999999995 106.512 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 41.9 mt -76.08 138.77 20.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.168 -1.79 . . . . 73.25 106.168 172.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -117.49 115.96 26.19 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 126.81 2.044 . . . . 72.109999999999999 107.111 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.4 mm -97.71 143.05 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 106.979 -1.489 . . . . 74.230000000000004 106.979 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -159.36 -2.62 0.08 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 115.067 1.506 . . . . 73.140000000000001 115.067 -178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -148.42 125.19 11.18 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 104.084 -2.562 . . . . 73.420000000000002 104.084 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.2 t -132.14 152.33 36.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 125.212 1.405 . . . . 63.119999999999997 107.787 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.4 151.94 48.7 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 125.833 1.653 . . . . 75.099999999999994 106.678 173.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.52 -6.74 50.3 Favored 'Cis proline' 0 CA--C 1.534 0.513 0 CA-C-N 119.378 0.814 . . . . 61.009999999999998 113.983 4.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.28 108.61 18.77 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.791 -1.929 . . . . 73.209999999999994 105.791 172.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -60.63 127.97 34.28 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 125.097 1.359 . . . . 74.230000000000004 108.142 169.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -125.16 160.38 29.27 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.635 0.774 . . . . 65.239999999999995 110.078 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -56.89 147.05 55.89 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.051 0.941 . . . . 63.149999999999999 109.437 -176.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.93 147.19 89.09 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.979 1.786 . . . . 70.310000000000002 111.07 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -157.56 151.41 24.24 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.269 1.828 . . . . 53.109999999999999 108.17 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -81.22 160.23 24.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 114.637 -1.165 . . . . 72.25 107.931 165.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.83 127.28 38.3 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 124.467 1.107 . . . . 73.010000000000005 108.711 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.22 115.2 20.51 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.621 -1.622 . . . . 70.150000000000006 106.621 175.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -146.1 151.7 38.11 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.717 1.207 . . . . 63.420000000000002 107.773 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -117.8 157.99 25.58 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.253 1.021 . . . . 73.319999999999993 109.373 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.4 tt -151.65 151.78 11.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 118.689 -0.672 . . . . 64.049999999999997 109.537 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.4 m -141.68 -6.98 0.99 Allowed 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.339 1.607 . . . . 73.120000000000005 115.339 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.23 -82.35 0.17 Allowed Glycine 0 N--CA 1.461 0.308 0 O-C-N 120.363 -1.46 . . . . 63.310000000000002 109.552 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.5 p -104.32 -13.54 16.1 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 118.534 -0.746 . . . . 44.32 112.057 170.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 m -90.01 101.63 14.34 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.45 1.477 . . . . 61.299999999999997 109.784 174.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.7 tp -81.58 138.94 35.32 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.419 -1.326 . . . . 72.430000000000007 107.419 159.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -127.66 144.43 51.08 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.617 -0.883 . . . . 74.129999999999995 108.617 163.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.8 t -127.99 127.21 67.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.793 -1.558 . . . . 73.120000000000005 106.793 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -96.45 -20.84 18.12 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.436 0.902 . . . . 70.019999999999996 113.436 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -155.48 172.89 17.49 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.62 1.568 . . . . 70.239999999999995 108.655 -175.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.92 177.93 49.11 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-O 122.285 0.936 . . . . 63.200000000000003 111.383 -173.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.3 t -60.84 -26.99 67.75 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.24 -0.565 . . . . 74.219999999999999 111.724 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.81 6.26 49.01 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.397 -0.811 . . . . 64.239999999999995 113.042 -172.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -46.4 101.61 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.926 1.691 . . . . 74.219999999999999 110.651 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.95 -174.14 39.88 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.067 0.841 . . . . 70.030000000000001 112.382 -158.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.7 p -140.43 100.75 3.95 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.551 1.541 . . . . 71.329999999999998 107.716 -169.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -115.78 150.94 36.1 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 122.721 0.408 . . . . 73.420000000000002 110.629 -169.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -120.59 16.87 12.05 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.331 1.234 . . . . 53.119999999999997 114.331 -167.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.5 tttt 68.16 142.42 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 129.891 3.277 . . . . 71.239999999999995 111.629 176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 30.3 mm-40 -132.75 47.67 2.49 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.708 2.403 . . . . 72.430000000000007 107.581 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? . . . . . 0 C--O 1.245 0.863 0 N-CA-C 105.072 -2.196 . . . . 75.120000000000005 105.072 170.935 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.128 0 CA-C-O 119.491 -0.616 . . . . 71.519999999999996 111.849 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -69.73 75.54 0.44 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 123.712 1.72 . . . . 72.430000000000007 107.947 167.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -137.81 112.2 8.67 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 105.683 -1.969 . . . . 72.239999999999995 105.683 -157.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -135.5 156.5 48.8 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 128.34 2.656 . . . . 72.549999999999997 108.077 -171.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -76.81 168.5 19.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.132 0.492 . . . . 62.149999999999999 111.304 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -55.45 143.95 27.42 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.993 1.317 . . . . 74.519999999999996 109.055 164.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.3 tp -83.73 121.96 27.99 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.244 -1.391 . . . . 73.530000000000001 107.244 164.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -131.17 172.7 11.82 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.363 1.065 . . . . 75.109999999999999 109.762 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.426 ' O ' HD11 ' A' ' 13' ' ' ILE . 0.5 OUTLIER -64.24 -10.36 23.05 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 117.92 -1.038 . . . . 74.420000000000002 113.103 173.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -107.42 -31.61 8.09 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 121.094 1.77 . . . . 75.120000000000005 113.073 -168.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -86.18 -27.76 24.34 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.008 -0.996 . . . . 34.32 112.452 -176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 tp -65.76 -27.7 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 120.791 1.632 . . . . 75.109999999999999 111.534 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 9' ' ' SER . 14.6 mm -54.09 121.79 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 C-N-CA 125.854 1.661 . . . . 60.049999999999997 110.744 -169.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.95 176.31 14.42 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 123.964 0.792 . . . . 72.439999999999998 111.255 177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -81.45 157.94 24.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.706 0.803 . . . . 75.209999999999994 109.433 173.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -147.02 143.68 28.57 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.87 0.868 . . . . 73.150000000000006 109.346 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.8 t -140.01 166.0 25.82 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.53 0.732 . . . . 62.530000000000001 110.82 173.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.49 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 14.2 t -119.34 -6.51 10.32 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.952 2.101 . . . . 73.549999999999997 111.393 176.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.66 175.8 43.37 Favored Glycine 0 C--N 1.337 0.593 0 O-C-N 120.503 -1.373 . . . . 55.420000000000002 110.978 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 48.7 pt -133.47 15.02 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.169 1.387 . . . . 74.129999999999995 110.046 -173.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -148.94 -175.8 5.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.145 1.778 . . . . 73.409999999999997 109.703 -165.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.69 -99.9 0.04 OUTLIER Glycine 0 C--N 1.337 0.592 0 C-N-CA 126.789 2.138 . . . . 63.329999999999998 112.823 165.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.9 m -148.14 129.24 14.55 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 104.364 -2.458 . . . . 74.219999999999999 104.364 167.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -143.47 -174.78 4.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.373 1.069 . . . . 55.329999999999998 109.342 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -136.39 164.67 27.58 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.284 1.434 . . . . 75.109999999999999 109.549 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.33 133.06 23.83 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.243 1.417 . . . . 72.329999999999998 108.63 -175.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 18.6 mt -121.07 160.41 23.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 123.953 0.901 . . . . 74.340000000000003 109.86 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 t -137.12 154.12 50.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.041 1.736 . . . . 62.450000000000003 106.631 159.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -145.03 130.26 18.58 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.566 1.546 . . . . 74.010000000000005 108.24 170.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.87 152.18 23.59 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.507 1.123 . . . . 64.349999999999994 109.822 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -70.82 -37.46 73.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.91 1.284 . . . . 73.25 110.516 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -131.67 21.26 4.65 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.31 1.044 . . . . 64.049999999999997 110.753 -171.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -130.36 -129.08 3.06 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.482 1.039 . . . . 71.230000000000004 110.599 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 p -124.19 -175.05 3.14 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.421 1.888 . . . . 73.109999999999999 108.442 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.79 167.13 13.04 Favored Glycine 0 C--O 1.237 0.322 0 N-CA-C 109.252 -1.539 . . . . 73.319999999999993 109.252 162.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.04 153.24 49.37 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.701 0.801 . . . . 74.010000000000005 108.859 177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -137.73 121.54 17.58 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.127 1.371 . . . . 54.399999999999999 107.761 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.61 162.53 19.83 Favored Glycine 0 C--N 1.331 0.297 0 N-CA-C 110.293 -1.123 . . . . 74.230000000000004 110.293 174.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.0 mt -127.15 143.36 40.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 105.962 -1.866 . . . . 73.310000000000002 105.962 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -136.01 124.65 23.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.417 1.087 . . . . 75.430000000000007 108.687 -166.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.2 m -84.69 124.27 31.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.837 -1.542 . . . . 55.210000000000001 106.837 166.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 44.64 -78.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 129.059 2.943 . . . . 71.230000000000004 115.127 176.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.2 68.03 1.09 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.64 1.576 . . . . 35.130000000000003 107.612 165.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 90.7 m -152.97 130.96 6.2 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 126.591 1.957 . . . . 62.310000000000002 107.089 170.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.01 135.85 26.12 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.563 2.842 . . . . 75.120000000000005 110.509 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.7 mm -130.89 -21.25 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.007 0.923 . . . . 74.310000000000002 111.729 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.1 m -142.01 155.58 45.43 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 120.551 -1.343 . . . . 71.329999999999998 109.105 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -155.98 143.27 19.22 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.751 1.22 . . . . 64.409999999999997 109.629 -173.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -159.75 159.59 32.97 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.1 1.76 . . . . 42.43 106.94 166.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 43.9 mtm -133.5 148.46 51.69 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.564 -1.643 . . . . 71.329999999999998 106.564 172.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -158.5 142.52 15.56 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.474 -0.565 . . . . 63.409999999999997 109.474 -173.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.47 157.16 30.61 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.591 -1.263 . . . . 72.150000000000006 107.591 170.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -151.08 164.53 36.26 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 121.629 -0.67 . . . . 74.310000000000002 109.953 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -132.1 158.3 41.96 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.614 1.166 . . . . 73.349999999999994 108.235 164.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.9 mm -113.63 87.11 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.552 -2.018 . . . . 73.230000000000004 105.552 166.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -126.25 23.04 7.08 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 122.424 1.107 . . . . 73.329999999999998 110.759 -170.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.76 14.28 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.317 1.847 . . . . 74.140000000000001 113.606 -170.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.61 15.55 61.99 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 121.368 -0.833 . . . . 54.130000000000003 111.338 -172.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -145.43 162.05 38.24 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 128.847 2.859 . . . . 74.420000000000002 105.893 -170.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.7 mt -91.27 109.46 21.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.612 -1.625 . . . . 63.549999999999997 106.612 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -78.86 104.78 9.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.77 -1.567 . . . . 75.540000000000006 106.77 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.0 mm -88.89 131.39 36.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.152 -2.166 . . . . 64.120000000000005 105.152 170.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -154.74 -1.14 0.17 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 115.93 1.826 . . . . 75.420000000000002 115.93 -175.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -148.86 123.5 9.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.761 -1.94 . . . . 72.219999999999999 105.761 162.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.5 t -129.14 141.45 46.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 125.823 1.649 . . . . 71.140000000000001 107.827 -174.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.41 164.06 46.68 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.327 1.051 . . . . 74.329999999999998 108.246 173.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.23 -19.76 15.33 Favored 'Cis proline' 0 N--CA 1.454 -0.84 0 CA-C-N 119.285 0.78 . . . . 63.32 111.98 -14.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -98.27 102.21 13.89 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.912 -1.514 . . . . 64.540000000000006 106.912 -176.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -88.41 131.8 34.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.022 -0.99 . . . . 71.530000000000001 110.493 -169.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.0 mtpp -127.39 174.7 8.78 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.676 1.19 . . . . 74.400000000000006 110.382 173.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 t -61.02 154.89 58.05 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.152 1.381 . . . . 71.430000000000007 111.625 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.51 147.3 57.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.359 2.706 . . . . 71.129999999999995 112.593 171.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -161.01 164.59 30.85 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.648 1.179 . . . . 74.519999999999996 110.441 171.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -91.68 148.54 22.18 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.956 -0.757 . . . . 74.140000000000001 108.956 169.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -124.39 137.43 54.46 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.178 1.791 . . . . 74.430000000000007 108.474 175.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -98.71 133.22 43.34 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.766 -0.827 . . . . 61.240000000000002 108.766 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.469 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 2.1 p -151.68 165.64 33.73 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.091 1.356 . . . . 65.129999999999995 109.433 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.44 161.18 19.48 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 109.404 -0.591 . . . . 65.420000000000002 109.404 160.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.432 HG12 ' H ' ' A' ' 81' ' ' GLY . 16.4 tt -137.47 146.94 26.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.462 -1.31 . . . . 73.420000000000002 107.462 174.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.3 p -111.7 -10.74 14.05 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.579 0.751 . . . . 64.519999999999996 112.037 176.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.432 ' H ' HG12 ' A' ' 79' ' ' ILE . . . 125.69 -63.09 0.59 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 107.452 -2.259 . . . . 51.119999999999997 107.452 -169.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 p -112.55 -15.57 13.02 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.575 -1.202 . . . . 73.310000000000002 114.155 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 37.1 m -104.45 137.0 42.96 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.599 1.545 . . . . 74.519999999999996 107.878 168.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.526 HD22 HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -98.76 143.4 29.14 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.898 -1.519 . . . . 74.510000000000005 106.898 161.677 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -133.07 85.65 2.24 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.154 -1.054 . . . . 73.329999999999998 108.154 170.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.526 HG23 HD22 ' A' ' 84' ' ' LEU . 44.4 t -75.65 124.75 34.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.3 -0.63 . . . . 73.340000000000003 109.3 174.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -92.94 -24.95 18.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.147 0.979 . . . . 65.230000000000004 112.547 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.0 t -152.52 160.86 43.2 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 119.013 0.824 . . . . 70.329999999999998 110.285 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.26 176.17 19.39 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 125.956 1.741 . . . . 65.239999999999995 111.134 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 71.1 m -55.62 -26.98 47.07 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.619 0.768 . . . . 53.350000000000001 111.548 169.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -101.89 11.79 38.02 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.022 0.929 . . . . 71.129999999999995 113.046 -174.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.6 108.73 0.37 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.207 1.403 . . . . 52.229999999999997 110.929 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.59 -169.8 41.51 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 122.113 0.841 . . . . 70.209999999999994 113.03 -169.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -118.65 126.29 51.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 126.929 2.092 . . . . 65.450000000000003 107.473 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.49 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 23.9 m-85 -140.07 159.33 42.42 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.789 0.328 . . . . 73.120000000000005 110.499 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -120.57 149.55 42.27 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.487 1.115 . . . . 72.430000000000007 109.154 170.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -61.17 143.19 55.98 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.99 -1.115 . . . . 64.25 107.99 174.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -116.5 56.67 0.79 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 105.685 -1.969 . . . . 74.120000000000005 105.685 175.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? . . . . . 0 C--O 1.248 0.998 0 C-N-CA 128.366 2.666 . . . . 55.509999999999998 105.68 -176.285 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.629 0 N-CA-C 108.485 -1.846 . . . . 35.140000000000001 108.485 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -153.3 75.46 1.06 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 104.219 -2.512 . . . . 74.010000000000005 104.219 170.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -117.47 65.57 0.73 Allowed 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 107.36 -1.348 . . . . 75.099999999999994 107.36 -149.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -87.57 147.79 25.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.187 -1.824 . . . . 75.040000000000006 109.936 -174.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.22 167.59 17.58 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.884 0.874 . . . . 71.310000000000002 110.528 168.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -55.58 136.26 50.38 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 122.882 1.325 . . . . 73.239999999999995 109.65 157.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.7 tp -66.96 139.24 57.69 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 107.363 -1.347 . . . . 73.420000000000002 107.363 154.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -140.11 170.42 15.88 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.713 -1.588 . . . . 63.229999999999997 106.713 163.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.9 p -44.25 -60.62 1.83 Allowed 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 128.248 2.619 . . . . 74.049999999999997 109.809 171.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -71.69 -17.24 62.24 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.259 -1.337 . . . . 73.430000000000007 110.245 -170.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -82.64 -37.16 25.3 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-O 117.763 -1.113 . . . . 73.120000000000005 110.596 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 tp -74.98 -15.87 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 121.381 1.901 . . . . 63.329999999999998 113.363 -170.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.0 mm -56.35 136.32 19.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.448 1.099 . . . . 62.130000000000003 110.762 -173.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 131.45 -175.08 19.79 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.777 1.18 . . . . 74.219999999999999 112.727 170.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.54 146.08 25.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 126.093 1.757 . . . . 71.409999999999997 108.612 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -140.3 111.61 7.19 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 123.789 0.836 . . . . 75.099999999999994 110.221 -173.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -118.18 143.59 46.39 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.257 1.023 . . . . 61.420000000000002 108.971 -175.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 25' ' ' LYS . 10.4 t -82.35 -43.99 16.74 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.251 0.621 . . . . 73.030000000000001 109.419 174.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.5 172.8 44.7 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.74 1.638 . . . . 32.310000000000002 110.335 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.9 pt -115.94 45.37 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 122.924 1.345 . . . . 64.209999999999994 109.854 -164.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -131.06 178.81 6.4 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.251 1.42 . . . . 52.520000000000003 111.619 -156.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.79 -24.34 18.63 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 127.228 2.347 . . . . 22.02 115.597 -163.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.2 m -150.2 119.94 7.05 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 106.596 -1.631 . . . . 63.100000000000001 106.596 170.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.0 p-80 -146.41 -178.95 6.43 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.043 0.838 . . . . 72.200000000000003 110.918 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' H ' HG22 ' A' ' 18' ' ' THR . 96.5 mttt -143.26 146.08 33.31 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.289 1.436 . . . . 73.439999999999998 108.39 -171.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.31 135.02 45.92 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.698 -1.223 . . . . 72.129999999999995 107.698 -172.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.6 mt -123.13 155.75 36.38 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.201 1.401 . . . . 60.439999999999998 108.275 172.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.9 p -146.85 152.42 38.69 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.695 0.798 . . . . 52.340000000000003 109.567 167.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -141.62 119.84 12.19 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.602 -1.629 . . . . 75.040000000000006 106.602 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -84.94 169.51 13.98 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.694 -0.854 . . . . 64.150000000000006 108.694 169.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -93.58 -25.61 17.47 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 124.599 1.16 . . . . 62.539999999999999 112.92 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.09 32.09 1.24 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.416 1.086 . . . . 75.510000000000005 108.714 -174.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -138.19 -112.57 1.1 Allowed Glycine 0 C--N 1.339 0.698 0 N-CA-C 109.02 -1.632 . . . . 64.140000000000001 109.02 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.4 p -139.92 -165.66 1.93 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.735 1.214 . . . . 74.209999999999994 109.346 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.09 171.18 14.77 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.423 1.011 . . . . 55.229999999999997 110.852 166.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.53 148.94 35.08 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.907 -0.775 . . . . 62.020000000000003 108.907 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -138.83 124.25 19.37 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.472 1.109 . . . . 71.340000000000003 108.572 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.62 165.49 21.46 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.808 -0.917 . . . . 71.200000000000003 110.808 175.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -124.49 148.49 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 104.862 -2.273 . . . . 52.5 104.862 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -141.84 165.1 28.41 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.449 1.1 . . . . 74.319999999999993 108.716 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.3 m -136.24 112.69 9.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.91 2.084 . . . . 75.439999999999998 107.866 171.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 54.13 -78.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 127.51 2.324 . . . . 71.430000000000007 114.374 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.21 47.97 1.49 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.202 1.801 . . . . 75.329999999999998 110.457 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.2 m -154.83 137.66 10.3 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.024 1.73 . . . . 64.109999999999999 108.669 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.68 142.21 22.72 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 124.057 3.172 . . . . 71.409999999999997 110.593 171.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.6 mm -130.69 -7.48 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 126.028 1.731 . . . . 55.240000000000002 110.843 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 32.9 t -153.7 164.76 37.76 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 119.721 -1.862 . . . . 72.409999999999997 109.117 163.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -157.31 123.07 4.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.71 2.404 . . . . 71.409999999999997 106.837 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -139.0 164.22 30.33 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 125.381 1.472 . . . . 64.129999999999995 107.152 164.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mtm -135.87 156.28 49.02 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.967 1.307 . . . . 72.25 107.673 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -159.39 151.94 21.44 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.575 0.75 . . . . 75.030000000000001 110.27 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -82.4 166.85 19.05 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.349 -0.612 . . . . 75.25 109.349 166.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -148.23 160.9 42.48 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.238 0.615 . . . . 74.439999999999998 111.787 172.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -131.39 154.99 48.06 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.215 -1.402 . . . . 64.450000000000003 107.215 164.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.3 mm -104.16 107.72 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 106.018 -1.845 . . . . 74.329999999999998 106.018 164.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.75 24.62 2.85 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.946 1.461 . . . . 73.349999999999994 114.946 171.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.88 14.66 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.631 1.573 . . . . 73.049999999999997 114.835 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.43 11.84 84.02 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 120.114 -1.616 . . . . 74.049999999999997 115.12 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.8 mtt85 -121.37 -165.73 1.27 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.292 1.837 . . . . 74.450000000000003 107.765 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 51.6 mt -114.84 110.18 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.753 1.615 . . . . 55.149999999999999 107.179 172.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -76.88 103.17 6.67 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 107.363 -1.347 . . . . 75.25 107.363 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 26.5 mm -90.49 140.12 16.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 105.697 -1.964 . . . . 74.010000000000005 105.697 170.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -158.31 -5.01 0.08 Allowed 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 115.131 1.53 . . . . 74.450000000000003 115.131 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -144.87 112.75 6.34 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.224 -2.88 . . . . 62.130000000000003 103.224 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.1 t -132.29 152.69 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 106.949 -1.501 . . . . 71.109999999999999 106.949 -178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.83 162.11 34.73 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.482 1.513 . . . . 75.439999999999998 107.18 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -76.84 -26.47 9.61 Favored 'Cis proline' 0 N--CA 1.459 -0.536 0 CA-C-N 119.833 0.976 . . . . 53.549999999999997 112.396 -9.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -87.16 107.7 18.58 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 104.789 -2.3 . . . . 50.109999999999999 104.789 167.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -70.74 159.66 34.1 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.954 0.407 . . . . 74.349999999999994 110.479 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.93 153.7 48.26 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.828 1.251 . . . . 73.140000000000001 108.778 171.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.4 t -50.89 151.13 4.64 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 126.559 1.944 . . . . 71.120000000000005 111.643 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -70.03 154.05 67.08 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.521 2.147 . . . . 74.129999999999995 113.335 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -168.45 166.04 12.38 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.142 1.377 . . . . 74.230000000000004 109.847 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -103.08 111.33 23.64 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.492 -1.299 . . . . 70.120000000000005 107.492 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.1 mt -77.61 113.99 16.0 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.956 0.903 . . . . 70.409999999999997 108.866 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.44 116.29 4.96 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.119 1.768 . . . . 70.230000000000004 108.697 174.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 9.5 p -151.13 158.77 44.43 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 121.658 -0.651 . . . . 74.439999999999998 112.637 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 163.0 16.9 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.316 -0.856 . . . . 71.319999999999993 110.972 174.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 tt -141.31 149.98 20.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 124.518 1.127 . . . . 72.329999999999998 108.425 170.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.6 p -129.02 -6.67 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.354 1.242 . . . . 74.420000000000002 114.354 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.6 -71.51 0.37 Allowed Glycine 0 C--N 1.333 0.371 0 N-CA-C 109.304 -1.519 . . . . 73.010000000000005 109.304 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.1 p -121.4 4.12 10.23 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 118.537 -0.745 . . . . 73.439999999999998 112.987 175.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.9 m -107.6 133.31 52.23 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.282 -1.377 . . . . 52.530000000000001 107.282 170.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.1 tp -108.6 130.57 55.31 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.258 2.223 . . . . 74.109999999999999 107.299 166.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -125.69 99.71 6.11 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.009 1.324 . . . . 75.099999999999994 110.009 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.8 t -93.61 131.81 39.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 108.854 -0.795 . . . . 73.019999999999996 108.854 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -87.56 -23.42 24.35 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.844 1.258 . . . . 75.420000000000002 113.329 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -153.12 166.39 32.63 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.129 -0.982 . . . . 64.040000000000006 109.849 -173.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.67 175.44 36.92 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 110.709 -0.956 . . . . 54.420000000000002 110.709 -176.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.1 m -60.05 -21.61 61.63 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.253 1.021 . . . . 75.219999999999999 112.016 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -101.85 6.34 41.45 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.914 1.686 . . . . 64.439999999999998 112.776 -172.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.65 110.66 0.83 Allowed 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.509 1.924 . . . . 55.109999999999999 109.337 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.52 -136.31 2.64 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 123.451 0.548 . . . . 73.010000000000005 112.527 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.5 t -154.92 113.45 3.54 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.289 -1.745 . . . . 64.200000000000003 106.289 -173.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -133.07 152.76 51.93 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.165 -0.959 . . . . 74.420000000000002 109.446 -168.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -118.98 141.42 48.68 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 124.282 1.033 . . . . 75.099999999999994 108.331 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -58.37 134.74 56.88 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.263 -1.384 . . . . 74.340000000000003 107.263 171.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -134.9 70.55 1.44 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.741 -1.207 . . . . 73.299999999999997 107.741 175.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 53.7 tttt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.5 -1.238 . . . . 61.140000000000001 108.695 -167.354 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.177 0 N-CA-C 109.687 -1.365 . . . . 60.409999999999997 109.687 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -128.15 98.69 5.19 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 118.934 1.367 . . . . 61.409999999999997 107.79 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -98.9 124.74 44.03 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.198 -2.149 . . . . 72.519999999999996 105.198 -178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -111.15 166.49 11.03 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.263 -1.79 . . . . 74.519999999999996 110.625 -173.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -84.65 163.93 18.95 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.055 -0.72 . . . . 53.109999999999999 109.055 168.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -51.71 124.33 12.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.109 0.957 . . . . 70.120000000000005 109.283 153.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.17 134.3 55.76 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-O 121.529 0.681 . . . . 45.119999999999997 109.538 157.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -139.02 169.14 18.34 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.624 -1.621 . . . . 71.319999999999993 106.624 163.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -49.85 -57.19 7.9 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.944 0.498 . . . . 72.420000000000002 109.687 173.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -64.34 -17.33 63.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.843 0.683 . . . . 61.140000000000001 112.843 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -78.87 -44.39 22.94 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.854 0.861 . . . . 71.219999999999999 110.496 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.9 tp -74.96 -24.56 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 O-C-N 120.329 -1.482 . . . . 70.420000000000002 112.225 -170.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 mm -47.88 125.46 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.573 1.949 . . . . 53.409999999999997 112.53 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 137.17 -178.57 18.87 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.11 0.862 . . . . 65.25 112.828 168.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -72.78 147.89 45.1 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 125.675 1.59 . . . . 73.549999999999997 110.534 171.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.493 ' CH2' ' HE3' ' A' ' 97' ' ' LYS . 93.7 m95 -137.76 117.84 13.45 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.257 1.423 . . . . 74.310000000000002 108.669 176.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t -116.61 174.2 6.21 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.785 1.234 . . . . 71.310000000000002 110.038 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -142.98 1.31 1.26 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.315 1.446 . . . . 72.510000000000005 111.363 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.49 176.91 14.6 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 126.477 1.989 . . . . 74.239999999999995 108.465 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.75 11.07 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 113.123 0.786 . . . . 65.340000000000003 113.123 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -113.06 -171.35 1.85 Allowed 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 125.426 1.49 . . . . 73.439999999999998 110.184 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 48.43 -90.42 0.01 OUTLIER Glycine 0 C--N 1.337 0.619 0 C-N-CA 126.495 1.998 . . . . 70.230000000000004 114.51 153.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.8 m -144.93 100.48 3.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 105.734 -1.95 . . . . 70.120000000000005 105.734 169.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -115.44 171.68 7.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.15 -0.685 . . . . 65.420000000000002 109.15 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.5 ' HE2' HG23 ' A' ' 39' ' ' ILE . 82.7 mttt -146.46 151.84 38.06 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 106.145 -1.798 . . . . 65.310000000000002 106.145 -175.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.67 146.83 50.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.815 -1.921 . . . . 61.25 105.815 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.03 159.97 35.98 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.479 -0.934 . . . . 63.509999999999998 108.479 161.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.2 p -133.36 154.55 50.64 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.498 0.719 . . . . 53.32 109.772 164.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -139.69 125.09 19.07 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 105.428 -2.064 . . . . 64.409999999999997 105.428 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -109.99 161.4 15.55 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.138 -1.43 . . . . 51.420000000000002 107.138 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -97.13 -21.04 17.56 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 121.586 -0.696 . . . . 71.239999999999995 112.518 -168.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -124.41 -5.78 7.67 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 122.853 0.461 . . . . 74.5 111.835 -178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.96 -120.38 4.36 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.01 1.767 . . . . 43.100000000000001 109.819 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 72.3 p -148.27 175.37 11.13 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 128.481 2.712 . . . . 73.430000000000007 106.535 -172.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.86 -166.87 23.33 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 119.392 0.996 . . . . 72.230000000000004 112.32 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 m -148.8 164.9 33.07 Favored 'General case' 0 CA--C 1.521 -0.144 0 O-C-N 121.214 -1.168 . . . . 71.510000000000005 109.674 168.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -143.15 125.33 15.44 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 107.488 -1.301 . . . . 70.209999999999994 107.488 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.14 159.04 20.49 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.064 -0.815 . . . . 72.530000000000001 111.064 170.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.5 HG23 ' HE2' ' A' ' 25' ' ' LYS . 69.6 mt -133.31 140.61 46.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 105.843 -1.91 . . . . 64.209999999999994 105.843 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -132.02 157.11 44.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.161 0.985 . . . . 71.549999999999997 110.022 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.3 m -125.86 116.88 22.24 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.19 2.196 . . . . 53.32 106.172 167.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 48.75 -76.38 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 129.182 2.993 . . . . 71.019999999999996 114.169 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -138.21 29.61 2.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.775 1.63 . . . . 72.129999999999995 112.969 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.0 m -137.22 130.46 17.28 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 124.911 1.284 . . . . 71.120000000000005 109.541 -174.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.38 133.63 21.22 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.997 3.132 . . . . 70.409999999999997 110.857 170.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.4 mm -128.44 -3.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 125.899 1.68 . . . . 70.219999999999999 111.275 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 t -145.63 171.28 14.94 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 119.277 -2.139 . . . . 65.129999999999995 107.837 165.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -166.37 140.89 4.32 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 125.729 1.612 . . . . 73.409999999999997 107.54 168.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -157.82 162.29 38.41 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.668 1.587 . . . . 64.450000000000003 107.074 169.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 41.6 mtm -130.44 155.42 46.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.237 -1.394 . . . . 74.329999999999998 107.237 166.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -163.35 156.22 18.67 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.206 1.002 . . . . 74.109999999999999 109.486 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -91.89 167.66 11.97 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.599 0.76 . . . . 72.219999999999999 109.385 170.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -135.97 164.71 27.36 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.642 1.177 . . . . 52.329999999999998 110.185 175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -130.1 126.38 37.44 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 106.649 -1.611 . . . . 74.5 106.649 160.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 mm -92.88 94.58 4.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 104.643 -2.354 . . . . 73.239999999999995 104.643 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -135.54 22.99 3.41 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.78 0.8 . . . . 72.319999999999993 112.237 -168.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -170.43 13.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.696 1.199 . . . . 44.100000000000001 112.696 171.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.17 13.4 82.94 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 121.6 -0.688 . . . . 72.230000000000004 112.33 -169.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -130.87 166.5 20.76 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 127.33 2.252 . . . . 74.239999999999995 106.828 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 59.6 mt -105.32 104.38 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 106.694 -1.595 . . . . 74.519999999999996 106.694 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -84.44 123.1 29.86 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.079 1.352 . . . . 74.129999999999995 107.865 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.6 mm -99.64 150.95 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.873 1.669 . . . . 74.430000000000007 107.82 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -160.97 -17.51 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 116.36 1.985 . . . . 73.530000000000001 116.36 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -135.66 109.4 8.07 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 105.318 -2.104 . . . . 71.140000000000001 105.318 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.74 149.99 25.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 125.975 1.71 . . . . 45.140000000000001 107.54 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.4 160.8 65.42 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.357 1.063 . . . . 72.239999999999995 108.203 173.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -82.46 -11.02 42.51 Favored 'Cis proline' 0 C--N 1.345 0.362 0 N-CA-C 114.222 0.816 . . . . 71.120000000000005 114.222 -2.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -108.14 109.39 20.79 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 105.053 -2.203 . . . . 74.25 105.053 174.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -66.38 145.61 55.5 Favored 'General case' 0 C--O 1.239 0.518 0 O-C-N 123.387 0.429 . . . . 65.439999999999998 110.106 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -129.66 164.34 24.13 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.675 1.19 . . . . 72.120000000000005 110.554 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -62.25 149.76 86.34 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 123.713 0.805 . . . . 70.510000000000005 109.944 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.99 147.37 49.05 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.188 2.592 . . . . 62.109999999999999 111.618 171.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -162.06 157.03 22.87 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.277 2.231 . . . . 65.099999999999994 110.2 174.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -94.74 119.5 33.45 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.001 0.921 . . . . 72.140000000000001 109.085 174.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -91.12 138.75 31.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.573 1.149 . . . . 63.140000000000001 109.815 171.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -81.88 123.2 28.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.694 -1.225 . . . . 72.120000000000005 107.694 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.6 p -148.49 168.54 22.43 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 123.41 0.684 . . . . 61.530000000000001 109.515 165.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.69 163.7 25.54 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.825 1.65 . . . . 72.340000000000003 112.604 159.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 tt -145.66 160.14 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.477 1.511 . . . . 52.130000000000003 107.058 170.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.2 t -126.71 -35.57 2.31 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.32 3.048 . . . . 53.119999999999997 109.413 174.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.79 -52.72 0.09 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 127.31 2.386 . . . . 72.329999999999998 110.177 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.7 p -138.73 7.75 2.54 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.565 1.32 . . . . 44.409999999999997 114.565 -158.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.1 m -131.25 105.41 7.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 129.26 3.024 . . . . 65.219999999999999 107.712 173.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.474 HD22 HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -77.48 121.41 23.81 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.701 -1.963 . . . . 71.230000000000004 105.701 173.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.2 ttmm -101.87 86.62 2.94 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.87 -1.159 . . . . 65.129999999999995 107.87 165.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.474 HG23 HD22 ' A' ' 84' ' ' LEU . 22.9 t -79.17 129.95 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.307 -1.368 . . . . 73.099999999999994 107.307 167.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -96.77 -30.57 13.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.956 0.902 . . . . 51.100000000000001 112.053 -176.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 t -150.99 173.43 14.32 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.297 1.039 . . . . 71.109999999999999 110.291 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 103.48 -178.69 25.36 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 109.849 -1.3 . . . . 52.200000000000003 109.849 -172.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 t -64.23 -25.12 67.92 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 122.119 -0.636 . . . . 71.530000000000001 110.718 172.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -101.44 10.26 40.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.241 1.417 . . . . 63.219999999999999 112.22 -168.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.45 0.28 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 127.001 2.121 . . . . 74.140000000000001 112.122 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 -162.94 31.1 Favored Glycine 0 CA--C 1.525 0.673 0 O-C-N 121.616 -0.677 . . . . 23.32 112.578 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.4 p -119.23 106.25 12.16 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.582 1.553 . . . . 72.340000000000003 107.978 -169.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -120.81 130.8 54.13 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.849 0.75 . . . . 64.510000000000005 111.44 -168.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.0 mmtm -81.39 127.96 33.33 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 123.971 0.908 . . . . 73.420000000000002 108.91 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HE3' ' CH2' ' A' ' 16' ' ' TRP . 31.2 ttmt -60.94 135.29 57.74 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.917 -1.142 . . . . 65.510000000000005 107.917 165.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -113.76 65.14 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.283 1.04 . . . . 74.109999999999999 109.117 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.255 1.382 0 N-CA-C 106.613 -1.625 . . . . 73.239999999999995 106.613 163.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.657 0 N-CA-C 110.885 -0.886 . . . . 63.109999999999999 110.885 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -123.69 75.69 1.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 105.224 -2.139 . . . . 73.239999999999995 105.224 171.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -108.52 60.64 0.61 Allowed 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 121.923 0.868 . . . . 72.0 109.194 -154.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -85.1 157.76 20.6 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.832 1.653 . . . . 73.109999999999999 111.045 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.14 176.29 8.15 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.705 0.802 . . . . 63.039999999999999 111.574 177.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -56.73 134.14 54.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.947 0.899 . . . . 74.109999999999999 109.772 156.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 tp -74.45 138.21 43.12 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.331 -1.359 . . . . 74.299999999999997 107.331 159.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -143.45 163.67 32.45 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.352 -1.721 . . . . 73.400000000000006 106.352 174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -51.12 -51.33 54.58 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 123.746 0.654 . . . . 73.430000000000007 109.502 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -71.34 -16.22 62.43 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 117.933 -1.032 . . . . 73.219999999999999 113.36 -170.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -80.14 -41.87 24.57 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 119.456 1.025 . . . . 71.140000000000001 109.678 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -84.45 41.58 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.77 0.828 . . . . 73.530000000000001 110.568 -176.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.3 mm -112.21 125.5 69.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 O-C-N 119.939 -1.726 . . . . 73.329999999999998 108.48 176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.46 179.69 16.47 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.651 1.119 . . . . 75.400000000000006 111.883 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -79.95 164.82 23.2 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.912 1.285 . . . . 72.219999999999999 109.474 171.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -142.35 145.65 34.14 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.176 0.99 . . . . 63.420000000000002 110.462 171.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.6 t -134.09 165.27 25.44 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.448 -1.407 . . . . 64.209999999999994 110.237 164.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.426 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 12.0 t -112.68 -12.21 13.43 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.587 1.555 . . . . 62.399999999999999 111.556 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.27 178.05 23.09 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 107.931 -2.068 . . . . 75.310000000000002 107.931 -166.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 34.3 pt -134.43 22.92 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 124.526 1.13 . . . . 61.399999999999999 110.827 -167.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 154.72 49.7 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.398 1.479 . . . . 72.010000000000005 107.238 -178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.49 -160.04 10.89 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.12 -0.491 . . . . 75.239999999999995 112.561 -172.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.8 m -79.95 88.59 5.32 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.678 1.191 . . . . 53.229999999999997 108.906 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -96.34 172.05 8.2 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 122.367 1.079 . . . . 71.030000000000001 110.843 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -141.15 118.26 11.27 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.184 -1.413 . . . . 74.319999999999993 107.184 -151.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.94 106.62 14.93 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.777 2.031 . . . . 55.130000000000003 109.226 -173.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 mt -90.81 158.26 16.92 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.509 1.124 . . . . 74.010000000000005 108.751 167.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.1 t -143.2 163.18 33.64 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.822 -0.807 . . . . 61.310000000000002 108.822 155.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -149.01 128.51 13.09 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.126 1.77 . . . . 75.230000000000004 109.34 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -104.38 144.77 31.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.084 1.354 . . . . 54.140000000000001 109.626 171.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.71 -27.41 63.96 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.37 1.068 . . . . 64.510000000000005 112.014 -174.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 -128.15 0.7 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 129.248 3.019 . . . . 51.020000000000003 110.93 -164.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.94 -116.61 2.17 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 125.229 1.395 . . . . 43.109999999999999 110.047 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.3 p -140.23 177.75 7.77 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.352 2.261 . . . . 73.439999999999998 107.188 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -103.96 176.72 23.95 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 124.07 0.843 . . . . 73.530000000000001 111.183 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.3 t -140.86 158.67 43.62 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.448 1.499 . . . . 60.109999999999999 108.813 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -141.56 120.08 12.43 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.195 1.398 . . . . 75.219999999999999 107.267 164.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -132.83 114.48 1.42 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.891 1.71 . . . . 75.310000000000002 110.103 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.402 ' H ' ' HB3' ' A' ' 47' ' ' SER . 8.0 mt -78.27 140.59 16.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 107.46 -1.311 . . . . 64.0 107.46 171.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -124.96 154.51 41.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.943 -1.503 . . . . 54.399999999999999 106.943 170.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.401 ' HB2' HG13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -126.63 118.11 24.13 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.286 -1.375 . . . . 75.109999999999999 107.286 174.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.3 m120 68.63 -64.68 0.3 Allowed 'General case' 0 C--O 1.232 0.174 0 C-N-CA 126.421 1.888 . . . . 71.430000000000007 113.675 162.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -158.06 49.75 0.4 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.048 1.295 . . . . 43.210000000000001 110.937 158.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.8 m -150.85 134.69 9.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.149 1.38 . . . . 71.140000000000001 109.109 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.19 131.19 21.49 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 123.12 2.547 . . . . 73.400000000000006 110.541 168.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.401 HG13 ' HB2' ' A' ' 41' ' ' SER . 10.7 mm -126.85 4.7 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.024 0.93 . . . . 74.0 110.816 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.402 ' HB3' ' H ' ' A' ' 39' ' ' ILE . 7.9 t -152.48 172.84 15.92 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 119.883 -1.761 . . . . 75.239999999999995 109.922 166.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -174.74 118.15 0.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 126.665 1.986 . . . . 75.019999999999996 108.113 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -142.48 158.04 44.11 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 125.281 1.432 . . . . 61.210000000000001 107.694 165.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 23.8 mtm -134.03 150.19 51.21 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.138 -1.43 . . . . 74.420000000000002 107.138 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.5 151.38 20.55 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 122.892 0.477 . . . . 75.319999999999993 110.985 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -76.76 167.21 22.22 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.838 -0.801 . . . . 63.140000000000001 108.838 166.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -146.79 166.86 25.38 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.677 0.791 . . . . 75.099999999999994 109.878 167.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -133.54 155.77 49.0 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.442 -1.688 . . . . 73.349999999999994 106.442 161.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 32.0 mm -114.02 98.56 7.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 105.844 -1.91 . . . . 63.299999999999997 105.844 172.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -130.03 23.13 5.29 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 113.029 0.752 . . . . 72.329999999999998 113.029 -173.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -170.01 14.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.09 1.356 . . . . 55.229999999999997 114.07 -174.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.43 18.61 75.47 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.272 -0.892 . . . . 64.239999999999995 112.461 -173.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -140.36 173.29 11.65 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 128.586 2.754 . . . . 75.340000000000003 105.963 176.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.0 mt -102.72 117.81 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.866 -1.161 . . . . 75.010000000000005 107.866 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -84.51 122.17 28.63 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.686 1.194 . . . . 64.150000000000006 108.154 170.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mm -109.95 132.88 57.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.92 1.688 . . . . 74.439999999999998 106.626 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -160.87 6.0 0.07 Allowed 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.777 1.399 . . . . 75.430000000000007 114.777 -169.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -148.68 123.15 9.71 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 104.024 -2.584 . . . . 73.329999999999998 104.024 163.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.8 t -136.27 148.85 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.467 -1.308 . . . . 74.150000000000006 107.467 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.68 163.31 32.12 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 107.364 -1.347 . . . . 75.349999999999994 107.364 173.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.63 -11.21 31.97 Favored 'Cis proline' 0 CA--C 1.534 0.487 0 CA-C-N 118.713 0.576 . . . . 74.329999999999998 113.378 -2.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.38 132.58 36.1 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.296 -1.742 . . . . 52.240000000000002 106.296 167.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.41 135.75 38.85 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 118.755 0.707 . . . . 73.319999999999993 109.335 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -124.14 168.4 12.95 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 124.169 0.987 . . . . 74.349999999999994 110.744 168.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 t -47.84 143.42 6.22 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 126.83 2.052 . . . . 72.319999999999993 110.675 166.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.03 159.0 53.78 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.253 1.969 . . . . 74.439999999999998 110.963 172.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -168.13 177.15 5.66 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.5 1.52 . . . . 74.299999999999997 108.349 172.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -106.99 155.94 19.27 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.708 -0.849 . . . . 75.019999999999996 108.708 171.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.8 mt -123.56 129.54 51.34 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 126.161 1.784 . . . . 73.319999999999993 109.298 -178.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.09 123.25 29.32 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.177 1.391 . . . . 73.209999999999994 109.522 174.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 2.1 p -148.84 168.38 23.15 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.582 1.953 . . . . 75.340000000000003 108.033 169.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.08 154.88 50.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.887 1.275 . . . . 73.409999999999997 108.482 169.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 tt -136.95 156.54 34.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 107.362 -1.347 . . . . 75.340000000000003 107.362 173.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.45 26.06 0.68 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.692 0.997 . . . . 74.420000000000002 113.692 166.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.47 -94.28 0.18 Allowed Glycine 0 C--O 1.228 -0.229 0 N-CA-C 107.849 -2.1 . . . . 74.109999999999999 107.849 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . 0.273 36.1 p -105.88 1.27 26.63 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 118.397 -0.811 . . . . 71.310000000000002 112.539 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.6 m -98.13 135.71 39.4 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.926 1.239 . . . . 75.019999999999996 109.207 168.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.43 137.0 45.2 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 106.824 -1.547 . . . . 74.230000000000004 106.824 162.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -121.37 85.05 2.34 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 124.356 1.062 . . . . 73.099999999999994 108.688 169.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.8 t -76.77 125.88 36.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.132 -1.062 . . . . 75.219999999999999 108.132 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -80.49 -53.27 6.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.148 0.579 . . . . 73.099999999999994 110.977 178.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.4 t -128.85 176.35 7.92 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 119.391 0.996 . . . . 60.009999999999998 112.251 -168.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.18 -175.81 44.89 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 125.622 1.582 . . . . 72.439999999999998 110.819 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.59 -27.9 65.07 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.083 -0.657 . . . . 74.120000000000005 111.583 176.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -101.17 14.26 32.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 118.983 -0.532 . . . . 72.439999999999998 112.128 -170.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.47 111.09 0.58 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.756 1.222 . . . . 55.5 110.385 172.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.49 -169.35 42.31 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.545 0.593 . . . . 42.229999999999997 113.885 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.9 p -113.8 118.15 33.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.479 1.911 . . . . 74.219999999999999 108.179 -174.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.426 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 47.2 m-85 -127.77 167.45 16.49 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.79 0.723 . . . . 62.210000000000001 112.879 -171.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -125.75 128.94 48.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 129.809 3.244 . . . . 74.0 106.932 -175.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -61.78 152.0 32.56 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.889 -0.782 . . . . 75.439999999999998 108.889 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -148.11 154.54 40.33 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 128.598 2.759 . . . . 60.399999999999999 109.621 171.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? . . . . . 0 C--O 1.254 1.297 0 CA-C-O 114.301 -2.761 . . . . 63.299999999999997 111.332 178.873 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.347 0 N-CA-C 109.778 -1.329 . . . . 73.329999999999998 109.778 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -133.79 174.71 10.16 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.209 1.804 . . . . 71.140000000000001 107.689 -172.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -116.54 51.64 0.97 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 122.789 1.281 . . . . 71.049999999999997 109.145 -151.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -76.11 152.34 36.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.082 -1.417 . . . . 73.540000000000006 110.925 -170.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 p -73.32 173.09 10.03 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.716 0.77 . . . . 61.149999999999999 110.635 173.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -49.6 133.63 20.67 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.238 -1.346 . . . . 72.049999999999997 109.676 160.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.9 tp -74.92 127.87 34.23 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.054 -1.461 . . . . 73.450000000000003 107.054 156.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -137.24 162.14 34.31 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.165 -1.42 . . . . 52.43 107.165 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -53.68 -48.46 69.47 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.775 1.23 . . . . 53.299999999999997 109.689 -176.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.36 -26.36 61.88 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 125.748 1.619 . . . . 65.25 111.133 -173.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -68.09 -37.36 81.13 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.949 0.795 . . . . 73.319999999999993 111.002 -174.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -85.26 -9.72 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 112.842 0.682 . . . . 74.519999999999996 112.842 -171.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.2 mm -61.65 124.76 16.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 124.788 1.235 . . . . 72.310000000000002 110.488 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 148.63 -177.24 27.0 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.58 1.086 . . . . 62.109999999999999 110.556 -178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -92.89 156.21 17.1 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 108.432 -0.951 . . . . 74.140000000000001 108.432 163.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -126.6 178.49 5.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.913 2.485 . . . . 63.340000000000003 108.473 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 t -167.72 169.41 11.77 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 126.012 1.725 . . . . 71.420000000000002 108.601 160.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.55 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 10.0 t -132.36 -1.26 3.57 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.089 1.756 . . . . 74.420000000000002 112.463 172.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.77 -178.17 30.86 Favored Glycine 0 C--N 1.336 0.553 0 O-C-N 120.922 -1.111 . . . . 50.100000000000001 110.556 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.8 pt -140.26 13.78 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.44 1.496 . . . . 70.430000000000007 111.146 -166.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -126.75 179.26 5.45 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 125.01 1.324 . . . . 64.299999999999997 111.518 -168.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 44.79 -93.81 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 C-N-CA 125.693 1.616 . . . . 44.32 114.881 153.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 93.6 m -134.68 127.39 30.99 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.245 -1.391 . . . . 63.229999999999997 107.245 157.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -136.66 -179.77 5.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 126.21 1.804 . . . . 71.420000000000002 108.813 177.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -154.0 153.71 32.45 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.132 1.373 . . . . 74.099999999999994 109.008 -171.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.05 124.46 23.4 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.191 1.797 . . . . 73.420000000000002 108.66 -171.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.423 ' CD1' ' HD1' ' A' ' 37' ' ' PHE . 1.0 OUTLIER -114.52 137.94 51.23 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.511 1.524 . . . . 71.120000000000005 109.336 176.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -139.66 134.63 32.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.215 -1.031 . . . . 53.329999999999998 108.215 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -133.12 106.75 7.79 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.919 1.688 . . . . 63.520000000000003 107.352 -170.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -77.03 152.54 35.09 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.231 -1.025 . . . . 71.439999999999998 108.231 169.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.35 -27.67 56.54 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.471 0.915 . . . . 71.310000000000002 113.471 -174.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -135.2 13.65 3.55 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 122.817 0.447 . . . . 75.299999999999997 111.16 -166.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.36 -112.2 1.57 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.246 1.403 . . . . 52.340000000000003 111.21 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 34.5 p -139.31 -173.96 3.74 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.555 1.542 . . . . 74.299999999999997 108.006 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -136.57 176.3 20.45 Favored Glycine 0 C--O 1.239 0.446 0 O-C-N 120.817 -1.177 . . . . 71.400000000000006 111.437 167.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.2 p -136.69 159.06 42.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.088 -0.654 . . . . 72.120000000000005 111.616 -166.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.423 ' HD1' ' CD1' ' A' ' 27' ' ' LEU . 29.1 t80 -134.8 113.14 11.31 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.768 1.227 . . . . 65.109999999999999 108.841 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -124.71 112.6 1.79 Allowed Glycine 0 C--N 1.339 0.704 0 N-CA-C 109.64 -1.384 . . . . 71.540000000000006 109.64 176.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.3 mt -86.47 144.54 9.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 N-CA-C 105.36 -2.089 . . . . 70.420000000000002 105.36 170.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -131.56 158.5 40.8 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.585 1.554 . . . . 64.400000000000006 108.022 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.45 126.77 50.09 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.361 1.464 . . . . 72.140000000000001 107.595 167.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 53.36 -78.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.024 2.529 . . . . 73.439999999999998 113.026 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.35 34.8 0.97 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.723 1.609 . . . . 61.130000000000003 111.871 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 98.8 m -141.7 131.67 12.73 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 127.345 2.258 . . . . 64.329999999999998 109.301 -170.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.24 132.99 10.59 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 123.997 3.132 . . . . 61.340000000000003 111.436 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.4 mm -124.48 -21.35 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 112.809 0.67 . . . . 71.140000000000001 112.809 -173.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -150.13 154.24 37.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 120.92 1.691 . . . . 61.130000000000003 108.308 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -160.69 128.88 4.54 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.715 1.206 . . . . 74.409999999999997 108.028 -169.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -162.23 160.02 26.44 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.179 -1.415 . . . . 74.299999999999997 107.179 173.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 28.2 mtm -134.13 154.02 51.46 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.939 0.896 . . . . 71.420000000000002 108.622 173.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -163.56 153.79 15.54 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.757 0.823 . . . . 71.099999999999994 111.117 -176.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -84.6 169.51 14.31 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.951 0.881 . . . . 71.219999999999999 109.868 171.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' HE3' ' A' ' 54' ' ' LYS . 7.2 m-85 -137.37 160.5 38.89 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.371 1.468 . . . . 72.439999999999998 110.53 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' A' ' 53' ' ' TYR . 9.2 mmpt? -132.96 153.84 51.05 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.751 -1.574 . . . . 63.119999999999997 106.751 154.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.1 mm -108.87 100.06 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 105.739 -1.948 . . . . 73.140000000000001 105.739 170.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -131.42 23.65 4.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.257 0.551 . . . . 42.119999999999997 112.045 -171.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -174.27 14.93 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.206 1.802 . . . . 74.010000000000005 113.351 -170.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.4 17.98 71.07 Favored Glycine 0 CA--C 1.535 1.296 0 O-C-N 120.465 -1.397 . . . . 43.450000000000003 110.901 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -144.09 164.42 30.72 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 129.359 3.064 . . . . 71.420000000000002 106.474 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 19.6 mt -95.48 121.26 45.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.963 -1.495 . . . . 74.340000000000003 106.963 -176.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -87.1 111.56 21.04 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.923 1.289 . . . . 72.540000000000006 107.606 167.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.2 mm -86.14 140.7 15.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.013 -1.847 . . . . 74.5 106.013 167.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -156.51 -5.24 0.11 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 115.794 1.776 . . . . 75.530000000000001 115.794 -176.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -151.55 103.25 2.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.931 -1.137 . . . . 73.420000000000002 107.931 -171.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.9 t -129.11 141.9 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.019 0.928 . . . . 73.439999999999998 109.692 -167.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.08 163.87 48.0 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 126.126 1.77 . . . . 75.329999999999998 107.271 175.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.37 -17.79 20.14 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 119.096 0.713 . . . . 63.130000000000003 113.479 -4.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -102.2 130.55 48.88 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 107.137 -1.431 . . . . 72.420000000000002 107.137 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -72.8 145.15 47.21 Favored 'General case' 0 C--O 1.24 0.599 0 O-C-N 123.601 0.563 . . . . 74.140000000000001 110.41 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -137.54 144.51 42.15 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.708 1.203 . . . . 73.510000000000005 108.734 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.0 t -52.14 148.33 11.52 Favored Pre-proline 0 C--O 1.238 0.468 0 CA-C-O 118.202 -0.904 . . . . 72.319999999999993 110.167 175.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.57 153.78 75.5 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.148 2.565 . . . . 54.200000000000003 111.476 172.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -160.18 164.61 32.73 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.947 1.299 . . . . 70.420000000000002 109.39 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -97.43 158.14 15.63 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.084 -0.71 . . . . 61.329999999999998 109.084 169.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.0 mt -134.17 116.9 15.92 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.849 2.059 . . . . 73.219999999999999 108.516 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -73.51 117.63 15.5 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.761 1.624 . . . . 61.219999999999999 107.577 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.8 p -146.8 161.95 39.61 Favored 'General case' 0 C--N 1.331 -0.222 0 O-C-N 121.232 -0.918 . . . . 71.310000000000002 109.566 168.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -115.62 161.48 18.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.817 -1.083 . . . . 74.129999999999995 110.08 161.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 tt -147.8 151.83 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 108.0 -1.111 . . . . 73.230000000000004 108.0 170.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.9 m -128.14 -1.96 5.76 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.471 1.108 . . . . 73.239999999999995 112.427 171.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.68 -74.68 0.43 Allowed Glycine 0 C--N 1.332 0.343 0 N-CA-C 108.316 -1.914 . . . . 41.43 108.316 175.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.0 p -93.7 -1.55 55.04 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 113.661 0.986 . . . . 65.319999999999993 113.661 -174.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 m -125.42 134.61 52.05 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.895 1.278 . . . . 70.209999999999994 108.423 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.54 131.67 49.12 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 106.152 -1.795 . . . . 74.239999999999995 106.152 166.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -120.39 84.38 2.21 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.313 -0.995 . . . . 74.540000000000006 108.313 171.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.3 t -77.4 128.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.362 -0.977 . . . . 64.099999999999994 108.362 176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -96.23 -22.41 17.27 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.227 1.195 . . . . 71.340000000000003 114.227 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.8 t -150.21 179.0 8.46 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.311 1.444 . . . . 71.530000000000001 109.651 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.52 -177.96 52.3 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-O 122.706 1.17 . . . . 71.310000000000002 110.567 -173.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.4 m -63.74 -11.83 29.7 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.155 1.782 . . . . 71.530000000000001 114.085 -177.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -107.97 9.17 28.65 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 124.528 1.131 . . . . 62.299999999999997 113.18 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.22 105.84 0.23 Allowed 'General case' 0 CA--C 1.538 0.503 0 O-C-N 120.126 -1.609 . . . . 74.310000000000002 110.633 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 173.32 -159.29 29.31 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.81 0.719 . . . . 42.439999999999998 113.042 -163.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.9 t -133.18 128.91 37.02 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 125.33 1.452 . . . . 72.409999999999997 109.003 -178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.55 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 16.6 m-85 -134.88 149.38 50.3 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 123.871 0.868 . . . . 61.140000000000001 108.996 -173.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -118.57 151.05 38.62 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.099 -1.074 . . . . 73.120000000000005 108.099 171.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -68.62 151.65 46.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.091 -1.077 . . . . 62.420000000000002 108.091 -178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -128.7 66.23 1.41 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 123.434 1.588 . . . . 71.400000000000006 106.944 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.269 0 C-N-CA 126.016 1.726 . . . . 72.519999999999996 108.338 171.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.619 0 N-CA-C 109.546 -1.422 . . . . 50.329999999999998 109.546 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -143.45 69.42 1.29 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 123.458 1.599 . . . . 65.0 106.698 171.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.94 102.37 2.91 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 129.153 2.981 . . . . 64.040000000000006 108.786 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.508 ' CD1' ' HE3' ' A' ' 78' ' ' LYS . 98.1 m95 -126.78 157.16 39.92 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.925 1.69 . . . . 70.400000000000006 110.647 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.2 p -82.73 175.24 10.28 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.037 0.835 . . . . 63.140000000000001 110.853 168.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -53.48 156.72 2.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.179 1.392 . . . . 75.040000000000006 110.345 163.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.419 HD21 HG13 ' A' ' 60' ' ' ILE . 7.0 tp -103.58 132.66 49.65 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 113.738 -1.574 . . . . 75.010000000000005 107.23 162.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.446 ' HA ' HG21 ' A' ' 55' ' ' ILE . 23.0 p30 -143.61 -175.3 4.51 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 127.323 2.249 . . . . 74.310000000000002 108.577 -175.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.6 p -78.65 9.29 4.22 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 124.431 1.092 . . . . 61.340000000000003 113.673 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -130.38 -40.28 1.28 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.56 1.527 . . . . 34.439999999999998 112.184 -162.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -72.3 -31.65 65.9 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.948 1.299 . . . . 54.43 110.272 178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.9 tp -75.76 -24.83 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 119.836 1.198 . . . . 73.200000000000003 111.864 -174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.6 mm -55.74 97.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 127.835 2.454 . . . . 74.239999999999995 111.974 -174.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.65 179.91 44.62 Favored Glycine 0 N--CA 1.445 -0.731 0 O-C-N 122.27 -0.269 . . . . 52.420000000000002 113.085 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -100.0 148.68 24.26 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.53 1.932 . . . . 75.140000000000001 108.531 172.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -146.55 135.34 22.29 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.753 0.821 . . . . 72.540000000000006 110.036 -171.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -140.44 170.9 14.93 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.941 -1.099 . . . . 74.540000000000006 108.841 166.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.409 ' HB ' ' CD1' ' A' ' 95' ' ' TYR . 14.5 t -118.8 -18.04 9.01 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.469 1.108 . . . . 61.509999999999998 111.559 -176.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.84 -168.15 38.14 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 107.501 -2.24 . . . . 53.039999999999999 107.501 -178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.5 pt -139.98 -5.52 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.018 0.927 . . . . 72.129999999999995 112.742 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -93.21 173.59 7.65 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 120.077 1.308 . . . . 74.209999999999994 110.746 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' H ' ' ND2' ' A' ' 42' ' ' ASN . . . 53.33 -94.56 0.01 OUTLIER Glycine 0 C--N 1.338 0.676 0 C-N-CA 126.528 2.014 . . . . 51.119999999999997 113.268 155.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.67 133.2 39.79 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.925 -1.139 . . . . 63.119999999999997 107.925 164.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -143.42 179.76 6.91 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.99 1.716 . . . . 75.439999999999998 107.67 174.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -143.28 133.5 24.49 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.962 -1.125 . . . . 62.509999999999998 107.962 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.8 155.17 18.98 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.996 1.718 . . . . 75.530000000000001 107.923 171.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.9 mt -145.9 141.81 28.16 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.552 -2.018 . . . . 75.140000000000001 105.552 164.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.0 m -138.24 147.83 44.11 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.156 -1.053 . . . . 74.439999999999998 108.156 173.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -141.85 121.31 13.23 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.087 1.755 . . . . 74.420000000000002 107.84 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -96.88 157.98 15.64 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.833 0.853 . . . . 74.409999999999997 109.579 167.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -78.87 -33.05 46.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.729 -0.669 . . . . 75.510000000000005 111.723 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -119.61 5.18 11.06 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 122.788 0.435 . . . . 71.319999999999993 111.4 -163.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -139.08 -111.09 0.95 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 125.448 1.499 . . . . 32.130000000000003 110.544 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.0 p -137.25 178.64 6.93 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.477 1.911 . . . . 72.310000000000002 108.797 -163.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -133.97 -174.78 13.63 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.493 -1.043 . . . . 73.310000000000002 110.493 164.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 t -148.28 160.02 43.39 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.609 -0.886 . . . . 62.299999999999997 108.609 -168.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -140.7 137.71 33.7 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 127.252 2.221 . . . . 64.420000000000002 105.695 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.53 147.35 16.66 Favored Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.402 -1.079 . . . . 35.140000000000001 110.402 166.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 59.1 mt -97.45 140.33 17.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 105.783 -1.932 . . . . 53.310000000000002 105.783 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -133.92 133.34 41.32 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-O 121.577 0.703 . . . . 75.510000000000005 109.867 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.715 ' N ' HD11 ' A' ' 46' ' ' ILE . 24.2 t -79.75 -172.58 3.4 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.108 2.163 . . . . 51.020000000000003 108.439 169.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.433 ' ND2' ' H ' ' A' ' 22' ' ' GLY . 4.6 m120 -44.68 -42.47 7.59 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 126.689 1.996 . . . . 60.310000000000002 113.422 -172.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -159.74 49.32 0.3 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 109.097 -0.705 . . . . 75.129999999999995 109.097 162.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.7 m -146.92 136.07 11.44 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 118.517 -0.754 . . . . 75.519999999999996 109.268 -173.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.56 142.27 18.23 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 124.295 3.33 . . . . 72.340000000000003 113.147 177.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.715 HD11 ' N ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -136.3 -8.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 114.137 1.162 . . . . 62.329999999999998 114.137 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.04 145.53 15.3 Favored 'General case' 0 CA--C 1.515 -0.395 0 O-C-N 120.021 -1.675 . . . . 72.340000000000003 107.751 172.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -159.2 129.28 5.7 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.022 -1.473 . . . . 75.109999999999999 107.022 -175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -153.77 167.69 28.8 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.129 1.372 . . . . 74.310000000000002 108.436 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.9 mtm -135.13 158.34 44.6 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 123.479 0.712 . . . . 74.200000000000003 109.93 165.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -155.1 160.05 40.69 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.235 -0.893 . . . . 72.340000000000003 108.909 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.14 164.05 15.18 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.304 -1.369 . . . . 74.420000000000002 107.304 168.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -136.27 165.66 25.24 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.962 -0.563 . . . . 64.340000000000003 109.758 170.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -131.37 159.2 38.66 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.024 -0.732 . . . . 72.040000000000006 109.024 158.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.446 HG21 ' HA ' ' A' ' 8' ' ' ASN . 16.3 mm -118.38 89.55 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 104.522 -2.399 . . . . 71.420000000000002 104.522 171.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -118.95 23.48 11.38 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.907 1.283 . . . . 62.020000000000003 111.474 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -173.33 21.59 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.339 1.456 . . . . 72.120000000000005 113.317 -173.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.95 22.65 70.58 Favored Glycine 0 CA--C 1.533 1.175 0 O-C-N 120.554 -1.341 . . . . 63.32 112.082 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 78.8 mtt85 -148.44 163.0 38.45 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 127.374 2.269 . . . . 74.400000000000006 107.02 -172.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.419 HG13 HD21 ' A' ' 7' ' ' LEU . 71.0 mt -87.92 130.33 37.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 106.924 -1.51 . . . . 61.409999999999997 106.924 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -108.56 107.54 18.08 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.198 1.399 . . . . 75.430000000000007 108.829 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 mm -78.67 138.9 19.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 106.655 -1.609 . . . . 63.229999999999997 106.655 171.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -158.25 -5.43 0.08 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 116.375 1.991 . . . . 75.019999999999996 116.375 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -150.78 110.06 3.96 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 103.959 -2.608 . . . . 73.019999999999996 103.959 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.4 t -128.74 141.9 45.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.137 -1.06 . . . . 72.230000000000004 108.137 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.41 164.29 45.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.172 1.389 . . . . 72.549999999999997 107.806 172.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -75.62 -7.87 25.45 Favored 'Cis proline' 0 CA--C 1.538 0.697 0 CA-C-N 119.259 0.771 . . . . 73.109999999999999 112.325 -11.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -110.1 109.63 20.23 Favored 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 124.183 0.993 . . . . 74.519999999999996 110.548 172.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.55 128.63 36.69 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 122.488 1.137 . . . . 64.049999999999997 110.365 176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.1 mtpp -107.92 177.79 4.71 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.684 1.594 . . . . 73.150000000000006 109.509 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -76.66 149.14 80.59 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 108.842 -0.799 . . . . 72.150000000000006 108.842 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.75 149.53 83.58 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.347 2.031 . . . . 52.420000000000002 111.037 171.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -168.39 167.35 11.96 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.072 0.949 . . . . 75.040000000000006 110.248 172.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -98.29 156.94 16.47 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.134 0.574 . . . . 54.340000000000003 109.849 173.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -133.69 128.9 35.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.7 2.0 . . . . 75.299999999999997 107.824 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.494 ' H ' ' CG2' ' A' ' 88' ' ' THR . 5.1 m-20 -84.68 129.63 34.81 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 106.037 -1.838 . . . . 74.019999999999996 106.037 174.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.42 150.47 23.48 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 126.371 1.868 . . . . 64.430000000000007 107.558 -176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.508 ' HE3' ' CD1' ' A' ' 4' ' ' TRP . 23.6 mtmt -128.55 145.46 51.12 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.069 -1.456 . . . . 75.019999999999996 107.069 -171.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.3 tt -143.93 152.4 16.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 107.02 -1.474 . . . . 74.099999999999994 107.02 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.9 t -128.64 -61.92 1.04 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.54 -1.282 . . . . 61.439999999999998 107.54 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.7 -102.0 0.27 Allowed Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 106.384 -2.686 . . . . 55.32 106.384 166.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.3 p -79.4 10.92 3.3 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.431 1.271 . . . . 75.340000000000003 114.431 -173.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 98.8 m -118.76 127.62 53.72 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 121.084 1.765 . . . . 72.209999999999994 109.7 171.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.15 125.64 41.79 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.085 1.354 . . . . 62.100000000000001 107.383 165.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.5 tttm -111.88 87.94 2.68 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 124.082 0.953 . . . . 74.439999999999998 109.065 169.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.9 t -72.03 134.5 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.777 -1.194 . . . . 64.310000000000002 107.777 174.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -97.11 -37.94 9.93 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.577 0.751 . . . . 62.420000000000002 110.292 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.494 ' CG2' ' H ' ' A' ' 76' ' ' ASP . 3.0 t -137.7 161.41 36.59 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.054 1.741 . . . . 73.239999999999995 110.004 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 113.38 179.08 19.37 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.284 1.421 . . . . 72.430000000000007 112.639 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.8 m -57.24 -24.02 51.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.36 0.664 . . . . 63.32 111.444 166.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -100.83 5.04 43.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.399 1.88 . . . . 72.019999999999996 111.545 -169.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.1 103.53 0.15 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.438 1.495 . . . . 74.230000000000004 111.235 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.25 -164.74 33.1 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 123.793 0.711 . . . . 60.32 112.64 -169.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 54.3 p -130.08 120.61 24.93 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.512 1.125 . . . . 74.209999999999994 109.589 -176.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.409 ' CD1' ' HB ' ' A' ' 18' ' ' THR . 48.3 m-85 -127.74 152.09 48.18 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.715 0.806 . . . . 55.140000000000001 109.226 -170.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -111.37 140.86 45.59 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 124.3 1.04 . . . . 75.200000000000003 108.458 175.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -66.59 125.87 27.13 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.772 -1.196 . . . . 75.340000000000003 107.772 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -101.26 55.16 0.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.833 1.253 . . . . 72.209999999999994 107.827 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt . . . . . 0 C--O 1.254 1.336 0 C-N-CA 127.63 2.372 . . . . 64.299999999999997 105.819 167.389 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.649 0 N-CA-C 108.541 -1.824 . . . . 74.450000000000003 108.541 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -109.75 106.45 16.08 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 107.937 -1.135 . . . . 71.450000000000003 107.937 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -100.03 127.71 46.22 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 105.645 -1.983 . . . . 72.450000000000003 105.645 170.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -125.61 150.33 47.63 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.798 1.639 . . . . 64.549999999999997 109.733 173.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 p -72.07 171.86 11.15 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.469 0.652 . . . . 71.140000000000001 110.219 170.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -51.79 130.97 30.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.244 -0.889 . . . . 75.450000000000003 108.75 158.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.46 HD22 HD12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -64.14 124.56 21.98 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.898 -1.149 . . . . 72.230000000000004 107.898 151.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -137.65 171.08 14.98 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 118.772 -1.171 . . . . 63.520000000000003 111.358 160.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p -69.08 36.02 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.142 2.577 . . . . 74.239999999999995 112.387 172.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -137.78 -58.18 0.67 Allowed 'General case' 0 N--CA 1.457 -0.092 0 C-N-CA 125.051 1.34 . . . . 63.149999999999999 109.006 -170.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -77.03 -21.53 54.4 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 118.563 -0.732 . . . . 73.239999999999995 112.107 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.7 -19.02 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 124.43 1.092 . . . . 75.439999999999998 113.57 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.3 mm -65.67 118.85 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.449 -0.945 . . . . 73.510000000000005 108.449 -171.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 154.75 173.69 23.88 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.336 0.97 . . . . 73.209999999999994 111.544 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -80.46 156.39 26.61 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.803 -1.184 . . . . 71.109999999999999 107.803 162.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -141.67 135.12 29.59 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.737 -0.602 . . . . 75.510000000000005 109.689 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -137.76 150.66 47.44 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.956 1.703 . . . . 74.129999999999995 109.627 -167.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.522 HG23 ' CE2' ' A' ' 95' ' ' TYR . 31.0 p -89.84 -77.16 0.4 Allowed 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.933 -1.506 . . . . 75.310000000000002 106.933 161.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.87 -168.48 14.23 Favored Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 126.682 2.087 . . . . 75.439999999999998 109.879 -177.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.0 pt -118.21 20.37 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 125.397 1.479 . . . . 73.420000000000002 110.792 -171.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -137.15 157.34 46.9 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.376 1.87 . . . . 63.130000000000003 108.478 -168.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.31 -172.09 7.69 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-O 121.633 0.574 . . . . 53.310000000000002 113.586 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.3 m -79.76 90.2 5.23 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 107.458 -1.312 . . . . 52.130000000000003 107.458 175.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.1 p-80 -110.54 -179.48 3.77 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.498 1.519 . . . . 53.340000000000003 110.371 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -140.89 157.6 45.14 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.073 1.349 . . . . 73.349999999999994 110.271 -169.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.95 140.94 32.9 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.702 1.601 . . . . 60.25 107.993 -173.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -123.87 169.48 11.54 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.981 0.913 . . . . 72.209999999999994 109.689 168.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.0 t -140.29 160.48 39.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.806 -1.553 . . . . 64.549999999999997 106.806 158.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -147.81 121.63 9.31 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.682 1.993 . . . . 63.329999999999998 106.271 168.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -95.33 156.23 16.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.829 0.851 . . . . 73.109999999999999 109.048 172.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.48 -23.96 37.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.192 -0.458 . . . . 61.109999999999999 111.957 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -133.16 10.68 4.18 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.046 0.758 . . . . 73.340000000000003 113.046 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.44 -119.98 3.92 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 109.588 -1.405 . . . . 21.41 109.588 173.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 p -141.33 -169.9 2.96 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.831 2.452 . . . . 74.129999999999995 106.505 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.6 179.05 19.21 Favored Glycine 0 CA--C 1.522 0.49 0 O-C-N 120.936 -1.102 . . . . 73.420000000000002 110.905 167.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.5 t -136.47 165.32 26.1 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.57 1.548 . . . . 73.109999999999999 109.284 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -152.44 109.62 3.54 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.551 1.541 . . . . 74.109999999999999 109.813 171.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.99 147.48 16.29 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.232 -1.147 . . . . 64.530000000000001 110.232 173.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.6 mt -119.87 139.85 45.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 105.828 -1.916 . . . . 65.129999999999995 105.828 169.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -122.41 165.82 15.71 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.942 1.297 . . . . 75.420000000000002 109.449 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.5 m -131.22 112.98 13.29 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 126.482 1.913 . . . . 73.200000000000003 106.869 160.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 m120 55.24 -73.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 130.161 3.384 . . . . 73.010000000000005 113.892 176.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.24 44.24 1.54 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.95 1.3 . . . . 54.229999999999997 109.649 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.5 m -150.17 123.01 4.27 Favored Pre-proline 0 CA--C 1.535 0.396 0 N-CA-C 107.758 -1.201 . . . . 55.439999999999998 107.758 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -69.6 137.73 36.65 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.342 2.028 . . . . 60.399999999999999 108.967 167.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.3 mm -126.35 -25.42 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.442 1.097 . . . . 74.329999999999998 110.791 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 47.5 t -141.12 157.85 44.72 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 120.63 -1.294 . . . . 63.130000000000003 109.194 169.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -151.0 135.84 17.32 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 129.166 2.987 . . . . 74.319999999999993 105.139 179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.58 163.19 40.09 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.454 -2.054 . . . . 53.149999999999999 105.454 165.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.9 mtm -130.28 167.98 17.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.431 -0.952 . . . . 74.519999999999996 108.431 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -160.6 148.85 16.35 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.585 0.754 . . . . 63.539999999999999 109.132 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.67 163.9 20.45 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.953 -1.129 . . . . 72.140000000000001 107.953 163.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -150.88 161.84 41.93 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.889 -0.507 . . . . 74.319999999999993 109.935 172.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -129.32 159.48 36.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.072 -1.084 . . . . 74.140000000000001 108.072 156.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.46 HD12 HD22 ' A' ' 7' ' ' LEU . 25.3 mm -105.02 102.43 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 103.638 -2.727 . . . . 73.450000000000003 103.638 162.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -137.94 27.22 2.69 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 122.093 0.949 . . . . 73.129999999999995 109.655 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.52 15.1 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 114.206 1.187 . . . . 70.409999999999997 114.206 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.93 23.72 66.01 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.564 -1.415 . . . . 73.510000000000005 109.564 -168.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 52.3 mtt180 -149.56 163.06 38.89 Favored 'General case' 0 N--CA 1.445 -0.712 1 C-N-CA 132.143 4.177 . . . . 73.530000000000001 103.843 -171.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.23 155.23 3.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.635 -1.617 . . . . 73.349999999999994 106.635 172.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -124.12 124.36 42.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 127.649 2.379 . . . . 61.450000000000003 106.911 164.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 mm -114.04 137.17 48.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.541 1.936 . . . . 63.350000000000001 106.458 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -160.08 6.96 0.09 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.281 1.215 . . . . 72.230000000000004 114.281 -172.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -151.96 123.81 8.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 104.17 -2.53 . . . . 71.109999999999999 104.17 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.3 t -132.57 144.81 35.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.943 -1.503 . . . . 74.109999999999999 106.943 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.21 159.95 68.9 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 108.165 -1.05 . . . . 73.510000000000005 108.165 176.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.58 -7.5 47.5 Favored 'Cis proline' 0 CA--C 1.534 0.485 0 N-CA-C 113.815 0.66 . . . . 74.329999999999998 113.815 -3.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -116.71 120.66 39.28 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.318 -1.734 . . . . 52.229999999999997 106.318 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -76.57 124.47 27.66 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.633 1.173 . . . . 71.430000000000007 108.686 -174.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 mttm -97.5 166.04 11.71 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.581 -0.896 . . . . 72.239999999999995 108.581 169.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -53.82 149.88 15.67 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.577 1.151 . . . . 50.32 109.315 171.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -68.9 142.84 53.01 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.217 1.944 . . . . 73.519999999999996 110.499 169.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -150.79 165.39 33.68 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 120.898 -1.126 . . . . 53.240000000000002 109.864 174.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -99.61 159.06 15.32 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.668 -0.864 . . . . 74.109999999999999 108.668 167.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.1 mt -131.54 118.9 20.76 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.373 1.069 . . . . 64.319999999999993 109.272 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -59.67 112.35 1.78 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.109 -1.441 . . . . 64.519999999999996 107.109 167.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -142.2 168.63 19.29 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 107.042 -1.466 . . . . 75.310000000000002 107.042 166.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.38 170.54 15.58 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.838 1.255 . . . . 73.109999999999999 111.49 163.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.4 tt -154.4 147.98 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 123.478 0.711 . . . . 75.409999999999997 109.303 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.4 m -151.39 48.81 0.82 Allowed 'General case' 0 C--O 1.238 0.471 0 C-N-CA 129.473 3.109 . . . . 73.25 110.412 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.68 -66.9 3.32 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 126.207 1.86 . . . . 61.509999999999998 112.19 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.1 p -124.7 2.57 8.21 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 114.82 1.415 . . . . 75.340000000000003 114.82 -168.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.5 m -118.9 100.88 7.65 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.698 1.599 . . . . 63.530000000000001 107.806 173.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.3 tp -77.52 125.15 28.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.933 -1.506 . . . . 75.519999999999996 106.933 166.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -119.06 92.64 3.85 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 123.988 0.915 . . . . 72.430000000000007 108.973 177.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.7 t -80.78 137.35 21.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.669 -1.234 . . . . 75.349999999999994 107.669 168.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -100.58 -14.68 18.09 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 114.209 1.188 . . . . 75.319999999999993 114.209 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.1 t -151.6 163.87 38.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.429 1.013 . . . . 70.549999999999997 112.525 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.79 -175.79 53.28 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-O 122.832 1.24 . . . . 51.149999999999999 110.314 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.3 m -49.22 -27.62 3.85 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.802 1.641 . . . . 71.230000000000004 113.362 176.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -95.83 2.06 53.52 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.191 1.182 . . . . 62.25 114.191 -173.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.68 105.17 0.14 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.347 1.059 . . . . 61.229999999999997 111.211 -173.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 173.47 -138.54 4.65 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.91 0.767 . . . . 72.349999999999994 112.62 -174.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.8 t -150.5 132.14 14.89 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.416 1.486 . . . . 74.329999999999998 107.934 -178.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.522 ' CE2' HG23 ' A' ' 18' ' ' THR . 36.7 m-85 -134.36 134.22 41.51 Favored 'General case' 0 CA--C 1.515 -0.388 0 C-N-CA 123.721 0.808 . . . . 73.540000000000006 109.323 -176.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -75.98 153.93 36.19 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.428 -0.953 . . . . 72.109999999999999 108.428 167.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -69.84 154.97 41.25 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.555 -0.905 . . . . 73.310000000000002 108.555 168.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -139.5 165.21 27.84 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 126.224 1.81 . . . . 74.510000000000005 107.461 163.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm . . . . . 0 C--O 1.25 1.115 0 C-N-CA 125.919 1.688 . . . . 61.240000000000002 111.115 -178.407 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.784 0 N-CA-C 107.559 -2.217 . . . . 32.329999999999998 107.559 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -94.25 85.05 4.53 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.655 -1.609 . . . . 64.400000000000006 106.655 -170.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -99.7 122.8 43.23 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.546 -2.02 . . . . 75.129999999999995 105.546 -173.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -114.55 155.17 26.96 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 126.447 1.899 . . . . 75.099999999999994 110.778 -174.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 p -72.27 175.64 5.93 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.35 -0.611 . . . . 64.420000000000002 109.35 164.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -56.92 150.23 17.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.337 1.065 . . . . 73.439999999999998 110.114 155.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.1 tp -84.76 129.23 34.85 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 125.722 1.609 . . . . 75.430000000000007 107.159 155.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -135.44 166.23 23.66 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.363 -1.347 . . . . 74.319999999999993 107.363 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 t -67.29 -2.61 6.24 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 124.574 1.15 . . . . 61.149999999999999 112.788 -177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -108.01 -36.8 6.24 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.131 -0.981 . . . . 73.329999999999998 109.436 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -61.82 -23.92 66.54 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.39 1.076 . . . . 74.209999999999994 112.895 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.3 tp -90.12 -16.1 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 125.0 1.32 . . . . 72.129999999999995 113.101 -174.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.3 mm -69.75 130.5 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 124.952 1.301 . . . . 62.130000000000003 110.983 -163.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.34 -175.24 20.82 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 125.783 1.658 . . . . 63.509999999999998 110.324 175.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -82.17 169.97 16.0 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.403 -0.962 . . . . 73.329999999999998 108.403 167.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -132.58 -175.86 3.9 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.556 -1.276 . . . . 74.200000000000003 107.556 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.2 t -169.05 167.04 10.81 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.722 1.601 . . . . 75.209999999999994 109.745 162.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.518 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 2.3 t -136.98 -19.43 1.3 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.506 1.122 . . . . 60.229999999999997 112.799 -177.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.78 171.27 38.77 Favored Glycine 0 CA--C 1.52 0.396 0 N-CA-C 108.666 -1.774 . . . . 60.119999999999997 108.666 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 46.5 pt -134.81 19.11 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.972 1.309 . . . . 55.340000000000003 110.578 -169.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.76 -179.65 6.59 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 127.195 2.198 . . . . 64.310000000000002 108.33 -174.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.02 -117.58 6.94 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.108 0.861 . . . . 74.019999999999996 111.964 170.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 70.2 m -132.13 98.95 4.56 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.664 -1.235 . . . . 63.329999999999998 107.664 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -114.56 171.11 7.83 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 124.471 1.108 . . . . 73.140000000000001 110.21 -175.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -138.92 136.05 35.07 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.854 -1.165 . . . . 74.439999999999998 107.854 -165.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.51 96.17 4.59 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.028 1.331 . . . . 75.25 109.392 -171.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.0 mt -77.89 153.24 32.8 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.633 1.573 . . . . 72.439999999999998 110.811 164.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.0 p -141.16 158.77 43.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.871 1.268 . . . . 75.549999999999997 109.267 162.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -141.12 124.65 16.75 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.015 1.326 . . . . 75.450000000000003 108.415 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.5 159.91 16.26 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 125.206 1.402 . . . . 52.409999999999997 107.746 170.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -83.96 -32.95 24.74 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.802 0.841 . . . . 73.329999999999998 112.239 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -138.87 30.32 2.27 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.641 1.176 . . . . 63.240000000000002 109.836 -172.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -127.86 -110.92 1.61 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.448 -1.461 . . . . 71.549999999999997 109.448 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 14.2 p -146.01 -170.66 3.53 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 127.049 2.14 . . . . 72.140000000000001 107.361 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.0 167.92 12.93 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.846 -1.302 . . . . 32.030000000000001 109.846 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 25.5 m -144.29 155.86 44.01 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.826 -0.808 . . . . 54.43 110.199 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -139.93 120.48 14.17 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.164 1.385 . . . . 60.049999999999997 107.764 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.85 157.18 15.13 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.752 -1.339 . . . . 71.049999999999997 109.752 168.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 41.3 mt -122.28 146.59 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 105.835 -1.913 . . . . 40.350000000000001 105.835 169.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -134.82 144.68 47.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.227 1.411 . . . . 72.310000000000002 108.449 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -101.9 125.87 48.67 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.192 -2.151 . . . . 71.340000000000003 105.192 158.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.2 m120 62.86 -83.58 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 125.582 1.553 . . . . 72.019999999999996 112.977 160.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -150.4 59.98 0.96 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.642 1.177 . . . . 74.030000000000001 108.651 163.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.0 m -144.89 130.19 9.36 Favored Pre-proline 0 N--CA 1.449 -0.475 0 C-N-CA 127.137 2.175 . . . . 75.129999999999995 106.316 170.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.94 141.48 48.76 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 122.452 2.101 . . . . 72.010000000000005 109.651 167.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.3 mm -131.73 -22.26 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.763 1.225 . . . . 62.109999999999999 110.998 -174.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.9 t -143.47 167.66 21.67 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 120.576 -1.328 . . . . 72.409999999999997 110.251 170.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -160.09 146.88 16.03 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.551 1.94 . . . . 75.340000000000003 108.726 -175.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -159.05 164.05 35.78 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.386 1.874 . . . . 74.319999999999993 107.573 163.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 67.5 mtm -121.18 156.84 31.52 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.744 1.618 . . . . 53.450000000000003 107.149 162.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -161.3 138.01 8.53 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.141 0.976 . . . . 63.109999999999999 109.711 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -75.11 163.24 27.77 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.705 0.764 . . . . 72.329999999999998 109.262 166.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -153.08 158.15 41.49 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.799 0.84 . . . . 75.040000000000006 111.064 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.1 mmtp -137.06 158.28 44.81 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.562 -0.711 . . . . 72.439999999999998 110.485 169.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 27.5 mm -111.14 90.85 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 106.81 -1.552 . . . . 55.530000000000001 106.81 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -121.5 22.86 10.55 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.381 1.252 . . . . 62.32 114.381 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -174.9 14.98 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 116.341 1.978 . . . . 64.049999999999997 116.341 -173.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.27 16.23 77.06 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 119.475 -2.016 . . . . 31.140000000000001 114.39 -174.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -130.69 -170.7 2.39 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.796 2.038 . . . . 71.040000000000006 108.269 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.4 mt -113.2 106.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 120.802 1.637 . . . . 74.310000000000002 107.263 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -72.12 124.13 24.33 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 107.539 -1.282 . . . . 73.430000000000007 107.539 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.8 mm -111.15 139.07 36.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 105.406 -2.072 . . . . 62.240000000000002 105.406 170.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -157.49 8.57 0.17 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.954 0.902 . . . . 75.340000000000003 112.306 -175.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -152.6 118.9 5.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 103.18 -2.896 . . . . 75.439999999999998 103.18 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.2 t -135.65 152.23 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.223 -2.14 . . . . 64.150000000000006 105.223 169.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.05 161.64 54.61 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 125.34 1.456 . . . . 73.150000000000006 107.583 173.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -81.86 -6.81 46.39 Favored 'Cis proline' 0 CA--C 1.54 0.789 0 N-CA-C 114.319 0.854 . . . . 71.209999999999994 114.319 -6.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.92 104.78 14.33 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 104.731 -2.322 . . . . 63.420000000000002 104.731 168.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -64.01 155.2 31.86 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 123.814 0.696 . . . . 62.340000000000003 110.495 170.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -129.67 162.29 28.67 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.109 1.364 . . . . 73.049999999999997 107.854 175.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 t -54.92 149.26 24.09 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 109.072 -0.714 . . . . 61.329999999999998 109.072 171.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.12 147.19 53.7 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.241 1.961 . . . . 61.340000000000003 110.992 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -156.52 174.05 16.01 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.825 1.25 . . . . 71.150000000000006 109.755 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -117.05 131.08 57.02 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.811 -1.181 . . . . 74.450000000000003 107.811 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.416 HD22 ' HA3' ' A' ' 89' ' ' GLY . 45.5 mt -101.06 116.4 32.75 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 124.649 1.179 . . . . 72.120000000000005 108.578 176.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.9 116.28 5.67 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.844 1.258 . . . . 72.049999999999997 108.045 172.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.1 p -139.42 156.77 46.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.757 0.789 . . . . 71.299999999999997 110.045 161.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -116.28 159.34 22.01 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.279 -1.328 . . . . 60.100000000000001 108.964 168.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.2 tt -152.89 154.35 7.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.671 -1.603 . . . . 55.240000000000002 106.671 -176.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.8 p -133.37 -11.22 2.83 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.836 1.421 . . . . 62.0 114.836 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.32 -91.17 0.15 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 107.098 -2.401 . . . . 74.430000000000007 107.098 -165.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.5 p -106.7 -0.42 23.62 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 115.454 1.65 . . . . 64.040000000000006 115.454 -167.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 67.6 m -114.16 109.93 19.18 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.568 1.947 . . . . 74.310000000000002 109.878 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.493 HD22 HG23 ' A' ' 86' ' ' VAL . 0.5 OUTLIER -75.89 136.1 40.12 Favored 'General case' 0 C--O 1.239 0.515 0 O-C-N 119.837 -1.789 . . . . 64.209999999999994 107.39 167.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -119.2 88.63 2.97 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.602 -0.518 . . . . 60.229999999999997 109.602 162.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.493 HG23 HD22 ' A' ' 84' ' ' LEU . 25.0 t -81.5 133.03 30.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.859 -0.793 . . . . 54.329999999999998 108.859 170.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -106.43 -18.59 13.94 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.708 1.203 . . . . 74.230000000000004 112.872 -171.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.4 t -155.75 171.66 19.64 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.244 1.417 . . . . 64.010000000000005 109.298 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.416 ' HA3' HD22 ' A' ' 75' ' ' LEU . . . 92.81 178.28 40.78 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-O 122.836 1.242 . . . . 61.109999999999999 110.378 -173.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 64.1 m -59.55 -21.37 60.18 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 113.706 1.002 . . . . 74.430000000000007 113.706 174.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -109.96 19.48 18.99 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 115.342 1.608 . . . . 73.109999999999999 115.342 -176.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.14 109.24 0.56 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.171 0.988 . . . . 62.140000000000001 111.484 177.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.83 -156.15 26.7 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.184 1.374 . . . . 53.409999999999997 112.912 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 2.0 t -119.81 125.48 48.67 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.979 1.312 . . . . 62.140000000000001 110.158 -173.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.518 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 6.1 m-85 -133.3 152.23 51.92 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.003 0.43 . . . . 73.319999999999993 110.848 -174.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -103.53 138.3 40.41 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.352 1.461 . . . . 71.219999999999999 107.473 172.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -52.78 149.23 6.43 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 119.295 0.952 . . . . 74.239999999999995 109.408 166.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.3 mm-40 -137.63 155.99 48.55 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.52 1.928 . . . . 64.310000000000002 108.208 169.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 79.5 mttt . . . . . 0 C--O 1.252 1.2 0 C-N-CA 125.761 1.624 . . . . 64.5 110.805 -175.832 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.45 0 N-CA-C 109.541 -1.424 . . . . 73.530000000000001 109.541 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.4 150.78 1.15 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 126.948 2.099 . . . . 74.340000000000003 106.245 167.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -135.71 105.54 6.19 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.172 -1.788 . . . . 75.099999999999994 106.172 -168.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.416 ' CG ' ' HB3' ' A' ' 78' ' ' LYS . 93.4 m95 -106.51 -174.09 2.45 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.755 2.022 . . . . 73.200000000000003 111.592 -173.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.7 p -110.4 160.67 16.37 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.597 0.759 . . . . 74.530000000000001 110.126 168.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -54.56 127.16 26.62 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 127.11 2.164 . . . . 73.430000000000007 109.288 173.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 tp -79.7 92.04 5.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.893 -1.151 . . . . 73.219999999999999 107.893 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -94.56 164.36 13.01 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 125.33 1.452 . . . . 65.209999999999994 107.581 174.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.45 -45.89 73.19 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 124.241 1.016 . . . . 74.120000000000005 109.873 172.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -76.51 -19.35 58.07 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 119.454 -0.898 . . . . 63.310000000000002 112.425 -170.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.2 -40.5 62.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.914 -0.491 . . . . 71.299999999999997 111.003 176.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 9.1 tp -76.61 -13.32 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 O-C-N 120.91 -1.119 . . . . 74.409999999999997 113.695 -170.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 mm -52.28 136.0 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.032 1.333 . . . . 72.530000000000001 112.655 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 130.58 178.85 15.66 Favored Glycine 0 CA--C 1.523 0.532 0 C-N-CA 125.855 1.693 . . . . 72.239999999999995 110.739 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -84.87 167.06 16.33 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.405 -0.961 . . . . 73.299999999999997 108.405 165.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -147.41 139.86 24.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.417 -1.327 . . . . 73.530000000000001 107.417 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 t -141.71 170.09 16.37 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.569 -1.332 . . . . 71.200000000000003 110.203 166.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.3 t -132.71 0.43 3.57 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.462 2.305 . . . . 75.329999999999998 111.546 -173.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 163.93 179.28 38.12 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 110.175 -1.17 . . . . 60.219999999999999 110.175 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.2 pt -130.8 22.87 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.711 1.604 . . . . 35.509999999999998 109.571 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -142.53 -175.88 4.64 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.328 1.451 . . . . 74.239999999999995 109.654 -169.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.84 -119.38 16.08 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.534 -1.026 . . . . 55.340000000000003 110.534 156.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -131.79 101.69 5.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 105.979 -1.86 . . . . 73.019999999999996 105.979 161.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.7 p-80 -114.34 172.5 6.97 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.641 0.734 . . . . 74.409999999999997 109.061 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -143.14 144.58 32.27 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.418 -0.956 . . . . 74.420000000000002 108.418 -160.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.84 103.13 5.93 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 122.994 0.518 . . . . 72.230000000000004 109.671 -167.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.5 mt -94.64 154.45 17.34 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.467 1.107 . . . . 71.549999999999997 110.068 169.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.5 p -146.12 125.16 12.82 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.425 1.09 . . . . 70.450000000000003 109.769 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -124.03 114.96 20.43 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 120.166 1.348 . . . . 72.120000000000005 109.793 -174.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -92.42 152.76 19.54 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 124.151 0.907 . . . . 73.299999999999997 110.033 177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -81.26 -20.48 40.85 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 114.268 1.21 . . . . 73.109999999999999 114.268 -174.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -133.48 1.11 3.39 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.328 0.513 . . . . 74.219999999999999 112.245 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.83 -123.17 5.2 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.435 -1.466 . . . . 43.149999999999999 109.435 173.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.3 p -134.74 -171.1 2.7 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 125.858 1.663 . . . . 63.210000000000001 108.542 -164.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -115.37 165.65 12.15 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 110.99 -0.844 . . . . 64.129999999999995 110.99 165.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.8 m -142.56 166.38 24.82 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.846 0.859 . . . . 45.030000000000001 110.832 176.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -146.99 133.0 19.18 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.492 -1.299 . . . . 73.519999999999996 107.492 -175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.45 161.62 24.48 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.184 -1.167 . . . . 52.219999999999999 110.184 171.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 48.3 mt -131.94 121.51 47.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.109 -1.811 . . . . 71.239999999999995 106.109 -174.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -118.49 132.53 56.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.72 1.208 . . . . 71.109999999999999 109.016 -171.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 m -97.68 119.24 35.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.554 -1.276 . . . . 73.129999999999995 107.554 166.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.5 m120 46.77 -85.2 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 127.844 2.457 . . . . 75.219999999999999 113.72 -177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -139.51 56.68 1.65 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.827 1.251 . . . . 72.040000000000006 109.402 170.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 m -143.58 122.57 7.32 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.154 1.782 . . . . 72.439999999999998 107.84 171.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.44 137.6 36.77 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.842 2.362 . . . . 73.129999999999995 109.847 165.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 7.0 mm -128.17 -15.27 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.187 0.995 . . . . 71.329999999999998 111.164 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.4 t -135.56 167.41 21.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 119.775 -1.828 . . . . 71.239999999999995 110.059 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -163.47 147.27 10.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.303 -0.862 . . . . 74.420000000000002 108.921 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -167.99 165.96 13.41 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.444 1.498 . . . . 63.149999999999999 108.311 166.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 46.3 mtm -133.48 161.29 34.97 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.089 1.356 . . . . 72.230000000000004 108.048 174.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -162.6 140.11 8.17 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.992 1.317 . . . . 71.319999999999993 109.155 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.42 161.81 26.8 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.271 -1.011 . . . . 74.340000000000003 108.271 163.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -144.14 164.56 30.33 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 121.669 -0.644 . . . . 74.530000000000001 109.344 169.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -136.7 156.42 48.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 108.806 -0.813 . . . . 74.120000000000005 108.806 166.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.0 mm -107.04 99.81 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 106.173 -1.788 . . . . 71.530000000000001 106.173 168.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -134.2 28.52 3.75 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.885 0.874 . . . . 61.43 112.353 173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -163.14 14.01 0.07 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.003 1.721 . . . . 74.329999999999998 115.129 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.49 21.03 47.92 Favored Glycine 0 CA--C 1.538 1.516 0 O-C-N 120.254 -1.529 . . . . 74.540000000000006 113.111 -168.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.3 mtt85 -132.69 -168.45 2.07 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.86 2.864 . . . . 74.439999999999998 106.875 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.7 mt -118.32 110.89 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 106.897 -1.52 . . . . 72.319999999999993 106.897 176.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -80.78 120.24 24.4 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.332 -1.359 . . . . 70.530000000000001 107.332 172.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 24.0 mm -108.02 135.0 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 105.356 -2.09 . . . . 71.140000000000001 105.356 172.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -154.06 8.29 0.35 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.809 0.843 . . . . 64.219999999999999 112.494 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -151.6 121.08 6.87 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 104.168 -2.53 . . . . 61.109999999999999 104.168 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.5 t -136.26 149.91 27.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.051 -1.833 . . . . 52.25 106.051 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.99 160.29 53.32 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 125.6 1.56 . . . . 72.530000000000001 108.04 177.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.78 -13.66 27.89 Favored 'Cis proline' 0 CA--C 1.535 0.555 0 CA-C-N 119.539 0.871 . . . . 71.140000000000001 113.802 -10.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -98.76 103.1 15.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 104.022 -2.584 . . . . 50.520000000000003 104.022 171.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -66.82 160.07 26.75 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.307 -0.627 . . . . 73.219999999999999 109.307 167.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -137.9 174.7 10.29 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.118 1.367 . . . . 74.430000000000007 108.315 168.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.5 t -51.32 150.76 5.86 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 108.861 -0.792 . . . . 71.349999999999994 108.861 168.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -65.2 153.23 79.27 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.077 1.851 . . . . 74.25 109.333 163.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -159.3 172.07 18.67 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.555 1.542 . . . . 74.430000000000007 109.008 175.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -114.15 146.01 40.89 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.846 -1.168 . . . . 53.109999999999999 107.846 172.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 76.3 mt -123.9 115.98 22.16 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.769 1.228 . . . . 73.409999999999997 107.94 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.06 127.53 33.46 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.205 1.002 . . . . 73.530000000000001 108.353 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.9 m -144.73 160.66 40.86 Favored 'General case' 0 CA--C 1.522 -0.124 0 O-C-N 121.787 -0.57 . . . . 72.409999999999997 109.803 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 4' ' ' TRP . 8.2 mttm -121.41 155.72 34.23 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.333 1.453 . . . . 55.140000000000001 108.695 173.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 tt -145.75 148.23 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 119.095 0.862 . . . . 45.32 110.532 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.0 p -152.37 77.53 1.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.552 1.141 . . . . 64.329999999999998 109.913 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.4 -59.63 0.17 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 127.838 2.637 . . . . 74.230000000000004 115.385 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.8 p -132.6 22.16 4.3 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.479 1.111 . . . . 71.430000000000007 112.294 174.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.7 m -127.68 131.89 49.74 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.682 1.193 . . . . 72.239999999999995 107.989 167.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 27.6 tp -117.98 131.96 56.44 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.524 1.929 . . . . 75.120000000000005 107.885 167.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.4 tttm -120.14 98.57 6.13 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 125.489 1.516 . . . . 72.319999999999993 108.183 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.6 t -75.89 125.59 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 106.436 -1.69 . . . . 34.530000000000001 106.436 167.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -83.15 -33.86 26.16 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.512 0.596 . . . . 64.200000000000003 111.474 176.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.0 t -146.76 155.77 42.64 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.446 1.498 . . . . 74.200000000000003 109.127 -170.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 118.07 -175.42 15.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 124.978 1.275 . . . . 53.210000000000001 111.414 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -24.61 63.29 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 117.895 -1.05 . . . . 63.43 112.432 169.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -111.68 24.19 13.01 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.406 1.003 . . . . 64.109999999999999 112.342 -168.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.39 102.41 0.23 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.341 1.456 . . . . 55.310000000000002 112.659 -178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.74 -124.97 0.92 Allowed Glycine 0 N--CA 1.463 0.498 0 C-N-CA 124.23 0.919 . . . . 73.219999999999999 112.557 -173.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 t -152.2 147.48 26.45 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.691 1.196 . . . . 35.229999999999997 111.186 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -143.51 146.7 33.59 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.336 1.454 . . . . 71.239999999999995 110.0 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -115.19 27.24 9.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.522 1.129 . . . . 72.109999999999999 113.69 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.4 tttt 61.76 159.28 0.06 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.692 1.997 . . . . 61.539999999999999 111.255 -170.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -144.22 163.05 34.78 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 127.786 2.434 . . . . 73.140000000000001 106.083 163.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.1 mmmt . . . . . 0 C--O 1.251 1.153 0 C-N-CA 125.949 1.699 . . . . 71.420000000000002 108.071 -173.183 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.563 0 N-CA-C 109.402 -1.479 . . . . 74.530000000000001 109.402 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -137.24 96.08 3.21 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.479 1.133 . . . . 74.510000000000005 109.532 178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -85.75 117.21 24.49 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 104.1 -2.556 . . . . 61.039999999999999 104.1 173.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -121.81 -178.63 3.88 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 125.755 1.622 . . . . 71.219999999999999 108.624 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.6 p -111.42 170.19 8.29 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 118.588 0.631 . . . . 73.450000000000003 111.072 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -56.36 119.07 5.42 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.548 1.139 . . . . 70.049999999999997 109.669 170.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.9 tp -70.84 123.24 21.51 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.528 -1.656 . . . . 73.439999999999998 106.528 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -136.85 175.2 9.83 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.053 0.941 . . . . 65.329999999999998 108.903 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.3 p -58.51 -41.07 84.55 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 125.56 1.544 . . . . 73.340000000000003 111.821 -174.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.89 -30.14 35.53 Favored 'General case' 0 N--CA 1.458 -0.072 0 C-N-CA 123.384 0.674 . . . . 61.219999999999999 109.857 -174.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.6 -38.51 91.38 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.394 0.543 . . . . 74.219999999999999 111.021 -170.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.5 tp -74.43 -24.81 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 124.616 1.166 . . . . 70.510000000000005 112.636 -172.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm -57.02 109.58 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.91 1.684 . . . . 70.310000000000002 111.21 -168.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.97 172.89 32.99 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.784 -0.926 . . . . 54.119999999999997 110.784 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -86.51 160.02 19.11 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.42 -0.956 . . . . 70.209999999999994 108.42 159.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -146.89 140.86 26.0 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.475 1.51 . . . . 74.109999999999999 108.894 -177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.0 t -138.09 179.42 6.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.238 1.415 . . . . 51.130000000000003 107.874 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.5 t -137.27 -40.03 0.59 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.647 -1.283 . . . . 70.519999999999996 112.034 177.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.86 179.6 30.79 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 106.652 -2.579 . . . . 61.119999999999997 106.652 167.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.8 pt -130.41 36.04 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 124.304 1.041 . . . . 65.439999999999998 109.678 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -139.61 174.39 10.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.947 1.299 . . . . 71.439999999999998 109.606 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.68 -95.22 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.991 1.758 . . . . 50.310000000000002 114.024 169.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.4 m -139.44 141.89 37.44 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 105.688 -1.967 . . . . 73.209999999999994 105.688 162.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -151.45 -179.47 7.41 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.487 1.115 . . . . 72.420000000000002 108.112 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -142.47 140.86 32.04 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.131 0.973 . . . . 72.430000000000007 108.767 -174.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.32 154.08 17.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 126.859 2.064 . . . . 71.540000000000006 107.032 170.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.479 HD21 ' HG2' ' A' ' 91' ' ' GLU . 5.0 mt -145.02 147.76 32.97 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.39 1.876 . . . . 73.430000000000007 105.951 169.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 p -151.02 154.71 37.57 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.015 0.825 . . . . 73.200000000000003 110.516 170.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.423 ' CE1' HD22 ' A' ' 27' ' ' LEU . 93.2 m-85 -143.56 118.12 9.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.257 1.023 . . . . 71.230000000000004 108.782 -174.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.5 158.76 25.76 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.61 -0.885 . . . . 43.130000000000003 108.61 164.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -79.6 -39.04 32.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.023 0.529 . . . . 71.310000000000002 110.427 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.29 8.79 7.88 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.897 0.879 . . . . 75.019999999999996 110.678 -166.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -115.27 -133.21 5.36 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 126.694 2.092 . . . . 74.540000000000006 108.062 172.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -126.35 -177.89 4.14 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.299 1.44 . . . . 75.140000000000001 108.441 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.27 160.1 15.27 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.667 1.603 . . . . 62.219999999999999 110.461 171.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 m -133.63 158.2 43.83 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.326 1.051 . . . . 31.219999999999999 109.871 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -149.1 129.11 13.49 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.464 1.906 . . . . 72.430000000000007 107.082 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.87 119.21 1.11 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.226 -1.15 . . . . 54.240000000000002 110.226 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.507 ' H ' ' HB3' ' A' ' 47' ' ' SER . 35.9 mt -75.95 150.63 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.558 -0.905 . . . . 73.129999999999995 108.558 174.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -132.09 133.58 44.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.443 1.497 . . . . 73.129999999999995 108.222 176.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 m -83.17 135.34 34.83 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 105.792 -1.929 . . . . 61.329999999999998 105.792 159.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 43.42 -80.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.785 2.434 . . . . 72.510000000000005 115.825 156.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.07 64.42 1.16 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.073 0.949 . . . . 22.440000000000001 111.597 162.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 m -157.65 135.83 7.48 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 128.469 2.707 . . . . 71.230000000000004 108.875 171.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.25 119.89 5.76 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.312 3.341 . . . . 74.109999999999999 111.927 170.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 mm -122.8 17.12 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.611 1.564 . . . . 73.530000000000001 111.071 -173.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 39' ' ' ILE . 30.4 t -158.03 164.26 36.91 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 119.492 -2.005 . . . . 63.520000000000003 108.117 157.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -158.72 127.86 5.53 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.898 2.079 . . . . 73.200000000000003 106.122 173.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -143.4 169.31 17.9 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.145 1.778 . . . . 71.439999999999998 107.604 163.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 11.0 mtm -145.92 160.43 41.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.44 1.096 . . . . 75.319999999999993 110.302 170.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -161.89 147.55 13.38 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 125.626 1.57 . . . . 71.219999999999999 108.23 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.59 176.18 7.87 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.447 1.476 . . . . 51.229999999999997 108.614 170.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -157.43 161.96 38.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.266 -0.896 . . . . 65.5 111.139 168.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mmtm -131.15 165.0 24.26 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.454 0.702 . . . . 74.040000000000006 109.338 163.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.8 mm -123.8 83.21 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 105.753 -1.943 . . . . 73.400000000000006 105.753 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.28 24.14 10.89 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.064 1.346 . . . . 65.439999999999998 110.074 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -164.25 13.51 0.05 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.963 1.305 . . . . 73.040000000000006 114.092 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.65 14.6 65.22 Favored Glycine 0 CA--C 1.534 1.23 0 O-C-N 120.977 -1.077 . . . . 65.430000000000007 111.843 -171.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -137.19 170.94 15.25 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.143 2.177 . . . . 64.209999999999994 106.625 173.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 mt -75.27 165.61 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.446 -1.316 . . . . 64.409999999999997 107.446 176.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -136.52 108.62 7.21 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.976 2.11 . . . . 65.319999999999993 106.179 162.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mm -93.46 145.59 7.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.447 0 N-CA-C 106.02 -1.845 . . . . 50.009999999999998 106.02 168.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -150.25 -1.45 0.41 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 114.131 1.16 . . . . 74.409999999999997 114.131 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.36 115.92 3.84 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.079 -2.563 . . . . 75.439999999999998 104.079 -167.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 t -132.34 149.43 32.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.295 1.038 . . . . 74.439999999999998 108.459 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.64 164.41 32.88 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 126.998 2.119 . . . . 63.32 106.094 168.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.03 -16.09 19.67 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 CA-C-N 119.412 0.826 . . . . 64.219999999999999 113.69 -5.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.09 119.89 34.37 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.683 -1.599 . . . . 72.310000000000002 106.683 172.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -79.4 141.66 36.67 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 118.668 0.667 . . . . 73.519999999999996 110.281 177.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp -136.61 160.16 39.65 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.605 1.162 . . . . 70.530000000000001 111.315 -177.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 t -57.69 151.62 40.59 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.588 1.955 . . . . 65.340000000000003 111.464 170.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.88 158.05 38.88 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.665 2.91 . . . . 74.420000000000002 112.484 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -171.04 172.4 5.45 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.664 1.186 . . . . 73.109999999999999 111.176 173.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -115.93 96.89 5.8 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.963 1.705 . . . . 71.510000000000005 110.052 -175.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.2 mt -75.54 133.13 41.06 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 126.238 1.815 . . . . 62.119999999999997 109.258 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.418 ' H ' HG22 ' A' ' 88' ' ' THR . 0.0 OUTLIER -87.1 130.49 34.48 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.776 1.23 . . . . 73.329999999999998 109.303 176.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.3 p -154.64 166.62 32.79 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 126.487 1.915 . . . . 64.310000000000002 109.306 170.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -131.57 155.33 47.69 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.643 1.577 . . . . 74.510000000000005 109.649 175.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.9 tt -146.89 147.92 17.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.411 1.084 . . . . 65.540000000000006 108.122 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.8 m -138.74 -5.37 1.53 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.185 1.394 . . . . 74.109999999999999 114.626 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.02 -89.89 0.11 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 107.978 -2.049 . . . . 54.509999999999998 107.978 -171.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.0 p -119.8 -4.35 10.2 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.676 1.361 . . . . 65.310000000000002 114.676 -172.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 91.0 m -99.08 114.14 26.7 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 121.039 1.745 . . . . 73.540000000000006 110.582 172.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 61.5 tp -85.49 116.17 23.64 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 119.441 -2.037 . . . . 50.240000000000002 108.297 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.87 105.51 15.73 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.011 0.924 . . . . 61.219999999999999 109.792 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.5 t -90.12 127.68 42.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.132 -0.692 . . . . 63.539999999999999 109.132 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -85.53 -38.2 18.79 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 118.662 0.664 . . . . 63.340000000000003 110.699 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 76' ' ' ASP . 1.4 t -148.54 173.35 13.23 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.092 0.86 . . . . 74.340000000000003 110.962 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 106.42 177.07 23.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 125.088 1.328 . . . . 64.129999999999995 110.361 -178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.8 m -53.48 -30.94 43.51 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.589 1.155 . . . . 74.219999999999999 110.252 169.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.479 ' HG2' HD21 ' A' ' 27' ' ' LEU . 1.4 mp0 -89.51 0.52 56.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 113.713 1.005 . . . . 73.5 113.713 -174.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -47.48 109.87 0.26 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.801 1.64 . . . . 71.409999999999997 109.651 -175.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 166.15 -167.97 39.6 Favored Glycine 0 CA--C 1.519 0.315 0 N-CA-C 109.024 -1.63 . . . . 71.439999999999998 109.024 -167.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.8 t -135.13 147.98 49.64 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.108 -1.071 . . . . 72.530000000000001 108.108 176.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -146.68 160.53 42.09 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 125.17 1.388 . . . . 73.430000000000007 109.97 -167.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.78 140.25 49.64 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.441 1.496 . . . . 70.209999999999994 109.405 175.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.503 ' HG2' ' H ' ' A' ' 99' ' ' LYS . 67.5 tttt -60.77 144.47 52.35 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.776 1.231 . . . . 74.239999999999995 109.952 178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -125.94 34.05 4.95 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.861 2.064 . . . . 74.519999999999996 109.11 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.503 ' H ' ' HG2' ' A' ' 97' ' ' LYS . 11.4 mtpp . . . . . 0 C--O 1.253 1.257 0 C-N-CA 128.471 2.709 . . . . 74.109999999999999 104.959 162.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.458 0 N-CA-C 108.85 -1.7 . . . . 72.439999999999998 108.85 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -138.86 160.09 40.54 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.439 1.096 . . . . 73.310000000000002 108.828 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -126.25 98.27 5.4 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.579 1.952 . . . . 65.150000000000006 105.745 -174.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.405 ' CD1' ' HE3' ' A' ' 78' ' ' LYS . 86.4 m95 -117.42 154.01 32.11 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.581 1.153 . . . . 65.140000000000001 110.48 -178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.2 p -75.32 165.85 24.52 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.28 -0.637 . . . . 73.25 109.28 172.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -64.19 130.93 45.86 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.755 1.264 . . . . 75.140000000000001 108.873 169.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.04 133.83 55.16 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 114.597 -1.183 . . . . 75.549999999999997 109.184 164.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.31 166.7 23.85 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.157 -1.383 . . . . 71.120000000000005 109.428 166.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.76 -44.9 78.09 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 124.328 1.017 . . . . 71.340000000000003 108.957 167.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -60.83 -24.82 66.17 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 120.963 -1.086 . . . . 73.120000000000005 112.152 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.418 ' HB3' HG21 ' A' ' 79' ' ' ILE . 1.3 m-20 -85.96 -26.86 25.25 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 118.432 -0.794 . . . . 71.439999999999998 112.457 -172.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.0 tp -88.07 -7.52 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 119.54 1.064 . . . . 73.519999999999996 112.168 -171.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.442 ' O ' ' HE3' ' A' ' 97' ' ' LYS . 18.3 mm -62.23 114.66 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 125.218 1.407 . . . . 75.310000000000002 110.445 -172.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.6 173.92 25.71 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.435 -1.066 . . . . 53.350000000000001 110.435 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -85.62 151.55 23.81 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.369 -1.345 . . . . 54.009999999999998 107.369 162.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -138.58 123.84 19.26 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.108 1.363 . . . . 73.310000000000002 108.772 -175.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -129.1 170.13 13.89 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.327 0.651 . . . . 60.420000000000002 109.403 173.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.455 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 12.5 t -126.82 -6.07 6.24 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.77 1.628 . . . . 61.240000000000002 111.369 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.07 177.46 19.9 Favored Glycine 0 C--N 1.334 0.471 0 N-CA-C 108.665 -1.774 . . . . 61.149999999999999 108.665 -174.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 pt -131.65 -11.04 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.702 0.801 . . . . 73.530000000000001 112.655 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -72.05 153.72 41.56 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 120.104 -1.623 . . . . 73.510000000000005 110.409 173.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.18 -111.64 3.31 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 118.698 -1.057 . . . . 70.230000000000004 111.237 165.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.6 m -141.78 107.49 5.11 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 106.966 -1.494 . . . . 62.100000000000001 106.966 171.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -103.11 175.43 5.48 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 122.229 1.014 . . . . 73.420000000000002 110.779 -174.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -126.89 140.08 52.6 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.461 1.905 . . . . 71.329999999999998 106.826 -173.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.45 143.51 51.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.94 1.296 . . . . 52.130000000000003 108.428 -176.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.0 mt -132.12 156.75 45.81 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.034 -1.469 . . . . 75.140000000000001 107.034 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.0 p -154.92 97.64 1.97 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.689 1.596 . . . . 60.530000000000001 112.311 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -91.59 132.42 36.33 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.243 1.417 . . . . 75.530000000000001 110.289 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -94.11 165.33 12.68 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 127.77 2.428 . . . . 60.350000000000001 108.949 159.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -104.26 6.64 35.57 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 126.059 1.744 . . . . 60.310000000000002 110.549 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -149.94 7.3 0.62 Allowed 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 115.162 1.541 . . . . 61.25 115.162 175.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.06 -110.97 1.51 Allowed Glycine 0 C--N 1.337 0.632 0 CA-C-N 118.498 0.59 . . . . 72.540000000000006 112.132 -170.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.4 p -147.16 131.83 17.86 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.418 1.487 . . . . 71.439999999999998 107.927 -174.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -69.95 175.96 34.06 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.137 -0.785 . . . . 71.420000000000002 111.137 176.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m -145.04 164.27 31.69 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.817 -1.402 . . . . 75.409999999999997 111.943 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -141.63 120.5 12.73 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.024 -0.732 . . . . 63.409999999999997 109.024 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -121.35 161.65 15.35 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.553 1.073 . . . . 44.219999999999999 111.097 177.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.4 mt -137.7 133.62 45.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.962 -1.866 . . . . 63.32 105.962 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -125.93 127.03 45.34 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.593 1.557 . . . . 43.140000000000001 108.965 -170.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -86.01 112.83 21.59 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.149 -1.056 . . . . 55.200000000000003 108.149 166.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 55.24 -85.95 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.921 2.089 . . . . 74.299999999999997 110.307 -169.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.92 -0.42 3.41 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.155 0.982 . . . . 60.100000000000001 112.264 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.5 m -84.11 119.65 73.61 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.267 1.427 . . . . 74.430000000000007 108.161 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.36 140.19 57.26 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.862 2.375 . . . . 64.510000000000005 109.778 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.8 mm -124.42 -41.61 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 124.213 1.005 . . . . 73.319999999999993 109.655 -177.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.2 t -124.63 156.18 37.91 Favored 'General case' 0 CA--C 1.512 -0.487 0 O-C-N 121.495 -0.753 . . . . 73.310000000000002 109.641 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -154.82 152.99 30.47 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.987 1.715 . . . . 74.299999999999997 108.235 172.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -161.48 161.07 29.92 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 127.723 2.409 . . . . 51.329999999999998 107.286 168.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 13.6 mtm -124.3 163.3 21.95 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.199 1.0 . . . . 72.430000000000007 110.048 166.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -164.57 141.7 6.38 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.433 1.093 . . . . 71.349999999999994 111.035 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.8 158.83 20.83 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.151 0.98 . . . . 72.540000000000006 108.961 164.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -151.33 166.73 30.07 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.158 -0.964 . . . . 74.349999999999994 110.556 177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -138.07 149.3 45.88 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.187 -1.042 . . . . 75.430000000000007 108.187 165.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.2 mm -116.61 92.98 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 106.888 -1.523 . . . . 74.329999999999998 106.888 172.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -134.31 23.32 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.648 0.779 . . . . 74.510000000000005 112.484 -173.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -166.71 14.13 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.805 0.842 . . . . 75.120000000000005 111.791 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 70.77 5.59 57.39 Favored Glycine 0 CA--C 1.539 1.576 0 O-C-N 121.342 -0.848 . . . . 72.150000000000006 111.947 -171.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.542 ' HB3' ' HA ' ' A' ' 76' ' ' ASP . 0.6 OUTLIER -121.51 145.01 48.39 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 130.458 3.503 . . . . 73.109999999999999 109.551 173.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.98 121.04 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.583 -1.636 . . . . 71.140000000000001 106.583 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -88.75 112.36 23.08 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 106.474 -1.676 . . . . 74.140000000000001 106.474 169.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 mm -103.92 138.4 28.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 106.304 -1.739 . . . . 72.310000000000002 106.304 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -158.62 2.59 0.1 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.767 1.025 . . . . 73.319999999999993 113.767 -172.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -153.43 125.15 7.72 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 103.544 -2.762 . . . . 64.530000000000001 103.544 175.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.9 t -135.49 152.23 31.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 106.973 -1.491 . . . . 73.230000000000004 106.973 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.78 160.66 52.59 Favored Pre-proline 0 C--O 1.239 0.549 0 C-N-CA 123.855 0.862 . . . . 72.409999999999997 109.046 175.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.78 -8.01 16.91 Favored 'Cis proline' 0 CA--C 1.534 0.523 0 CA-C-N 118.794 0.605 . . . . 62.43 113.45 -8.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -108.09 107.05 17.55 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.643 -1.244 . . . . 71.510000000000005 107.643 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -67.35 140.67 57.25 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.966 -0.753 . . . . 73.230000000000004 108.966 169.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -130.89 172.8 11.63 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.143 1.377 . . . . 75.319999999999993 109.146 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.7 t -49.81 150.53 3.77 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.422 1.489 . . . . 72.439999999999998 110.798 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -66.1 154.23 74.89 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.874 1.716 . . . . 60.32 110.009 163.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -160.82 153.02 20.22 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.471 1.908 . . . . 74.310000000000002 109.767 170.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -98.11 140.38 32.51 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.185 -1.042 . . . . 74.239999999999995 108.185 167.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.1 mt -119.76 109.22 15.36 Favored 'General case' 0 CA--C 1.522 -0.111 0 C-N-CA 126.53 1.932 . . . . 70.230000000000004 108.683 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.542 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 5.0 m-20 -62.58 131.56 49.48 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.828 -1.175 . . . . 63.210000000000001 107.828 174.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 4.8 p -150.8 173.0 14.72 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 125.483 1.513 . . . . 71.519999999999996 109.831 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HE3' ' CD1' ' A' ' 4' ' ' TRP . 17.9 mtmt -139.23 158.43 44.19 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.227 0.611 . . . . 70.519999999999996 110.233 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.418 HG21 ' HB3' ' A' ' 11' ' ' ASN . 4.8 tt -151.06 144.02 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 118.227 0.467 . . . . 64.140000000000001 110.528 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 34.0 t -133.23 33.46 3.61 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.662 1.585 . . . . 74.409999999999997 108.244 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.4 -56.85 4.22 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 120.912 -1.118 . . . . 74.310000000000002 111.962 175.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.85 -25.25 11.32 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.043 1.127 . . . . 73.109999999999999 114.043 -175.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.0 m -102.29 127.76 49.13 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.827 1.194 . . . . 75.510000000000005 108.056 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.8 tp -94.81 137.7 33.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.875 2.07 . . . . 63.32 108.808 159.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -136.15 87.91 2.34 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.6 1.16 . . . . 63.549999999999997 110.221 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.1 t -76.64 128.5 37.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.189 -1.041 . . . . 63.340000000000003 108.189 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -86.35 -25.72 25.23 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.607 0.763 . . . . 74.219999999999999 111.367 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 t -153.71 158.36 40.89 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.181 1.392 . . . . 72.219999999999999 110.579 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.18 177.47 20.93 Favored Glycine 0 CA--C 1.522 0.519 0 C-N-CA 124.664 1.126 . . . . 74.439999999999998 111.17 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.3 m -60.69 -16.82 43.4 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.204 1.402 . . . . 61.140000000000001 113.694 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -109.32 8.81 25.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.8 1.64 . . . . 64.519999999999996 112.844 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.12 116.34 2.73 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.311 1.844 . . . . 74.439999999999998 109.5 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.15 -153.26 21.76 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 122.158 0.866 . . . . 63.409999999999997 113.204 -172.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.7 t -135.43 123.93 23.5 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 126.191 1.796 . . . . 64.540000000000006 106.503 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.455 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 60.9 m-85 -141.01 157.72 44.94 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 122.556 1.169 . . . . 74.230000000000004 109.481 -175.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 6.3 mmmt -127.62 138.06 52.73 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.356 -1.35 . . . . 72.340000000000003 107.356 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 13' ' ' ILE . 25.5 tttt -51.39 145.88 7.87 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.641 1.576 . . . . 62.25 109.32 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -122.54 20.1 10.36 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.469 2.708 . . . . 61.509999999999998 109.463 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.8 mmtp . . . . . 0 C--O 1.246 0.918 0 C-N-CA 130.007 3.323 . . . . 60.130000000000003 103.817 171.942 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.62 0 N-CA-C 110.155 -1.178 . . . . 54.240000000000002 110.155 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -133.55 146.49 51.07 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.202 -1.036 . . . . 62.329999999999998 108.202 170.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -82.77 117.82 22.95 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 104.814 -2.291 . . . . 65.109999999999999 104.814 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -115.15 157.2 23.95 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 125.056 1.343 . . . . 72.439999999999998 110.157 172.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.59 173.08 12.95 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.18 0.514 . . . . 64.310000000000002 109.877 169.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -59.21 151.65 22.48 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.948 -1.023 . . . . 74.129999999999995 109.754 167.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 tp -90.89 130.0 36.88 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.872 -1.529 . . . . 73.25 106.872 165.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -139.2 168.02 20.76 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.694 1.198 . . . . 74.450000000000003 109.259 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 t -74.04 33.89 0.09 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.945 0.898 . . . . 51.43 111.482 175.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.76 -32.44 0.44 Allowed 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 119.875 -1.765 . . . . 74.010000000000005 113.178 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -82.82 -30.3 28.86 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 116.976 -1.488 . . . . 65.219999999999999 111.969 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 tp -70.43 -24.63 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 121.636 2.016 . . . . 73.030000000000001 113.136 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.2 mm -59.83 104.57 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.778 2.031 . . . . 74.25 111.246 -174.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.99 171.2 32.82 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 124.089 0.852 . . . . 72.140000000000001 111.034 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -76.13 152.28 36.77 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.106 0.962 . . . . 65.209999999999994 109.066 163.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -146.41 153.5 40.55 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.601 1.16 . . . . 70.329999999999998 109.299 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 t -153.45 165.24 36.45 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.812 -1.18 . . . . 70.140000000000001 110.304 166.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.458 HG22 ' H ' ' A' ' 25' ' ' LYS . 4.4 t -115.79 -9.82 11.82 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.69 1.596 . . . . 65.120000000000005 111.413 -175.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.04 -172.6 44.85 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 121.489 -0.757 . . . . 72.230000000000004 111.209 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.5 pt -134.77 14.69 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 127.032 2.133 . . . . 61.450000000000003 110.71 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -144.34 179.35 7.3 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.861 1.664 . . . . 74.340000000000003 111.653 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.25 -104.98 0.23 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 126.038 1.78 . . . . 63.549999999999997 111.755 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.6 m -139.74 101.88 4.3 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 106.128 -1.804 . . . . 74.209999999999994 106.128 169.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -117.7 178.73 4.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.827 1.251 . . . . 72.049999999999997 109.423 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.458 ' H ' HG22 ' A' ' 18' ' ' THR . 1.5 mptt -144.8 154.38 42.63 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.072 0.949 . . . . 71.430000000000007 109.941 -177.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.22 154.5 18.41 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.382 1.873 . . . . 64.25 107.529 172.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.6 mt -138.31 144.82 40.6 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.855 -1.535 . . . . 41.509999999999998 106.855 160.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.9 p -139.03 155.03 48.27 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 119.814 1.188 . . . . 73.140000000000001 109.764 166.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.426 ' CD2' ' CE2' ' A' ' 53' ' ' TYR . 22.2 m-85 -143.09 125.19 15.33 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.549 1.94 . . . . 72.239999999999995 106.039 -175.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -101.35 154.04 19.13 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.467 -1.679 . . . . 72.120000000000005 106.467 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -74.87 -41.38 59.93 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 118.841 0.746 . . . . 51.409999999999997 111.38 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -108.59 -1.74 19.37 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.113 0.565 . . . . 65.409999999999997 111.672 -162.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -129.81 -112.22 1.54 Allowed Glycine 0 CA--C 1.52 0.36 0 N-CA-C 111.26 -0.736 . . . . 31.039999999999999 111.26 -169.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 80.3 p -145.3 172.67 12.82 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.022 1.329 . . . . 51.329999999999998 107.773 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -116.03 -166.46 14.64 Favored Glycine 0 CA--C 1.524 0.627 0 O-C-N 120.973 -1.08 . . . . 43.219999999999999 111.865 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.5 m -155.44 156.94 36.2 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 121.264 -1.139 . . . . 71.319999999999993 111.694 -170.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -135.52 145.54 47.17 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.325 1.45 . . . . 65.430000000000007 108.104 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.15 154.5 25.54 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 109.93 -1.268 . . . . 54.219999999999999 109.93 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.7 mt -113.29 143.77 22.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 107.034 -1.469 . . . . 73.140000000000001 107.034 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -132.22 119.27 20.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.499 1.52 . . . . 73.239999999999995 109.211 -177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.8 m -85.86 107.98 17.93 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.617 -1.994 . . . . 74.439999999999998 105.617 166.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.72 -57.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 129.749 3.219 . . . . 74.319999999999993 115.721 174.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -154.94 25.3 0.43 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.684 1.594 . . . . 44.420000000000002 112.307 167.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.5 m -131.51 125.16 20.51 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.89 1.276 . . . . 54.240000000000002 108.282 -172.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.06 124.8 7.53 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.738 2.959 . . . . 74.310000000000002 112.159 -175.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.2 mm -114.65 -13.17 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.264 1.426 . . . . 73.109999999999999 112.762 -171.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.7 m -151.6 163.73 38.42 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.086 -1.009 . . . . 74.209999999999994 109.133 170.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -164.23 127.47 2.51 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.639 1.976 . . . . 64.439999999999998 108.057 -173.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.77 166.94 26.94 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.879 1.671 . . . . 53.340000000000003 108.354 173.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 49.8 mtm -137.93 151.25 47.79 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.545 -0.909 . . . . 65.049999999999997 108.545 170.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -158.74 146.76 18.11 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.327 1.451 . . . . 74.209999999999994 110.913 -171.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -81.22 176.24 9.94 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.301 -1.0 . . . . 74.439999999999998 108.301 167.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.426 ' CE2' ' CD2' ' A' ' 29' ' ' PHE . 5.9 m-85 -141.97 159.19 42.73 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.87 -0.604 . . . . 74.129999999999995 110.2 171.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -130.78 132.21 45.14 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.296 -1.372 . . . . 65.019999999999996 107.296 161.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.42 106.88 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 105.939 -1.875 . . . . 73.310000000000002 105.939 164.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -127.94 23.98 6.08 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.401 0.62 . . . . 74.25 111.244 174.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.67 13.73 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.471 0.915 . . . . 65.349999999999994 113.471 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 67.32 13.43 62.59 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 120.892 -1.13 . . . . 71.030000000000001 111.286 -163.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 76' ' ' ASP . 9.4 mmt85 -136.89 152.82 50.65 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.768 2.027 . . . . 73.120000000000005 105.917 -172.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.8 mt -88.06 115.24 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 N-CA-C 107.147 -1.427 . . . . 72.219999999999999 107.147 -170.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -87.38 111.11 20.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.147 -1.057 . . . . 72.019999999999996 108.147 169.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.2 mm -79.51 138.99 18.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.021 -1.844 . . . . 65.129999999999995 106.021 163.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -145.79 2.84 0.94 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.859 1.429 . . . . 74.109999999999999 114.859 175.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.4 100.46 0.34 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.014 -1.476 . . . . 65.150000000000006 107.014 -156.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.9 t -130.34 143.27 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.401 1.08 . . . . 52.149999999999999 108.34 -176.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.04 158.91 71.32 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.371 1.869 . . . . 72.299999999999997 106.597 171.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -84.95 -6.41 53.31 Favored 'Cis proline' 0 CA--C 1.54 0.793 0 CA-C-N 119.533 0.869 . . . . 64.010000000000005 113.581 -6.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.09 102.79 10.73 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 105.973 -1.862 . . . . 72.019999999999996 105.973 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -71.43 151.97 43.53 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.234 1.016 . . . . 74.409999999999997 112.079 -174.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -128.48 164.66 22.27 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 126.35 1.86 . . . . 72.209999999999994 111.017 -176.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.6 t -63.01 150.43 88.33 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.796 0.838 . . . . 73.439999999999998 109.292 165.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.77 137.66 25.07 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.696 2.264 . . . . 65.340000000000003 111.186 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -152.77 164.1 38.44 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.729 0.812 . . . . 74.150000000000006 111.451 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -93.39 154.37 17.99 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.244 0.617 . . . . 73.049999999999997 110.932 173.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -128.62 126.13 39.57 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.553 1.941 . . . . 70.450000000000003 107.728 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.426 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 48.0 m-20 -76.77 116.08 17.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.669 -1.975 . . . . 63.210000000000001 105.669 172.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -142.46 159.24 42.62 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.157 -0.683 . . . . 63.229999999999997 109.157 169.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -132.01 156.97 45.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.444 1.498 . . . . 71.209999999999994 110.537 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 tt -146.85 156.81 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.495 -0.557 . . . . 70.430000000000007 109.495 -177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -153.4 46.5 0.66 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 123.482 1.61 . . . . 73.140000000000001 110.898 174.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.19 -73.13 0.33 Allowed Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 113.583 -1.644 . . . . 65.409999999999997 109.262 171.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.4 p -119.91 -2.77 10.26 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 114.152 1.168 . . . . 74.310000000000002 114.152 -173.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.3 m -106.62 130.11 54.43 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.264 -1.384 . . . . 73.310000000000002 107.264 164.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.91 136.42 38.23 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.177 1.791 . . . . 61.25 107.524 163.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -120.65 88.77 3.0 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.662 1.185 . . . . 65.329999999999998 109.329 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.6 t -77.07 118.85 24.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 106.922 -1.51 . . . . 73.150000000000006 106.922 172.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -78.14 -39.97 39.5 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.465 0.575 . . . . 65.439999999999998 111.142 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.7 t -144.0 174.73 10.6 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.123 0.874 . . . . 73.310000000000002 111.258 -166.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.55 -179.17 47.65 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 125.683 1.611 . . . . 34.43 111.272 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.4 m -58.92 -21.87 58.75 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.356 1.462 . . . . 72.439999999999998 113.101 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -106.62 10.28 31.13 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.938 1.295 . . . . 73.409999999999997 112.474 -177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.45 109.57 0.46 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.298 1.439 . . . . 61.119999999999997 110.738 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -175.74 -169.89 37.91 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.547 1.07 . . . . 65.120000000000005 111.269 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.8 t -129.61 121.58 27.37 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.481 -1.674 . . . . 52.240000000000002 106.481 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -126.29 145.45 50.41 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 123.048 0.539 . . . . 73.049999999999997 109.842 -165.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.3 tppt? -97.38 148.95 22.65 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.448 -0.945 . . . . 64.049999999999997 108.448 164.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -59.7 150.13 28.69 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.435 1.494 . . . . 74.319999999999993 109.486 166.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -145.26 20.66 1.56 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.251 1.82 . . . . 73.230000000000004 113.076 -170.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.6 tttt . . . . . 0 C--O 1.255 1.371 0 C-N-CA 128.473 2.709 . . . . 72.409999999999997 112.839 -178.985 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.733 0 N-CA-C 109.395 -1.482 . . . . 74.319999999999993 109.395 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -87.41 87.18 7.34 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 105.874 -1.899 . . . . 61.200000000000003 105.874 156.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -79.8 85.98 5.41 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.56 -1.274 . . . . 74.219999999999999 107.56 -172.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -88.47 150.86 22.91 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.134 0.974 . . . . 75.409999999999997 110.283 176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.64 175.99 7.64 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.619 1.568 . . . . 52.340000000000003 109.996 171.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -74.15 123.08 23.79 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.06 0.944 . . . . 72.340000000000003 111.164 172.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.431 HD22 ' SG ' ' A' ' 77' ' ' CYS . 24.7 tp -60.69 129.29 40.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.239 -0.652 . . . . 74.420000000000002 109.239 162.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -146.35 168.27 21.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.653 0.74 . . . . 72.439999999999998 109.709 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.07 21.14 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 129.814 3.245 . . . . 72.510000000000005 113.446 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.83 -52.13 0.63 Allowed 'General case' 0 C--O 1.232 0.177 0 O-C-N 119.904 -1.748 . . . . 74.099999999999994 110.916 176.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -64.19 -26.38 68.49 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.66 1.118 . . . . 53.030000000000001 113.015 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.429 HD13 HD11 ' A' ' 7' ' ' LEU . 10.8 tp -70.52 -25.09 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.417 1.487 . . . . 64.310000000000002 113.469 177.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.77 129.89 34.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 123.443 0.697 . . . . 45.039999999999999 110.08 -163.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 127.36 -172.42 18.72 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.12 1.819 . . . . 63.530000000000001 111.397 174.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -82.27 160.7 22.88 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.361 1.465 . . . . 72.530000000000001 111.264 176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -141.13 158.28 44.13 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.702 1.601 . . . . 73.25 108.182 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 p -146.78 169.08 19.83 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 121.8 2.091 . . . . 71.140000000000001 112.733 166.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.0 t -132.78 -5.33 3.19 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.608 1.563 . . . . 61.310000000000002 112.704 -171.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.8 172.94 14.9 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 108.251 -1.939 . . . . 74.049999999999997 108.251 -171.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 37.9 pt -138.11 27.42 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.452 1.101 . . . . 62.43 110.79 -168.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -125.89 174.88 8.07 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 124.559 1.144 . . . . 74.019999999999996 112.063 -171.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 43.66 -88.47 0.01 OUTLIER Glycine 0 C--N 1.341 0.854 0 C-N-CA 127.505 2.479 . . . . 55.420000000000002 114.017 149.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 86.3 m -130.44 122.23 27.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.485 -1.672 . . . . 62.030000000000001 106.485 159.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -131.72 -167.54 1.88 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.822 1.649 . . . . 72.230000000000004 107.757 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.43 156.08 18.31 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 126.241 1.816 . . . . 64.010000000000005 107.522 -162.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.95 132.4 20.78 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.789 2.436 . . . . 54.229999999999997 109.812 -177.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.59 HD21 ' HG3' ' A' ' 91' ' ' GLU . 48.4 mt -116.71 156.75 26.61 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 127.218 2.207 . . . . 75.340000000000003 108.498 175.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.9 t -137.18 156.31 48.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 106.025 -1.842 . . . . 43.409999999999997 106.025 160.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -143.1 129.78 20.3 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.35 1.46 . . . . 64.319999999999993 107.704 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.21 167.04 11.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.569 0.748 . . . . 71.219999999999999 110.76 171.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -81.88 -33.41 30.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.237 0.615 . . . . 71.5 110.572 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -138.08 28.82 2.55 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.867 0.841 . . . . 70.140000000000001 110.927 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -120.31 -116.62 2.54 Favored Glycine 0 C--N 1.33 0.232 0 N-CA-C 108.565 -1.814 . . . . 65.510000000000005 108.565 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.2 p -146.11 -175.07 4.61 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 125.398 1.479 . . . . 65.519999999999996 107.173 174.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.82 170.52 17.09 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.881 -0.888 . . . . 65.530000000000001 110.881 162.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.1 p -135.42 166.85 22.2 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.322 1.049 . . . . 74.409999999999997 110.89 171.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -149.59 105.96 3.5 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 107.044 -1.465 . . . . 71.329999999999998 107.044 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.51 104.02 1.02 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.577 -1.009 . . . . 63.310000000000002 110.577 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 mt -73.83 134.26 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 N-CA-C 106.42 -1.696 . . . . 52.439999999999998 106.42 170.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -123.56 135.85 54.22 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.257 1.423 . . . . 63.25 108.238 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.28 136.29 36.96 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 107.622 -1.251 . . . . 62.229999999999997 107.622 163.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 45.89 -78.91 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 129.065 2.946 . . . . 74.019999999999996 114.655 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -149.27 65.47 1.02 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.793 1.237 . . . . 74.329999999999998 110.335 163.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.0 m -155.32 132.84 6.5 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.562 1.945 . . . . 64.319999999999993 108.939 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.15 134.99 26.2 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.433 2.756 . . . . 63.439999999999998 110.357 172.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.3 mm -127.48 -20.78 2.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.146 0.578 . . . . 71.019999999999996 111.31 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.7 t -138.76 163.69 31.53 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 120.526 -1.359 . . . . 74.230000000000004 108.268 167.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -163.45 132.36 3.93 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 126.891 2.076 . . . . 53.43 106.694 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -148.96 159.22 44.4 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.474 -1.676 . . . . 75.349999999999994 106.474 162.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 22.9 mtm -130.78 145.56 52.0 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.643 -1.614 . . . . 74.150000000000006 106.643 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -164.09 140.13 6.35 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.955 -0.387 . . . . 62.420000000000002 109.955 -167.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.42 174.16 3.55 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.503 1.121 . . . . 62.530000000000001 109.671 173.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -154.13 172.12 18.06 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.302 -0.873 . . . . 73.430000000000007 110.941 162.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -133.31 153.77 51.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.407 -0.961 . . . . 72.239999999999995 108.407 158.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.1 mm -102.67 101.12 11.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 106.356 -1.72 . . . . 62.5 106.356 165.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -136.67 24.52 3.13 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.503 1.521 . . . . 73.109999999999999 110.363 -171.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -169.73 14.27 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.641 1.576 . . . . 54.409999999999997 114.045 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.47 18.88 68.23 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 120.773 -1.204 . . . . 71.140000000000001 112.129 -170.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 -136.48 166.56 23.22 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 128.704 2.802 . . . . 74.200000000000003 105.436 177.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mt -80.58 150.09 4.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.117 -1.438 . . . . 71.310000000000002 107.117 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -119.99 125.17 47.73 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 126.61 1.964 . . . . 75.409999999999997 105.757 165.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 28.8 mm -113.44 132.7 61.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 105.479 -2.045 . . . . 72.140000000000001 105.479 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -156.41 -2.61 0.12 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.314 0.857 . . . . 71.519999999999996 113.314 -170.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -145.52 111.65 5.66 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 105.526 -2.027 . . . . 74.340000000000003 105.526 174.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.2 t -130.28 146.84 33.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.067 -1.827 . . . . 72.140000000000001 106.067 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.58 160.73 58.01 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 106.72 -1.585 . . . . 70.239999999999995 106.72 174.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -79.47 -10.0 38.23 Favored 'Cis proline' 0 CA--C 1.537 0.645 0 CA-C-N 119.085 0.709 . . . . 70.450000000000003 113.532 -7.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.96 97.23 7.12 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 104.563 -2.384 . . . . 71.430000000000007 104.563 172.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -65.76 140.53 58.44 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.547 -0.908 . . . . 71.219999999999999 108.547 168.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.4 mttt -126.59 171.15 11.36 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 124.308 1.043 . . . . 74.150000000000006 109.459 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 t -47.15 141.69 5.94 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.276 1.031 . . . . 63.240000000000002 108.719 171.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.45 139.72 42.0 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 121.518 1.478 . . . . 43.32 109.466 172.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -144.64 162.33 36.93 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.629 0.772 . . . . 75.120000000000005 110.397 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -99.28 156.61 16.9 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.467 -0.938 . . . . 71.420000000000002 108.467 170.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.4 mt -127.55 110.12 12.4 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.734 -1.21 . . . . 63.200000000000003 107.734 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -57.98 129.19 40.8 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.481 -1.303 . . . . 73.120000000000005 107.481 170.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.47 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 1.8 p -157.48 165.46 35.59 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.508 0.723 . . . . 75.510000000000005 109.359 173.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -126.86 167.94 15.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.506 1.522 . . . . 71.209999999999994 111.143 164.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.0 tt -157.71 154.79 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.796 -0.816 . . . . 75.530000000000001 108.796 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.8 m -138.48 -5.27 1.59 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 118.195 2.665 . . . . 64.530000000000001 118.195 168.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.2 -52.52 0.51 Allowed Glycine 0 CA--C 1.518 0.28 0 N-CA-C 109.956 -1.258 . . . . 73.409999999999997 109.956 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -121.22 -20.88 6.58 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 116.757 -1.592 . . . . 51.030000000000001 113.82 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.1 m -96.51 116.83 29.72 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 121.141 1.791 . . . . 53.100000000000001 110.124 168.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.3 tp -87.45 140.13 29.84 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.645 1.178 . . . . 75.510000000000005 109.752 159.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -132.1 91.25 2.93 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.131 0.972 . . . . 74.540000000000006 110.968 170.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 29.4 t -80.67 133.24 29.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.106 -1.072 . . . . 75.109999999999999 108.106 173.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -89.84 -30.7 17.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.499 0.72 . . . . 74.209999999999994 112.675 -175.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.5 t -143.38 171.59 13.92 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.571 1.078 . . . . 63.210000000000001 110.69 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.25 179.67 49.61 Favored Glycine 0 N--CA 1.44 -1.09 0 CA-C-O 122.997 1.331 . . . . 73.140000000000001 110.787 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.3 m -58.13 -20.07 37.49 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 124.691 1.197 . . . . 35.439999999999998 113.757 -176.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.59 ' HG3' HD21 ' A' ' 27' ' ' LEU . 5.4 mm-40 -110.46 16.49 21.54 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.386 0.513 . . . . 62.119999999999997 112.386 -174.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.15 105.37 0.58 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.787 0.835 . . . . 73.329999999999998 111.69 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.35 -135.18 2.16 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 118.836 0.744 . . . . 42.439999999999998 113.074 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 8.4 t -138.58 119.9 14.77 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.866 1.666 . . . . 74.109999999999999 109.12 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.59 152.06 51.1 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.354 -0.841 . . . . 74.200000000000003 109.24 -166.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -119.05 129.8 55.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 117.636 -1.173 . . . . 74.109999999999999 108.698 -175.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -47.39 140.65 5.47 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.333 1.053 . . . . 74.530000000000001 109.297 172.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -120.77 45.06 2.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.107 1.763 . . . . 63.329999999999998 109.172 178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt . . . . . 0 C--O 1.257 1.457 0 C-N-CA 128.673 2.789 . . . . 74.140000000000001 105.418 178.058 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.572 0 N-CA-C 109.897 -1.281 . . . . 63.240000000000002 109.897 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -142.08 66.37 1.34 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 122.861 1.315 . . . . 75.349999999999994 107.693 162.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.14 64.67 7.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.315 -1.311 . . . . 53.119999999999997 108.34 -166.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -72.73 152.55 41.59 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.064 1.346 . . . . 75.109999999999999 110.385 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -78.63 166.39 22.58 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.027 0.376 . . . . 54.039999999999999 110.356 167.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -51.58 132.49 30.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 122.269 1.033 . . . . 73.329999999999998 108.669 163.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.8 tp -72.41 122.97 22.12 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 106.454 -1.684 . . . . 60.329999999999998 106.454 157.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -135.43 165.24 25.94 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.015 -1.476 . . . . 74.530000000000001 107.015 174.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.1 m -57.91 -43.68 86.36 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 124.184 0.928 . . . . 53.399999999999999 110.732 -165.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -75.75 -24.03 56.05 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.784 0.834 . . . . 72.049999999999997 111.728 -171.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -71.15 -39.55 71.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 118.517 0.599 . . . . 75.230000000000004 111.806 -174.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.7 tp -83.18 -14.72 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.214 1.006 . . . . 74.129999999999995 112.307 -167.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 mm -57.97 145.29 9.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 124.846 1.258 . . . . 73.109999999999999 109.755 -176.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.72 -170.09 13.46 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 124.684 1.135 . . . . 74.0 110.733 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -104.65 152.84 21.98 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.712 1.605 . . . . 74.439999999999998 109.447 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -147.45 126.47 12.84 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.845 1.258 . . . . 71.099999999999994 110.231 -170.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.6 t -135.66 166.89 22.19 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.89 0.876 . . . . 75.430000000000007 110.117 173.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.484 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 15.3 t -114.23 -13.96 12.32 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.76 1.624 . . . . 52.439999999999998 111.438 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.09 -174.9 41.7 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 109.704 -1.358 . . . . 60.020000000000003 109.704 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 30.0 pt -132.51 28.17 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.9 1.68 . . . . 63.140000000000001 110.165 -177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -129.39 175.48 8.72 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.454 1.102 . . . . 53.439999999999998 109.568 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 52.45 -107.79 0.57 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 125.927 1.727 . . . . 74.209999999999994 111.872 161.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.3 m -139.02 94.78 2.85 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.408 -1.701 . . . . 62.340000000000003 106.408 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -125.48 168.21 13.94 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 122.151 0.977 . . . . 61.100000000000001 111.653 -172.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -137.56 145.41 42.85 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.233 0.613 . . . . 63.5 109.839 -161.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.61 127.94 48.13 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.807 1.643 . . . . 55.299999999999997 107.71 -172.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.0 mt -117.33 153.23 33.35 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.322 -1.362 . . . . 62.200000000000003 107.322 169.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.0 p -148.88 158.05 43.89 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.68 -0.236 . . . . 62.43 110.655 159.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -142.62 138.76 30.94 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 125.169 1.388 . . . . 64.319999999999993 107.298 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.49 156.57 17.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 124.067 0.947 . . . . 71.219999999999999 109.622 171.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.9 -21.09 44.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.018 -0.537 . . . . 54.210000000000001 111.857 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -128.96 -1.61 5.24 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.325 0.65 . . . . 74.299999999999997 112.431 -173.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.94 -129.96 4.36 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.256 1.408 . . . . 55.409999999999997 111.992 -166.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.0 p -137.04 172.45 13.0 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 127.302 2.241 . . . . 75.099999999999994 107.38 175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.9 175.83 25.51 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.523 -0.735 . . . . 35.340000000000003 112.241 -176.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.37 152.08 50.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.904 1.282 . . . . 75.310000000000002 108.317 176.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -145.14 106.5 4.21 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.447 1.499 . . . . 62.509999999999998 108.693 175.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -113.78 149.66 18.64 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 110.785 -0.926 . . . . 75.120000000000005 110.785 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 54.3 mt -116.1 131.7 67.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 105.362 -2.088 . . . . 71.409999999999997 105.362 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -130.95 127.74 39.03 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.932 1.293 . . . . 62.32 109.006 -170.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -100.93 115.83 31.36 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.668 -1.975 . . . . 44.119999999999997 105.668 173.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 51.73 -65.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 129.602 3.161 . . . . 75.129999999999995 115.849 178.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -153.62 36.23 0.45 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.947 1.299 . . . . 74.010000000000005 111.785 172.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.1 m -136.85 133.92 19.01 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.953 1.301 . . . . 75.340000000000003 108.788 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.06 133.04 17.52 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.408 2.738 . . . . 75.219999999999999 110.656 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 mm -128.89 -6.72 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.231 1.012 . . . . 73.129999999999995 112.261 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.3 t -153.23 157.92 40.93 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 119.783 -1.823 . . . . 74.129999999999995 109.437 167.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -146.93 134.56 21.03 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.055 2.142 . . . . 54.32 107.936 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -141.45 160.28 40.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.184 -1.043 . . . . 71.109999999999999 108.184 162.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 20.8 mtm -130.82 139.13 50.16 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 105.465 -2.05 . . . . 75.340000000000003 105.465 172.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.616 ' HB3' HG23 ' A' ' 65' ' ' VAL . 7.7 p90 -157.37 152.5 25.96 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.706 -1.22 . . . . 73.010000000000005 107.706 -173.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.9 p30 -79.32 -177.35 5.67 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.648 1.213 . . . . 75.299999999999997 111.003 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.535 ' CD1' HG23 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -173.16 135.04 0.56 Allowed 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 125.858 1.663 . . . . 72.319999999999993 111.461 -164.717 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.582 ' HE3' ' CE1' ' A' ' 63' ' ' TYR . 4.1 mttt -135.34 159.96 39.91 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 124.536 1.147 . . . . 74.329999999999998 109.239 159.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 50.0 mm -94.71 118.91 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 105.723 -1.954 . . . . 75.230000000000004 105.723 149.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -136.93 25.09 3.05 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.769 0.828 . . . . 63.420000000000002 110.062 162.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.6 14.92 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 115.377 1.621 . . . . 74.239999999999995 115.377 -174.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 63.99 20.47 64.66 Favored Glycine 0 CA--C 1.531 1.094 0 O-C-N 120.299 -1.501 . . . . 64.129999999999995 110.951 -174.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -148.41 156.68 42.8 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.63 2.772 . . . . 63.100000000000001 105.007 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.535 HG23 ' CD1' ' A' ' 53' ' ' TYR . 72.1 mt -84.06 115.73 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 105.318 -2.104 . . . . 72.310000000000002 105.318 -176.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -90.26 116.87 28.56 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 117.918 -1.039 . . . . 73.200000000000003 109.236 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.5 mm -95.82 148.83 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 107.162 -1.421 . . . . 71.099999999999994 107.162 172.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.582 ' CE1' ' HE3' ' A' ' 54' ' ' LYS . 13.1 p90 -158.26 -0.19 0.1 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 115.755 1.761 . . . . 73.5 115.755 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -152.95 124.97 7.95 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.762 -2.31 . . . . 64.540000000000006 104.762 175.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.746 ' CG1' ' H ' ' A' ' 70' ' ' LYS . 7.2 p -139.23 158.21 28.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 125.139 1.376 . . . . 74.439999999999998 109.948 173.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.89 158.72 48.64 Favored Pre-proline 0 C--O 1.24 0.577 0 C-N-CA 126.839 2.056 . . . . 71.0 106.894 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -80.64 -10.96 39.95 Favored 'Cis proline' 0 N--CA 1.463 -0.321 0 N-CA-C 113.863 0.678 . . . . 72.519999999999996 113.863 0.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.11 124.35 50.65 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 103.555 -2.757 . . . . 70.510000000000005 103.555 169.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.713 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -75.68 148.15 38.88 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.382 -0.599 . . . . 74.239999999999995 109.382 172.305 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.746 ' H ' ' CG1' ' A' ' 65' ' ' VAL . 23.2 mtpt -128.05 158.66 37.33 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 109.574 -0.528 . . . . 74.109999999999999 109.574 169.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.9 t -53.26 149.28 13.91 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 125.283 1.433 . . . . 74.540000000000006 111.727 -178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.68 140.37 42.8 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.352 2.035 . . . . 63.219999999999999 111.482 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -159.31 174.58 14.55 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.708 1.203 . . . . 73.439999999999998 110.24 175.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.81 125.49 54.06 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.779 1.632 . . . . 73.299999999999997 110.248 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.0 mt -89.44 112.53 23.7 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 124.608 1.163 . . . . 64.400000000000006 109.146 172.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.09 114.08 3.51 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.377 -1.342 . . . . 73.519999999999996 107.377 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 86' ' ' VAL . 3.9 p -152.6 157.92 41.71 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.876 0.845 . . . . 53.009999999999998 110.429 175.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.0 mtpt -129.31 152.95 48.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.916 1.687 . . . . 74.530000000000001 108.827 -175.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.6 tt -146.92 152.75 12.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.466 -0.568 . . . . 54.039999999999999 109.466 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 t -159.26 45.75 0.27 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 122.945 1.355 . . . . 74.319999999999993 110.779 -178.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.52 -127.89 9.28 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 106.811 -2.515 . . . . 54.130000000000003 106.811 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.5 p -71.36 -11.41 60.88 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 116.383 -1.77 . . . . 64.140000000000001 114.16 -167.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.5 m -95.05 119.74 34.07 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 121.664 2.029 . . . . 42.030000000000001 108.822 173.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.9 tp -92.56 131.56 37.58 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.748 1.619 . . . . 72.120000000000005 108.13 160.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -119.48 100.59 7.38 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 125.246 1.418 . . . . 64.319999999999993 108.175 173.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.467 ' HA ' ' HB3' ' A' ' 77' ' ' CYS . 59.9 t -94.25 131.48 41.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.807 -1.183 . . . . 62.520000000000003 107.807 174.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -92.14 -29.22 16.62 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.579 0.752 . . . . 52.409999999999997 112.652 -172.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.9 t -140.78 173.17 11.75 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.003 1.721 . . . . 45.020000000000003 110.04 -172.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.09 -176.15 45.29 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 122.976 1.32 . . . . 45.219999999999999 112.311 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.59 -32.09 73.6 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.056 -0.673 . . . . 71.209999999999994 110.572 172.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.72 7.36 39.97 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.725 -0.609 . . . . 73.310000000000002 112.391 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.6 104.99 0.21 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.252 2.221 . . . . 71.519999999999996 111.584 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.96 -158.84 29.0 Favored Glycine 0 N--CA 1.451 -0.312 0 O-C-N 121.656 -0.652 . . . . 61.310000000000002 112.444 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.6 p -115.85 120.48 39.37 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.481 1.912 . . . . 55.439999999999998 107.327 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.484 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 67.1 m-85 -135.67 148.05 48.79 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.04 -0.726 . . . . 75.140000000000001 109.04 -174.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 7.0 mmmm -111.86 146.2 38.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.068 -1.086 . . . . 54.420000000000002 108.068 172.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -55.6 144.79 25.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.91 0.884 . . . . 72.439999999999998 108.891 172.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -126.6 86.6 2.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.743 -1.947 . . . . 73.200000000000003 105.743 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.5 mttt . . . . . 0 C--O 1.249 1.048 0 C-N-CA 126.897 2.079 . . . . 64.030000000000001 111.759 179.05 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.581 0 N-CA-C 110.386 -1.086 . . . . 71.230000000000004 110.386 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -106.02 156.73 18.1 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 117.724 0.762 . . . . 71.430000000000007 109.49 170.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -92.1 106.81 18.75 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.285 -1.746 . . . . 74.219999999999999 106.285 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -120.78 161.15 21.97 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.684 1.193 . . . . 64.340000000000003 110.502 172.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.47 178.43 7.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.049 2.14 . . . . 73.200000000000003 109.966 176.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -67.07 135.36 53.52 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.633 -1.167 . . . . 73.209999999999994 110.359 161.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -73.89 129.73 38.48 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 126.143 1.777 . . . . 71.420000000000002 108.097 158.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -141.3 179.57 6.69 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 119.64 -0.824 . . . . 71.030000000000001 110.132 161.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -69.27 25.1 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.386 1.875 . . . . 74.219999999999999 112.65 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.63 -53.64 0.82 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 119.873 -1.767 . . . . 64.409999999999997 109.317 -171.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -65.65 -28.5 69.14 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.451 -1.262 . . . . 74.120000000000005 112.517 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.19 -18.64 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 121.366 1.894 . . . . 71.340000000000003 114.002 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.4 mm -62.89 121.19 11.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 O-C-N 121.375 -0.828 . . . . 74.040000000000006 110.247 -169.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.98 -174.05 26.93 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.085 1.802 . . . . 74.150000000000006 111.12 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 28' ' ' SER . 1.8 m-85 -88.74 163.27 15.81 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.003 1.321 . . . . 73.239999999999995 109.513 171.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 84' ' ' LEU . 94.9 m95 -150.22 133.85 16.65 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.925 -1.109 . . . . 73.140000000000001 111.116 -175.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.4 t -138.2 162.75 33.47 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.292 1.437 . . . . 64.120000000000005 109.596 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.482 ' HB ' ' CD2' ' A' ' 95' ' ' TYR . 8.9 t -126.73 -14.79 5.62 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.496 1.118 . . . . 70.340000000000003 112.234 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 165.3 170.53 30.37 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 107.159 -2.376 . . . . 72.239999999999995 107.159 -169.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.0 pt -138.76 34.87 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.493 1.117 . . . . 73.219999999999999 108.746 -161.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -148.79 -176.14 5.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.8 1.64 . . . . 74.400000000000006 109.908 -165.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 44.97 -99.84 0.02 OUTLIER Glycine 0 CA--C 1.525 0.702 0 C-N-CA 126.603 2.049 . . . . 52.240000000000002 113.18 158.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.2 m -134.83 115.98 14.27 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.424 -1.695 . . . . 72.219999999999999 106.424 165.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 39.7 p-80 -127.34 168.55 14.64 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.679 0.752 . . . . 74.099999999999994 109.699 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -139.79 137.16 34.8 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.746 -1.576 . . . . 65.140000000000001 106.746 -164.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.43 HD13 ' H ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -123.32 143.3 50.18 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.214 1.406 . . . . 72.420000000000002 107.686 -172.098 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.447 HD22 ' CZ ' ' A' ' 29' ' ' PHE . 6.9 mt -138.95 158.99 43.2 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.785 1.634 . . . . 72.150000000000006 107.823 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB3' ' CD1' ' A' ' 15' ' ' TYR . 23.6 p -150.56 157.08 42.59 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.765 0.826 . . . . 65.219999999999999 109.747 163.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.447 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 92.4 m-85 -144.16 135.64 25.78 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.53 1.532 . . . . 74.010000000000005 107.798 174.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -110.53 150.56 28.74 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 124.295 1.038 . . . . 74.409999999999997 109.216 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -25.54 56.16 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 121.879 -0.513 . . . . 72.209999999999994 110.937 -174.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.6 -3.36 5.39 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.503 0.721 . . . . 72.030000000000001 111.12 -172.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -117.33 -140.47 6.64 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 126.085 1.803 . . . . 74.219999999999999 110.272 -176.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 74.7 p -122.89 158.68 29.83 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.806 1.242 . . . . 72.310000000000002 109.17 -176.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.89 165.56 43.89 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 109.889 -1.285 . . . . 74.219999999999999 109.889 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.16 161.54 37.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.393 -0.595 . . . . 72.209999999999994 109.393 173.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -140.56 150.17 43.32 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.086 -1.079 . . . . 72.209999999999994 108.086 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.81 155.69 26.39 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 110.069 -1.212 . . . . 62.43 110.069 173.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 55.5 mt -125.66 136.88 59.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 105.508 -2.034 . . . . 72.310000000000002 105.508 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -119.9 155.45 32.68 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 124.837 1.255 . . . . 72.230000000000004 108.278 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.05 130.93 56.45 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.254 -1.758 . . . . 71.329999999999998 106.254 162.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 44.85 -81.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 128.369 2.668 . . . . 71.239999999999995 114.653 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.01 54.25 1.37 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.928 1.691 . . . . 72.319999999999993 110.433 172.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.2 m -155.15 124.11 3.05 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 125.604 1.562 . . . . 73.420000000000002 108.544 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.69 139.74 41.22 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.891 2.394 . . . . 73.129999999999995 109.999 171.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.9 mm -129.79 -16.66 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 125.208 1.403 . . . . 72.340000000000003 111.416 -176.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 40.5 t -139.94 161.91 36.45 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 119.995 -1.691 . . . . 73.140000000000001 108.966 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -160.48 145.17 14.37 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 126.282 1.833 . . . . 74.430000000000007 107.983 -176.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.13 168.41 25.55 Favored 'General case' 0 C--O 1.239 0.553 0 C-N-CA 125.765 1.626 . . . . 61.439999999999998 107.512 167.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.7 mtm -133.03 138.07 46.68 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.921 -1.511 . . . . 75.310000000000002 106.921 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.555 ' HB3' HG23 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -149.25 137.16 20.52 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.732 1.213 . . . . 71.409999999999997 110.409 -173.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -82.05 166.26 19.91 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.533 -0.914 . . . . 64.239999999999995 108.533 169.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.05 168.34 27.32 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.904 0.882 . . . . 63.43 111.914 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -139.99 158.13 44.55 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.036 0.935 . . . . 65.019999999999996 111.434 162.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.5 mm -113.2 83.1 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.382 1.473 . . . . 61.149999999999999 108.1 171.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -116.77 24.29 11.36 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.395 1.878 . . . . 72.349999999999994 111.204 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -164.74 14.7 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.284 1.216 . . . . 64.25 114.284 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 68.8 21.28 74.95 Favored Glycine 0 CA--C 1.531 1.09 0 O-C-N 121.287 -0.883 . . . . 54.310000000000002 111.27 -170.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -145.46 166.06 26.74 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 127.011 2.124 . . . . 63.109999999999999 107.994 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.8 mt -99.31 115.54 40.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.517 -1.66 . . . . 72.439999999999998 106.517 -177.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -89.53 122.72 32.97 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.55 1.54 . . . . 63.149999999999999 107.912 172.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.8 mm -98.79 143.36 13.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.185 -1.413 . . . . 74.329999999999998 107.185 173.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -160.63 2.34 0.07 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.333 1.235 . . . . 71.150000000000006 114.333 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -153.75 112.49 3.68 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 104.388 -2.449 . . . . 52.509999999999998 104.388 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.727 HG13 ' HA ' ' A' ' 69' ' ' GLU . 11.8 p -138.62 157.82 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.575 -1.268 . . . . 74.129999999999995 107.575 171.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.87 165.99 23.13 Favored Pre-proline 0 N--CA 1.447 -0.609 0 C-N-CA 124.889 1.276 . . . . 73.409999999999997 108.465 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.09 -44.36 0.46 Allowed 'Cis proline' 0 N--CA 1.461 -0.42 0 C-N-CA 125.334 -0.694 . . . . 74.430000000000007 111.684 -10.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.62 125.28 26.68 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.892 -1.522 . . . . 61.049999999999997 106.892 167.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.727 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.2 pt-20 -75.5 158.01 33.18 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 124.285 0.991 . . . . 64.340000000000003 108.678 168.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.675 ' H ' HG12 ' A' ' 65' ' ' VAL . 9.4 mmpt? -115.14 158.73 21.8 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 120.509 -1.369 . . . . 72.25 108.068 164.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.73 145.91 20.08 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.624 -1.25 . . . . 51.539999999999999 107.624 168.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.4 139.8 32.36 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.852 1.701 . . . . 74.420000000000002 109.611 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -153.28 173.37 15.67 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.992 1.317 . . . . 74.109999999999999 108.554 175.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -107.09 153.5 22.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.93 -1.137 . . . . 74.120000000000005 107.93 171.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.3 mt -124.04 116.07 22.21 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 125.943 1.697 . . . . 63.43 107.218 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.51 121.08 9.44 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 125.211 1.404 . . . . 64.140000000000001 109.188 166.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.0 168.63 21.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 125.211 1.404 . . . . 65.430000000000007 108.415 172.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.54 165.76 26.05 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.789 1.636 . . . . 54.210000000000001 111.04 163.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.415 HG22 ' HG ' ' A' ' 7' ' ' LEU . 7.2 tt -157.38 159.46 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.453 -1.314 . . . . 71.329999999999998 107.453 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 t -137.48 -2.57 1.97 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.726 1.21 . . . . 72.129999999999995 112.612 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.73 -152.38 20.08 Favored Glycine 0 C--N 1.333 0.404 0 N-CA-C 107.664 -2.175 . . . . 62.009999999999998 107.664 -149.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.0 p -51.97 7.4 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 119.554 3.168 . . . . 72.340000000000003 119.554 -173.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.9 m -130.1 110.71 11.82 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.528 2.731 . . . . 70.319999999999993 108.059 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.415 ' HB2' ' CE3' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -88.09 128.32 35.42 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.946 -1.502 . . . . 52.219999999999999 106.946 170.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -117.78 82.87 1.9 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.61 0.764 . . . . 72.409999999999997 110.687 172.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -77.74 128.77 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.101 -1.074 . . . . 73.040000000000006 108.101 170.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -77.45 -42.99 33.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.661 1.184 . . . . 72.129999999999995 110.008 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.4 t -130.22 -173.77 3.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.205 1.002 . . . . 73.209999999999994 112.523 -170.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.7 -172.48 39.04 Favored Glycine 0 C--N 1.335 0.494 0 O-C-N 120.337 -1.477 . . . . 72.209999999999994 110.592 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.2 m -62.92 -28.24 69.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 121.849 -0.795 . . . . 64.140000000000001 109.814 158.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.59 -1.12 57.39 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.387 1.475 . . . . 53.43 112.131 -167.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.71 108.03 0.24 Allowed 'General case' 0 C--O 1.239 0.55 0 C-N-CA 127.395 2.278 . . . . 72.120000000000005 109.34 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.6 -154.9 19.96 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-O 122.192 0.884 . . . . 73.200000000000003 112.692 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 t -140.44 97.83 3.3 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.759 -1.941 . . . . 52.299999999999997 105.759 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.482 ' CD2' ' HB ' ' A' ' 18' ' ' THR . 52.0 m-85 -110.38 151.3 27.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 107.503 -1.295 . . . . 63.310000000000002 107.503 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -104.96 148.04 27.14 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.26 -1.385 . . . . 65.109999999999999 107.26 174.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -54.79 139.6 39.05 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 106.66 -1.607 . . . . 71.109999999999999 106.66 173.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -116.85 122.76 45.31 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 104.831 -2.285 . . . . 73.329999999999998 104.831 160.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.3 mttt . . . . . 0 C--O 1.249 1.05 0 C-N-CA 126.035 1.734 . . . . 74.200000000000003 111.187 168.645 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.887 0 N-CA-C 109.672 -1.371 . . . . 62.009999999999998 109.672 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -110.0 133.3 53.34 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 107.868 -1.16 . . . . 71.030000000000001 107.868 174.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -90.69 68.84 6.57 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.555 1.942 . . . . 73.040000000000006 107.568 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -61.0 144.52 53.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.876 -1.057 . . . . 74.239999999999995 111.149 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.6 172.39 12.67 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.263 1.03 . . . . 73.319999999999993 110.652 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -68.72 140.87 55.39 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 122.169 0.985 . . . . 62.350000000000001 110.036 167.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.466 HD11 HD13 ' A' ' 12' ' ' ILE . 15.6 tp -78.85 133.68 36.99 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.55 -1.278 . . . . 74.430000000000007 107.55 168.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -143.22 167.99 20.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 123.741 0.816 . . . . 54.409999999999997 109.032 173.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.7 t -75.95 43.16 0.27 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.573 1.549 . . . . 72.030000000000001 109.877 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.21 -50.83 0.14 Allowed 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 119.85 -1.781 . . . . 62.439999999999998 110.609 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -70.49 -29.98 66.65 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 119.092 -0.48 . . . . 71.239999999999995 111.251 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.466 HD13 HD11 ' A' ' 7' ' ' LEU . 4.1 tp -64.46 -26.16 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 119.344 0.974 . . . . 73.120000000000005 112.941 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mm -62.85 132.56 28.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 124.774 1.23 . . . . 75.329999999999998 110.242 -168.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 129.13 -178.8 17.09 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 125.796 1.665 . . . . 73.430000000000007 112.08 172.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -76.24 157.36 32.69 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.404 0.682 . . . . 71.329999999999998 110.323 174.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -143.33 110.38 5.66 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.544 -0.909 . . . . 62.439999999999998 108.544 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 45.9 t -115.02 151.62 33.88 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.759 0.824 . . . . 75.209999999999994 109.332 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.6 t -105.32 -17.31 14.49 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.864 0.866 . . . . 52.350000000000001 111.888 175.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.93 179.95 35.07 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.896 -1.682 . . . . 64.319999999999993 108.896 -174.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 pt -131.86 9.15 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 117.708 0.754 . . . . 75.340000000000003 112.819 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.9 163.65 12.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 119.358 0.981 . . . . 74.400000000000006 110.295 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.57 -90.23 0.02 OUTLIER Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.167 1.365 . . . . 62.43 114.956 155.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 m -134.07 123.41 24.44 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.15 1.975 . . . . 74.540000000000006 107.683 163.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 29.0 p-80 -140.91 176.47 8.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.562 1.145 . . . . 74.109999999999999 109.385 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -143.23 140.78 30.84 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.943 1.297 . . . . 64.340000000000003 108.68 -172.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.56 147.01 38.78 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 126.243 1.817 . . . . 63.149999999999999 108.621 176.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.59 168.2 19.69 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.121 0.969 . . . . 75.129999999999995 111.29 161.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.5 t -143.86 156.49 44.48 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.288 1.835 . . . . 73.310000000000002 108.845 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -146.12 111.91 5.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 128.508 2.723 . . . . 74.010000000000005 106.525 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.73 163.33 20.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.854 0.752 . . . . 73.319999999999993 109.308 166.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -88.87 -27.12 21.24 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.309 0.643 . . . . 75.340000000000003 112.095 175.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -130.98 12.94 5.23 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.631 1.172 . . . . 72.239999999999995 111.871 -172.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -126.92 -129.61 3.28 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 126.7 2.095 . . . . 74.420000000000002 108.989 -176.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.0 p -132.63 -166.6 1.77 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.244 1.818 . . . . 61.439999999999998 107.906 175.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -129.58 -175.26 13.97 Favored Glycine 0 CA--C 1.505 -0.552 0 O-C-N 119.823 -1.798 . . . . 74.109999999999999 112.058 172.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -144.84 154.38 42.6 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 118.281 -0.866 . . . . 71.219999999999999 110.057 -166.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -136.72 135.11 37.86 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.788 1.235 . . . . 74.239999999999995 109.493 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -138.39 158.01 24.74 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.573 -1.011 . . . . 51.409999999999997 110.573 167.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.8 mt -128.01 133.05 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 105.515 -2.031 . . . . 63.350000000000001 105.515 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -129.4 124.43 34.16 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.402 -0.962 . . . . 73.540000000000006 108.402 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.8 m -86.09 106.74 17.45 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.204 -2.147 . . . . 72.329999999999998 105.204 166.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 61.96 -75.73 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 127.371 2.268 . . . . 72.409999999999997 113.039 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -147.08 34.57 0.9 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 124.283 1.033 . . . . 72.439999999999998 112.495 172.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 87.5 m -137.59 118.44 10.58 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.498 1.919 . . . . 73.519999999999996 108.018 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -71.31 133.58 23.03 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 123.243 2.629 . . . . 74.230000000000004 111.125 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 9.5 mm -122.05 1.71 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 126.501 1.92 . . . . 64.219999999999999 111.046 -175.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.7 t -160.39 153.04 21.02 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 119.867 -1.771 . . . . 32.43 109.335 166.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -148.66 136.04 20.34 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 126.332 1.853 . . . . 63.140000000000001 109.302 172.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -158.57 163.22 37.22 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.746 1.618 . . . . 75.239999999999995 107.677 169.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 47.7 mtm -138.68 151.12 46.91 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.091 0.956 . . . . 73.450000000000003 108.808 170.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -159.0 155.09 26.88 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.949 0.9 . . . . 63.030000000000001 109.752 -176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -83.23 167.25 17.87 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 109.657 -0.497 . . . . 73.140000000000001 109.657 173.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.08 159.87 42.69 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.01 -1.107 . . . . 61.43 108.01 169.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HA ' ' HE2' ' A' ' 54' ' ' LYS . 10.7 mmpt? -125.27 163.31 22.8 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.675 0.671 . . . . 75.140000000000001 109.826 162.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.6 mm -120.77 82.34 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 125.464 1.505 . . . . 51.240000000000002 106.956 174.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -117.45 24.11 11.33 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.795 1.238 . . . . 74.230000000000004 110.097 -172.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.71 14.56 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.434 1.894 . . . . 62.439999999999998 112.842 -164.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.78 10.02 53.95 Favored Glycine 0 CA--C 1.534 1.257 0 O-C-N 120.483 -1.385 . . . . 72.120000000000005 112.965 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.69 169.05 18.44 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 127.707 2.403 . . . . 74.349999999999994 106.739 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.8 mt -81.27 150.63 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 106.972 -1.492 . . . . 63.229999999999997 106.972 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -132.1 111.63 11.63 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 126.412 1.885 . . . . 75.239999999999995 108.501 172.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.0 mm -85.43 148.89 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 107.519 -1.289 . . . . 74.209999999999994 107.519 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -158.08 -5.51 0.09 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 116.132 1.901 . . . . 74.409999999999997 116.132 173.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -156.36 107.48 2.44 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 106.087 -1.82 . . . . 75.140000000000001 106.087 -164.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.9 ' CG1' ' H ' ' A' ' 70' ' ' LYS . 4.0 p -137.62 150.67 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 125.149 1.379 . . . . 75.120000000000005 110.741 -175.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.06 161.75 61.85 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.286 1.035 . . . . 75.519999999999996 108.388 167.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.48 -24.61 9.98 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 N-CA-C 114.493 0.92 . . . . 72.349999999999994 114.493 1.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -121.27 111.8 17.82 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.698 -0.852 . . . . 73.549999999999997 108.698 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.761 ' HA ' HG13 ' A' ' 65' ' ' VAL . 42.4 mt-10 -60.57 123.34 17.1 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 128.199 2.599 . . . . 63.43 109.057 -174.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.9 ' H ' ' CG1' ' A' ' 65' ' ' VAL . 3.6 mtpp -103.35 152.25 21.8 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.405 -0.961 . . . . 63.140000000000001 108.405 174.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.0 t -56.72 147.56 51.52 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 109.064 -0.717 . . . . 71.129999999999995 109.064 176.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -61.8 158.92 35.41 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.855 2.37 . . . . 62.140000000000001 112.272 170.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -172.44 168.58 5.41 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.791 2.436 . . . . 72.349999999999994 107.648 170.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -95.86 154.42 17.24 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.587 -0.894 . . . . 63.049999999999997 108.587 171.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.8 mt -131.93 134.36 45.57 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.956 1.302 . . . . 74.209999999999994 108.987 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -96.07 125.22 40.46 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 125.869 1.667 . . . . 64.439999999999998 108.716 -169.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.7 p -158.3 165.42 34.83 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.685 1.194 . . . . 73.140000000000001 109.723 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.19 160.27 29.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 124.376 1.071 . . . . 74.439999999999998 111.866 170.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.6 tt -144.99 151.98 15.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 124.996 1.318 . . . . 72.310000000000002 107.71 177.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.9 t -147.75 19.58 1.15 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.663 0.986 . . . . 74.420000000000002 113.663 161.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.11 -102.46 0.26 Allowed Glycine 0 C--N 1.334 0.423 0 N-CA-C 108.634 -1.786 . . . . 73.219999999999999 108.634 173.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.1 p -87.61 -12.94 44.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.332 0.566 . . . . 72.209999999999994 112.298 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.2 m -89.26 126.69 35.61 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.137 -1.431 . . . . 62.240000000000002 107.137 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.7 tp -113.42 132.8 55.5 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.649 1.579 . . . . 75.349999999999994 108.342 160.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.5 93.76 4.0 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.938 2.095 . . . . 65.430000000000007 108.005 177.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.95 138.55 19.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.274 -1.38 . . . . 61.130000000000003 107.274 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -101.96 -31.49 10.65 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.737 -0.649 . . . . 74.239999999999995 112.289 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -145.9 171.24 15.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.405 1.002 . . . . 75.340000000000003 110.84 -175.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.77 174.02 38.07 Favored Glycine 0 C--N 1.334 0.44 0 N-CA-C 108.924 -1.67 . . . . 52.240000000000002 108.924 -174.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 67.0 m -61.0 -22.02 64.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.295 -1.12 . . . . 72.049999999999997 112.011 173.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -84.11 -5.56 59.26 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 113.634 0.976 . . . . 74.439999999999998 113.634 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -46.52 108.81 0.15 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 127.22 2.208 . . . . 75.420000000000002 110.616 -170.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.03 -172.75 44.94 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 122.284 0.935 . . . . 52.140000000000001 113.277 -159.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.1 p -137.61 104.98 5.48 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.614 1.966 . . . . 64.329999999999998 107.287 -156.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -124.36 167.3 14.56 Favored 'General case' 0 C--O 1.239 0.545 0 O-C-N 120.929 -1.107 . . . . 75.120000000000005 112.368 -165.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -124.02 127.38 47.79 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 129.311 3.045 . . . . 64.310000000000002 107.894 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -57.57 135.13 56.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.122 1.369 . . . . 55.350000000000001 109.005 171.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -143.81 38.27 1.33 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.248 1.203 . . . . 75.319999999999993 114.248 176.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.582 0 N-CA-C 108.823 -0.806 . . . . 62.109999999999999 108.823 163.472 . . . . . . . . 1 1 . 1 stop_ save_